data_1pls_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pls _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' HD3' ' CB ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' CG2' HD13 ' A' ' 28' ' ' LEU . 50.6 mt -73.59 -58.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.537 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.35 107.46 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' CB ' HG11 ' A' ' 27' ' ' VAL . 1.8 pt-20 -111.97 143.92 42.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.632 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.19 -151.06 6.26 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 6.3 p90 -145.26 96.27 2.81 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.385 -1.068 . . . . 0.0 110.086 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.649 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -119.17 163.5 16.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG23 ' CE3' ' A' ' 21' ' ' TRP . 1.4 p -86.17 130.69 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 81' ' ' PHE . 1.1 tttt -122.43 135.0 54.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.388 -0.82 . . . . 0.0 109.717 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -101.13 99.57 10.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 108.864 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 166.69 90.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 2.5 p 161.85 -41.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.35 -1.088 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.524 ' CG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 m -100.92 -144.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 19' ' ' ASN . 19.4 m-85 -94.27 72.95 3.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.772 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.492 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 2.8 m-20 44.16 88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.007 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.524 ' OG1' ' CG2' ' A' ' 17' ' ' VAL . 76.1 p -146.88 -162.52 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CE3' HG23 ' A' ' 12' ' ' VAL . 3.2 m95 -151.4 102.82 2.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.383 -0.823 . . . . 0.0 109.354 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.514 ' N ' HG21 ' A' ' 12' ' ' VAL . 24.1 mmtt -137.85 142.02 34.8 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.7 Cg_exo -52.63 160.23 4.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.92 1.746 . . . . 0.0 109.759 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.746 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -167.43 166.65 14.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.951 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.728 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.1 t-105 -92.78 141.07 28.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.556 HG23 ' CH2' ' A' ' 92' ' ' TRP . 1.3 p -149.9 133.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.764 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 8' ' ' GLU . 8.0 m -124.98 111.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.06 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.57 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -82.4 119.86 24.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -0.976 . . . . 0.0 108.761 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -106.04 166.75 10.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.811 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HB3' HD13 ' A' ' 6' ' ' ILE . 3.9 pt-20 -71.93 -6.63 43.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.865 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.91 -1.73 11.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' N ' HD12 ' A' ' 50' ' ' LEU . . . 155.35 146.64 4.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -97.12 105.15 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -1.087 . . . . 0.0 109.956 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 5.4 pt-20 -102.38 128.2 49.06 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.746 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.0 p90 -124.7 147.29 48.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 110.903 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.13 -145.41 0.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.7 -42.47 5.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.947 -1.096 . . . . 0.0 108.986 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -115.63 -177.79 3.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 108.821 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 4.2 tppt? -46.68 -34.69 5.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -157.12 73.47 0.75 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.515 -0.741 . . . . 0.0 109.469 178.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 31.5 t70 -52.61 -17.36 1.24 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 5.8 m120 91.16 -18.32 0.15 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -135.45 116.44 11.93 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 47.1 Cg_endo -69.2 144.18 56.12 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.735 1.623 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 8.1 mmtt -90.07 -25.6 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 108.926 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.54 150.5 10.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.4 mtt -118.23 166.97 11.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.435 HG21 ' HD2' ' A' ' 49' ' ' PRO . 39.9 mt -128.99 131.24 23.6 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HD2' HG21 ' A' ' 48' ' ' ILE . 45.9 Cg_endo -69.77 135.46 30.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.353 1.369 . . . . 0.0 109.797 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HA ' ' CG1' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -85.49 37.98 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 109.924 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HB2' HG23 ' A' ' 103' ' ' ILE . 12.7 tttm -172.71 99.36 0.14 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.032 -1.042 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 123.87 11.28 4.94 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.311 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 1.2 t -97.15 156.87 16.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.934 -1.333 . . . . 0.0 109.777 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -116.9 173.13 6.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD1' HG23 ' A' ' 93' ' ' VAL . 1.7 tt -134.64 135.64 42.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.021 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 4.3 m -121.32 108.23 13.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.533 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 13.4 p -142.22 116.14 6.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 57' ' ' SER . 33.7 Cg_exo -62.15 -172.85 2.32 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.936 -1.693 . . . . 0.0 110.682 -1.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.7 p -98.14 -146.78 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.33 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.542 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -102.72 -149.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.3 17.81 3.52 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.337 -0.852 . . . . 0.0 108.887 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CZ ' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -89.33 77.67 7.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.308 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 102.27 -73.42 0.32 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 42.79 29.86 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -1.093 . . . . 0.0 109.477 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -93.78 -99.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 45.3 m-85 -129.55 87.2 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 0.0 109.531 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' CH2' ' A' ' 21' ' ' TRP . 1.3 p -120.15 117.32 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.618 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 4.4 p90 -106.97 165.12 11.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.331 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 1.9 ttpp -123.44 120.02 31.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.813 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.58 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.5 mt -106.8 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.551 ' N ' HG23 ' A' ' 54' ' ' THR . 87.1 m -134.17 94.48 3.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.09 150.29 25.45 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 108.976 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -45.94 -21.96 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.242 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -86.62 29.22 0.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 109.801 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.81 31.56 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.99 . . . . 0.0 109.67 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.492 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -97.49 97.45 9.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.42 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 77.4 m-20 -61.55 152.69 29.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.492 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 32.7 m-70 -142.32 88.92 2.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.872 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -91.13 101.63 14.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 108.95 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.42 146.83 51.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.528 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -116.39 143.71 45.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.331 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . . . -89.64 -146.69 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.5 ' C ' ' CD1' ' A' ' 85' ' ' PHE . . . -107.48 -15.87 14.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 1.7 p90 -170.59 172.44 5.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -53.84 -50.25 66.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 109.969 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 1.2 tm-20 -53.28 -39.23 63.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.271 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.574 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 20.8 tt0 -83.86 -16.13 45.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.071 -1.018 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 1.6 ttt180 -76.99 -46.51 23.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.992 . . . . 0.0 109.638 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 8.4 t0 -79.97 -27.2 39.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 109.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -73.81 -34.78 64.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.725 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.587 ' CE2' HD22 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -80.22 -48.44 13.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.825 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 HG23 ' CD1' ' A' ' 55' ' ' LEU . 3.6 p -68.71 -27.12 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 33.5 ptt85 -79.76 -30.72 40.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.052 . . . . 0.0 109.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -75.21 -39.39 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.368 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 33' ' ' ILE . 28.2 mt -72.5 -42.4 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.57 -27.09 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 109.252 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 5.3 tppt? -72.27 -46.13 57.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . . . -64.13 -37.15 86.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.875 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.538 ' CG1' ' HA ' ' A' ' 50' ' ' LEU . 7.6 mt -69.58 -34.15 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.403 -0.811 . . . . 0.0 108.928 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -85.26 -8.28 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.399 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -30.97 14.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 108.989 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.476 HG13 HD21 ' A' ' 50' ' ' LEU . 1.1 mm -69.44 -28.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.2 mt-10 -64.86 -10.51 29.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.583 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.21 10.93 5.59 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 106' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.066 . . . . 0.0 109.385 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.527 ' CG ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 30' ' ' GLU . 2.5 mp -66.81 -71.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.536 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.1 tpm_? -107.35 125.96 51.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 110.094 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 6.7 pm0 -145.88 122.91 11.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 0.0 109.178 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.596 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.62 -147.57 4.94 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 16.7 p90 -139.63 99.88 3.82 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.356 -1.085 . . . . 0.0 109.873 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.607 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -105.86 -143.03 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.544 HG12 ' CE3' ' A' ' 21' ' ' TRP . 9.9 p -149.71 129.12 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.013 . . . . 0.0 109.65 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.765 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.3 tttt -116.38 169.16 9.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' HB3' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -125.71 148.13 49.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 14' ' ' LYS . . . 115.58 107.72 2.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p 177.03 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 18' ' ' PHE . 17.9 m -143.06 -39.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 4.7 m-85 -168.29 61.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 48.69 43.55 20.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.548 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 12.7 p -89.99 172.35 8.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.544 ' CE3' HG12 ' A' ' 12' ' ' VAL . 5.1 m95 -126.21 120.08 29.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 6.2 mmtp -138.88 129.64 15.01 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 32.5 Cg_exo -59.14 119.06 6.08 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.916 1.744 . . . . 0.0 110.177 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.765 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 7.7 ptm -124.48 168.5 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.909 -1.119 . . . . 0.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.596 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 72.5 t-105 -90.45 145.53 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.578 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -151.49 139.67 14.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.403 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 6.1 m -130.25 98.31 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' LEU . 1.9 pp -76.04 123.78 26.34 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.939 -1.1 . . . . 0.0 108.803 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 HD23 ' CG ' ' A' ' 5' ' ' ARG . 2.4 mp -107.26 166.08 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.461 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 31.5 tt0 -73.69 -9.2 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.28 4.27 15.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.915 . . . . 0.0 109.472 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 149.67 148.61 4.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 50' ' ' LEU . 3.5 mp -99.02 127.09 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 110.084 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 7.9 pt-20 -127.87 115.02 17.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.5 p90 -117.54 151.54 36.93 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -132.77 -153.32 0.54 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.141 -0.975 . . . . 0.0 108.38 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 40.8 mttt -124.62 -173.27 2.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 5.9 tppt? -45.5 -25.65 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.976 -1.077 . . . . 0.0 109.255 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -148.53 -50.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.54 10.86 3.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' ASP . 1.4 m-20 42.61 23.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -169.84 108.19 0.46 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.051 -1.031 . . . . 0.0 109.706 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.594 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.1 Cg_endo -71.49 136.57 28.82 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.8 1.666 . . . . 0.0 110.549 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.79 -17.95 27.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.02 140.36 4.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.1 mtm -133.16 124.8 28.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.29 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.429 HG22 ' CG2' ' A' ' 73' ' ' THR . 6.5 mt -89.73 134.84 31.43 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 73' ' ' THR . 56.7 Cg_endo -72.13 137.76 29.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.689 1.592 . . . . 0.0 110.078 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 30' ' ' GLU . 1.0 OUTLIER -85.82 38.7 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.542 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 -70.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.99 72.95 0.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 p -80.12 -170.1 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.363 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.33 111.53 6.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.516 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.4 tm? -88.59 116.42 26.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.017 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.8 m -102.09 130.56 48.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.421 -0.799 . . . . 0.0 109.578 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 t -150.05 120.05 3.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.41 -163.02 2.66 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.595 -1.835 . . . . 0.0 110.396 0.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.15 -158.84 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -71.33 -149.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -84.07 14.31 4.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.418 -0.801 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -10.1 49.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.884 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -124.75 -103.65 1.49 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 42.67 59.44 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.281 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 6.2 ttt-85 179.73 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.8 mtp -141.03 -155.95 0.63 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.471 -0.768 . . . . 0.0 109.766 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.546 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -92.99 65.37 4.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.91 . . . . 0.0 109.221 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.488 HG13 ' HA2' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -116.25 128.16 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.622 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 7.7 p90 -120.36 173.66 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 109.61 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.627 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 ttpt -129.99 108.34 10.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 0.0 109.396 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.59 HG13 ' CE1' ' A' ' 69' ' ' PHE . 1.3 mt -89.2 165.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 109.377 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.8 m -144.93 91.08 2.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 77' ' ' GLN . 2.7 p -45.7 162.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.364 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -13.26 15.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.678 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.99 15.84 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.83 32.28 4.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.55 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -89.95 -175.9 4.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.235 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 77' ' ' GLN . 2.6 m-20 -141.8 146.6 36.1 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.414 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.488 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 80.6 m-70 -145.79 92.63 2.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' CD ' ' A' ' 70' ' ' LYS . 36.1 m-85 -90.48 110.29 21.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.306 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.92 146.11 31.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.698 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 2.4 tt0 -113.06 139.54 48.6 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.471 -0.768 . . . . 0.0 108.948 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.93 -155.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.499 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.73 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 175.62 5.44 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 25.4 tp -56.41 -22.93 34.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 109.109 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -66.07 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.57 -16.88 58.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -0.871 . . . . 0.0 109.153 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.538 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -71.26 -64.04 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.533 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 10.4 t0 -62.01 -12.81 20.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.115 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.74 -30.93 28.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 108.666 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.578 ' CH2' HG23 ' A' ' 26' ' ' VAL . 5.8 m95 -84.02 -28.72 27.47 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 4.1 m -75.28 -36.76 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.543 -0.723 . . . . 0.0 109.535 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 8.5 ptp180 -83.83 -24.72 30.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.5 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.6 t0 -77.14 -45.7 25.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 28' ' ' LEU . 32.1 mt -76.51 -42.32 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 28.1 t-20 -69.44 -31.46 69.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.5 tmtp? -75.37 -50.75 14.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.31 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.23 70.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.37 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 96' ' ' ILE . 5.2 mt -70.23 -39.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.239 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -71.21 -11.64 61.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.322 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.25 -33.91 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 109.244 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.462 HG13 ' HB3' ' A' ' 50' ' ' LEU . 8.5 mm -67.82 -16.9 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.57 -2.99 25.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.517 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.97 17.51 0.93 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.454 ' N ' HD21 ' A' ' 106' ' ' LEU . 2.0 mm? . . . . . 0 C--N 1.301 -1.526 0 O-C-N 121.48 -1.012 . . . . 0.0 109.462 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 28' ' ' LEU . 28.2 mm -73.01 -59.79 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.928 . . . . 0.0 109.739 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.59 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.72 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.63 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -145.33 129.32 17.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.46 -146.95 4.76 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 p90 -135.89 99.84 4.27 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.615 ' HG ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -115.11 153.79 30.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 5.7 p -94.1 140.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.894 -1.129 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.747 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 11.3 mttp -123.07 169.7 10.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.92 113.58 21.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.37 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 153.99 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.14 -46.49 70.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.465 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.2 p -50.46 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 12.7 m-85 61.11 159.62 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -76.71 86.04 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.6 p -128.77 171.53 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CH2' HG22 ' A' ' 68' ' ' VAL . 23.6 m95 -133.01 101.62 5.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.456 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 2.5 mttm -107.54 134.19 20.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.35 147.77 44.93 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.644 1.563 . . . . 0.0 109.775 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.747 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 23.1 ptm -154.11 162.44 41.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.991 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.664 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.9 t-105 -94.79 147.91 22.84 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.584 HG23 ' CZ3' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -151.52 138.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.491 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.541 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 9.7 m -129.46 94.55 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.632 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -68.41 120.15 14.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.808 -1.182 . . . . 0.0 108.882 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.0 mp -102.62 164.83 11.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.56 -0.713 . . . . 0.0 109.372 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' HD21 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -71.63 -14.72 62.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -0.827 . . . . 0.0 109.818 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -109.3 4.62 22.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.657 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 149.62 150.32 5.22 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -92.5 121.11 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 109.938 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 10.3 mt-10 -116.75 107.94 15.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.625 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 12.9 p90 -117.68 145.64 44.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.953 -1.092 . . . . 0.0 110.686 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.646 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.44 -154.72 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 2.8 mtmt -91.95 -43.94 9.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 108.46 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -102.09 -170.9 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 108.743 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.664 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 mtpt -64.24 -10.04 21.06 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -150.99 -52.13 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.508 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 4.2 t70 59.95 11.37 2.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER 41.89 22.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -176.76 99.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.789 -1.194 . . . . 0.0 110.747 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.1 Cg_exo -52.79 135.1 56.52 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.989 1.793 . . . . 0.0 110.525 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.55 -18.74 26.04 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.65 126.16 1.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 51.7 mtm -122.05 123.47 41.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.594 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.493 HG21 ' CG2' ' A' ' 73' ' ' THR . 26.0 mt -89.82 132.81 35.43 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.005 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' HG21 ' A' ' 48' ' ' ILE . 54.5 Cg_endo -72.11 129.7 15.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.681 1.587 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD2' ' CG1' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -84.67 43.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HB2' HG22 ' A' ' 74' ' ' THR . 8.5 mmtm -95.73 -71.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.52 61.74 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.418 ' CB ' ' HA ' ' A' ' 73' ' ' THR . 2.4 m -85.43 171.39 11.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -1.171 . . . . 0.0 109.325 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.553 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.71 172.06 8.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -0.81 . . . . 0.0 109.455 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.535 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.2 tm? -133.96 136.41 44.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 108.74 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 32.9 m -126.29 131.5 51.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.076 -1.015 . . . . 0.0 110.118 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.5 p -150.37 119.89 3.72 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.449 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' O ' HG21 ' A' ' 56' ' ' THR . 52.9 Cg_endo -71.95 -161.49 2.08 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.56 -1.85 . . . . 0.0 110.179 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -146.68 130.12 16.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 57.04 163.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -103.49 -12.03 17.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.915 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.564 ' CD1' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -89.14 4.55 48.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.796 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -120.71 -19.48 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -49.65 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -144.1 -77.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.545 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -99.9 -39.86 7.96 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.5 0.667 . . . . 0.0 109.563 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CD1' ' HG3' ' A' ' 89' ' ' ARG . 0.4 OUTLIER 158.57 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.564 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -119.59 128.0 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.7 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 2.3 p90 -109.02 164.54 12.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.051 -1.031 . . . . 0.0 109.673 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -127.0 108.41 10.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 11.1 mt -89.33 160.29 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 99.8 m -131.59 85.43 2.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.493 ' CG2' HG21 ' A' ' 48' ' ' ILE . 6.9 p -44.13 158.14 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -58.71 -15.34 11.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.357 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -90.43 21.8 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 61.01 35.79 18.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.507 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -103.1 109.18 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.9 m-20 -76.08 146.64 39.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.507 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 39.4 m-70 -140.46 116.57 10.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.66 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CB ' ' CH2' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -98.54 128.49 44.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.7 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.94 160.35 40.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 108.783 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -142.14 132.55 25.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.75 -84.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' SD ' ' A' ' 66' ' ' MET . . . 179.16 -67.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -114.26 169.72 8.82 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.635 -0.665 . . . . 0.0 109.807 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -62.3 -19.74 63.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.591 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -71.28 -66.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.129 -0.982 . . . . 0.0 109.415 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -16.54 64.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HG3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -74.02 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.551 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 20.2 t70 -67.96 -14.72 63.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.03 -33.73 29.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 7.8 m95 -82.55 -25.87 32.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.9 m -79.96 -39.3 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.0 ptm180 -77.79 -23.93 49.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD1' ' CD1' ' A' ' 28' ' ' LEU . 1.5 t70 -81.61 -49.33 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.06 . . . . 0.0 109.506 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.496 ' CG1' HD21 ' A' ' 28' ' ' LEU . 32.5 mt -72.92 -31.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 6.1 t-20 -81.17 -36.02 30.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 3.2 ttpt -71.6 -37.81 70.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.456 ' O ' HD22 ' A' ' 50' ' ' LEU . . . -68.22 -43.38 78.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.92 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 60.0 mt -68.37 -30.47 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.163 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 5.4 mmtt -85.03 -10.9 56.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.11 -21.44 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.045 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.532 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 2.0 mm -75.51 -28.31 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.009 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.27 -5.54 33.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.17 11.69 5.85 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 106' ' ' LEU . 1.7 mt . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.486 -1.008 . . . . 0.0 109.25 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.407 ' HD3' HG13 ' A' ' 27' ' ' VAL . 1.3 mpt_? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.0 mm -56.19 -53.65 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.546 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 1.7 tpm_? -141.88 108.68 5.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.207 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.464 ' HB3' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.99 131.23 55.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.987 -1.071 . . . . 0.0 109.189 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.4 -149.4 5.61 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 20.3 p90 -138.12 95.72 3.07 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.637 ' CD2' ' CZ2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -114.36 169.77 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -96.4 159.81 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.834 -1.166 . . . . 0.0 109.6 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.704 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -148.75 130.17 14.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HG3' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -50.73 150.9 2.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.414 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.06 -139.48 8.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.64 47.84 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -1.11 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 10.9 p -155.1 109.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' ASN . 25.1 m-85 58.52 22.0 9.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' PHE . 4.0 m-20 46.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.2 p -125.4 -179.29 4.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.595 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.573 ' CH2' HG23 ' A' ' 68' ' ' VAL . 39.0 m95 -144.97 88.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.204 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.3 mttm -107.8 139.71 20.88 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.746 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.09 167.81 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.959 1.773 . . . . 0.0 110.598 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.704 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 25.6 ptm -174.8 158.43 2.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.89 . . . . 0.0 109.479 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.602 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.0 t-105 -89.79 147.17 23.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.413 -0.805 . . . . 0.0 109.03 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.555 ' HA ' ' CB ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.61 133.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.666 -178.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 34' ' ' GLU . 8.2 m -125.59 103.26 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -86.89 108.97 19.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.75 164.26 14.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.529 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -73.64 -17.65 61.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.591 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.67 9.4 43.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' N ' HD12 ' A' ' 50' ' ' LEU . . . 152.23 -176.59 30.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' A' ' 48' ' ' ILE . 2.8 mp -138.16 125.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.256 . . . . 0.0 109.528 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' HG21 ' A' ' 27' ' ' VAL . 4.3 pt-20 -132.23 116.77 17.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 108.929 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.633 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -119.49 147.54 44.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.13 -0.981 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.77 -157.2 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -88.39 -55.66 3.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.48 -178.82 5.02 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -49.28 -21.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.898 -1.126 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -146.63 -47.36 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.679 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 43' ' ' SER . 5.2 t0 62.29 9.9 3.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.8 t30 45.84 21.04 0.08 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.942 -1.099 . . . . 0.0 109.606 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.8 t -173.29 115.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.3 Cg_endo -72.35 132.27 19.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.922 1.748 . . . . 0.0 110.593 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -89.62 -19.65 24.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.58 120.66 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.0 mtm -119.28 125.58 49.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.118 -1.225 . . . . 0.0 109.84 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.539 HD11 ' CG2' ' A' ' 33' ' ' ILE . 2.7 mt -90.78 121.53 68.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.995 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.76 140.14 38.29 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.719 1.613 . . . . 0.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.526 ' HG ' ' CG1' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -84.9 37.82 0.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.864 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -70.09 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.132 -0.98 . . . . 0.0 109.375 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 74' ' ' THR . . . -136.33 24.71 3.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -40.09 141.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.441 -1.035 . . . . 0.0 110.383 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.552 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.47 167.26 10.6 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD21 ' N ' ' A' ' 56' ' ' THR . 2.2 tm? -137.66 117.38 13.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.985 -1.072 . . . . 0.0 109.449 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.502 ' N ' HD21 ' A' ' 55' ' ' LEU . 23.2 m -107.96 135.54 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.35 120.94 3.86 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.878 . . . . 0.0 109.239 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.91 -161.14 2.11 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.651 -1.812 . . . . 0.0 110.346 -0.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 9.2 p -102.93 -148.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.899 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.61 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 11.2 tt0 -71.6 -142.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -68.07 -2.23 7.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 24.9 m-85 -88.99 -24.71 22.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 108.948 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -74.39 -49.14 12.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -19.83 6.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -1.063 . . . . 0.0 109.189 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -75.48 0.34 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -155.62 0.58 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 109.553 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.44 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 25.0 m-85 -97.52 86.66 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 ' CH2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -126.64 136.3 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.539 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.69 175.62 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -142.67 100.74 3.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.898 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 69' ' ' PHE . 12.6 mt -90.12 160.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 108.995 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 53.2 m -140.71 105.36 4.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.349 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.467 ' C ' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -48.67 107.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.298 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER 39.55 28.94 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' THR . 5.5 tttt 82.73 46.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.979 -1.076 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -133.44 -86.71 0.43 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.079 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -90.9 136.84 32.81 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.645 -0.659 . . . . 0.0 109.669 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -89.29 168.26 12.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -148.04 98.41 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.5 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -96.04 119.6 34.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -137.01 167.99 20.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.05 -1.031 . . . . 0.0 109.061 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.53 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 34.7 tt0 -135.12 138.03 43.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.704 -1.248 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -90.14 -89.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.44 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.25 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.601 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.07 171.31 14.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD1' ' NH2' ' A' ' 89' ' ' ARG . 24.1 tp -53.65 -42.81 68.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.199 -0.938 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.07 -59.27 4.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 9.0 tt0 -65.23 -15.12 62.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.277 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -71.99 -65.22 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.539 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -69.56 -11.19 60.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.311 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 88' ' ' GLU . . . -80.52 -41.06 24.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 3.3 m95 -79.19 -28.56 42.64 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.335 -0.853 . . . . 0.0 109.165 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.1 m -71.24 -39.05 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 109.095 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -77.43 -23.03 50.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -76.74 -52.05 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.691 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.564 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 47.8 mt -73.03 -31.92 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 18.7 t-20 -78.1 -28.65 48.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.331 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.9 -42.29 49.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.11 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 6' ' ' ILE . . . -64.2 -36.35 83.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.871 . . . . 0.0 108.822 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 96' ' ' ILE . 4.9 mt -76.04 -31.47 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.127 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -83.08 -12.35 57.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.1 m -93.49 -28.39 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 108.931 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 2.6 tp -64.97 -33.18 61.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.418 -0.801 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG2' HG21 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -70.92 -12.55 61.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.25 6.62 25.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.435 -1.038 . . . . 0.0 109.117 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.424 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.338 0.589 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 30' ' ' GLU . 34.3 mt -56.22 -67.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.593 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -116.89 148.86 40.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -157.6 134.33 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.592 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.67 -149.0 5.45 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 p90 -138.48 91.38 2.54 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.379 -1.071 . . . . 0.0 110.099 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.66 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -120.11 165.3 14.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.745 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.4 p -85.58 131.47 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.198 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' CG ' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -131.14 152.11 50.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -70.4 125.94 28.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.265 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 178.82 120.46 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 163.74 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.377 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG12 ' CD2' ' A' ' 18' ' ' PHE . 1.5 p -140.37 -47.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 17' ' ' VAL . 4.0 p90 -140.01 -172.97 3.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.418 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 18.3 p-10 -47.49 92.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.567 HG21 ' CD1' ' A' ' 18' ' ' PHE . 59.2 p -130.07 155.57 45.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.625 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.0 m0 -126.67 119.75 27.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.452 -0.78 . . . . 0.0 109.389 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.06 131.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.815 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.6 Cg_exo -53.36 150.75 25.25 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.751 1.634 . . . . 0.0 109.751 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 11.6 ptm -168.98 165.83 11.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.066 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.594 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.8 t-105 -89.94 145.89 24.79 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -151.04 136.07 10.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.118 -178.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 4.0 m -125.72 103.63 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.593 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -77.59 112.25 14.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 27' ' ' VAL . 1.8 mp -89.54 159.75 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.447 -0.783 . . . . 0.0 109.496 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 7.7 pt-20 -70.75 -15.35 62.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' C ' ' HB2' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -112.56 6.8 18.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 109.687 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' HA2' HD21 ' A' ' 50' ' ' LEU . . . 167.45 -165.81 38.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.519 ' CG2' HD13 ' A' ' 48' ' ' ILE . 1.9 mp -144.85 121.99 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -1.097 . . . . 0.0 109.186 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 8.9 mt-10 -127.56 115.02 18.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.344 -0.848 . . . . 0.0 108.92 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.629 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 8.3 p90 -121.45 145.77 47.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 109.982 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -130.62 -167.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.119 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -80.22 -40.87 26.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -113.06 -176.14 2.83 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.76 -24.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.84 -1.162 . . . . 0.0 109.184 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.6 -49.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 43' ' ' SER . 4.8 t70 61.38 10.97 3.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.373 -0.829 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 27.1 m120 43.96 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.971 -1.08 . . . . 0.0 109.546 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.2 t -170.89 103.13 0.41 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 109.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.6 Cg_endo -72.25 145.14 43.03 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.709 1.606 . . . . 0.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.96 -26.15 20.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.81 147.52 11.35 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.472 ' HE2' ' HG3' ' A' ' 44' ' ' PRO . 1.9 mtt -134.1 125.73 28.59 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.492 -1.005 . . . . 0.0 109.159 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 33' ' ' ILE . 3.0 mt -89.74 137.06 28.71 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.209 -0.932 . . . . 0.0 109.007 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 51.7 Cg_endo -70.81 147.61 56.5 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.707 1.605 . . . . 0.0 110.284 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -88.21 24.24 1.92 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' A' ' 103' ' ' ILE . 8.5 tttm -157.02 114.17 3.09 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.106 -0.996 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 96.58 32.84 6.41 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.476 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.441 ' OG ' HG12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -109.48 172.12 7.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.268 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.92 110.98 6.29 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.056 -1.027 . . . . 0.0 109.95 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.543 HD22 ' CG ' ' A' ' 69' ' ' PHE . 3.4 tm? -89.02 130.66 35.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.155 -0.965 . . . . 0.0 109.015 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.508 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.6 m -113.43 100.54 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -133.51 129.19 20.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.08 -1.012 . . . . 0.0 109.747 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.95 179.71 29.61 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.696 -1.793 . . . . 0.0 110.128 -0.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 41.6 t -105.42 170.84 7.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.566 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 4.6 mm100 -147.76 143.8 27.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.896 -1.127 . . . . 0.0 110.282 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 6.5 t70 84.17 -54.02 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.15 0.5 . . . . 0.0 109.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -94.64 -55.25 3.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 108.437 179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -91.81 34.76 4.23 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -65.99 -9.31 29.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.611 -0.934 . . . . 0.0 109.542 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' MET . 5.8 mtm180 -76.98 -3.09 37.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.509 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 76.96 171.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.842 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 54.05 20.59 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.786 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG12 ' CA ' ' A' ' 63' ' ' GLY . 3.3 p -140.41 134.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.89 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 8.2 p90 -117.22 -179.77 3.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 2.8 ttpt -133.71 111.29 10.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.553 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.9 mt -89.29 165.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.066 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.9 m -144.93 90.14 2.03 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.431 HG21 HG21 ' A' ' 48' ' ' ILE . 4.3 p -50.8 161.16 0.38 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -54.63 -17.19 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.815 . . . . 0.0 109.819 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -88.43 24.1 2.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.13 30.51 16.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' HB3' ' NE2' ' A' ' 79' ' ' HIS . 2.1 tm0? -95.96 100.74 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 56.3 m-20 -69.91 152.78 44.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 97.7 m-70 -150.1 101.39 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.135 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.619 ' CE2' ' CD ' ' A' ' 70' ' ' LYS . 8.4 m-85 -90.98 124.95 35.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.647 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.92 140.59 38.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.128 -0.983 . . . . 0.0 109.404 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.7 tt0 -113.15 136.82 52.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . . . -88.88 -92.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.425 -0.797 . . . . 0.0 109.436 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.579 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -145.18 -39.89 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 109.94 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -159.32 175.81 12.92 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.51 -0.743 . . . . 0.0 109.734 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -51.6 -50.09 60.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.57 -0.706 . . . . 0.0 109.56 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.6 tt0 -49.64 -67.5 0.26 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 110.1 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.76 -13.82 17.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.521 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.76 -62.25 1.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.694 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 6.8 t70 -64.33 -14.86 58.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.208 -0.932 . . . . 0.0 109.574 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -79.54 -46.83 16.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.574 ' CZ3' HD21 ' A' ' 28' ' ' LEU . 2.4 m95 -71.31 -27.92 63.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.436 -0.79 . . . . 0.0 109.223 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.7 m -78.64 -38.43 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.378 -0.826 . . . . 0.0 109.827 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -74.42 -19.37 60.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.179 -0.951 . . . . 0.0 109.996 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -86.33 -54.26 4.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.053 -1.029 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 28' ' ' LEU . 11.6 mt -66.98 -33.36 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 0.0 108.393 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 25.6 t-20 -76.17 -44.62 37.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -63.76 -27.98 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -51.46 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.181 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.549 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -57.44 -51.52 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.01 -17.35 62.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 109.345 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 44.7 t -81.85 -30.23 32.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.055 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.43 -38.31 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -12.43 59.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.264 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.68 7.89 12.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 108.953 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.421 ' CG ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.453 HG23 ' OD2' ' A' ' 95' ' ' ASP . 46.1 mm -51.48 -74.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.358 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.529 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.85 142.45 46.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.201 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.6 pm0 -149.74 132.14 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.024 -1.048 . . . . 0.0 110.162 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.69 -144.03 3.83 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.583 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 2.7 p90 -144.67 104.56 4.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.977 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.647 ' CD2' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.05 179.07 4.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 108.753 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG12 ' CB ' ' A' ' 82' ' ' GLN . 1.5 p -114.04 125.42 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.759 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -107.46 142.97 36.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 110.014 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -87.15 112.36 21.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.406 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.62 39.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 22' ' ' LYS . 8.5 t -79.54 -50.97 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 0.0 109.392 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.2 -46.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.428 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -136.23 -78.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 8.1 m-20 -137.89 70.39 1.39 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.878 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.525 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 5.3 p -127.2 155.95 42.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.585 ' CH2' ' HB3' ' A' ' 80' ' ' PHE . 47.3 m95 -117.94 98.2 6.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.204 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HD2' ' OG ' ' A' ' 16' ' ' SER . 17.3 mttm -110.87 133.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 0.0 109.711 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.5 Cg_exo -53.35 172.76 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.942 1.761 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 9.2 ptm 176.03 162.45 0.34 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 66.6 t-105 -89.3 151.11 22.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.578 HG21 ' CH2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -150.85 146.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.147 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 11.1 m -145.29 106.61 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.556 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.585 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -78.82 116.39 19.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.465 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 27' ' ' VAL . 2.2 mp -104.33 167.27 9.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.675 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 5.7 pt-20 -73.67 -17.78 61.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.501 ' C ' ' CD1' ' A' ' 50' ' ' LEU . 2.1 p30 -101.35 8.73 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . 140.22 148.31 5.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 HG12 ' CG1' ' A' ' 96' ' ' ILE . 4.3 mp -94.73 109.01 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -1.166 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 7.1 pt-20 -111.12 123.76 50.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 108.856 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.4 p90 -121.26 142.8 49.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -119.5 -151.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.43 -0.794 . . . . 0.0 109.031 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 -39.22 9.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -119.87 -176.04 3.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -43.12 -25.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.024 -1.048 . . . . 0.0 109.567 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -146.57 -53.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' SER . 1.2 t70 62.98 7.67 2.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.453 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.5 m-80 40.6 23.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -164.72 101.49 0.83 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.791 -1.193 . . . . 0.0 110.377 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.5 Cg_exo -51.78 164.07 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.055 1.837 . . . . 0.0 110.702 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 3.1 tppt? -134.52 3.45 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 156.18 134.57 1.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.457 ' HE2' ' CB ' ' A' ' 44' ' ' PRO . 1.3 mtt -135.15 138.16 43.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.648 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' HD2' ' A' ' 49' ' ' PRO . 9.5 mt -104.73 125.82 32.9 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' HG21 ' A' ' 48' ' ' ILE . 53.2 Cg_endo -71.39 130.56 17.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.665 1.577 . . . . 0.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -74.88 -0.34 18.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.168 -0.957 . . . . 0.0 109.609 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HB2' HG23 ' A' ' 74' ' ' THR . 1.1 mmtp -44.0 -62.28 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.53 57.94 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.7 m -81.21 170.21 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 109.169 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.548 HG21 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.89 160.52 25.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 3.0 tm? -134.72 96.14 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.081 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.72 HG23 ' SG ' ' A' ' 59' ' ' CYS . 85.7 m -90.19 109.36 20.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 55' ' ' LEU . 11.1 p -146.41 142.28 17.29 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.15 -176.11 17.55 Favored 'Cis proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.336 -1.943 . . . . 0.0 110.54 -0.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 56' ' ' THR . 4.8 m -150.28 60.27 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.285 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.52 ' CG ' ' HA ' ' A' ' 64' ' ' LYS . 5.5 tt0 -71.12 124.26 24.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.822 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 1.6 m-20 166.49 -43.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -88.97 -68.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 64' ' ' LYS . . . -81.42 -26.94 49.96 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' HA ' ' CG ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 34.41 39.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.452 0.644 . . . . 0.0 110.015 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 ttt-85 -117.99 -137.49 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt -42.51 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.01 . . . . 0.0 109.662 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.61 ' CD1' ' CD ' ' A' ' 89' ' ' ARG . 2.1 m-85 -142.21 111.18 6.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.406 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.577 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -120.66 119.95 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.833 . . . . 0.0 109.653 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.5 p90 -118.14 168.33 10.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 5.9 pttt -127.91 121.42 29.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.507 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.0 mt -96.1 161.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 108.98 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' HG21 ' A' ' 54' ' ' THR . 50.4 m -140.27 99.58 3.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.242 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.444 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -52.89 155.63 2.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.361 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -41.2 -27.56 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.729 -0.607 . . . . 0.0 109.819 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 73' ' ' THR . 2.0 mmmm -77.63 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.62 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 177.6 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -103.17 72.0 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.076 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 5.7 p-10 -43.51 141.72 1.34 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 109.752 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -127.17 137.73 53.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.09 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.585 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 40.8 m-85 -93.46 128.95 39.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.706 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.8 t80 -129.86 139.44 51.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.558 -0.714 . . . . 0.0 109.366 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.54 ' CB ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.27 119.86 13.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.05 -150.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.556 ' CB ' ' CE1' ' A' ' 85' ' ' PHE . . . -120.27 -26.01 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.054 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -156.18 175.55 13.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 0.0 109.871 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.661 ' CD1' ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.3 -60.48 3.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.747 . . . . 0.0 110.249 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.661 ' N ' ' CD1' ' A' ' 86' ' ' LEU . 3.6 tm-20 -46.33 -56.65 5.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.219 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.599 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 33.2 tt0 -58.4 -30.52 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.673 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.61 ' CD ' ' CD1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.926 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.548 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -54.7 -23.26 16.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.06 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.06 -35.75 59.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 109.583 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.593 ' CE2' HD22 ' A' ' 11' ' ' LEU . 13.0 m95 -76.36 -41.23 48.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.323 -0.861 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -75.37 -28.1 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.797 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.1 ptm180 -76.83 -30.02 56.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.996 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.524 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -90.43 -30.65 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 110.039 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.532 HG13 ' CB ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -72.48 -31.22 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.06 . . . . 0.0 108.518 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -85.42 -36.5 20.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -66.82 -47.16 72.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.0 109.096 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.84 -37.16 83.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.494 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 46.6 mt -71.94 -23.9 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.96 -15.04 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 t -95.42 -26.4 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.773 . . . . 0.0 109.337 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 30' ' ' GLU . 6.2 tp -76.58 -21.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 51' ' ' LYS . 1.8 mm-40 -67.03 -11.48 57.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.81 5.22 12.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.416 -1.049 . . . . 0.0 109.16 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.493 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.26 -46.4 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.62 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -128.36 138.43 52.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.66 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.544 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.6 pm0 -156.06 133.89 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.253 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.02 -146.13 4.63 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.83 97.03 4.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -1.015 . . . . 0.0 110.053 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.647 ' CD2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -108.65 172.69 6.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 108.57 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 2.4 p -117.77 125.3 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.879 -1.138 . . . . 0.0 109.402 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.756 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 7.6 mmtp -95.53 159.9 14.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.695 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 15.1 ttpp -85.95 94.45 9.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.67 141.29 3.72 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 17' ' ' VAL . 22.8 t -102.21 108.08 19.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.139 . . . . 0.0 109.534 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 16' ' ' SER . 2.6 p 172.19 -30.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.376 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.43 ' N ' HG11 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -166.72 36.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.323 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.84 68.22 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.371 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.6 p -117.95 169.72 9.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 109.701 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 10.7 m95 -148.09 100.37 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 mttt -118.93 136.35 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.839 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.9 Cg_exo -53.99 176.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.833 1.689 . . . . 0.0 109.975 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 19.5 ptm 176.74 159.96 0.36 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.584 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.7 t-105 -89.54 146.69 24.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.579 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.32 134.28 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.097 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.4 m -128.72 98.66 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.59 -0.693 . . . . 0.0 109.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.588 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 4.0 pp -77.55 123.62 26.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.09 -1.006 . . . . 0.0 109.081 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.0 mp -109.35 165.16 11.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.82 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.523 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 1.9 tm-20 -74.87 -9.28 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 2.5 p30 -112.32 7.92 19.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.925 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 145.06 147.08 4.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 4.0 mp -103.15 120.59 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -1.162 . . . . 0.0 109.861 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 2.6 pt-20 -120.07 121.94 39.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 10.6 p90 -125.55 141.24 52.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.096 -1.003 . . . . 0.0 110.405 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.86 -145.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 24' ' ' MET . 2.6 mmtm -99.16 -39.18 8.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.076 -1.015 . . . . 0.0 109.349 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -119.42 -178.27 3.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.269 -0.895 . . . . 0.0 109.09 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 tppt? -43.21 -30.8 0.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 108.708 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.448 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -165.29 72.48 0.18 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.515 -0.741 . . . . 0.0 109.49 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 1.6 t0 -51.39 -18.85 1.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 8.6 t-20 91.48 -18.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -127.69 106.3 20.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.508 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 42.6 Cg_endo -68.79 134.39 29.97 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.726 1.618 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -25.74 20.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' C ' ' CZ ' ' A' ' 35' ' ' PHE . . . -165.51 145.01 9.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -128.65 -168.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -1.073 . . . . 0.0 109.407 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 3.5 mt -150.31 111.16 3.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.31 131.29 23.04 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.58 1.52 . . . . 0.0 110.355 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 30' ' ' GLU . 5.4 mp -84.46 41.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -99.15 -40.07 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.641 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.15 76.22 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.494 ' CB ' ' HA ' ' A' ' 73' ' ' THR . 6.2 m -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.276 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -115.02 171.76 7.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.647 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 2.4 tm? -143.51 119.61 10.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.819 . . . . 0.0 108.895 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 20.7 m -114.42 139.1 49.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.101 -0.999 . . . . 0.0 110.345 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.483 ' N ' HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -150.51 118.06 3.49 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.086 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.513 ' O ' ' CG2' ' A' ' 56' ' ' THR . 46.2 Cg_endo -70.21 -160.05 1.41 Allowed 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.562 -1.849 . . . . 0.0 110.399 0.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -117.14 -78.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.239 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.806 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -134.12 -159.94 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.033 . . . . 0.0 110.25 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.54 14.24 3.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.578 ' CZ ' ' OE1' ' A' ' 60' ' ' GLN . 16.6 m-85 -88.5 86.86 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 88.35 41.92 6.01 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 4.5 pttt -37.72 111.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.85 -0.794 . . . . 0.0 110.042 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER 178.26 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.766 ' SD ' ' HB2' ' A' ' 86' ' ' LEU . 22.4 ptp 171.93 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.678 0.751 . . . . 0.0 109.363 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.537 ' HA ' ' CB ' ' A' ' 89' ' ' ARG . 2.2 m-85 -60.09 -21.79 61.94 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.94 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 2.1 p -94.65 105.85 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -99.93 170.78 8.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -140.24 103.28 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.682 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 72' ' ' THR . 14.3 mt -90.54 165.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 59.1 m -141.52 87.78 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.8 p -47.35 160.2 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 0.0 108.841 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -13.67 14.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.706 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.25 20.45 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.94 29.22 16.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -92.45 98.49 11.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.234 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 5.6 p30 -68.5 135.4 51.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.791 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -140.07 95.69 2.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.398 -0.814 . . . . 0.0 108.837 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -109.72 135.59 50.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 0.0 110.144 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.706 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -149.99 159.23 44.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.778 . . . . 0.0 109.361 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' CG ' ' HB2' ' A' ' 67' ' ' PHE . 6.8 tt0 -114.04 138.08 50.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -139.49 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.269 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -118.48 -7.82 10.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.897 -1.127 . . . . 0.0 110.056 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -168.11 175.64 6.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -0.963 . . . . 0.0 109.751 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.766 ' HB2' ' SD ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -72.74 -37.17 67.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 109.236 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -60.21 -49.18 78.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.043 -1.036 . . . . 0.0 109.712 -179.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -72.96 -33.53 65.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.099 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.537 ' CB ' ' HA ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -62.43 -39.1 92.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.992 . . . . 0.0 109.411 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.554 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 13.5 t0 -78.88 -20.03 50.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -0.994 . . . . 0.0 108.614 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -76.94 -26.87 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.647 ' CE2' ' CD2' ' A' ' 11' ' ' LEU . 26.8 m95 -85.52 -37.85 19.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.9 m -71.32 -37.74 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 110.113 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 7.1 ptt180 -80.89 -30.93 35.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.226 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 5.4 t0 -75.06 -41.43 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.914 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.524 ' CG1' HD21 ' A' ' 28' ' ' LEU . 5.2 mt -75.08 -32.96 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 109.334 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 58.8 t-20 -75.25 -32.05 60.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.5 -45.13 40.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.103 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' HD22 ' A' ' 50' ' ' LEU . . . -58.11 -43.05 86.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.842 . . . . 0.0 109.141 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.468 HG13 ' HG ' ' A' ' 50' ' ' LEU . 17.0 mt -70.09 -37.76 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.183 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -72.31 -10.57 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.457 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -38.99 12.03 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 4.0 mm -65.32 -40.32 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 51' ' ' LYS . 2.4 mt-10 -68.96 -7.6 36.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.09 11.37 5.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mt . . . . . 0 C--N 1.302 -1.46 0 O-C-N 121.401 -1.058 . . . . 0.0 109.114 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.495 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.267 0.556 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 30' ' ' GLU . 85.9 mt -76.32 -58.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.646 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.554 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 4.9 tpm_? -133.34 111.89 11.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.941 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -118.31 132.5 56.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.054 -1.029 . . . . 0.0 109.417 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.42 -147.69 4.97 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.3 p90 -141.38 96.62 3.02 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.322 -1.105 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -121.51 176.42 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' CG1' ' CG ' ' A' ' 82' ' ' GLN . 2.1 p -103.06 147.5 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.699 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 26.8 mmtt -118.64 179.82 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 3.6 tttt -133.41 64.1 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.616 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -157.39 131.63 2.96 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 12.6 t 169.54 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.134 . . . . 0.0 109.437 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 4.2 p -100.79 -30.75 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 4.8 m-85 -174.73 176.78 2.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 25.0 p-10 -45.61 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 36.9 p -142.95 -176.83 5.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.654 ' CH2' ' CG2' ' A' ' 68' ' ' VAL . 56.5 m95 -156.13 105.55 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.143 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -137.6 135.16 18.84 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.495 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.5 Cg_exo -51.65 166.87 0.48 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.954 1.769 . . . . 0.0 110.461 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 13.1 ptm 178.04 165.36 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -0.907 . . . . 0.0 109.729 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.3 t-105 -90.15 145.16 25.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.599 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.97 135.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.702 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 8.8 m -125.5 103.2 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -82.44 117.11 22.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.947 -1.095 . . . . 0.0 109.972 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.545 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mp -105.35 166.33 10.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -74.45 -17.61 60.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 0.0 109.435 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' C ' HD13 ' A' ' 50' ' ' LEU . 2.4 p30 -97.39 8.47 44.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' HD11 ' A' ' 29' ' ' LEU . . . 139.43 152.13 5.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 50' ' ' LEU . 2.8 mp -101.27 118.55 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.196 -1.179 . . . . 0.0 109.655 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.545 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 17.8 pt-20 -117.97 116.15 26.34 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.599 ' HB3' ' CB ' ' A' ' 26' ' ' VAL . 1.8 p90 -116.12 150.62 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.054 -1.029 . . . . 0.0 110.594 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -128.6 -153.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -41.38 9.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.0 mttt -115.7 -172.26 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 6.1 tppt? -44.85 -25.36 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 109.288 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -154.83 -47.07 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.594 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.8 t70 61.65 11.21 3.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.35 22.52 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.776 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -163.36 111.37 1.0 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.994 -1.066 . . . . 0.0 109.743 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.2 Cg_endo -71.92 133.25 21.32 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.888 1.725 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 2.2 tttt -89.5 -23.24 22.11 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 178.47 151.79 9.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 mtm -137.65 135.57 36.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -1.154 . . . . 0.0 109.743 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.57 HG22 ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -101.92 137.68 19.58 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 48' ' ' ILE . 48.4 Cg_endo -71.0 99.16 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.447 1.431 . . . . 0.0 109.832 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' N ' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -66.74 -4.51 9.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.945 . . . . 0.0 110.528 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' N ' HD12 ' A' ' 50' ' ' LEU . 3.4 ptmm? -85.45 48.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.544 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . 151.38 -22.35 0.95 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.891 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -42.48 146.75 0.31 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.096 -1.238 . . . . 0.0 109.828 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.2 162.75 13.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 56' ' ' THR . 3.0 tm? -117.51 147.19 42.99 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.063 -1.023 . . . . 0.0 108.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.557 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 26.4 m -149.31 129.45 13.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.924 -1.11 . . . . 0.0 110.086 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.515 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.71 126.81 5.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 109.138 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 57' ' ' SER . 25.0 Cg_exo -67.0 -150.46 0.33 Allowed 'Cis proline' 0 C--N 1.309 -1.52 0 C-N-CA 123.148 -1.605 . . . . 0.0 110.903 -1.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.593 ' SG ' HG23 ' A' ' 68' ' ' VAL . 30.1 p -131.81 -148.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.407 -0.808 . . . . 0.0 109.974 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 173.98 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -91.62 5.03 51.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.437 -0.789 . . . . 0.0 109.601 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -88.74 45.26 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.219 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.22 38.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 85.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.381 -1.07 . . . . 0.0 109.518 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -147.96 23.35 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.561 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 12.8 mtt 62.7 159.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.466 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 2.6 m-85 82.43 -28.85 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.561 -0.712 . . . . 0.0 110.47 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.654 ' CG2' ' CH2' ' A' ' 21' ' ' TRP . 15.0 p -93.11 135.11 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.195 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.4 -176.47 4.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HD3' ' CA ' ' A' ' 59' ' ' CYS . 0.4 OUTLIER -150.11 118.93 6.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.07 . . . . 0.0 110.292 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 54' ' ' THR . 3.7 mt -96.67 162.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.541 ' CB ' HG23 ' A' ' 54' ' ' THR . 90.4 m -127.39 91.43 3.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 108.842 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.497 ' CG2' HG21 ' A' ' 48' ' ' ILE . 1.4 p -43.21 144.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.474 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.484 ' HB ' ' HA3' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -41.07 -34.7 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.804 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -66.36 -74.9 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.227 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 166.11 35.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.588 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.407 ' O ' HG22 ' A' ' 73' ' ' THR . 1.4 mm-40 -105.78 118.95 37.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 3.2 m-20 -83.31 103.3 12.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.57 ' CD2' HG22 ' A' ' 48' ' ' ILE . 53.3 m-70 -89.78 105.31 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.165 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 5.6 m-85 -94.63 117.99 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.705 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -136.86 138.74 41.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 108.623 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.572 ' CG ' ' CG1' ' A' ' 12' ' ' VAL . 8.3 pt20 -118.01 146.27 44.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 -153.05 0.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 109.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -108.31 -2.21 19.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -169.09 169.94 9.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 0.0 109.187 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.601 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 27.6 tp -69.81 -30.81 68.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -56.89 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 108.868 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.515 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -69.17 -15.33 63.38 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.178 -0.951 . . . . 0.0 108.74 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.524 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 5.1 ttt180 -68.94 -63.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.818 . . . . 0.0 109.354 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.92 -13.26 62.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.9 25.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.047 -1.033 . . . . 0.0 108.861 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 1.9 m95 -81.97 -27.91 32.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.1 m -75.33 -33.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.164 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 2.5 mmm180 -79.74 -29.95 40.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -74.74 -49.38 21.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.523 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 28' ' ' LEU . 9.8 mt -72.58 -36.6 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.025 -1.047 . . . . 0.0 108.866 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 11.1 t-20 -73.28 -26.39 61.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -76.68 -45.22 30.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.867 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . . . -59.91 -34.02 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.332 -0.855 . . . . 0.0 108.969 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 50' ' ' LEU . 1.3 mt -74.9 -40.84 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 108.826 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 13.9 tptm -73.2 -7.87 53.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.073 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -40.72 9.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 30' ' ' GLU . 1.2 mm -60.64 -44.01 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 108.805 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 3.1 mt-10 -46.49 -26.23 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.37 -103.29 2.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.543 0 O-C-N 121.375 -1.073 . . . . 0.0 109.218 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.534 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 77.2 mt -47.13 -70.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.531 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -101.58 169.12 9.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.786 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 1.3 pm0 173.65 132.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.575 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -173.12 -143.68 4.32 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -124.03 106.97 10.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.933 . . . . 0.0 109.427 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.655 ' CD2' ' CZ ' ' A' ' 81' ' ' PHE . 0.8 OUTLIER -120.53 178.47 4.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.818 . . . . 0.0 108.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 1.6 p -123.41 122.68 65.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 108.596 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.772 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -104.02 126.62 51.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 109.466 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.586 ' HG3' ' CD1' ' A' ' 21' ' ' TRP . 19.1 tttt -73.17 99.76 2.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 178.36 48.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 t -98.07 114.5 26.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -1.164 . . . . 0.0 109.56 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 5.1 p -167.33 -45.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -174.93 48.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.406 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 20.5 m-20 49.56 63.53 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 1.1 p -129.41 161.59 30.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.604 ' CH2' ' HB3' ' A' ' 80' ' ' PHE . 34.0 m95 -125.64 118.98 26.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 4.2 mttt -121.88 130.04 24.91 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.684 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 24' ' ' MET . 49.1 Cg_exo -55.04 -179.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.8 1.667 . . . . 0.0 110.119 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.772 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 6.5 ptm 169.29 169.63 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.7 t-105 -92.46 152.25 19.79 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.552 ' HA ' ' CB ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -149.66 149.96 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.581 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 4.8 m -144.52 112.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 7' ' ' ARG . 5.1 mt -78.94 121.66 25.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.449 -0.782 . . . . 0.0 109.095 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.541 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.1 mp -110.79 156.28 21.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.295 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.525 ' CA ' HD13 ' A' ' 6' ' ' ILE . 1.3 tt0 -72.46 -21.97 61.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.872 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' HA ' HD13 ' A' ' 103' ' ' ILE . 2.8 m-20 -98.64 10.93 39.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 109.369 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 146.77 -175.66 26.06 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' HG12 ' A' ' 48' ' ' ILE . 1.9 mp -132.47 137.9 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.051 -1.264 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 3.5 pt-20 -144.55 123.44 12.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.299 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 13' ' ' LYS . 5.0 p90 -121.65 140.18 52.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -121.69 -148.37 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 109.027 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -60.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.1 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -96.65 -177.14 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 108.727 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.68 -28.39 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 108.612 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.447 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -163.01 69.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.452 -0.78 . . . . 0.0 109.387 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 60.6 t0 -48.26 -21.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.7 t-20 91.8 -21.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.89 107.03 42.78 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 44.1 Cg_endo -68.86 146.97 67.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.778 1.652 . . . . 0.0 110.826 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 -31.58 9.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.397 -0.814 . . . . 0.0 109.076 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -154.3 143.24 9.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.8 mtt -133.26 135.74 45.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.492 HG12 ' CG2' ' A' ' 33' ' ' ILE . 2.2 mm -95.16 107.94 35.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 109.265 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' A' ' 53' ' ' SER . 46.3 Cg_endo -70.04 118.91 5.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.707 1.605 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 2.8 mp -63.29 -9.57 12.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.898 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.8 -71.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 109.84 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' O ' ' CA ' ' A' ' 74' ' ' THR . . . -152.46 71.79 0.28 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -100.53 166.0 11.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.161 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.54 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.89 157.32 36.25 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' A' ' 69' ' ' PHE . 2.3 tm? -127.48 102.06 6.71 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 19.5 m -89.6 133.45 34.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 0.0 110.009 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.6 122.94 5.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.403 -0.811 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.23 -161.88 2.26 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.558 -1.851 . . . . 0.0 110.416 -0.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.749 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 21.8 p -103.95 -147.16 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -71.68 -141.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 109.922 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -3.03 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.505 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 68' ' ' VAL . 19.9 m-85 -88.82 -21.13 23.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.509 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.749 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -76.61 -22.81 71.65 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -2.83 31.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.541 -0.976 . . . . 0.0 109.156 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -104.59 -95.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.555 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.47 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 9.4 mtt -94.34 -147.26 0.26 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.645 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 44.2 m-85 -101.79 92.69 4.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 82' ' ' GLN . 3.8 p -135.71 132.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.493 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 3.2 p90 -110.29 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.955 -1.091 . . . . 0.0 109.718 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -124.94 106.12 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.651 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 5.8 mt -88.48 160.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 74.8 m -133.53 90.69 2.75 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.482 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 3.3 p -45.3 158.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.062 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.486 ' CA ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -59.89 -14.07 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -86.89 16.81 4.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.58 43.37 4.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 72' ' ' THR . 13.6 tt0 -118.48 118.24 31.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.3 m-20 -70.61 163.3 27.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.482 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 12.3 m-70 -143.98 128.64 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.035 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.604 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 14.5 m-85 -91.59 113.42 25.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.7 t80 -128.16 128.19 44.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 110.689 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.547 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -126.91 136.05 51.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -0.827 . . . . 0.0 109.735 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -107.48 -150.84 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 0.0 109.798 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -100.29 -88.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.821 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -106.94 -179.27 3.89 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.59 -0.694 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -56.08 -58.18 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.69 . . . . 0.0 109.75 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 7.1 tp10 -43.46 -70.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.972 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.2 tt0 -48.94 -33.71 11.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 13.1 ttp180 -56.36 -65.01 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.545 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.86 -22.18 9.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.958 . . . . 0.0 109.263 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -70.9 -40.94 71.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.602 ' CD2' HD22 ' A' ' 11' ' ' LEU . 77.8 m95 -73.03 -52.73 13.27 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.507 -0.746 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.56 -24.84 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.518 -0.739 . . . . 0.0 110.794 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.542 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.6 ptt85 -85.24 -23.58 28.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.903 -1.123 . . . . 0.0 110.074 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -85.61 -38.66 18.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.075 -1.016 . . . . 0.0 109.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.526 HG13 ' CD1' ' A' ' 28' ' ' LEU . 21.1 mt -76.73 -35.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.102 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.46 -31.76 58.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -72.2 -55.92 6.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 108.983 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.0 67.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 59.2 mt -63.67 -45.27 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.035 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -67.88 -8.87 40.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.7 t -95.1 -35.38 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' HD21 ' A' ' 50' ' ' LEU . 2.2 mt -79.82 -26.68 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.032 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -73.14 -7.65 52.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.22 12.51 5.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.438 -1.037 . . . . 0.0 109.306 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 2.0 mpt_? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.361 0.6 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.6 mm -64.36 -56.8 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.217 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.535 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -132.85 90.61 2.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.981 -1.074 . . . . 0.0 110.414 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.52 ' CB ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -103.33 128.91 50.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.867 -1.146 . . . . 0.0 109.185 178.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.597 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.43 -149.94 5.68 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.0 p90 -141.26 97.15 3.11 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -114.19 171.65 7.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.9 p -102.34 129.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.776 -1.202 . . . . 0.0 109.872 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.574 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -119.75 166.04 13.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.311 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -68.21 121.65 16.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.32 -161.69 2.8 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' VAL . 23.3 t -119.16 -16.61 9.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -1.161 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -46.68 -93.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -126.67 52.0 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.511 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.0 OUTLIER 59.01 78.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 40.0 p -124.74 -165.79 1.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CH2' HG22 ' A' ' 68' ' ' VAL . 2.1 m95 -144.78 104.83 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 6.9 mttp -132.65 144.0 51.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -52.21 166.39 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.77 1.647 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.632 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 23.1 ptm -176.51 159.53 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -0.954 . . . . 0.0 109.648 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.6 t-105 -89.81 143.64 26.63 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.546 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.27 150.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.672 -179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 7.6 m -137.52 119.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.873 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.536 ' CD1' HG13 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -85.05 105.61 15.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.452 -0.78 . . . . 0.0 108.914 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -96.85 157.92 15.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.0 109.681 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' O ' HD21 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -72.89 -17.5 61.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 109.788 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -101.9 5.86 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' HD11 ' A' ' 50' ' ' LEU . . . 153.29 -171.6 32.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 32' ' ' GLY . 4.4 mm -133.05 122.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.383 -1.069 . . . . 0.0 109.283 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 6.0 pt-20 -129.12 127.27 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 6.7 p90 -131.09 146.4 52.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.46 -150.31 0.44 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 -32.43 11.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 108.877 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 2.8 tttp -121.05 -179.58 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -45.56 -27.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -166.96 73.36 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.0 109.702 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 24.8 t70 -50.98 -19.04 0.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.996 -1.065 . . . . 0.0 108.172 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 6.3 t-20 90.92 -17.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -132.34 94.55 22.84 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.497 ' HG3' ' CE2' ' A' ' 36' ' ' TYR . 50.7 Cg_exo -49.41 139.0 29.95 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.968 1.779 . . . . 0.0 110.878 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 9.7 mmtt -90.07 -23.02 21.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -164.9 143.8 8.81 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 mtm -134.97 123.87 24.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -1.19 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.464 HG21 ' HD2' ' A' ' 49' ' ' PRO . 5.5 mt -91.77 129.76 41.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.318 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 55.7 Cg_endo -72.51 137.45 27.89 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.687 1.592 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD23 ' CB ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -88.11 23.06 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.612 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' HB2' ' A' ' 49' ' ' PRO . 12.9 ptpt -91.77 -18.78 23.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.185 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -157.76 -91.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER 56.99 132.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.545 -0.973 . . . . 0.0 110.674 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.55 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.51 167.71 9.85 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.1 tm? -133.73 142.48 47.97 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.027 -1.045 . . . . 0.0 109.025 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.493 ' N ' HD12 ' A' ' 55' ' ' LEU . 52.6 m -130.22 119.88 23.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.891 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.7 t -143.61 120.27 6.6 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -72.07 -160.92 1.92 Allowed 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.573 -1.844 . . . . 0.0 110.143 -0.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.438 ' HA ' HG23 ' A' ' 56' ' ' THR . 17.9 p -89.67 -149.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.435 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 18.4 tt0 -110.17 -139.86 0.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.536 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.25 26.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.877 -1.139 . . . . 0.0 109.367 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 1.3 t80 -88.86 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -101.56 -42.3 2.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 7.2 tttt 55.45 19.4 3.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -1.007 . . . . 0.0 109.488 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 9.7 mmm180 -87.09 -144.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mtt -126.62 -4.05 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.11 -0.994 . . . . 0.0 109.85 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' MET . 0.5 OUTLIER -130.08 32.62 4.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.013 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.571 HG22 ' CH2' ' A' ' 21' ' ' TRP . 2.7 p -128.56 123.49 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.002 -1.062 . . . . 0.0 109.637 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 11.0 p90 -118.79 174.31 6.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -135.06 127.07 29.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CG1' HD21 ' A' ' 55' ' ' LEU . 6.6 mt -105.99 163.39 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 98.0 m -145.13 99.91 3.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.25 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.368 -0.832 . . . . 0.0 109.994 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER 43.46 37.74 1.54 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.935 . . . . 0.0 110.864 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 80.24 45.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 0.0 109.57 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.97 -82.87 0.32 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.028 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.53 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.7 OUTLIER -90.17 131.25 36.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.499 -0.75 . . . . 0.0 110.118 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.543 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 9.5 t0 -97.56 145.16 26.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -137.72 109.23 6.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -101.39 115.04 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.382 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -143.84 145.98 32.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 109.617 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 pt20 -116.78 147.01 42.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.51 -0.744 . . . . 0.0 109.052 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -143.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.45 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.91 -60.83 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 110.12 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.28 175.1 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.668 -0.645 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -45.7 -50.14 13.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.583 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 1.7 tm-20 -51.63 -57.93 7.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.045 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.19 -18.04 63.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.461 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 15.8 ttp180 -72.96 -65.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 59.3 t0 -65.75 -11.57 46.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.277 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.35 -41.19 22.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.003 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CE2' HD22 ' A' ' 11' ' ' LEU . 12.4 m95 -76.68 -31.1 57.05 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.454 -0.779 . . . . 0.0 108.99 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.9 m -70.6 -38.65 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.567 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -78.91 -20.08 50.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.533 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 9.5 t70 -77.73 -58.0 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.536 HG13 ' CD1' ' A' ' 28' ' ' LEU . 1.1 mt -63.6 -35.09 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 108.707 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 35.0 t30 -73.77 -32.54 63.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.91 -57.13 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.533 ' CB ' HD23 ' A' ' 50' ' ' LEU . . . -51.66 -42.42 62.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.238 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.473 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 45.0 mt -59.68 -50.62 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.314 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -10.89 35.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -93.12 -28.84 16.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.285 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.446 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 4.9 mm -78.0 -34.06 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.57 -4.85 33.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.4 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.72 13.02 4.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 102' ' ' CYS . 2.6 mt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.448 -1.031 . . . . 0.0 109.218 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HD3' HG13 ' A' ' 27' ' ' VAL . 1.2 mpt_? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.54 HD12 ' CG ' ' A' ' 30' ' ' GLU . 46.7 mt -92.81 -77.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.546 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -107.5 104.83 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 110.099 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.2 pm0 -115.65 135.51 53.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.3 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.589 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.73 -146.8 4.65 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 11.6 p90 -138.57 97.4 3.34 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.411 -1.052 . . . . 0.0 109.78 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.611 ' HG ' ' CE2' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -119.36 146.8 45.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.593 HG23 ' CE3' ' A' ' 21' ' ' TRP . 1.4 p -76.34 137.68 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.026 -1.047 . . . . 0.0 109.298 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -117.18 165.19 13.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.42 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HB2' ' NE1' ' A' ' 21' ' ' TRP . 2.1 tmtt? -116.31 125.11 51.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.348 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' VAL . . . 164.86 -120.11 0.92 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 51.21 -91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -1.146 . . . . 0.0 109.383 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 18' ' ' PHE . 14.8 m -117.51 -147.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.519 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -42.71 165.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.478 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' PHE . 3.1 m120 -43.53 105.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.376 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -132.29 174.42 10.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.764 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.593 ' CE3' HG23 ' A' ' 12' ' ' VAL . 3.4 m95 -152.33 106.94 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.467 ' O ' HG21 ' A' ' 12' ' ' VAL . 6.6 mmtt -138.18 138.8 23.8 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.33 151.58 17.4 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.849 1.7 . . . . 0.0 109.922 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.774 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.15 171.07 20.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 110.341 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.774 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.9 t-105 -96.94 145.8 25.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.581 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -150.19 139.24 15.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.05 -178.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 7.5 m -129.09 106.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.821 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.583 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 1.5 pp -86.45 111.91 21.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.992 . . . . 0.0 109.193 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.9 mp -93.29 164.58 13.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.789 . . . . 0.0 109.564 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' CG ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -74.99 -15.8 60.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.6 p30 -101.87 10.11 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.339 -0.85 . . . . 0.0 109.169 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 148.49 -165.15 29.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 32' ' ' GLY . 2.9 mt -141.07 141.51 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -1.198 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 12.1 pt-20 -148.12 115.03 6.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.74 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.5 p90 -112.81 148.72 34.24 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 110.792 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -124.62 -156.76 0.74 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -46.42 6.56 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -111.37 -169.22 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -46.5 -24.79 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.793 -1.192 . . . . 0.0 109.024 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -153.52 -50.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.199 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.67 10.08 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.418 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' ASP . 38.8 m-20 41.9 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -156.79 96.17 2.18 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 110.037 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.9 Cg_exo -51.82 171.7 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.054 1.836 . . . . 0.0 110.58 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.49 4.98 2.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.455 -0.778 . . . . 0.0 109.287 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.53 141.68 3.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.513 ' HG2' ' CB ' ' A' ' 34' ' ' GLU . 26.4 mtm -124.41 139.69 53.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 0.0 109.634 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 33' ' ' ILE . 2.3 mt -101.31 125.85 36.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.075 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.71 131.91 19.34 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.547 1.498 . . . . 0.0 110.08 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.505 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 1.5 mp -73.74 -0.03 14.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' CB ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -42.14 -88.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.78 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.51 54.99 0.56 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.397 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -66.95 156.25 36.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.246 . . . . 0.0 108.941 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.548 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -103.73 171.07 7.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 108.855 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD21 ' N ' ' A' ' 56' ' ' THR . 2.2 tm? -143.33 114.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.205 -0.934 . . . . 0.0 109.114 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.524 ' N ' HD21 ' A' ' 55' ' ' LEU . 12.4 m -112.89 128.23 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.426 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.19 122.18 4.12 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.473 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' THR . 54.7 Cg_endo -72.31 -177.87 19.21 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.603 -1.832 . . . . 0.0 110.199 -0.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.82 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -96.04 -85.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.82 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -152.95 -165.58 2.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -87.28 21.39 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.504 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.6 t80 -89.26 85.7 6.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 88.94 26.89 25.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER -43.81 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.253 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -141.3 132.63 26.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.1 mtp 44.27 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 6.0 m-85 -145.86 108.25 4.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.51 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -113.32 138.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.278 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.84 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 33.9 ttpt -141.67 98.8 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 HG13 ' CE2' ' A' ' 69' ' ' PHE . 7.5 mt -89.38 163.76 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 45.6 m -139.35 87.38 2.19 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 77' ' ' GLN . 2.7 p -45.63 155.34 0.16 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.238 -0.914 . . . . 0.0 108.905 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.468 HG22 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -55.44 -17.51 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.761 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.15 23.74 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 109.85 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 35.27 18.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.887 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.89 94.09 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.8 m-20 -66.32 153.12 43.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -148.68 114.84 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 109.261 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -108.27 124.15 49.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.502 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.49 -176.29 4.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.53 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 1.8 tt0 -150.38 138.1 19.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.842 -1.162 . . . . 0.0 110.025 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . . . -89.82 -145.8 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.535 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -115.52 -11.45 11.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 109.64 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.535 ' CG ' ' C ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -170.61 171.3 6.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -55.79 -48.78 74.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 109.474 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -48.62 -60.45 2.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 0.0 109.769 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 22.6 tt0 -61.49 -22.45 65.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.884 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.68 -63.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.782 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.543 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -66.08 -12.83 58.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.15 -39.06 26.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.112 -0.992 . . . . 0.0 108.868 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CZ3' HD22 ' A' ' 28' ' ' LEU . 9.6 m95 -78.1 -29.76 49.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.805 . . . . 0.0 109.028 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.8 m -74.09 -31.27 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.591 -0.693 . . . . 0.0 109.699 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.7 ptp180 -83.5 -23.16 32.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.901 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -83.31 -54.54 4.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.07 -1.019 . . . . 0.0 109.713 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 28' ' ' LEU . 2.6 mt -65.14 -39.75 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 108.575 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 20.5 t-20 -70.09 -56.59 6.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.89 . . . . 0.0 109.155 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 22.3 tttm -44.17 -49.69 8.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -57.31 -43.92 83.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 50' ' ' LEU . 1.2 mp -57.63 -58.79 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.7 -10.78 21.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 109.904 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -92.7 -22.78 19.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.313 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 50' ' ' LEU . 3.1 mm -84.7 -22.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.987 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 41.0 mt-10 -68.3 -7.8 34.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.85 9.44 5.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 5.8 mt . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.288 -1.125 . . . . 0.0 109.16 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.254 0.549 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HB ' ' CD1' ' A' ' 28' ' ' LEU . 8.3 mm -46.33 -46.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.557 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -137.88 152.48 49.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 109.491 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.548 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.6 pm0 -161.6 124.05 3.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.584 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -157.92 -145.7 4.3 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 9.7 p90 -143.26 93.45 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.339 -1.094 . . . . 0.0 109.971 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CD2' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -115.37 166.53 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.548 HG23 ' CE3' ' A' ' 21' ' ' TRP . 1.6 p -90.83 135.61 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.775 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.4 OUTLIER -126.98 131.08 51.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.464 -0.773 . . . . 0.0 109.597 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 35.0 tttm -95.47 138.62 32.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 109.423 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.1 -2.49 4.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.482 ' CB ' ' CE ' ' A' ' 45' ' ' LYS . 3.7 p -76.72 -93.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.552 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 12.0 p -97.43 109.54 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.344 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-30 59.23 -180.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 28.8 p-10 -82.73 88.79 6.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 21.6 p -132.24 -167.27 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.755 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.637 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.4 m95 -146.4 116.83 7.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 0.0 109.59 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 21' ' ' TRP . 33.4 mttt -148.17 137.38 12.02 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 110.048 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 46.6 Cg_exo -56.3 161.13 9.66 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.937 1.758 . . . . 0.0 109.787 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.775 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 21.6 ptm -171.1 167.36 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 109.798 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.59 ' CD2' ' HA ' ' A' ' 39' ' ' LYS . 54.5 t-105 -88.77 142.61 27.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.6 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -150.41 132.39 5.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.446 -178.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 11.4 m -125.15 105.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.592 -0.693 . . . . 0.0 109.285 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.557 ' CD2' ' HB3' ' A' ' 7' ' ' ARG . 1.7 pp -79.6 124.14 28.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.036 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.494 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 2.7 mp -112.15 166.42 11.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.505 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -72.02 -12.97 61.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.906 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.432 ' OD1' HD12 ' A' ' 103' ' ' ILE . 1.1 m-20 -106.07 -2.67 22.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 50' ' ' LEU . . . 152.9 151.69 5.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 28' ' ' LEU . 4.7 mp -98.36 108.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' OE2' ' CD1' ' A' ' 29' ' ' LEU . 4.8 pt-20 -107.22 119.96 40.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.0 p90 -121.3 144.64 48.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 110.431 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -121.25 -148.93 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -51.97 3.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 109.174 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -105.13 -177.26 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 108.855 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.11 -40.45 10.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.058 -1.026 . . . . 0.0 108.512 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -153.43 72.04 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 109.765 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 23.6 t70 -50.15 -20.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 3.7 t30 90.86 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 101.6 51.66 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 53.4 Cg_exo -49.69 142.68 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.888 1.725 . . . . 0.0 111.246 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' CE ' ' CB ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -98.18 -25.63 14.83 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.39 146.77 5.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 9.5 mtm -127.31 -174.92 3.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -1.166 . . . . 0.0 109.628 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.3 mt -140.59 127.83 12.22 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.46 84.79 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.494 1.462 . . . . 0.0 110.073 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -60.95 -14.2 21.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.412 -0.805 . . . . 0.0 109.201 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' HD22 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -58.36 -15.41 10.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.9 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -165.68 27.91 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.132 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.469 ' OG ' HG22 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -77.54 168.73 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 0.0 109.348 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -126.67 160.25 31.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.403 -0.81 . . . . 0.0 109.167 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.543 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 2.8 tm? -121.28 149.47 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.042 -1.037 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 98.9 m -136.42 134.79 38.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 110.052 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 5.4 t -150.38 118.87 3.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.327 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.6 Cg_endo -72.49 -161.86 2.29 Favored 'Cis proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.642 -1.816 . . . . 0.0 110.369 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 18.2 p -96.34 -161.25 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.694 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -67.84 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.867 . . . . 0.0 109.756 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -84.89 15.37 4.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.2 t80 -89.16 -27.13 20.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.918 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' CG1' ' A' ' 68' ' ' VAL . . . -103.97 -91.69 2.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 tttt 43.66 27.26 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -1.093 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' GLY . 12.7 mtp180 -124.67 -90.14 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.437 -0.789 . . . . 0.0 109.424 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.7 mmm -81.92 -114.36 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.321 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 84.1 m-85 -130.96 89.99 2.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.824 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' CG1' ' HA3' ' A' ' 63' ' ' GLY . 1.6 p -129.62 119.71 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.829 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.707 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.8 p90 -97.8 168.77 10.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.091 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 6.0 ttpt -127.17 117.39 22.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.4 mt -95.5 167.84 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.828 . . . . 0.0 108.872 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.2 m -141.05 92.23 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -42.76 152.09 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 1.2 t -52.15 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.522 -0.736 . . . . 0.0 109.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 158.52 -71.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 164.55 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.441 ' HB3' HG22 ' A' ' 73' ' ' THR . 0.7 OUTLIER -100.93 79.08 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.092 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 1.7 p30 -56.07 144.01 30.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.701 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 42.0 m-70 -137.49 145.26 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.8 m-85 -100.88 137.61 39.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.707 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.1 t80 -143.97 123.3 13.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -129.36 120.13 25.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.04 . . . . 0.0 109.879 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.98 -146.51 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -97.51 -90.05 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -96.22 167.88 10.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -52.45 -20.33 2.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.819 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.526 ' N ' HD22 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -72.35 -46.7 54.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.731 -179.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -73.97 -48.61 29.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.88 -30.5 71.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.004 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 51.2 t0 -75.09 -42.36 56.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.989 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -73.91 -19.69 60.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.566 ' CH2' HG23 ' A' ' 26' ' ' VAL . 3.4 m95 -83.6 -37.15 23.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.393 -0.817 . . . . 0.0 109.048 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.543 ' CG2' ' CD1' ' A' ' 55' ' ' LEU . 3.9 p -76.84 -31.59 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.789 . . . . 0.0 109.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 13.2 mmm180 -83.83 -24.34 30.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.605 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 33.5 t0 -83.71 -39.7 19.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.975 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 28' ' ' LEU . 5.3 mt -71.81 -32.79 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 0.0 108.696 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -84.31 -30.7 25.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.222 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -67.16 -50.97 59.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.949 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -67.25 -32.72 73.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.951 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 20.6 mt -61.91 -41.26 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.423 -0.798 . . . . 0.0 109.095 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -83.58 -13.46 54.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.62 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.67 -12.24 25.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 109.58 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 50' ' ' LEU . 5.6 tp -93.43 -14.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 4.0 mt-10 -80.15 -6.63 58.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.511 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.97 8.63 7.17 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.51 ' HG2' ' CD2' ' A' ' 29' ' ' LEU . 4.1 mtt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.233 0.54 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.525 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 18.9 mt -90.17 -70.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.597 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.549 ' HB3' ' CG ' ' A' ' 28' ' ' LEU . 3.3 tpm_? -114.45 121.86 44.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.4 pm0 -130.21 135.42 48.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.122 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.05 -145.68 4.44 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.2 p90 -142.26 102.41 4.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -1.06 . . . . 0.0 110.485 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.655 ' CD2' ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -129.54 150.89 50.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.575 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -81.17 135.82 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.091 -1.006 . . . . 0.0 108.759 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HG3' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -127.82 84.79 2.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.087 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 34.41 -149.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.259 0.552 . . . . 0.0 110.207 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 20' ' ' THR . . . -145.92 163.35 28.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.6 m -89.22 23.24 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.472 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.7 p -167.86 118.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.455 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 44.9 m-85 60.24 153.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -59.45 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -119.39 152.48 36.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.517 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.626 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -133.6 121.51 22.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.1 -179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.511 ' N ' HG22 ' A' ' 12' ' ' VAL . 11.6 mttm -147.01 142.87 17.49 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.571 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 41.1 Cg_endo -73.08 130.79 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.094 1.863 . . . . 0.0 110.224 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.779 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -138.53 175.02 9.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.709 ' O ' ' SD ' ' A' ' 24' ' ' MET . 66.1 t-105 -92.27 145.39 24.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -148.87 144.3 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.101 -178.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -137.1 99.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.369 -0.832 . . . . 0.0 109.566 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.634 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -76.22 120.17 21.13 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.237 -0.914 . . . . 0.0 109.231 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -106.03 167.27 9.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 109.507 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.511 ' CA ' HD13 ' A' ' 6' ' ' ILE . 4.8 pt-20 -71.99 -10.85 60.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.75 -2.23 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.618 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 154.89 147.7 4.77 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -95.93 108.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 23.8 pt-20 -107.82 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.665 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.779 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 1.4 p90 -117.09 150.49 38.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.094 -1.004 . . . . 0.0 109.993 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -127.5 -172.56 2.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.308 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -77.58 -50.04 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.58 -174.28 2.5 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.7 -23.65 0.44 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.932 -1.105 . . . . 0.0 109.415 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.87 -49.59 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.045 . . . . 0.0 109.642 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 2.8 t70 62.26 9.79 3.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 41.46 23.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 110.066 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -165.14 102.22 0.79 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.169 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.6 Cg_exo -52.79 133.23 49.96 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.978 1.785 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.98 -21.96 22.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 175.09 149.0 7.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.793 ' SD ' ' N ' ' A' ' 47' ' ' MET . 0.5 OUTLIER -125.62 169.02 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.422 ' HB ' HD11 ' A' ' 33' ' ' ILE . 57.1 mt -132.35 134.69 25.24 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.51 121.26 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.38 1.387 . . . . 0.0 110.472 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -58.51 -39.02 78.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.429 -0.794 . . . . 0.0 109.707 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.487 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -101.11 108.27 19.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 125.24 -1.32 8.27 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.499 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 7.6 t -89.89 170.32 10.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.869 -1.371 . . . . 0.0 109.864 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.496 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.16 122.22 13.74 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.303 -0.873 . . . . 0.0 109.438 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.53 ' CD2' ' CD2' ' A' ' 69' ' ' PHE . 3.2 tm? -88.91 127.19 35.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.457 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.684 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 3.4 m -117.46 102.24 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.172 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 3.3 m -140.51 135.84 16.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 57' ' ' SER . 58.4 Cg_endo -77.3 176.32 44.25 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.35 -1.938 . . . . 0.0 110.345 -0.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' A' ' 56' ' ' THR . 5.0 m -148.59 82.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -98.69 112.93 24.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -177.74 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 109.562 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.0 t80 -89.14 -39.68 13.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 108.329 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -117.14 -39.32 0.81 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER 39.36 72.44 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.859 . . . . 0.0 109.317 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.57 -95.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.738 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.6 mmm -77.1 -122.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 38.6 m-85 -112.71 92.57 4.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.774 -1.204 . . . . 0.0 109.677 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -118.85 126.77 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.34 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -112.62 176.19 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 3.0 tmmm? -135.78 114.63 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.783 . . . . 0.0 110.238 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -97.78 171.08 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.8 m -145.89 94.16 2.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.163 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.2 p -59.86 153.53 20.68 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.0 109.094 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -44.46 -23.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.223 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER -86.86 31.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 0.0 109.771 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.85 28.43 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.407 ' OE1' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -89.88 92.29 8.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.287 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.572 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 8.3 t70 -58.92 152.76 18.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -142.55 103.04 4.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.572 ' CZ ' ' OD1' ' A' ' 78' ' ' ASP . 10.8 m-85 -95.1 117.69 30.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -131.58 171.26 13.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.104 -0.998 . . . . 0.0 109.263 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.22 130.13 26.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.035 -1.041 . . . . 0.0 109.188 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . . . -89.75 164.66 14.58 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.471 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -97.43 53.37 1.15 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER 166.08 162.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.915 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -88.33 -51.09 5.93 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.483 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -65.19 -29.22 70.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 29.8 tt0 -79.87 -43.28 22.57 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.481 -0.762 . . . . 0.0 109.426 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.531 ' CD ' ' HB3' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.49 -55.7 26.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 93' ' ' VAL . 1.5 m-20 -65.83 -25.81 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 108.866 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 88' ' ' GLU . . . -69.19 -24.66 64.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.655 ' CZ2' ' CD2' ' A' ' 11' ' ' LEU . 11.7 m95 -83.27 -31.71 26.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 90' ' ' ASP . 1.5 m -79.44 -23.34 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.395 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.3 mmp_? -86.4 -34.15 20.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 0.0 109.546 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 2.7 t0 -82.98 -41.55 18.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.149 -0.969 . . . . 0.0 109.681 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 28' ' ' LEU . 4.4 mt -72.88 -35.17 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.293 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 1.5 t-20 -81.59 -32.74 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -68.52 -40.31 80.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 109.18 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.443 ' C ' HD13 ' A' ' 50' ' ' LEU . . . -70.94 -40.37 72.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.295 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 10.9 mt -67.48 -28.95 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.102 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -89.11 -8.75 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -30.8 13.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -70.11 -30.03 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 108.791 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.75 -5.98 34.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.06 10.89 5.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.422 -1.046 . . . . 0.0 109.144 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.314 0.578 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.3 mt -73.17 -28.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.806 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.528 ' CB ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -145.28 166.53 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.075 -1.015 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.7 pm0 178.83 127.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.481 -0.762 . . . . 0.0 109.567 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.593 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.87 -145.6 4.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.2 p90 -140.43 91.96 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 110.219 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.577 HD21 ' CG1' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -118.9 161.88 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.933 . . . . 0.0 108.677 178.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 22' ' ' LYS . 1.6 p -85.4 141.74 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.672 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HE2' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -123.21 142.72 50.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.203 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 19' ' ' ASN . 5.2 tttt -88.17 115.62 25.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.4 93.91 0.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -85.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -1.156 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.67 -19.08 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.96 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 14' ' ' LYS . 50.5 m-80 63.95 100.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 17.4 p -149.18 -170.65 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.162 -0.961 . . . . 0.0 109.697 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.585 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.5 m95 -141.6 105.92 4.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 35.5 mttt -146.75 136.62 11.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.47 157.55 6.87 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.915 1.744 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.777 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -168.18 165.92 13.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 110.111 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.748 ' O ' ' SD ' ' A' ' 24' ' ' MET . 62.6 t-105 -90.23 143.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.577 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -150.6 138.57 14.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.935 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 6.5 m -126.09 120.23 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.802 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 7' ' ' ARG . 1.6 mt -78.95 120.52 23.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.446 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.6 mp -115.18 158.55 22.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 50' ' ' LEU . 6.5 pt-20 -73.02 -9.65 58.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 2.9 p30 -107.89 -3.4 18.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.126 -0.984 . . . . 0.0 109.482 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' HA2' HD21 ' A' ' 50' ' ' LEU . . . 152.78 155.54 7.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.072 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.53 107.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.349 -1.089 . . . . 0.0 109.252 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 2.7 tp10 -104.7 117.84 35.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.777 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.2 p90 -125.59 147.71 49.2 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -123.67 -157.69 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -93.77 -43.6 8.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.163 -0.961 . . . . 0.0 108.471 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -111.88 -176.39 2.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.587 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -44.95 -25.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.933 -1.105 . . . . 0.0 109.248 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -149.91 -50.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.551 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.9 t0 61.15 10.82 3.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.868 . . . . 0.0 109.352 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.5 m-80 41.6 23.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.745 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -163.93 115.05 0.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.849 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.6 Cg_endo -71.4 134.7 25.12 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.888 1.726 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -89.75 -20.21 23.84 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 168.48 157.73 11.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.447 ' HG2' ' OE1' ' A' ' 34' ' ' GLU . 6.7 mtt -133.11 169.82 16.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -1.06 . . . . 0.0 109.18 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.9 mt -136.78 127.35 16.25 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.78 124.65 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.252 1.301 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' HG13 ' A' ' 103' ' ' ILE . 1.8 pt? -89.19 23.6 2.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.128 -0.983 . . . . 0.0 109.856 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HA ' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -86.98 -66.45 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.864 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -101.26 -2.19 54.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -39.56 148.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -1.052 . . . . 0.0 110.512 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.54 HG21 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -119.03 155.94 30.55 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -124.74 130.54 52.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.931 -1.106 . . . . 0.0 109.301 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 59' ' ' CYS . 90.2 m -121.8 123.38 41.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.709 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.49 119.56 3.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' HG23 ' A' ' 56' ' ' THR . 56.9 Cg_endo -74.04 -175.12 14.62 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.7 -1.791 . . . . 0.0 110.299 -0.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.762 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -102.95 170.11 8.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 109.574 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.762 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 mt-30 -107.66 133.19 52.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 3.7 t0 83.84 -49.42 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 5.7 m-85 -100.38 -32.25 10.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 108.727 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -83.83 0.82 89.38 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -89.51 23.23 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -1.176 . . . . 0.0 109.272 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -143.8 -96.96 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.636 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -158.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 109.763 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 81.6 m-85 -97.53 87.97 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 81' ' ' PHE . 2.1 p -135.18 130.71 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 81' ' ' PHE . 3.7 p90 -100.03 167.5 10.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.304 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -125.63 116.91 22.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.77 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 72' ' ' THR . 3.4 mt -99.51 165.85 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 16.7 m -142.16 103.85 4.36 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.5 ' C ' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -53.38 108.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.869 0.843 . . . . 0.0 109.689 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.12 27.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 179.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 74' ' ' THR . 1.7 ttpp 80.71 42.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.016 . . . . 0.0 109.412 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.01 -78.88 0.51 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -89.96 133.97 34.49 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.533 -0.729 . . . . 0.0 110.254 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 3.5 p30 -95.2 152.18 18.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.356 -0.84 . . . . 0.0 108.752 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -141.99 104.72 4.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 110.214 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.559 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.8 m-85 -93.51 109.0 20.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 108.794 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -118.43 144.91 45.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.416 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 4.4 tm0? -118.93 133.97 55.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.165 . . . . 0.0 109.827 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -89.47 -145.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 85' ' ' PHE . . . -103.02 -10.1 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 171.19 174.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.829 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -47.38 -50.08 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.148 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 5.9 tt0 -45.07 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 110.21 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -60.51 -14.48 19.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -71.62 -38.82 70.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HA ' HG11 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -85.09 -27.93 25.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.58 -29.37 56.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.576 ' CZ2' HD22 ' A' ' 11' ' ' LEU . 10.4 m95 -84.31 -42.72 15.51 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 55' ' ' LEU . 4.8 p -72.12 -29.27 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 14.4 ptm180 -79.01 -34.9 43.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.818 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.445 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 13.4 t70 -75.62 -54.43 7.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.0 109.458 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.519 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 7.2 mt -55.34 -35.89 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.028 -1.045 . . . . 0.0 108.738 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.411 ' OD1' ' HG3' ' A' ' 101' ' ' LYS . 15.9 t30 -79.72 -24.69 41.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 108.907 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -63.09 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 108.901 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.469 ' O ' HD13 ' A' ' 50' ' ' LEU . . . -56.45 -35.4 67.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 34.4 mt -62.35 -35.86 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 108.796 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.411 ' HG3' ' OD1' ' A' ' 97' ' ' ASN . 1.9 mtmp? -83.97 -8.38 59.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.9 t -93.57 -28.0 16.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -78.55 -79.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 103' ' ' ILE . 68.6 mt-10 37.38 52.5 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.771 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.461 ' O ' HD21 ' A' ' 106' ' ' LEU . . . 74.78 93.0 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.743 0 O-C-N 121.59 -0.947 . . . . 0.0 109.405 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 99' ' ' ALA . 12.1 mt -67.81 -49.04 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.598 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -144.4 111.04 5.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 109.67 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.55 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.7 pm0 -119.65 132.7 55.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.11 -146.21 4.59 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 20.0 p90 -142.68 102.73 4.1 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.523 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB2' ' CD2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -121.03 160.47 23.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.213 -0.929 . . . . 0.0 108.555 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 1.3 p -86.03 151.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.074 -1.016 . . . . 0.0 109.52 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.523 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -140.49 147.72 40.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -0.829 . . . . 0.0 109.853 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' THR . 24.4 tttm -117.5 133.67 55.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . 168.41 174.3 37.04 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 58.15 -174.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -1.074 . . . . 0.0 109.204 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 18' ' ' PHE . 6.2 p -42.96 -42.63 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG21 ' A' ' 20' ' ' THR . 12.2 m-85 -39.69 -68.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.919 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 22.03 3.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.516 HG21 ' O ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -108.27 -171.52 1.88 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 80' ' ' PHE . 14.4 m95 -132.03 82.19 2.01 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 108.675 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.481 ' N ' HG21 ' A' ' 12' ' ' VAL . 2.1 mttm -115.6 136.95 22.89 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.036 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.74 156.83 6.15 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.055 1.837 . . . . 0.0 110.16 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.762 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -162.31 170.1 19.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -0.952 . . . . 0.0 109.877 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.762 ' O ' ' SD ' ' A' ' 24' ' ' MET . 73.5 t-105 -97.7 142.61 29.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.556 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.17 135.4 10.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.977 -178.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -125.93 100.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.409 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.585 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -76.89 116.37 17.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.883 . . . . 0.0 109.502 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.7 mp -101.08 161.75 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -70.59 -13.83 62.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 -1.31 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 0.0 109.854 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA2' ' CD2' ' A' ' 50' ' ' LEU . . . 158.5 140.42 2.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 HD13 HD23 ' A' ' 50' ' ' LEU . 3.6 mp -95.57 121.11 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -1.203 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.1 pt-20 -120.82 120.74 36.45 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.607 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 p90 -121.95 147.44 46.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.981 -1.074 . . . . 0.0 110.893 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.94 -150.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.19 -43.46 6.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -108.8 -175.96 2.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -47.87 -22.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.878 -1.139 . . . . 0.0 109.337 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -148.46 -51.54 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.7 t70 61.81 10.34 3.41 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 42.2 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.112 -0.992 . . . . 0.0 109.954 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.1 t -167.54 109.45 0.61 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.938 -1.101 . . . . 0.0 109.891 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 54.1 Cg_endo -71.61 134.26 23.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.849 1.7 . . . . 0.0 110.557 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.75 -19.4 24.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.22 142.5 5.8 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.408 ' HG3' ' C ' ' A' ' 46' ' ' GLY . 16.7 mtm -136.27 126.96 27.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.155 -1.203 . . . . 0.0 109.533 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 49' ' ' PRO . 4.7 mt -88.94 136.8 30.2 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 108.8 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 48' ' ' ILE . 55.8 Cg_endo -72.31 140.74 34.23 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.721 1.614 . . . . 0.0 110.504 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -74.89 0.13 16.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.438 -0.789 . . . . 0.0 109.493 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.8 -92.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.04 68.81 0.24 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.51 ' HA ' ' N ' ' A' ' 74' ' ' THR . 14.4 m -60.27 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 109.6 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.34 122.32 15.61 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 -179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' CD1' HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -89.07 122.1 32.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.175 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 59.7 m -115.26 114.43 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.105 -0.997 . . . . 0.0 109.62 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.0 p -145.5 121.36 5.84 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' O ' HG21 ' A' ' 56' ' ' THR . 55.0 Cg_endo -71.92 175.3 43.23 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.559 -1.851 . . . . 0.0 110.342 -0.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.771 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 9.5 t -90.69 -94.75 0.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.6 mt-30 -141.75 -149.76 0.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.371 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -15.12 8.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.901 . . . . 0.0 108.818 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 -28.98 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.533 ' HA2' ' CG1' ' A' ' 68' ' ' VAL . . . -85.36 -14.38 68.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 65' ' ' ARG . 5.4 tttm -84.46 70.5 10.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -1.192 . . . . 0.0 109.579 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 165.17 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.586 ' SD ' ' NE2' ' A' ' 82' ' ' GLN . 2.7 mtt 67.2 -172.82 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 1.3 m-85 -88.15 83.37 6.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.2 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.539 HG22 ' CH2' ' A' ' 21' ' ' TRP . 1.5 p -127.08 136.27 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.841 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CD2' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -124.3 178.71 5.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.771 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 3.2 tttp -143.35 107.25 4.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 109.808 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.571 HG13 ' CE2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -90.45 170.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 108.987 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.561 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.4 m -145.86 90.87 2.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 72' ' ' THR . 2.4 p -40.44 142.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 109.837 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.51 ' N ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -40.55 -29.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 0.0 109.963 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -73.02 -70.77 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.319 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.9 pt20 164.15 38.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.0 99.83 9.37 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 p30 -63.35 152.96 36.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -144.57 96.41 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.727 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -91.15 117.65 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.059 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -135.82 162.53 32.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.956 -1.09 . . . . 0.0 109.587 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 36.5 tt0 -127.77 131.11 49.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.994 -1.066 . . . . 0.0 109.272 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 89' ' ' ARG . . . -89.5 -168.37 2.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.439 -0.788 . . . . 0.0 109.732 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -70.8 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.13 -179.98 4.1 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 109.473 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -55.62 -59.45 4.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.609 -0.682 . . . . 0.0 109.602 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.579 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 12.5 tm-20 -47.31 -67.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.048 . . . . 0.0 110.358 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 54.7 tt0 -52.42 -26.44 12.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HA ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -68.47 -63.6 1.03 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.036 . . . . 0.0 109.707 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.483 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 3.9 p30 -55.78 -27.84 53.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.27 -35.83 68.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 108.956 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.585 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.25 -41.53 73.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.613 -0.679 . . . . 0.0 110.358 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.614 HG22 ' CD2' ' A' ' 69' ' ' PHE . 5.3 p -76.89 -34.68 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 111.052 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -71.56 -23.55 61.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.768 -1.207 . . . . 0.0 109.323 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.41 -39.36 22.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.472 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.533 ' CG1' HD21 ' A' ' 28' ' ' LEU . 6.3 mt -69.82 -37.59 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.4 -26.96 38.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.113 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 3.5 tptp -65.13 -44.95 87.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.935 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . . . -71.62 -35.7 70.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.133 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 46.7 mt -72.72 -19.45 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.258 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.36 -16.24 26.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.53 -29.39 14.39 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 50' ' ' LEU . 7.9 mm -71.52 -26.24 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 67.9 mt-10 -51.92 -22.53 3.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.59 -104.97 1.7 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.624 0 O-C-N 121.412 -1.051 . . . . 0.0 109.576 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.444 ' HB2' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 30' ' ' GLU . 7.5 mt -52.42 -45.98 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.828 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.583 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -140.43 145.19 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.857 -179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.6 pm0 -155.04 132.46 11.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.081 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.46 -147.57 4.88 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.4 p90 -140.49 93.89 2.67 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.545 -0.973 . . . . 0.0 110.232 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -118.27 157.08 27.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 108.807 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 1.6 p -81.49 151.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -132.13 139.87 48.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 14.1 ttpp -84.14 113.92 21.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.375 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.11 167.7 42.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -91.43 -24.84 19.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 3.3 p -46.23 -32.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -177.03 -171.39 0.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.414 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -82.72 85.01 7.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.1 p -127.16 166.0 18.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 20' ' ' THR . 18.1 m95 -150.69 106.82 3.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' O ' HG21 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -131.73 133.14 23.84 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.23 149.95 20.93 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 109.922 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.742 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -159.38 168.3 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.699 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.0 t-105 -92.57 144.22 25.55 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.94 134.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.024 -178.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.5 m -124.07 105.66 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.761 . . . . 0.0 109.396 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 1.8 pp -80.74 111.87 17.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.137 -0.977 . . . . 0.0 109.581 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.512 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.3 mp -96.98 161.07 14.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -73.42 -11.23 60.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 4.5 p30 -108.86 2.79 21.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' HD21 ' A' ' 50' ' ' LEU . . . 150.86 144.57 3.95 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 50' ' ' LEU . 4.6 mm -92.86 130.49 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 110.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 5.5 pt-20 -132.86 113.71 13.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.742 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.3 p90 -119.43 147.0 44.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.09 -1.006 . . . . 0.0 110.735 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -127.92 -150.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.46 -53.54 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.53 -172.62 2.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.6 OUTLIER -54.1 -18.69 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.916 -1.115 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.92 -53.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.1 t0 61.35 9.42 2.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m120 40.5 24.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.221 -0.924 . . . . 0.0 110.071 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.6 t -167.45 122.46 0.84 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.982 -1.074 . . . . 0.0 109.499 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 59.2 Cg_endo -75.56 156.83 40.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.803 1.669 . . . . 0.0 111.276 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 2.8 tptt -119.13 -16.88 9.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -178.68 136.68 2.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.0 mtm -131.41 119.33 21.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -1.137 . . . . 0.0 109.697 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mt -89.77 139.47 27.77 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 38.6 Cg_endo -68.05 148.12 74.95 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.528 1.485 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.566 ' CD2' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -85.04 36.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.812 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -167.42 136.6 2.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.995 -1.066 . . . . 0.0 109.927 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 91.07 -36.18 3.69 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 2.7 m -42.11 156.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.396 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.481 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -123.31 169.89 10.86 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD1' HG21 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -131.47 124.24 29.75 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.06 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.494 ' N ' HD22 ' A' ' 55' ' ' LEU . 20.4 m -115.97 125.81 53.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.422 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -150.2 127.91 5.69 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.588 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 57' ' ' SER . 56.3 Cg_endo -73.96 -178.28 22.12 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.471 -1.887 . . . . 0.0 110.277 -0.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.782 ' SG ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -150.06 175.1 12.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.662 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.589 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 2.3 tt0 66.84 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -0.795 . . . . 0.0 110.172 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.84 18.61 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -89.26 -64.25 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -90.84 -21.85 35.15 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 8.0 pttt 40.33 32.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.724 -0.868 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -97.05 20.71 10.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.583 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 9.8 mtp 58.89 179.32 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' A' ' 66' ' ' MET . 1.8 m-85 81.22 -13.66 0.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.497 -0.752 . . . . 0.0 109.911 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG23 ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -109.84 135.18 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.979 -1.075 . . . . 0.0 109.423 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.735 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 4.0 p90 -121.36 167.18 13.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 19.5 ttpt -129.11 98.03 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.925 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.482 HG13 ' CE1' ' A' ' 69' ' ' PHE . 20.0 mt -90.9 155.41 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.538 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.565 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 39.9 m -134.61 112.31 10.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.049 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 49' ' ' PRO . 2.7 t -55.83 113.82 1.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 39.29 26.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 111.333 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.565 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tptm 80.86 47.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.904 -1.122 . . . . 0.0 109.16 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -83.64 0.6 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.206 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -101.21 129.81 47.2 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.662 -0.649 . . . . 0.0 109.441 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.96 171.1 15.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 69.6 m-70 -146.15 96.01 2.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.559 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 22.6 m-85 -93.16 100.22 12.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -0.796 . . . . 0.0 108.887 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.695 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.68 157.62 23.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.394 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.525 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 2.4 tt0 -121.19 128.85 52.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.065 -1.022 . . . . 0.0 108.999 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.52 -7.66 56.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.05 12.27 5.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.443 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.08 163.37 39.47 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.807 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -93.35 -48.03 6.61 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.577 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -69.48 -44.32 71.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.52 -0.738 . . . . 0.0 109.281 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.62 -34.65 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.684 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -62.07 -61.63 2.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -37.73 64.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -71.86 -26.79 62.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.084 -1.01 . . . . 0.0 109.773 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.574 ' CE2' HD22 ' A' ' 11' ' ' LEU . 1.1 m95 -79.84 -31.44 40.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.075 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 55' ' ' LEU . 1.3 p -83.43 -31.55 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.6 ptm180 -77.94 -25.16 48.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.308 -0.87 . . . . 0.0 109.187 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -82.0 -42.5 19.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.544 HD13 ' CZ3' ' A' ' 92' ' ' TRP . 29.5 mt -72.13 -37.46 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.177 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 7.7 t-20 -79.6 -33.81 41.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -67.37 -39.44 85.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.14 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.493 ' C ' ' CD1' ' A' ' 50' ' ' LEU . . . -68.81 -47.45 66.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.32 -0.863 . . . . 0.0 109.091 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.524 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 6.9 mt -67.89 -20.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 3.0 mmtp -90.11 -11.29 41.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.351 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.5 m -93.81 -38.16 11.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 108.856 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.8 mm -67.91 -29.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.49 -15.9 63.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.13 3.29 26.93 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.392 -1.064 . . . . 0.0 109.097 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.459 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.492 HD13 ' CA ' ' A' ' 30' ' ' GLU . 33.3 mt -74.43 -49.01 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.562 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -136.79 142.14 42.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.5 OUTLIER -148.45 137.05 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.398 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.585 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.42 -149.5 5.69 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.1 p90 -140.42 98.25 3.39 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -1.026 . . . . 0.0 110.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -120.09 171.91 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 108.621 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.532 ' CG1' ' HG2' ' A' ' 82' ' ' GLN . 2.2 p -102.97 131.54 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.669 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 18.4 ttmt -132.33 168.09 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' CD ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -63.83 103.97 0.63 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -67.33 -74.01 0.6 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.491 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.3 OUTLIER 175.84 -159.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -1.155 . . . . 0.0 109.316 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 16' ' ' SER . 2.5 p 39.93 94.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.558 -0.714 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.3 m-85 63.0 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.458 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -47.75 97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -120.38 -177.19 3.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' A' ' 68' ' ' VAL . 2.0 m95 -142.9 106.63 4.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 2.8 mmtp -130.33 140.84 39.88 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.85 163.85 1.82 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.876 1.717 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' A' ' 13' ' ' LYS . 17.7 ptm -176.91 159.67 1.75 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.778 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.9 t-105 -90.24 145.28 25.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.569 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -150.49 136.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.297 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.1 m -127.38 101.68 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.511 -0.743 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.638 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -74.01 119.68 18.56 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD13 ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -109.11 165.44 11.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.499 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.492 ' CA ' HD13 ' A' ' 6' ' ' ILE . 2.1 tt0 -73.44 -14.5 61.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.492 ' C ' ' CD1' ' A' ' 50' ' ' LEU . 5.2 p-10 -105.6 5.88 31.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.379 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.574 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . 143.58 144.07 4.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -90.94 107.79 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.285 -1.126 . . . . 0.0 109.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 11.3 pt-20 -105.22 116.68 32.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 108.769 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CE1' ' CA ' ' A' ' 46' ' ' GLY . 7.6 p90 -120.21 147.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.82 -152.06 0.5 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.02 -40.75 9.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.9 OUTLIER -112.83 -178.24 3.34 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -43.0 -25.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.069 -1.019 . . . . 0.0 109.54 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.18 -50.63 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.3 t0 62.99 8.42 3.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m120 41.16 23.58 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.8 t -166.51 96.69 0.72 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.1 Cg_exo -53.26 132.35 47.74 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.056 1.837 . . . . 0.0 110.739 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' HE3' ' CE ' ' A' ' 24' ' ' MET . 3.0 ttpt -89.77 -22.04 22.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.72 145.82 7.88 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 30.4 mtm -124.22 165.82 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -132.93 117.7 15.06 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 54.8 Cg_endo -71.07 125.29 11.32 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.682 1.588 . . . . 0.0 109.916 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -90.2 39.59 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.319 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -89.77 -43.01 10.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.109 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -159.41 42.8 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.9 OUTLIER -68.98 179.04 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -1.153 . . . . 0.0 109.562 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.487 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -144.23 108.75 4.86 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.283 -0.886 . . . . 0.0 109.593 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.1 tm? -89.79 115.65 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.483 ' HB ' ' HG3' ' A' ' 70' ' ' LYS . 3.2 m -110.4 119.86 40.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.175 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -144.2 123.88 7.35 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 0.0 109.654 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 56' ' ' THR . 57.5 Cg_endo -74.5 -170.21 7.88 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.648 -1.813 . . . . 0.0 110.171 -0.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 10.3 t -102.64 -105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.279 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.638 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 pt20 162.97 119.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.944 -1.098 . . . . 0.0 109.789 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER 81.27 -40.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.722 . . . . 0.0 110.651 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -90.59 85.8 6.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.934 -1.104 . . . . 0.0 110.001 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.536 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . 78.08 20.33 73.09 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 51.1 tptt -53.2 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.242 . . . . 0.0 109.175 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' GLY . 3.4 mtt-85 174.6 -86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.551 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mtp -60.38 -148.91 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.581 -0.699 . . . . 0.0 109.473 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 86' ' ' LEU . 98.4 m-85 -99.9 76.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' CH2' ' A' ' 21' ' ' TRP . 1.1 p -122.53 128.23 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.31 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 10.4 p90 -122.95 173.4 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HG2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -132.97 122.01 23.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.9 mt -93.62 167.94 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.057 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -146.49 85.86 1.66 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 49' ' ' PRO . 5.2 p -44.39 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.569 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.09 63.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.246 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 5.9 mttp -89.76 12.06 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.451 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 72.44 26.28 2.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.4 OUTLIER -89.84 119.55 30.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.13 -0.981 . . . . 0.0 108.998 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 4.4 t0 -89.36 135.92 33.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 89.1 m-70 -130.01 97.12 4.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.405 -0.809 . . . . 0.0 108.97 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 78' ' ' ASP . 1.9 m-85 -90.19 120.49 31.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.28 146.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.217 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.532 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 6.5 pt20 -116.52 145.71 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 108.777 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -92.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.72 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.74 174.94 6.36 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.652 -0.655 . . . . 0.0 109.615 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -65.16 -41.31 94.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.53 -0.731 . . . . 0.0 109.184 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -57.48 -67.0 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.701 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.5 -31.73 56.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' CD ' ' OD1' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -58.82 -65.13 0.71 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 109.967 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.533 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 47.6 m-20 -58.84 -23.76 61.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.902 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.91 -31.96 64.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.015 -1.053 . . . . 0.0 109.507 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.638 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 4.2 m95 -82.57 -39.05 22.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -77.4 -21.92 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.246 -0.909 . . . . 0.0 109.341 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 90' ' ' ASP . 10.0 ptp180 -85.3 -29.44 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -84.35 -39.32 19.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.589 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.54 ' CG1' HD21 ' A' ' 28' ' ' LEU . 5.6 mt -72.85 -34.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 108.801 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -80.7 -28.93 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -53.33 17.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . . . -59.01 -40.67 85.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 108.928 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 50' ' ' LEU . 44.9 mt -65.06 -33.76 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 108.943 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 8.8 ttpt -78.03 -9.42 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.484 ' SG ' ' HG ' ' A' ' 106' ' ' LEU . 8.8 t -95.13 -32.31 13.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.809 . . . . 0.0 109.141 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 3.2 mm -67.74 -33.74 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 15.2 mt-10 -75.01 -2.1 25.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.289 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.74 20.7 2.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.635 -0.921 . . . . 0.0 109.235 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.87 -39.77 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.543 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -131.73 169.55 16.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 109.866 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER 175.09 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 109.676 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.62 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.86 -147.14 5.02 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.0 p90 -138.96 103.83 4.9 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.975 -1.309 . . . . 0.0 110.902 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.644 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -120.63 158.17 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 0.0 108.546 178.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.526 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 2.1 p -86.53 129.78 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.968 -1.083 . . . . 0.0 109.295 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HD2' ' CB ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.97 170.15 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.467 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -116.18 134.83 54.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.82 0.21 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -125.31 -34.02 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.31 -84.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -133.06 71.8 1.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.61 60.76 3.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 48.7 p -115.83 -165.07 1.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.574 ' CH2' HG22 ' A' ' 68' ' ' VAL . 3.3 m95 -149.42 109.01 4.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 0.0 109.668 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 6.1 mttm -140.38 143.21 32.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -51.26 156.42 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.987 1.791 . . . . 0.0 110.188 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -160.88 176.65 11.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.759 ' O ' ' SD ' ' A' ' 24' ' ' MET . 68.1 t-105 -109.69 146.16 35.32 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.567 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -150.41 147.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.948 -178.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 5.3 m -130.96 119.32 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -0.969 . . . . 0.0 110.187 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -81.15 124.35 29.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 2.4 mp -119.95 159.94 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.97 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 8.9 pt-20 -72.88 -22.18 60.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 109.698 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.487 ' C ' ' CD1' ' A' ' 50' ' ' LEU . 3.2 p30 -96.17 13.07 28.59 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.118 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . 137.17 169.77 11.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 ' N ' HD11 ' A' ' 33' ' ' ILE . 3.6 mp -111.86 112.57 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.126 -1.22 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 16.8 pt-20 -107.83 117.39 34.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 108.637 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.644 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -115.67 148.88 39.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.44 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -130.89 -158.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 -34.3 14.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.405 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.503 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -123.78 -169.05 1.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 6.9 tppt? -46.4 -25.38 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.909 -1.119 . . . . 0.0 109.011 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -155.25 -48.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.4 t70 60.96 11.14 3.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 48.2 t30 43.62 23.07 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.01 -1.056 . . . . 0.0 109.353 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.7 t -164.4 99.99 0.88 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 51.4 Cg_endo -71.43 144.36 45.25 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.919 1.746 . . . . 0.0 110.704 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -89.65 -22.68 22.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.049 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.621 ' N ' ' CE1' ' A' ' 35' ' ' PHE . . . 172.89 158.49 17.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 3.8 mtt -123.3 -178.71 4.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -1.176 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 73' ' ' THR . 5.8 mt -135.98 116.26 11.38 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 109.279 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 73' ' ' THR . 51.1 Cg_endo -70.58 122.1 8.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.623 1.549 . . . . 0.0 110.099 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -73.01 -0.61 14.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.167 -0.958 . . . . 0.0 109.744 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' HB3' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -43.04 -60.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 70.02 0.18 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.129 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.2 m -82.72 177.32 8.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -1.197 . . . . 0.0 109.146 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.543 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -134.19 165.47 25.01 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.08 124.32 42.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.162 -0.961 . . . . 0.0 108.84 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.511 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 30.5 m -111.77 119.87 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.738 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 52.4 p -150.5 115.89 3.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' THR . 52.6 Cg_endo -71.6 -172.1 8.4 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.596 -1.835 . . . . 0.0 110.263 -0.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -94.69 -91.75 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.733 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 10.5 pt20 -145.36 -155.68 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.818 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 21.1 2.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.565 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 7.8 t80 -89.84 -57.22 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -112.55 16.31 24.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 20.2 tttm -48.55 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -1.167 . . . . 0.0 109.358 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 177.55 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.0 mtm -64.74 -148.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 77.9 m-85 -100.66 79.92 2.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.967 . . . . 0.0 109.464 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -117.45 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.326 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 9.2 p90 -126.63 172.09 10.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.663 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -133.43 116.1 15.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 109.786 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 69' ' ' PHE . 5.0 mt -95.4 162.01 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 64.8 m -131.19 92.68 3.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.47 ' CG2' HG21 ' A' ' 48' ' ' ILE . 2.8 p -57.54 150.3 19.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 108.839 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.523 ' CG2' ' HB3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -43.2 -26.04 0.15 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.508 -0.745 . . . . 0.0 109.846 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -88.28 35.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.554 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 43.87 31.02 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.743 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.463 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -89.64 87.46 7.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.17 143.92 42.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.829 . . . . 0.0 110.148 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.62 106.11 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -101.68 111.3 23.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.65 147.71 36.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 0.0 109.181 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -114.12 141.53 47.36 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.162 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.71 -147.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -93.78 -75.13 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -114.43 179.31 3.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.401 0.619 . . . . 0.0 109.482 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -56.55 -57.17 13.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.586 -0.696 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.488 ' N ' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -50.77 -51.02 54.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 60.8 tt0 -65.37 -24.85 67.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.029 . . . . 0.0 109.662 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -67.23 -66.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.805 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.571 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 14.5 m-20 -59.29 -32.21 69.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.51 84.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.524 ' CZ2' HD23 ' A' ' 11' ' ' LEU . 3.1 m95 -71.79 -56.77 5.16 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -0.937 . . . . 0.0 108.586 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -62.35 -13.65 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.542 -0.724 . . . . 0.0 109.152 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -80.48 -36.01 33.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 0.0 109.558 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.543 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -85.78 -27.19 25.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.06 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.527 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 4.8 mt -77.91 -36.9 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.929 -1.107 . . . . 0.0 108.957 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -84.94 -37.24 20.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.172 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.31 -49.74 52.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 0.0 108.971 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.47 95.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.107 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 ' CG1' HD22 ' A' ' 50' ' ' LEU . 22.5 mt -62.04 -39.13 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 108.752 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -79.32 -9.86 59.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.52 -20.08 19.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.409 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.552 HG22 ' CB ' ' A' ' 50' ' ' LEU . 3.2 tp -88.5 -16.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.18 -12.95 61.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.62 4.86 19.24 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.075 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.538 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.53 -61.52 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.972 . . . . 0.0 109.779 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.589 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.981 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.532 ' CB ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -166.48 130.43 2.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.063 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.61 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.31 -148.97 5.33 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 13.4 p90 -135.99 89.99 2.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.126 -1.22 . . . . 0.0 110.635 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.655 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -111.46 158.99 18.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 108.758 178.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.495 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 1.5 p -83.58 132.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 2.0 tttt -119.1 157.29 28.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -100.34 98.57 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.532 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 80.22 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.96 -42.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -1.117 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 10.8 p -179.35 106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 17' ' ' VAL . 5.3 m-85 56.82 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' PHE . 4.4 m120 -43.06 106.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.105 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 1.2 p -148.91 146.79 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.811 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.3 m0 -126.94 113.78 16.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' O ' HG21 ' A' ' 12' ' ' VAL . 1.5 mmtp -138.61 135.93 18.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.027 -1.046 . . . . 0.0 110.035 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.4 Cg_exo -53.99 152.76 22.68 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.914 1.743 . . . . 0.0 109.882 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.766 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -163.39 168.03 20.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.976 -1.078 . . . . 0.0 109.89 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.766 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.2 t-105 -96.06 143.79 26.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.57 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -151.61 139.82 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.236 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' CD ' ' A' ' 5' ' ' ARG . 5.7 m -125.94 113.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.621 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -85.82 102.89 14.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 108.964 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 5' ' ' ARG . 1.8 mp -89.51 155.78 19.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.192 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 7.2 tt0 -70.27 -19.3 63.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.324 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.26 4.91 31.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' CA ' HD22 ' A' ' 50' ' ' LEU . . . 164.21 -179.96 38.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' MET . 12.2 mm -137.0 119.42 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -1.153 . . . . 0.0 109.422 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' O ' HG21 ' A' ' 27' ' ' VAL . 4.2 pt-20 -127.51 117.24 21.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 108.87 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CE1' ' CA ' ' A' ' 46' ' ' GLY . 3.2 p90 -120.96 147.1 45.93 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.903 -1.123 . . . . 0.0 110.347 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.644 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.96 172.75 12.91 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -61.14 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.033 . . . . 0.0 109.288 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.3 mmtt -78.87 -168.76 1.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.985 . . . . 0.0 108.757 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 7.6 mtpt -77.61 5.69 8.68 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.89 -43.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 109.125 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 43' ' ' SER . 13.2 t0 48.61 18.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.304 -0.872 . . . . 0.0 109.541 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 43' ' ' SER . 59.9 t30 40.65 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.9 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t 178.05 112.83 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.626 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.486 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.7 Cg_endo -71.55 142.53 40.54 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.83 1.686 . . . . 0.0 110.638 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.3 -5.45 57.54 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -179.33 129.2 1.33 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.4 mtm -126.69 127.45 45.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -1.207 . . . . 0.0 109.978 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.446 HG22 HG21 ' A' ' 73' ' ' THR . 2.7 mt -94.59 131.81 30.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' HG21 ' A' ' 48' ' ' ILE . 56.2 Cg_endo -72.08 151.63 55.86 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.784 1.656 . . . . 0.0 110.626 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -90.95 5.26 49.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -0.865 . . . . 0.0 109.202 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.43 -72.15 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.125 -0.985 . . . . 0.0 109.689 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.29 74.83 0.17 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -78.79 -179.7 6.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -1.191 . . . . 0.0 109.382 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.493 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -133.55 107.77 8.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.326 -0.859 . . . . 0.0 109.673 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -89.65 117.71 28.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.324 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.552 ' N ' HD23 ' A' ' 55' ' ' LEU . 8.6 m -106.52 131.95 53.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -142.95 125.22 8.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.286 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 55.7 Cg_endo -73.25 -161.78 2.38 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.479 -1.884 . . . . 0.0 110.337 -0.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.4 p -104.43 -148.02 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.568 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.525 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.6 OUTLIER -89.78 -149.84 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.68 19.75 2.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.188 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.03 84.41 6.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.169 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 107.97 -55.91 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 63' ' ' GLY . 3.8 tttt 42.37 26.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.423 -1.045 . . . . 0.0 109.788 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 67' ' ' PHE . 19.4 mtp180 -88.01 16.56 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.295 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.514 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 19.3 mtm 65.8 8.74 5.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 65' ' ' ARG . 1.5 m-85 -135.45 28.29 3.36 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.465 HG12 ' SG ' ' A' ' 59' ' ' CYS . 2.5 p -127.18 127.13 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -0.999 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.733 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.51 166.44 10.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 109.884 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 15.8 ttpt -134.88 105.45 6.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.883 . . . . 0.0 109.134 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 ' CE2' ' A' ' 69' ' ' PHE . 2.7 mt -89.63 165.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.5 m -144.58 93.27 2.4 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -47.88 153.44 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 109.408 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -52.7 87.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.655 . . . . 0.0 109.655 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER 158.59 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.9 pt20 178.59 31.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.625 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.506 ' CB ' HG22 ' A' ' 73' ' ' THR . 10.0 mt-30 -97.12 105.67 17.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 108.758 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.577 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 11.9 p30 -82.85 144.1 30.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.012 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 94.5 m-70 -139.76 91.78 2.5 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -93.54 128.35 39.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.044 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.733 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -145.52 141.91 28.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -110.08 143.82 39.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.14 -146.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.538 ' C ' ' CD1' ' A' ' 85' ' ' PHE . . . -102.38 -18.65 15.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.627 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -166.9 172.13 10.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.561 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 tp -56.28 -39.94 73.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 109.831 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.16 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -63.68 -16.19 60.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.437 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -72.03 -64.12 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.561 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -66.13 -15.63 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.603 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.39 -40.67 29.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 109.012 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.621 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 3.0 m95 -77.97 -26.91 48.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.0 m -77.43 -32.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 7.3 ptp180 -80.44 -23.85 39.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.544 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' OD1' HD13 ' A' ' 28' ' ' LEU . 1.1 t70 -85.01 -46.87 10.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.016 -1.052 . . . . 0.0 109.706 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 28' ' ' LEU . 5.8 mt -70.05 -30.56 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.072 -1.018 . . . . 0.0 109.141 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 55' ' ' LEU . 7.8 t30 -84.65 -37.62 20.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.255 -0.903 . . . . 0.0 109.707 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 2.6 tppt? -69.92 -29.49 66.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -82.13 -28.71 32.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 31.1 mt -77.9 -30.05 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -16.69 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -95.77 -26.57 15.62 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.572 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 50' ' ' LEU . 8.4 tp -73.33 -25.48 21.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -0.93 . . . . 0.0 109.62 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' N ' HG21 ' A' ' 103' ' ' ILE . 2.2 mm-40 -50.96 -22.64 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 108.965 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -120.59 -104.5 1.98 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 O-C-N 121.408 -1.054 . . . . 0.0 109.594 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.492 ' CG ' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.565 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.5 mp -64.6 -49.04 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.588 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -119.17 147.17 44.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.987 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.54 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.3 pm0 -163.57 122.24 1.98 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.267 -0.895 . . . . 0.0 109.217 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.598 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.19 -145.71 4.42 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.59 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 p90 -135.48 93.33 2.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.018 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.624 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.19 161.29 14.39 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 ' N ' ' A' ' 13' ' ' LYS . 1.5 p -92.65 146.87 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.866 -1.146 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' N ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -134.74 150.18 50.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.757 . . . . 0.0 109.224 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.564 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 4.1 ttpp -62.11 140.33 58.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.0 158.02 20.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 55.63 2.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.59 -90.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 19' ' ' ASN . 80.3 m-85 -131.91 55.54 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 39.9 t-20 60.31 85.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 38.0 p -138.01 174.01 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.935 . . . . 0.0 109.718 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.586 ' CH2' HG22 ' A' ' 68' ' ' VAL . 15.6 m95 -150.2 100.66 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 108.941 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' O ' HG21 ' A' ' 12' ' ' VAL . 4.9 mttm -123.21 145.02 45.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.146 -0.971 . . . . 0.0 110.093 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -53.05 166.01 1.1 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.129 1.886 . . . . 0.0 110.507 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.757 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -173.32 169.33 4.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.276 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.757 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.8 t-105 -89.81 141.39 28.67 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.113 -0.992 . . . . 0.0 108.651 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.576 HG23 ' CH2' ' A' ' 92' ' ' TRP . 1.2 p -151.53 129.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.964 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 6.2 m -125.37 111.98 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.786 . . . . 0.0 109.568 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 2.6 pp -86.6 113.71 22.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.038 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 HD22 ' CG ' ' A' ' 5' ' ' ARG . 1.5 mp -92.93 157.75 16.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -71.61 -21.42 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.685 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -104.59 13.31 31.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 33' ' ' ILE . . . 157.49 -169.12 34.37 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 HD13 ' CD2' ' A' ' 50' ' ' LEU . 3.7 mp -149.63 131.64 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -1.182 . . . . 0.0 109.59 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 pt-20 -142.0 122.68 14.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.8 p90 -120.87 144.4 48.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.19 -155.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -92.28 -50.38 5.69 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.48 -174.26 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.41 -26.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.025 -1.047 . . . . 0.0 109.507 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 1.4 m -150.69 -48.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.348 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 3.4 t0 67.48 -6.58 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.725 -0.609 . . . . 0.0 110.589 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m-20 79.25 -40.57 0.24 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.292 -0.88 . . . . 0.0 110.122 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.1 119.12 35.3 Favored Pre-proline 0 C--N 1.31 -1.129 0 O-C-N 120.918 -1.114 . . . . 0.0 109.987 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 58.7 Cg_endo -74.96 145.26 31.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.799 1.666 . . . . 0.0 110.436 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.18 -32.32 16.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 108.991 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -155.49 138.2 5.95 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.5 mtp -130.59 118.53 21.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -1.121 . . . . 0.0 109.709 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.5 ' CD1' HG23 ' A' ' 33' ' ' ILE . 2.6 mp -89.88 128.99 47.99 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 48' ' ' ILE . 54.6 Cg_endo -71.34 146.65 51.16 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.816 1.677 . . . . 0.0 110.508 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -86.98 34.91 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.52 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -84.91 -82.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -150.01 62.89 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -66.61 -176.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -1.187 . . . . 0.0 109.458 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -136.94 113.36 10.03 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 55' ' ' LEU . 2.4 tm? -88.61 118.63 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.412 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' ' 59' ' ' CYS . 7.8 m -109.96 129.56 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.67 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -150.36 121.5 3.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.812 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' THR . 51.8 Cg_endo -71.8 -170.86 7.31 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.619 -1.826 . . . . 0.0 110.277 -0.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 1.7 t -100.3 -99.56 0.24 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.722 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -143.34 -147.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.997 -1.064 . . . . 0.0 109.756 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 24.5 m-20 -45.36 -22.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -0.996 . . . . 0.0 109.312 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.564 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 4.7 m-85 -89.86 -46.17 8.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.021 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.48 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -75.34 1.34 57.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 10.2 pttm -71.95 -9.23 58.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -1.199 . . . . 0.0 109.57 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 mtt180 -147.6 173.76 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ARG . 42.9 mtm 48.97 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.645 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 16.3 m-85 -98.15 65.09 1.7 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -108.14 124.11 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.682 -0.637 . . . . 0.0 109.338 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.76 177.03 5.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.766 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 5.0 ttpp -141.7 103.8 4.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 72' ' ' THR . 6.4 mt -89.41 168.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.089 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.2 m -143.73 88.75 2.01 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 75' ' ' LYS . 2.8 p -45.01 150.25 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -51.49 87.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.659 -0.65 . . . . 0.0 109.623 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 159.43 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 5.5 pt20 170.59 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.379 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -100.83 84.84 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.146 -0.971 . . . . 0.0 109.066 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.537 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 7.1 p30 -65.91 138.01 57.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.397 -0.814 . . . . 0.0 109.93 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 54.7 m-70 -132.23 99.61 4.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 108.933 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -94.56 124.31 38.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 109.944 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.706 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.21 142.88 24.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.965 . . . . 0.0 109.179 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 2.5 tt0 -108.15 136.42 47.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -91.7 -148.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.5 -90.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.242 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.578 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.91 177.65 4.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.071 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 24.7 tp -59.07 -25.42 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.114 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -63.81 1.0 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.331 -0.855 . . . . 0.0 109.2 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.91 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.459 ' HD2' HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -64.58 -67.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 109.398 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.506 ' O ' HG21 ' A' ' 93' ' ' VAL . 16.9 t0 -60.71 -14.61 22.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.074 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.74 43.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.606 ' CE2' ' CD2' ' A' ' 11' ' ' LEU . 6.2 m95 -78.95 -33.17 45.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 90' ' ' ASP . 1.8 m -72.19 -33.89 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.729 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -82.68 -22.76 34.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -80.01 -49.98 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 25.1 mt -68.85 -41.56 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.349 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -72.38 -29.72 64.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 12.1 tttm -70.67 -44.41 67.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . . . -63.97 -44.14 93.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.531 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 2.2 mt -64.98 -36.12 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.301 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -12.65 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.294 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.37 -25.98 16.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 50' ' ' LEU . 8.1 mm -81.69 -25.21 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.3 mt-10 -69.06 -6.99 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.29 9.08 7.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.354 -1.086 . . . . 0.0 109.302 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG23 ' OD2' ' A' ' 95' ' ' ASP . 19.8 mm -84.88 -42.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.949 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.554 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -150.57 104.29 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 2.4 pm0 -113.98 136.77 52.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 109.763 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.581 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.31 -146.69 4.8 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 3.8 p90 -141.8 95.81 2.87 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.317 -1.108 . . . . 0.0 109.961 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.64 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -115.77 156.3 26.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 108.748 179.172 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 22' ' ' LYS . 1.5 p -84.04 130.51 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.479 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 28.6 ttmt -131.29 164.53 25.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.302 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -113.48 138.01 50.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.004 . . . . 0.0 109.735 -179.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 161.61 117.08 0.42 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 164.53 -94.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -1.113 . . . . 0.0 109.442 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 18' ' ' PHE . 13.8 m -98.94 -21.9 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 17' ' ' VAL . 37.6 p90 -179.92 179.97 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.801 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.9 p30 -53.33 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.854 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' LYS . 65.8 p -113.92 151.87 31.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 108.649 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.527 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.0 m95 -128.56 113.52 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.762 -1.211 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -150.43 138.05 11.94 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.67 147.52 23.84 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.716 1.61 . . . . 0.0 109.812 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.726 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.74 167.65 28.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.01 . . . . 0.0 110.012 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.726 ' O ' ' SD ' ' A' ' 24' ' ' MET . 64.6 t-105 -89.79 143.35 26.87 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.542 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.86 127.29 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.177 -178.814 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -117.53 101.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.195 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.597 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.6 pp -81.78 109.81 16.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.1 mp -94.84 161.78 14.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.391 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HA ' ' CB ' ' A' ' 99' ' ' ALA . 4.2 pt-20 -72.29 -16.77 61.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.973 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.68 7.12 34.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.015 . . . . 0.0 109.441 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 151.6 154.5 6.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.537 ' CD1' HD13 ' A' ' 50' ' ' LEU . 2.6 mp -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -1.195 . . . . 0.0 109.877 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 12.3 pt-20 -127.3 113.79 16.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.674 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.5 p90 -117.81 147.97 42.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -131.3 -158.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -43.95 9.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 108.534 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.8 mmtt -107.31 -171.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -52.92 -19.61 2.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.195 . . . . 0.0 109.358 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -150.68 -49.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.955 . . . . 0.0 109.489 179.552 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.8 t0 62.0 10.55 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.445 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 33.9 t30 41.69 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.944 . . . . 0.0 109.906 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -168.57 110.13 0.53 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.811 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.4 Cg_endo -71.74 135.4 25.82 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.879 1.719 . . . . 0.0 110.545 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.1 ttpt -89.42 -23.66 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -170.86 148.08 11.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.426 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 5.0 mtm -137.21 128.98 28.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.08 109.66 36.85 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' O ' ' OG ' ' A' ' 53' ' ' SER . 50.6 Cg_endo -70.21 125.19 11.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.81 1.673 . . . . 0.0 110.348 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.537 HD13 ' CD1' ' A' ' 33' ' ' ILE . 3.1 mp -74.71 -2.79 27.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -44.98 -58.36 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 109.306 179.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -162.84 72.45 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -96.73 -175.47 3.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -1.131 . . . . 0.0 109.74 -179.88 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.72 108.06 5.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.377 -0.827 . . . . 0.0 109.551 -179.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD23 ' CG2' ' A' ' 93' ' ' VAL . 1.7 tm? -89.47 113.24 24.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 109.715 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 55' ' ' LEU . 31.1 m -104.52 113.05 26.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.505 ' CB ' HG23 ' A' ' 93' ' ' VAL . 1.6 t -143.44 139.38 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.422 -0.799 . . . . 0.0 109.532 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 57' ' ' SER . 60.0 Cg_endo -78.11 -179.58 27.56 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.277 -1.968 . . . . 0.0 110.503 -0.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -127.9 137.76 52.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 108.93 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -141.71 90.33 2.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 0.0 109.718 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 2.3 p-10 179.53 -32.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 109.161 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -88.57 -45.38 9.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -113.41 -24.63 4.66 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 178.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 10.9 ttmt 38.49 43.05 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.79 0.805 . . . . 0.0 109.499 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 66' ' ' MET . 6.4 mtt85 -136.24 18.5 3.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 108.892 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.546 ' C ' ' CG ' ' A' ' 67' ' ' PHE . 53.0 mtt 64.37 159.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.506 -0.746 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER 71.81 15.57 5.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG23 ' SG ' ' A' ' 59' ' ' CYS . 1.9 p -121.26 124.09 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.0 167.05 10.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.392 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 3.0 ptmt -142.86 109.58 5.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.175 -0.953 . . . . 0.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 36.2 mt -91.15 166.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.1 m -143.78 86.5 1.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' A' ' 77' ' ' GLN . 3.0 p -49.54 163.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -20.15 21.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -89.07 26.11 1.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.17 30.01 13.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.455 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 1.4 mt-30 -89.64 102.23 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.0 m-20 -77.22 145.97 37.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -143.14 109.96 5.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 1.5 m-85 -107.37 120.79 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -137.54 139.01 40.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 178.722 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 83' ' ' ALA . 1.5 tt0 -105.7 145.4 31.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 0.0 109.32 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.5 -166.93 1.72 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.146 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.541 ' CB ' ' CE1' ' A' ' 85' ' ' PHE . . . -86.48 -18.85 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.541 ' CE1' ' CB ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -160.83 169.83 21.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.632 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -60.4 -54.77 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.584 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.6 tt0 -43.21 -53.53 5.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.1 tt0 -65.5 -32.16 73.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.958 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -67.26 -26.13 66.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.97 . . . . 0.0 109.767 -179.696 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 3.4 t0 -83.32 -42.2 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.529 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . . . -70.01 -22.45 63.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 3.2 m95 -83.86 -39.09 20.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.529 ' CG2' HD23 ' A' ' 55' ' ' LEU . 2.5 p -76.39 -26.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.765 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.529 ' CG ' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -82.87 -31.12 28.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -75.45 -53.34 8.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 28' ' ' LEU . 22.9 mt -62.69 -32.51 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.222 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 4.4 t-20 -79.89 -26.62 40.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.317 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -69.68 -53.57 17.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 50' ' ' LEU . . . -62.02 -37.98 86.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.252 -0.905 . . . . 0.0 109.185 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 96' ' ' ILE . 26.5 mt -62.64 -38.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.019 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -80.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.581 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 13.5 t -95.32 -18.6 20.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.395 -0.815 . . . . 0.0 109.152 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.521 HG13 ' CD2' ' A' ' 50' ' ' LEU . 7.6 mm -90.59 -27.62 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.127 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.434 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.2 mt-10 -75.66 -3.41 34.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.36 12.91 5.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 102' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.457 -1.025 . . . . 0.0 109.378 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' HD3' ' CG1' ' A' ' 27' ' ' VAL . 3.5 mtt85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 43.4 mt -63.76 -56.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 109.431 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.577 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.32 148.22 46.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.7 pm0 -161.61 135.84 6.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.384 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.594 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.45 -147.44 4.97 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 11.0 p90 -139.18 98.17 3.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.464 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.637 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -118.94 159.07 24.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 108.863 179.56 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.527 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 1.7 p -86.77 125.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.119 -0.988 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 4.6 tppp? -113.49 145.95 40.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 109.208 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.528 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 9.2 tttt -64.36 150.16 46.82 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.311 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 101.51 -135.8 12.39 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 5.2 t 74.85 0.1 3.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.5 ' CG1' ' OG1' ' A' ' 20' ' ' THR . 2.6 p 175.48 -52.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.2 73.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.143 -0.973 . . . . 0.0 109.751 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m120 48.23 44.95 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.5 ' OG1' ' CG1' ' A' ' 17' ' ' VAL . 1.5 p -101.86 -166.16 1.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.622 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.4 m95 -141.32 109.34 5.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.007 -1.058 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.522 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -148.93 145.96 20.68 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 0.0 109.563 179.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.98 160.06 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.019 1.813 . . . . 0.0 109.923 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.745 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -169.38 166.43 10.4 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.802 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.745 ' O ' ' SD ' ' A' ' 24' ' ' MET . 63.3 t-105 -91.32 142.11 28.06 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.97 130.57 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.119 -178.952 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 7.8 m -121.13 113.16 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.489 -0.757 . . . . 0.0 109.556 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 1.8 pp -86.32 117.9 25.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.955 . . . . 0.0 109.081 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -104.95 162.32 13.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.51 -0.744 . . . . 0.0 109.861 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . 7.3 pt-20 -73.66 -7.43 51.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.431 -0.793 . . . . 0.0 110.366 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 103' ' ' ILE . 1.4 t0 -115.1 0.87 13.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.093 -1.004 . . . . 0.0 109.419 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 154.84 165.83 14.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 50' ' ' LEU . 6.9 mm -112.92 126.46 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.359 -1.083 . . . . 0.0 110.468 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 6.4 pt-20 -125.71 112.2 15.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.653 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 4.1 p90 -118.2 143.65 46.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.004 -1.06 . . . . 0.0 110.655 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -125.22 -150.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.98 -49.46 5.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.74 -175.83 2.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 108.833 179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 1.0 OUTLIER -49.51 -21.84 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.407 -179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -148.08 -51.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.4 t70 59.13 10.97 1.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.933 . . . . 0.0 109.333 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.7 m-80 39.63 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.375 -0.828 . . . . 0.0 110.174 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.0 t -166.04 118.91 0.85 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.764 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 57.7 Cg_endo -74.7 147.89 36.0 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.626 1.55 . . . . 0.0 111.096 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -101.64 -30.21 11.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.72 152.76 12.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.466 ' HE1' ' HB2' ' A' ' 44' ' ' PRO . 12.4 mtt -135.17 138.65 43.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 109.559 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.466 HG21 ' HD2' ' A' ' 49' ' ' PRO . 8.6 mt -104.57 134.18 19.8 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 108.732 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' CD ' ' OG1' ' A' ' 73' ' ' THR . 36.4 Cg_endo -66.12 137.53 48.5 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.492 1.462 . . . . 0.0 110.474 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.503 ' CD1' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -85.15 -6.32 59.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.276 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 48.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.022 -1.049 . . . . 0.0 109.895 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 175.22 -40.2 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.034 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 72' ' ' THR . 3.4 t -42.28 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 110.174 -179.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.54 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.91 170.15 11.38 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.602 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -130.97 148.5 52.74 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.97 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 21.3 m -145.17 137.28 25.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 108.941 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 58' ' ' PRO . 32.7 t -138.89 122.75 11.18 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' SER . 59.5 Cg_endo -75.62 -94.89 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.709 -1.788 . . . . 0.0 110.095 -0.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.636 ' SG ' HG23 ' A' ' 68' ' ' VAL . 14.8 p -143.69 -147.12 0.2 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.397 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.526 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -93.99 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.789 -179.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.99 18.67 2.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.217 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.4 t80 -89.11 -26.4 21.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.195 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -143.84 12.33 2.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 28.6 tttt -49.06 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 169.53 -91.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.462 -0.774 . . . . 0.0 109.191 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.9 mmm -61.5 -141.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 9.7 m-85 -107.42 76.11 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.461 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.636 HG23 ' SG ' ' A' ' 59' ' ' CYS . 1.3 p -113.75 122.84 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -105.83 168.94 8.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 7.8 ttpt -128.53 134.92 48.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.077 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.584 HG13 ' CE2' ' A' ' 69' ' ' PHE . 1.8 mt -124.97 169.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.575 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 74.1 m -147.81 110.99 4.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -0.975 . . . . 0.0 110.12 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 73' ' ' THR . 5.8 t -58.08 113.37 1.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.017 . . . . 0.0 110.235 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 40.74 24.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.772 . . . . 0.0 111.042 179.266 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 81.77 45.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.102 . . . . 0.0 109.19 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.1 OUTLIER -126.5 -85.31 0.61 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 -179.785 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.3 OUTLIER -94.16 146.22 24.14 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.641 -0.662 . . . . 0.0 109.649 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 68.3 m-20 -99.72 116.59 32.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -102.1 103.98 14.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.574 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -101.28 129.26 47.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 109.402 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -142.18 146.46 35.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.334 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 6.0 tt0 -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -91.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.628 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 67' ' ' PHE . . . -160.16 -83.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -101.59 171.92 7.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.705 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -55.04 -58.38 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.772 -179.67 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.59 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 2.0 tt0 -46.14 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -178.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 41.9 tt0 -40.87 -38.72 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 110.471 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -58.92 -61.34 2.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.997 . . . . 0.0 110.141 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 71.8 m-20 -57.26 -31.32 65.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.452 -179.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.68 68.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.934 -1.103 . . . . 0.0 109.851 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.579 ' CE2' HD23 ' A' ' 11' ' ' LEU . 2.2 m95 -76.36 -45.49 31.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.096 -1.002 . . . . 0.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.602 ' CG2' ' CD1' ' A' ' 55' ' ' LEU . 13.7 p -69.5 -23.12 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.0 mmt180 -81.4 -36.98 28.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.974 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -77.1 -39.53 49.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.092 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG13 HD21 ' A' ' 28' ' ' LEU . 6.0 mt -70.64 -46.31 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.774 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 17.3 t-20 -73.97 -30.55 62.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 0.0 109.712 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 7.8 ttpt -72.1 -34.92 69.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.232 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.499 ' O ' ' CG2' ' A' ' 103' ' ' ILE . . . -77.48 -23.0 50.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.481 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 5.5 mt -81.76 -36.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.119 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -14.77 48.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 2.4 t -95.77 -33.31 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.437 -0.79 . . . . 0.0 109.56 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 5.8 tp -73.06 -15.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 1.2 mm-40 -73.04 -7.66 52.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.93 9.81 7.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.382 -1.069 . . . . 0.0 109.236 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' HB ' HD13 ' A' ' 28' ' ' LEU . 7.0 mt -90.52 -32.3 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.572 ' CB ' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -139.94 157.56 45.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 179.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.551 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 2.0 pm0 -171.02 126.21 0.68 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.7 -147.33 4.99 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 p90 -136.57 91.98 2.71 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.398 -1.06 . . . . 0.0 110.225 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.65 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.24 168.49 9.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 2.1 p -100.23 124.46 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 110.071 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.761 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 mtpm? -104.68 163.67 12.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.6 -0.687 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.583 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -68.2 107.53 2.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 109.259 179.695 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' LYS . . . -41.17 139.99 1.42 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 p -85.69 64.51 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.13 -87.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -131.27 67.45 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.3 m120 54.55 77.42 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.192 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.1 p -129.08 172.53 11.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.593 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' CD1' ' HG2' ' A' ' 14' ' ' LYS . 3.1 m95 -141.08 121.86 14.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.361 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 8.0 mttt -149.18 136.08 10.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.78 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.2 Cg_exo -53.12 163.35 2.27 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.854 1.703 . . . . 0.0 109.986 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.761 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 22.3 ptm -177.34 164.14 2.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.044 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.9 t-105 -91.06 143.68 26.44 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.588 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -150.76 132.69 5.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.153 -179.052 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.551 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.7 m -121.64 100.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 ' CB ' ' A' ' 7' ' ' ARG . 2.3 pp -74.64 132.33 41.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.849 -1.157 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.2 mp -117.95 168.56 10.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.554 -0.716 . . . . 0.0 109.597 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' C ' ' CD2' ' A' ' 50' ' ' LEU . 15.1 pt-20 -74.42 -0.17 16.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.032 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.46 -3.62 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.142 -0.974 . . . . 0.0 109.235 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 154.41 158.47 8.69 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 2.3 mm -95.26 112.5 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 110.009 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 15.2 mt-10 -107.74 103.6 12.92 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.649 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 13.2 p90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.783 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -130.26 -153.96 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.328 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.98 -43.38 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 11.6 mttt -110.65 -176.55 3.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -43.34 -26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 109.531 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -149.61 -46.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.031 . . . . 0.0 109.854 179.863 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.0 t70 62.16 10.11 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.63 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.13 22.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.03 . . . . 0.0 109.823 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.4 t -168.7 98.33 0.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.925 -1.11 . . . . 0.0 110.287 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.608 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.6 Cg_exo -51.75 130.09 32.6 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.96 1.774 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 3.1 tttt -89.66 -19.57 24.71 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -176.06 132.62 2.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.1 mtm -121.65 121.17 36.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.211 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.466 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 24.6 mt -89.45 139.39 28.25 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 108.777 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 49.8 Cg_endo -70.63 131.85 20.8 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.587 1.524 . . . . 0.0 109.963 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 33' ' ' ILE . 2.4 tp -76.4 -0.75 23.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -136.11 129.11 31.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -0.994 . . . . 0.0 109.545 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 100.39 -5.51 57.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -97.64 172.97 7.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -1.152 . . . . 0.0 109.658 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.543 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -132.25 158.31 42.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.527 -0.733 . . . . 0.0 109.267 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.4 tm? -123.88 110.74 15.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.495 ' N ' HD21 ' A' ' 55' ' ' LEU . 87.0 m -102.83 110.38 22.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.0 p -148.64 131.3 7.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.701 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.77 150.78 93.34 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.462 -1.891 . . . . 0.0 110.391 -0.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 68' ' ' VAL . 1.2 p -90.03 167.53 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 27.2 tt0 -167.31 108.11 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.96 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 9.7 t0 165.63 -43.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 6.6 t80 -89.77 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -94.21 -21.78 26.6 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 31.61 44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.437 0.637 . . . . 0.0 110.206 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.2 ttp180 179.53 -170.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 65' ' ' ARG . 3.1 mtt 42.4 -153.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -110.17 69.29 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.488 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.774 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -107.63 130.25 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.354 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -109.08 169.37 8.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.218 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' O ' ' HB ' ' A' ' 56' ' ' THR . 15.3 ttpt -136.63 109.39 7.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.336 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 72' ' ' THR . 7.1 mt -95.41 165.46 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.344 -0.847 . . . . 0.0 108.996 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 89.0 m -138.98 89.79 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 3.1 p -54.63 155.69 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.103 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -51.65 -19.18 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.397 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.47 26.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.99 -1.068 . . . . 0.0 109.6 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.95 30.41 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.16 105.79 17.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.222 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 80' ' ' PHE . 3.4 m-20 -75.21 133.42 41.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -124.97 100.51 6.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -98.57 128.38 44.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.596 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -148.27 144.17 27.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 179.142 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 1.2 tt0 -103.99 136.39 43.73 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.36 -149.59 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.798 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 -86.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.869 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -124.2 173.69 8.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.748 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -42.55 -45.81 4.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.826 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 7.6 tt0 -52.61 -66.51 0.37 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.064 -1.023 . . . . 0.0 110.145 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -7.69 21.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.855 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -76.18 -54.74 6.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.554 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -77.75 -12.61 59.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.7 -33.33 35.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.56 ' CE2' ' HG2' ' A' ' 7' ' ' ARG . 3.7 m95 -78.01 -32.9 51.37 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 4.3 m -76.98 -29.7 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.667 -0.645 . . . . 0.0 109.771 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 17.0 mmt85 -79.62 -27.19 41.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.513 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -87.02 -44.27 11.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.025 . . . . 0.0 110.041 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.555 HG12 ' CB ' ' A' ' 28' ' ' LEU . 4.2 mt -69.23 -31.94 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.044 . . . . 0.0 109.128 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 3.7 t-20 -85.09 -36.11 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 27.2 tttt -66.27 -34.39 77.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.229 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.453 ' O ' ' CG2' ' A' ' 103' ' ' ILE . . . -80.78 -30.17 36.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.341 -0.849 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.474 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 22.9 mt -72.94 -29.55 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 7.4 mmpt? -93.43 -17.74 23.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 9.7 m -95.88 -16.58 21.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.481 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 6.5 tp -87.27 -15.85 9.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.8 -11.91 61.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.425 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.99 12.34 9.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.482 -1.011 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.553 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 30' ' ' GLU . 96.3 mt -67.38 -44.37 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.997 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.544 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.4 tpm_? -125.4 150.38 47.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -0.997 . . . . 0.0 110.237 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.53 ' CB ' HG11 ' A' ' 27' ' ' VAL . 2.1 pm0 -160.49 121.26 2.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.144 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.599 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.5 -145.28 4.19 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.2 p90 -142.1 102.6 4.15 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.286 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.59 ' CD2' ' CG1' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.16 169.08 9.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -101.34 133.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 0.0 109.891 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -128.31 131.89 48.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.619 ' HD3' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -96.3 151.28 19.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 108.795 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 14' ' ' LYS . . . 178.45 151.7 9.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 30.9 t 61.06 -88.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.242 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 18' ' ' PHE . 7.2 p -44.44 166.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' N ' HG23 ' A' ' 17' ' ' VAL . 27.3 p90 -73.78 -176.08 2.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.703 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' ' CD1' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -43.66 109.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' TRP . 18.6 p -146.38 -58.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -0.9 . . . . 0.0 109.902 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.643 ' NE1' ' CZ ' ' A' ' 62' ' ' PHE . 32.9 m95 63.51 106.1 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.488 0.661 . . . . 0.0 110.207 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' N ' HG21 ' A' ' 12' ' ' VAL . 45.0 mttm -125.54 134.86 26.22 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.65 159.71 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.906 1.737 . . . . 0.0 110.611 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.578 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 13.5 ptm -173.23 171.05 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.243 -0.91 . . . . 0.0 109.273 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 52.4 t-105 -89.56 140.83 29.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.59 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.54 127.63 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.171 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.53 HG11 ' CB ' ' A' ' 8' ' ' GLU . 17.2 m -126.42 119.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 109.46 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 28' ' ' LEU . 2.8 pp -87.99 106.02 17.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.553 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 3.6 mp -90.34 162.53 15.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.898 . . . . 0.0 109.473 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -72.61 -12.39 61.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.68 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HA ' HD12 ' A' ' 103' ' ' ILE . 1.6 m-20 -107.27 -0.81 22.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 157.93 144.68 4.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' A' ' 50' ' ' LEU . 3.1 mm -96.41 109.07 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -1.105 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 9.2 pt-20 -119.79 131.94 55.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 108.869 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.8 p90 -127.63 142.36 51.37 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 110.073 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -123.42 -149.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.628 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -63.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 109.179 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.0 -178.66 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 108.939 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.79 -42.75 17.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -144.14 69.54 1.28 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.507 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 18.4 t70 -47.41 -21.33 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 2.9 t-20 91.78 -18.49 0.14 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -134.25 119.63 14.5 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 45.1 Cg_endo -69.43 132.93 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.685 1.59 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.69 -21.56 22.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.563 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -160.01 117.98 0.8 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 167.8 9.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -1.156 . . . . 0.0 109.662 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 5.5 mt -140.8 109.72 6.59 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.25 118.23 5.55 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.597 1.531 . . . . 0.0 110.35 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' CB ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -67.93 -7.06 25.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.545 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -42.88 -68.13 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.725 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.432 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -150.14 71.46 0.3 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.009 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -177.65 5.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.196 . . . . 0.0 109.256 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.17 113.09 8.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.251 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 71' ' ' ILE . 3.4 tm? -88.67 131.37 35.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.281 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 31.6 m -115.99 137.63 51.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.436 ' N ' HG21 ' A' ' 56' ' ' THR . 17.9 p -150.13 118.03 3.6 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.456 ' O ' ' CG2' ' A' ' 56' ' ' THR . 48.2 Cg_endo -70.78 -160.87 1.7 Allowed 'Cis proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.493 -1.878 . . . . 0.0 110.424 0.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.559 ' SG ' HG12 ' A' ' 68' ' ' VAL . 22.7 p -91.07 -149.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -163.43 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.85 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 21.11 2.34 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.643 ' CZ ' ' NE1' ' A' ' 21' ' ' TRP . 8.3 t80 -88.64 -56.44 3.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 108.738 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -75.27 -50.14 8.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 15.7 pttm 40.53 28.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.98 . . . . 0.0 109.59 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.9 ttt180 -137.75 15.5 2.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt 64.6 -162.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 49.31 23.11 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG12 ' SG ' ' A' ' 59' ' ' CYS . 10.7 p -161.28 126.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.715 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.4 p90 -116.23 167.38 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.7 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -124.7 108.61 12.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.4 mt -90.1 166.71 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.635 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -148.95 89.47 1.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.53 ' OG1' ' CG ' ' A' ' 77' ' ' GLN . 3.2 p -47.22 173.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -22.06 64.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.443 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -74.14 -5.92 44.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.184 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 2.7 mt-30 79.13 36.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.8 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 1.9 pt20 -109.11 90.66 3.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 m-20 -53.76 159.53 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.394 -0.816 . . . . 0.0 110.342 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 77' ' ' GLN . 82.7 m-70 -150.56 124.48 9.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -100.4 114.85 28.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.082 -1.012 . . . . 0.0 109.892 -179.461 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.715 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.11 148.8 42.65 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 68' ' ' VAL . 2.7 tt0 -138.14 133.87 33.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.063 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.63 -160.8 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.399 -0.813 . . . . 0.0 109.194 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.531 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -106.48 -2.03 22.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.514 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -173.02 167.1 5.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.0 179.973 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.438 ' CD1' ' HD2' ' A' ' 89' ' ' ARG . 33.2 tp -66.36 -14.16 61.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.558 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -67.21 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.189 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.68 -14.68 61.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.274 179.715 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.54 ' CG ' ' HA ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -76.05 -51.55 12.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -68.34 -19.95 64.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 109.478 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -87.47 -31.34 20.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.581 ' CH2' HG23 ' A' ' 26' ' ' VAL . 1.6 m95 -79.95 -32.28 39.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' CG2' HD13 ' A' ' 55' ' ' LEU . 1.7 p -82.55 -34.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.17 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 7.9 ptm180 -73.58 -25.97 60.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 108.998 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 19.4 t0 -85.4 -49.05 8.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.531 ' CG2' HD12 ' A' ' 71' ' ' ILE . 23.9 mt -61.62 -38.42 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.048 -1.032 . . . . 0.0 108.831 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.483 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 11.3 t-20 -75.92 -66.02 0.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 8.4 tttp -43.08 -32.75 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.412 ' C ' HD22 ' A' ' 50' ' ' LEU . . . -69.47 -47.09 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.13 -55.54 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.766 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -63.69 -12.64 36.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -85.82 -32.39 21.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.8 . . . . 0.0 109.184 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.554 HD13 ' CB ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -78.26 -30.46 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -0.868 . . . . 0.0 108.937 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.0 mm-40 -72.97 -5.35 38.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.356 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.75 13.99 5.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.465 -1.02 . . . . 0.0 109.284 179.984 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.552 ' CG ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.312 0.577 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.472 ' HB ' HD13 ' A' ' 28' ' ' LEU . 31.3 mt -63.83 -53.95 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -113.7 147.22 38.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 109.858 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.54 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.1 pm0 -163.93 126.05 2.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.794 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.587 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.08 -145.08 4.16 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 p90 -134.89 92.32 2.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.954 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.694 ' CD2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -106.96 162.78 13.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.149 -0.969 . . . . 0.0 109.419 179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.572 ' CG1' ' CB ' ' A' ' 82' ' ' GLN . 2.3 p -98.92 130.38 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HE2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.47 135.11 53.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.322 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 tttt -64.46 96.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LYS . . . -43.61 166.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 t -84.52 -4.45 58.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.541 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.3 p -93.37 114.55 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' VAL . 21.9 m-85 52.34 174.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -87.21 86.39 7.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.252 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 61.3 p -120.58 -177.14 3.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.954 . . . . 0.0 109.757 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.642 ' CZ3' ' CG ' ' A' ' 82' ' ' GLN . 44.0 m95 -154.52 106.2 2.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.035 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.499 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -125.3 133.25 24.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 109.989 -179.55 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 Cg_exo -53.55 166.14 1.38 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.972 1.781 . . . . 0.0 110.323 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.77 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -174.92 169.68 3.39 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.77 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.1 t-105 -91.37 145.31 24.74 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.592 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -150.34 132.43 5.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.329 -178.324 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -127.79 102.95 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.549 HD21 ' CE3' ' A' ' 92' ' ' TRP . 2.5 pp -79.4 125.8 30.0 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.269 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' CD2' ' CG ' ' A' ' 5' ' ' ARG . 2.2 mp -112.74 163.66 14.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.428 -0.795 . . . . 0.0 109.114 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.482 ' O ' HD21 ' A' ' 50' ' ' LEU . 7.6 pt-20 -73.84 -6.27 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.28 -0.1 13.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.296 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.49 ' CA ' HD12 ' A' ' 50' ' ' LEU . . . 156.14 148.04 4.93 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 ' CB ' ' A' ' 28' ' ' LEU . 4.0 mm -98.93 108.16 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -1.139 . . . . 0.0 109.313 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 10.7 pt-20 -111.1 112.54 24.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.018 -1.051 . . . . 0.0 109.185 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.684 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.9 p90 -115.13 142.6 46.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.192 -0.943 . . . . 0.0 110.053 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.67 -149.38 0.41 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 108.613 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -99.91 -54.64 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 108.586 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -93.15 -171.28 2.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.642 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 8.1 mtpt -63.85 -9.89 17.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.657 -1.277 . . . . 0.0 109.704 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -152.65 -51.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.359 178.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.6 t0 57.46 11.0 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 38.67 24.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.814 . . . . 0.0 110.557 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.7 t -176.68 95.57 0.24 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.831 -1.168 . . . . 0.0 110.029 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.656 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 52.8 Cg_exo -53.9 153.77 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.169 1.913 . . . . 0.0 111.524 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 tttt -101.55 -21.7 14.67 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.42 141.07 5.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 5.5 mtm -139.83 132.11 28.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.261 . . . . 0.0 109.841 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.486 HG21 ' HD2' ' A' ' 49' ' ' PRO . 19.7 mt -89.07 129.15 49.15 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.8 . . . . 0.0 108.905 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 48' ' ' ILE . 42.9 Cg_endo -68.84 131.75 23.28 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.774 1.649 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' CD2' HG13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -89.22 30.66 0.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.403 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -36.15 15.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.415 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 74' ' ' THR . . . -177.51 84.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.12 -177.68 3.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -1.158 . . . . 0.0 109.675 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -135.43 114.51 12.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.405 -0.809 . . . . 0.0 109.696 -179.193 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.3 tm? -88.58 131.88 34.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.216 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.413 ' N ' HD12 ' A' ' 55' ' ' LEU . 23.9 m -124.06 121.37 35.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m -148.46 137.06 11.67 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 109.745 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.05 177.89 37.05 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.391 -1.92 . . . . 0.0 110.438 -0.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' CB ' ' A' ' 70' ' ' LYS . 1.9 t -150.14 -149.53 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER 63.17 115.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.413 -0.804 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.38 7.14 28.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.015 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -89.49 -42.7 11.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.66 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -118.16 -17.92 5.2 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 36.66 31.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.839 -0.801 . . . . 0.0 109.582 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 22.54 5.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.525 -0.735 . . . . 0.0 109.639 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.563 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER 55.81 -179.43 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 108.956 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.1 m-30 83.26 -20.18 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.732 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -102.22 135.45 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.388 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -110.91 152.32 26.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.958 . . . . 0.0 109.985 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.773 ' CB ' ' SG ' ' A' ' 59' ' ' CYS . 1.7 tttp -124.41 103.89 8.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.525 -0.734 . . . . 0.0 109.314 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 12.7 mt -90.87 167.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.9 m -145.64 84.11 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.467 HG23 ' HD2' ' A' ' 49' ' ' PRO . 4.5 p -42.96 165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 109.594 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -62.68 -16.8 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.472 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.42 19.71 5.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.26 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.17 34.66 16.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.765 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.461 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -97.82 94.52 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 66.2 m-20 -62.8 155.73 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 51.3 m-70 -139.38 124.07 18.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 71.1 m-85 -93.01 124.36 36.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.436 -0.79 . . . . 0.0 109.866 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.691 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -122.8 141.78 51.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.337 -0.852 . . . . 0.0 110.017 -179.53 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.642 ' CG ' ' CZ3' ' A' ' 21' ' ' TRP . 1.4 mm100 -135.51 108.74 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.322 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.37 -145.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.505 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -132.75 1.53 3.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.849 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -172.28 154.15 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.14 -22.18 66.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 -179.821 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -66.16 -68.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 0.0 109.091 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 85' ' ' PHE . 3.0 tt0 -60.28 -21.95 62.55 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 108.792 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -62.0 -65.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 179.592 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.562 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -57.06 -34.25 68.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.807 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.43 75.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.116 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.694 ' CE2' ' CD2' ' A' ' 11' ' ' LEU . 13.2 m95 -74.83 -56.29 4.92 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.341 -0.849 . . . . 0.0 108.795 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -64.48 -11.07 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.607 -0.683 . . . . 0.0 109.252 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 19.4 mmt180 -84.42 -39.74 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -87.28 -21.33 25.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.939 -179.745 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.507 ' CG1' HD23 ' A' ' 28' ' ' LEU . 6.2 mt -87.42 -38.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 109.095 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 2.0 t-20 -80.17 -33.34 38.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 108.874 179.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -72.5 -45.06 61.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.078 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB2' HD23 ' A' ' 50' ' ' LEU . . . -64.95 -41.69 95.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.206 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.526 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 33.6 mt -66.64 -32.79 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.111 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -81.92 -11.83 58.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.16 -24.34 16.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 108.954 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' A' ' 50' ' ' LEU . 9.1 mm -69.05 -23.75 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.457 -0.777 . . . . 0.0 109.213 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.7 -1.78 32.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.407 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.54 19.55 1.02 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 121.554 -0.968 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.1 mt-10 -72.51 -51.51 7.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.654 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 53.6 Cg_exo -49.31 124.95 12.67 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.774 1.649 . . . . 0.0 110.219 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 71.05 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' HD3' ' CB ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.69 167.86 11.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' CG2' HD13 ' A' ' 28' ' ' LEU . 50.6 mt -73.59 -58.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.537 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.35 107.46 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' CB ' HG11 ' A' ' 27' ' ' VAL . 1.8 pt-20 -111.97 143.92 42.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.632 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.19 -151.06 6.26 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 6.3 p90 -145.26 96.27 2.81 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.385 -1.068 . . . . 0.0 110.086 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.649 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -119.17 163.5 16.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG23 ' CE3' ' A' ' 21' ' ' TRP . 1.4 p -86.17 130.69 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 81' ' ' PHE . 1.1 tttt -122.43 135.0 54.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.388 -0.82 . . . . 0.0 109.717 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -101.13 99.57 10.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 108.864 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 166.69 90.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 2.5 p 161.85 -41.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.35 -1.088 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.524 ' CG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 m -100.92 -144.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 19' ' ' ASN . 19.4 m-85 -94.27 72.95 3.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.772 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.492 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 2.8 m-20 44.16 88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.007 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.524 ' OG1' ' CG2' ' A' ' 17' ' ' VAL . 76.1 p -146.88 -162.52 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.575 ' CE3' HG23 ' A' ' 12' ' ' VAL . 3.2 m95 -151.4 102.82 2.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.383 -0.823 . . . . 0.0 109.354 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.514 ' N ' HG21 ' A' ' 12' ' ' VAL . 24.1 mmtt -137.85 142.02 34.8 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.7 Cg_exo -52.63 160.23 4.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.92 1.746 . . . . 0.0 109.759 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.746 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -167.43 166.65 14.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.951 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.728 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.1 t-105 -92.78 141.07 28.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.556 HG23 ' CH2' ' A' ' 92' ' ' TRP . 1.3 p -149.9 133.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.764 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG11 ' CB ' ' A' ' 8' ' ' GLU . 8.0 m -124.98 111.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.06 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.57 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -82.4 119.86 24.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -0.976 . . . . 0.0 108.761 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -106.04 166.75 10.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.811 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HB3' HD13 ' A' ' 6' ' ' ILE . 3.9 pt-20 -71.93 -6.63 43.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.865 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.91 -1.73 11.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' N ' HD12 ' A' ' 50' ' ' LEU . . . 155.35 146.64 4.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -97.12 105.15 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -1.087 . . . . 0.0 109.956 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 5.4 pt-20 -102.38 128.2 49.06 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.746 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.0 p90 -124.7 147.29 48.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 110.903 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.13 -145.41 0.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.7 -42.47 5.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.947 -1.096 . . . . 0.0 108.986 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -115.63 -177.79 3.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 108.821 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 4.2 tppt? -46.68 -34.69 5.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -157.12 73.47 0.75 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.515 -0.741 . . . . 0.0 109.469 178.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 31.5 t70 -52.61 -17.36 1.24 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 5.8 m120 91.16 -18.32 0.15 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -135.45 116.44 11.93 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 47.1 Cg_endo -69.2 144.18 56.12 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.735 1.623 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 8.1 mmtt -90.07 -25.6 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 108.926 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.54 150.5 10.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.4 mtt -118.23 166.97 11.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.435 HG21 ' HD2' ' A' ' 49' ' ' PRO . 39.9 mt -128.99 131.24 23.6 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HD2' HG21 ' A' ' 48' ' ' ILE . 45.9 Cg_endo -69.77 135.46 30.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.353 1.369 . . . . 0.0 109.797 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HA ' ' CG1' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -85.49 37.98 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 109.924 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HB2' HG23 ' A' ' 103' ' ' ILE . 12.7 tttm -172.71 99.36 0.14 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.032 -1.042 . . . . 0.0 109.425 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 123.87 11.28 4.94 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.311 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 1.2 t -97.15 156.87 16.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.934 -1.333 . . . . 0.0 109.777 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -116.9 173.13 6.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' CD1' HG23 ' A' ' 93' ' ' VAL . 1.7 tt -134.64 135.64 42.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.021 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 70' ' ' LYS . 4.3 m -121.32 108.23 13.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.533 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 13.4 p -142.22 116.14 6.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 57' ' ' SER . 33.7 Cg_exo -62.15 -172.85 2.32 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.936 -1.693 . . . . 0.0 110.682 -1.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.7 p -98.14 -146.78 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.33 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.542 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -102.72 -149.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.3 17.81 3.52 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.337 -0.852 . . . . 0.0 108.887 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CZ ' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -89.33 77.67 7.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.308 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 102.27 -73.42 0.32 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 42.79 29.86 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -1.093 . . . . 0.0 109.477 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -93.78 -99.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 45.3 m-85 -129.55 87.2 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 0.0 109.531 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' CH2' ' A' ' 21' ' ' TRP . 1.3 p -120.15 117.32 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.618 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 4.4 p90 -106.97 165.12 11.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.331 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.485 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 1.9 ttpp -123.44 120.02 31.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.813 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.58 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.5 mt -106.8 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.551 ' N ' HG23 ' A' ' 54' ' ' THR . 87.1 m -134.17 94.48 3.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.09 150.29 25.45 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 108.976 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -45.94 -21.96 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.242 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -86.62 29.22 0.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 109.801 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.81 31.56 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.99 . . . . 0.0 109.67 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.492 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -97.49 97.45 9.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.42 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 77.4 m-20 -61.55 152.69 29.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 32.7 m-70 -142.32 88.92 2.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.872 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -91.13 101.63 14.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 108.95 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.42 146.83 51.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.528 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -116.39 143.71 45.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.331 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HB3' ' HG2' ' A' ' 88' ' ' GLU . . . -89.64 -146.69 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.5 ' C ' ' CD1' ' A' ' 85' ' ' PHE . . . -107.48 -15.87 14.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.574 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 1.7 p90 -170.59 172.44 5.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -53.84 -50.25 66.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 109.969 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 1.2 tm-20 -53.28 -39.23 63.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.271 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.574 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 20.8 tt0 -83.86 -16.13 45.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.071 -1.018 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 1.6 ttt180 -76.99 -46.51 23.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.992 . . . . 0.0 109.638 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 8.4 t0 -79.97 -27.2 39.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 109.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.499 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -73.81 -34.78 64.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.725 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.587 ' CE2' HD22 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -80.22 -48.44 13.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.825 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 HG23 ' CD1' ' A' ' 55' ' ' LEU . 3.6 p -68.71 -27.12 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.502 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 33.5 ptt85 -79.76 -30.72 40.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.052 . . . . 0.0 109.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.5 OUTLIER -75.21 -39.39 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.368 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 33' ' ' ILE . 28.2 mt -72.5 -42.4 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.57 -27.09 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 109.252 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 5.3 tppt? -72.27 -46.13 57.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 50' ' ' LEU . . . -64.13 -37.15 86.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.875 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.538 ' CG1' ' HA ' ' A' ' 50' ' ' LEU . 7.6 mt -69.58 -34.15 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.403 -0.811 . . . . 0.0 108.928 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -85.26 -8.28 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.399 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.61 -30.97 14.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 108.989 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.476 HG13 HD21 ' A' ' 50' ' ' LEU . 1.1 mm -69.44 -28.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.2 mt-10 -64.86 -10.51 29.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.583 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.21 10.93 5.59 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD21 ' N ' ' A' ' 106' ' ' LEU . 3.2 mm? -116.65 62.67 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.066 . . . . 0.0 109.385 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -102.36 171.79 7.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.489 -0.757 . . . . 0.0 109.316 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -117.43 -157.54 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 55.72 87.34 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -91.28 141.64 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -121.18 52.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -69.14 -34.21 74.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.44 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' CB ' ' HG3' ' A' ' 4' ' ' LYS . 1.5 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.367 0.603 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.576 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.8 mt-10 -60.85 -61.63 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.744 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 56.0 Cg_endo -71.54 -95.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.91 1.74 . . . . 0.0 110.431 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 1' ' ' MET . 0.7 OUTLIER 56.16 93.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.527 ' CG ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -79.06 148.19 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 30' ' ' GLU . 2.5 mp -66.81 -71.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.536 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.1 tpm_? -107.35 125.96 51.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 110.094 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 6.7 pm0 -145.88 122.91 11.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 0.0 109.178 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.596 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.62 -147.57 4.94 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 16.7 p90 -139.63 99.88 3.82 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.356 -1.085 . . . . 0.0 109.873 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.607 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -105.86 -143.03 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.544 HG12 ' CE3' ' A' ' 21' ' ' TRP . 9.9 p -149.71 129.12 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.013 . . . . 0.0 109.65 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.765 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.3 tttt -116.38 169.16 9.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' HB3' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -125.71 148.13 49.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' N ' ' HD2' ' A' ' 14' ' ' LYS . . . 115.58 107.72 2.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p 177.03 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 18' ' ' PHE . 17.9 m -143.06 -39.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 4.7 m-85 -168.29 61.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 48.69 43.55 20.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.548 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 12.7 p -89.99 172.35 8.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.544 ' CE3' HG12 ' A' ' 12' ' ' VAL . 5.1 m95 -126.21 120.08 29.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 6.2 mmtp -138.88 129.64 15.01 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 32.5 Cg_exo -59.14 119.06 6.08 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.916 1.744 . . . . 0.0 110.177 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.765 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 7.7 ptm -124.48 168.5 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.909 -1.119 . . . . 0.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.596 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 72.5 t-105 -90.45 145.53 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.578 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -151.49 139.67 14.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.403 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 6.1 m -130.25 98.31 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' ' CD1' ' A' ' 28' ' ' LEU . 1.9 pp -76.04 123.78 26.34 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.939 -1.1 . . . . 0.0 108.803 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 HD23 ' CG ' ' A' ' 5' ' ' ARG . 2.4 mp -107.26 166.08 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.461 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 31.5 tt0 -73.69 -9.2 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.28 4.27 15.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.915 . . . . 0.0 109.472 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 149.67 148.61 4.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 50' ' ' LEU . 3.5 mp -99.02 127.09 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 110.084 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 7.9 pt-20 -127.87 115.02 17.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.5 p90 -117.54 151.54 36.93 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -132.77 -153.32 0.54 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.141 -0.975 . . . . 0.0 108.38 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 40.8 mttt -124.62 -173.27 2.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 5.9 tppt? -45.5 -25.65 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.976 -1.077 . . . . 0.0 109.255 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -148.53 -50.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.54 10.86 3.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' ASP . 1.4 m-20 42.61 23.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -169.84 108.19 0.46 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.051 -1.031 . . . . 0.0 109.706 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.594 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.1 Cg_endo -71.49 136.57 28.82 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.8 1.666 . . . . 0.0 110.549 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.79 -17.95 27.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.02 140.36 4.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.1 mtm -133.16 124.8 28.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.29 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.429 HG22 ' CG2' ' A' ' 73' ' ' THR . 6.5 mt -89.73 134.84 31.43 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 73' ' ' THR . 56.7 Cg_endo -72.13 137.76 29.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.689 1.592 . . . . 0.0 110.078 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 30' ' ' GLU . 1.0 OUTLIER -85.82 38.7 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.542 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.53 -70.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.99 72.95 0.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 p -80.12 -170.1 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.363 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.488 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.33 111.53 6.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.516 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.4 tm? -88.59 116.42 26.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.017 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.8 m -102.09 130.56 48.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.421 -0.799 . . . . 0.0 109.578 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 t -150.05 120.05 3.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.41 -163.02 2.66 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.595 -1.835 . . . . 0.0 110.396 0.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.15 -158.84 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -71.33 -149.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -84.07 14.31 4.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.418 -0.801 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -10.1 49.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.884 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -124.75 -103.65 1.49 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 42.67 59.44 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.281 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 6.2 ttt-85 179.73 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.8 mtp -141.03 -155.95 0.63 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.471 -0.768 . . . . 0.0 109.766 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.546 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -92.99 65.37 4.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.91 . . . . 0.0 109.221 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.488 HG13 ' HA2' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -116.25 128.16 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.622 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 7.7 p90 -120.36 173.66 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 109.61 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.627 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 ttpt -129.99 108.34 10.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 0.0 109.396 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.59 HG13 ' CE1' ' A' ' 69' ' ' PHE . 1.3 mt -89.2 165.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 109.377 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.8 m -144.93 91.08 2.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 77' ' ' GLN . 2.7 p -45.7 162.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.364 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -13.26 15.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.678 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.99 15.84 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.83 32.28 4.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.55 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -89.95 -175.9 4.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.235 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 77' ' ' GLN . 2.6 m-20 -141.8 146.6 36.1 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.414 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.488 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 80.6 m-70 -145.79 92.63 2.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' CD ' ' A' ' 70' ' ' LYS . 36.1 m-85 -90.48 110.29 21.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.306 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.92 146.11 31.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.698 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 2.4 tt0 -113.06 139.54 48.6 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.471 -0.768 . . . . 0.0 108.948 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.93 -155.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.499 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.73 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 175.62 5.44 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 25.4 tp -56.41 -22.93 34.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 109.109 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -66.07 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.57 -16.88 58.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -0.871 . . . . 0.0 109.153 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.538 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -71.26 -64.04 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.533 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 10.4 t0 -62.01 -12.81 20.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.115 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.74 -30.93 28.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 108.666 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.578 ' CH2' HG23 ' A' ' 26' ' ' VAL . 5.8 m95 -84.02 -28.72 27.47 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 4.1 m -75.28 -36.76 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.543 -0.723 . . . . 0.0 109.535 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 8.5 ptp180 -83.83 -24.72 30.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.5 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' OD2' ' HD2' ' A' ' 7' ' ' ARG . 12.6 t0 -77.14 -45.7 25.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 28' ' ' LEU . 32.1 mt -76.51 -42.32 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 28.1 t-20 -69.44 -31.46 69.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.5 tmtp? -75.37 -50.75 14.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.31 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.43 -42.23 70.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.37 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 96' ' ' ILE . 5.2 mt -70.23 -39.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.239 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -71.21 -11.64 61.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.322 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.25 -33.91 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 109.244 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.462 HG13 ' HB3' ' A' ' 50' ' ' LEU . 8.5 mm -67.82 -16.9 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -73.57 -2.99 25.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.517 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.97 17.51 0.93 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.454 HD21 ' N ' ' A' ' 106' ' ' LEU . 2.0 mm? -110.5 60.69 0.61 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -1.012 . . . . 0.0 109.462 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.86 129.61 41.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.345 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -123.85 70.66 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.612 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.37 35.76 1.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.6 115.07 26.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 0.3 OUTLIER 179.17 -154.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.501 ' O ' ' CB ' ' A' ' 113' ' ' HIS . 0.7 OUTLIER 67.42 -86.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 112' ' ' HIS . 20.2 t-80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.492 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.1 mt-10 60.33 162.04 0.1 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 56.0 Cg_endo -75.48 148.92 34.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.009 1.806 . . . . 0.0 110.357 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 9.1 mttm -113.48 96.95 6.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 69.38 136.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.251 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 28' ' ' LEU . 28.2 mm -73.01 -59.79 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.928 . . . . 0.0 109.739 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.72 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.63 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -145.33 129.32 17.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.46 -146.95 4.76 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 p90 -135.89 99.84 4.27 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.615 ' HG ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -115.11 153.79 30.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 5.7 p -94.1 140.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.894 -1.129 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.747 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 11.3 mttp -123.07 169.7 10.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.92 113.58 21.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.37 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 153.99 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.14 -46.49 70.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.465 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.2 p -50.46 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 12.7 m-85 61.11 159.62 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -76.71 86.04 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.6 p -128.77 171.53 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CH2' HG22 ' A' ' 68' ' ' VAL . 23.6 m95 -133.01 101.62 5.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.456 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 2.5 mttm -107.54 134.19 20.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.35 147.77 44.93 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.644 1.563 . . . . 0.0 109.775 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.747 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 23.1 ptm -154.11 162.44 41.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.991 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.664 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.9 t-105 -94.79 147.91 22.84 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.584 HG23 ' CZ3' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -151.52 138.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.491 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.541 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 9.7 m -129.46 94.55 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.632 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -68.41 120.15 14.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.808 -1.182 . . . . 0.0 108.882 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.0 mp -102.62 164.83 11.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.56 -0.713 . . . . 0.0 109.372 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' HD21 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -71.63 -14.72 62.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -0.827 . . . . 0.0 109.818 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -109.3 4.62 22.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.657 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 149.62 150.32 5.22 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -92.5 121.11 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 109.938 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 10.3 mt-10 -116.75 107.94 15.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.625 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 12.9 p90 -117.68 145.64 44.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.953 -1.092 . . . . 0.0 110.686 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.646 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.44 -154.72 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 2.8 mtmt -91.95 -43.94 9.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 108.46 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -102.09 -170.9 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 108.743 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.664 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 mtpt -64.24 -10.04 21.06 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -150.99 -52.13 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.508 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 4.2 t70 59.95 11.37 2.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER 41.89 22.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -176.76 99.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.789 -1.194 . . . . 0.0 110.747 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.602 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.1 Cg_exo -52.79 135.1 56.52 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.989 1.793 . . . . 0.0 110.525 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.55 -18.74 26.04 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.65 126.16 1.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 51.7 mtm -122.05 123.47 41.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.594 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.493 HG21 ' CG2' ' A' ' 73' ' ' THR . 26.0 mt -89.82 132.81 35.43 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.005 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HD2' HG21 ' A' ' 48' ' ' ILE . 54.5 Cg_endo -72.11 129.7 15.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.681 1.587 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD2' ' CG1' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -84.67 43.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' HB2' HG22 ' A' ' 74' ' ' THR . 8.5 mmtm -95.73 -71.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.52 61.74 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.418 ' CB ' ' HA ' ' A' ' 73' ' ' THR . 2.4 m -85.43 171.39 11.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -1.171 . . . . 0.0 109.325 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.553 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.71 172.06 8.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -0.81 . . . . 0.0 109.455 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.2 tm? -133.96 136.41 44.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 108.74 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 32.9 m -126.29 131.5 51.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.076 -1.015 . . . . 0.0 110.118 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.5 p -150.37 119.89 3.72 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.449 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' O ' HG21 ' A' ' 56' ' ' THR . 52.9 Cg_endo -71.95 -161.49 2.08 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.56 -1.85 . . . . 0.0 110.179 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -146.68 130.12 16.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.564 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 57.04 163.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -103.49 -12.03 17.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.915 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.564 ' CD1' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -89.14 4.55 48.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.796 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -120.71 -19.48 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -49.65 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -144.1 -77.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.545 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -99.9 -39.86 7.96 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.5 0.667 . . . . 0.0 109.563 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CD1' ' HG3' ' A' ' 89' ' ' ARG . 0.4 OUTLIER 158.57 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.564 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -119.59 128.0 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.7 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 2.3 p90 -109.02 164.54 12.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.051 -1.031 . . . . 0.0 109.673 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.725 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -127.0 108.41 10.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 11.1 mt -89.33 160.29 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 99.8 m -131.59 85.43 2.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.493 ' CG2' HG21 ' A' ' 48' ' ' ILE . 6.9 p -44.13 158.14 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -58.71 -15.34 11.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.357 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -90.43 21.8 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 61.01 35.79 18.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.507 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -103.1 109.18 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.9 m-20 -76.08 146.64 39.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.507 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 39.4 m-70 -140.46 116.57 10.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.66 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CB ' ' CH2' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -98.54 128.49 44.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.7 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.94 160.35 40.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 108.783 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -142.14 132.55 25.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.75 -84.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' SD ' ' A' ' 66' ' ' MET . . . 179.16 -67.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -114.26 169.72 8.82 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.635 -0.665 . . . . 0.0 109.807 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -62.3 -19.74 63.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.591 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -71.28 -66.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.129 -0.982 . . . . 0.0 109.415 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -16.54 64.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HG3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -74.02 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.551 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 20.2 t70 -67.96 -14.72 63.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.03 -33.73 29.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.632 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 7.8 m95 -82.55 -25.87 32.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.9 m -79.96 -39.3 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.0 ptm180 -77.79 -23.93 49.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.483 ' OD1' ' CD1' ' A' ' 28' ' ' LEU . 1.5 t70 -81.61 -49.33 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.06 . . . . 0.0 109.506 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.496 ' CG1' HD21 ' A' ' 28' ' ' LEU . 32.5 mt -72.92 -31.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 6.1 t-20 -81.17 -36.02 30.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 3.2 ttpt -71.6 -37.81 70.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.456 ' O ' HD22 ' A' ' 50' ' ' LEU . . . -68.22 -43.38 78.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.92 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 60.0 mt -68.37 -30.47 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.163 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 5.4 mmtt -85.03 -10.9 56.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.11 -21.44 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.045 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.532 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 2.0 mm -75.51 -28.31 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.009 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.27 -5.54 33.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.17 11.69 5.85 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 106' ' ' LEU . 1.7 mt -101.22 57.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.486 -1.008 . . . . 0.0 109.25 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -120.72 19.51 11.83 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.704 -0.623 . . . . 0.0 109.595 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 5.6 t-80 -170.79 87.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 0.1 OUTLIER 171.07 122.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 84.95 7.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.432 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 58.96 -170.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -58.53 2.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.403 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.475 ' OXT' ' ND1' ' A' ' 113' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.068 -0.967 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 3' ' ' PRO . 15.8 pt-20 -144.8 159.44 50.48 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 2' ' ' GLU . 53.1 Cg_exo -55.22 -143.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.213 1.942 . . . . 0.0 110.474 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 64.07 96.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.407 ' HD3' HG13 ' A' ' 27' ' ' VAL . 1.3 mpt_? -73.75 150.72 40.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.237 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.0 mm -56.19 -53.65 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.546 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 1.7 tpm_? -141.88 108.68 5.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.207 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.464 ' HB3' HG13 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.99 131.23 55.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.987 -1.071 . . . . 0.0 109.189 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.4 -149.4 5.61 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 20.3 p90 -138.12 95.72 3.07 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.637 ' CD2' ' CZ2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -114.36 169.77 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -96.4 159.81 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.834 -1.166 . . . . 0.0 109.6 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.704 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -148.75 130.17 14.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HG3' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -50.73 150.9 2.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.414 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.06 -139.48 8.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.64 47.84 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -1.11 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 10.9 p -155.1 109.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' ASN . 25.1 m-85 58.52 22.0 9.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' PHE . 4.0 m-20 46.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.2 p -125.4 -179.29 4.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.595 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.573 ' CH2' HG23 ' A' ' 68' ' ' VAL . 39.0 m95 -144.97 88.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.204 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 12' ' ' VAL . 12.3 mttm -107.8 139.71 20.88 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.746 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.09 167.81 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.959 1.773 . . . . 0.0 110.598 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.704 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 25.6 ptm -174.8 158.43 2.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.89 . . . . 0.0 109.479 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.602 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.0 t-105 -89.79 147.17 23.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.413 -0.805 . . . . 0.0 109.03 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.555 ' HA ' ' CB ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.61 133.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.666 -178.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 34' ' ' GLU . 8.2 m -125.59 103.26 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -86.89 108.97 19.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.75 164.26 14.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.529 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -73.64 -17.65 61.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.591 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.67 9.4 43.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' N ' HD12 ' A' ' 50' ' ' LEU . . . 152.23 -176.59 30.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' A' ' 48' ' ' ILE . 2.8 mp -138.16 125.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.256 . . . . 0.0 109.528 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' HG21 ' A' ' 27' ' ' VAL . 4.3 pt-20 -132.23 116.77 17.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 108.929 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.633 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -119.49 147.54 44.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.13 -0.981 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.631 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.77 -157.2 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -88.39 -55.66 3.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.48 -178.82 5.02 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -49.28 -21.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.898 -1.126 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -146.63 -47.36 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.679 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 43' ' ' SER . 5.2 t0 62.29 9.9 3.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.8 t30 45.84 21.04 0.08 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.942 -1.099 . . . . 0.0 109.606 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.8 t -173.29 115.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.531 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.3 Cg_endo -72.35 132.27 19.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.922 1.748 . . . . 0.0 110.593 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -89.62 -19.65 24.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.58 120.66 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.0 mtm -119.28 125.58 49.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.118 -1.225 . . . . 0.0 109.84 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.539 HD11 ' CG2' ' A' ' 33' ' ' ILE . 2.7 mt -90.78 121.53 68.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.995 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.76 140.14 38.29 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.719 1.613 . . . . 0.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.526 ' HG ' ' CG1' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -84.9 37.82 0.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.864 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -70.09 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.132 -0.98 . . . . 0.0 109.375 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 74' ' ' THR . . . -136.33 24.71 3.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -40.09 141.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.441 -1.035 . . . . 0.0 110.383 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.552 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.47 167.26 10.6 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD21 ' N ' ' A' ' 56' ' ' THR . 2.2 tm? -137.66 117.38 13.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.985 -1.072 . . . . 0.0 109.449 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.502 ' N ' HD21 ' A' ' 55' ' ' LEU . 23.2 m -107.96 135.54 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.35 120.94 3.86 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.878 . . . . 0.0 109.239 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.91 -161.14 2.11 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.651 -1.812 . . . . 0.0 110.346 -0.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 9.2 p -102.93 -148.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.899 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.61 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 11.2 tt0 -71.6 -142.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -68.07 -2.23 7.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' O ' ' CG1' ' A' ' 68' ' ' VAL . 24.9 m-85 -88.99 -24.71 22.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 108.948 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -74.39 -49.14 12.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -19.83 6.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -1.063 . . . . 0.0 109.189 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -75.48 0.34 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -155.62 0.58 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 109.553 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.44 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 25.0 m-85 -97.52 86.66 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.573 HG23 ' CH2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -126.64 136.3 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.539 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.69 175.62 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -142.67 100.74 3.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.898 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.479 HD13 ' CE2' ' A' ' 69' ' ' PHE . 12.6 mt -90.12 160.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 108.995 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 53.2 m -140.71 105.36 4.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.349 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.467 ' C ' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -48.67 107.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.298 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER 39.55 28.94 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' THR . 5.5 tttt 82.73 46.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.979 -1.076 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -133.44 -86.71 0.43 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.079 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -90.9 136.84 32.81 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.645 -0.659 . . . . 0.0 109.669 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -89.29 168.26 12.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -148.04 98.41 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.5 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -96.04 119.6 34.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -137.01 167.99 20.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.05 -1.031 . . . . 0.0 109.061 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.53 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 34.7 tt0 -135.12 138.03 43.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.704 -1.248 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -90.14 -89.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.44 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.25 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.601 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.07 171.31 14.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD1' ' NH2' ' A' ' 89' ' ' ARG . 24.1 tp -53.65 -42.81 68.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.199 -0.938 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.07 -59.27 4.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 9.0 tt0 -65.23 -15.12 62.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.277 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -71.99 -65.22 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.539 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -69.56 -11.19 60.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.311 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 88' ' ' GLU . . . -80.52 -41.06 24.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 3.3 m95 -79.19 -28.56 42.64 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.335 -0.853 . . . . 0.0 109.165 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.539 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.1 m -71.24 -39.05 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 109.095 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -77.43 -23.03 50.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -76.74 -52.05 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.691 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 47.8 mt -73.03 -31.92 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 18.7 t-20 -78.1 -28.65 48.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.331 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.9 -42.29 49.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.11 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 6' ' ' ILE . . . -64.2 -36.35 83.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.871 . . . . 0.0 108.822 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 96' ' ' ILE . 4.9 mt -76.04 -31.47 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.127 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -83.08 -12.35 57.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.1 m -93.49 -28.39 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 108.931 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 2.6 tp -64.97 -33.18 61.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.418 -0.801 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' HG2' HG21 ' A' ' 103' ' ' ILE . 0.6 OUTLIER -70.92 -12.55 61.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.25 6.62 25.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -90.82 54.34 2.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.435 -1.038 . . . . 0.0 109.117 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.56 120.77 43.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -142.96 39.36 1.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.434 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -64.76 -160.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 51.9 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 109' ' ' HIS . 2.7 m-70 -69.64 103.3 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -92.18 114.12 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.3 mm-40 173.65 -61.94 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.696 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 53.7 Cg_endo -71.57 134.97 25.3 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.712 1.608 . . . . 0.0 110.243 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' O ' ' OE2' ' A' ' 8' ' ' GLU . 12.5 mmtt -101.22 73.58 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.299 -0.876 . . . . 0.0 109.275 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER 64.15 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 30' ' ' GLU . 34.3 mt -56.22 -67.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.593 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -116.89 148.86 40.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -157.6 134.33 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.592 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.67 -149.0 5.45 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.543 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 p90 -138.48 91.38 2.54 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.379 -1.071 . . . . 0.0 110.099 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.66 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -120.11 165.3 14.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.745 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.4 p -85.58 131.47 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.198 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' CG ' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -131.14 152.11 50.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -70.4 125.94 28.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.265 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 178.82 120.46 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 163.74 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.377 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG12 ' CD2' ' A' ' 18' ' ' PHE . 1.5 p -140.37 -47.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.574 ' CD2' HG12 ' A' ' 17' ' ' VAL . 4.0 p90 -140.01 -172.97 3.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.418 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 18.3 p-10 -47.49 92.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.567 HG21 ' CD1' ' A' ' 18' ' ' PHE . 59.2 p -130.07 155.57 45.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.625 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.0 m0 -126.67 119.75 27.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.452 -0.78 . . . . 0.0 109.389 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.06 131.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.815 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.6 Cg_exo -53.36 150.75 25.25 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.751 1.634 . . . . 0.0 109.751 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 11.6 ptm -168.98 165.83 11.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.066 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.594 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.8 t-105 -89.94 145.89 24.79 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -151.04 136.07 10.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.118 -178.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 4.0 m -125.72 103.63 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.593 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -77.59 112.25 14.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 27' ' ' VAL . 1.8 mp -89.54 159.75 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.447 -0.783 . . . . 0.0 109.496 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 7.7 pt-20 -70.75 -15.35 62.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' C ' ' HB2' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -112.56 6.8 18.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 109.687 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' HA2' HD21 ' A' ' 50' ' ' LEU . . . 167.45 -165.81 38.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.519 ' CG2' HD13 ' A' ' 48' ' ' ILE . 1.9 mp -144.85 121.99 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -1.097 . . . . 0.0 109.186 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 8.9 mt-10 -127.56 115.02 18.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.344 -0.848 . . . . 0.0 108.92 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.629 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 8.3 p90 -121.45 145.77 47.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 109.982 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -130.62 -167.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.119 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -80.22 -40.87 26.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -113.06 -176.14 2.83 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.76 -24.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.84 -1.162 . . . . 0.0 109.184 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.6 -49.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 43' ' ' SER . 4.8 t70 61.38 10.97 3.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.373 -0.829 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 27.1 m120 43.96 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.971 -1.08 . . . . 0.0 109.546 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.2 t -170.89 103.13 0.41 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 109.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.572 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.6 Cg_endo -72.25 145.14 43.03 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.709 1.606 . . . . 0.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.96 -26.15 20.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.81 147.52 11.35 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.472 ' HE2' ' HG3' ' A' ' 44' ' ' PRO . 1.9 mtt -134.1 125.73 28.59 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.492 -1.005 . . . . 0.0 109.159 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 33' ' ' ILE . 3.0 mt -89.74 137.06 28.71 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.209 -0.932 . . . . 0.0 109.007 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 51.7 Cg_endo -70.81 147.61 56.5 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.707 1.605 . . . . 0.0 110.284 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -88.21 24.24 1.92 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' A' ' 103' ' ' ILE . 8.5 tttm -157.02 114.17 3.09 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.106 -0.996 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 96.58 32.84 6.41 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.476 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.441 ' OG ' HG12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -109.48 172.12 7.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.268 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.92 110.98 6.29 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.056 -1.027 . . . . 0.0 109.95 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.543 HD22 ' CG ' ' A' ' 69' ' ' PHE . 3.4 tm? -89.02 130.66 35.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.155 -0.965 . . . . 0.0 109.015 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.508 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.6 m -113.43 100.54 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -133.51 129.19 20.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.08 -1.012 . . . . 0.0 109.747 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.95 179.71 29.61 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.696 -1.793 . . . . 0.0 110.128 -0.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 41.6 t -105.42 170.84 7.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.566 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 4.6 mm100 -147.76 143.8 27.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.896 -1.127 . . . . 0.0 110.282 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 6.5 t70 84.17 -54.02 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.15 0.5 . . . . 0.0 109.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -94.64 -55.25 3.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 108.437 179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' HG12 ' A' ' 68' ' ' VAL . . . -91.81 34.76 4.23 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -65.99 -9.31 29.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.611 -0.934 . . . . 0.0 109.542 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' MET . 5.8 mtm180 -76.98 -3.09 37.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.509 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 76.96 171.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.842 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 54.05 20.59 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.786 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG12 ' CA ' ' A' ' 63' ' ' GLY . 3.3 p -140.41 134.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.89 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 8.2 p90 -117.22 -179.77 3.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 2.8 ttpt -133.71 111.29 10.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.553 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.9 mt -89.29 165.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.066 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.9 m -144.93 90.14 2.03 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.431 HG21 HG21 ' A' ' 48' ' ' ILE . 4.3 p -50.8 161.16 0.38 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -54.63 -17.19 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.815 . . . . 0.0 109.819 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -88.43 24.1 2.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.13 30.51 16.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' HB3' ' NE2' ' A' ' 79' ' ' HIS . 2.1 tm0? -95.96 100.74 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 56.3 m-20 -69.91 152.78 44.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 97.7 m-70 -150.1 101.39 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.135 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.619 ' CE2' ' CD ' ' A' ' 70' ' ' LYS . 8.4 m-85 -90.98 124.95 35.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.647 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.92 140.59 38.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.128 -0.983 . . . . 0.0 109.404 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.7 tt0 -113.15 136.82 52.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . . . -88.88 -92.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.425 -0.797 . . . . 0.0 109.436 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.579 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -145.18 -39.89 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 109.94 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -159.32 175.81 12.92 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.51 -0.743 . . . . 0.0 109.734 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.555 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -51.6 -50.09 60.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.57 -0.706 . . . . 0.0 109.56 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.6 tt0 -49.64 -67.5 0.26 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 110.1 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.76 -13.82 17.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.76 -62.25 1.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.694 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 6.8 t70 -64.33 -14.86 58.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.208 -0.932 . . . . 0.0 109.574 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -79.54 -46.83 16.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.574 ' CZ3' HD21 ' A' ' 28' ' ' LEU . 2.4 m95 -71.31 -27.92 63.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.436 -0.79 . . . . 0.0 109.223 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.7 m -78.64 -38.43 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.378 -0.826 . . . . 0.0 109.827 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -74.42 -19.37 60.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.179 -0.951 . . . . 0.0 109.996 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.464 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -86.33 -54.26 4.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.053 -1.029 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' A' ' 28' ' ' LEU . 11.6 mt -66.98 -33.36 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 0.0 108.393 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 25.6 t-20 -76.17 -44.62 37.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -63.76 -27.98 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -51.46 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.181 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.549 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -57.44 -51.52 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HD2' ' O ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.01 -17.35 62.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 109.345 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 44.7 t -81.85 -30.23 32.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.055 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.43 -38.31 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -12.43 59.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.264 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.68 7.89 12.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 mt -101.88 57.85 0.83 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 108.953 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -95.73 27.26 3.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.647 -0.658 . . . . 0.0 109.643 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.13 85.33 6.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -145.59 36.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -93.13 104.94 17.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -153.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -175.14 94.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.828 . . . . 0.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.389 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.499 ' SD ' ' OE1' ' A' ' 2' ' ' GLU . 8.4 tmm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.318 0.58 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' OE1' ' SD ' ' A' ' 1' ' ' MET . 6.6 pt-20 -141.02 156.21 68.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 2' ' ' GLU . 52.5 Cg_exo -50.59 -176.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.01 1.806 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 78.8 mttt -93.18 74.82 4.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 64.66 143.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.453 HG23 ' OD2' ' A' ' 95' ' ' ASP . 46.1 mm -51.48 -74.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.358 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.529 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.85 142.45 46.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.201 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.6 pm0 -149.74 132.14 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.024 -1.048 . . . . 0.0 110.162 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.69 -144.03 3.83 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.583 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 2.7 p90 -144.67 104.56 4.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.977 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.647 ' CD2' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.05 179.07 4.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 108.753 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG12 ' CB ' ' A' ' 82' ' ' GLN . 1.5 p -114.04 125.42 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.759 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -107.46 142.97 36.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 110.014 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.592 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -87.15 112.36 21.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.406 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.62 39.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 22' ' ' LYS . 8.5 t -79.54 -50.97 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 0.0 109.392 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.2 -46.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.428 ' O ' ' OD1' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -136.23 -78.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 8.1 m-20 -137.89 70.39 1.39 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.878 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.525 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 5.3 p -127.2 155.95 42.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.585 ' CH2' ' HB3' ' A' ' 80' ' ' PHE . 47.3 m95 -117.94 98.2 6.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.204 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' HD2' ' OG ' ' A' ' 16' ' ' SER . 17.3 mttm -110.87 133.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 0.0 109.711 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.5 Cg_exo -53.35 172.76 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.942 1.761 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 9.2 ptm 176.03 162.45 0.34 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 66.6 t-105 -89.3 151.11 22.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.578 HG21 ' CH2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -150.85 146.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.147 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 11.1 m -145.29 106.61 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.556 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.585 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -78.82 116.39 19.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.465 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 27' ' ' VAL . 2.2 mp -104.33 167.27 9.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.675 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 5.7 pt-20 -73.67 -17.78 61.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' C ' ' CD1' ' A' ' 50' ' ' LEU . 2.1 p30 -101.35 8.73 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . 140.22 148.31 5.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 HG12 ' CG1' ' A' ' 96' ' ' ILE . 4.3 mp -94.73 109.01 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -1.166 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 7.1 pt-20 -111.12 123.76 50.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 108.856 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.4 p90 -121.26 142.8 49.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -119.5 -151.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.43 -0.794 . . . . 0.0 109.031 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 -39.22 9.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -119.87 -176.04 3.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -43.12 -25.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.024 -1.048 . . . . 0.0 109.567 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -146.57 -53.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' SER . 1.2 t70 62.98 7.67 2.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.453 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.5 m-80 40.6 23.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -164.72 101.49 0.83 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.791 -1.193 . . . . 0.0 110.377 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.5 Cg_exo -51.78 164.07 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.055 1.837 . . . . 0.0 110.702 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 3.1 tppt? -134.52 3.45 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 156.18 134.57 1.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.457 ' HE2' ' CB ' ' A' ' 44' ' ' PRO . 1.3 mtt -135.15 138.16 43.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.648 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' HD2' ' A' ' 49' ' ' PRO . 9.5 mt -104.73 125.82 32.9 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' HG21 ' A' ' 48' ' ' ILE . 53.2 Cg_endo -71.39 130.56 17.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.665 1.577 . . . . 0.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -74.88 -0.34 18.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.168 -0.957 . . . . 0.0 109.609 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HB2' HG23 ' A' ' 74' ' ' THR . 1.1 mmtp -44.0 -62.28 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.53 57.94 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.7 m -81.21 170.21 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 109.169 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.548 HG21 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.89 160.52 25.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 3.0 tm? -134.72 96.14 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.081 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.72 HG23 ' SG ' ' A' ' 59' ' ' CYS . 85.7 m -90.19 109.36 20.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 55' ' ' LEU . 11.1 p -146.41 142.28 17.29 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.15 -176.11 17.55 Favored 'Cis proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.336 -1.943 . . . . 0.0 110.54 -0.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 56' ' ' THR . 4.8 m -150.28 60.27 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.285 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.52 ' CG ' ' HA ' ' A' ' 64' ' ' LYS . 5.5 tt0 -71.12 124.26 24.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.822 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 1.6 m-20 166.49 -43.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -88.97 -68.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 64' ' ' LYS . . . -81.42 -26.94 49.96 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' HA ' ' CG ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 34.41 39.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.452 0.644 . . . . 0.0 110.015 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 ttt-85 -117.99 -137.49 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt -42.51 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.01 . . . . 0.0 109.662 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.61 ' CD1' ' CD ' ' A' ' 89' ' ' ARG . 2.1 m-85 -142.21 111.18 6.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.406 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.577 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -120.66 119.95 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.833 . . . . 0.0 109.653 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.5 p90 -118.14 168.33 10.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 5.9 pttt -127.91 121.42 29.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.507 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.0 mt -96.1 161.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 108.98 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' HG21 ' A' ' 54' ' ' THR . 50.4 m -140.27 99.58 3.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.242 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.444 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -52.89 155.63 2.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.361 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -41.2 -27.56 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.729 -0.607 . . . . 0.0 109.819 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 73' ' ' THR . 2.0 mmmm -77.63 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.62 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 177.6 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -103.17 72.0 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.076 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 5.7 p-10 -43.51 141.72 1.34 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 109.752 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -127.17 137.73 53.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.09 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.585 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 40.8 m-85 -93.46 128.95 39.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.706 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.8 t80 -129.86 139.44 51.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.558 -0.714 . . . . 0.0 109.366 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.54 ' CB ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.27 119.86 13.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.05 -150.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.556 ' CB ' ' CE1' ' A' ' 85' ' ' PHE . . . -120.27 -26.01 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.054 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -156.18 175.55 13.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 0.0 109.871 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.661 ' CD1' ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.3 -60.48 3.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.747 . . . . 0.0 110.249 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' N ' ' CD1' ' A' ' 86' ' ' LEU . 3.6 tm-20 -46.33 -56.65 5.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.219 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.599 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 33.2 tt0 -58.4 -30.52 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.673 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.61 ' CD ' ' CD1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.926 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.548 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -54.7 -23.26 16.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.06 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.06 -35.75 59.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 109.583 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.593 ' CE2' HD22 ' A' ' 11' ' ' LEU . 13.0 m95 -76.36 -41.23 48.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.323 -0.861 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -75.37 -28.1 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.797 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.1 ptm180 -76.83 -30.02 56.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.996 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.524 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -90.43 -30.65 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 110.039 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.532 HG13 ' CB ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -72.48 -31.22 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.06 . . . . 0.0 108.518 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -85.42 -36.5 20.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -66.82 -47.16 72.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.0 109.096 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.84 -37.16 83.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.494 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 46.6 mt -71.94 -23.9 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.96 -15.04 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 t -95.42 -26.4 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.773 . . . . 0.0 109.337 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 30' ' ' GLU . 6.2 tp -76.58 -21.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 51' ' ' LYS . 1.8 mm-40 -67.03 -11.48 57.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.81 5.22 12.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.35 58.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.416 -1.049 . . . . 0.0 109.16 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.99 163.14 12.72 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.655 -0.653 . . . . 0.0 109.548 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 94.12 2.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.433 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -46.22 131.88 10.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.492 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' HIS . 6.3 t-160 -128.06 50.83 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 110' ' ' HIS . 37.0 m80 44.2 43.01 5.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -86.73 51.0 2.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.5 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.3 mm-40 -64.33 162.85 29.55 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 53.5 Cg_exo -50.93 163.98 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.973 1.782 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -146.52 73.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.586 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.493 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -96.28 146.01 25.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.324 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.26 -46.4 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.62 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -128.36 138.43 52.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.66 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.544 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.6 pm0 -156.06 133.89 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.253 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.02 -146.13 4.63 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.83 97.03 4.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -1.015 . . . . 0.0 110.053 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.647 ' CD2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -108.65 172.69 6.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 108.57 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 2.4 p -117.77 125.3 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.879 -1.138 . . . . 0.0 109.402 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.756 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 7.6 mmtp -95.53 159.9 14.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.695 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 15.1 ttpp -85.95 94.45 9.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.67 141.29 3.72 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 17' ' ' VAL . 22.8 t -102.21 108.08 19.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.139 . . . . 0.0 109.534 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 16' ' ' SER . 2.6 p 172.19 -30.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.376 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.43 ' N ' HG11 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -166.72 36.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.323 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.84 68.22 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.371 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.6 p -117.95 169.72 9.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 109.701 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.576 ' CE2' ' HB2' ' A' ' 14' ' ' LYS . 10.7 m95 -148.09 100.37 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 mttt -118.93 136.35 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.839 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.9 Cg_exo -53.99 176.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.833 1.689 . . . . 0.0 109.975 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 19.5 ptm 176.74 159.96 0.36 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.584 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.7 t-105 -89.54 146.69 24.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.579 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.32 134.28 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.097 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.544 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.4 m -128.72 98.66 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.59 -0.693 . . . . 0.0 109.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.588 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 4.0 pp -77.55 123.62 26.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.09 -1.006 . . . . 0.0 109.081 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.0 mp -109.35 165.16 11.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.82 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.523 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 1.9 tm-20 -74.87 -9.28 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 2.5 p30 -112.32 7.92 19.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.925 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 145.06 147.08 4.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 28' ' ' LEU . 4.0 mp -103.15 120.59 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -1.162 . . . . 0.0 109.861 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.469 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 2.6 pt-20 -120.07 121.94 39.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.568 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 10.6 p90 -125.55 141.24 52.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.096 -1.003 . . . . 0.0 110.405 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.86 -145.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 24' ' ' MET . 2.6 mmtm -99.16 -39.18 8.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.076 -1.015 . . . . 0.0 109.349 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -119.42 -178.27 3.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.269 -0.895 . . . . 0.0 109.09 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 tppt? -43.21 -30.8 0.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 108.708 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.448 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -165.29 72.48 0.18 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.515 -0.741 . . . . 0.0 109.49 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 1.6 t0 -51.39 -18.85 1.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 8.6 t-20 91.48 -18.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -127.69 106.3 20.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.508 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 42.6 Cg_endo -68.79 134.39 29.97 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.726 1.618 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -25.74 20.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' C ' ' CZ ' ' A' ' 35' ' ' PHE . . . -165.51 145.01 9.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.444 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -128.65 -168.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -1.073 . . . . 0.0 109.407 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 3.5 mt -150.31 111.16 3.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.31 131.29 23.04 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.58 1.52 . . . . 0.0 110.355 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 30' ' ' GLU . 5.4 mp -84.46 41.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' O ' ' CD ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -99.15 -40.07 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.641 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.15 76.22 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.494 ' CB ' ' HA ' ' A' ' 73' ' ' THR . 6.2 m -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.276 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -115.02 171.76 7.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.647 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 2.4 tm? -143.51 119.61 10.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.819 . . . . 0.0 108.895 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 20.7 m -114.42 139.1 49.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.101 -0.999 . . . . 0.0 110.345 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.483 ' N ' HG21 ' A' ' 56' ' ' THR . 0.1 OUTLIER -150.51 118.06 3.49 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.086 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.513 ' O ' ' CG2' ' A' ' 56' ' ' THR . 46.2 Cg_endo -70.21 -160.05 1.41 Allowed 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.562 -1.849 . . . . 0.0 110.399 0.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -117.14 -78.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.239 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.806 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -134.12 -159.94 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.033 . . . . 0.0 110.25 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.54 14.24 3.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.578 ' CZ ' ' OE1' ' A' ' 60' ' ' GLN . 16.6 m-85 -88.5 86.86 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 88.35 41.92 6.01 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 4.5 pttt -37.72 111.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.85 -0.794 . . . . 0.0 110.042 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER 178.26 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.766 ' SD ' ' HB2' ' A' ' 86' ' ' LEU . 22.4 ptp 171.93 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.678 0.751 . . . . 0.0 109.363 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.537 ' HA ' ' CB ' ' A' ' 89' ' ' ARG . 2.2 m-85 -60.09 -21.79 61.94 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.94 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 2.1 p -94.65 105.85 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -99.93 170.78 8.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.666 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -140.24 103.28 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.682 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 72' ' ' THR . 14.3 mt -90.54 165.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 59.1 m -141.52 87.78 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.494 ' HA ' ' CB ' ' A' ' 53' ' ' SER . 1.8 p -47.35 160.2 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 0.0 108.841 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -13.67 14.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.706 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.25 20.45 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.94 29.22 16.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -92.45 98.49 11.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.234 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 5.6 p30 -68.5 135.4 51.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.791 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -140.07 95.69 2.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.398 -0.814 . . . . 0.0 108.837 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -109.72 135.59 50.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 0.0 110.144 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.706 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.6 OUTLIER -149.99 159.23 44.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.778 . . . . 0.0 109.361 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' CG ' ' HB2' ' A' ' 67' ' ' PHE . 6.8 tt0 -114.04 138.08 50.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -139.49 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.269 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -118.48 -7.82 10.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.897 -1.127 . . . . 0.0 110.056 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -168.11 175.64 6.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -0.963 . . . . 0.0 109.751 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.766 ' HB2' ' SD ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -72.74 -37.17 67.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 109.236 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -60.21 -49.18 78.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.043 -1.036 . . . . 0.0 109.712 -179.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -72.96 -33.53 65.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.099 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.537 ' CB ' ' HA ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -62.43 -39.1 92.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.992 . . . . 0.0 109.411 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.554 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 13.5 t0 -78.88 -20.03 50.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -0.994 . . . . 0.0 108.614 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -76.94 -26.87 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.647 ' CE2' ' CD2' ' A' ' 11' ' ' LEU . 26.8 m95 -85.52 -37.85 19.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.9 m -71.32 -37.74 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 110.113 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 7.1 ptt180 -80.89 -30.93 35.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.226 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 5.4 t0 -75.06 -41.43 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.914 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.524 ' CG1' HD21 ' A' ' 28' ' ' LEU . 5.2 mt -75.08 -32.96 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 109.334 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 58.8 t-20 -75.25 -32.05 60.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.5 -45.13 40.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.103 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' HD22 ' A' ' 50' ' ' LEU . . . -58.11 -43.05 86.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.842 . . . . 0.0 109.141 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 HG13 ' HG ' ' A' ' 50' ' ' LEU . 17.0 mt -70.09 -37.76 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.183 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -72.31 -10.57 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.457 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -38.99 12.03 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 4.0 mm -65.32 -40.32 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 51' ' ' LYS . 2.4 mt-10 -68.96 -7.6 36.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.09 11.37 5.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mt -97.4 56.76 1.36 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.401 -1.058 . . . . 0.0 109.114 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.51 100.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.736 -0.603 . . . . 0.0 109.484 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -113.03 -179.11 3.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -77.59 92.27 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -51.09 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.614 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -92.84 7.42 43.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -68.63 139.29 55.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.408 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 3' ' ' PRO . 28.9 mm-40 -100.62 161.2 24.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' GLU . 51.1 Cg_exo -51.65 -167.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.165 1.91 . . . . 0.0 110.508 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -111.57 92.66 4.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.41 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.495 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -43.7 157.21 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.526 HD13 ' N ' ' A' ' 30' ' ' GLU . 85.9 mt -76.32 -58.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.646 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.554 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 4.9 tpm_? -133.34 111.89 11.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.941 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.537 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -118.31 132.5 56.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.054 -1.029 . . . . 0.0 109.417 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.42 -147.69 4.97 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.3 p90 -141.38 96.62 3.02 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.322 -1.105 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -121.51 176.42 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' CG1' ' CG ' ' A' ' 82' ' ' GLN . 2.1 p -103.06 147.5 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.699 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 26.8 mmtt -118.64 179.82 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.558 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 3.6 tttt -133.41 64.1 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.616 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -157.39 131.63 2.96 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 12.6 t 169.54 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.134 . . . . 0.0 109.437 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 4.2 p -100.79 -30.75 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 4.8 m-85 -174.73 176.78 2.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 25.0 p-10 -45.61 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 36.9 p -142.95 -176.83 5.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.654 ' CH2' ' CG2' ' A' ' 68' ' ' VAL . 56.5 m95 -156.13 105.55 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.143 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -137.6 135.16 18.84 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.495 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.5 Cg_exo -51.65 166.87 0.48 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.954 1.769 . . . . 0.0 110.461 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 13.1 ptm 178.04 165.36 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -0.907 . . . . 0.0 109.729 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.3 t-105 -90.15 145.16 25.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.599 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.97 135.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.702 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 8.8 m -125.5 103.2 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.64 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -82.44 117.11 22.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.947 -1.095 . . . . 0.0 109.972 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.545 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.0 mp -105.35 166.33 10.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -74.45 -17.61 60.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 0.0 109.435 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' C ' HD13 ' A' ' 50' ' ' LEU . 2.4 p30 -97.39 8.47 44.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' O ' HD11 ' A' ' 29' ' ' LEU . . . 139.43 152.13 5.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 50' ' ' LEU . 2.8 mp -101.27 118.55 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.196 -1.179 . . . . 0.0 109.655 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.545 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 17.8 pt-20 -117.97 116.15 26.34 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.599 ' HB3' ' CB ' ' A' ' 26' ' ' VAL . 1.8 p90 -116.12 150.62 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.054 -1.029 . . . . 0.0 110.594 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -128.6 -153.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -41.38 9.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.0 mttt -115.7 -172.26 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.572 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 6.1 tppt? -44.85 -25.36 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 109.288 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -154.83 -47.07 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.594 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.8 t70 61.65 11.21 3.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.35 22.52 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.776 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -163.36 111.37 1.0 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.994 -1.066 . . . . 0.0 109.743 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.2 Cg_endo -71.92 133.25 21.32 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.888 1.725 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 2.2 tttt -89.5 -23.24 22.11 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 178.47 151.79 9.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 mtm -137.65 135.57 36.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -1.154 . . . . 0.0 109.743 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.57 HG22 ' CD2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -101.92 137.68 19.58 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 48' ' ' ILE . 48.4 Cg_endo -71.0 99.16 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.447 1.431 . . . . 0.0 109.832 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' N ' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -66.74 -4.51 9.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.945 . . . . 0.0 110.528 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' N ' HD12 ' A' ' 50' ' ' LEU . 3.4 ptmm? -85.45 48.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.544 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . 151.38 -22.35 0.95 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.891 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -42.48 146.75 0.31 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.096 -1.238 . . . . 0.0 109.828 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.2 162.75 13.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 56' ' ' THR . 3.0 tm? -117.51 147.19 42.99 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.063 -1.023 . . . . 0.0 108.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.557 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 26.4 m -149.31 129.45 13.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.924 -1.11 . . . . 0.0 110.086 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.515 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.71 126.81 5.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 109.138 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 57' ' ' SER . 25.0 Cg_exo -67.0 -150.46 0.33 Allowed 'Cis proline' 0 C--N 1.309 -1.52 0 C-N-CA 123.148 -1.605 . . . . 0.0 110.903 -1.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.593 ' SG ' HG23 ' A' ' 68' ' ' VAL . 30.1 p -131.81 -148.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.407 -0.808 . . . . 0.0 109.974 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 173.98 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -91.62 5.03 51.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.437 -0.789 . . . . 0.0 109.601 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -88.74 45.26 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.219 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.22 38.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 85.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.381 -1.07 . . . . 0.0 109.518 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -147.96 23.35 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.561 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 12.8 mtt 62.7 159.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.466 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 2.6 m-85 82.43 -28.85 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.561 -0.712 . . . . 0.0 110.47 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.654 ' CG2' ' CH2' ' A' ' 21' ' ' TRP . 15.0 p -93.11 135.11 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.195 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.705 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.4 -176.47 4.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HD3' ' CA ' ' A' ' 59' ' ' CYS . 0.4 OUTLIER -150.11 118.93 6.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.07 . . . . 0.0 110.292 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 54' ' ' THR . 3.7 mt -96.67 162.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.541 ' CB ' HG23 ' A' ' 54' ' ' THR . 90.4 m -127.39 91.43 3.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 108.842 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.497 ' CG2' HG21 ' A' ' 48' ' ' ILE . 1.4 p -43.21 144.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.474 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.484 ' HB ' ' HA3' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -41.07 -34.7 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.804 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -66.36 -74.9 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.227 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 166.11 35.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.588 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.407 ' O ' HG22 ' A' ' 73' ' ' THR . 1.4 mm-40 -105.78 118.95 37.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 3.2 m-20 -83.31 103.3 12.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.57 ' CD2' HG22 ' A' ' 48' ' ' ILE . 53.3 m-70 -89.78 105.31 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.165 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 5.6 m-85 -94.63 117.99 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.705 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -136.86 138.74 41.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 108.623 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.572 ' CG ' ' CG1' ' A' ' 12' ' ' VAL . 8.3 pt20 -118.01 146.27 44.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 -153.05 0.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 109.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -108.31 -2.21 19.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -169.09 169.94 9.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 0.0 109.187 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.601 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 27.6 tp -69.81 -30.81 68.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -56.89 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 108.868 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.515 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -69.17 -15.33 63.38 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.178 -0.951 . . . . 0.0 108.74 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.524 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 5.1 ttt180 -68.94 -63.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.818 . . . . 0.0 109.354 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.92 -13.26 62.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.9 25.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.047 -1.033 . . . . 0.0 108.861 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.64 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 1.9 m95 -81.97 -27.91 32.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.1 m -75.33 -33.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.164 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 2.5 mmm180 -79.74 -29.95 40.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -74.74 -49.38 21.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.523 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 28' ' ' LEU . 9.8 mt -72.58 -36.6 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.025 -1.047 . . . . 0.0 108.866 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 11.1 t-20 -73.28 -26.39 61.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -76.68 -45.22 30.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.867 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . . . -59.91 -34.02 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.332 -0.855 . . . . 0.0 108.969 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.513 ' CG1' ' O ' ' A' ' 50' ' ' LEU . 1.3 mt -74.9 -40.84 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 108.826 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 13.9 tptm -73.2 -7.87 53.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.073 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -40.72 9.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 30' ' ' GLU . 1.2 mm -60.64 -44.01 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 108.805 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 3.1 mt-10 -46.49 -26.23 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.37 -103.29 2.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER 46.92 66.34 1.02 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.375 -1.073 . . . . 0.0 109.218 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -112.23 38.78 2.61 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.184 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.13 -13.69 32.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.9 m170 58.52 78.12 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.18 73.74 1.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.91 -25.06 11.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.441 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -167.19 137.66 3.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.484 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.441 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.338 0.589 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 6.0 tt0 -179.79 -63.3 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.249 -0.907 . . . . 0.0 109.278 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 50.1 Cg_endo -69.67 173.0 11.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.791 1.661 . . . . 0.0 110.037 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HB3' ' HD2' ' A' ' 5' ' ' ARG . 8.4 mmtt -141.09 106.54 5.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER 64.3 120.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.394 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.534 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 77.2 mt -47.13 -70.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.531 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -101.58 169.12 9.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.786 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 1.3 pm0 173.65 132.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.575 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -173.12 -143.68 4.32 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' O ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -124.03 106.97 10.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.933 . . . . 0.0 109.427 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.655 ' CD2' ' CZ ' ' A' ' 81' ' ' PHE . 0.8 OUTLIER -120.53 178.47 4.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.818 . . . . 0.0 108.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 1.6 p -123.41 122.68 65.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 108.596 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.772 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -104.02 126.62 51.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 109.466 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' HG3' ' CD1' ' A' ' 21' ' ' TRP . 19.1 tttt -73.17 99.76 2.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 178.36 48.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 t -98.07 114.5 26.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -1.164 . . . . 0.0 109.56 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 5.1 p -167.33 -45.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -174.93 48.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.406 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 20.5 m-20 49.56 63.53 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 1.1 p -129.41 161.59 30.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.604 ' CH2' ' HB3' ' A' ' 80' ' ' PHE . 34.0 m95 -125.64 118.98 26.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 4.2 mttt -121.88 130.04 24.91 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.684 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 24' ' ' MET . 49.1 Cg_exo -55.04 -179.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.8 1.667 . . . . 0.0 110.119 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.772 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 6.5 ptm 169.29 169.63 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.7 t-105 -92.46 152.25 19.79 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.552 ' HA ' ' CB ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -149.66 149.96 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.581 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 4.8 m -144.52 112.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 7' ' ' ARG . 5.1 mt -78.94 121.66 25.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.449 -0.782 . . . . 0.0 109.095 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.541 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.1 mp -110.79 156.28 21.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.295 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.525 ' CA ' HD13 ' A' ' 6' ' ' ILE . 1.3 tt0 -72.46 -21.97 61.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.872 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' HA ' HD13 ' A' ' 103' ' ' ILE . 2.8 m-20 -98.64 10.93 39.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 109.369 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 146.77 -175.66 26.06 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.492 ' CG2' HG12 ' A' ' 48' ' ' ILE . 1.9 mp -132.47 137.9 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.051 -1.264 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 3.5 pt-20 -144.55 123.44 12.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.299 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 13' ' ' LYS . 5.0 p90 -121.65 140.18 52.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -121.69 -148.37 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 109.027 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -60.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.1 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -96.65 -177.14 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 108.727 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.68 -28.39 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 108.612 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.447 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -163.01 69.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.452 -0.78 . . . . 0.0 109.387 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 60.6 t0 -48.26 -21.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.7 t-20 91.8 -21.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.89 107.03 42.78 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 44.1 Cg_endo -68.86 146.97 67.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.778 1.652 . . . . 0.0 110.826 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 -31.58 9.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.397 -0.814 . . . . 0.0 109.076 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -154.3 143.24 9.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 5.8 mtt -133.26 135.74 45.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.492 HG12 ' CG2' ' A' ' 33' ' ' ILE . 2.2 mm -95.16 107.94 35.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 109.265 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' A' ' 53' ' ' SER . 46.3 Cg_endo -70.04 118.91 5.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.707 1.605 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 2.8 mp -63.29 -9.57 12.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.898 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.8 -71.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 109.84 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' O ' ' CA ' ' A' ' 74' ' ' THR . . . -152.46 71.79 0.28 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -100.53 166.0 11.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.161 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.54 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.89 157.32 36.25 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.583 HD22 ' CG ' ' A' ' 69' ' ' PHE . 2.3 tm? -127.48 102.06 6.71 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' PHE . 19.5 m -89.6 133.45 34.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 0.0 110.009 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.6 122.94 5.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.403 -0.811 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -72.23 -161.88 2.26 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.558 -1.851 . . . . 0.0 110.416 -0.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.749 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 21.8 p -103.95 -147.16 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -71.68 -141.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 109.922 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -3.03 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.505 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 68' ' ' VAL . 19.9 m-85 -88.82 -21.13 23.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.509 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.749 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -76.61 -22.81 71.65 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -2.83 31.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.541 -0.976 . . . . 0.0 109.156 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -104.59 -95.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.555 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.47 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 9.4 mtt -94.34 -147.26 0.26 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.645 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 44.2 m-85 -101.79 92.69 4.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 82' ' ' GLN . 3.8 p -135.71 132.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.493 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 3.2 p90 -110.29 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.955 -1.091 . . . . 0.0 109.718 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -124.94 106.12 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.651 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 5.8 mt -88.48 160.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.54 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 74.8 m -133.53 90.69 2.75 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.482 ' CG2' ' NE2' ' A' ' 79' ' ' HIS . 3.3 p -45.3 158.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.062 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.486 ' CA ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -59.89 -14.07 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -86.89 16.81 4.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.58 43.37 4.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 72' ' ' THR . 13.6 tt0 -118.48 118.24 31.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.3 m-20 -70.61 163.3 27.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.482 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 12.3 m-70 -143.98 128.64 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.035 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.604 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 14.5 m-85 -91.59 113.42 25.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.7 t80 -128.16 128.19 44.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 110.689 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.547 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -126.91 136.05 51.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -0.827 . . . . 0.0 109.735 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -107.48 -150.84 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 0.0 109.798 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -100.29 -88.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.821 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -106.94 -179.27 3.89 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.59 -0.694 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -56.08 -58.18 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.69 . . . . 0.0 109.75 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 7.1 tp10 -43.46 -70.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.972 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.2 tt0 -48.94 -33.71 11.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 13.1 ttp180 -56.36 -65.01 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.86 -22.18 9.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.958 . . . . 0.0 109.263 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.542 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -70.9 -40.94 71.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.602 ' CD2' HD22 ' A' ' 11' ' ' LEU . 77.8 m95 -73.03 -52.73 13.27 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.507 -0.746 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -65.56 -24.84 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.518 -0.739 . . . . 0.0 110.794 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.542 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.6 ptt85 -85.24 -23.58 28.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.903 -1.123 . . . . 0.0 110.074 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.4 OUTLIER -85.61 -38.66 18.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.075 -1.016 . . . . 0.0 109.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.526 HG13 ' CD1' ' A' ' 28' ' ' LEU . 21.1 mt -76.73 -35.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.102 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.46 -31.76 58.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -72.2 -55.92 6.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 108.983 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.0 67.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 59.2 mt -63.67 -45.27 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.035 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -67.88 -8.87 40.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.7 t -95.1 -35.38 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' HD21 ' A' ' 50' ' ' LEU . 2.2 mt -79.82 -26.68 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.032 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -73.14 -7.65 52.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.22 12.51 5.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 107' ' ' GLU . 2.5 mt -99.25 56.74 1.03 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -1.037 . . . . 0.0 109.306 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 106' ' ' LEU . 31.3 mt-10 56.66 160.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.7 -0.625 . . . . 0.0 109.521 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -120.7 48.62 1.58 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.565 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -100.26 68.23 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' HIS . 0.3 OUTLIER 47.64 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.402 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 112' ' ' HIS . 72.1 m-70 -115.18 29.21 8.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.422 ' O ' ' OXT' ' A' ' 113' ' ' HIS . 9.8 t-160 64.11 113.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.274 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.422 ' OXT' ' O ' ' A' ' 112' ' ' HIS . 7.9 t60 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.393 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.585 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -56.72 -61.83 6.14 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 49.8 Cg_endo -70.85 -173.04 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.849 1.699 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 40.2 64.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.719 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 2.0 mpt_? 57.71 154.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.6 mm -64.36 -56.8 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.217 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.535 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -132.85 90.61 2.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.981 -1.074 . . . . 0.0 110.414 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.52 ' CB ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -103.33 128.91 50.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.867 -1.146 . . . . 0.0 109.185 178.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.597 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.43 -149.94 5.68 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.0 p90 -141.26 97.15 3.11 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -114.19 171.65 7.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.9 p -102.34 129.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.776 -1.202 . . . . 0.0 109.872 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.574 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -119.75 166.04 13.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.311 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -68.21 121.65 16.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.536 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.32 -161.69 2.8 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' VAL . 23.3 t -119.16 -16.61 9.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -1.161 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -46.68 -93.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -126.67 52.0 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.511 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.0 OUTLIER 59.01 78.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 40.0 p -124.74 -165.79 1.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CH2' HG22 ' A' ' 68' ' ' VAL . 2.1 m95 -144.78 104.83 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 6.9 mttp -132.65 144.0 51.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -52.21 166.39 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.77 1.647 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.632 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 23.1 ptm -176.51 159.53 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -0.954 . . . . 0.0 109.648 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.6 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.6 t-105 -89.81 143.64 26.63 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.546 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.27 150.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.672 -179.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 7.6 m -137.52 119.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.873 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.536 ' CD1' HG13 ' A' ' 96' ' ' ILE . 1.0 OUTLIER -85.05 105.61 15.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.452 -0.78 . . . . 0.0 108.914 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -96.85 157.92 15.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.0 109.681 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' O ' HD21 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -72.89 -17.5 61.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 109.788 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -101.9 5.86 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' CA ' HD11 ' A' ' 50' ' ' LEU . . . 153.29 -171.6 32.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 32' ' ' GLY . 4.4 mm -133.05 122.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.383 -1.069 . . . . 0.0 109.283 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 6.0 pt-20 -129.12 127.27 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 6.7 p90 -131.09 146.4 52.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.46 -150.31 0.44 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 -32.43 11.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 108.877 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 2.8 tttp -121.05 -179.58 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -45.56 -27.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -166.96 73.36 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.0 109.702 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 24.8 t70 -50.98 -19.04 0.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.996 -1.065 . . . . 0.0 108.172 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 6.3 t-20 90.92 -17.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -132.34 94.55 22.84 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.497 ' HG3' ' CE2' ' A' ' 36' ' ' TYR . 50.7 Cg_exo -49.41 139.0 29.95 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.968 1.779 . . . . 0.0 110.878 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 9.7 mmtt -90.07 -23.02 21.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -164.9 143.8 8.81 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 mtm -134.97 123.87 24.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -1.19 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 HG21 ' HD2' ' A' ' 49' ' ' PRO . 5.5 mt -91.77 129.76 41.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.318 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 55.7 Cg_endo -72.51 137.45 27.89 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.687 1.592 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD23 ' CB ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -88.11 23.06 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.612 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG2' ' HB2' ' A' ' 49' ' ' PRO . 12.9 ptpt -91.77 -18.78 23.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.185 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -157.76 -91.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER 56.99 132.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.545 -0.973 . . . . 0.0 110.674 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.55 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.51 167.71 9.85 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.1 tm? -133.73 142.48 47.97 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.027 -1.045 . . . . 0.0 109.025 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.493 ' N ' HD12 ' A' ' 55' ' ' LEU . 52.6 m -130.22 119.88 23.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.891 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.4 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.7 t -143.61 120.27 6.6 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 57' ' ' SER . 55.3 Cg_endo -72.07 -160.92 1.92 Allowed 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.573 -1.844 . . . . 0.0 110.143 -0.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.438 ' HA ' HG23 ' A' ' 56' ' ' THR . 17.9 p -89.67 -149.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.435 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 18.4 tt0 -110.17 -139.86 0.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.536 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.25 26.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.877 -1.139 . . . . 0.0 109.367 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 1.3 t80 -88.86 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -101.56 -42.3 2.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 7.2 tttt 55.45 19.4 3.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -1.007 . . . . 0.0 109.488 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 9.7 mmm180 -87.09 -144.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mtt -126.62 -4.05 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.11 -0.994 . . . . 0.0 109.85 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' MET . 0.5 OUTLIER -130.08 32.62 4.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.013 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.571 HG22 ' CH2' ' A' ' 21' ' ' TRP . 2.7 p -128.56 123.49 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.002 -1.062 . . . . 0.0 109.637 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 11.0 p90 -118.79 174.31 6.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -135.06 127.07 29.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 ' CG1' HD21 ' A' ' 55' ' ' LEU . 6.6 mt -105.99 163.39 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 98.0 m -145.13 99.91 3.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -44.25 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.368 -0.832 . . . . 0.0 109.994 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.554 ' OG1' ' O ' ' A' ' 74' ' ' THR . 0.2 OUTLIER 43.46 37.74 1.54 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.935 . . . . 0.0 110.864 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 80.24 45.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 0.0 109.57 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.97 -82.87 0.32 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.028 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.53 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.7 OUTLIER -90.17 131.25 36.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.499 -0.75 . . . . 0.0 110.118 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.543 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 9.5 t0 -97.56 145.16 26.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -137.72 109.23 6.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -101.39 115.04 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.382 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -143.84 145.98 32.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 109.617 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 pt20 -116.78 147.01 42.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.51 -0.744 . . . . 0.0 109.052 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -143.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.45 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.91 -60.83 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 110.12 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.28 175.1 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.668 -0.645 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -45.7 -50.14 13.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.583 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 1.7 tm-20 -51.63 -57.93 7.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.045 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -63.19 -18.04 63.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 15.8 ttp180 -72.96 -65.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 59.3 t0 -65.75 -11.57 46.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.277 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.35 -41.19 22.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.003 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CE2' HD22 ' A' ' 11' ' ' LEU . 12.4 m95 -76.68 -31.1 57.05 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.454 -0.779 . . . . 0.0 108.99 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.9 m -70.6 -38.65 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.567 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 0.6 OUTLIER -78.91 -20.08 50.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.533 ' HB3' ' CD1' ' A' ' 28' ' ' LEU . 9.5 t70 -77.73 -58.0 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.536 HG13 ' CD1' ' A' ' 28' ' ' LEU . 1.1 mt -63.6 -35.09 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 108.707 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 35.0 t30 -73.77 -32.54 63.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.91 -57.13 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.533 ' CB ' HD23 ' A' ' 50' ' ' LEU . . . -51.66 -42.42 62.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.238 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.473 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 45.0 mt -59.68 -50.62 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.314 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -10.89 35.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -93.12 -28.84 16.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.285 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.446 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 4.9 mm -78.0 -34.06 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.57 -4.85 33.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.4 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.72 13.02 4.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 102' ' ' CYS . 2.6 mt -97.57 56.7 1.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.448 -1.031 . . . . 0.0 109.218 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -51.9 -84.58 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.665 -0.647 . . . . 0.0 109.533 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 108' ' ' HIS . 0.1 OUTLIER -47.57 133.59 13.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.543 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.52 -44.78 1.52 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.468 ' O ' ' CB ' ' A' ' 111' ' ' HIS . 21.1 t-80 -135.98 24.84 3.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER 74.01 31.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.387 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 5.6 t60 179.45 -71.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 55.0 p-80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 9.7 mt-10 -48.76 -61.75 2.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.6 Cg_endo -72.2 -175.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.762 1.642 . . . . 0.0 110.159 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 25.9 mttt 45.72 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.681 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 mpt_? 68.02 169.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.54 HD12 ' CG ' ' A' ' 30' ' ' GLU . 46.7 mt -92.81 -77.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.546 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -107.5 104.83 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 110.099 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.2 pm0 -115.65 135.51 53.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.3 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.589 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.73 -146.8 4.65 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 11.6 p90 -138.57 97.4 3.34 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.411 -1.052 . . . . 0.0 109.78 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.611 ' HG ' ' CE2' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -119.36 146.8 45.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.593 HG23 ' CE3' ' A' ' 21' ' ' TRP . 1.4 p -76.34 137.68 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.026 -1.047 . . . . 0.0 109.298 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -117.18 165.19 13.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.42 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HB2' ' NE1' ' A' ' 21' ' ' TRP . 2.1 tmtt? -116.31 125.11 51.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.348 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' VAL . . . 164.86 -120.11 0.92 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 51.21 -91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -1.146 . . . . 0.0 109.383 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 HG21 ' N ' ' A' ' 18' ' ' PHE . 14.8 m -117.51 -147.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.519 ' N ' HG21 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -42.71 165.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.478 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' PHE . 3.1 m120 -43.53 105.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.376 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -132.29 174.42 10.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.764 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.593 ' CE3' HG23 ' A' ' 12' ' ' VAL . 3.4 m95 -152.33 106.94 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' O ' HG21 ' A' ' 12' ' ' VAL . 6.6 mmtt -138.18 138.8 23.8 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.33 151.58 17.4 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.849 1.7 . . . . 0.0 109.922 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.774 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.15 171.07 20.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 110.341 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.774 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.9 t-105 -96.94 145.8 25.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.581 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.6 OUTLIER -150.19 139.24 15.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.05 -178.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 7.5 m -129.09 106.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.821 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.583 HD22 ' CZ3' ' A' ' 92' ' ' TRP . 1.5 pp -86.45 111.91 21.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.992 . . . . 0.0 109.193 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.9 mp -93.29 164.58 13.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.789 . . . . 0.0 109.564 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' CG ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -74.99 -15.8 60.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.6 p30 -101.87 10.11 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.339 -0.85 . . . . 0.0 109.169 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 148.49 -165.15 29.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 32' ' ' GLY . 2.9 mt -141.07 141.51 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -1.198 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 12.1 pt-20 -148.12 115.03 6.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.74 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.5 p90 -112.81 148.72 34.24 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 110.792 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -124.62 -156.76 0.74 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -46.42 6.56 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -111.37 -169.22 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -46.5 -24.79 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.793 -1.192 . . . . 0.0 109.024 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -153.52 -50.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.199 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.67 10.08 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.418 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' ASP . 38.8 m-20 41.9 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -156.79 96.17 2.18 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 110.037 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.9 Cg_exo -51.82 171.7 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.054 1.836 . . . . 0.0 110.58 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.49 4.98 2.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.455 -0.778 . . . . 0.0 109.287 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.53 141.68 3.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.513 ' HG2' ' CB ' ' A' ' 34' ' ' GLU . 26.4 mtm -124.41 139.69 53.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 0.0 109.634 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 33' ' ' ILE . 2.3 mt -101.31 125.85 36.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.075 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.71 131.91 19.34 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.547 1.498 . . . . 0.0 110.08 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.505 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 1.5 mp -73.74 -0.03 14.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' CB ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -42.14 -88.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.78 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.51 54.99 0.56 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.397 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -66.95 156.25 36.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.246 . . . . 0.0 108.941 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.548 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -103.73 171.07 7.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 108.855 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD21 ' N ' ' A' ' 56' ' ' THR . 2.2 tm? -143.33 114.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.205 -0.934 . . . . 0.0 109.114 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.524 ' N ' HD21 ' A' ' 55' ' ' LEU . 12.4 m -112.89 128.23 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.426 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.19 122.18 4.12 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.473 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' O ' HG23 ' A' ' 56' ' ' THR . 54.7 Cg_endo -72.31 -177.87 19.21 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.603 -1.832 . . . . 0.0 110.199 -0.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.82 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -96.04 -85.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.82 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -152.95 -165.58 2.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -87.28 21.39 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.504 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.6 t80 -89.26 85.7 6.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 88.94 26.89 25.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER -43.81 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.253 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -141.3 132.63 26.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.1 mtp 44.27 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 6.0 m-85 -145.86 108.25 4.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.51 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -113.32 138.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.278 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.84 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 33.9 ttpt -141.67 98.8 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 HG13 ' CE2' ' A' ' 69' ' ' PHE . 7.5 mt -89.38 163.76 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 45.6 m -139.35 87.38 2.19 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 77' ' ' GLN . 2.7 p -45.63 155.34 0.16 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.238 -0.914 . . . . 0.0 108.905 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.468 HG22 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -55.44 -17.51 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.761 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.15 23.74 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 109.85 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 35.27 18.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.887 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.89 94.09 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.8 m-20 -66.32 153.12 43.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -148.68 114.84 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 109.261 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -108.27 124.15 49.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.502 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.49 -176.29 4.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.53 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 1.8 tt0 -150.38 138.1 19.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.842 -1.162 . . . . 0.0 110.025 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . . . -89.82 -145.8 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.535 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -115.52 -11.45 11.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 109.64 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.535 ' CG ' ' C ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -170.61 171.3 6.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -55.79 -48.78 74.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 109.474 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -48.62 -60.45 2.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 0.0 109.769 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 22.6 tt0 -61.49 -22.45 65.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.884 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.68 -63.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.782 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.543 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -66.08 -12.83 58.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.15 -39.06 26.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.112 -0.992 . . . . 0.0 108.868 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CZ3' HD22 ' A' ' 28' ' ' LEU . 9.6 m95 -78.1 -29.76 49.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.805 . . . . 0.0 109.028 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 2.8 m -74.09 -31.27 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.591 -0.693 . . . . 0.0 109.699 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.7 ptp180 -83.5 -23.16 32.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.901 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -83.31 -54.54 4.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.07 -1.019 . . . . 0.0 109.713 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 28' ' ' LEU . 2.6 mt -65.14 -39.75 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 108.575 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 20.5 t-20 -70.09 -56.59 6.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.89 . . . . 0.0 109.155 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 22.3 tttm -44.17 -49.69 8.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HB3' HD23 ' A' ' 50' ' ' LEU . . . -57.31 -43.92 83.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 50' ' ' LEU . 1.2 mp -57.63 -58.79 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.7 -10.78 21.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 109.904 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -92.7 -22.78 19.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.313 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.47 HG13 ' HB3' ' A' ' 50' ' ' LEU . 3.1 mm -84.7 -22.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.987 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 41.0 mt-10 -68.3 -7.8 34.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.85 9.44 5.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 5.8 mt -105.73 59.41 0.66 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.288 -1.125 . . . . 0.0 109.16 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -44.55 162.95 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.61 -0.681 . . . . 0.0 109.709 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.501 ' C ' ' CD2' ' A' ' 109' ' ' HIS . 74.7 m-70 -105.2 -148.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.501 ' CD2' ' C ' ' A' ' 108' ' ' HIS . 16.6 m-70 74.75 79.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 37.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 20.0 m170 -72.89 106.92 5.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 171.56 165.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.3 m170 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.454 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 2.1 mpp? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 3' ' ' PRO . 1.9 mm-40 -93.64 159.35 35.02 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 2' ' ' GLU . 52.9 Cg_exo -51.09 -170.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.077 1.851 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.7 pttt -116.2 77.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.408 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.69 130.89 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HB ' ' CD1' ' A' ' 28' ' ' LEU . 8.3 mm -46.33 -46.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.557 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -137.88 152.48 49.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 109.491 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.548 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.6 pm0 -161.6 124.05 3.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.584 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -157.92 -145.7 4.3 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 9.7 p90 -143.26 93.45 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.339 -1.094 . . . . 0.0 109.971 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CD2' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -115.37 166.53 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.548 HG23 ' CE3' ' A' ' 21' ' ' TRP . 1.6 p -90.83 135.61 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.775 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.4 OUTLIER -126.98 131.08 51.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.464 -0.773 . . . . 0.0 109.597 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.59 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 35.0 tttm -95.47 138.62 32.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 109.423 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.1 -2.49 4.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.482 ' CB ' ' CE ' ' A' ' 45' ' ' LYS . 3.7 p -76.72 -93.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.552 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 12.0 p -97.43 109.54 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.344 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-30 59.23 -180.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 28.8 p-10 -82.73 88.79 6.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 21.6 p -132.24 -167.27 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.755 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.637 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.4 m95 -146.4 116.83 7.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 0.0 109.59 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 21' ' ' TRP . 33.4 mttt -148.17 137.38 12.02 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 110.048 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 46.6 Cg_exo -56.3 161.13 9.66 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.937 1.758 . . . . 0.0 109.787 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.775 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 21.6 ptm -171.1 167.36 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 109.798 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.59 ' CD2' ' HA ' ' A' ' 39' ' ' LYS . 54.5 t-105 -88.77 142.61 27.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.6 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -150.41 132.39 5.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.446 -178.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 11.4 m -125.15 105.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.592 -0.693 . . . . 0.0 109.285 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.557 ' CD2' ' HB3' ' A' ' 7' ' ' ARG . 1.7 pp -79.6 124.14 28.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.036 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.494 ' CD1' ' OE2' ' A' ' 34' ' ' GLU . 2.7 mp -112.15 166.42 11.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.505 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -72.02 -12.97 61.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.906 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.432 ' OD1' HD12 ' A' ' 103' ' ' ILE . 1.1 m-20 -106.07 -2.67 22.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 50' ' ' LEU . . . 152.9 151.69 5.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.478 HG13 ' HB2' ' A' ' 28' ' ' LEU . 4.7 mp -98.36 108.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' OE2' ' CD1' ' A' ' 29' ' ' LEU . 4.8 pt-20 -107.22 119.96 40.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.0 p90 -121.3 144.64 48.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 110.431 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -121.25 -148.93 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -51.97 3.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 109.174 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -105.13 -177.26 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 108.855 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.11 -40.45 10.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.058 -1.026 . . . . 0.0 108.512 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.45 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -153.43 72.04 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 109.765 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 23.6 t70 -50.15 -20.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 3.7 t30 90.86 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 101.6 51.66 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 53.4 Cg_exo -49.69 142.68 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.888 1.725 . . . . 0.0 111.246 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' CE ' ' CB ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -98.18 -25.63 14.83 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.39 146.77 5.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 9.5 mtm -127.31 -174.92 3.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -1.166 . . . . 0.0 109.628 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.3 mt -140.59 127.83 12.22 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.46 84.79 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.494 1.462 . . . . 0.0 110.073 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.535 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -60.95 -14.2 21.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.412 -0.805 . . . . 0.0 109.201 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' N ' HD22 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -58.36 -15.41 10.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.9 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -165.68 27.91 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.132 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.469 ' OG ' HG22 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -77.54 168.73 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 0.0 109.348 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -126.67 160.25 31.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.403 -0.81 . . . . 0.0 109.167 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.543 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 2.8 tm? -121.28 149.47 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.042 -1.037 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.517 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 98.9 m -136.42 134.79 38.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 110.052 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 5.4 t -150.38 118.87 3.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.327 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 53.6 Cg_endo -72.49 -161.86 2.29 Favored 'Cis proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.642 -1.816 . . . . 0.0 110.369 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 18.2 p -96.34 -161.25 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.694 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -67.84 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.867 . . . . 0.0 109.756 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -84.89 15.37 4.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.2 t80 -89.16 -27.13 20.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.918 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' CG1' ' A' ' 68' ' ' VAL . . . -103.97 -91.69 2.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 tttt 43.66 27.26 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -1.093 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' GLY . 12.7 mtp180 -124.67 -90.14 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.437 -0.789 . . . . 0.0 109.424 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.7 mmm -81.92 -114.36 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.321 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 84.1 m-85 -130.96 89.99 2.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.824 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' CG1' ' HA3' ' A' ' 63' ' ' GLY . 1.6 p -129.62 119.71 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.829 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.707 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.8 p90 -97.8 168.77 10.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.091 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 6.0 ttpt -127.17 117.39 22.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.4 mt -95.5 167.84 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.828 . . . . 0.0 108.872 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.2 m -141.05 92.23 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -42.76 152.09 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 1.2 t -52.15 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.522 -0.736 . . . . 0.0 109.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 158.52 -71.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 164.55 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.441 ' HB3' HG22 ' A' ' 73' ' ' THR . 0.7 OUTLIER -100.93 79.08 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.092 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 1.7 p30 -56.07 144.01 30.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.701 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.455 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 42.0 m-70 -137.49 145.26 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.8 m-85 -100.88 137.61 39.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.707 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 1.1 t80 -143.97 123.3 13.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -129.36 120.13 25.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.04 . . . . 0.0 109.879 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.98 -146.51 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -97.51 -90.05 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -96.22 167.88 10.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -52.45 -20.33 2.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.819 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.526 ' N ' HD22 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -72.35 -46.7 54.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.731 -179.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -73.97 -48.61 29.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.88 -30.5 71.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.004 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 51.2 t0 -75.09 -42.36 56.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.989 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -73.91 -19.69 60.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.566 ' CH2' HG23 ' A' ' 26' ' ' VAL . 3.4 m95 -83.6 -37.15 23.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.393 -0.817 . . . . 0.0 109.048 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.543 ' CG2' ' CD1' ' A' ' 55' ' ' LEU . 3.9 p -76.84 -31.59 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.789 . . . . 0.0 109.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 13.2 mmm180 -83.83 -24.34 30.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.605 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 33.5 t0 -83.71 -39.7 19.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.975 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.537 HG12 ' CB ' ' A' ' 28' ' ' LEU . 5.3 mt -71.81 -32.79 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 0.0 108.696 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -84.31 -30.7 25.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.222 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -67.16 -50.97 59.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.949 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -67.25 -32.72 73.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.951 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 20.6 mt -61.91 -41.26 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.423 -0.798 . . . . 0.0 109.095 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -83.58 -13.46 54.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.62 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.67 -12.24 25.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 109.58 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.526 ' CG2' ' HG ' ' A' ' 50' ' ' LEU . 5.6 tp -93.43 -14.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 4.0 mt-10 -80.15 -6.63 58.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.511 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.97 8.63 7.17 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.71 57.23 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.27 -88.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.721 -0.612 . . . . 0.0 109.551 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 171.42 -38.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -119.64 113.61 20.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.409 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -72.24 -154.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -111.83 165.46 12.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.395 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.1 t60 50.7 80.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.446 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 13.5 mm-40 -93.39 164.41 21.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.363 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 54.4 Cg_exo -49.63 -179.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.015 1.81 . . . . 0.0 110.316 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -80.33 80.73 6.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.48 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.51 ' HG2' ' CD2' ' A' ' 29' ' ' LEU . 4.1 mtt180 58.26 165.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.525 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 18.9 mt -90.17 -70.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.597 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.549 ' HB3' ' CG ' ' A' ' 28' ' ' LEU . 3.3 tpm_? -114.45 121.86 44.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.4 pm0 -130.21 135.42 48.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.122 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.05 -145.68 4.44 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.2 p90 -142.26 102.41 4.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -1.06 . . . . 0.0 110.485 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.655 ' CD2' ' CZ2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -129.54 150.89 50.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.575 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -81.17 135.82 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.091 -1.006 . . . . 0.0 108.759 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HG3' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -127.82 84.79 2.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.087 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 34.41 -149.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.259 0.552 . . . . 0.0 110.207 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 20' ' ' THR . . . -145.92 163.35 28.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.6 m -89.22 23.24 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.472 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.7 p -167.86 118.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.455 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 44.9 m-85 60.24 153.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -59.45 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -119.39 152.48 36.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.517 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.626 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -133.6 121.51 22.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.1 -179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.511 ' N ' HG22 ' A' ' 12' ' ' VAL . 11.6 mttm -147.01 142.87 17.49 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.571 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 41.1 Cg_endo -73.08 130.79 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.094 1.863 . . . . 0.0 110.224 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.779 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -138.53 175.02 9.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.709 ' O ' ' SD ' ' A' ' 24' ' ' MET . 66.1 t-105 -92.27 145.39 24.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.591 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -148.87 144.3 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.101 -178.364 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -137.1 99.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.369 -0.832 . . . . 0.0 109.566 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.634 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -76.22 120.17 21.13 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.237 -0.914 . . . . 0.0 109.231 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -106.03 167.27 9.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 109.507 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.511 ' CA ' HD13 ' A' ' 6' ' ' ILE . 4.8 pt-20 -71.99 -10.85 60.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.75 -2.23 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.618 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 154.89 147.7 4.77 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -95.93 108.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 23.8 pt-20 -107.82 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.665 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.779 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 1.4 p90 -117.09 150.49 38.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.094 -1.004 . . . . 0.0 109.993 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -127.5 -172.56 2.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.308 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -77.58 -50.04 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.58 -174.28 2.5 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.7 -23.65 0.44 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.932 -1.105 . . . . 0.0 109.415 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.87 -49.59 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.045 . . . . 0.0 109.642 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 2.8 t70 62.26 9.79 3.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 41.46 23.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 110.066 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -165.14 102.22 0.79 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.169 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.578 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.6 Cg_exo -52.79 133.23 49.96 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.978 1.785 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.98 -21.96 22.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 175.09 149.0 7.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.793 ' SD ' ' N ' ' A' ' 47' ' ' MET . 0.5 OUTLIER -125.62 169.02 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.422 ' HB ' HD11 ' A' ' 33' ' ' ILE . 57.1 mt -132.35 134.69 25.24 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.51 121.26 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.38 1.387 . . . . 0.0 110.472 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -58.51 -39.02 78.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.429 -0.794 . . . . 0.0 109.707 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.487 ' HB2' ' CG2' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -101.11 108.27 19.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 125.24 -1.32 8.27 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.499 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 7.6 t -89.89 170.32 10.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.869 -1.371 . . . . 0.0 109.864 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.496 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.16 122.22 13.74 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.303 -0.873 . . . . 0.0 109.438 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.53 ' CD2' ' CD2' ' A' ' 69' ' ' PHE . 3.2 tm? -88.91 127.19 35.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.457 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.684 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 3.4 m -117.46 102.24 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.172 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 3.3 m -140.51 135.84 16.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 57' ' ' SER . 58.4 Cg_endo -77.3 176.32 44.25 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.35 -1.938 . . . . 0.0 110.345 -0.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' A' ' 56' ' ' THR . 5.0 m -148.59 82.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -98.69 112.93 24.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -177.74 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 109.562 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.0 t80 -89.14 -39.68 13.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 108.329 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -117.14 -39.32 0.81 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER 39.36 72.44 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.859 . . . . 0.0 109.317 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.57 -95.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.738 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.6 mmm -77.1 -122.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 38.6 m-85 -112.71 92.57 4.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.774 -1.204 . . . . 0.0 109.677 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -118.85 126.77 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.34 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.675 ' CE1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -112.62 176.19 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 3.0 tmmm? -135.78 114.63 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.783 . . . . 0.0 110.238 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -97.78 171.08 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.8 m -145.89 94.16 2.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.163 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.2 p -59.86 153.53 20.68 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.0 109.094 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -44.46 -23.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.223 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER -86.86 31.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 0.0 109.771 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.85 28.43 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.407 ' OE1' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -89.88 92.29 8.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.287 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.572 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 8.3 t70 -58.92 152.76 18.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -142.55 103.04 4.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.572 ' CZ ' ' OD1' ' A' ' 78' ' ' ASP . 10.8 m-85 -95.1 117.69 30.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -131.58 171.26 13.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.104 -0.998 . . . . 0.0 109.263 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.22 130.13 26.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.035 -1.041 . . . . 0.0 109.188 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.515 ' HA ' ' CD1' ' A' ' 11' ' ' LEU . . . -89.75 164.66 14.58 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.471 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -97.43 53.37 1.15 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER 166.08 162.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.915 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -88.33 -51.09 5.93 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.483 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -65.19 -29.22 70.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 29.8 tt0 -79.87 -43.28 22.57 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.481 -0.762 . . . . 0.0 109.426 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.531 ' CD ' ' HB3' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.49 -55.7 26.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 93' ' ' VAL . 1.5 m-20 -65.83 -25.81 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 108.866 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 88' ' ' GLU . . . -69.19 -24.66 64.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.655 ' CZ2' ' CD2' ' A' ' 11' ' ' LEU . 11.7 m95 -83.27 -31.71 26.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 90' ' ' ASP . 1.5 m -79.44 -23.34 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.395 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.3 mmp_? -86.4 -34.15 20.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 0.0 109.546 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 2.7 t0 -82.98 -41.55 18.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.149 -0.969 . . . . 0.0 109.681 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 28' ' ' LEU . 4.4 mt -72.88 -35.17 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.293 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 1.5 t-20 -81.59 -32.74 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -68.52 -40.31 80.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 109.18 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.443 ' C ' HD13 ' A' ' 50' ' ' LEU . . . -70.94 -40.37 72.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.295 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 10.9 mt -67.48 -28.95 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.102 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -89.11 -8.75 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -30.8 13.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -70.11 -30.03 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 108.791 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.75 -5.98 34.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.06 10.89 5.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.04 57.13 1.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.422 -1.046 . . . . 0.0 109.144 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 108' ' ' HIS . 2.1 mp0 -92.42 68.18 4.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.677 -0.64 . . . . 0.0 109.37 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 107' ' ' GLU . 17.9 p80 -46.49 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.463 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.68 146.43 16.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.516 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -99.57 38.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -120.85 40.19 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.558 ' N ' ' CD2' ' A' ' 112' ' ' HIS . 2.7 m170 79.8 -73.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.646 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 66.7 t60 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.446 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -162.23 160.34 21.15 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 2' ' ' GLU . 53.2 Cg_exo -50.25 129.63 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ARG . 26.7 mttt -92.1 75.87 5.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.5 OUTLIER 61.1 139.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.3 mt -73.17 -28.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.806 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.528 ' CB ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -145.28 166.53 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.075 -1.015 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.7 pm0 178.83 127.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.481 -0.762 . . . . 0.0 109.567 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.593 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.87 -145.6 4.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.2 p90 -140.43 91.96 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 110.219 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.577 HD21 ' CG1' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -118.9 161.88 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.933 . . . . 0.0 108.677 178.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 22' ' ' LYS . 1.6 p -85.4 141.74 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.672 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HE2' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -123.21 142.72 50.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.203 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 19' ' ' ASN . 5.2 tttt -88.17 115.62 25.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.4 93.91 0.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -85.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -1.156 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.67 -19.08 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.96 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HB3' ' CE ' ' A' ' 14' ' ' LYS . 50.5 m-80 63.95 100.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 17.4 p -149.18 -170.65 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.162 -0.961 . . . . 0.0 109.697 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.585 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.5 m95 -141.6 105.92 4.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 35.5 mttt -146.75 136.62 11.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.47 157.55 6.87 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.915 1.744 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.777 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -168.18 165.92 13.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 110.111 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.748 ' O ' ' SD ' ' A' ' 24' ' ' MET . 62.6 t-105 -90.23 143.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.577 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -150.6 138.57 14.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.935 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 6.5 m -126.09 120.23 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.802 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 7' ' ' ARG . 1.6 mt -78.95 120.52 23.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.446 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.6 mp -115.18 158.55 22.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' O ' HD12 ' A' ' 50' ' ' LEU . 6.5 pt-20 -73.02 -9.65 58.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 2.9 p30 -107.89 -3.4 18.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.126 -0.984 . . . . 0.0 109.482 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' HA2' HD21 ' A' ' 50' ' ' LEU . . . 152.78 155.54 7.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.072 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.53 107.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.349 -1.089 . . . . 0.0 109.252 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 2.7 tp10 -104.7 117.84 35.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.777 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.2 p90 -125.59 147.71 49.2 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -123.67 -157.69 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -93.77 -43.6 8.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.163 -0.961 . . . . 0.0 108.471 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -111.88 -176.39 2.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.587 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -44.95 -25.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.933 -1.105 . . . . 0.0 109.248 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -149.91 -50.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.551 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.9 t0 61.15 10.82 3.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.868 . . . . 0.0 109.352 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.5 m-80 41.6 23.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.745 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -163.93 115.05 0.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.849 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.6 Cg_endo -71.4 134.7 25.12 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.888 1.726 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -89.75 -20.21 23.84 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 168.48 157.73 11.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.447 ' HG2' ' OE1' ' A' ' 34' ' ' GLU . 6.7 mtt -133.11 169.82 16.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -1.06 . . . . 0.0 109.18 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 56.9 mt -136.78 127.35 16.25 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.78 124.65 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.252 1.301 . . . . 0.0 109.713 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' HG13 ' A' ' 103' ' ' ILE . 1.8 pt? -89.19 23.6 2.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.128 -0.983 . . . . 0.0 109.856 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HA ' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -86.98 -66.45 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.864 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -101.26 -2.19 54.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -39.56 148.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -1.052 . . . . 0.0 110.512 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.54 HG21 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -119.03 155.94 30.55 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -124.74 130.54 52.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.931 -1.106 . . . . 0.0 109.301 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 59' ' ' CYS . 90.2 m -121.8 123.38 41.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.709 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.49 119.56 3.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' HG23 ' A' ' 56' ' ' THR . 56.9 Cg_endo -74.04 -175.12 14.62 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.7 -1.791 . . . . 0.0 110.299 -0.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.762 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -102.95 170.11 8.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 109.574 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.762 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 mt-30 -107.66 133.19 52.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 3.7 t0 83.84 -49.42 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 5.7 m-85 -100.38 -32.25 10.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 108.727 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -83.83 0.82 89.38 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -89.51 23.23 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -1.176 . . . . 0.0 109.272 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -143.8 -96.96 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.636 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -158.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 109.763 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 81.6 m-85 -97.53 87.97 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 81' ' ' PHE . 2.1 p -135.18 130.71 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 81' ' ' PHE . 3.7 p90 -100.03 167.5 10.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.304 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -125.63 116.91 22.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.77 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 72' ' ' THR . 3.4 mt -99.51 165.85 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.55 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 16.7 m -142.16 103.85 4.36 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.5 ' C ' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -53.38 108.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.869 0.843 . . . . 0.0 109.689 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.12 27.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 179.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 74' ' ' THR . 1.7 ttpp 80.71 42.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.016 . . . . 0.0 109.412 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.01 -78.88 0.51 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.551 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -89.96 133.97 34.49 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.533 -0.729 . . . . 0.0 110.254 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 3.5 p30 -95.2 152.18 18.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.356 -0.84 . . . . 0.0 108.752 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -141.99 104.72 4.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 110.214 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.559 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.8 m-85 -93.51 109.0 20.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 108.794 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -118.43 144.91 45.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.416 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.534 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 4.4 tm0? -118.93 133.97 55.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.165 . . . . 0.0 109.827 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -89.47 -145.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 85' ' ' PHE . . . -103.02 -10.1 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 171.19 174.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.829 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -47.38 -50.08 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.148 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 5.9 tt0 -45.07 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 110.21 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -60.51 -14.48 19.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -71.62 -38.82 70.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HA ' HG11 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -85.09 -27.93 25.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.58 -29.37 56.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.576 ' CZ2' HD22 ' A' ' 11' ' ' LEU . 10.4 m95 -84.31 -42.72 15.51 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 55' ' ' LEU . 4.8 p -72.12 -29.27 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 14.4 ptm180 -79.01 -34.9 43.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.818 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.445 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 13.4 t70 -75.62 -54.43 7.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.0 109.458 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.519 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 7.2 mt -55.34 -35.89 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.028 -1.045 . . . . 0.0 108.738 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.411 ' OD1' ' HG3' ' A' ' 101' ' ' LYS . 15.9 t30 -79.72 -24.69 41.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 108.907 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -63.09 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 108.901 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.469 ' O ' HD13 ' A' ' 50' ' ' LEU . . . -56.45 -35.4 67.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 34.4 mt -62.35 -35.86 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 108.796 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.411 ' HG3' ' OD1' ' A' ' 97' ' ' ASN . 1.9 mtmp? -83.97 -8.38 59.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.9 t -93.57 -28.0 16.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.572 ' CG2' ' N ' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -78.55 -79.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 103' ' ' ILE . 68.6 mt-10 37.38 52.5 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.771 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.461 ' O ' HD21 ' A' ' 106' ' ' LEU . . . 74.78 93.0 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -154.13 64.82 0.7 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.59 -0.947 . . . . 0.0 109.405 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.8 62.14 0.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.438 -0.788 . . . . 0.0 109.531 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.42 171.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.68 74.85 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 110' ' ' HIS . 28.3 p80 -48.99 120.58 4.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.551 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 112' ' ' HIS . 21.5 m80 52.45 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 111' ' ' HIS . 55.8 m-70 44.82 81.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.478 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.542 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 5.5 mp0 -134.79 164.49 43.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 52.4 Cg_exo -50.87 138.17 42.52 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.025 1.817 . . . . 0.0 110.166 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 97.76 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -58.42 165.07 2.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.447 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 99' ' ' ALA . 12.1 mt -67.81 -49.04 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.598 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.513 ' HB2' ' CD1' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -144.4 111.04 5.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 109.67 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.55 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.7 pm0 -119.65 132.7 55.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.11 -146.21 4.59 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 20.0 p90 -142.68 102.73 4.1 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.523 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB2' ' CD2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -121.03 160.47 23.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.213 -0.929 . . . . 0.0 108.555 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 1.3 p -86.03 151.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.074 -1.016 . . . . 0.0 109.52 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -140.49 147.72 40.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -0.829 . . . . 0.0 109.853 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 20' ' ' THR . 24.4 tttm -117.5 133.67 55.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . 168.41 174.3 37.04 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 58.15 -174.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -1.074 . . . . 0.0 109.204 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 18' ' ' PHE . 6.2 p -42.96 -42.63 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG21 ' A' ' 20' ' ' THR . 12.2 m-85 -39.69 -68.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.919 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 22.03 3.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.516 HG21 ' O ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -108.27 -171.52 1.88 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.586 ' CZ2' ' HB2' ' A' ' 80' ' ' PHE . 14.4 m95 -132.03 82.19 2.01 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 108.675 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.481 ' N ' HG21 ' A' ' 12' ' ' VAL . 2.1 mttm -115.6 136.95 22.89 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.036 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.74 156.83 6.15 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.055 1.837 . . . . 0.0 110.16 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.762 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -162.31 170.1 19.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -0.952 . . . . 0.0 109.877 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.762 ' O ' ' SD ' ' A' ' 24' ' ' MET . 73.5 t-105 -97.7 142.61 29.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.556 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.17 135.4 10.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.977 -178.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -125.93 100.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.409 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.585 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -76.89 116.37 17.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.883 . . . . 0.0 109.502 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.7 mp -101.08 161.75 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 0.6 OUTLIER -70.59 -13.83 62.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 -1.31 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 0.0 109.854 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA2' ' CD2' ' A' ' 50' ' ' LEU . . . 158.5 140.42 2.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 HD13 HD23 ' A' ' 50' ' ' LEU . 3.6 mp -95.57 121.11 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -1.203 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.1 pt-20 -120.82 120.74 36.45 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.607 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 p90 -121.95 147.44 46.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.981 -1.074 . . . . 0.0 110.893 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.94 -150.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.19 -43.46 6.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -108.8 -175.96 2.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -47.87 -22.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.878 -1.139 . . . . 0.0 109.337 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -148.46 -51.54 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.7 t70 61.81 10.34 3.41 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 42.2 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.112 -0.992 . . . . 0.0 109.954 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.1 t -167.54 109.45 0.61 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.938 -1.101 . . . . 0.0 109.891 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 54.1 Cg_endo -71.61 134.26 23.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.849 1.7 . . . . 0.0 110.557 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.75 -19.4 24.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.22 142.5 5.8 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.408 ' HG3' ' C ' ' A' ' 46' ' ' GLY . 16.7 mtm -136.27 126.96 27.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.155 -1.203 . . . . 0.0 109.533 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.452 HG22 ' HD2' ' A' ' 49' ' ' PRO . 4.7 mt -88.94 136.8 30.2 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 108.8 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 48' ' ' ILE . 55.8 Cg_endo -72.31 140.74 34.23 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.721 1.614 . . . . 0.0 110.504 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -74.89 0.13 16.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.438 -0.789 . . . . 0.0 109.493 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -44.8 -92.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.04 68.81 0.24 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.51 ' HA ' ' N ' ' A' ' 74' ' ' THR . 14.4 m -60.27 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 109.6 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.34 122.32 15.61 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 -179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' CD1' HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -89.07 122.1 32.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.175 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 59.7 m -115.26 114.43 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.105 -0.997 . . . . 0.0 109.62 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.0 p -145.5 121.36 5.84 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' O ' HG21 ' A' ' 56' ' ' THR . 55.0 Cg_endo -71.92 175.3 43.23 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.559 -1.851 . . . . 0.0 110.342 -0.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.771 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 9.5 t -90.69 -94.75 0.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.6 mt-30 -141.75 -149.76 0.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.371 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -15.12 8.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.901 . . . . 0.0 108.818 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 -28.98 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.533 ' HA2' ' CG1' ' A' ' 68' ' ' VAL . . . -85.36 -14.38 68.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 65' ' ' ARG . 5.4 tttm -84.46 70.5 10.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -1.192 . . . . 0.0 109.579 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 165.17 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.586 ' SD ' ' NE2' ' A' ' 82' ' ' GLN . 2.7 mtt 67.2 -172.82 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 1.3 m-85 -88.15 83.37 6.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.2 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.539 HG22 ' CH2' ' A' ' 21' ' ' TRP . 1.5 p -127.08 136.27 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.841 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CD2' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -124.3 178.71 5.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.771 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 3.2 tttp -143.35 107.25 4.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 109.808 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.571 HG13 ' CE2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -90.45 170.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 108.987 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.561 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.4 m -145.86 90.87 2.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.458 ' C ' ' O ' ' A' ' 72' ' ' THR . 2.4 p -40.44 142.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 109.837 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.51 ' N ' ' HA ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -40.55 -29.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 0.0 109.963 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -73.02 -70.77 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.319 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.9 pt20 164.15 38.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.0 99.83 9.37 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 p30 -63.35 152.96 36.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -144.57 96.41 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.727 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -91.15 117.65 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.059 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -135.82 162.53 32.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.956 -1.09 . . . . 0.0 109.587 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 36.5 tt0 -127.77 131.11 49.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.994 -1.066 . . . . 0.0 109.272 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 89' ' ' ARG . . . -89.5 -168.37 2.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.439 -0.788 . . . . 0.0 109.732 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -70.8 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.13 -179.98 4.1 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 109.473 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -55.62 -59.45 4.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.609 -0.682 . . . . 0.0 109.602 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 12.5 tm-20 -47.31 -67.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.048 . . . . 0.0 110.358 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 54.7 tt0 -52.42 -26.44 12.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HA ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -68.47 -63.6 1.03 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.036 . . . . 0.0 109.707 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.483 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 3.9 p30 -55.78 -27.84 53.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.518 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.27 -35.83 68.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 108.956 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.585 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.25 -41.53 73.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.613 -0.679 . . . . 0.0 110.358 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.614 HG22 ' CD2' ' A' ' 69' ' ' PHE . 5.3 p -76.89 -34.68 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 111.052 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.518 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -71.56 -23.55 61.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.768 -1.207 . . . . 0.0 109.323 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.41 -39.36 22.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.472 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.533 ' CG1' HD21 ' A' ' 28' ' ' LEU . 6.3 mt -69.82 -37.59 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.4 -26.96 38.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.113 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 3.5 tptp -65.13 -44.95 87.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.935 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.529 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . . . -71.62 -35.7 70.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.133 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 46.7 mt -72.72 -19.45 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.258 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.36 -16.24 26.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.53 -29.39 14.39 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 50' ' ' LEU . 7.9 mm -71.52 -26.24 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 67.9 mt-10 -51.92 -22.53 3.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.59 -104.97 1.7 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.42 66.07 1.11 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.412 -1.051 . . . . 0.0 109.576 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.33 135.17 52.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.451 -0.781 . . . . 0.0 109.409 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -120.77 -29.77 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 109.683 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 176.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -85.55 64.07 8.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.461 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -143.75 88.08 1.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -127.29 -37.43 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' C ' ' CG ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.0 mt-10 68.11 161.92 0.14 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 57.9 Cg_endo -75.17 -95.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.28 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.67 90.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' HB2' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -111.46 126.11 54.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.261 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 30' ' ' GLU . 7.5 mt -52.42 -45.98 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.828 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.583 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -140.43 145.19 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.857 -179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.6 pm0 -155.04 132.46 11.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.081 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.46 -147.57 4.88 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.4 p90 -140.49 93.89 2.67 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.545 -0.973 . . . . 0.0 110.232 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -118.27 157.08 27.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 108.807 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 82' ' ' GLN . 1.6 p -81.49 151.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -132.13 139.87 48.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 14.1 ttpp -84.14 113.92 21.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.375 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.11 167.7 42.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -91.43 -24.84 19.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 3.3 p -46.23 -32.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -177.03 -171.39 0.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.414 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -82.72 85.01 7.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.1 p -127.16 166.0 18.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 20' ' ' THR . 18.1 m95 -150.69 106.82 3.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' O ' HG21 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -131.73 133.14 23.84 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.23 149.95 20.93 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 109.922 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.742 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -159.38 168.3 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.699 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.0 t-105 -92.57 144.22 25.55 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.94 134.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.024 -178.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.5 m -124.07 105.66 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.761 . . . . 0.0 109.396 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.583 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 1.8 pp -80.74 111.87 17.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.137 -0.977 . . . . 0.0 109.581 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.512 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.3 mp -96.98 161.07 14.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -73.42 -11.23 60.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 4.5 p30 -108.86 2.79 21.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA2' HD21 ' A' ' 50' ' ' LEU . . . 150.86 144.57 3.95 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.566 HD12 ' CD2' ' A' ' 50' ' ' LEU . 4.6 mm -92.86 130.49 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 110.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 5.5 pt-20 -132.86 113.71 13.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.742 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.3 p90 -119.43 147.0 44.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.09 -1.006 . . . . 0.0 110.735 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -127.92 -150.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.46 -53.54 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.53 -172.62 2.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.6 OUTLIER -54.1 -18.69 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.916 -1.115 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.92 -53.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.1 t0 61.35 9.42 2.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m120 40.5 24.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.221 -0.924 . . . . 0.0 110.071 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.6 t -167.45 122.46 0.84 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.982 -1.074 . . . . 0.0 109.499 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 59.2 Cg_endo -75.56 156.83 40.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.803 1.669 . . . . 0.0 111.276 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 2.8 tptt -119.13 -16.88 9.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -178.68 136.68 2.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.0 mtm -131.41 119.33 21.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -1.137 . . . . 0.0 109.697 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mt -89.77 139.47 27.77 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 38.6 Cg_endo -68.05 148.12 74.95 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.528 1.485 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.566 ' CD2' HD12 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -85.04 36.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.812 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -167.42 136.6 2.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.995 -1.066 . . . . 0.0 109.927 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 91.07 -36.18 3.69 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 2.7 m -42.11 156.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.396 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.481 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -123.31 169.89 10.86 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD1' HG21 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -131.47 124.24 29.75 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.06 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.494 ' N ' HD22 ' A' ' 55' ' ' LEU . 20.4 m -115.97 125.81 53.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.422 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -150.2 127.91 5.69 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.588 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 57' ' ' SER . 56.3 Cg_endo -73.96 -178.28 22.12 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.471 -1.887 . . . . 0.0 110.277 -0.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.782 ' SG ' HG23 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -150.06 175.1 12.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.662 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.589 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 2.3 tt0 66.84 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -0.795 . . . . 0.0 110.172 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.84 18.61 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' CE2' ' HG3' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -89.26 -64.25 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -90.84 -21.85 35.15 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 8.0 pttt 40.33 32.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.724 -0.868 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -97.05 20.71 10.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.583 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 9.8 mtp 58.89 179.32 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' A' ' 66' ' ' MET . 1.8 m-85 81.22 -13.66 0.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.497 -0.752 . . . . 0.0 109.911 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG23 ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -109.84 135.18 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.979 -1.075 . . . . 0.0 109.423 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.735 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 4.0 p90 -121.36 167.18 13.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 19.5 ttpt -129.11 98.03 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.925 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.482 HG13 ' CE1' ' A' ' 69' ' ' PHE . 20.0 mt -90.9 155.41 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.538 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.565 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 39.9 m -134.61 112.31 10.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.049 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 49' ' ' PRO . 2.7 t -55.83 113.82 1.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 39.29 26.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 111.333 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.565 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tptm 80.86 47.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.904 -1.122 . . . . 0.0 109.16 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -83.64 0.6 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.206 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -101.21 129.81 47.2 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.662 -0.649 . . . . 0.0 109.441 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.96 171.1 15.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 69.6 m-70 -146.15 96.01 2.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.559 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 22.6 m-85 -93.16 100.22 12.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -0.796 . . . . 0.0 108.887 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.695 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.68 157.62 23.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.394 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.525 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 2.4 tt0 -121.19 128.85 52.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.065 -1.022 . . . . 0.0 108.999 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.52 -7.66 56.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 63.05 12.27 5.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.443 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.08 163.37 39.47 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.807 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -93.35 -48.03 6.61 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.577 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -69.48 -44.32 71.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.52 -0.738 . . . . 0.0 109.281 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.62 -34.65 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.684 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -62.07 -61.63 2.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -37.73 64.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -71.86 -26.79 62.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.084 -1.01 . . . . 0.0 109.773 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.574 ' CE2' HD22 ' A' ' 11' ' ' LEU . 1.1 m95 -79.84 -31.44 40.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.075 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 55' ' ' LEU . 1.3 p -83.43 -31.55 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.6 ptm180 -77.94 -25.16 48.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.308 -0.87 . . . . 0.0 109.187 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -82.0 -42.5 19.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.544 HD13 ' CZ3' ' A' ' 92' ' ' TRP . 29.5 mt -72.13 -37.46 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.177 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 7.7 t-20 -79.6 -33.81 41.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -67.37 -39.44 85.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.14 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.493 ' C ' ' CD1' ' A' ' 50' ' ' LEU . . . -68.81 -47.45 66.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.32 -0.863 . . . . 0.0 109.091 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.524 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 6.9 mt -67.89 -20.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 3.0 mmtp -90.11 -11.29 41.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.351 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.5 m -93.81 -38.16 11.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 108.856 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 50' ' ' LEU . 2.8 mm -67.91 -29.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.49 -15.9 63.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.13 3.29 26.93 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.0 mt -106.09 58.94 0.65 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.392 -1.064 . . . . 0.0 109.097 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -64.5 -51.73 61.49 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.624 -0.672 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 108' ' ' HIS . 0.1 OUTLIER -154.29 177.16 11.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.624 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 41.2 m-70 61.65 152.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.91 -26.86 8.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 66.87 155.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.35 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -46.73 4.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.494 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.7 175.96 0.98 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.553 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 52.9 Cg_exo -51.7 147.94 22.91 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.062 1.841 . . . . 0.0 110.327 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -131.17 95.91 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.535 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.459 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -80.95 145.25 31.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.492 HD13 ' CA ' ' A' ' 30' ' ' GLU . 33.3 mt -74.43 -49.01 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.562 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -136.79 142.14 42.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 0.5 OUTLIER -148.45 137.05 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.398 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.585 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.42 -149.5 5.69 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.1 p90 -140.42 98.25 3.39 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -1.026 . . . . 0.0 110.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -120.09 171.91 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 108.621 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.532 ' CG1' ' HG2' ' A' ' 82' ' ' GLN . 2.2 p -102.97 131.54 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.669 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 18.4 ttmt -132.33 168.09 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' CD ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -63.83 103.97 0.63 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -67.33 -74.01 0.6 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.491 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.3 OUTLIER 175.84 -159.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -1.155 . . . . 0.0 109.316 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 16' ' ' SER . 2.5 p 39.93 94.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.558 -0.714 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.3 m-85 63.0 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.458 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -47.75 97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -120.38 -177.19 3.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' A' ' 68' ' ' VAL . 2.0 m95 -142.9 106.63 4.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 2.8 mmtp -130.33 140.84 39.88 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.85 163.85 1.82 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.876 1.717 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' A' ' 13' ' ' LYS . 17.7 ptm -176.91 159.67 1.75 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.778 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.9 t-105 -90.24 145.28 25.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.569 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -150.49 136.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.297 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.1 m -127.38 101.68 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.511 -0.743 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.638 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -74.01 119.68 18.56 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD13 ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -109.11 165.44 11.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.499 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.492 ' CA ' HD13 ' A' ' 6' ' ' ILE . 2.1 tt0 -73.44 -14.5 61.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' C ' ' CD1' ' A' ' 50' ' ' LEU . 5.2 p-10 -105.6 5.88 31.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.379 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.574 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . 143.58 144.07 4.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -90.94 107.79 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.285 -1.126 . . . . 0.0 109.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 11.3 pt-20 -105.22 116.68 32.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 108.769 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.592 ' CE1' ' CA ' ' A' ' 46' ' ' GLY . 7.6 p90 -120.21 147.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.82 -152.06 0.5 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.02 -40.75 9.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.9 OUTLIER -112.83 -178.24 3.34 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -43.0 -25.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.069 -1.019 . . . . 0.0 109.54 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.18 -50.63 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.3 t0 62.99 8.42 3.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m120 41.16 23.58 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.8 t -166.51 96.69 0.72 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.1 Cg_exo -53.26 132.35 47.74 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.056 1.837 . . . . 0.0 110.739 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' HE3' ' CE ' ' A' ' 24' ' ' MET . 3.0 ttpt -89.77 -22.04 22.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.72 145.82 7.88 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 30.4 mtm -124.22 165.82 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.4 mt -132.93 117.7 15.06 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 54.8 Cg_endo -71.07 125.29 11.32 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.682 1.588 . . . . 0.0 109.916 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -90.2 39.59 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.319 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -89.77 -43.01 10.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.109 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -159.41 42.8 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.9 OUTLIER -68.98 179.04 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -1.153 . . . . 0.0 109.562 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.487 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -144.23 108.75 4.86 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.283 -0.886 . . . . 0.0 109.593 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.1 tm? -89.79 115.65 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.483 ' HB ' ' HG3' ' A' ' 70' ' ' LYS . 3.2 m -110.4 119.86 40.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.175 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -144.2 123.88 7.35 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 0.0 109.654 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 56' ' ' THR . 57.5 Cg_endo -74.5 -170.21 7.88 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.648 -1.813 . . . . 0.0 110.171 -0.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 10.3 t -102.64 -105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.279 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.638 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 pt20 162.97 119.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.944 -1.098 . . . . 0.0 109.789 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER 81.27 -40.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.722 . . . . 0.0 110.651 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -90.59 85.8 6.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.934 -1.104 . . . . 0.0 110.001 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.536 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . 78.08 20.33 73.09 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 51.1 tptt -53.2 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.242 . . . . 0.0 109.175 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' GLY . 3.4 mtt-85 174.6 -86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.551 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mtp -60.38 -148.91 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.581 -0.699 . . . . 0.0 109.473 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.587 ' CE1' ' HA ' ' A' ' 86' ' ' LEU . 98.4 m-85 -99.9 76.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' CH2' ' A' ' 21' ' ' TRP . 1.1 p -122.53 128.23 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.31 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 10.4 p90 -122.95 173.4 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HG2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -132.97 122.01 23.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.9 mt -93.62 167.94 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.057 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -146.49 85.86 1.66 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.48 ' HB ' ' HG2' ' A' ' 49' ' ' PRO . 5.2 p -44.39 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.569 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.09 63.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.246 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 5.9 mttp -89.76 12.06 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.451 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 72.44 26.28 2.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.4 OUTLIER -89.84 119.55 30.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.13 -0.981 . . . . 0.0 108.998 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 4.4 t0 -89.36 135.92 33.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 89.1 m-70 -130.01 97.12 4.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.405 -0.809 . . . . 0.0 108.97 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 78' ' ' ASP . 1.9 m-85 -90.19 120.49 31.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.28 146.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.217 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.532 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 6.5 pt20 -116.52 145.71 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 108.777 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -92.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.72 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.74 174.94 6.36 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.652 -0.655 . . . . 0.0 109.615 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.587 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -65.16 -41.31 94.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.53 -0.731 . . . . 0.0 109.184 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -57.48 -67.0 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.701 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.5 -31.73 56.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' CD ' ' OD1' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -58.82 -65.13 0.71 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 109.967 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.533 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 47.6 m-20 -58.84 -23.76 61.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.902 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.91 -31.96 64.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.015 -1.053 . . . . 0.0 109.507 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.638 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 4.2 m95 -82.57 -39.05 22.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -77.4 -21.92 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.246 -0.909 . . . . 0.0 109.341 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 90' ' ' ASP . 10.0 ptp180 -85.3 -29.44 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -84.35 -39.32 19.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.589 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.54 ' CG1' HD21 ' A' ' 28' ' ' LEU . 5.6 mt -72.85 -34.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 108.801 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -80.7 -28.93 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -53.33 17.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . . . -59.01 -40.67 85.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 108.928 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 50' ' ' LEU . 44.9 mt -65.06 -33.76 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 108.943 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 8.8 ttpt -78.03 -9.42 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.484 ' SG ' ' HG ' ' A' ' 106' ' ' LEU . 8.8 t -95.13 -32.31 13.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.809 . . . . 0.0 109.141 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 3.2 mm -67.74 -33.74 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 15.2 mt-10 -75.01 -2.1 25.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.289 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.74 20.7 2.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -87.7 54.34 3.09 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.635 -0.921 . . . . 0.0 109.235 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.04 -170.48 3.15 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -123.44 -37.09 2.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 64.55 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -96.8 -64.06 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.4 58.33 1.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -112.1 -58.4 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 109.42 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 21.5 mt-10 -101.16 163.3 18.21 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 51.3 Cg_exo -52.2 -165.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.088 1.859 . . . . 0.0 110.381 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -121.06 100.46 7.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.406 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 71.99 126.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.87 -39.77 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.543 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -131.73 169.55 16.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 109.866 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER 175.09 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 109.676 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.62 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.86 -147.14 5.02 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.0 p90 -138.96 103.83 4.9 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.975 -1.309 . . . . 0.0 110.902 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.644 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -120.63 158.17 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 0.0 108.546 178.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.526 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 2.1 p -86.53 129.78 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.968 -1.083 . . . . 0.0 109.295 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HD2' ' CB ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.97 170.15 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.467 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -116.18 134.83 54.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.82 0.21 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -125.31 -34.02 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.31 -84.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -133.06 71.8 1.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.61 60.76 3.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 48.7 p -115.83 -165.07 1.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.574 ' CH2' HG22 ' A' ' 68' ' ' VAL . 3.3 m95 -149.42 109.01 4.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 0.0 109.668 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' C ' ' CG2' ' A' ' 12' ' ' VAL . 6.1 mttm -140.38 143.21 32.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -51.26 156.42 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.987 1.791 . . . . 0.0 110.188 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -160.88 176.65 11.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.759 ' O ' ' SD ' ' A' ' 24' ' ' MET . 68.1 t-105 -109.69 146.16 35.32 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.567 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -150.41 147.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.948 -178.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 34' ' ' GLU . 5.3 m -130.96 119.32 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -0.969 . . . . 0.0 110.187 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 ' CB ' ' A' ' 7' ' ' ARG . 0.9 OUTLIER -81.15 124.35 29.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 2.4 mp -119.95 159.94 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.97 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 8.9 pt-20 -72.88 -22.18 60.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 109.698 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.487 ' C ' ' CD1' ' A' ' 50' ' ' LEU . 3.2 p30 -96.17 13.07 28.59 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.118 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . 137.17 169.77 11.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 ' N ' HD11 ' A' ' 33' ' ' ILE . 3.6 mp -111.86 112.57 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.126 -1.22 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 16.8 pt-20 -107.83 117.39 34.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 108.637 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.644 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -115.67 148.88 39.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.44 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -130.89 -158.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 -34.3 14.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.405 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -123.78 -169.05 1.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.54 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 6.9 tppt? -46.4 -25.38 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.909 -1.119 . . . . 0.0 109.011 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -155.25 -48.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.4 t70 60.96 11.14 3.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 48.2 t30 43.62 23.07 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.01 -1.056 . . . . 0.0 109.353 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.7 t -164.4 99.99 0.88 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 51.4 Cg_endo -71.43 144.36 45.25 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.919 1.746 . . . . 0.0 110.704 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -89.65 -22.68 22.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.049 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.621 ' N ' ' CE1' ' A' ' 35' ' ' PHE . . . 172.89 158.49 17.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 3.8 mtt -123.3 -178.71 4.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -1.176 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 73' ' ' THR . 5.8 mt -135.98 116.26 11.38 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 109.279 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 73' ' ' THR . 51.1 Cg_endo -70.58 122.1 8.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.623 1.549 . . . . 0.0 110.099 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -73.01 -0.61 14.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.167 -0.958 . . . . 0.0 109.744 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' HB3' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -43.04 -60.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 70.02 0.18 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.129 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.2 m -82.72 177.32 8.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -1.197 . . . . 0.0 109.146 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.543 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -134.19 165.47 25.01 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.08 124.32 42.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.162 -0.961 . . . . 0.0 108.84 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.511 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 30.5 m -111.77 119.87 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.738 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 52.4 p -150.5 115.89 3.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' THR . 52.6 Cg_endo -71.6 -172.1 8.4 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.596 -1.835 . . . . 0.0 110.263 -0.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -94.69 -91.75 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.733 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 10.5 pt20 -145.36 -155.68 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.818 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 21.1 2.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.565 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 7.8 t80 -89.84 -57.22 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -112.55 16.31 24.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 20.2 tttm -48.55 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -1.167 . . . . 0.0 109.358 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 177.55 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.0 mtm -64.74 -148.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 77.9 m-85 -100.66 79.92 2.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.967 . . . . 0.0 109.464 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -117.45 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.326 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.613 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 9.2 p90 -126.63 172.09 10.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.663 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -133.43 116.1 15.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 109.786 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 69' ' ' PHE . 5.0 mt -95.4 162.01 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 64.8 m -131.19 92.68 3.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.47 ' CG2' HG21 ' A' ' 48' ' ' ILE . 2.8 p -57.54 150.3 19.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 108.839 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.523 ' CG2' ' HB3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -43.2 -26.04 0.15 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.508 -0.745 . . . . 0.0 109.846 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -88.28 35.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.554 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 43.87 31.02 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.743 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.463 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -89.64 87.46 7.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.17 143.92 42.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.829 . . . . 0.0 110.148 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.62 106.11 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -101.68 111.3 23.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.65 147.71 36.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 0.0 109.181 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -114.12 141.53 47.36 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.162 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.71 -147.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . . . -93.78 -75.13 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.694 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -114.43 179.31 3.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.401 0.619 . . . . 0.0 109.482 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -56.55 -57.17 13.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.586 -0.696 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.488 ' N ' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -50.77 -51.02 54.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 60.8 tt0 -65.37 -24.85 67.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.029 . . . . 0.0 109.662 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -67.23 -66.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.805 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.571 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 14.5 m-20 -59.29 -32.21 69.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.51 84.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.524 ' CZ2' HD23 ' A' ' 11' ' ' LEU . 3.1 m95 -71.79 -56.77 5.16 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -0.937 . . . . 0.0 108.586 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.571 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -62.35 -13.65 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.542 -0.724 . . . . 0.0 109.152 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -80.48 -36.01 33.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 0.0 109.558 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.543 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -85.78 -27.19 25.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.06 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.527 ' CG1' ' CD1' ' A' ' 28' ' ' LEU . 4.8 mt -77.91 -36.9 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.929 -1.107 . . . . 0.0 108.957 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -84.94 -37.24 20.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.172 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.31 -49.74 52.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 0.0 108.971 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.47 95.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.107 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 ' CG1' HD22 ' A' ' 50' ' ' LEU . 22.5 mt -62.04 -39.13 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 108.752 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -79.32 -9.86 59.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.52 -20.08 19.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.409 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.552 HG22 ' CB ' ' A' ' 50' ' ' LEU . 3.2 tp -88.5 -16.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.18 -12.95 61.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.62 4.86 19.24 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 0.3 OUTLIER -106.28 59.24 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.075 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 31.9 mt-10 61.01 -171.61 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -159.75 -49.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.18 -39.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 140.52 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.77 -75.07 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -161.77 150.88 15.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.2 m80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.49 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -53.34 -61.69 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.835 . . . . 0.0 109.808 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.2 Cg_endo -71.78 158.93 52.04 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.751 1.634 . . . . 0.0 110.68 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 5' ' ' ARG . 3.7 mttt 55.06 101.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.538 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER 64.72 150.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.53 -61.52 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.972 . . . . 0.0 109.779 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.981 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.532 ' CB ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -166.48 130.43 2.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.063 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.61 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.31 -148.97 5.33 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 13.4 p90 -135.99 89.99 2.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.126 -1.22 . . . . 0.0 110.635 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.655 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -111.46 158.99 18.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 108.758 178.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.495 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 1.5 p -83.58 132.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 2.0 tttt -119.1 157.29 28.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -100.34 98.57 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.532 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 80.22 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.96 -42.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -1.117 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.465 ' CG1' ' O ' ' A' ' 17' ' ' VAL . 10.8 p -179.35 106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 17' ' ' VAL . 5.3 m-85 56.82 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' PHE . 4.4 m120 -43.06 106.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.105 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 1.2 p -148.91 146.79 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.811 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.3 m0 -126.94 113.78 16.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' O ' HG21 ' A' ' 12' ' ' VAL . 1.5 mmtp -138.61 135.93 18.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.027 -1.046 . . . . 0.0 110.035 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.495 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.4 Cg_exo -53.99 152.76 22.68 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.914 1.743 . . . . 0.0 109.882 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.766 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -163.39 168.03 20.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.976 -1.078 . . . . 0.0 109.89 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.766 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.2 t-105 -96.06 143.79 26.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.57 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -151.61 139.82 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.236 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' CD ' ' A' ' 5' ' ' ARG . 5.7 m -125.94 113.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.621 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -85.82 102.89 14.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 108.964 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 5' ' ' ARG . 1.8 mp -89.51 155.78 19.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.192 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 7.2 tt0 -70.27 -19.3 63.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.324 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.26 4.91 31.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' CA ' HD22 ' A' ' 50' ' ' LEU . . . 164.21 -179.96 38.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' MET . 12.2 mm -137.0 119.42 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -1.153 . . . . 0.0 109.422 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' O ' HG21 ' A' ' 27' ' ' VAL . 4.2 pt-20 -127.51 117.24 21.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 108.87 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.598 ' CE1' ' CA ' ' A' ' 46' ' ' GLY . 3.2 p90 -120.96 147.1 45.93 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.903 -1.123 . . . . 0.0 110.347 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.644 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.96 172.75 12.91 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -61.14 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.033 . . . . 0.0 109.288 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.3 mmtt -78.87 -168.76 1.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.985 . . . . 0.0 108.757 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.652 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 7.6 mtpt -77.61 5.69 8.68 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.89 -43.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 109.125 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 43' ' ' SER . 13.2 t0 48.61 18.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.304 -0.872 . . . . 0.0 109.541 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 43' ' ' SER . 59.9 t30 40.65 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.9 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t 178.05 112.83 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.626 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.486 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.7 Cg_endo -71.55 142.53 40.54 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.83 1.686 . . . . 0.0 110.638 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.3 -5.45 57.54 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -179.33 129.2 1.33 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.4 mtm -126.69 127.45 45.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -1.207 . . . . 0.0 109.978 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.446 HG22 HG21 ' A' ' 73' ' ' THR . 2.7 mt -94.59 131.81 30.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' HG21 ' A' ' 48' ' ' ILE . 56.2 Cg_endo -72.08 151.63 55.86 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.784 1.656 . . . . 0.0 110.626 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -90.95 5.26 49.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -0.865 . . . . 0.0 109.202 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HB3' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.43 -72.15 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.125 -0.985 . . . . 0.0 109.689 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.29 74.83 0.17 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -78.79 -179.7 6.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -1.191 . . . . 0.0 109.382 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.493 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -133.55 107.77 8.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.326 -0.859 . . . . 0.0 109.673 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -89.65 117.71 28.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.324 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.552 ' N ' HD23 ' A' ' 55' ' ' LEU . 8.6 m -106.52 131.95 53.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.425 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -142.95 125.22 8.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.286 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.507 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 55.7 Cg_endo -73.25 -161.78 2.38 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.479 -1.884 . . . . 0.0 110.337 -0.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.4 p -104.43 -148.02 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.568 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.525 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.6 OUTLIER -89.78 -149.84 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.68 19.75 2.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.188 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.03 84.41 6.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.169 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 107.97 -55.91 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 63' ' ' GLY . 3.8 tttt 42.37 26.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.423 -1.045 . . . . 0.0 109.788 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 67' ' ' PHE . 19.4 mtp180 -88.01 16.56 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.295 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.514 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 19.3 mtm 65.8 8.74 5.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 65' ' ' ARG . 1.5 m-85 -135.45 28.29 3.36 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.465 HG12 ' SG ' ' A' ' 59' ' ' CYS . 2.5 p -127.18 127.13 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -0.999 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.733 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.51 166.44 10.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 109.884 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 15.8 ttpt -134.88 105.45 6.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.883 . . . . 0.0 109.134 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 ' CE2' ' A' ' 69' ' ' PHE . 2.7 mt -89.63 165.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.5 m -144.58 93.27 2.4 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -47.88 153.44 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 109.408 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -52.7 87.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.655 . . . . 0.0 109.655 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER 158.59 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.9 pt20 178.59 31.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.625 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.506 ' CB ' HG22 ' A' ' 73' ' ' THR . 10.0 mt-30 -97.12 105.67 17.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 108.758 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.577 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 11.9 p30 -82.85 144.1 30.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.012 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 94.5 m-70 -139.76 91.78 2.5 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -93.54 128.35 39.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.044 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.733 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -145.52 141.91 28.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -110.08 143.82 39.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.14 -146.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.538 ' C ' ' CD1' ' A' ' 85' ' ' PHE . . . -102.38 -18.65 15.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.627 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -166.9 172.13 10.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.561 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 tp -56.28 -39.94 73.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 109.831 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.16 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -63.68 -16.19 60.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.437 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -72.03 -64.12 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.561 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -66.13 -15.63 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.603 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.39 -40.67 29.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 109.012 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.621 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 3.0 m95 -77.97 -26.91 48.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 3.0 m -77.43 -32.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 7.3 ptp180 -80.44 -23.85 39.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.544 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' OD1' HD13 ' A' ' 28' ' ' LEU . 1.1 t70 -85.01 -46.87 10.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.016 -1.052 . . . . 0.0 109.706 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.538 HG12 ' CB ' ' A' ' 28' ' ' LEU . 5.8 mt -70.05 -30.56 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.072 -1.018 . . . . 0.0 109.141 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 55' ' ' LEU . 7.8 t30 -84.65 -37.62 20.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.255 -0.903 . . . . 0.0 109.707 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 2.6 tppt? -69.92 -29.49 66.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 103' ' ' ILE . . . -82.13 -28.71 32.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 31.1 mt -77.9 -30.05 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -16.69 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -95.77 -26.57 15.62 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.572 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 50' ' ' LEU . 8.4 tp -73.33 -25.48 21.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -0.93 . . . . 0.0 109.62 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' N ' HG21 ' A' ' 103' ' ' ILE . 2.2 mm-40 -50.96 -22.64 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 108.965 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -120.59 -104.5 1.98 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER 43.71 70.89 0.27 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.408 -1.054 . . . . 0.0 109.594 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -110.31 -84.88 0.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -167.86 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.408 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 1.6 t60 -118.66 -164.73 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 109' ' ' HIS . 35.4 t-80 69.86 125.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -98.24 112.28 24.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.536 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 113' ' ' HIS . 10.9 t-160 -112.71 -50.68 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.403 ' CD2' ' O ' ' A' ' 112' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.595 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -69.18 -61.95 3.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.595 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.5 Cg_endo -71.73 -32.3 11.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.854 1.703 . . . . 0.0 110.051 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' PRO . 4.0 mttm 59.91 113.91 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.492 ' CG ' HD22 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -91.09 139.06 31.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.425 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.565 ' CD1' ' N ' ' A' ' 6' ' ' ILE . 1.5 mp -64.6 -49.04 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.588 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -119.17 147.17 44.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.987 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.54 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.3 pm0 -163.57 122.24 1.98 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.267 -0.895 . . . . 0.0 109.217 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.598 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.19 -145.71 4.42 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.0 p90 -135.48 93.33 2.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.018 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.624 ' HB3' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.19 161.29 14.39 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 ' N ' ' A' ' 13' ' ' LYS . 1.5 p -92.65 146.87 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.866 -1.146 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' N ' HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -134.74 150.18 50.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.757 . . . . 0.0 109.224 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.564 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 4.1 ttpp -62.11 140.33 58.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.0 158.02 20.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 55.63 2.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.59 -90.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.421 ' O ' ' HB3' ' A' ' 19' ' ' ASN . 80.3 m-85 -131.91 55.54 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 39.9 t-20 60.31 85.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 38.0 p -138.01 174.01 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.935 . . . . 0.0 109.718 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.586 ' CH2' HG22 ' A' ' 68' ' ' VAL . 15.6 m95 -150.2 100.66 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 108.941 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' O ' HG21 ' A' ' 12' ' ' VAL . 4.9 mttm -123.21 145.02 45.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.146 -0.971 . . . . 0.0 110.093 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -53.05 166.01 1.1 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.129 1.886 . . . . 0.0 110.507 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.757 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -173.32 169.33 4.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.276 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.757 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.8 t-105 -89.81 141.39 28.67 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.113 -0.992 . . . . 0.0 108.651 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.576 HG23 ' CH2' ' A' ' 92' ' ' TRP . 1.2 p -151.53 129.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.964 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 6.2 m -125.37 111.98 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.786 . . . . 0.0 109.568 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 2.6 pp -86.6 113.71 22.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.038 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 HD22 ' CG ' ' A' ' 5' ' ' ARG . 1.5 mp -92.93 157.75 16.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 99' ' ' ALA . 0.0 OUTLIER -71.61 -21.42 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.685 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -104.59 13.31 31.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 33' ' ' ILE . . . 157.49 -169.12 34.37 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 HD13 ' CD2' ' A' ' 50' ' ' LEU . 3.7 mp -149.63 131.64 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -1.182 . . . . 0.0 109.59 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 2.8 pt-20 -142.0 122.68 14.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.8 p90 -120.87 144.4 48.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.19 -155.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -92.28 -50.38 5.69 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.48 -174.26 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.41 -26.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.025 -1.047 . . . . 0.0 109.507 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 1.4 m -150.69 -48.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.348 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 3.4 t0 67.48 -6.58 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.725 -0.609 . . . . 0.0 110.589 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m-20 79.25 -40.57 0.24 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.292 -0.88 . . . . 0.0 110.122 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.1 119.12 35.3 Favored Pre-proline 0 C--N 1.31 -1.129 0 O-C-N 120.918 -1.114 . . . . 0.0 109.987 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.601 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 58.7 Cg_endo -74.96 145.26 31.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.799 1.666 . . . . 0.0 110.436 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.18 -32.32 16.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 108.991 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -155.49 138.2 5.95 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.5 mtp -130.59 118.53 21.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -1.121 . . . . 0.0 109.709 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.5 ' CD1' HG23 ' A' ' 33' ' ' ILE . 2.6 mp -89.88 128.99 47.99 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' HG21 ' A' ' 48' ' ' ILE . 54.6 Cg_endo -71.34 146.65 51.16 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.816 1.677 . . . . 0.0 110.508 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -86.98 34.91 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.52 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.3 mtmt -84.91 -82.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -150.01 62.89 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -66.61 -176.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -1.187 . . . . 0.0 109.458 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -136.94 113.36 10.03 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 2.4 tm? -88.61 118.63 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.412 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' ' 59' ' ' CYS . 7.8 m -109.96 129.56 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.67 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -150.36 121.5 3.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.812 . . . . 0.0 109.251 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' THR . 51.8 Cg_endo -71.8 -170.86 7.31 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.619 -1.826 . . . . 0.0 110.277 -0.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 1.7 t -100.3 -99.56 0.24 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.722 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -143.34 -147.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.997 -1.064 . . . . 0.0 109.756 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 24.5 m-20 -45.36 -22.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -0.996 . . . . 0.0 109.312 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.564 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 4.7 m-85 -89.86 -46.17 8.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.021 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.48 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -75.34 1.34 57.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 10.2 pttm -71.95 -9.23 58.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -1.199 . . . . 0.0 109.57 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 mtt180 -147.6 173.76 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ARG . 42.9 mtm 48.97 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.645 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 16.3 m-85 -98.15 65.09 1.7 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG22 ' CH2' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -108.14 124.11 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.682 -0.637 . . . . 0.0 109.338 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.76 177.03 5.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.766 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 5.0 ttpp -141.7 103.8 4.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 72' ' ' THR . 6.4 mt -89.41 168.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.089 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.2 m -143.73 88.75 2.01 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.53 ' O ' ' N ' ' A' ' 75' ' ' LYS . 2.8 p -45.01 150.25 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.538 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -51.49 87.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.659 -0.65 . . . . 0.0 109.623 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 159.43 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.478 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 5.5 pt20 170.59 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.379 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -100.83 84.84 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.146 -0.971 . . . . 0.0 109.066 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.537 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 7.1 p30 -65.91 138.01 57.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.397 -0.814 . . . . 0.0 109.93 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 54.7 m-70 -132.23 99.61 4.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 108.933 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 78' ' ' ASP . 0.3 OUTLIER -94.56 124.31 38.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 109.944 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.706 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.21 142.88 24.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.965 . . . . 0.0 109.179 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 2.5 tt0 -108.15 136.42 47.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.481 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -91.7 -148.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.5 -90.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.242 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.578 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.91 177.65 4.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.071 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 24.7 tp -59.07 -25.42 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.114 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -63.81 1.0 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.331 -0.855 . . . . 0.0 109.2 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.91 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' HD2' HD13 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -64.58 -67.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 109.398 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.506 ' O ' HG21 ' A' ' 93' ' ' VAL . 16.9 t0 -60.71 -14.61 22.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.074 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.74 43.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.606 ' CE2' ' CD2' ' A' ' 11' ' ' LEU . 6.2 m95 -78.95 -33.17 45.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 90' ' ' ASP . 1.8 m -72.19 -33.89 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.729 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -82.68 -22.76 34.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -80.01 -49.98 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.527 ' O ' ' CD1' ' A' ' 100' ' ' ILE . 25.1 mt -68.85 -41.56 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.349 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -72.38 -29.72 64.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 12.1 tttm -70.67 -44.41 67.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . . . -63.97 -44.14 93.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.531 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 2.2 mt -64.98 -36.12 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.301 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -12.65 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.294 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.37 -25.98 16.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.453 HG12 HD13 ' A' ' 50' ' ' LEU . 8.1 mm -81.69 -25.21 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.3 mt-10 -69.06 -6.99 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.29 9.08 7.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.33 60.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -1.086 . . . . 0.0 109.302 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 108' ' ' HIS . 51.8 mt-10 -152.7 25.99 0.57 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 107' ' ' GLU . 21.9 t-80 76.17 42.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.88 86.12 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.354 -0.841 . . . . 0.0 109.433 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.18 133.58 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.34 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -142.3 -174.21 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -139.81 70.44 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 mtm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.5 mt-10 -143.39 162.37 42.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 57.0 Cg_endo -74.82 149.74 38.03 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.01 1.807 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' O ' ' OE2' ' A' ' 8' ' ' GLU . 3.5 mttt -129.56 78.71 1.87 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 0.3 OUTLIER 56.09 169.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.203 -0.936 . . . . 0.0 109.144 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG23 ' OD2' ' A' ' 95' ' ' ASP . 19.8 mm -84.88 -42.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.949 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.554 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -150.57 104.29 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 2.4 pm0 -113.98 136.77 52.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 109.763 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.581 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.31 -146.69 4.8 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 3.8 p90 -141.8 95.81 2.87 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.317 -1.108 . . . . 0.0 109.961 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.64 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -115.77 156.3 26.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 108.748 179.172 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 22' ' ' LYS . 1.5 p -84.04 130.51 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.479 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 28.6 ttmt -131.29 164.53 25.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.302 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -113.48 138.01 50.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.004 . . . . 0.0 109.735 -179.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 161.61 117.08 0.42 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 164.53 -94.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -1.113 . . . . 0.0 109.442 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 18' ' ' PHE . 13.8 m -98.94 -21.9 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.503 ' CD2' HG21 ' A' ' 17' ' ' VAL . 37.6 p90 -179.92 179.97 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.801 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.9 p30 -53.33 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.854 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' LYS . 65.8 p -113.92 151.87 31.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 108.649 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.527 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.0 m95 -128.56 113.52 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.762 -1.211 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -150.43 138.05 11.94 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.67 147.52 23.84 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.716 1.61 . . . . 0.0 109.812 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.726 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.74 167.65 28.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.01 . . . . 0.0 110.012 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.726 ' O ' ' SD ' ' A' ' 24' ' ' MET . 64.6 t-105 -89.79 143.35 26.87 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.542 ' CG1' HD21 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -150.86 127.29 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.177 -178.814 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -117.53 101.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.195 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.597 ' CD2' ' CZ3' ' A' ' 92' ' ' TRP . 1.6 pp -81.78 109.81 16.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.1 mp -94.84 161.78 14.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.391 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HA ' ' CB ' ' A' ' 99' ' ' ALA . 4.2 pt-20 -72.29 -16.77 61.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.973 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.68 7.12 34.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.015 . . . . 0.0 109.441 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 151.6 154.5 6.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.537 ' CD1' HD13 ' A' ' 50' ' ' LEU . 2.6 mp -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -1.195 . . . . 0.0 109.877 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 12.3 pt-20 -127.3 113.79 16.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.674 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.5 p90 -117.81 147.97 42.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -131.3 -158.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -43.95 9.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 108.534 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.8 mmtt -107.31 -171.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -52.92 -19.61 2.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.195 . . . . 0.0 109.358 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -150.68 -49.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.955 . . . . 0.0 109.489 179.552 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.8 t0 62.0 10.55 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.445 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 33.9 t30 41.69 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.944 . . . . 0.0 109.906 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -168.57 110.13 0.53 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.811 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.4 Cg_endo -71.74 135.4 25.82 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.879 1.719 . . . . 0.0 110.545 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.1 ttpt -89.42 -23.66 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -170.86 148.08 11.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.426 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 5.0 mtm -137.21 128.98 28.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.08 109.66 36.85 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' O ' ' OG ' ' A' ' 53' ' ' SER . 50.6 Cg_endo -70.21 125.19 11.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.81 1.673 . . . . 0.0 110.348 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.537 HD13 ' CD1' ' A' ' 33' ' ' ILE . 3.1 mp -74.71 -2.79 27.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -44.98 -58.36 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 109.306 179.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -162.84 72.45 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -96.73 -175.47 3.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -1.131 . . . . 0.0 109.74 -179.88 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.72 108.06 5.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.377 -0.827 . . . . 0.0 109.551 -179.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD23 ' CG2' ' A' ' 93' ' ' VAL . 1.7 tm? -89.47 113.24 24.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 109.715 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 55' ' ' LEU . 31.1 m -104.52 113.05 26.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.505 ' CB ' HG23 ' A' ' 93' ' ' VAL . 1.6 t -143.44 139.38 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.422 -0.799 . . . . 0.0 109.532 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 57' ' ' SER . 60.0 Cg_endo -78.11 -179.58 27.56 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.277 -1.968 . . . . 0.0 110.503 -0.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -127.9 137.76 52.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 108.93 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -141.71 90.33 2.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 0.0 109.718 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 2.3 p-10 179.53 -32.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 109.161 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -88.57 -45.38 9.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -113.41 -24.63 4.66 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 178.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 10.9 ttmt 38.49 43.05 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.79 0.805 . . . . 0.0 109.499 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 66' ' ' MET . 6.4 mtt85 -136.24 18.5 3.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 108.892 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.546 ' C ' ' CG ' ' A' ' 67' ' ' PHE . 53.0 mtt 64.37 159.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.506 -0.746 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER 71.81 15.57 5.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG23 ' SG ' ' A' ' 59' ' ' CYS . 1.9 p -121.26 124.09 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.0 167.05 10.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.392 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 3.0 ptmt -142.86 109.58 5.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.175 -0.953 . . . . 0.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 36.2 mt -91.15 166.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.1 m -143.78 86.5 1.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' A' ' 77' ' ' GLN . 3.0 p -49.54 163.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -20.15 21.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -89.07 26.11 1.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.17 30.01 13.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.455 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 1.4 mt-30 -89.64 102.23 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.0 m-20 -77.22 145.97 37.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -143.14 109.96 5.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 1.5 m-85 -107.37 120.79 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -137.54 139.01 40.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 178.722 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 83' ' ' ALA . 1.5 tt0 -105.7 145.4 31.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 0.0 109.32 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.5 -166.93 1.72 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.146 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.541 ' CB ' ' CE1' ' A' ' 85' ' ' PHE . . . -86.48 -18.85 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.541 ' CE1' ' CB ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -160.83 169.83 21.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.632 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -60.4 -54.77 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.584 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 3.6 tt0 -43.21 -53.53 5.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.1 tt0 -65.5 -32.16 73.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.958 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -67.26 -26.13 66.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.97 . . . . 0.0 109.767 -179.696 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 3.4 t0 -83.32 -42.2 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.529 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . . . -70.01 -22.45 63.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.597 ' CZ3' ' CD2' ' A' ' 28' ' ' LEU . 3.2 m95 -83.86 -39.09 20.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.529 ' CG2' HD23 ' A' ' 55' ' ' LEU . 2.5 p -76.39 -26.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.765 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.529 ' CG ' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -82.87 -31.12 28.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -75.45 -53.34 8.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 28' ' ' LEU . 22.9 mt -62.69 -32.51 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.222 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 4.4 t-20 -79.89 -26.62 40.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.317 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -69.68 -53.57 17.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.466 ' HB2' HD22 ' A' ' 50' ' ' LEU . . . -62.02 -37.98 86.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.252 -0.905 . . . . 0.0 109.185 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 96' ' ' ILE . 26.5 mt -62.64 -38.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.019 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -80.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.581 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 13.5 t -95.32 -18.6 20.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.395 -0.815 . . . . 0.0 109.152 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.521 HG13 ' CD2' ' A' ' 50' ' ' LEU . 7.6 mm -90.59 -27.62 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.127 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.434 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.2 mt-10 -75.66 -3.41 34.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.36 12.91 5.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 102' ' ' CYS . 0.2 OUTLIER -105.72 58.89 0.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -1.025 . . . . 0.0 109.378 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.98 -57.81 1.31 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.558 -0.714 . . . . 0.0 109.433 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -179.71 86.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.365 -179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 109' ' ' HIS . 1.5 m170 61.42 152.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 110' ' ' HIS . 16.0 p80 -68.49 98.43 0.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -138.15 78.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 179.48 87.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.454 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 4' ' ' LYS . 10.5 mt-10 -106.51 162.62 19.12 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 50.2 Cg_exo -52.45 147.65 28.88 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.074 1.849 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' HB3' ' NH1' ' A' ' 5' ' ' ARG . 21.0 mttm -152.4 99.32 2.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.287 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.496 ' NH1' ' HB3' ' A' ' 4' ' ' LYS . 3.5 mtt85 61.2 136.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 30' ' ' GLU . 43.4 mt -63.76 -56.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 109.431 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.577 ' CB ' ' CD2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.32 148.22 46.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.7 pm0 -161.61 135.84 6.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.384 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.594 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.45 -147.44 4.97 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 11.0 p90 -139.18 98.17 3.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.464 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.637 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -118.94 159.07 24.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 108.863 179.56 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.527 ' CA ' ' HA ' ' A' ' 23' ' ' PRO . 1.7 p -86.77 125.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.119 -0.988 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 4.6 tppp? -113.49 145.95 40.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 109.208 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.528 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 9.2 tttt -64.36 150.16 46.82 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.311 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 101.51 -135.8 12.39 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 5.2 t 74.85 0.1 3.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.5 ' CG1' ' OG1' ' A' ' 20' ' ' THR . 2.6 p 175.48 -52.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.2 73.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.143 -0.973 . . . . 0.0 109.751 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m120 48.23 44.95 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.5 ' OG1' ' CG1' ' A' ' 17' ' ' VAL . 1.5 p -101.86 -166.16 1.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.622 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.4 m95 -141.32 109.34 5.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.007 -1.058 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.522 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -148.93 145.96 20.68 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 0.0 109.563 179.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.98 160.06 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.019 1.813 . . . . 0.0 109.923 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.745 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -169.38 166.43 10.4 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.802 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.745 ' O ' ' SD ' ' A' ' 24' ' ' MET . 63.3 t-105 -91.32 142.11 28.06 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' HA ' ' CB ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.97 130.57 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.119 -178.952 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 7.8 m -121.13 113.16 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.489 -0.757 . . . . 0.0 109.556 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' CD2' ' CB ' ' A' ' 7' ' ' ARG . 1.8 pp -86.32 117.9 25.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.955 . . . . 0.0 109.081 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -104.95 162.32 13.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.51 -0.744 . . . . 0.0 109.861 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 6' ' ' ILE . 7.3 pt-20 -73.66 -7.43 51.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.431 -0.793 . . . . 0.0 110.366 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HA ' HD12 ' A' ' 103' ' ' ILE . 1.4 t0 -115.1 0.87 13.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.093 -1.004 . . . . 0.0 109.419 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 29' ' ' LEU . . . 154.84 165.83 14.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 50' ' ' LEU . 6.9 mm -112.92 126.46 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.359 -1.083 . . . . 0.0 110.468 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 6.4 pt-20 -125.71 112.2 15.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.653 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 4.1 p90 -118.2 143.65 46.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.004 -1.06 . . . . 0.0 110.655 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -125.22 -150.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.98 -49.46 5.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.74 -175.83 2.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 108.833 179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 1.0 OUTLIER -49.51 -21.84 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.407 -179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -148.08 -51.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.4 t70 59.13 10.97 1.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.933 . . . . 0.0 109.333 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.7 m-80 39.63 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.375 -0.828 . . . . 0.0 110.174 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.0 t -166.04 118.91 0.85 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.764 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.637 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 57.7 Cg_endo -74.7 147.89 36.0 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.626 1.55 . . . . 0.0 111.096 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -101.64 -30.21 11.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.72 152.76 12.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.466 ' HE1' ' HB2' ' A' ' 44' ' ' PRO . 12.4 mtt -135.17 138.65 43.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 109.559 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.466 HG21 ' HD2' ' A' ' 49' ' ' PRO . 8.6 mt -104.57 134.18 19.8 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 108.732 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' CD ' ' OG1' ' A' ' 73' ' ' THR . 36.4 Cg_endo -66.12 137.53 48.5 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.492 1.462 . . . . 0.0 110.474 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.503 ' CD1' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -85.15 -6.32 59.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.276 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 48.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.022 -1.049 . . . . 0.0 109.895 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 175.22 -40.2 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.034 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 72' ' ' THR . 3.4 t -42.28 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 110.174 -179.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.54 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.91 170.15 11.38 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.602 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -130.97 148.5 52.74 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.97 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.551 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 21.3 m -145.17 137.28 25.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 108.941 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 58' ' ' PRO . 32.7 t -138.89 122.75 11.18 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' SER . 59.5 Cg_endo -75.62 -94.89 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.709 -1.788 . . . . 0.0 110.095 -0.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.636 ' SG ' HG23 ' A' ' 68' ' ' VAL . 14.8 p -143.69 -147.12 0.2 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.397 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.526 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -93.99 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.789 -179.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.99 18.67 2.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.217 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.4 t80 -89.11 -26.4 21.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.195 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 68' ' ' VAL . . . -143.84 12.33 2.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 28.6 tttt -49.06 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 169.53 -91.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.462 -0.774 . . . . 0.0 109.191 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.9 mmm -61.5 -141.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 9.7 m-85 -107.42 76.11 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.461 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.636 HG23 ' SG ' ' A' ' 59' ' ' CYS . 1.3 p -113.75 122.84 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -105.83 168.94 8.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 7.8 ttpt -128.53 134.92 48.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.077 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.584 HG13 ' CE2' ' A' ' 69' ' ' PHE . 1.8 mt -124.97 169.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.575 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 74.1 m -147.81 110.99 4.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -0.975 . . . . 0.0 110.12 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 73' ' ' THR . 5.8 t -58.08 113.37 1.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.017 . . . . 0.0 110.235 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 40.74 24.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.772 . . . . 0.0 111.042 179.266 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 81.77 45.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.102 . . . . 0.0 109.19 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.1 OUTLIER -126.5 -85.31 0.61 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 -179.785 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.3 OUTLIER -94.16 146.22 24.14 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.641 -0.662 . . . . 0.0 109.649 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 68.3 m-20 -99.72 116.59 32.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -102.1 103.98 14.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.574 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -101.28 129.26 47.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 109.402 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -142.18 146.46 35.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.334 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 6.0 tt0 -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -91.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.628 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 67' ' ' PHE . . . -160.16 -83.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -101.59 171.92 7.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.705 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -55.04 -58.38 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.772 -179.67 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.59 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 2.0 tt0 -46.14 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -178.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 41.9 tt0 -40.87 -38.72 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 110.471 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -58.92 -61.34 2.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.997 . . . . 0.0 110.141 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 71.8 m-20 -57.26 -31.32 65.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.452 -179.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.68 68.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.934 -1.103 . . . . 0.0 109.851 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.579 ' CE2' HD23 ' A' ' 11' ' ' LEU . 2.2 m95 -76.36 -45.49 31.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.096 -1.002 . . . . 0.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.602 ' CG2' ' CD1' ' A' ' 55' ' ' LEU . 13.7 p -69.5 -23.12 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.0 mmt180 -81.4 -36.98 28.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.974 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' HB3' HD23 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -77.1 -39.53 49.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.092 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG13 HD21 ' A' ' 28' ' ' LEU . 6.0 mt -70.64 -46.31 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.774 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 17.3 t-20 -73.97 -30.55 62.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 0.0 109.712 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 7.8 ttpt -72.1 -34.92 69.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.232 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.499 ' O ' ' CG2' ' A' ' 103' ' ' ILE . . . -77.48 -23.0 50.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.481 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 5.5 mt -81.76 -36.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.119 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -14.77 48.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 2.4 t -95.77 -33.31 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.437 -0.79 . . . . 0.0 109.56 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.513 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 5.8 tp -73.06 -15.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 1.2 mm-40 -73.04 -7.66 52.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.93 9.81 7.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.92 61.03 0.61 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -1.069 . . . . 0.0 109.236 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -61.62 -63.62 1.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.535 -0.728 . . . . 0.0 109.676 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.34 27.25 15.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 48.12 -154.73 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.53 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.458 ' O ' ' CB ' ' A' ' 111' ' ' HIS . 2.9 p-80 -141.77 32.33 1.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 110' ' ' HIS . 6.1 t60 72.73 -172.74 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -56.87 -27.14 60.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -94.01 177.19 2.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.447 -179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 2' ' ' GLU . 55.2 Cg_endo -79.05 147.54 21.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.833 1.689 . . . . 0.0 110.264 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -135.86 90.49 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -101.88 161.78 13.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.567 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' HB ' HD13 ' A' ' 28' ' ' LEU . 7.0 mt -90.52 -32.3 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.572 ' CB ' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -139.94 157.56 45.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 179.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.551 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 2.0 pm0 -171.02 126.21 0.68 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.7 -147.33 4.99 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.9 p90 -136.57 91.98 2.71 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.398 -1.06 . . . . 0.0 110.225 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.65 ' CB ' ' CE1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.24 168.49 9.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 2.1 p -100.23 124.46 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 110.071 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.761 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 mtpm? -104.68 163.67 12.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.6 -0.687 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.583 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -68.2 107.53 2.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 109.259 179.695 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' LYS . . . -41.17 139.99 1.42 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 p -85.69 64.51 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.13 -87.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -131.27 67.45 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.254 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.3 m120 54.55 77.42 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.192 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.1 p -129.08 172.53 11.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.593 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' CD1' ' HG2' ' A' ' 14' ' ' LYS . 3.1 m95 -141.08 121.86 14.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.361 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 8.0 mttt -149.18 136.08 10.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.78 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.2 Cg_exo -53.12 163.35 2.27 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.854 1.703 . . . . 0.0 109.986 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.761 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 22.3 ptm -177.34 164.14 2.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.044 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.9 t-105 -91.06 143.68 26.44 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.588 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -150.76 132.69 5.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.153 -179.052 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.551 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 5.7 m -121.64 100.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 ' CB ' ' A' ' 7' ' ' ARG . 2.3 pp -74.64 132.33 41.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.849 -1.157 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.2 mp -117.95 168.56 10.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.554 -0.716 . . . . 0.0 109.597 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' C ' ' CD2' ' A' ' 50' ' ' LEU . 15.1 pt-20 -74.42 -0.17 16.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.032 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.46 -3.62 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.142 -0.974 . . . . 0.0 109.235 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 154.41 158.47 8.69 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 2.3 mm -95.26 112.5 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 110.009 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 15.2 mt-10 -107.74 103.6 12.92 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.649 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 13.2 p90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.783 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -130.26 -153.96 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.328 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.98 -43.38 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 11.6 mttt -110.65 -176.55 3.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -43.34 -26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 109.531 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -149.61 -46.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.031 . . . . 0.0 109.854 179.863 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.0 t70 62.16 10.11 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.63 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.13 22.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.03 . . . . 0.0 109.823 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.4 t -168.7 98.33 0.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.925 -1.11 . . . . 0.0 110.287 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.608 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.6 Cg_exo -51.75 130.09 32.6 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.96 1.774 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 3.1 tttt -89.66 -19.57 24.71 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -176.06 132.62 2.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.1 mtm -121.65 121.17 36.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.211 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.466 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 24.6 mt -89.45 139.39 28.25 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 108.777 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 49.8 Cg_endo -70.63 131.85 20.8 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.587 1.524 . . . . 0.0 109.963 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD1' HD12 ' A' ' 33' ' ' ILE . 2.4 tp -76.4 -0.75 23.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -136.11 129.11 31.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -0.994 . . . . 0.0 109.545 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 100.39 -5.51 57.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -97.64 172.97 7.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -1.152 . . . . 0.0 109.658 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.543 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -132.25 158.31 42.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.527 -0.733 . . . . 0.0 109.267 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.4 tm? -123.88 110.74 15.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.495 ' N ' HD21 ' A' ' 55' ' ' LEU . 87.0 m -102.83 110.38 22.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.0 p -148.64 131.3 7.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.701 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.77 150.78 93.34 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.462 -1.891 . . . . 0.0 110.391 -0.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 68' ' ' VAL . 1.2 p -90.03 167.53 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 27.2 tt0 -167.31 108.11 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.96 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 9.7 t0 165.63 -43.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 6.6 t80 -89.77 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -94.21 -21.78 26.6 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 31.61 44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.437 0.637 . . . . 0.0 110.206 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 68' ' ' VAL . 5.2 ttp180 179.53 -170.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 65' ' ' ARG . 3.1 mtt 42.4 -153.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -110.17 69.29 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.488 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.774 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -107.63 130.25 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.354 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -109.08 169.37 8.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.218 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' O ' ' HB ' ' A' ' 56' ' ' THR . 15.3 ttpt -136.63 109.39 7.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.336 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 72' ' ' THR . 7.1 mt -95.41 165.46 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.344 -0.847 . . . . 0.0 108.996 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 89.0 m -138.98 89.79 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 3.1 p -54.63 155.69 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.103 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -51.65 -19.18 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.397 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.47 26.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.99 -1.068 . . . . 0.0 109.6 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.95 30.41 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.16 105.79 17.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.222 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 80' ' ' PHE . 3.4 m-20 -75.21 133.42 41.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -124.97 100.51 6.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -98.57 128.38 44.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.596 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -148.27 144.17 27.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 179.142 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 1.2 tt0 -103.99 136.39 43.73 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.36 -149.59 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.798 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 -86.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.869 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -124.2 173.69 8.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.748 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -42.55 -45.81 4.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.826 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 7.6 tt0 -52.61 -66.51 0.37 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.064 -1.023 . . . . 0.0 110.145 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -7.69 21.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.855 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -76.18 -54.74 6.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.554 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.9 OUTLIER -77.75 -12.61 59.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.7 -33.33 35.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.56 ' CE2' ' HG2' ' A' ' 7' ' ' ARG . 3.7 m95 -78.01 -32.9 51.37 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 4.3 m -76.98 -29.7 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.667 -0.645 . . . . 0.0 109.771 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 17.0 mmt85 -79.62 -27.19 41.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -87.02 -44.27 11.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.025 . . . . 0.0 110.041 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.555 HG12 ' CB ' ' A' ' 28' ' ' LEU . 4.2 mt -69.23 -31.94 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.044 . . . . 0.0 109.128 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 3.7 t-20 -85.09 -36.11 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 27.2 tttt -66.27 -34.39 77.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.229 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.453 ' O ' ' CG2' ' A' ' 103' ' ' ILE . . . -80.78 -30.17 36.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.341 -0.849 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 22.9 mt -72.94 -29.55 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 7.4 mmpt? -93.43 -17.74 23.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 9.7 m -95.88 -16.58 21.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.481 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 30' ' ' GLU . 6.5 tp -87.27 -15.85 9.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.8 -11.91 61.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.425 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.99 12.34 9.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -103.09 58.4 0.76 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -1.011 . . . . 0.0 109.096 -179.921 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -109.19 -166.77 1.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.9 m170 55.48 27.74 10.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.481 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.95 70.0 1.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -102.21 -16.71 16.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.96 95.26 2.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' HIS . 5.0 t60 -113.96 51.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' HIS . 8.8 t60 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 1.5 mt-10 -147.0 173.86 3.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.566 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 52.0 Cg_exo -55.23 -149.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.296 1.997 . . . . 0.0 110.418 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 3' ' ' PRO . 77.9 mttt 42.51 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.553 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER 69.16 86.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 30' ' ' GLU . 96.3 mt -67.38 -44.37 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.997 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.544 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.4 tpm_? -125.4 150.38 47.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -0.997 . . . . 0.0 110.237 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.53 ' CB ' HG11 ' A' ' 27' ' ' VAL . 2.1 pm0 -160.49 121.26 2.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.144 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.599 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.5 -145.28 4.19 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.2 p90 -142.1 102.6 4.15 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.286 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.59 ' CD2' ' CG1' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.16 169.08 9.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.947 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -101.34 133.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 0.0 109.891 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -128.31 131.89 48.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.619 ' HD3' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -96.3 151.28 19.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 108.795 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 14' ' ' LYS . . . 178.45 151.7 9.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 30.9 t 61.06 -88.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.242 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 18' ' ' PHE . 7.2 p -44.44 166.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' N ' HG23 ' A' ' 17' ' ' VAL . 27.3 p90 -73.78 -176.08 2.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.703 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' ' CD1' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -43.66 109.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 21' ' ' TRP . 18.6 p -146.38 -58.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -0.9 . . . . 0.0 109.902 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.643 ' NE1' ' CZ ' ' A' ' 62' ' ' PHE . 32.9 m95 63.51 106.1 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.488 0.661 . . . . 0.0 110.207 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' N ' HG21 ' A' ' 12' ' ' VAL . 45.0 mttm -125.54 134.86 26.22 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.65 159.71 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.906 1.737 . . . . 0.0 110.611 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.578 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 13.5 ptm -173.23 171.05 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.243 -0.91 . . . . 0.0 109.273 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 52.4 t-105 -89.56 140.83 29.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.59 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 0.9 OUTLIER -151.54 127.63 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.171 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 HG11 ' CB ' ' A' ' 8' ' ' GLU . 17.2 m -126.42 119.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 109.46 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 28' ' ' LEU . 2.8 pp -87.99 106.02 17.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.553 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 3.6 mp -90.34 162.53 15.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.898 . . . . 0.0 109.473 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -72.61 -12.39 61.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.68 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HA ' HD12 ' A' ' 103' ' ' ILE . 1.6 m-20 -107.27 -0.81 22.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 157.93 144.68 4.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' A' ' 50' ' ' LEU . 3.1 mm -96.41 109.07 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -1.105 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 9.2 pt-20 -119.79 131.94 55.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 108.869 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.578 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.8 p90 -127.63 142.36 51.37 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 110.073 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -123.42 -149.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.628 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -63.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 109.179 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.0 -178.66 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 108.939 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.79 -42.75 17.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -144.14 69.54 1.28 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.507 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 18.4 t70 -47.41 -21.33 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 2.9 t-20 91.78 -18.49 0.14 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -134.25 119.63 14.5 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 45.1 Cg_endo -69.43 132.93 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.685 1.59 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.69 -21.56 22.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -160.01 117.98 0.8 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 167.8 9.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -1.156 . . . . 0.0 109.662 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 5.5 mt -140.8 109.72 6.59 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.25 118.23 5.55 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.597 1.531 . . . . 0.0 110.35 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' CB ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -67.93 -7.06 25.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.545 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -42.88 -68.13 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.725 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.432 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -150.14 71.46 0.3 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.009 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -177.65 5.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.196 . . . . 0.0 109.256 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.17 113.09 8.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.251 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 71' ' ' ILE . 3.4 tm? -88.67 131.37 35.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.281 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 58' ' ' PRO . 31.6 m -115.99 137.63 51.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.436 ' N ' HG21 ' A' ' 56' ' ' THR . 17.9 p -150.13 118.03 3.6 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.456 ' O ' ' CG2' ' A' ' 56' ' ' THR . 48.2 Cg_endo -70.78 -160.87 1.7 Allowed 'Cis proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.493 -1.878 . . . . 0.0 110.424 0.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.559 ' SG ' HG12 ' A' ' 68' ' ' VAL . 22.7 p -91.07 -149.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -163.43 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.85 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 21.11 2.34 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.643 ' CZ ' ' NE1' ' A' ' 21' ' ' TRP . 8.3 t80 -88.64 -56.44 3.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 108.738 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -75.27 -50.14 8.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 15.7 pttm 40.53 28.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.98 . . . . 0.0 109.59 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.9 ttt180 -137.75 15.5 2.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt 64.6 -162.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 49.31 23.11 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG12 ' SG ' ' A' ' 59' ' ' CYS . 10.7 p -161.28 126.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.715 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.4 p90 -116.23 167.38 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.7 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -124.7 108.61 12.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.586 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.4 mt -90.1 166.71 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.635 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -148.95 89.47 1.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.53 ' OG1' ' CG ' ' A' ' 77' ' ' GLN . 3.2 p -47.22 173.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -22.06 64.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.443 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -74.14 -5.92 44.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.184 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 2.7 mt-30 79.13 36.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.8 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 1.9 pt20 -109.11 90.66 3.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 m-20 -53.76 159.53 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.394 -0.816 . . . . 0.0 110.342 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 77' ' ' GLN . 82.7 m-70 -150.56 124.48 9.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -100.4 114.85 28.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.082 -1.012 . . . . 0.0 109.892 -179.461 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.715 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -119.11 148.8 42.65 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 68' ' ' VAL . 2.7 tt0 -138.14 133.87 33.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.063 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.63 -160.8 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.399 -0.813 . . . . 0.0 109.194 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.531 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -106.48 -2.03 22.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.514 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -173.02 167.1 5.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.0 179.973 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.438 ' CD1' ' HD2' ' A' ' 89' ' ' ARG . 33.2 tp -66.36 -14.16 61.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.558 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -67.21 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.189 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.68 -14.68 61.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.274 179.715 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' CG ' ' HA ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -76.05 -51.55 12.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -68.34 -19.95 64.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 109.478 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -87.47 -31.34 20.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.581 ' CH2' HG23 ' A' ' 26' ' ' VAL . 1.6 m95 -79.95 -32.28 39.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' CG2' HD13 ' A' ' 55' ' ' LEU . 1.7 p -82.55 -34.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.17 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 7.9 ptm180 -73.58 -25.97 60.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 108.998 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 19.4 t0 -85.4 -49.05 8.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.531 ' CG2' HD12 ' A' ' 71' ' ' ILE . 23.9 mt -61.62 -38.42 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.048 -1.032 . . . . 0.0 108.831 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.483 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 11.3 t-20 -75.92 -66.02 0.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 8.4 tttp -43.08 -32.75 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' C ' HD22 ' A' ' 50' ' ' LEU . . . -69.47 -47.09 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.528 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.13 -55.54 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.766 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -63.69 -12.64 36.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -85.82 -32.39 21.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.8 . . . . 0.0 109.184 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.554 HD13 ' CB ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -78.26 -30.46 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -0.868 . . . . 0.0 108.937 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.0 mm-40 -72.97 -5.35 38.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.356 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.75 13.99 5.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 107' ' ' GLU . 1.7 mt -101.46 57.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.465 -1.02 . . . . 0.0 109.284 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 106' ' ' LEU . 3.9 mt-10 -42.42 139.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.698 -0.626 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -67.22 -169.76 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.27 46.99 25.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.01 61.43 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 64.41 -179.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 42.3 t-80 -125.93 3.32 7.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.435 ' N ' ' ND1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.504 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.575 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 167.33 -61.34 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.689 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.1 Cg_endo -72.06 -160.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.833 1.689 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 5' ' ' ARG . 2.2 mtpt -93.57 92.13 7.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.251 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.561 ' CB ' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 83.75 126.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.312 0.577 . . . . 0.0 109.445 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' HB ' HD13 ' A' ' 28' ' ' LEU . 31.3 mt -63.83 -53.95 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -113.7 147.22 38.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 109.858 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.54 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 1.1 pm0 -163.93 126.05 2.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.794 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.587 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.08 -145.08 4.16 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 p90 -134.89 92.32 2.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.954 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.694 ' CD2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -106.96 162.78 13.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.149 -0.969 . . . . 0.0 109.419 179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.572 ' CG1' ' CB ' ' A' ' 82' ' ' GLN . 2.3 p -98.92 130.38 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HE2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.47 135.11 53.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.322 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 tttt -64.46 96.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LYS . . . -43.61 166.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 t -84.52 -4.45 58.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.541 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' HG11 ' A' ' 17' ' ' VAL . 2.3 p -93.37 114.55 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' VAL . 21.9 m-85 52.34 174.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -87.21 86.39 7.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.252 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 61.3 p -120.58 -177.14 3.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.954 . . . . 0.0 109.757 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.642 ' CZ3' ' CG ' ' A' ' 82' ' ' GLN . 44.0 m95 -154.52 106.2 2.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.035 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.499 ' N ' HG22 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -125.3 133.25 24.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 109.989 -179.55 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 12' ' ' VAL . 52.2 Cg_exo -53.55 166.14 1.38 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.972 1.781 . . . . 0.0 110.323 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.77 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -174.92 169.68 3.39 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.77 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.1 t-105 -91.37 145.31 24.74 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.592 HG23 ' CH2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -150.34 132.43 5.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.329 -178.324 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -127.79 102.95 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.549 HD21 ' CE3' ' A' ' 92' ' ' TRP . 2.5 pp -79.4 125.8 30.0 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.269 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 ' CD2' ' CG ' ' A' ' 5' ' ' ARG . 2.2 mp -112.74 163.66 14.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.428 -0.795 . . . . 0.0 109.114 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.482 ' O ' HD21 ' A' ' 50' ' ' LEU . 7.6 pt-20 -73.84 -6.27 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.28 -0.1 13.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.296 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.49 ' CA ' HD12 ' A' ' 50' ' ' LEU . . . 156.14 148.04 4.93 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 ' CB ' ' A' ' 28' ' ' LEU . 4.0 mm -98.93 108.16 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -1.139 . . . . 0.0 109.313 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 10.7 pt-20 -111.1 112.54 24.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.018 -1.051 . . . . 0.0 109.185 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.684 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.9 p90 -115.13 142.6 46.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.192 -0.943 . . . . 0.0 110.053 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.67 -149.38 0.41 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 108.613 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -99.91 -54.64 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 108.586 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -93.15 -171.28 2.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.642 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 8.1 mtpt -63.85 -9.89 17.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.657 -1.277 . . . . 0.0 109.704 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -152.65 -51.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.359 178.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.6 t0 57.46 11.0 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 38.67 24.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.814 . . . . 0.0 110.557 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.7 t -176.68 95.57 0.24 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.831 -1.168 . . . . 0.0 110.029 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.656 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 52.8 Cg_exo -53.9 153.77 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.169 1.913 . . . . 0.0 111.524 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 tttt -101.55 -21.7 14.67 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.42 141.07 5.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 5.5 mtm -139.83 132.11 28.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.261 . . . . 0.0 109.841 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.486 HG21 ' HD2' ' A' ' 49' ' ' PRO . 19.7 mt -89.07 129.15 49.15 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.8 . . . . 0.0 108.905 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HD2' HG21 ' A' ' 48' ' ' ILE . 42.9 Cg_endo -68.84 131.75 23.28 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.774 1.649 . . . . 0.0 110.447 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' CD2' HG13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -89.22 30.66 0.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.403 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -36.15 15.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.415 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 74' ' ' THR . . . -177.51 84.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.12 -177.68 3.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -1.158 . . . . 0.0 109.675 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -135.43 114.51 12.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.405 -0.809 . . . . 0.0 109.696 -179.193 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.53 HD21 ' CG1' ' A' ' 71' ' ' ILE . 3.3 tm? -88.58 131.88 34.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.216 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.413 ' N ' HD12 ' A' ' 55' ' ' LEU . 23.9 m -124.06 121.37 35.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.6 m -148.46 137.06 11.67 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 109.745 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.05 177.89 37.05 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.391 -1.92 . . . . 0.0 110.438 -0.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.773 ' SG ' ' CB ' ' A' ' 70' ' ' LYS . 1.9 t -150.14 -149.53 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 68' ' ' VAL . 0.3 OUTLIER 63.17 115.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.413 -0.804 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.38 7.14 28.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.015 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.548 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -89.49 -42.7 11.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.66 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -118.16 -17.92 5.2 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 36.66 31.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.839 -0.801 . . . . 0.0 109.582 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 22.54 5.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.525 -0.735 . . . . 0.0 109.639 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.563 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER 55.81 -179.43 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 108.956 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.1 m-30 83.26 -20.18 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.732 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -102.22 135.45 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.388 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.691 ' CE2' ' CD2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -110.91 152.32 26.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.958 . . . . 0.0 109.985 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.773 ' CB ' ' SG ' ' A' ' 59' ' ' CYS . 1.7 tttp -124.41 103.89 8.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.525 -0.734 . . . . 0.0 109.314 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 12.7 mt -90.87 167.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.9 m -145.64 84.11 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.467 HG23 ' HD2' ' A' ' 49' ' ' PRO . 4.5 p -42.96 165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 109.594 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -62.68 -16.8 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.472 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.42 19.71 5.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.26 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.17 34.66 16.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.765 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.461 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -97.82 94.52 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 66.2 m-20 -62.8 155.73 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 51.3 m-70 -139.38 124.07 18.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 71.1 m-85 -93.01 124.36 36.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.436 -0.79 . . . . 0.0 109.866 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.691 ' CD2' ' CE2' ' A' ' 69' ' ' PHE . 0.5 OUTLIER -122.8 141.78 51.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.337 -0.852 . . . . 0.0 110.017 -179.53 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.642 ' CG ' ' CZ3' ' A' ' 21' ' ' TRP . 1.4 mm100 -135.51 108.74 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.322 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.37 -145.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.505 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -132.75 1.53 3.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.849 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -172.28 154.15 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.14 -22.18 66.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 -179.821 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' N ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -66.16 -68.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 0.0 109.091 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.458 ' CB ' ' CE1' ' A' ' 85' ' ' PHE . 3.0 tt0 -60.28 -21.95 62.55 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 108.792 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -62.0 -65.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 179.592 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.562 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -57.06 -34.25 68.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.807 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.43 75.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.116 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.694 ' CE2' ' CD2' ' A' ' 11' ' ' LEU . 13.2 m95 -74.83 -56.29 4.92 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.341 -0.849 . . . . 0.0 108.795 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -64.48 -11.07 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.607 -0.683 . . . . 0.0 109.252 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 19.4 mmt180 -84.42 -39.74 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -87.28 -21.33 25.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.939 -179.745 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.507 ' CG1' HD23 ' A' ' 28' ' ' LEU . 6.2 mt -87.42 -38.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 109.095 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 2.0 t-20 -80.17 -33.34 38.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 108.874 179.392 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -72.5 -45.06 61.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.078 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.469 ' HB2' HD23 ' A' ' 50' ' ' LEU . . . -64.95 -41.69 95.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.206 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.526 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 33.6 mt -66.64 -32.79 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.111 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -81.92 -11.83 58.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.16 -24.34 16.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 108.954 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.537 HG13 ' CD2' ' A' ' 50' ' ' LEU . 9.1 mm -69.05 -23.75 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.457 -0.777 . . . . 0.0 109.213 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.7 -1.78 32.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.407 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.54 19.55 1.02 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 53.77 2.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.554 -0.968 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.01 128.81 36.35 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.704 -0.623 . . . . 0.0 109.437 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 34.9 t60 -75.57 135.37 40.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 108' ' ' HIS . 0.5 OUTLIER 176.12 128.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.958 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -110.98 158.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.63 10.19 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -41.07 56.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.504 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 28' ' ' LEU . 50.6 mt -73.59 -58.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.995 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.35 107.46 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.042 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.8 pt-20 -111.97 143.92 42.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.632 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.19 -151.06 6.26 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.987 ' C ' HD13 ' A' ' 11' ' ' LEU . 6.3 p90 -145.26 96.27 2.81 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.385 -1.068 . . . . 0.0 110.086 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.987 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -119.17 163.5 16.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.722 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -86.17 130.69 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 81' ' ' PHE . 1.1 tttt -122.43 135.0 54.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.388 -0.82 . . . . 0.0 109.717 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -101.13 99.57 10.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 108.864 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 166.69 90.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 2.5 p 161.85 -41.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.35 -1.088 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.63 HG21 ' OG1' ' A' ' 20' ' ' THR . 13.2 m -100.92 -144.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' N ' HG23 ' A' ' 17' ' ' VAL . 19.4 m-85 -94.27 72.95 3.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.772 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 2.8 m-20 44.16 88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.007 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.63 ' OG1' HG21 ' A' ' 17' ' ' VAL . 76.1 p -146.88 -162.52 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.657 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.2 m95 -151.4 102.82 2.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.383 -0.823 . . . . 0.0 109.354 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.722 ' N ' HG23 ' A' ' 12' ' ' VAL . 24.1 mmtt -137.85 142.02 34.8 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.7 Cg_exo -52.63 160.23 4.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.92 1.746 . . . . 0.0 109.759 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -167.43 166.65 14.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.951 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.728 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.1 t-105 -92.78 141.07 28.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.3 p -149.9 133.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.764 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.042 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.0 m -124.98 111.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.06 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.041 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -82.4 119.86 24.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -0.976 . . . . 0.0 108.761 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -106.04 166.75 10.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.811 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.688 ' C ' HD22 ' A' ' 50' ' ' LEU . 3.9 pt-20 -71.93 -6.63 43.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.865 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.91 -1.73 11.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.574 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 155.35 146.64 4.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -97.12 105.15 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -1.087 . . . . 0.0 109.956 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 27' ' ' VAL . 5.4 pt-20 -102.38 128.2 49.06 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.0 p90 -124.7 147.29 48.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 110.903 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.13 -145.41 0.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.7 -42.47 5.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.947 -1.096 . . . . 0.0 108.986 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -115.63 -177.79 3.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 108.821 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 4.2 tppt? -46.68 -34.69 5.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -157.12 73.47 0.75 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.515 -0.741 . . . . 0.0 109.469 178.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 31.5 t70 -52.61 -17.36 1.24 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 19.1 m-20 91.16 -18.32 0.15 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -135.45 116.44 11.93 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 47.1 Cg_endo -69.2 144.18 56.12 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.735 1.623 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 8.1 mmtt -90.07 -25.6 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 108.926 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.54 150.5 10.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.4 mtt -118.23 166.97 11.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 39.9 mt -128.99 131.24 23.6 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.77 135.46 30.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.353 1.369 . . . . 0.0 109.797 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -85.49 37.98 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 109.924 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -172.71 99.36 0.14 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.032 -1.042 . . . . 0.0 109.425 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 123.87 11.28 4.94 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.311 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 1.2 t -97.15 156.87 16.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.934 -1.333 . . . . 0.0 109.777 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -116.9 173.13 6.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 93' ' ' VAL . 1.7 tt -134.64 135.64 42.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.021 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.852 ' N ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -121.32 108.23 13.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 13.4 p -142.22 116.14 6.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 57' ' ' SER . 33.7 Cg_exo -62.15 -172.85 2.32 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.936 -1.693 . . . . 0.0 110.682 -1.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.7 p -98.14 -146.78 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.33 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.542 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -102.72 -149.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.3 17.81 3.52 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.337 -0.852 . . . . 0.0 108.887 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -89.33 77.67 7.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.308 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 102.27 -73.42 0.32 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 42.79 29.86 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -1.093 . . . . 0.0 109.477 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -93.78 -99.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 45.3 m-85 -129.55 87.2 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 0.0 109.531 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.3 p -120.15 117.32 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.618 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 4.4 p90 -106.97 165.12 11.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.331 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 1.9 ttpp -123.44 120.02 31.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.813 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.5 mt -106.8 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 54' ' ' THR . 87.1 m -134.17 94.48 3.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.09 150.29 25.45 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 108.976 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -45.94 -21.96 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.242 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -86.62 29.22 0.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 109.801 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.81 31.56 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.99 . . . . 0.0 109.67 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.491 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -97.49 97.45 9.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.42 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 77.4 m-20 -61.55 152.69 29.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.491 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 32.7 m-70 -142.32 88.92 2.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.872 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -91.13 101.63 14.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 108.95 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.42 146.83 51.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.528 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 83' ' ' ALA . 1.9 tt0 -116.39 143.71 45.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.331 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -89.64 -146.69 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.666 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -107.48 -15.87 14.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 1.7 p90 -170.59 172.44 5.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.965 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.84 -50.25 66.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 109.969 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.965 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.2 tm-20 -53.28 -39.23 63.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.271 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 20.8 tt0 -83.86 -16.13 45.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.071 -1.018 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 1.6 ttt180 -76.99 -46.51 23.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.992 . . . . 0.0 109.638 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 8.4 t0 -79.97 -27.2 39.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 109.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.509 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -73.81 -34.78 64.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.725 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.041 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -80.22 -48.44 13.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.825 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.984 HG22 HD11 ' A' ' 55' ' ' LEU . 3.6 p -68.71 -27.12 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 33.5 ptt85 -79.76 -30.72 40.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.052 . . . . 0.0 109.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -75.21 -39.39 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.368 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.693 ' O ' HD12 ' A' ' 100' ' ' ILE . 28.2 mt -72.5 -42.4 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.57 -27.09 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 109.252 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 5.3 tppt? -72.27 -46.13 57.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -64.13 -37.15 86.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.875 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 96' ' ' ILE . 7.6 mt -69.58 -34.15 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.403 -0.811 . . . . 0.0 108.928 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -85.26 -8.28 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.399 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.543 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -94.61 -30.97 14.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.507 HG12 HD23 ' A' ' 50' ' ' LEU . 1.1 mm -69.44 -28.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.2 mt-10 -64.86 -10.51 29.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.583 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' HD22 ' A' ' 106' ' ' LEU . . . -131.21 10.93 5.59 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 102' ' ' CYS . 3.2 mm? . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.066 . . . . 0.0 109.385 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.629 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 30' ' ' GLU . 2.5 mp -66.81 -71.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.1 tpm_? -107.35 125.96 51.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 110.094 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.001 ' HB3' HG12 ' A' ' 27' ' ' VAL . 6.7 pm0 -145.88 122.91 11.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 0.0 109.178 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.596 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.62 -147.57 4.94 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.791 ' C ' HD13 ' A' ' 11' ' ' LEU . 16.7 p90 -139.63 99.88 3.82 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.356 -1.085 . . . . 0.0 109.873 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -105.86 -143.03 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.036 HG23 ' C ' ' A' ' 22' ' ' LYS . 9.9 p -149.71 129.12 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.013 . . . . 0.0 109.65 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.79 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.3 tttt -116.38 169.16 9.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -125.71 148.13 49.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 14' ' ' LYS . . . 115.58 107.72 2.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p 177.03 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 18' ' ' PHE . 17.9 m -143.06 -39.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 4.7 m-85 -168.29 61.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 48.69 43.55 20.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.548 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 12.7 p -89.99 172.35 8.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 14' ' ' LYS . 5.1 m95 -126.21 120.08 29.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.036 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.2 mmtp -138.88 129.64 15.01 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.668 ' N ' HG23 ' A' ' 12' ' ' VAL . 32.5 Cg_exo -59.14 119.06 6.08 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.916 1.744 . . . . 0.0 110.177 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.79 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 7.7 ptm -124.48 168.5 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.909 -1.119 . . . . 0.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.596 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 72.5 t-105 -90.45 145.53 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -151.49 139.67 14.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.403 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.1 m -130.25 98.31 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.9 pp -76.04 123.78 26.34 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.939 -1.1 . . . . 0.0 108.803 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 5' ' ' ARG . 2.4 mp -107.26 166.08 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.461 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 31.5 tt0 -73.69 -9.2 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.28 4.27 15.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.915 . . . . 0.0 109.472 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 149.67 148.61 4.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.5 mp -99.02 127.09 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 110.084 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 7.9 pt-20 -127.87 115.02 17.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.5 p90 -117.54 151.54 36.93 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -132.77 -153.32 0.54 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.141 -0.975 . . . . 0.0 108.38 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 40.8 mttt -124.62 -173.27 2.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 5.9 tppt? -45.5 -25.65 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.976 -1.077 . . . . 0.0 109.255 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -148.53 -50.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.54 10.86 3.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' ASP . 1.4 m-20 42.61 23.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -169.84 108.19 0.46 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.051 -1.031 . . . . 0.0 109.706 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.1 Cg_endo -71.49 136.57 28.82 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.8 1.666 . . . . 0.0 110.549 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.79 -17.95 27.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.02 140.36 4.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.1 mtm -133.16 124.8 28.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.29 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 73' ' ' THR . 6.5 mt -89.73 134.84 31.43 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 48' ' ' ILE . 56.7 Cg_endo -72.13 137.76 29.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.689 1.592 . . . . 0.0 110.078 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.675 HD23 ' CG1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.82 38.7 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.542 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -91.53 -70.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.99 72.95 0.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.712 ' H ' HG21 ' A' ' 100' ' ' ILE . 1.5 p -80.12 -170.1 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.363 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.33 111.53 6.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.516 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.756 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.4 tm? -88.59 116.42 26.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.017 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 58' ' ' PRO . 86.8 m -102.09 130.56 48.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.421 -0.799 . . . . 0.0 109.578 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 t -150.05 120.05 3.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.713 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.41 -163.02 2.66 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.595 -1.835 . . . . 0.0 110.396 0.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.15 -158.84 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -71.33 -149.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -84.07 14.31 4.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.418 -0.801 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -10.1 49.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.884 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -124.75 -103.65 1.49 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 42.67 59.44 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.281 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 6.2 ttt-85 179.73 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.8 mtp -141.03 -155.95 0.63 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.471 -0.768 . . . . 0.0 109.766 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -92.99 65.37 4.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.91 . . . . 0.0 109.221 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG11 ' HA2' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -116.25 128.16 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.622 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 7.7 p90 -120.36 173.66 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 109.61 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.627 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 ttpt -129.99 108.34 10.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 0.0 109.396 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.582 HG13 ' CE1' ' A' ' 69' ' ' PHE . 1.3 mt -89.2 165.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 109.377 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.8 m -144.93 91.08 2.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.714 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.7 162.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.364 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -61.09 -13.26 15.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.678 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.99 15.84 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.83 32.28 4.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.55 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -89.95 -175.9 4.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.235 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 77' ' ' GLN . 2.6 m-20 -141.8 146.6 36.1 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.414 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.493 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 80.6 m-70 -145.79 92.63 2.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' CD ' ' A' ' 70' ' ' LYS . 36.1 m-85 -90.48 110.29 21.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.306 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.92 146.11 31.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.698 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -113.06 139.54 48.6 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.471 -0.768 . . . . 0.0 108.948 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.93 -155.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.499 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.73 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 175.62 5.44 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 25.4 tp -56.41 -22.93 34.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 109.109 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -66.07 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.57 -16.88 58.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -0.871 . . . . 0.0 109.153 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.719 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -71.26 -64.04 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.561 ' HA ' HG22 ' A' ' 93' ' ' VAL . 10.4 t0 -62.01 -12.81 20.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.115 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.74 -30.93 28.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 108.666 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.66 ' CH2' HG22 ' A' ' 26' ' ' VAL . 5.8 m95 -84.02 -28.72 27.47 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.1 m -75.28 -36.76 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.543 -0.723 . . . . 0.0 109.535 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 8.5 ptp180 -83.83 -24.72 30.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.5 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' HD11 ' A' ' 28' ' ' LEU . 12.6 t0 -77.14 -45.7 25.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.019 ' O ' HD12 ' A' ' 100' ' ' ILE . 32.1 mt -76.51 -42.32 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 28.1 t-20 -69.44 -31.46 69.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.5 tmtp? -75.37 -50.75 14.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.31 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -54.43 -42.23 70.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.37 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.019 HD12 ' O ' ' A' ' 96' ' ' ILE . 5.2 mt -70.23 -39.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.239 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -71.21 -11.64 61.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.322 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -95.25 -33.91 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 109.244 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.675 ' CG1' HD23 ' A' ' 50' ' ' LEU . 8.5 mm -67.82 -16.9 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 39.3 mt-10 -73.57 -2.99 25.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.517 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.97 17.51 0.93 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 102' ' ' CYS . 2.0 mm? . . . . . 0 C--N 1.301 -1.526 0 O-C-N 121.48 -1.012 . . . . 0.0 109.462 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 28.2 mm -73.01 -59.79 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.928 . . . . 0.0 109.739 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 1.024 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.72 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.63 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.979 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -145.33 129.32 17.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.46 -146.95 4.76 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.728 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.9 p90 -135.89 99.84 4.27 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -115.11 153.79 30.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 22' ' ' LYS . 5.7 p -94.1 140.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.894 -1.129 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.74 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 11.3 mttp -123.07 169.7 10.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.92 113.58 21.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.37 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 153.99 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.14 -46.49 70.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' PHE . 2.2 p -50.46 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 12.7 m-85 61.11 159.62 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -76.71 86.04 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.6 p -128.77 171.53 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.521 ' CH2' ' CB ' ' A' ' 80' ' ' PHE . 23.6 m95 -133.01 101.62 5.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.984 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.5 mttm -107.54 134.19 20.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.35 147.77 44.93 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.644 1.563 . . . . 0.0 109.775 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.74 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 23.1 ptm -154.11 162.44 41.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.991 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.683 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.9 t-105 -94.79 147.91 22.84 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -151.52 138.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.491 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.979 HG12 ' HB3' ' A' ' 8' ' ' GLU . 9.7 m -129.46 94.55 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.027 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -68.41 120.15 14.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.808 -1.182 . . . . 0.0 108.882 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.0 mp -102.62 164.83 11.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.56 -0.713 . . . . 0.0 109.372 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -71.63 -14.72 62.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -0.827 . . . . 0.0 109.818 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -109.3 4.62 22.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.657 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 149.62 150.32 5.22 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -92.5 121.11 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 109.938 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.557 ' O ' HG22 ' A' ' 27' ' ' VAL . 10.3 mt-10 -116.75 107.94 15.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.625 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 12.9 p90 -117.68 145.64 44.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.953 -1.092 . . . . 0.0 110.686 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.646 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.44 -154.72 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 2.8 mtmt -91.95 -43.94 9.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 108.46 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -102.09 -170.9 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 108.743 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 mtpt -64.24 -10.04 21.06 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -150.99 -52.13 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 4.2 t70 59.95 11.37 2.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER 41.89 22.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -176.76 99.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.789 -1.194 . . . . 0.0 110.747 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.1 Cg_exo -52.79 135.1 56.52 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.989 1.793 . . . . 0.0 110.525 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.55 -18.74 26.04 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.65 126.16 1.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 51.7 mtm -122.05 123.47 41.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.594 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.918 HG23 HG22 ' A' ' 73' ' ' THR . 26.0 mt -89.82 132.81 35.43 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.005 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 73' ' ' THR . 54.5 Cg_endo -72.11 129.7 15.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.681 1.587 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.735 HD23 ' CG1' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -84.67 43.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.723 ' HB2' HG21 ' A' ' 74' ' ' THR . 8.5 mmtm -95.73 -71.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.52 61.74 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 100' ' ' ILE . 2.4 m -85.43 171.39 11.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -1.171 . . . . 0.0 109.325 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.71 172.06 8.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -0.81 . . . . 0.0 109.455 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 56' ' ' THR . 3.2 tm? -133.96 136.41 44.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 108.74 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.792 ' N ' HD13 ' A' ' 55' ' ' LEU . 32.9 m -126.29 131.5 51.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.076 -1.015 . . . . 0.0 110.118 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.402 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 24.5 p -150.37 119.89 3.72 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.449 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 56' ' ' THR . 52.9 Cg_endo -71.95 -161.49 2.08 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.56 -1.85 . . . . 0.0 110.179 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -146.68 130.12 16.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 57.04 163.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -103.49 -12.03 17.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.915 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -89.14 4.55 48.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.796 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -120.71 -19.48 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -49.65 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -144.1 -77.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.545 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -99.9 -39.86 7.96 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.5 0.667 . . . . 0.0 109.563 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' A' ' 89' ' ' ARG . 0.4 OUTLIER 158.57 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -119.59 128.0 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.7 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 2.3 p90 -109.02 164.54 12.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.051 -1.031 . . . . 0.0 109.673 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -127.0 108.41 10.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mt -89.33 160.29 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 99.8 m -131.59 85.43 2.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 48' ' ' ILE . 6.9 p -44.13 158.14 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -58.71 -15.34 11.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.357 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -90.43 21.8 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 61.01 35.79 18.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.467 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.1 109.18 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.9 m-20 -76.08 146.64 39.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 39.4 m-70 -140.46 116.57 10.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.66 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CB ' ' CH2' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -98.54 128.49 44.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.7 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.94 160.35 40.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 108.783 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -142.14 132.55 25.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -92.75 -84.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' SD ' ' A' ' 66' ' ' MET . . . 179.16 -67.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -114.26 169.72 8.82 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.635 -0.665 . . . . 0.0 109.807 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -62.3 -19.74 63.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.591 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.985 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -71.28 -66.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.129 -0.982 . . . . 0.0 109.415 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -16.54 64.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 1.052 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.02 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.618 ' HA ' HG22 ' A' ' 93' ' ' VAL . 20.2 t70 -67.96 -14.72 63.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.03 -33.73 29.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.027 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 7.8 m95 -82.55 -25.87 32.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.052 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -79.96 -39.3 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.0 ptm180 -77.79 -23.93 49.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.5 t70 -81.61 -49.33 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.06 . . . . 0.0 109.506 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.781 HG13 HD22 ' A' ' 28' ' ' LEU . 32.5 mt -72.92 -31.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 52.7 t30 -81.17 -36.02 30.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 3.2 ttpt -71.6 -37.81 70.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.639 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -68.22 -43.38 78.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.92 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 53' ' ' SER . 60.0 mt -68.37 -30.47 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.163 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 5.4 mmtt -85.03 -10.9 56.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.11 -21.44 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.045 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.735 ' CG1' HD23 ' A' ' 50' ' ' LEU . 2.0 mm -75.51 -28.31 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.009 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.27 -5.54 33.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.17 11.69 5.85 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 106' ' ' LEU . 1.7 mt . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.486 -1.008 . . . . 0.0 109.25 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 30' ' ' GLU . 23.0 mm -56.19 -53.65 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.747 ' HB3' HD11 ' A' ' 28' ' ' LEU . 1.7 tpm_? -141.88 108.68 5.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.207 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.983 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.99 131.23 55.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.987 -1.071 . . . . 0.0 109.189 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.4 -149.4 5.61 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.737 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.3 p90 -138.12 95.72 3.07 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.069 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -114.36 169.77 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -96.4 159.81 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.834 -1.166 . . . . 0.0 109.6 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -148.75 130.17 14.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -50.73 150.9 2.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.414 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.06 -139.48 8.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.64 47.84 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -1.11 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 17' ' ' VAL . 10.9 p -155.1 109.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' ASN . 25.1 m-85 58.52 22.0 9.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' PHE . 4.0 m-20 46.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.2 p -125.4 -179.29 4.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.595 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.683 ' CH2' HG21 ' A' ' 68' ' ' VAL . 39.0 m95 -144.97 88.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.204 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.3 mttm -107.8 139.71 20.88 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.746 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.09 167.81 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.959 1.773 . . . . 0.0 110.598 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 25.6 ptm -174.8 158.43 2.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.89 . . . . 0.0 109.479 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.0 t-105 -89.79 147.17 23.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.413 -0.805 . . . . 0.0 109.03 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.61 133.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.666 -178.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.983 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.2 m -125.59 103.26 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.05 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.4 OUTLIER -86.89 108.97 19.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.75 164.26 14.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -73.64 -17.65 61.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.591 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.67 9.4 43.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 50' ' ' LEU . . . 152.23 -176.59 30.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' HA ' ' A' ' 28' ' ' LEU . 2.8 mp -138.16 125.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.256 . . . . 0.0 109.528 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.3 pt-20 -132.23 116.77 17.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 108.929 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.635 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.1 p90 -119.49 147.54 44.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.13 -0.981 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.77 -157.2 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -88.39 -55.66 3.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.48 -178.82 5.02 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -49.28 -21.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.898 -1.126 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -146.63 -47.36 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.679 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 43' ' ' SER . 5.2 t0 62.29 9.9 3.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.8 t30 45.84 21.04 0.08 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.942 -1.099 . . . . 0.0 109.606 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.8 t -173.29 115.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.497 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.3 Cg_endo -72.35 132.27 19.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.922 1.748 . . . . 0.0 110.593 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -89.62 -19.65 24.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . -167.58 120.66 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.0 mtm -119.28 125.58 49.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.118 -1.225 . . . . 0.0 109.84 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.548 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 mt -90.78 121.53 68.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.995 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.76 140.14 38.29 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.719 1.613 . . . . 0.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -84.9 37.82 0.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.864 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -70.09 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.132 -0.98 . . . . 0.0 109.375 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' THR . . . -136.33 24.71 3.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -40.09 141.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.441 -1.035 . . . . 0.0 110.383 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.47 167.26 10.6 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.763 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.2 tm? -137.66 117.38 13.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.985 -1.072 . . . . 0.0 109.449 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 58' ' ' PRO . 23.2 m -107.96 135.54 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -150.35 120.94 3.86 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.878 . . . . 0.0 109.239 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.854 ' O ' HG22 ' A' ' 56' ' ' THR . 55.5 Cg_endo -72.91 -161.14 2.11 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.651 -1.812 . . . . 0.0 110.346 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 9.2 p -102.93 -148.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.899 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.61 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 11.2 tt0 -71.6 -142.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -68.07 -2.23 7.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 68' ' ' VAL . 24.9 m-85 -88.99 -24.71 22.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 108.948 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -74.39 -49.14 12.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -19.83 6.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -1.063 . . . . 0.0 109.189 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -75.48 0.34 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -155.62 0.58 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 109.553 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 25.0 m-85 -97.52 86.66 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.683 HG21 ' CH2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -126.64 136.3 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.539 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.69 175.62 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 13.9 ttpt -142.67 100.74 3.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.898 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 54' ' ' THR . 12.6 mt -90.12 160.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 108.995 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 53.2 m -140.71 105.36 4.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.349 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.612 HG23 ' H ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -48.67 107.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.298 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER 39.55 28.94 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' THR . 5.5 tttt 82.73 46.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.979 -1.076 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -133.44 -86.71 0.43 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.079 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.612 ' H ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -90.9 136.84 32.81 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.645 -0.659 . . . . 0.0 109.669 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -89.29 168.26 12.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -148.04 98.41 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -96.04 119.6 34.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -137.01 167.99 20.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.05 -1.031 . . . . 0.0 109.061 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.607 ' HB3' HG13 ' A' ' 12' ' ' VAL . 34.7 tt0 -135.12 138.03 43.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.704 -1.248 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.14 -89.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.25 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.601 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.07 171.31 14.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD1' ' NH2' ' A' ' 89' ' ' ARG . 24.1 tp -53.65 -42.81 68.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.199 -0.938 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.07 -59.27 4.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.23 -15.12 62.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.277 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 1.021 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -71.99 -65.22 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.546 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -69.56 -11.19 60.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.311 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.52 -41.06 24.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.239 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.069 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.3 m95 -79.19 -28.56 42.64 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.335 -0.853 . . . . 0.0 109.165 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.021 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -71.24 -39.05 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 109.095 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -77.43 -23.03 50.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -76.74 -52.05 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.691 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.051 ' O ' HD12 ' A' ' 100' ' ' ILE . 47.8 mt -73.03 -31.92 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 18.7 t-20 -78.1 -28.65 48.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.331 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.9 -42.29 49.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.11 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.2 -36.35 83.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.871 . . . . 0.0 108.822 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.051 HD12 ' O ' ' A' ' 96' ' ' ILE . 4.9 mt -76.04 -31.47 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.127 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -83.08 -12.35 57.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.1 m -93.49 -28.39 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 108.931 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 30' ' ' GLU . 2.6 tp -64.97 -33.18 61.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.418 -0.801 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -12.55 61.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.25 6.62 25.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.435 -1.038 . . . . 0.0 109.117 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.43 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.338 0.589 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 30' ' ' GLU . 34.3 mt -56.22 -67.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 1.017 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -116.89 148.86 40.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.028 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -157.6 134.33 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.592 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.67 -149.0 5.45 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.028 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -138.48 91.38 2.54 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.379 -1.071 . . . . 0.0 110.099 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 165.3 14.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.745 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.677 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -85.58 131.47 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.198 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HE2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -131.14 152.11 50.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -70.4 125.94 28.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.265 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 178.82 120.46 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 163.74 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.377 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 18' ' ' PHE . 1.5 p -140.37 -47.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.548 ' O ' HG23 ' A' ' 20' ' ' THR . 4.0 p90 -140.01 -172.97 3.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.418 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 18.3 p-10 -47.49 92.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' PHE . 59.2 p -130.07 155.57 45.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.896 ' CH2' HG21 ' A' ' 68' ' ' VAL . 2.0 m0 -126.67 119.75 27.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.452 -0.78 . . . . 0.0 109.389 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.677 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.06 131.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.815 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.6 Cg_exo -53.36 150.75 25.25 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.751 1.634 . . . . 0.0 109.751 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 11.6 ptm -168.98 165.83 11.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.066 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.8 t-105 -89.94 145.89 24.79 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -151.04 136.07 10.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.118 -178.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.028 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.0 m -125.72 103.63 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.017 HD21 ' CB ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -77.59 112.25 14.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' H ' ' A' ' 29' ' ' LEU . 1.8 mp -89.54 159.75 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.447 -0.783 . . . . 0.0 109.496 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HB3' HD11 ' A' ' 6' ' ' ILE . 7.7 pt-20 -70.75 -15.35 62.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' HD11 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -112.56 6.8 18.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 109.687 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.955 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 167.45 -165.81 38.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HD12 ' A' ' 48' ' ' ILE . 1.9 mp -144.85 121.99 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -1.097 . . . . 0.0 109.186 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 8.9 mt-10 -127.56 115.02 18.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.344 -0.848 . . . . 0.0 108.92 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HB3' HG23 ' A' ' 26' ' ' VAL . 8.3 p90 -121.45 145.77 47.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 109.982 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -130.62 -167.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.119 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -80.22 -40.87 26.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -113.06 -176.14 2.83 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.76 -24.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.84 -1.162 . . . . 0.0 109.184 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.6 -49.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 43' ' ' SER . 4.8 t70 61.38 10.97 3.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.373 -0.829 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 27.1 m120 43.96 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.971 -1.08 . . . . 0.0 109.546 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.2 t -170.89 103.13 0.41 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 109.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.505 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 55.6 Cg_endo -72.25 145.14 43.03 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.709 1.606 . . . . 0.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.96 -26.15 20.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.81 147.52 11.35 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.9 mtt -134.1 125.73 28.59 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.492 -1.005 . . . . 0.0 109.159 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.984 HD12 HG21 ' A' ' 33' ' ' ILE . 3.0 mt -89.74 137.06 28.71 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.209 -0.932 . . . . 0.0 109.007 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 51.7 Cg_endo -70.81 147.61 56.5 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.707 1.605 . . . . 0.0 110.284 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -88.21 24.24 1.92 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' ILE . 8.5 tttm -157.02 114.17 3.09 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.106 -0.996 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 96.58 32.84 6.41 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.476 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.451 ' OG ' HG12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -109.48 172.12 7.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.268 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.92 110.98 6.29 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.056 -1.027 . . . . 0.0 109.95 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.4 tm? -89.02 130.66 35.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.155 -0.965 . . . . 0.0 109.015 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.748 ' N ' HD13 ' A' ' 55' ' ' LEU . 7.6 m -113.43 100.54 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 55' ' ' LEU . 79.1 p -133.51 129.19 20.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.08 -1.012 . . . . 0.0 109.747 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.9 Cg_endo -78.95 179.71 29.61 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.696 -1.793 . . . . 0.0 110.128 -0.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 41.6 t -105.42 170.84 7.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.566 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 4.6 mm100 -147.76 143.8 27.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.896 -1.127 . . . . 0.0 110.282 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 6.5 t70 84.17 -54.02 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.15 0.5 . . . . 0.0 109.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -94.64 -55.25 3.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 108.437 179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' HG11 ' A' ' 68' ' ' VAL . . . -91.81 34.76 4.23 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -65.99 -9.31 29.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.611 -0.934 . . . . 0.0 109.542 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' MET . 5.8 mtm180 -76.98 -3.09 37.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.509 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 76.96 171.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.842 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 54.05 20.59 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.786 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.896 HG21 ' CH2' ' A' ' 21' ' ' TRP . 3.3 p -140.41 134.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.89 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CD2' HG12 ' A' ' 93' ' ' VAL . 8.2 p90 -117.22 -179.77 3.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 2.8 ttpt -133.71 111.29 10.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.9 mt -89.29 165.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.066 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.9 m -144.93 90.14 2.03 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.894 HG22 HG23 ' A' ' 48' ' ' ILE . 4.3 p -50.8 161.16 0.38 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -54.63 -17.19 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.815 . . . . 0.0 109.819 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -88.43 24.1 2.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.13 30.51 16.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.423 ' HB3' ' NE2' ' A' ' 79' ' ' HIS . 2.1 tm0? -95.96 100.74 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 56.3 m-20 -69.91 152.78 44.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 97.7 m-70 -150.1 101.39 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.135 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.619 ' CE2' ' CD ' ' A' ' 70' ' ' LYS . 8.4 m-85 -90.98 124.95 35.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.647 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.92 140.59 38.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.128 -0.983 . . . . 0.0 109.404 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.7 tt0 -113.15 136.82 52.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . . . -88.88 -92.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.425 -0.797 . . . . 0.0 109.436 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -145.18 -39.89 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 109.94 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -159.32 175.81 12.92 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.51 -0.743 . . . . 0.0 109.734 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.006 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -51.6 -50.09 60.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.57 -0.706 . . . . 0.0 109.56 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.006 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -49.64 -67.5 0.26 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 110.1 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.76 -13.82 17.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 1.033 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.76 -62.25 1.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.694 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 93' ' ' VAL . 6.8 t70 -64.33 -14.86 58.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.208 -0.932 . . . . 0.0 109.574 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -79.54 -46.83 16.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.4 m95 -71.31 -27.92 63.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.436 -0.79 . . . . 0.0 109.223 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.033 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.7 m -78.64 -38.43 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.378 -0.826 . . . . 0.0 109.827 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -74.42 -19.37 60.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.179 -0.951 . . . . 0.0 109.996 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -86.33 -54.26 4.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.053 -1.029 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.787 HG13 HD22 ' A' ' 28' ' ' LEU . 11.6 mt -66.98 -33.36 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 0.0 108.393 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 25.6 t-20 -76.17 -44.62 37.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -63.76 -27.98 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -51.46 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.181 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.804 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -57.44 -51.52 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.01 -17.35 62.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 109.345 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 44.7 t -81.85 -30.23 32.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.055 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -65.43 -38.31 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -12.43 59.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.264 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.68 7.89 12.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 108.953 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.525 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 28' ' ' LEU . 46.1 mm -51.48 -74.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.358 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.925 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.85 142.45 46.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.201 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.991 ' CB ' HG12 ' A' ' 27' ' ' VAL . 3.6 pm0 -149.74 132.14 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.024 -1.048 . . . . 0.0 110.162 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.69 -144.03 3.83 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.847 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.7 p90 -144.67 104.56 4.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.977 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.033 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.05 179.07 4.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 108.753 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.825 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -114.04 125.42 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.765 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -107.46 142.97 36.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 110.014 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -87.15 112.36 21.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.406 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.62 39.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.451 ' OG ' ' HD2' ' A' ' 22' ' ' LYS . 8.5 t -79.54 -50.97 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 0.0 109.392 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 18' ' ' PHE . 4.2 m -148.2 -46.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -136.23 -78.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 8.1 m-20 -137.89 70.39 1.39 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.878 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 5.3 p -127.2 155.95 42.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.632 ' HH2' HG23 ' A' ' 68' ' ' VAL . 47.3 m95 -117.94 98.2 6.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.204 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.825 ' C ' HG23 ' A' ' 12' ' ' VAL . 17.3 mttm -110.87 133.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 0.0 109.711 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.5 Cg_exo -53.35 172.76 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.942 1.761 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.765 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 9.2 ptm 176.03 162.45 0.34 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.601 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 66.6 t-105 -89.3 151.11 22.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.894 HG11 HD22 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -150.85 146.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.147 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.991 HG12 ' CB ' ' A' ' 8' ' ' GLU . 11.1 m -145.29 106.61 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.556 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -78.82 116.39 19.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.465 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.2 mp -104.33 167.27 9.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.675 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.702 ' O ' HD13 ' A' ' 103' ' ' ILE . 5.7 pt-20 -73.67 -17.78 61.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.889 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.1 p30 -101.35 8.73 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 1.106 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 140.22 148.31 5.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.3 mp -94.73 109.01 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -1.166 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 29' ' ' LEU . 7.1 pt-20 -111.12 123.76 50.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 108.856 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.4 p90 -121.26 142.8 49.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -119.5 -151.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.43 -0.794 . . . . 0.0 109.031 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 -39.22 9.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -119.87 -176.04 3.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -43.12 -25.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.024 -1.048 . . . . 0.0 109.567 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -146.57 -53.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' SER . 1.2 t70 62.98 7.67 2.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.453 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' ASP . 5.1 m120 40.6 23.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -164.72 101.49 0.83 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.791 -1.193 . . . . 0.0 110.377 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.5 Cg_exo -51.78 164.07 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.055 1.837 . . . . 0.0 110.702 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 3.1 tppt? -134.52 3.45 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 156.18 134.57 1.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.3 mtt -135.15 138.16 43.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.648 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.5 mt -104.73 125.82 32.9 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HG2' ' OG1' ' A' ' 73' ' ' THR . 53.2 Cg_endo -71.39 130.56 17.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.665 1.577 . . . . 0.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.106 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -74.88 -0.34 18.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.168 -0.957 . . . . 0.0 109.609 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HB2' HG21 ' A' ' 74' ' ' THR . 1.1 mmtp -44.0 -62.28 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.53 57.94 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.7 m -81.21 170.21 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 109.169 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.89 160.52 25.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 55' ' ' LEU . 3.0 tm? -134.72 96.14 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.081 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.634 HG22 ' SG ' ' A' ' 59' ' ' CYS . 85.7 m -90.19 109.36 20.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 55' ' ' LEU . 11.1 p -146.41 142.28 17.29 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.15 -176.11 17.55 Favored 'Cis proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.336 -1.943 . . . . 0.0 110.54 -0.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 56' ' ' THR . 4.8 m -150.28 60.27 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.285 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.532 ' CG ' ' HA ' ' A' ' 64' ' ' LYS . 5.5 tt0 -71.12 124.26 24.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.822 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 1.6 m-20 166.49 -43.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -88.97 -68.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 64' ' ' LYS . . . -81.42 -26.94 49.96 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CG ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 34.41 39.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.452 0.644 . . . . 0.0 110.015 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 ttt-85 -117.99 -137.49 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt -42.51 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.01 . . . . 0.0 109.662 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.61 ' CD1' ' CD ' ' A' ' 89' ' ' ARG . 2.1 m-85 -142.21 111.18 6.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.406 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.632 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -120.66 119.95 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.833 . . . . 0.0 109.653 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.5 p90 -118.14 168.33 10.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.9 pttt -127.91 121.42 29.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 55' ' ' LEU . 9.0 mt -96.1 161.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 108.98 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.555 ' N ' HG22 ' A' ' 54' ' ' THR . 50.4 m -140.27 99.58 3.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.242 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -52.89 155.63 2.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.361 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -41.2 -27.56 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.729 -0.607 . . . . 0.0 109.819 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 73' ' ' THR . 2.0 mmmm -77.63 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.62 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 177.6 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -103.17 72.0 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.076 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 5.7 p-10 -43.51 141.72 1.34 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 109.752 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -127.17 137.73 53.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.09 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 14' ' ' LYS . 40.8 m-85 -93.46 128.95 39.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 1.033 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.8 t80 -129.86 139.44 51.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.558 -0.714 . . . . 0.0 109.366 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.57 ' CB ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.27 119.86 13.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.05 -150.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.819 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -120.27 -26.01 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.054 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -156.18 175.55 13.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 0.0 109.871 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.3 -60.48 3.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.747 . . . . 0.0 110.249 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.072 ' N ' HD13 ' A' ' 86' ' ' LEU . 3.6 tm-20 -46.33 -56.65 5.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.219 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 33.2 tt0 -58.4 -30.52 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.673 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.787 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.926 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.558 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -54.7 -23.26 16.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.06 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.06 -35.75 59.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 109.583 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CE2' HD21 ' A' ' 11' ' ' LEU . 13.0 m95 -76.36 -41.23 48.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.323 -0.861 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -75.37 -28.1 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.797 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.539 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.1 ptm180 -76.83 -30.02 56.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.996 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -90.43 -30.65 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 110.039 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -72.48 -31.22 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.06 . . . . 0.0 108.518 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -85.42 -36.5 20.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -66.82 -47.16 72.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.0 109.096 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.84 -37.16 83.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.876 HG12 HD23 ' A' ' 50' ' ' LEU . 46.6 mt -71.94 -23.9 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.96 -15.04 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 t -95.42 -26.4 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.773 . . . . 0.0 109.337 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.2 tp -76.58 -21.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 51' ' ' LYS . 1.8 mm-40 -67.03 -11.48 57.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.81 5.22 12.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.416 -1.049 . . . . 0.0 109.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.26 -46.4 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.62 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.746 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -128.36 138.43 52.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.66 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.004 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -156.06 133.89 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.253 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.02 -146.13 4.63 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' C ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -131.83 97.03 4.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -1.015 . . . . 0.0 110.053 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.045 HD23 ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -108.65 172.69 6.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 108.57 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.945 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.4 p -117.77 125.3 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.879 -1.138 . . . . 0.0 109.402 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 7.6 mmtp -95.53 159.9 14.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.695 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 15.1 ttpp -85.95 94.45 9.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.67 141.29 3.72 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 17' ' ' VAL . 22.8 t -102.21 108.08 19.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.139 . . . . 0.0 109.534 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 16' ' ' SER . 2.6 p 172.19 -30.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.376 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.72 36.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.323 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.84 68.22 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.371 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.6 p -117.95 169.72 9.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 109.701 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.62 ' HH2' HG23 ' A' ' 68' ' ' VAL . 10.7 m95 -148.09 100.37 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.945 ' C ' HG23 ' A' ' 12' ' ' VAL . 19.1 mttt -118.93 136.35 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.839 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.9 Cg_exo -53.99 176.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.833 1.689 . . . . 0.0 109.975 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 19.5 ptm 176.74 159.96 0.36 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.7 t-105 -89.54 146.69 24.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.32 134.28 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.097 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.4 m -128.72 98.66 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.59 -0.693 . . . . 0.0 109.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.05 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 4.0 pp -77.55 123.62 26.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.09 -1.006 . . . . 0.0 109.081 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 32' ' ' GLY . 2.0 mp -109.35 165.16 11.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.82 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.567 ' O ' HD22 ' A' ' 50' ' ' LEU . 1.9 tm-20 -74.87 -9.28 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 2.5 p30 -112.32 7.92 19.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.925 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.782 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 145.06 147.08 4.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.0 mp -103.15 120.59 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -1.162 . . . . 0.0 109.861 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 2.6 pt-20 -120.07 121.94 39.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.675 ' HB3' HG23 ' A' ' 26' ' ' VAL . 10.6 p90 -125.55 141.24 52.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.096 -1.003 . . . . 0.0 110.405 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.86 -145.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 24' ' ' MET . 2.6 mmtm -99.16 -39.18 8.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.076 -1.015 . . . . 0.0 109.349 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -119.42 -178.27 3.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.269 -0.895 . . . . 0.0 109.09 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 tppt? -43.21 -30.8 0.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 108.708 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.448 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -165.29 72.48 0.18 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.515 -0.741 . . . . 0.0 109.49 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 1.6 t0 -51.39 -18.85 1.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 8.6 t-20 91.48 -18.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -127.69 106.3 20.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 42.6 Cg_endo -68.79 134.39 29.97 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.726 1.618 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -25.74 20.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' C ' ' CZ ' ' A' ' 35' ' ' PHE . . . -165.51 145.01 9.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -128.65 -168.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -1.073 . . . . 0.0 109.407 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.63 HG23 HG22 ' A' ' 73' ' ' THR . 3.5 mt -150.31 111.16 3.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.31 131.29 23.04 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.58 1.52 . . . . 0.0 110.355 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.782 HD13 ' HA2' ' A' ' 32' ' ' GLY . 5.4 mp -84.46 41.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -99.15 -40.07 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.641 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.15 76.22 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.526 ' HB2' HD13 ' A' ' 100' ' ' ILE . 6.2 m -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.276 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -115.02 171.76 7.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.647 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.4 tm? -143.51 119.61 10.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.819 . . . . 0.0 108.895 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 1.043 HG22 ' O ' ' A' ' 58' ' ' PRO . 20.7 m -114.42 139.1 49.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.101 -0.999 . . . . 0.0 110.345 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -150.51 118.06 3.49 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.086 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.043 ' O ' HG22 ' A' ' 56' ' ' THR . 46.2 Cg_endo -70.21 -160.05 1.41 Allowed 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.562 -1.849 . . . . 0.0 110.399 0.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -117.14 -78.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.239 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.806 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -134.12 -159.94 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.033 . . . . 0.0 110.25 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.54 14.24 3.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 21' ' ' TRP . 16.6 m-85 -88.5 86.86 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 88.35 41.92 6.01 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 4.5 pttt -37.72 111.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.85 -0.794 . . . . 0.0 110.042 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER 178.26 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.771 ' SD ' ' HB2' ' A' ' 86' ' ' LEU . 22.4 ptp 171.93 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.678 0.751 . . . . 0.0 109.363 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HA ' ' CB ' ' A' ' 89' ' ' ARG . 2.2 m-85 -60.09 -21.79 61.94 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.94 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.62 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.1 p -94.65 105.85 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -99.93 170.78 8.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.682 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -140.24 103.28 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.682 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 72' ' ' THR . 14.3 mt -90.54 165.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.629 ' CB ' HG22 ' A' ' 54' ' ' THR . 59.1 m -141.52 87.78 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.63 HG22 HG23 ' A' ' 48' ' ' ILE . 1.8 p -47.35 160.2 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 0.0 108.841 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.43 -13.67 14.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.706 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.25 20.45 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.94 29.22 16.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -92.45 98.49 11.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.234 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 5.6 p30 -68.5 135.4 51.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.791 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -140.07 95.69 2.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.398 -0.814 . . . . 0.0 108.837 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -109.72 135.59 50.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 0.0 110.144 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 1.045 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -149.99 159.23 44.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.778 . . . . 0.0 109.361 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -114.04 138.08 50.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -139.49 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.269 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -118.48 -7.82 10.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.897 -1.127 . . . . 0.0 110.056 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -168.11 175.64 6.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -0.963 . . . . 0.0 109.751 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.74 -37.17 67.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 109.236 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.968 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -60.21 -49.18 78.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.043 -1.036 . . . . 0.0 109.712 -179.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -72.96 -33.53 65.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.099 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 1.047 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.43 -39.1 92.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.992 . . . . 0.0 109.411 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.705 ' HA ' HG22 ' A' ' 93' ' ' VAL . 13.5 t0 -78.88 -20.03 50.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -0.994 . . . . 0.0 108.614 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -76.94 -26.87 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.05 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 26.8 m95 -85.52 -37.85 19.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.9 m -71.32 -37.74 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 110.113 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 7.1 ptt180 -80.89 -30.93 35.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.226 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 5.4 t0 -75.06 -41.43 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.914 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.2 mt -75.08 -32.96 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 109.334 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 58.8 t-20 -75.25 -32.05 60.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.5 -45.13 40.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.103 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -58.11 -43.05 86.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.842 . . . . 0.0 109.141 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 96' ' ' ILE . 17.0 mt -70.09 -37.76 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.183 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -72.31 -10.57 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.457 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -38.99 12.03 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 50' ' ' LEU . 4.0 mm -65.32 -40.32 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 51' ' ' LYS . 2.4 mt-10 -68.96 -7.6 36.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.09 11.37 5.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 2.3 mt . . . . . 0 C--N 1.302 -1.46 0 O-C-N 121.401 -1.058 . . . . 0.0 109.114 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.679 ' HG3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.267 0.556 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' A' ' 30' ' ' GLU . 85.9 mt -76.32 -58.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.646 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.739 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.9 tpm_? -133.34 111.89 11.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.941 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.035 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -118.31 132.5 56.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.054 -1.029 . . . . 0.0 109.417 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.42 -147.69 4.97 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.952 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.3 p90 -141.38 96.62 3.02 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.322 -1.105 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.971 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -121.51 176.42 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.907 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -103.06 147.5 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 26.8 mmtt -118.64 179.82 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 3.6 tttt -133.41 64.1 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.616 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -157.39 131.63 2.96 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 12.6 t 169.54 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.134 . . . . 0.0 109.437 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 4.2 p -100.79 -30.75 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 4.8 m-85 -174.73 176.78 2.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 25.0 p-10 -45.61 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 36.9 p -142.95 -176.83 5.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.727 ' CH2' HG23 ' A' ' 68' ' ' VAL . 56.5 m95 -156.13 105.55 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.143 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.907 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -137.6 135.16 18.84 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.495 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.5 Cg_exo -51.65 166.87 0.48 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.954 1.769 . . . . 0.0 110.461 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 13.1 ptm 178.04 165.36 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -0.907 . . . . 0.0 109.729 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.3 t-105 -90.15 145.16 25.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -150.97 135.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.702 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.035 HG12 ' HB3' ' A' ' 8' ' ' GLU . 8.8 m -125.5 103.2 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -82.44 117.11 22.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.947 -1.095 . . . . 0.0 109.972 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 5' ' ' ARG . 2.0 mp -105.35 166.33 10.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.662 ' CG ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -74.45 -17.61 60.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 0.0 109.435 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -97.39 8.47 44.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.727 ' HA2' HD12 ' A' ' 50' ' ' LEU . . . 139.43 152.13 5.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.8 mp -101.27 118.55 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.196 -1.179 . . . . 0.0 109.655 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 17.8 pt-20 -117.97 116.15 26.34 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 26' ' ' VAL . 1.8 p90 -116.12 150.62 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.054 -1.029 . . . . 0.0 110.594 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -128.6 -153.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -41.38 9.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.0 mttt -115.7 -172.26 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 6.1 tppt? -44.85 -25.36 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 109.288 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -154.83 -47.07 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.594 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.8 t70 61.65 11.21 3.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.35 22.52 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.776 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -163.36 111.37 1.0 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.994 -1.066 . . . . 0.0 109.743 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.2 Cg_endo -71.92 133.25 21.32 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.888 1.725 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 2.2 tttt -89.5 -23.24 22.11 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 178.47 151.79 9.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 mtm -137.65 135.57 36.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -1.154 . . . . 0.0 109.743 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.92 137.68 19.58 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 48.4 Cg_endo -71.0 99.16 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.447 1.431 . . . . 0.0 109.832 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -66.74 -4.51 9.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.945 . . . . 0.0 110.528 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 50' ' ' LEU . 3.4 ptmm? -85.45 48.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.544 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . 151.38 -22.35 0.95 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.891 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.586 ' O ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -42.48 146.75 0.31 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.096 -1.238 . . . . 0.0 109.828 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.2 162.75 13.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 56' ' ' THR . 3.0 tm? -117.51 147.19 42.99 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.063 -1.023 . . . . 0.0 108.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 1.07 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 m -149.31 129.45 13.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.924 -1.11 . . . . 0.0 110.086 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.71 126.81 5.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 109.138 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 57' ' ' SER . 25.0 Cg_exo -67.0 -150.46 0.33 Allowed 'Cis proline' 0 C--N 1.309 -1.52 0 C-N-CA 123.148 -1.605 . . . . 0.0 110.903 -1.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' CA ' ' HD3' ' A' ' 70' ' ' LYS . 30.1 p -131.81 -148.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.407 -0.808 . . . . 0.0 109.974 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 173.98 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -91.62 5.03 51.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.437 -0.789 . . . . 0.0 109.601 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -88.74 45.26 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.219 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 160.22 38.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 85.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.381 -1.07 . . . . 0.0 109.518 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -147.96 23.35 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.561 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 12.8 mtt 62.7 159.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.466 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 2.6 m-85 82.43 -28.85 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.561 -0.712 . . . . 0.0 110.47 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.727 HG23 ' CH2' ' A' ' 21' ' ' TRP . 15.0 p -93.11 135.11 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.195 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.808 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -133.4 -176.47 4.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -150.11 118.93 6.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.07 . . . . 0.0 110.292 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 54' ' ' THR . 3.7 mt -96.67 162.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 54' ' ' THR . 90.4 m -127.39 91.43 3.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 108.842 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.877 HG22 HG22 ' A' ' 48' ' ' ILE . 1.4 p -43.21 144.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.474 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.496 ' HB ' ' HA3' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -41.07 -34.7 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.804 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -66.36 -74.9 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.227 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 166.11 35.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.588 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.469 ' O ' HG23 ' A' ' 73' ' ' THR . 1.4 mm-40 -105.78 118.95 37.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 3.2 m-20 -83.31 103.3 12.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.747 ' CE1' HG23 ' A' ' 48' ' ' ILE . 68.1 m80 -89.78 105.31 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.165 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 5.6 m-85 -94.63 117.99 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.705 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -136.86 138.74 41.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 108.623 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.572 ' CG ' ' CG1' ' A' ' 12' ' ' VAL . 8.3 pt20 -118.01 146.27 44.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 -153.05 0.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 109.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -108.31 -2.21 19.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -169.09 169.94 9.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 0.0 109.187 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.601 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 27.6 tp -69.81 -30.81 68.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -56.89 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 108.868 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -69.17 -15.33 63.38 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.178 -0.951 . . . . 0.0 108.74 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 1.046 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.1 ttt180 -68.94 -63.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.818 . . . . 0.0 109.354 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.92 -13.26 62.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.9 25.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.047 -1.033 . . . . 0.0 108.861 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.971 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 1.9 m95 -81.97 -27.91 32.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -75.33 -33.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.164 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 2.5 mmm180 -79.74 -29.95 40.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.61 ' OD1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -74.74 -49.38 21.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.523 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.006 ' O ' HD12 ' A' ' 100' ' ' ILE . 9.8 mt -72.58 -36.6 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.025 -1.047 . . . . 0.0 108.866 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 58.2 t30 -73.28 -26.39 61.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -76.68 -45.22 30.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.867 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.91 -34.02 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.332 -0.855 . . . . 0.0 108.969 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.006 HD12 ' O ' ' A' ' 96' ' ' ILE . 1.3 mt -74.9 -40.84 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 108.826 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 13.9 tptm -73.2 -7.87 53.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.073 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -40.72 9.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.814 ' CG1' HD21 ' A' ' 50' ' ' LEU . 1.2 mm -60.64 -44.01 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 108.805 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 3.1 mt-10 -46.49 -26.23 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.37 -103.29 2.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.543 0 O-C-N 121.375 -1.073 . . . . 0.0 109.218 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.581 HG21 ' OD1' ' A' ' 95' ' ' ASP . 77.2 mt -47.13 -70.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.702 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -101.58 169.12 9.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.786 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.837 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 173.65 132.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.575 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -173.12 -143.68 4.32 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.566 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -124.03 106.97 10.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.933 . . . . 0.0 109.427 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -120.53 178.47 4.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.818 . . . . 0.0 108.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -123.41 122.68 65.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 108.596 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.794 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -104.02 126.62 51.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 109.466 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HG3' ' CD1' ' A' ' 21' ' ' TRP . 19.1 tttt -73.17 99.76 2.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 178.36 48.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 t -98.07 114.5 26.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -1.164 . . . . 0.0 109.56 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 18' ' ' PHE . 5.1 p -167.33 -45.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.53 ' N ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -174.93 48.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.406 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 20.5 m-20 49.56 63.53 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 1.1 p -129.41 161.59 30.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.735 ' CH2' HG21 ' A' ' 68' ' ' VAL . 34.0 m95 -125.64 118.98 26.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.851 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.2 mttt -121.88 130.04 24.91 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.684 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 49.1 Cg_exo -55.04 -179.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.8 1.667 . . . . 0.0 110.119 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.794 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 6.5 ptm 169.29 169.63 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.584 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.7 t-105 -92.46 152.25 19.79 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.741 HG11 ' HB2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -149.66 149.96 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.581 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.837 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.8 m -144.52 112.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.007 HD13 HG13 ' A' ' 96' ' ' ILE . 5.1 mt -78.94 121.66 25.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.449 -0.782 . . . . 0.0 109.095 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.58 HD21 ' CG ' ' A' ' 5' ' ' ARG . 1.1 mp -110.79 156.28 21.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.295 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.539 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.3 tt0 -72.46 -21.97 61.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.872 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' HD11 ' A' ' 103' ' ' ILE . 2.8 m-20 -98.64 10.93 39.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 109.369 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.736 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 146.77 -175.66 26.06 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.512 HD13 ' HB ' ' A' ' 48' ' ' ILE . 1.9 mp -132.47 137.9 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.051 -1.264 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 3.5 pt-20 -144.55 123.44 12.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.299 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CZ ' ' HD3' ' A' ' 13' ' ' LYS . 5.0 p90 -121.65 140.18 52.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -121.69 -148.37 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 109.027 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -60.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.1 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -96.65 -177.14 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 108.727 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.68 -28.39 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 108.612 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -163.01 69.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.452 -0.78 . . . . 0.0 109.387 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 60.6 t0 -48.26 -21.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.7 t-20 91.8 -21.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -118.89 107.03 42.78 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 44.1 Cg_endo -68.86 146.97 67.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.778 1.652 . . . . 0.0 110.826 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 -31.58 9.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.397 -0.814 . . . . 0.0 109.076 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -154.3 143.24 9.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.517 ' C ' HD13 ' A' ' 48' ' ' ILE . 5.8 mtt -133.26 135.74 45.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.644 ' N ' HD13 ' A' ' 48' ' ' ILE . 2.2 mm -95.16 107.94 35.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 109.265 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' A' ' 53' ' ' SER . 46.3 Cg_endo -70.04 118.91 5.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.707 1.605 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.736 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.8 mp -63.29 -9.57 12.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.898 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -71.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 109.84 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' O ' ' CA ' ' A' ' 74' ' ' THR . . . -152.46 71.79 0.28 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -100.53 166.0 11.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.161 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.89 157.32 36.25 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.3 tm? -127.48 102.06 6.71 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 58' ' ' PRO . 19.5 m -89.6 133.45 34.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 0.0 110.009 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -146.6 122.94 5.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.403 -0.811 . . . . 0.0 109.385 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 56' ' ' THR . 49.7 Cg_endo -72.23 -161.88 2.26 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.558 -1.851 . . . . 0.0 110.416 -0.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.769 ' SG ' HG13 ' A' ' 68' ' ' VAL . 21.8 p -103.95 -147.16 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -71.68 -141.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 109.922 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -3.03 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.505 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 68' ' ' VAL . 19.9 m-85 -88.82 -21.13 23.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.509 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.749 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -76.61 -22.81 71.65 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -2.83 31.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.541 -0.976 . . . . 0.0 109.156 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -104.59 -95.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.555 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.489 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 9.4 mtt -94.34 -147.26 0.26 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.645 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 44.2 m-85 -101.79 92.69 4.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 81' ' ' PHE . 3.8 p -135.71 132.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.493 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.731 ' CE1' HD12 ' A' ' 71' ' ' ILE . 3.2 p90 -110.29 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.955 -1.091 . . . . 0.0 109.718 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -124.94 106.12 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.731 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.8 mt -88.48 160.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 74.8 m -133.53 90.69 2.75 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 79' ' ' HIS . 3.3 p -45.3 158.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.062 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -59.89 -14.07 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -86.89 16.81 4.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.58 43.37 4.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' THR . 13.6 tt0 -118.48 118.24 31.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.3 m-20 -70.61 163.3 27.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 73' ' ' THR . 12.3 m-70 -143.98 128.64 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.035 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 14.5 m-85 -91.59 113.42 25.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.858 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 1.7 t80 -128.16 128.19 44.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 110.689 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.576 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -126.91 136.05 51.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -0.827 . . . . 0.0 109.735 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -107.48 -150.84 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 0.0 109.798 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.29 -88.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -106.94 -179.27 3.89 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.59 -0.694 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.029 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -56.08 -58.18 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.69 . . . . 0.0 109.75 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.029 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.1 tp10 -43.46 -70.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.972 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 1.2 tt0 -48.94 -33.71 11.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 93' ' ' VAL . 13.1 ttp180 -56.36 -65.01 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.86 -22.18 9.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.958 . . . . 0.0 109.263 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -70.9 -40.94 71.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.861 ' CE2' HD21 ' A' ' 11' ' ' LEU . 77.8 m95 -73.03 -52.73 13.27 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.507 -0.746 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -65.56 -24.84 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.518 -0.739 . . . . 0.0 110.794 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.552 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.6 ptt85 -85.24 -23.58 28.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.903 -1.123 . . . . 0.0 110.074 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.581 ' OD1' HG21 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -85.61 -38.66 18.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.075 -1.016 . . . . 0.0 109.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.007 HG13 HD13 ' A' ' 28' ' ' LEU . 21.1 mt -76.73 -35.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.102 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.46 -31.76 58.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -72.2 -55.92 6.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 108.983 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.0 67.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 59.2 mt -63.67 -45.27 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.035 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -67.88 -8.87 40.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.7 t -95.1 -35.38 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.68 HD12 HD22 ' A' ' 50' ' ' LEU . 2.2 mt -79.82 -26.68 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.032 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -73.14 -7.65 52.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.22 12.51 5.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 2.5 mt . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.438 -1.037 . . . . 0.0 109.306 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 2.0 mpt_? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.361 0.6 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.6 mm -64.36 -56.8 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.217 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.556 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -132.85 90.61 2.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.981 -1.074 . . . . 0.0 110.414 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.011 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -103.33 128.91 50.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.867 -1.146 . . . . 0.0 109.185 178.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.597 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.43 -149.94 5.68 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.929 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.0 p90 -141.26 97.15 3.11 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -114.19 171.65 7.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.929 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.9 p -102.34 129.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.776 -1.202 . . . . 0.0 109.872 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.574 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -119.75 166.04 13.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.311 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 10.8 ttpt -68.21 121.65 16.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.32 -161.69 2.8 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' VAL . 23.3 t -119.16 -16.61 9.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -1.161 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -46.68 -93.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' H ' HG23 ' A' ' 17' ' ' VAL . 36.6 m-85 -126.67 52.0 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.511 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.0 OUTLIER 59.01 78.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 40.0 p -124.74 -165.79 1.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.779 ' HH2' HG23 ' A' ' 68' ' ' VAL . 2.1 m95 -144.78 104.83 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.929 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.9 mttp -132.65 144.0 51.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -52.21 166.39 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.77 1.647 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.632 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 23.1 ptm -176.51 159.53 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -0.954 . . . . 0.0 109.648 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.6 t-105 -89.81 143.64 26.63 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.654 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.27 150.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.672 -179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.011 HG12 ' CB ' ' A' ' 8' ' ' GLU . 7.6 m -137.52 119.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.873 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.865 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -85.05 105.61 15.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.452 -0.78 . . . . 0.0 108.914 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -96.85 157.92 15.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.0 109.681 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -72.89 -17.5 61.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 109.788 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -101.9 5.86 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 153.29 -171.6 32.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.4 mm -133.05 122.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.383 -1.069 . . . . 0.0 109.283 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 27' ' ' VAL . 6.0 pt-20 -129.12 127.27 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 6.7 p90 -131.09 146.4 52.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.46 -150.31 0.44 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 -32.43 11.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 108.877 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 2.8 tttp -121.05 -179.58 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -45.56 -27.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -166.96 73.36 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.0 109.702 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 24.8 t70 -50.98 -19.04 0.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.996 -1.065 . . . . 0.0 108.172 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 6.3 t-20 90.92 -17.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -132.34 94.55 22.84 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 36' ' ' TYR . 50.7 Cg_exo -49.41 139.0 29.95 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.968 1.779 . . . . 0.0 110.878 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 9.7 mmtt -90.07 -23.02 21.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -164.9 143.8 8.81 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 mtm -134.97 123.87 24.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -1.19 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.77 129.76 41.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.318 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 55.7 Cg_endo -72.51 137.45 27.89 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.687 1.592 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -88.11 23.06 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.612 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 49' ' ' PRO . 12.9 ptpt -91.77 -18.78 23.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.185 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -157.76 -91.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER 56.99 132.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.545 -0.973 . . . . 0.0 110.674 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.567 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.51 167.71 9.85 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -133.73 142.48 47.97 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.027 -1.045 . . . . 0.0 109.025 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.984 ' N ' HD13 ' A' ' 55' ' ' LEU . 52.6 m -130.22 119.88 23.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.891 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.7 t -143.61 120.27 6.6 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.07 -160.92 1.92 Allowed 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.573 -1.844 . . . . 0.0 110.143 -0.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 17.9 p -89.67 -149.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.435 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 18.4 tt0 -110.17 -139.86 0.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.536 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.25 26.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.877 -1.139 . . . . 0.0 109.367 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 1.3 t80 -88.86 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -101.56 -42.3 2.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 7.2 tttt 55.45 19.4 3.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -1.007 . . . . 0.0 109.488 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 9.7 mmm180 -87.09 -144.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mtt -126.62 -4.05 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.11 -0.994 . . . . 0.0 109.85 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' MET . 0.5 OUTLIER -130.08 32.62 4.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.013 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.7 p -128.56 123.49 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.002 -1.062 . . . . 0.0 109.637 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 11.0 p90 -118.79 174.31 6.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -135.06 127.07 29.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.553 HG13 ' CD2' ' A' ' 55' ' ' LEU . 6.6 mt -105.99 163.39 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.567 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 98.0 m -145.13 99.91 3.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.25 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.368 -0.832 . . . . 0.0 109.994 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER 43.46 37.74 1.54 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.935 . . . . 0.0 110.864 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 80.24 45.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 0.0 109.57 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.97 -82.87 0.32 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.028 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.7 OUTLIER -90.17 131.25 36.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.499 -0.75 . . . . 0.0 110.118 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.543 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 9.5 t0 -97.56 145.16 26.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 13' ' ' LYS . 81.3 m-70 -137.72 109.23 6.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -101.39 115.04 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.382 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -143.84 145.98 32.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 109.617 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.503 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 pt20 -116.78 147.01 42.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.51 -0.744 . . . . 0.0 109.052 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -143.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.45 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.91 -60.83 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 110.12 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.28 175.1 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.668 -0.645 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.041 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -45.7 -50.14 13.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.041 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.7 tm-20 -51.63 -57.93 7.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.045 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 92' ' ' TRP . 11.8 tt0 -63.19 -18.04 63.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.977 ' O ' HG13 ' A' ' 93' ' ' VAL . 15.8 ttp180 -72.96 -65.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HA ' HG22 ' A' ' 93' ' ' VAL . 59.3 t0 -65.75 -11.57 46.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.277 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.35 -41.19 22.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.003 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 12.4 m95 -76.68 -31.1 57.05 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.454 -0.779 . . . . 0.0 108.99 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.977 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -70.6 -38.65 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.567 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -78.91 -20.08 50.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.708 ' HB3' HD12 ' A' ' 28' ' ' LEU . 9.5 t70 -77.73 -58.0 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.834 HG13 HD13 ' A' ' 28' ' ' LEU . 1.1 mt -63.6 -35.09 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 108.707 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 35.0 t30 -73.77 -32.54 63.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.91 -57.13 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -51.66 -42.42 62.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.238 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.483 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 45.0 mt -59.68 -50.62 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.314 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -10.89 35.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -93.12 -28.84 16.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.285 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.618 ' CG1' HD23 ' A' ' 50' ' ' LEU . 4.9 mm -78.0 -34.06 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.57 -4.85 33.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.4 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.72 13.02 4.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 106' ' ' LEU . 2.6 mt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.448 -1.031 . . . . 0.0 109.218 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.665 HD11 ' CB ' ' A' ' 30' ' ' GLU . 46.7 mt -92.81 -77.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.97 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -107.5 104.83 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 110.099 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.022 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.2 pm0 -115.65 135.51 53.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.3 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.589 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.73 -146.8 4.65 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.764 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.6 p90 -138.57 97.4 3.34 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.411 -1.052 . . . . 0.0 109.78 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -119.36 146.8 45.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.4 p -76.34 137.68 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.026 -1.047 . . . . 0.0 109.298 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -117.18 165.19 13.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.42 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 2.1 tmtt? -116.31 125.11 51.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.348 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' VAL . . . 164.86 -120.11 0.92 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 51.21 -91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -1.146 . . . . 0.0 109.383 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 18' ' ' PHE . 14.8 m -117.51 -147.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.524 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -42.71 165.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.478 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' PHE . 3.1 m120 -43.53 105.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.376 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -132.29 174.42 10.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.764 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CD1' ' O ' ' A' ' 20' ' ' THR . 3.4 m95 -152.33 106.94 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.619 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.6 mmtt -138.18 138.8 23.8 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.33 151.58 17.4 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.849 1.7 . . . . 0.0 109.922 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.774 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.15 171.07 20.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 110.341 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.774 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.9 t-105 -96.94 145.8 25.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -150.19 139.24 15.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.05 -178.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -129.09 106.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.821 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.022 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.5 pp -86.45 111.91 21.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.992 . . . . 0.0 109.193 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.9 mp -93.29 164.58 13.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.789 . . . . 0.0 109.564 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.665 ' CB ' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -74.99 -15.8 60.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.6 p30 -101.87 10.11 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.339 -0.85 . . . . 0.0 109.169 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.932 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 148.49 -165.15 29.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.682 HG21 HD12 ' A' ' 48' ' ' ILE . 2.9 mt -141.07 141.51 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -1.198 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.691 ' HG2' HD11 ' A' ' 29' ' ' LEU . 12.1 pt-20 -148.12 115.03 6.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.747 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.5 p90 -112.81 148.72 34.24 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 110.792 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -124.62 -156.76 0.74 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -46.42 6.56 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -111.37 -169.22 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -46.5 -24.79 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.793 -1.192 . . . . 0.0 109.024 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -153.52 -50.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.199 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.67 10.08 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.418 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' ASP . 38.8 m-20 41.9 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -156.79 96.17 2.18 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 110.037 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.9 Cg_exo -51.82 171.7 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.054 1.836 . . . . 0.0 110.58 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.49 4.98 2.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.455 -0.778 . . . . 0.0 109.287 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.53 141.68 3.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.52 ' HG2' ' CB ' ' A' ' 34' ' ' GLU . 26.4 mtm -124.41 139.69 53.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 0.0 109.634 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 HG22 ' A' ' 73' ' ' THR . 2.3 mt -101.31 125.85 36.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.075 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.71 131.91 19.34 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.547 1.498 . . . . 0.0 110.08 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.048 HD21 ' HB1' ' A' ' 99' ' ' ALA . 1.5 mp -73.74 -0.03 14.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.699 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.1 OUTLIER -42.14 -88.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.78 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.51 54.99 0.56 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.397 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -66.95 156.25 36.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.246 . . . . 0.0 108.941 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -103.73 171.07 7.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 108.855 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.2 tm? -143.33 114.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.205 -0.934 . . . . 0.0 109.114 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 58' ' ' PRO . 12.4 m -112.89 128.23 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.19 122.18 4.12 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.473 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 56' ' ' THR . 54.7 Cg_endo -72.31 -177.87 19.21 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.603 -1.832 . . . . 0.0 110.199 -0.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.82 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -96.04 -85.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.82 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -152.95 -165.58 2.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -87.28 21.39 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 14' ' ' LYS . 1.6 t80 -89.26 85.7 6.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 88.94 26.89 25.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER -43.81 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.253 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -141.3 132.63 26.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.1 mtp 44.27 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 6.0 m-85 -145.86 108.25 4.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -113.32 138.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.278 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.84 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 33.9 ttpt -141.67 98.8 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 96' ' ' ILE . 7.5 mt -89.38 163.76 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.642 ' CB ' HG22 ' A' ' 54' ' ' THR . 45.6 m -139.35 87.38 2.19 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.63 155.34 0.16 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.238 -0.914 . . . . 0.0 108.905 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.699 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -55.44 -17.51 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.761 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.15 23.74 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 109.85 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 35.27 18.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.887 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.89 94.09 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.8 m-20 -66.32 153.12 43.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -148.68 114.84 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 109.261 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -108.27 124.15 49.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.502 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.49 -176.29 4.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.544 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 4.8 tt0 -150.38 138.1 19.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.842 -1.162 . . . . 0.0 110.025 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.82 -145.8 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -115.52 -11.45 11.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 109.64 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.599 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -170.61 171.3 6.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -55.79 -48.78 74.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 109.474 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -48.62 -60.45 2.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 0.0 109.769 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -61.49 -22.45 65.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.884 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.995 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.68 -63.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.782 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.583 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -66.08 -12.83 58.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.15 -39.06 26.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.112 -0.992 . . . . 0.0 108.868 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.022 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 9.6 m95 -78.1 -29.76 49.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.805 . . . . 0.0 109.028 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.8 m -74.09 -31.27 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.591 -0.693 . . . . 0.0 109.699 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.7 ptp180 -83.5 -23.16 32.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.901 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.608 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -83.31 -54.54 4.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.07 -1.019 . . . . 0.0 109.713 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.606 ' O ' HD13 ' A' ' 100' ' ' ILE . 2.6 mt -65.14 -39.75 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 108.575 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 20.5 t-20 -70.09 -56.59 6.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.89 . . . . 0.0 109.155 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 22.3 tttm -44.17 -49.69 8.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 1.048 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -57.31 -43.92 83.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.643 HD12 ' HG ' ' A' ' 50' ' ' LEU . 1.2 mp -57.63 -58.79 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.7 -10.78 21.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 109.904 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -92.7 -22.78 19.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.313 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.785 HG12 HD23 ' A' ' 50' ' ' LEU . 3.1 mm -84.7 -22.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.987 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 41.0 mt-10 -68.3 -7.8 34.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.85 9.44 5.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 106' ' ' LEU . 5.8 mt . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.288 -1.125 . . . . 0.0 109.16 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.511 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.254 0.549 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.559 ' HB ' HD11 ' A' ' 28' ' ' LEU . 8.3 mm -46.33 -46.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.591 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -137.88 152.48 49.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 109.491 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.018 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -161.6 124.05 3.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.584 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -157.92 -145.7 4.3 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.024 ' C ' HD13 ' A' ' 11' ' ' LEU . 9.7 p90 -143.26 93.45 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.339 -1.094 . . . . 0.0 109.971 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.117 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -115.37 166.53 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.6 p -90.83 135.61 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.797 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.4 OUTLIER -126.98 131.08 51.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.464 -0.773 . . . . 0.0 109.597 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 35.0 tttm -95.47 138.62 32.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 109.423 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.1 -2.49 4.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 3.7 p -76.72 -93.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.552 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.0 p -97.43 109.54 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.344 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-30 59.23 -180.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 28.8 p-10 -82.73 88.79 6.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 21.6 p -132.24 -167.27 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.755 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.637 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.4 m95 -146.4 116.83 7.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 0.0 109.59 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 12' ' ' VAL . 33.4 mttt -148.17 137.38 12.02 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 110.048 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 46.6 Cg_exo -56.3 161.13 9.66 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.937 1.758 . . . . 0.0 109.787 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.797 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 21.6 ptm -171.1 167.36 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 109.798 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.594 ' CD2' ' HA ' ' A' ' 39' ' ' LYS . 54.5 t-105 -88.77 142.61 27.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.773 ' CG1' HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -150.41 132.39 5.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.446 -178.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' A' ' 8' ' ' GLU . 11.4 m -125.15 105.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.592 -0.693 . . . . 0.0 109.285 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 7' ' ' ARG . 1.7 pp -79.6 124.14 28.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.036 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.7 mp -112.15 166.42 11.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.505 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.773 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -72.02 -12.97 61.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.906 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.607 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.1 m-20 -106.07 -2.67 22.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.63 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.9 151.69 5.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.7 mp -98.36 108.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' OE2' ' CD1' ' A' ' 29' ' ' LEU . 4.8 pt-20 -107.22 119.96 40.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.666 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.0 p90 -121.3 144.64 48.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 110.431 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.632 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -121.25 -148.93 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -51.97 3.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 109.174 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -105.13 -177.26 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 108.855 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.11 -40.45 10.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.058 -1.026 . . . . 0.0 108.512 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.466 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -153.43 72.04 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 109.765 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 23.6 t70 -50.15 -20.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 3.7 t30 90.86 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 101.6 51.66 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 53.4 Cg_exo -49.69 142.68 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.888 1.725 . . . . 0.0 111.246 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -98.18 -25.63 14.83 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.39 146.77 5.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.435 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 9.5 mtm -127.31 -174.92 3.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -1.166 . . . . 0.0 109.628 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' THR . 39.3 mt -140.59 127.83 12.22 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.46 84.79 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.494 1.462 . . . . 0.0 110.073 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.991 ' HG ' HG21 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -60.95 -14.2 21.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.412 -0.805 . . . . 0.0 109.201 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.672 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -58.36 -15.41 10.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.9 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -165.68 27.91 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.132 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.423 ' OG ' HG23 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -77.54 168.73 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 0.0 109.348 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -126.67 160.25 31.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.403 -0.81 . . . . 0.0 109.167 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 56' ' ' THR . 2.8 tm? -121.28 149.47 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.042 -1.037 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 1.022 ' N ' HD13 ' A' ' 55' ' ' LEU . 98.9 m -136.42 134.79 38.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 110.052 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 5.4 t -150.38 118.87 3.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.327 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 56' ' ' THR . 53.6 Cg_endo -72.49 -161.86 2.29 Favored 'Cis proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.642 -1.816 . . . . 0.0 110.369 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 18.2 p -96.34 -161.25 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.694 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -67.84 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.867 . . . . 0.0 109.756 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -84.89 15.37 4.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.2 t80 -89.16 -27.13 20.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.918 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.613 ' HA3' HG11 ' A' ' 68' ' ' VAL . . . -103.97 -91.69 2.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 tttt 43.66 27.26 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -1.093 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' GLY . 12.7 mtp180 -124.67 -90.14 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.437 -0.789 . . . . 0.0 109.424 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.7 mmm -81.92 -114.36 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.321 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 84.1 m-85 -130.96 89.99 2.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.824 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HA3' ' A' ' 63' ' ' GLY . 1.6 p -129.62 119.71 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.829 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.707 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.8 p90 -97.8 168.77 10.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.091 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 6.0 ttpt -127.17 117.39 22.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.633 HD11 HG21 ' A' ' 96' ' ' ILE . 2.4 mt -95.5 167.84 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.828 . . . . 0.0 108.872 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.2 m -141.05 92.23 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -42.76 152.09 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 1.2 t -52.15 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.522 -0.736 . . . . 0.0 109.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 158.52 -71.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 164.55 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.93 79.08 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.092 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 1.7 p30 -56.07 144.01 30.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.701 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 42.0 m-70 -137.49 145.26 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.8 m-85 -100.88 137.61 39.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 1.117 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.1 t80 -143.97 123.3 13.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 1.2 tt0 -129.36 120.13 25.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.04 . . . . 0.0 109.879 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -89.98 -146.51 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 -90.05 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -96.22 167.88 10.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.86 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -52.45 -20.33 2.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.819 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.86 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -72.35 -46.7 54.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.731 -179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -73.97 -48.61 29.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.88 -30.5 71.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.004 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 51.2 t0 -75.09 -42.36 56.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.989 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -73.91 -19.69 60.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.698 ' CH2' HG22 ' A' ' 26' ' ' VAL . 3.4 m95 -83.6 -37.15 23.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.393 -0.817 . . . . 0.0 109.048 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.89 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 p -76.84 -31.59 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.789 . . . . 0.0 109.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 13.2 mmm180 -83.83 -24.34 30.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.605 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 33.5 t0 -83.71 -39.7 19.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.975 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.3 mt -71.81 -32.79 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 0.0 108.696 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -84.31 -30.7 25.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.222 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -67.16 -50.97 59.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.949 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -67.25 -32.72 73.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.951 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ILE . 20.6 mt -61.91 -41.26 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.423 -0.798 . . . . 0.0 109.095 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -83.58 -13.46 54.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.62 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.67 -12.24 25.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 109.58 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.991 HG21 ' HG ' ' A' ' 50' ' ' LEU . 5.6 tp -93.43 -14.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 4.0 mt-10 -80.15 -6.63 58.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.511 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.97 8.63 7.17 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.713 ' HG2' HD21 ' A' ' 29' ' ' LEU . 4.1 mtt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.233 0.54 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 30' ' ' GLU . 18.9 mt -90.17 -70.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.597 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.719 ' HB3' HD11 ' A' ' 28' ' ' LEU . 3.3 tpm_? -114.45 121.86 44.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.009 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.4 pm0 -130.21 135.42 48.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.122 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.05 -145.68 4.44 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.999 ' O ' HD13 ' A' ' 11' ' ' LEU . 8.2 p90 -142.26 102.41 4.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -1.06 . . . . 0.0 110.485 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.999 HD13 ' O ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -129.54 150.89 50.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG23 ' N ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -81.17 135.82 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.091 -1.006 . . . . 0.0 108.759 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HG3' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -127.82 84.79 2.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.087 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 34.41 -149.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.259 0.552 . . . . 0.0 110.207 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 20' ' ' THR . . . -145.92 163.35 28.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.6 m -89.22 23.24 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.564 HG22 ' CD2' ' A' ' 18' ' ' PHE . 2.7 p -167.86 118.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.455 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 17' ' ' VAL . 44.9 m-85 60.24 153.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -59.45 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -119.39 152.48 36.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.517 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.626 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -133.6 121.51 22.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.1 -179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.643 ' N ' HG23 ' A' ' 12' ' ' VAL . 11.6 mttm -147.01 142.87 17.49 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.571 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.583 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 41.1 Cg_endo -73.08 130.79 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.094 1.863 . . . . 0.0 110.224 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.787 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -138.53 175.02 9.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.709 ' O ' ' SD ' ' A' ' 24' ' ' MET . 66.1 t-105 -92.27 145.39 24.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -148.87 144.3 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.101 -178.364 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.009 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -137.1 99.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.369 -0.832 . . . . 0.0 109.566 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.878 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -76.22 120.17 21.13 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.237 -0.914 . . . . 0.0 109.231 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.713 HD21 ' HG2' ' A' ' 5' ' ' ARG . 3.8 mp -106.03 167.27 9.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 109.507 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 6' ' ' ILE . 4.8 pt-20 -71.99 -10.85 60.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.75 -2.23 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.618 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.944 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 154.89 147.7 4.77 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -95.93 108.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.585 ' HG2' HD11 ' A' ' 29' ' ' LEU . 23.8 pt-20 -107.82 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.665 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.787 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 1.4 p90 -117.09 150.49 38.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.094 -1.004 . . . . 0.0 109.993 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -127.5 -172.56 2.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.308 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -77.58 -50.04 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.58 -174.28 2.5 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.7 -23.65 0.44 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.932 -1.105 . . . . 0.0 109.415 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.87 -49.59 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.045 . . . . 0.0 109.642 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 2.8 t70 62.26 9.79 3.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 41.46 23.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 110.066 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -165.14 102.22 0.79 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.169 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.6 Cg_exo -52.79 133.23 49.96 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.978 1.785 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.98 -21.96 22.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 175.09 149.0 7.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.793 ' SD ' ' N ' ' A' ' 47' ' ' MET . 0.5 OUTLIER -125.62 169.02 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 73' ' ' THR . 57.1 mt -132.35 134.69 25.24 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.51 121.26 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.38 1.387 . . . . 0.0 110.472 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 ' CA ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -58.51 -39.02 78.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.429 -0.794 . . . . 0.0 109.707 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -101.11 108.27 19.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 125.24 -1.32 8.27 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.499 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 7.6 t -89.89 170.32 10.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.869 -1.371 . . . . 0.0 109.864 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.511 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.16 122.22 13.74 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.303 -0.873 . . . . 0.0 109.438 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.84 HD21 ' CD2' ' A' ' 69' ' ' PHE . 3.2 tm? -88.91 127.19 35.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.457 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 55' ' ' LEU . 3.4 m -117.46 102.24 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.172 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 3.3 m -140.51 135.84 16.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 57' ' ' SER . 58.4 Cg_endo -77.3 176.32 44.25 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.35 -1.938 . . . . 0.0 110.345 -0.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 70' ' ' LYS . 5.0 m -148.59 82.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -98.69 112.93 24.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -177.74 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 109.562 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.0 t80 -89.14 -39.68 13.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 108.329 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -117.14 -39.32 0.81 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER 39.36 72.44 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.859 . . . . 0.0 109.317 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.57 -95.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.738 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.6 mmm -77.1 -122.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 38.6 m-85 -112.71 92.57 4.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.774 -1.204 . . . . 0.0 109.677 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -118.85 126.77 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.34 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.84 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -112.62 176.19 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 3.0 tmmm? -135.78 114.63 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.783 . . . . 0.0 110.238 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -97.78 171.08 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.8 m -145.89 94.16 2.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.163 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.65 HG22 HG23 ' A' ' 48' ' ' ILE . 2.2 p -59.86 153.53 20.68 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.0 109.094 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -44.46 -23.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.223 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER -86.86 31.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 0.0 109.771 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.85 28.43 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.416 ' OE1' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -89.88 92.29 8.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.287 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.572 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 8.3 t70 -58.92 152.76 18.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -142.55 103.04 4.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.572 ' CZ ' ' OD1' ' A' ' 78' ' ' ASP . 10.8 m-85 -95.1 117.69 30.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -131.58 171.26 13.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.104 -0.998 . . . . 0.0 109.263 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 1.3 tt0 -139.22 130.13 26.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.035 -1.041 . . . . 0.0 109.188 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.75 164.66 14.58 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.471 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -97.43 53.37 1.15 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER 166.08 162.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.915 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -88.33 -51.09 5.93 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.925 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -65.19 -29.22 70.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -79.87 -43.28 22.57 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.481 -0.762 . . . . 0.0 109.426 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.679 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -54.49 -55.7 26.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 m-20 -65.83 -25.81 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 108.866 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.19 -24.66 64.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.99 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 11.7 m95 -83.27 -31.71 26.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.5 m -79.44 -23.34 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.395 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.3 mmp_? -86.4 -34.15 20.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 0.0 109.546 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.77 ' HB3' HD11 ' A' ' 28' ' ' LEU . 2.7 t0 -82.98 -41.55 18.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.149 -0.969 . . . . 0.0 109.681 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.878 ' CG1' HD22 ' A' ' 28' ' ' LEU . 4.4 mt -72.88 -35.17 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.293 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 40.6 t30 -81.59 -32.74 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -68.52 -40.31 80.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 109.18 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -70.94 -40.37 72.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.295 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 96' ' ' ILE . 10.9 mt -67.48 -28.95 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.102 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -89.11 -8.75 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -30.8 13.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.656 HG22 ' HG3' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -70.11 -30.03 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 108.791 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.75 -5.98 34.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.06 10.89 5.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 106' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.422 -1.046 . . . . 0.0 109.144 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.477 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.314 0.578 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.3 mt -73.17 -28.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.806 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HB3' ' HG ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -145.28 166.53 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.075 -1.015 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.969 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 178.83 127.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.481 -0.762 . . . . 0.0 109.567 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.593 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.87 -145.6 4.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.981 ' C ' HD13 ' A' ' 11' ' ' LEU . 4.2 p90 -140.43 91.96 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 110.219 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.981 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.9 161.88 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.933 . . . . 0.0 108.677 178.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -85.4 141.74 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.672 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HE2' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -123.21 142.72 50.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.203 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HD2' ' CD1' ' A' ' 80' ' ' PHE . 5.2 tttt -88.17 115.62 25.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.4 93.91 0.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -85.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -1.156 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.67 -19.08 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.96 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB3' ' CE ' ' A' ' 14' ' ' LYS . 50.5 m-80 63.95 100.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 17.4 p -149.18 -170.65 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.162 -0.961 . . . . 0.0 109.697 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.585 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.5 m95 -141.6 105.92 4.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.735 ' C ' HG23 ' A' ' 12' ' ' VAL . 35.5 mttt -146.75 136.62 11.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.47 157.55 6.87 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.915 1.744 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.789 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -168.18 165.92 13.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 110.111 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.748 ' O ' ' SD ' ' A' ' 24' ' ' MET . 62.6 t-105 -90.23 143.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.6 138.57 14.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.935 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.969 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.5 m -126.09 120.23 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.802 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 mt -78.95 120.52 23.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.446 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -115.18 158.55 22.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 6.5 pt-20 -73.02 -9.65 58.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.9 p30 -107.89 -3.4 18.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.126 -0.984 . . . . 0.0 109.482 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.653 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.78 155.54 7.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.072 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.53 107.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.349 -1.089 . . . . 0.0 109.252 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 27' ' ' VAL . 2.7 tp10 -104.7 117.84 35.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.2 p90 -125.59 147.71 49.2 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -123.67 -157.69 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -93.77 -43.6 8.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.163 -0.961 . . . . 0.0 108.471 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -111.88 -176.39 2.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -44.95 -25.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.933 -1.105 . . . . 0.0 109.248 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -149.91 -50.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.551 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.9 t0 61.15 10.82 3.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.868 . . . . 0.0 109.352 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.5 m-80 41.6 23.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.745 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -163.93 115.05 0.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.849 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.6 Cg_endo -71.4 134.7 25.12 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.888 1.726 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -89.75 -20.21 23.84 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 168.48 157.73 11.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' OE1' ' A' ' 34' ' ' GLU . 6.7 mtt -133.11 169.82 16.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -1.06 . . . . 0.0 109.18 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 73' ' ' THR . 56.9 mt -136.78 127.35 16.25 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 39.0 Cg_endo -67.78 124.65 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.252 1.301 . . . . 0.0 109.713 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.902 HD11 ' CG1' ' A' ' 103' ' ' ILE . 1.8 pt? -89.19 23.6 2.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.128 -0.983 . . . . 0.0 109.856 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -66.45 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -101.26 -2.19 54.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -39.56 148.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -1.052 . . . . 0.0 110.512 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -119.03 155.94 30.55 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.005 HD11 ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -124.74 130.54 52.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.931 -1.106 . . . . 0.0 109.301 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 55' ' ' LEU . 90.2 m -121.8 123.38 41.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.709 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -150.49 119.56 3.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 56' ' ' THR . 56.9 Cg_endo -74.04 -175.12 14.62 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.7 -1.791 . . . . 0.0 110.299 -0.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.762 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -102.95 170.11 8.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 109.574 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.762 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 mt-30 -107.66 133.19 52.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 3.7 t0 83.84 -49.42 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 5.7 m-85 -100.38 -32.25 10.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 108.727 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA3' ' H ' ' A' ' 59' ' ' CYS . . . -83.83 0.82 89.38 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -89.51 23.23 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -1.176 . . . . 0.0 109.272 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -143.8 -96.96 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.636 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -158.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 109.763 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 81.6 m-85 -97.53 87.97 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 81' ' ' PHE . 2.1 p -135.18 130.71 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 81' ' ' PHE . 3.7 p90 -100.03 167.5 10.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.304 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -125.63 116.91 22.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.77 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 69' ' ' PHE . 3.4 mt -99.51 165.85 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.635 ' N ' HG22 ' A' ' 54' ' ' THR . 16.7 m -142.16 103.85 4.36 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -53.38 108.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.869 0.843 . . . . 0.0 109.689 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.12 27.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 179.406 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 74' ' ' THR . 1.7 ttpp 80.71 42.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.016 . . . . 0.0 109.412 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -132.01 -78.88 0.51 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.551 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -89.96 133.97 34.49 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.533 -0.729 . . . . 0.0 110.254 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 3.5 p30 -95.2 152.18 18.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.356 -0.84 . . . . 0.0 108.752 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -141.99 104.72 4.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 110.214 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.8 m-85 -93.51 109.0 20.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 108.794 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.938 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -118.43 144.91 45.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.416 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 4.4 tm0? -118.93 133.97 55.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.165 . . . . 0.0 109.827 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.47 -145.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 85' ' ' PHE . . . -103.02 -10.1 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 171.19 174.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.829 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.915 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -47.38 -50.08 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.148 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.915 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.9 tt0 -45.07 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 110.21 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -60.51 -14.48 19.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -71.62 -38.82 70.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HA ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -85.09 -27.93 25.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.58 -29.37 56.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CZ3' HD21 ' A' ' 28' ' ' LEU . 10.4 m95 -84.31 -42.72 15.51 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.005 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.8 p -72.12 -29.27 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 14.4 ptm180 -79.01 -34.9 43.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.818 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 13.4 t70 -75.62 -54.43 7.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.0 109.458 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG1' HD13 ' A' ' 28' ' ' LEU . 7.2 mt -55.34 -35.89 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.028 -1.045 . . . . 0.0 108.738 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 101' ' ' LYS . 15.9 t30 -79.72 -24.69 41.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 108.907 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -63.09 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 108.901 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -56.45 -35.4 67.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 34.4 mt -62.35 -35.86 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 108.796 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 97' ' ' ASN . 1.9 mtmp? -83.97 -8.38 59.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.9 t -93.57 -28.0 16.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.902 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -78.55 -79.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.799 ' N ' HG22 ' A' ' 103' ' ' ILE . 68.6 mt-10 37.38 52.5 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.771 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' O ' HD22 ' A' ' 106' ' ' LEU . . . 74.78 93.0 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.743 0 O-C-N 121.59 -0.947 . . . . 0.0 109.405 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.714 ' HB ' HD12 ' A' ' 28' ' ' LEU . 12.1 mt -67.81 -49.04 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.598 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.991 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -144.4 111.04 5.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 109.67 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.023 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -119.65 132.7 55.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.11 -146.21 4.59 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.857 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.0 p90 -142.68 102.73 4.1 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.523 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -121.03 160.47 23.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.213 -0.929 . . . . 0.0 108.555 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.3 p -86.03 151.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.074 -1.016 . . . . 0.0 109.52 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -140.49 147.72 40.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -0.829 . . . . 0.0 109.853 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HD2' ' NE1' ' A' ' 21' ' ' TRP . 24.4 tttm -117.5 133.67 55.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . 168.41 174.3 37.04 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 58.15 -174.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -1.074 . . . . 0.0 109.204 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 18' ' ' PHE . 6.2 p -42.96 -42.63 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' N ' HG13 ' A' ' 17' ' ' VAL . 12.2 m-85 -39.69 -68.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.919 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 22.03 3.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -108.27 -171.52 1.88 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.663 ' HH2' HG23 ' A' ' 68' ' ' VAL . 14.4 m95 -132.03 82.19 2.01 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 108.675 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' N ' HG23 ' A' ' 12' ' ' VAL . 2.1 mttm -115.6 136.95 22.89 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.036 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.74 156.83 6.15 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.055 1.837 . . . . 0.0 110.16 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.762 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -162.31 170.1 19.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -0.952 . . . . 0.0 109.877 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.762 ' O ' ' SD ' ' A' ' 24' ' ' MET . 73.5 t-105 -97.7 142.61 29.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.652 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.17 135.4 10.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.977 -178.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.023 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -125.93 100.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.409 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -76.89 116.37 17.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.883 . . . . 0.0 109.502 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.7 mp -101.08 161.75 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.59 -13.83 62.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 -1.31 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 0.0 109.854 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 1.001 ' HA2' HD23 ' A' ' 50' ' ' LEU . . . 158.5 140.42 2.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 50' ' ' LEU . 3.6 mp -95.57 121.11 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -1.203 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 29' ' ' LEU . 4.1 pt-20 -120.82 120.74 36.45 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.652 ' HB3' HG23 ' A' ' 26' ' ' VAL . 5.6 p90 -121.95 147.44 46.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.981 -1.074 . . . . 0.0 110.893 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.94 -150.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.091 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.19 -43.46 6.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -108.8 -175.96 2.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.103 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -47.87 -22.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.878 -1.139 . . . . 0.0 109.337 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -148.46 -51.54 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.7 t70 61.81 10.34 3.41 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 42.2 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.112 -0.992 . . . . 0.0 109.954 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.1 t -167.54 109.45 0.61 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.938 -1.101 . . . . 0.0 109.891 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 54.1 Cg_endo -71.61 134.26 23.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.849 1.7 . . . . 0.0 110.557 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.75 -19.4 24.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.22 142.5 5.8 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.422 ' HG3' ' C ' ' A' ' 46' ' ' GLY . 16.7 mtm -136.27 126.96 27.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.155 -1.203 . . . . 0.0 109.533 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.581 HG23 HG22 ' A' ' 73' ' ' THR . 4.7 mt -88.94 136.8 30.2 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 108.8 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 48' ' ' ILE . 55.8 Cg_endo -72.31 140.74 34.23 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.721 1.614 . . . . 0.0 110.504 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.001 HD23 ' HA2' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -74.89 0.13 16.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.438 -0.789 . . . . 0.0 109.493 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -92.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.04 68.81 0.24 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.524 ' HA ' ' N ' ' A' ' 74' ' ' THR . 14.4 m -60.27 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 109.6 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.34 122.32 15.61 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 -179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.784 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -89.07 122.1 32.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.175 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 55' ' ' LEU . 59.7 m -115.26 114.43 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.105 -0.997 . . . . 0.0 109.62 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 66.0 p -145.5 121.36 5.84 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 56' ' ' THR . 55.0 Cg_endo -71.92 175.3 43.23 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.559 -1.851 . . . . 0.0 110.342 -0.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.795 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 9.5 t -90.69 -94.75 0.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.6 mt-30 -141.75 -149.76 0.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.371 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -15.12 8.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.901 . . . . 0.0 108.818 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 -28.98 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -85.36 -14.38 68.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 65' ' ' ARG . 5.4 tttm -84.46 70.5 10.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -1.192 . . . . 0.0 109.579 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 165.17 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.586 ' SD ' ' NE2' ' A' ' 82' ' ' GLN . 2.7 mtt 67.2 -172.82 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 1.3 m-85 -88.15 83.37 6.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.2 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.5 p -127.08 136.27 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.841 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -124.3 178.71 5.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.795 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 3.2 tttp -143.35 107.25 4.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 109.808 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -90.45 170.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 108.987 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.561 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.4 m -145.86 90.87 2.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.581 HG22 HG23 ' A' ' 48' ' ' ILE . 2.4 p -40.44 142.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 109.837 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.55 -29.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 0.0 109.963 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -73.02 -70.77 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.319 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.9 pt20 164.15 38.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.0 99.83 9.37 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 p30 -63.35 152.96 36.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -144.57 96.41 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.727 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -91.15 117.65 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.059 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -135.82 162.53 32.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.956 -1.09 . . . . 0.0 109.587 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 36.5 tt0 -127.77 131.11 49.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.994 -1.066 . . . . 0.0 109.272 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.5 -168.37 2.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.439 -0.788 . . . . 0.0 109.732 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.8 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.13 -179.98 4.1 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 109.473 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.044 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -55.62 -59.45 4.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.609 -0.682 . . . . 0.0 109.602 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.044 ' N ' HD23 ' A' ' 86' ' ' LEU . 12.5 tm-20 -47.31 -67.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.048 . . . . 0.0 110.358 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 54.7 tt0 -52.42 -26.44 12.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -68.47 -63.6 1.03 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.036 . . . . 0.0 109.707 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 3.9 p30 -55.78 -27.84 53.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.27 -35.83 68.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 108.956 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.982 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.25 -41.53 73.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.613 -0.679 . . . . 0.0 110.358 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.784 ' CG2' HD11 ' A' ' 55' ' ' LEU . 5.3 p -76.89 -34.68 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 111.052 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -71.56 -23.55 61.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.768 -1.207 . . . . 0.0 109.323 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.41 -39.36 22.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.472 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.624 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.3 mt -69.82 -37.59 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.4 -26.96 38.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.113 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 3.5 tptp -65.13 -44.95 87.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.935 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -71.62 -35.7 70.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.133 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.904 ' HA ' HD13 ' A' ' 50' ' ' LEU . 46.7 mt -72.72 -19.45 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.258 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.36 -16.24 26.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.53 -29.39 14.39 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.824 ' CG1' HD12 ' A' ' 50' ' ' LEU . 7.9 mm -71.52 -26.24 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 67.9 mt-10 -51.92 -22.53 3.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.59 -104.97 1.7 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.624 0 O-C-N 121.412 -1.051 . . . . 0.0 109.576 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' HB2' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 30' ' ' GLU . 7.5 mt -52.42 -45.98 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.828 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -140.43 145.19 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.857 -179.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.039 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -155.04 132.46 11.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.081 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.46 -147.57 4.88 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.82 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.4 p90 -140.49 93.89 2.67 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.545 -0.973 . . . . 0.0 110.232 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.82 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -118.27 157.08 27.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 108.807 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.672 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -81.49 151.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -132.13 139.87 48.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 14.1 ttpp -84.14 113.92 21.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.375 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.11 167.7 42.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -91.43 -24.84 19.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 3.3 p -46.23 -32.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -177.03 -171.39 0.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.414 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -82.72 85.01 7.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.1 p -127.16 166.0 18.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 20' ' ' THR . 18.1 m95 -150.69 106.82 3.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.672 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -131.73 133.14 23.84 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.23 149.95 20.93 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 109.922 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -159.38 168.3 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.699 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.0 t-105 -92.57 144.22 25.55 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.94 134.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.024 -178.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.5 m -124.07 105.66 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.761 . . . . 0.0 109.396 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.986 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.8 pp -80.74 111.87 17.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.137 -0.977 . . . . 0.0 109.581 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.3 mp -96.98 161.07 14.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.42 -11.23 60.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 4.5 p30 -108.86 2.79 21.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.871 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 150.86 144.57 3.95 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.986 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.6 mm -92.86 130.49 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 110.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 5.5 pt-20 -132.86 113.71 13.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.3 p90 -119.43 147.0 44.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.09 -1.006 . . . . 0.0 110.735 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.572 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -127.92 -150.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.46 -53.54 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.53 -172.62 2.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.6 OUTLIER -54.1 -18.69 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.916 -1.115 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.92 -53.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.1 t0 61.35 9.42 2.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m120 40.5 24.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.221 -0.924 . . . . 0.0 110.071 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.6 t -167.45 122.46 0.84 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.982 -1.074 . . . . 0.0 109.499 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 59.2 Cg_endo -75.56 156.83 40.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.803 1.669 . . . . 0.0 111.276 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 2.8 tptt -119.13 -16.88 9.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -178.68 136.68 2.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.0 mtm -131.41 119.33 21.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -1.137 . . . . 0.0 109.697 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mt -89.77 139.47 27.77 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 38.6 Cg_endo -68.05 148.12 74.95 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.528 1.485 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.943 HD13 ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -85.04 36.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.812 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -167.42 136.6 2.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.995 -1.066 . . . . 0.0 109.927 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 91.07 -36.18 3.69 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 100' ' ' ILE . 2.7 m -42.11 156.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.396 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -123.31 169.89 10.86 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -131.47 124.24 29.75 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.06 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.774 ' N ' HD23 ' A' ' 55' ' ' LEU . 20.4 m -115.97 125.81 53.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -150.2 127.91 5.69 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.588 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' SER . 56.3 Cg_endo -73.96 -178.28 22.12 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.471 -1.887 . . . . 0.0 110.277 -0.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.938 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -150.06 175.1 12.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.662 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.617 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 16.0 tt0 66.84 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -0.795 . . . . 0.0 110.172 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.84 18.61 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.617 ' CE2' ' HG3' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -89.26 -64.25 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -90.84 -21.85 35.15 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 8.0 pttt 40.33 32.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.724 -0.868 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.05 20.71 10.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.583 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 9.8 mtp 58.89 179.32 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' A' ' 66' ' ' MET . 1.8 m-85 81.22 -13.66 0.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.497 -0.752 . . . . 0.0 109.911 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.938 HG22 ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -109.84 135.18 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.979 -1.075 . . . . 0.0 109.423 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.735 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 4.0 p90 -121.36 167.18 13.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 80' ' ' PHE . 19.5 ttpt -129.11 98.03 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.925 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 54' ' ' THR . 20.0 mt -90.9 155.41 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.538 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.569 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 39.9 m -134.61 112.31 10.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.049 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 76' ' ' GLN . 2.7 t -55.83 113.82 1.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 39.29 26.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 111.333 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tptm 80.86 47.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.904 -1.122 . . . . 0.0 109.16 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.593 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -127.77 -83.64 0.6 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.206 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' H ' ' CG2' ' A' ' 73' ' ' THR . 11.0 tt0 -101.21 129.81 47.2 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.662 -0.649 . . . . 0.0 109.441 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.96 171.1 15.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 69.6 m-70 -146.15 96.01 2.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.559 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 22.6 m-85 -93.16 100.22 12.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -0.796 . . . . 0.0 108.887 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.695 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.68 157.62 23.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.394 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 2.4 tt0 -121.19 128.85 52.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.065 -1.022 . . . . 0.0 108.999 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -88.52 -7.66 56.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 83' ' ' ALA . . . 63.05 12.27 5.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.443 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.08 163.37 39.47 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.807 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.034 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -93.35 -48.03 6.61 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.034 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -69.48 -44.32 71.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.52 -0.738 . . . . 0.0 109.281 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.62 -34.65 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.684 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -62.07 -61.63 2.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -37.73 64.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -71.86 -26.79 62.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.084 -1.01 . . . . 0.0 109.773 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.974 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 1.1 m95 -79.84 -31.44 40.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.075 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' LEU . 1.3 p -83.43 -31.55 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.6 ptm180 -77.94 -25.16 48.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.308 -0.87 . . . . 0.0 109.187 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -82.0 -42.5 19.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 100' ' ' ILE . 29.5 mt -72.13 -37.46 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.177 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 62.2 t30 -79.6 -33.81 41.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -67.37 -39.44 85.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.14 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -68.81 -47.45 66.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.32 -0.863 . . . . 0.0 109.091 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.943 ' HA ' HD13 ' A' ' 50' ' ' LEU . 6.9 mt -67.89 -20.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 3.0 mmtp -90.11 -11.29 41.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.351 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.5 m -93.81 -38.16 11.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 108.856 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG1' HD12 ' A' ' 50' ' ' LEU . 2.8 mm -67.91 -29.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.49 -15.9 63.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.13 3.29 26.93 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 106' ' ' LEU . 5.0 mt . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.392 -1.064 . . . . 0.0 109.097 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.859 HG22 ' OD2' ' A' ' 95' ' ' ASP . 33.3 mt -74.43 -49.01 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.99 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -136.79 142.14 42.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.054 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -148.45 137.05 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.398 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.585 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.42 -149.5 5.69 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 1.023 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.1 p90 -140.42 98.25 3.39 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -1.026 . . . . 0.0 110.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.023 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.09 171.91 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 108.621 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.957 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.2 p -102.97 131.54 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.69 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 18.4 ttmt -132.33 168.09 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -63.83 103.97 0.63 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -67.33 -74.01 0.6 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.491 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.3 OUTLIER 175.84 -159.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -1.155 . . . . 0.0 109.316 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 16' ' ' SER . 2.5 p 39.93 94.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.558 -0.714 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.3 m-85 63.0 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.54 HD21 ' HE2' ' A' ' 62' ' ' PHE . 2.2 m120 -47.75 97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -120.38 -177.19 3.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.757 ' CH2' HG23 ' A' ' 68' ' ' VAL . 2.0 m95 -142.9 106.63 4.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.957 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.8 mmtp -130.33 140.84 39.88 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.85 163.85 1.82 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.876 1.717 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.69 ' SD ' ' HB3' ' A' ' 13' ' ' LYS . 17.7 ptm -176.91 159.67 1.75 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.778 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.9 t-105 -90.24 145.28 25.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.49 136.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.297 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.054 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.1 m -127.38 101.68 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.511 -0.743 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.02 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -74.01 119.68 18.56 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -109.11 165.44 11.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.499 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HG3' HD11 ' A' ' 6' ' ' ILE . 2.1 tt0 -73.44 -14.5 61.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.906 ' C ' HD11 ' A' ' 50' ' ' LEU . 5.2 p-10 -105.6 5.88 31.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.379 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 1.045 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 143.58 144.07 4.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.813 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -90.94 107.79 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.285 -1.126 . . . . 0.0 109.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' HD11 ' A' ' 29' ' ' LEU . 11.3 pt-20 -105.22 116.68 32.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 108.769 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.6 p90 -120.21 147.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.82 -152.06 0.5 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.02 -40.75 9.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.9 OUTLIER -112.83 -178.24 3.34 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -43.0 -25.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.069 -1.019 . . . . 0.0 109.54 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.18 -50.63 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.3 t0 62.99 8.42 3.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m120 41.16 23.58 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.8 t -166.51 96.69 0.72 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.1 Cg_exo -53.26 132.35 47.74 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.056 1.837 . . . . 0.0 110.739 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.525 ' HE3' ' CE ' ' A' ' 24' ' ' MET . 3.0 ttpt -89.77 -22.04 22.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.72 145.82 7.88 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 30.4 mtm -124.22 165.82 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 73' ' ' THR . 2.4 mt -132.93 117.7 15.06 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 54.8 Cg_endo -71.07 125.29 11.32 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.682 1.588 . . . . 0.0 109.916 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.045 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -90.2 39.59 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.319 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -89.77 -43.01 10.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.109 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -159.41 42.8 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.495 ' HB2' HD13 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -68.98 179.04 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -1.153 . . . . 0.0 109.562 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.497 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -144.23 108.75 4.86 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.283 -0.886 . . . . 0.0 109.593 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.832 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.1 tm? -89.79 115.65 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.2 m -110.4 119.86 40.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.175 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -144.2 123.88 7.35 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 0.0 109.654 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.487 ' O ' HG22 ' A' ' 56' ' ' THR . 57.5 Cg_endo -74.5 -170.21 7.88 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.648 -1.813 . . . . 0.0 110.171 -0.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 10.3 t -102.64 -105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.279 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.638 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 pt20 162.97 119.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.944 -1.098 . . . . 0.0 109.789 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER 81.27 -40.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.722 . . . . 0.0 110.651 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HE2' HD21 ' A' ' 19' ' ' ASN . 0.1 OUTLIER -90.59 85.8 6.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.934 -1.104 . . . . 0.0 110.001 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.601 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 78.08 20.33 73.09 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 51.1 tptt -53.2 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.242 . . . . 0.0 109.175 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' GLY . 3.4 mtt-85 174.6 -86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.551 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mtp -60.38 -148.91 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.581 -0.699 . . . . 0.0 109.473 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 86' ' ' LEU . 98.4 m-85 -99.9 76.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.757 HG23 ' CH2' ' A' ' 21' ' ' TRP . 1.1 p -122.53 128.23 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.31 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 10.4 p90 -122.95 173.4 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -132.97 122.01 23.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.9 mt -93.62 167.94 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.057 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -146.49 85.86 1.66 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 HG23 ' A' ' 48' ' ' ILE . 5.2 p -44.39 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.569 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.09 63.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.246 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 5.9 mttp -89.76 12.06 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.451 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 72.44 26.28 2.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.4 OUTLIER -89.84 119.55 30.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.13 -0.981 . . . . 0.0 108.998 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 4.4 t0 -89.36 135.92 33.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 89.1 m-70 -130.01 97.12 4.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.405 -0.809 . . . . 0.0 108.97 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 78' ' ' ASP . 1.9 m-85 -90.19 120.49 31.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.28 146.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.217 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.55 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 6.5 pt20 -116.52 145.71 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 108.777 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -92.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.72 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.74 174.94 6.36 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.652 -0.655 . . . . 0.0 109.615 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.958 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -65.16 -41.31 94.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.53 -0.731 . . . . 0.0 109.184 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.958 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -57.48 -67.0 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.701 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.5 -31.73 56.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.716 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.82 -65.13 0.71 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 109.967 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.611 ' HA ' HG23 ' A' ' 93' ' ' VAL . 47.6 m-20 -58.84 -23.76 61.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.902 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.91 -31.96 64.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.015 -1.053 . . . . 0.0 109.507 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.02 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 4.2 m95 -82.57 -39.05 22.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.4 -21.92 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.246 -0.909 . . . . 0.0 109.341 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 10.0 ptp180 -85.3 -29.44 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -84.35 -39.32 19.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.589 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HD22 ' A' ' 28' ' ' LEU . 5.6 mt -72.85 -34.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 108.801 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -80.7 -28.93 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -53.33 17.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.01 -40.67 85.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 108.928 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 44.9 mt -65.06 -33.76 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 108.943 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 8.8 ttpt -78.03 -9.42 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.489 ' SG ' ' HG ' ' A' ' 106' ' ' LEU . 8.8 t -95.13 -32.31 13.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.809 . . . . 0.0 109.141 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 50' ' ' LEU . 3.2 mm -67.74 -33.74 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 15.2 mt-10 -75.01 -2.1 25.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.289 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.74 20.7 2.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.635 -0.921 . . . . 0.0 109.235 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.573 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 30' ' ' GLU . 2.2 mp -67.87 -39.77 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.554 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -131.73 169.55 16.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 109.866 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.916 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 175.09 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 109.676 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.62 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.86 -147.14 5.02 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.962 ' C ' HD13 ' A' ' 11' ' ' LEU . 8.0 p90 -138.96 103.83 4.9 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.975 -1.309 . . . . 0.0 110.902 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.969 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -120.63 158.17 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 0.0 108.546 178.264 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.884 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -86.53 129.78 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.968 -1.083 . . . . 0.0 109.295 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HD2' ' CB ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.97 170.15 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.467 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -116.18 134.83 54.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.82 0.21 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -125.31 -34.02 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -132.31 -84.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 17' ' ' VAL . 4.6 m-85 -133.06 71.8 1.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.61 60.76 3.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 48.7 p -115.83 -165.07 1.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.738 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.3 m95 -149.42 109.01 4.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 0.0 109.668 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.884 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.1 mttm -140.38 143.21 32.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -51.26 156.42 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.987 1.791 . . . . 0.0 110.188 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -160.88 176.65 11.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.759 ' O ' ' SD ' ' A' ' 24' ' ' MET . 68.1 t-105 -109.69 146.16 35.32 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -150.41 147.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.948 -178.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.3 m -130.96 119.32 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -0.969 . . . . 0.0 110.187 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.922 HD21 ' HZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -81.15 124.35 29.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.767 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 mp -119.95 159.94 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.97 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HB3' HD11 ' A' ' 6' ' ' ILE . 8.9 pt-20 -72.88 -22.18 60.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 109.698 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.928 ' C ' HD11 ' A' ' 50' ' ' LEU . 3.2 p30 -96.17 13.07 28.59 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.118 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 1.092 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 137.17 169.77 11.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' MET . 3.6 mp -111.86 112.57 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.126 -1.22 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.767 ' HG2' HD11 ' A' ' 29' ' ' LEU . 16.8 pt-20 -107.83 117.39 34.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 108.637 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.644 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -115.67 148.88 39.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.44 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -130.89 -158.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.11 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 -34.3 14.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.405 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.503 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -123.78 -169.05 1.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 6.9 tppt? -46.4 -25.38 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.909 -1.119 . . . . 0.0 109.011 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -155.25 -48.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.4 t70 60.96 11.14 3.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 48.2 t30 43.62 23.07 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.01 -1.056 . . . . 0.0 109.353 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.7 t -164.4 99.99 0.88 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 51.4 Cg_endo -71.43 144.36 45.25 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.919 1.746 . . . . 0.0 110.704 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -89.65 -22.68 22.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.049 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.621 ' N ' ' CE1' ' A' ' 35' ' ' PHE . . . 172.89 158.49 17.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 3.8 mtt -123.3 -178.71 4.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -1.176 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 73' ' ' THR . 5.8 mt -135.98 116.26 11.38 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 109.279 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.58 122.1 8.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.623 1.549 . . . . 0.0 110.099 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.092 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -73.01 -0.61 14.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.167 -0.958 . . . . 0.0 109.744 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.842 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.2 OUTLIER -43.04 -60.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 70.02 0.18 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.129 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.2 m -82.72 177.32 8.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -1.197 . . . . 0.0 109.146 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -134.19 165.47 25.01 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.746 HD11 ' HB ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.08 124.32 42.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.162 -0.961 . . . . 0.0 108.84 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.681 ' N ' HD23 ' A' ' 55' ' ' LEU . 30.5 m -111.77 119.87 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.738 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 52.4 p -150.5 115.89 3.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 56' ' ' THR . 52.6 Cg_endo -71.6 -172.1 8.4 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.596 -1.835 . . . . 0.0 110.263 -0.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -94.69 -91.75 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.733 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 5.8 pt20 -145.36 -155.68 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.818 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 21.1 2.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.57 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 7.8 t80 -89.84 -57.22 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -112.55 16.31 24.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 20.2 tttm -48.55 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -1.167 . . . . 0.0 109.358 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 177.55 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.0 mtm -64.74 -148.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 77.9 m-85 -100.66 79.92 2.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.967 . . . . 0.0 109.464 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -117.45 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.326 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 93' ' ' VAL . 9.2 p90 -126.63 172.09 10.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.663 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -133.43 116.1 15.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 109.786 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.584 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.0 mt -95.4 162.01 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 64.8 m -131.19 92.68 3.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.591 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -57.54 150.3 19.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 108.839 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.842 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -43.2 -26.04 0.15 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.508 -0.745 . . . . 0.0 109.846 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -88.28 35.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.554 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 43.87 31.02 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.743 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -89.64 87.46 7.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 7.7 m-20 -58.17 143.92 42.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.829 . . . . 0.0 110.148 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.62 106.11 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -101.68 111.3 23.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.65 147.71 36.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 0.0 109.181 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -114.12 141.53 47.36 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.162 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.71 -147.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.78 -75.13 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -114.43 179.31 3.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.401 0.619 . . . . 0.0 109.482 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.55 -57.17 13.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.586 -0.696 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.862 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -50.77 -51.02 54.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.589 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 60.8 tt0 -65.37 -24.85 67.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.029 . . . . 0.0 109.662 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.23 -66.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.805 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.576 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 14.5 m-20 -59.29 -32.21 69.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.51 84.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.969 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.1 m95 -71.79 -56.77 5.16 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -0.937 . . . . 0.0 108.586 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.35 -13.65 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.542 -0.724 . . . . 0.0 109.152 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -80.48 -36.01 33.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 0.0 109.558 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.78 -27.19 25.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.06 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.891 ' CG1' HD13 ' A' ' 28' ' ' LEU . 4.8 mt -77.91 -36.9 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.929 -1.107 . . . . 0.0 108.957 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -84.94 -37.24 20.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.172 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.31 -49.74 52.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 0.0 108.971 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.47 95.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.107 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.653 ' CG1' HD23 ' A' ' 50' ' ' LEU . 22.5 mt -62.04 -39.13 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 108.752 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -79.32 -9.86 59.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.52 -20.08 19.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.409 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 50' ' ' LEU . 3.2 tp -88.5 -16.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.18 -12.95 61.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.62 4.86 19.24 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.075 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.53 -61.52 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.972 . . . . 0.0 109.779 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.981 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -166.48 130.43 2.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.063 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.61 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.31 -148.97 5.33 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.939 ' C ' HD13 ' A' ' 11' ' ' LEU . 13.4 p90 -135.99 89.99 2.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.126 -1.22 . . . . 0.0 110.635 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.939 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -111.46 158.99 18.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 108.758 178.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -83.58 132.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 2.0 tttt -119.1 157.29 28.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -100.34 98.57 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.532 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 80.22 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.96 -42.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -1.117 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 17' ' ' VAL . 10.8 p -179.35 106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 17' ' ' VAL . 5.3 m-85 56.82 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' PHE . 4.4 m120 -43.06 106.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.105 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 1.2 p -148.91 146.79 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.811 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.3 m0 -126.94 113.78 16.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.661 ' C ' HG23 ' A' ' 12' ' ' VAL . 1.5 mmtp -138.61 135.93 18.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.027 -1.046 . . . . 0.0 110.035 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.4 Cg_exo -53.99 152.76 22.68 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.914 1.743 . . . . 0.0 109.882 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.766 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -163.39 168.03 20.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.976 -1.078 . . . . 0.0 109.89 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.766 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.2 t-105 -96.06 143.79 26.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.694 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.61 139.82 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.236 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . 5.7 m -125.94 113.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.045 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -85.82 102.89 14.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 108.964 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 5' ' ' ARG . 1.8 mp -89.51 155.78 19.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.192 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.2 tt0 -70.27 -19.3 63.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.324 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.26 4.91 31.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.989 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 164.21 -179.96 38.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm -137.0 119.42 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -1.153 . . . . 0.0 109.422 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.2 pt-20 -127.51 117.24 21.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 108.87 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.694 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.2 p90 -120.96 147.1 45.93 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.903 -1.123 . . . . 0.0 110.347 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.644 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.96 172.75 12.91 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -61.14 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.033 . . . . 0.0 109.288 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.3 mmtt -78.87 -168.76 1.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.985 . . . . 0.0 108.757 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 7.6 mtpt -77.61 5.69 8.68 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.89 -43.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 109.125 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 43' ' ' SER . 13.2 t0 48.61 18.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.304 -0.872 . . . . 0.0 109.541 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' SER . 59.9 t30 40.65 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.9 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t 178.05 112.83 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.626 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.7 Cg_endo -71.55 142.53 40.54 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.83 1.686 . . . . 0.0 110.638 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.3 -5.45 57.54 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -179.33 129.2 1.33 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.4 mtm -126.69 127.45 45.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -1.207 . . . . 0.0 109.978 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.693 HG23 HG22 ' A' ' 73' ' ' THR . 2.7 mt -94.59 131.81 30.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 151.63 55.86 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.784 1.656 . . . . 0.0 110.626 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.033 HD12 HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -90.95 5.26 49.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -0.865 . . . . 0.0 109.202 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.627 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.43 -72.15 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.125 -0.985 . . . . 0.0 109.689 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.29 74.83 0.17 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB3' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -78.79 -179.7 6.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -1.191 . . . . 0.0 109.382 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.493 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -133.55 107.77 8.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.326 -0.859 . . . . 0.0 109.673 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -89.65 117.71 28.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.324 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.909 ' N ' HD22 ' A' ' 55' ' ' LEU . 8.6 m -106.52 131.95 53.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -142.95 125.22 8.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.286 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.727 ' O ' HG22 ' A' ' 56' ' ' THR . 55.7 Cg_endo -73.25 -161.78 2.38 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.479 -1.884 . . . . 0.0 110.337 -0.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.4 p -104.43 -148.02 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.568 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.525 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.1 pt20 -89.78 -149.84 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.68 19.75 2.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.188 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.03 84.41 6.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.169 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 107.97 -55.91 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 63' ' ' GLY . 3.8 tttt 42.37 26.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.423 -1.045 . . . . 0.0 109.788 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 67' ' ' PHE . 19.4 mtp180 -88.01 16.56 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.295 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.514 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 19.3 mtm 65.8 8.74 5.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 65' ' ' ARG . 1.5 m-85 -135.45 28.29 3.36 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 62' ' ' PHE . 2.5 p -127.18 127.13 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -0.999 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.733 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.51 166.44 10.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 109.884 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 15.8 ttpt -134.88 105.45 6.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.883 . . . . 0.0 109.134 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 96' ' ' ILE . 2.7 mt -89.63 165.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.5 m -144.58 93.27 2.4 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 48' ' ' ILE . 1.6 p -47.88 153.44 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 109.408 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.627 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.7 87.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.655 . . . . 0.0 109.655 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER 158.59 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.9 pt20 178.59 31.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.625 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 10.0 mt-30 -97.12 105.67 17.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 108.758 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.584 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 11.9 p30 -82.85 144.1 30.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.012 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 94.5 m-70 -139.76 91.78 2.5 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -93.54 128.35 39.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.044 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.733 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -145.52 141.91 28.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 3.0 tt0 -110.08 143.82 39.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.14 -146.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.754 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -102.38 -18.65 15.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.627 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -166.9 172.13 10.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.561 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 tp -56.28 -39.94 73.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 109.831 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.16 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 21.5 tt0 -63.68 -16.19 60.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.437 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 1.05 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -72.03 -64.12 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.612 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -66.13 -15.63 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.603 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.39 -40.67 29.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 109.012 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.0 m95 -77.97 -26.91 48.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.05 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.0 m -77.43 -32.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 7.3 ptp180 -80.44 -23.85 39.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.544 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.774 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.1 t70 -85.01 -46.87 10.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.016 -1.052 . . . . 0.0 109.706 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.651 HG21 HD11 ' A' ' 71' ' ' ILE . 5.8 mt -70.05 -30.56 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.072 -1.018 . . . . 0.0 109.141 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 55' ' ' LEU . 7.8 t30 -84.65 -37.62 20.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.255 -0.903 . . . . 0.0 109.707 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 2.6 tppt? -69.92 -29.49 66.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.13 -28.71 32.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 53' ' ' SER . 31.1 mt -77.9 -30.05 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -16.69 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -95.77 -26.57 15.62 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.572 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 1.033 HG21 HD12 ' A' ' 50' ' ' LEU . 8.4 tp -73.33 -25.48 21.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -0.93 . . . . 0.0 109.62 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -50.96 -22.64 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 108.965 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -120.59 -104.5 1.98 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 O-C-N 121.408 -1.054 . . . . 0.0 109.594 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 6' ' ' ILE . 1.5 mp -64.6 -49.04 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.609 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -119.17 147.17 44.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.987 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.007 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 -163.57 122.24 1.98 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.267 -0.895 . . . . 0.0 109.217 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.598 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.19 -145.71 4.42 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.0 p90 -135.48 93.33 2.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.018 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -105.19 161.29 14.39 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -92.65 146.87 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.866 -1.146 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -134.74 150.18 50.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.757 . . . . 0.0 109.224 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 4.1 ttpp -62.11 140.33 58.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.0 158.02 20.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 55.63 2.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.59 -90.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.497 ' H ' HG23 ' A' ' 17' ' ' VAL . 80.3 m-85 -131.91 55.54 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 39.9 t-20 60.31 85.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 38.0 p -138.01 174.01 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.935 . . . . 0.0 109.718 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 80' ' ' PHE . 15.6 m95 -150.2 100.66 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 108.941 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.9 mttm -123.21 145.02 45.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.146 -0.971 . . . . 0.0 110.093 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -53.05 166.01 1.1 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.129 1.886 . . . . 0.0 110.507 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.757 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -173.32 169.33 4.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.276 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.757 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.8 t-105 -89.81 141.39 28.67 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.113 -0.992 . . . . 0.0 108.651 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.2 p -151.53 129.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.964 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.007 HG12 ' CB ' ' A' ' 8' ' ' GLU . 6.2 m -125.37 111.98 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.786 . . . . 0.0 109.568 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.725 HD11 ' OD1' ' A' ' 95' ' ' ASP . 2.6 pp -86.6 113.71 22.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.038 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.596 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -92.93 157.75 16.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.61 -21.42 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.685 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -104.59 13.31 31.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.813 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 157.49 -169.12 34.37 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 3.7 mp -149.63 131.64 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -1.182 . . . . 0.0 109.59 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' HD11 ' A' ' 29' ' ' LEU . 2.8 pt-20 -142.0 122.68 14.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.672 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.8 p90 -120.87 144.4 48.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.19 -155.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -92.28 -50.38 5.69 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.48 -174.26 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.41 -26.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.025 -1.047 . . . . 0.0 109.507 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 1.4 m -150.69 -48.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.348 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 3.4 t0 67.48 -6.58 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.725 -0.609 . . . . 0.0 110.589 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m-20 79.25 -40.57 0.24 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.292 -0.88 . . . . 0.0 110.122 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.1 119.12 35.3 Favored Pre-proline 0 C--N 1.31 -1.129 0 O-C-N 120.918 -1.114 . . . . 0.0 109.987 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 58.7 Cg_endo -74.96 145.26 31.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.799 1.666 . . . . 0.0 110.436 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.18 -32.32 16.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 108.991 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -155.49 138.2 5.95 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.5 mtp -130.59 118.53 21.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -1.121 . . . . 0.0 109.709 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.732 HG23 HG22 ' A' ' 73' ' ' THR . 2.6 mp -89.88 128.99 47.99 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.34 146.65 51.16 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.816 1.677 . . . . 0.0 110.508 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 ' CG1' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -86.98 34.91 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.52 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 74' ' ' THR . 36.3 mtmt -84.91 -82.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -150.01 62.89 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -66.61 -176.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -1.187 . . . . 0.0 109.458 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -136.94 113.36 10.03 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.4 tm? -88.61 118.63 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.412 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 58' ' ' PRO . 7.8 m -109.96 129.56 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.67 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 3.5 m -150.36 121.5 3.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.812 . . . . 0.0 109.251 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 56' ' ' THR . 51.8 Cg_endo -71.8 -170.86 7.31 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.619 -1.826 . . . . 0.0 110.277 -0.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 1.7 t -100.3 -99.56 0.24 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.722 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -143.34 -147.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.997 -1.064 . . . . 0.0 109.756 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 24.5 m-20 -45.36 -22.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -0.996 . . . . 0.0 109.312 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 4.7 m-85 -89.86 -46.17 8.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.021 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.763 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -75.34 1.34 57.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 10.2 pttm -71.95 -9.23 58.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -1.199 . . . . 0.0 109.57 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 mtt180 -147.6 173.76 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ARG . 42.9 mtm 48.97 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.645 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 16.3 m-85 -98.15 65.09 1.7 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG13 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -108.14 124.11 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.682 -0.637 . . . . 0.0 109.338 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.76 177.03 5.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.784 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 5.0 ttpp -141.7 103.8 4.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.65 ' CD1' HG21 ' A' ' 96' ' ' ILE . 6.4 mt -89.41 168.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.089 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.2 m -143.73 88.75 2.01 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -45.01 150.25 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.49 87.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.659 -0.65 . . . . 0.0 109.623 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 159.43 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 5.5 pt20 170.59 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.379 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -100.83 84.84 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.146 -0.971 . . . . 0.0 109.066 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.546 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 7.1 p30 -65.91 138.01 57.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.397 -0.814 . . . . 0.0 109.93 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 54.7 m-70 -132.23 99.61 4.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 108.933 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -94.56 124.31 38.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 109.944 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.816 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.21 142.88 24.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.965 . . . . 0.0 109.179 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 2.5 tt0 -108.15 136.42 47.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -91.7 -148.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.5 -90.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.242 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.91 177.65 4.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.071 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 24.7 tp -59.07 -25.42 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.114 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -63.81 1.0 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.331 -0.855 . . . . 0.0 109.2 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.91 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -64.58 -67.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 109.398 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 93' ' ' VAL . 16.9 t0 -60.71 -14.61 22.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.074 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.74 43.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CE2' HD21 ' A' ' 11' ' ' LEU . 6.2 m95 -78.95 -33.17 45.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.8 m -72.19 -33.89 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.729 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -82.68 -22.76 34.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.725 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -80.01 -49.98 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.053 ' O ' HD12 ' A' ' 100' ' ' ILE . 25.1 mt -68.85 -41.56 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.349 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -72.38 -29.72 64.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 12.1 tttm -70.67 -44.41 67.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -63.97 -44.14 93.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.053 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.2 mt -64.98 -36.12 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.301 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -12.65 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.294 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.37 -25.98 16.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.855 ' CG1' HD12 ' A' ' 50' ' ' LEU . 8.1 mm -81.69 -25.21 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.3 mt-10 -69.06 -6.99 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.29 9.08 7.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.354 -1.086 . . . . 0.0 109.302 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.566 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HB ' HD12 ' A' ' 28' ' ' LEU . 19.8 mm -84.88 -42.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.949 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.973 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -150.57 104.29 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.045 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.4 pm0 -113.98 136.77 52.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 109.763 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.581 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.31 -146.69 4.8 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.789 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.8 p90 -141.8 95.81 2.87 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.317 -1.108 . . . . 0.0 109.961 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.803 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -115.77 156.3 26.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 108.748 179.172 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -84.04 130.51 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.479 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 28.6 ttmt -131.29 164.53 25.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.302 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -113.48 138.01 50.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.004 . . . . 0.0 109.735 -179.77 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 161.61 117.08 0.42 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 164.53 -94.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -1.113 . . . . 0.0 109.442 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.822 HG23 ' CD2' ' A' ' 18' ' ' PHE . 13.8 m -98.94 -21.9 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.822 ' CD2' HG23 ' A' ' 17' ' ' VAL . 37.6 p90 -179.92 179.97 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.801 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -53.33 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.854 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.793 HG22 ' CZ ' ' A' ' 18' ' ' PHE . 65.8 p -113.92 151.87 31.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 108.649 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.0 m95 -128.56 113.52 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.762 -1.211 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.824 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -150.43 138.05 11.94 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.67 147.52 23.84 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.716 1.61 . . . . 0.0 109.812 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.726 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.74 167.65 28.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.01 . . . . 0.0 110.012 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.726 ' O ' ' SD ' ' A' ' 24' ' ' MET . 64.6 t-105 -89.79 143.35 26.87 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.86 127.29 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.177 -178.814 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -117.53 101.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.195 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.976 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 pp -81.78 109.81 16.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.1 mp -94.84 161.78 14.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.391 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.692 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 4.2 pt-20 -72.29 -16.77 61.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.973 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.68 7.12 34.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.015 . . . . 0.0 109.441 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 151.6 154.5 6.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 50' ' ' LEU . 2.6 mp -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -1.195 . . . . 0.0 109.877 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 12.3 pt-20 -127.3 113.79 16.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.5 p90 -117.81 147.97 42.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -131.3 -158.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -43.95 9.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 108.534 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.8 mmtt -107.31 -171.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -52.92 -19.61 2.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.195 . . . . 0.0 109.358 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -150.68 -49.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.955 . . . . 0.0 109.489 179.552 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.8 t0 62.0 10.55 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.445 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 33.9 t30 41.69 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.944 . . . . 0.0 109.906 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -168.57 110.13 0.53 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.811 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.4 Cg_endo -71.74 135.4 25.82 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.879 1.719 . . . . 0.0 110.545 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.1 ttpt -89.42 -23.66 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -170.86 148.08 11.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.443 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 5.0 mtm -137.21 128.98 28.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 71' ' ' ILE . 2.8 mt -91.08 109.66 36.85 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' O ' ' OG ' ' A' ' 53' ' ' SER . 50.6 Cg_endo -70.21 125.19 11.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.81 1.673 . . . . 0.0 110.348 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 103' ' ' ILE . 3.1 mp -74.71 -2.79 27.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -44.98 -58.36 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 109.306 179.801 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -162.84 72.45 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -96.73 -175.47 3.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -1.131 . . . . 0.0 109.74 -179.88 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.72 108.06 5.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.377 -0.827 . . . . 0.0 109.551 -179.235 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.7 tm? -89.47 113.24 24.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 109.715 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.562 ' N ' HD22 ' A' ' 55' ' ' LEU . 31.1 m -104.52 113.05 26.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.925 ' HB2' HG21 ' A' ' 93' ' ' VAL . 1.6 t -143.44 139.38 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.422 -0.799 . . . . 0.0 109.532 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 60.0 Cg_endo -78.11 -179.58 27.56 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.277 -1.968 . . . . 0.0 110.503 -0.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.71 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -127.9 137.76 52.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 108.93 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -141.71 90.33 2.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 0.0 109.718 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 2.3 p-10 179.53 -32.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 109.161 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -88.57 -45.38 9.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -113.41 -24.63 4.66 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 178.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 10.9 ttmt 38.49 43.05 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.79 0.805 . . . . 0.0 109.499 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' MET . 6.4 mtt85 -136.24 18.5 3.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 108.892 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.546 ' C ' ' CG ' ' A' ' 67' ' ' PHE . 53.0 mtt 64.37 159.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.506 -0.746 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER 71.81 15.57 5.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.71 HG22 ' SG ' ' A' ' 59' ' ' CYS . 1.9 p -121.26 124.09 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.0 167.05 10.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.392 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 3.0 ptmt -142.86 109.58 5.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.175 -0.953 . . . . 0.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 48' ' ' ILE . 36.2 mt -91.15 166.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.1 m -143.78 86.5 1.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 48' ' ' ILE . 3.0 p -49.54 163.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -20.15 21.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -89.07 26.11 1.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.17 30.01 13.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.9 OUTLIER -89.64 102.23 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.637 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.0 m-20 -77.22 145.97 37.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -143.14 109.96 5.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 1.5 m-85 -107.37 120.79 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -137.54 139.01 40.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 178.722 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 83' ' ' ALA . 1.5 tt0 -105.7 145.4 31.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 0.0 109.32 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.5 -166.93 1.72 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.146 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -86.48 -18.85 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.617 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -160.83 169.83 21.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.632 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.043 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.4 -54.77 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.043 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -43.21 -53.53 5.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.1 tt0 -65.5 -32.16 73.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.958 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -67.26 -26.13 66.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.97 . . . . 0.0 109.767 -179.696 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 3.4 t0 -83.32 -42.2 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . . . -70.01 -22.45 63.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.976 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.2 m95 -83.86 -39.09 20.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 57' ' ' SER . 2.5 p -76.39 -26.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.765 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -82.87 -31.12 28.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -75.45 -53.34 8.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.876 HG13 HD22 ' A' ' 28' ' ' LEU . 22.9 mt -62.69 -32.51 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.222 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 13.1 t30 -79.89 -26.62 40.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.317 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -69.68 -53.57 17.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -62.02 -37.98 86.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.252 -0.905 . . . . 0.0 109.185 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ILE . 26.5 mt -62.64 -38.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.019 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -80.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.581 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 13.5 t -95.32 -18.6 20.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.395 -0.815 . . . . 0.0 109.152 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 50' ' ' LEU . 7.6 mm -90.59 -27.62 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.127 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.2 mt-10 -75.66 -3.41 34.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.36 12.91 5.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.457 -1.025 . . . . 0.0 109.378 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.715 ' HD3' HG11 ' A' ' 27' ' ' VAL . 3.5 mtt85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 30' ' ' GLU . 43.4 mt -63.76 -56.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 109.431 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.905 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.32 148.22 46.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.993 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -161.61 135.84 6.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.384 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.594 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.45 -147.44 4.97 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.967 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.0 p90 -139.18 98.17 3.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.464 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.967 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -118.94 159.07 24.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 108.863 179.56 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.795 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.7 p -86.77 125.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.119 -0.988 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 4.6 tppp? -113.49 145.95 40.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 109.208 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.54 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 9.2 tttt -64.36 150.16 46.82 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.311 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 101.51 -135.8 12.39 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 5.2 t 74.85 0.1 3.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.568 HG13 ' H ' ' A' ' 18' ' ' PHE . 2.6 p 175.48 -52.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.568 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -168.2 73.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.143 -0.973 . . . . 0.0 109.751 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m120 48.23 44.95 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.5 ' OG1' ' CG1' ' A' ' 17' ' ' VAL . 1.5 p -101.86 -166.16 1.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.622 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.4 m95 -141.32 109.34 5.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.007 -1.058 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.795 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -148.93 145.96 20.68 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 0.0 109.563 179.904 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.98 160.06 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.019 1.813 . . . . 0.0 109.923 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.745 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -169.38 166.43 10.4 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.802 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.745 ' O ' ' SD ' ' A' ' 24' ' ' MET . 63.3 t-105 -91.32 142.11 28.06 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.97 130.57 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.119 -178.952 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.993 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.8 m -121.13 113.16 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.489 -0.757 . . . . 0.0 109.556 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.924 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.8 pp -86.32 117.9 25.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.955 . . . . 0.0 109.081 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.5 mp -104.95 162.32 13.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.51 -0.744 . . . . 0.0 109.861 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.3 pt-20 -73.66 -7.43 51.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.431 -0.793 . . . . 0.0 110.366 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -115.1 0.87 13.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.093 -1.004 . . . . 0.0 109.419 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.84 165.83 14.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.858 HG23 ' HA ' ' A' ' 28' ' ' LEU . 6.9 mm -112.92 126.46 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.359 -1.083 . . . . 0.0 110.468 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' HG23 ' A' ' 27' ' ' VAL . 6.4 pt-20 -125.71 112.2 15.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.662 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 4.1 p90 -118.2 143.65 46.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.004 -1.06 . . . . 0.0 110.655 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.623 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -125.22 -150.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.98 -49.46 5.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.74 -175.83 2.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 108.833 179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 1.0 OUTLIER -49.51 -21.84 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.407 -179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -148.08 -51.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.4 t70 59.13 10.97 1.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.933 . . . . 0.0 109.333 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.7 m-80 39.63 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.375 -0.828 . . . . 0.0 110.174 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.0 t -166.04 118.91 0.85 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.764 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 57.7 Cg_endo -74.7 147.89 36.0 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.626 1.55 . . . . 0.0 111.096 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -101.64 -30.21 11.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.72 152.76 12.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 mtt -135.17 138.65 43.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 109.559 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.652 HG22 ' HB2' ' A' ' 53' ' ' SER . 8.6 mt -104.57 134.18 19.8 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 108.732 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' CD ' ' OG1' ' A' ' 73' ' ' THR . 36.4 Cg_endo -66.12 137.53 48.5 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.492 1.462 . . . . 0.0 110.474 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.747 ' HB3' HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.15 -6.32 59.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.276 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 48.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.022 -1.049 . . . . 0.0 109.895 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 175.22 -40.2 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.034 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB2' HG22 ' A' ' 48' ' ' ILE . 3.4 t -42.28 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 110.174 -179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.91 170.15 11.38 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.064 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -130.97 148.5 52.74 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.97 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 1.064 ' N ' HD13 ' A' ' 55' ' ' LEU . 21.3 m -145.17 137.28 25.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 108.941 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' PRO . 32.7 t -138.89 122.75 11.18 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 57' ' ' SER . 59.5 Cg_endo -75.62 -94.89 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.709 -1.788 . . . . 0.0 110.095 -0.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.8 p -143.69 -147.12 0.2 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.397 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.526 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -93.99 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.789 -179.76 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.99 18.67 2.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.217 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.4 t80 -89.11 -26.4 21.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.195 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.623 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -143.84 12.33 2.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 28.6 tttt -49.06 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 169.53 -91.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.462 -0.774 . . . . 0.0 109.191 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.9 mmm -61.5 -141.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 9.7 m-85 -107.42 76.11 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.461 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 63' ' ' GLY . 1.3 p -113.75 122.84 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -105.83 168.94 8.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.902 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 7.8 ttpt -128.53 134.92 48.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.077 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 69' ' ' PHE . 1.8 mt -124.97 169.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 54' ' ' THR . 74.1 m -147.81 110.99 4.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -0.975 . . . . 0.0 110.12 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 73' ' ' THR . 5.8 t -58.08 113.37 1.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.017 . . . . 0.0 110.235 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 40.74 24.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.772 . . . . 0.0 111.042 179.266 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 81.77 45.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.102 . . . . 0.0 109.19 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -126.5 -85.31 0.61 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 -179.785 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.644 ' H ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER -94.16 146.22 24.14 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.641 -0.662 . . . . 0.0 109.649 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 68.3 m-20 -99.72 116.59 32.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -102.1 103.98 14.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -101.28 129.26 47.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 109.402 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -142.18 146.46 35.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.334 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 67' ' ' PHE . 6.0 tt0 -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -91.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.628 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 67' ' ' PHE . . . -160.16 -83.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -101.59 171.92 7.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.705 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -55.04 -58.38 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.772 -179.67 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.046 ' N ' HD23 ' A' ' 86' ' ' LEU . 2.0 tt0 -46.14 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.561 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 41.9 tt0 -40.87 -38.72 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 110.471 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -58.92 -61.34 2.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.997 . . . . 0.0 110.141 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 71.8 m-20 -57.26 -31.32 65.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.452 -179.312 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.68 68.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.934 -1.103 . . . . 0.0 109.851 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.924 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.2 m95 -76.36 -45.49 31.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.096 -1.002 . . . . 0.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.928 HG23 HD21 ' A' ' 55' ' ' LEU . 13.7 p -69.5 -23.12 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.0 mmt180 -81.4 -36.98 28.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.974 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -77.1 -39.53 49.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.092 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' ILE . 6.0 mt -70.64 -46.31 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.774 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 17.3 t-20 -73.97 -30.55 62.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 0.0 109.712 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 7.8 ttpt -72.1 -34.92 69.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.232 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -77.48 -23.0 50.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 50' ' ' LEU . 5.5 mt -81.76 -36.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.119 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -14.77 48.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 2.4 t -95.77 -33.31 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.437 -0.79 . . . . 0.0 109.56 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 30' ' ' GLU . 5.8 tp -73.06 -15.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 1.2 mm-40 -73.04 -7.66 52.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.93 9.81 7.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.382 -1.069 . . . . 0.0 109.236 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.74 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.0 mt -90.52 -32.3 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HG2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -139.94 157.56 45.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 179.829 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.031 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.0 pm0 -171.02 126.21 0.68 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.7 -147.33 4.99 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.909 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -136.57 91.98 2.71 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.398 -1.06 . . . . 0.0 110.225 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.909 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.24 168.49 9.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.937 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -100.23 124.46 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 110.071 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 mtpm? -104.68 163.67 12.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.6 -0.687 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -68.2 107.53 2.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 109.259 179.695 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' LYS . . . -41.17 139.99 1.42 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 p -85.69 64.51 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -142.13 -87.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' H ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-85 -131.27 67.45 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.3 m120 54.55 77.42 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.192 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.1 p -129.08 172.53 11.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.593 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 14' ' ' LYS . 3.1 m95 -141.08 121.86 14.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.361 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.937 ' C ' HG23 ' A' ' 12' ' ' VAL . 8.0 mttt -149.18 136.08 10.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.78 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.2 Cg_exo -53.12 163.35 2.27 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.854 1.703 . . . . 0.0 109.986 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 22.3 ptm -177.34 164.14 2.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.044 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.604 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.9 t-105 -91.06 143.68 26.44 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -150.76 132.69 5.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.153 -179.052 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.031 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.7 m -121.64 100.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 95' ' ' ASP . 2.3 pp -74.64 132.33 41.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.849 -1.157 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 29' ' ' LEU . 2.2 mp -117.95 168.56 10.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.554 -0.716 . . . . 0.0 109.597 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.983 ' O ' HD13 ' A' ' 103' ' ' ILE . 15.1 pt-20 -74.42 -0.17 16.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.032 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD22 ' A' ' 50' ' ' LEU . 2.1 m-20 -121.46 -3.62 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.142 -0.974 . . . . 0.0 109.235 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.691 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.41 158.47 8.69 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 28' ' ' LEU . 2.3 mm -95.26 112.5 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 110.009 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 27' ' ' VAL . 15.2 mt-10 -107.74 103.6 12.92 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.2 p90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.783 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -130.26 -153.96 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.328 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.98 -43.38 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.594 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 11.6 mttt -110.65 -176.55 3.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -43.34 -26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 109.531 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -149.61 -46.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.031 . . . . 0.0 109.854 179.863 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.0 t70 62.16 10.11 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.63 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.13 22.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.03 . . . . 0.0 109.823 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.4 t -168.7 98.33 0.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.925 -1.11 . . . . 0.0 110.287 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.6 Cg_exo -51.75 130.09 32.6 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.96 1.774 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 3.1 tttt -89.66 -19.57 24.71 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -176.06 132.62 2.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.1 mtm -121.65 121.17 36.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.211 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 ' HD2' ' A' ' 49' ' ' PRO . 24.6 mt -89.45 139.39 28.25 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 108.777 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.626 ' HD2' HG23 ' A' ' 48' ' ' ILE . 49.8 Cg_endo -70.63 131.85 20.8 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.587 1.524 . . . . 0.0 109.963 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.691 HD13 ' CA ' ' A' ' 32' ' ' GLY . 2.4 tp -76.4 -0.75 23.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -136.11 129.11 31.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -0.994 . . . . 0.0 109.545 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 100.39 -5.51 57.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -97.64 172.97 7.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -1.152 . . . . 0.0 109.658 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -132.25 158.31 42.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.527 -0.733 . . . . 0.0 109.267 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.4 tm? -123.88 110.74 15.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.538 ' N ' HD22 ' A' ' 55' ' ' LEU . 87.0 m -102.83 110.38 22.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.0 p -148.64 131.3 7.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.701 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.77 150.78 93.34 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.462 -1.891 . . . . 0.0 110.391 -0.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 68' ' ' VAL . 1.2 p -90.03 167.53 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 27.2 tt0 -167.31 108.11 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.96 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 9.7 t0 165.63 -43.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 6.6 t80 -89.77 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -94.21 -21.78 26.6 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 31.61 44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.437 0.637 . . . . 0.0 110.206 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' HG12 ' A' ' 68' ' ' VAL . 5.2 ttp180 179.53 -170.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 65' ' ' ARG . 3.1 mtt 42.4 -153.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -110.17 69.29 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.488 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.774 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -107.63 130.25 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.354 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -109.08 169.37 8.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.218 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 56' ' ' THR . 15.3 ttpt -136.63 109.39 7.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.336 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 72' ' ' THR . 7.1 mt -95.41 165.46 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.344 -0.847 . . . . 0.0 108.996 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 89.0 m -138.98 89.79 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 3.1 p -54.63 155.69 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.103 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -51.65 -19.18 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.397 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.47 26.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.99 -1.068 . . . . 0.0 109.6 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.95 30.41 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.16 105.79 17.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.222 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 80' ' ' PHE . 3.4 m-20 -75.21 133.42 41.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -124.97 100.51 6.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -98.57 128.38 44.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.596 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -148.27 144.17 27.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 179.142 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 1.2 tt0 -103.99 136.39 43.73 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.36 -149.59 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.798 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 -86.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.869 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -124.2 173.69 8.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.748 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -42.55 -45.81 4.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.826 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.953 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.6 tt0 -52.61 -66.51 0.37 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.064 -1.023 . . . . 0.0 110.145 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -7.69 21.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.855 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.813 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -76.18 -54.74 6.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.647 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -77.75 -12.61 59.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.7 -33.33 35.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.568 ' CE2' ' HG2' ' A' ' 7' ' ' ARG . 3.7 m95 -78.01 -32.9 51.37 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.3 m -76.98 -29.7 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.667 -0.645 . . . . 0.0 109.771 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 17.0 mmt85 -79.62 -27.19 41.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.834 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.7 OUTLIER -87.02 -44.27 11.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.025 . . . . 0.0 110.041 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.702 ' O ' HD12 ' A' ' 100' ' ' ILE . 4.2 mt -69.23 -31.94 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.044 . . . . 0.0 109.128 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 18.1 t30 -85.09 -36.11 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 27.2 tttt -66.27 -34.39 77.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.229 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -80.78 -30.17 36.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.341 -0.849 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 96' ' ' ILE . 22.9 mt -72.94 -29.55 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 7.4 mmpt? -93.43 -17.74 23.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 9.7 m -95.88 -16.58 21.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.481 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.983 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.5 tp -87.27 -15.85 9.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.8 -11.91 61.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.425 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.99 12.34 9.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.482 -1.011 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.858 ' HE ' HG21 ' A' ' 27' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.38 -44.37 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.997 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.4 tpm_? -125.4 150.38 47.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -0.997 . . . . 0.0 110.237 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.768 ' CB ' HG12 ' A' ' 27' ' ' VAL . 2.1 pm0 -160.49 121.26 2.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.144 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.599 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.5 -145.28 4.19 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.785 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.2 p90 -142.1 102.6 4.15 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.286 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.785 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -117.16 169.08 9.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.947 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -101.34 133.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 0.0 109.891 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -128.31 131.89 48.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.635 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -96.3 151.28 19.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 108.795 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.514 ' N ' ' HG3' ' A' ' 14' ' ' LYS . . . 178.45 151.7 9.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 30.9 t 61.06 -88.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.242 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 18' ' ' PHE . 7.2 p -44.44 166.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.609 ' N ' HG22 ' A' ' 17' ' ' VAL . 27.3 p90 -73.78 -176.08 2.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.703 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' ' CD1' ' A' ' 18' ' ' PHE . 5.7 t30 -43.66 109.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' TRP . 18.6 p -146.38 -58.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -0.9 . . . . 0.0 109.902 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.643 ' NE1' ' CZ ' ' A' ' 62' ' ' PHE . 32.9 m95 63.51 106.1 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.488 0.661 . . . . 0.0 110.207 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . 45.0 mttm -125.54 134.86 26.22 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.65 159.71 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.906 1.737 . . . . 0.0 110.611 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.604 ' HE2' ' CD1' ' A' ' 35' ' ' PHE . 13.5 ptm -173.23 171.05 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.243 -0.91 . . . . 0.0 109.273 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.608 ' CE2' ' HA ' ' A' ' 39' ' ' LYS . 52.4 t-105 -89.56 140.83 29.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.911 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -151.54 127.63 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.171 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.858 HG21 ' HE ' ' A' ' 5' ' ' ARG . 17.2 m -126.42 119.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 109.46 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.939 ' HA ' HG23 ' A' ' 33' ' ' ILE . 2.8 pp -87.99 106.02 17.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -90.34 162.53 15.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.898 . . . . 0.0 109.473 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -72.61 -12.39 61.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.68 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HA ' HD11 ' A' ' 103' ' ' ILE . 1.6 m-20 -107.27 -0.81 22.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 157.93 144.68 4.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.939 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm -96.41 109.07 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -1.105 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 9.2 pt-20 -119.79 131.94 55.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 108.869 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.649 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.8 p90 -127.63 142.36 51.37 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 110.073 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -123.42 -149.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.628 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -63.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 109.179 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.0 -178.66 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 108.939 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.79 -42.75 17.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -144.14 69.54 1.28 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.507 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 18.4 t70 -47.41 -21.33 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 2.9 t-20 91.78 -18.49 0.14 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -134.25 119.63 14.5 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 45.1 Cg_endo -69.43 132.93 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.685 1.59 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.69 -21.56 22.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -160.01 117.98 0.8 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 167.8 9.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -1.156 . . . . 0.0 109.662 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.86 HG23 HG22 ' A' ' 73' ' ' THR . 5.5 mt -140.8 109.72 6.59 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.25 118.23 5.55 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.597 1.531 . . . . 0.0 110.35 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.79 HD11 HD11 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.93 -7.06 25.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.545 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -42.88 -68.13 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.725 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -150.14 71.46 0.3 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.009 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -177.65 5.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.196 . . . . 0.0 109.256 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.17 113.09 8.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.251 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' N ' ' A' ' 56' ' ' THR . 3.4 tm? -88.67 131.37 35.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.281 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 58' ' ' PRO . 31.6 m -115.99 137.63 51.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 17.9 p -150.13 118.03 3.6 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.994 ' O ' HG22 ' A' ' 56' ' ' THR . 48.2 Cg_endo -70.78 -160.87 1.7 Allowed 'Cis proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.493 -1.878 . . . . 0.0 110.424 0.211 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 22.7 p -91.07 -149.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -163.43 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.85 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 21.11 2.34 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.643 ' CZ ' ' NE1' ' A' ' 21' ' ' TRP . 8.3 t80 -88.64 -56.44 3.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 108.738 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -75.27 -50.14 8.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 15.7 pttm 40.53 28.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.98 . . . . 0.0 109.59 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.9 ttt180 -137.75 15.5 2.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.9 mtt 64.6 -162.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 49.31 23.11 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' PHE . 10.7 p -161.28 126.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.715 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.4 p90 -116.23 167.38 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.7 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -124.7 108.61 12.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 96' ' ' ILE . 4.4 mt -90.1 166.71 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.635 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -148.95 89.47 1.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.86 HG22 HG23 ' A' ' 48' ' ' ILE . 3.2 p -47.22 173.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.054 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -22.06 64.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.443 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -74.14 -5.92 44.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.184 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 2.7 mt-30 79.13 36.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.8 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 1.9 pt20 -109.11 90.66 3.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 m-20 -53.76 159.53 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.394 -0.816 . . . . 0.0 110.342 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 77' ' ' GLN . 82.7 m-70 -150.56 124.48 9.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -100.4 114.85 28.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.082 -1.012 . . . . 0.0 109.892 -179.461 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.11 148.8 42.65 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 12' ' ' VAL . 2.7 tt0 -138.14 133.87 33.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.063 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.63 -160.8 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.399 -0.813 . . . . 0.0 109.194 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -106.48 -2.03 22.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.514 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -173.02 167.1 5.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.0 179.973 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.463 ' CD1' ' HD2' ' A' ' 89' ' ' ARG . 33.2 tp -66.36 -14.16 61.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.558 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -67.21 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.189 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.68 -14.68 61.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.274 179.715 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -76.05 -51.55 12.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -68.34 -19.95 64.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 109.478 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -87.47 -31.34 20.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.911 ' CH2' HG22 ' A' ' 26' ' ' VAL . 1.6 m95 -79.95 -32.28 39.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.79 ' CG2' HD11 ' A' ' 55' ' ' LEU . 1.7 p -82.55 -34.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.17 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 7.9 ptm180 -73.58 -25.97 60.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 108.998 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 19.4 t0 -85.4 -49.05 8.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 71' ' ' ILE . 23.9 mt -61.62 -38.42 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.048 -1.032 . . . . 0.0 108.831 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 11.3 t-20 -75.92 -66.02 0.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 8.4 tttp -43.08 -32.75 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.401 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -69.47 -47.09 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.537 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.13 -55.54 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.766 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.482 ' N ' HG22 ' A' ' 100' ' ' ILE . 12.2 mttt -63.69 -12.64 36.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -85.82 -32.39 21.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.8 . . . . 0.0 109.184 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.622 HD12 ' CB ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -78.26 -30.46 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -0.868 . . . . 0.0 108.937 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.0 mm-40 -72.97 -5.35 38.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.356 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.75 13.99 5.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 106' ' ' LEU . 1.7 mt . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.465 -1.02 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.797 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.312 0.577 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 6' ' ' ILE . 31.3 mt -63.83 -53.95 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.559 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -113.7 147.22 38.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 109.858 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 1.004 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.1 pm0 -163.93 126.05 2.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.794 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.587 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.08 -145.08 4.16 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 p90 -134.89 92.32 2.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.954 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.098 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.96 162.78 13.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.149 -0.969 . . . . 0.0 109.419 179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 82' ' ' GLN . 2.3 p -98.92 130.38 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HE2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.47 135.11 53.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.322 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 tttt -64.46 96.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LYS . . . -43.61 166.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 t -84.52 -4.45 58.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.541 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 18' ' ' PHE . 2.3 p -93.37 114.55 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' VAL . 21.9 m-85 52.34 174.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 19' ' ' ASN . 1.1 p-10 -87.21 86.39 7.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.252 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 61.3 p -120.58 -177.14 3.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.954 . . . . 0.0 109.757 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.642 ' CZ3' ' CG ' ' A' ' 82' ' ' GLN . 44.0 m95 -154.52 106.2 2.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.035 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.934 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -125.3 133.25 24.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 109.989 -179.55 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.2 Cg_exo -53.55 166.14 1.38 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.972 1.781 . . . . 0.0 110.323 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.77 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -174.92 169.68 3.39 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.77 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.1 t-105 -91.37 145.31 24.74 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -150.34 132.43 5.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.329 -178.324 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -127.79 102.95 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.901 ' HB2' HD12 ' A' ' 33' ' ' ILE . 2.5 pp -79.4 125.8 30.0 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.269 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 5' ' ' ARG . 2.2 mp -112.74 163.66 14.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.428 -0.795 . . . . 0.0 109.114 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 7.6 pt-20 -73.84 -6.27 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.28 -0.1 13.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.296 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 29' ' ' LEU . . . 156.14 148.04 4.93 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.901 HD12 ' HB2' ' A' ' 28' ' ' LEU . 4.0 mm -98.93 108.16 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -1.139 . . . . 0.0 109.313 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 29' ' ' LEU . 10.7 pt-20 -111.1 112.54 24.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.018 -1.051 . . . . 0.0 109.185 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.688 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.9 p90 -115.13 142.6 46.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.192 -0.943 . . . . 0.0 110.053 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.67 -149.38 0.41 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 108.613 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -99.91 -54.64 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 108.586 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -93.15 -171.28 2.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.661 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 8.1 mtpt -63.85 -9.89 17.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.657 -1.277 . . . . 0.0 109.704 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -152.65 -51.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.359 178.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.6 t0 57.46 11.0 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 38.67 24.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.814 . . . . 0.0 110.557 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.7 t -176.68 95.57 0.24 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.831 -1.168 . . . . 0.0 110.029 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 52.8 Cg_exo -53.9 153.77 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.169 1.913 . . . . 0.0 111.524 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 tttt -101.55 -21.7 14.67 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.42 141.07 5.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 5.5 mtm -139.83 132.11 28.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.261 . . . . 0.0 109.841 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.761 HG23 HG22 ' A' ' 73' ' ' THR . 19.7 mt -89.07 129.15 49.15 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.8 . . . . 0.0 108.905 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.84 131.75 23.28 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.774 1.649 . . . . 0.0 110.447 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.881 HD23 HG13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -89.22 30.66 0.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.403 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -36.15 15.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.415 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 74' ' ' THR . . . -177.51 84.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.12 -177.68 3.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -1.158 . . . . 0.0 109.675 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -135.43 114.51 12.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.405 -0.809 . . . . 0.0 109.696 -179.193 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 56' ' ' THR . 3.3 tm? -88.58 131.88 34.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.216 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.848 ' N ' HD13 ' A' ' 55' ' ' LEU . 23.9 m -124.06 121.37 35.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 35.6 m -148.46 137.06 11.67 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 109.745 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 57' ' ' SER . 60.7 Cg_endo -78.05 177.89 37.05 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.391 -1.92 . . . . 0.0 110.438 -0.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.779 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 1.9 t -150.14 -149.53 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.907 ' HB2' HG21 ' A' ' 68' ' ' VAL . 2.3 tt0 63.17 115.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.413 -0.804 . . . . 0.0 109.859 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.38 7.14 28.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.015 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -89.49 -42.7 11.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.66 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -118.16 -17.92 5.2 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 36.66 31.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.839 -0.801 . . . . 0.0 109.582 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 22.54 5.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.525 -0.735 . . . . 0.0 109.639 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.563 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER 55.81 -179.43 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 108.956 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.1 m-30 83.26 -20.18 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.732 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -102.22 135.45 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.388 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.771 ' CE1' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -110.91 152.32 26.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.958 . . . . 0.0 109.985 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.779 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 1.7 tttp -124.41 103.89 8.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.525 -0.734 . . . . 0.0 109.314 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 69' ' ' PHE . 12.7 mt -90.87 167.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 72' ' ' THR . 3.9 m -145.64 84.11 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 48' ' ' ILE . 4.5 p -42.96 165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 109.594 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -62.68 -16.8 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.472 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.42 19.71 5.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.26 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.17 34.66 16.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.765 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -97.82 94.52 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.727 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 66.2 m-20 -62.8 155.73 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 30.3 m80 -139.38 124.07 18.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.613 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 71.1 m-85 -93.01 124.36 36.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.436 -0.79 . . . . 0.0 109.866 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 1.098 ' CE2' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -122.8 141.78 51.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.337 -0.852 . . . . 0.0 110.017 -179.53 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.959 ' HB2' HG13 ' A' ' 12' ' ' VAL . 1.4 mm100 -135.51 108.74 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.322 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.37 -145.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.505 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -132.75 1.53 3.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.849 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -172.28 154.15 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.061 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.14 -22.18 66.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 -179.821 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 1.061 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -66.16 -68.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 0.0 109.091 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 3.0 tt0 -60.28 -21.95 62.55 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 108.792 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.0 -65.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 179.592 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -57.06 -34.25 68.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.807 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.43 75.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.116 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.976 ' NE1' HD21 ' A' ' 11' ' ' LEU . 13.2 m95 -74.83 -56.29 4.92 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.341 -0.849 . . . . 0.0 108.795 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.791 HG12 HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -64.48 -11.07 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.607 -0.683 . . . . 0.0 109.252 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 19.4 mmt180 -84.42 -39.74 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.694 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -87.28 -21.33 25.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.939 -179.745 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.684 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.2 mt -87.42 -38.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 109.095 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 27.3 t30 -80.17 -33.34 38.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 108.874 179.392 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -72.5 -45.06 61.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.078 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.95 -41.69 95.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.206 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 96' ' ' ILE . 33.6 mt -66.64 -32.79 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.111 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -81.92 -11.83 58.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.16 -24.34 16.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 108.954 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.881 HG13 HD23 ' A' ' 50' ' ' LEU . 9.1 mm -69.05 -23.75 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.457 -0.777 . . . . 0.0 109.213 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.7 -1.78 32.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.407 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.54 19.55 1.02 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 121.554 -0.968 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.1 mt-10 -72.51 -51.51 7.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.654 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 53.6 Cg_exo -49.31 124.95 12.67 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.774 1.649 . . . . 0.0 110.219 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 71.05 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.69 167.86 11.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 28' ' ' LEU . 50.6 mt -73.59 -58.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.995 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.35 107.46 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.042 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.8 pt-20 -111.97 143.92 42.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.632 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.19 -151.06 6.26 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.987 ' C ' HD13 ' A' ' 11' ' ' LEU . 6.3 p90 -145.26 96.27 2.81 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.385 -1.068 . . . . 0.0 110.086 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.987 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -119.17 163.5 16.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.722 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -86.17 130.69 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 81' ' ' PHE . 1.1 tttt -122.43 135.0 54.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.388 -0.82 . . . . 0.0 109.717 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -101.13 99.57 10.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 108.864 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 166.69 90.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 2.5 p 161.85 -41.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.35 -1.088 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG21 ' OG1' ' A' ' 20' ' ' THR . 13.2 m -100.92 -144.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' N ' HG23 ' A' ' 17' ' ' VAL . 19.4 m-85 -94.27 72.95 3.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.772 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 2.8 m-20 44.16 88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.007 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.63 ' OG1' HG21 ' A' ' 17' ' ' VAL . 76.1 p -146.88 -162.52 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.657 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.2 m95 -151.4 102.82 2.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.383 -0.823 . . . . 0.0 109.354 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.722 ' N ' HG23 ' A' ' 12' ' ' VAL . 24.1 mmtt -137.85 142.02 34.8 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.7 Cg_exo -52.63 160.23 4.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.92 1.746 . . . . 0.0 109.759 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -167.43 166.65 14.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.951 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.728 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.1 t-105 -92.78 141.07 28.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.3 p -149.9 133.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.764 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.042 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.0 m -124.98 111.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.06 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.041 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -82.4 119.86 24.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -0.976 . . . . 0.0 108.761 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -106.04 166.75 10.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.811 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.688 ' C ' HD22 ' A' ' 50' ' ' LEU . 3.9 pt-20 -71.93 -6.63 43.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.865 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.91 -1.73 11.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.574 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 155.35 146.64 4.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -97.12 105.15 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -1.087 . . . . 0.0 109.956 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 27' ' ' VAL . 5.4 pt-20 -102.38 128.2 49.06 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.0 p90 -124.7 147.29 48.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 110.903 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.13 -145.41 0.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.7 -42.47 5.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.947 -1.096 . . . . 0.0 108.986 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -115.63 -177.79 3.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 108.821 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 4.2 tppt? -46.68 -34.69 5.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.456 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -157.12 73.47 0.75 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.515 -0.741 . . . . 0.0 109.469 178.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 31.5 t70 -52.61 -17.36 1.24 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 19.1 m-20 91.16 -18.32 0.15 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -135.45 116.44 11.93 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 47.1 Cg_endo -69.2 144.18 56.12 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.735 1.623 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 8.1 mmtt -90.07 -25.6 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 108.926 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.54 150.5 10.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.4 mtt -118.23 166.97 11.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 39.9 mt -128.99 131.24 23.6 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.77 135.46 30.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.353 1.369 . . . . 0.0 109.797 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -85.49 37.98 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 109.924 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -172.71 99.36 0.14 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.032 -1.042 . . . . 0.0 109.425 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 123.87 11.28 4.94 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.311 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 1.2 t -97.15 156.87 16.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.934 -1.333 . . . . 0.0 109.777 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -116.9 173.13 6.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 93' ' ' VAL . 1.7 tt -134.64 135.64 42.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.021 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.852 ' N ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -121.32 108.23 13.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 13.4 p -142.22 116.14 6.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 57' ' ' SER . 33.7 Cg_exo -62.15 -172.85 2.32 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.936 -1.693 . . . . 0.0 110.682 -1.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.7 p -98.14 -146.78 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.33 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.542 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -102.72 -149.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.3 17.81 3.52 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.337 -0.852 . . . . 0.0 108.887 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -89.33 77.67 7.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.308 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 102.27 -73.42 0.32 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 42.79 29.86 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -1.093 . . . . 0.0 109.477 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -93.78 -99.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 45.3 m-85 -129.55 87.2 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 0.0 109.531 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.3 p -120.15 117.32 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.618 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 4.4 p90 -106.97 165.12 11.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.331 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 1.9 ttpp -123.44 120.02 31.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.813 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.5 mt -106.8 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 54' ' ' THR . 87.1 m -134.17 94.48 3.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.09 150.29 25.45 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 108.976 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -45.94 -21.96 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.242 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -86.62 29.22 0.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 109.801 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.81 31.56 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.99 . . . . 0.0 109.67 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.491 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -97.49 97.45 9.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.42 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 77.4 m-20 -61.55 152.69 29.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.491 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 32.7 m-70 -142.32 88.92 2.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.872 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -91.13 101.63 14.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 108.95 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.42 146.83 51.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.528 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 83' ' ' ALA . 1.9 tt0 -116.39 143.71 45.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.331 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' O ' ' NE2' ' A' ' 82' ' ' GLN . . . -89.64 -146.69 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.666 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -107.48 -15.87 14.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 1.7 p90 -170.59 172.44 5.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.965 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.84 -50.25 66.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 109.969 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.965 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.2 tm-20 -53.28 -39.23 63.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.271 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 20.8 tt0 -83.86 -16.13 45.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.071 -1.018 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 1.6 ttt180 -76.99 -46.51 23.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.992 . . . . 0.0 109.638 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 8.4 t0 -79.97 -27.2 39.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 109.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.509 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -73.81 -34.78 64.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.725 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.041 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -80.22 -48.44 13.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.825 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.984 HG22 HD11 ' A' ' 55' ' ' LEU . 3.6 p -68.71 -27.12 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 33.5 ptt85 -79.76 -30.72 40.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.052 . . . . 0.0 109.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -75.21 -39.39 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.368 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.693 ' O ' HD12 ' A' ' 100' ' ' ILE . 28.2 mt -72.5 -42.4 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.57 -27.09 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 109.252 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 5.3 tppt? -72.27 -46.13 57.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -64.13 -37.15 86.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.875 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 96' ' ' ILE . 7.6 mt -69.58 -34.15 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.403 -0.811 . . . . 0.0 108.928 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -85.26 -8.28 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.399 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.543 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -94.61 -30.97 14.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.507 HG12 HD23 ' A' ' 50' ' ' LEU . 1.1 mm -69.44 -28.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.2 mt-10 -64.86 -10.51 29.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.583 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' HD22 ' A' ' 106' ' ' LEU . . . -131.21 10.93 5.59 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 102' ' ' CYS . 3.2 mm? -116.65 62.67 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.066 . . . . 0.0 109.385 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -102.36 171.79 7.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.489 -0.757 . . . . 0.0 109.316 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.8 m80 -117.43 -157.54 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 55.72 87.34 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -91.28 141.64 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -121.18 52.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -69.14 -34.21 74.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.44 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' CB ' ' HG3' ' A' ' 4' ' ' LYS . 1.5 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.367 0.603 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.576 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.8 mt-10 -60.85 -61.63 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.744 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 56.0 Cg_endo -71.54 -95.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.91 1.74 . . . . 0.0 110.431 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 1' ' ' MET . 0.7 OUTLIER 56.16 93.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.629 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -79.06 148.19 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 30' ' ' GLU . 2.5 mp -66.81 -71.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.1 tpm_? -107.35 125.96 51.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 110.094 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.001 ' HB3' HG12 ' A' ' 27' ' ' VAL . 6.7 pm0 -145.88 122.91 11.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 0.0 109.178 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.596 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.62 -147.57 4.94 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.791 ' C ' HD13 ' A' ' 11' ' ' LEU . 16.7 p90 -139.63 99.88 3.82 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.356 -1.085 . . . . 0.0 109.873 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -105.86 -143.03 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.036 HG23 ' C ' ' A' ' 22' ' ' LYS . 9.9 p -149.71 129.12 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.013 . . . . 0.0 109.65 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.79 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.3 tttt -116.38 169.16 9.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -125.71 148.13 49.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 14' ' ' LYS . . . 115.58 107.72 2.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p 177.03 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 18' ' ' PHE . 17.9 m -143.06 -39.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 4.7 m-85 -168.29 61.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 48.69 43.55 20.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.548 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 12.7 p -89.99 172.35 8.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 14' ' ' LYS . 5.1 m95 -126.21 120.08 29.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.036 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.2 mmtp -138.88 129.64 15.01 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.668 ' N ' HG23 ' A' ' 12' ' ' VAL . 32.5 Cg_exo -59.14 119.06 6.08 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.916 1.744 . . . . 0.0 110.177 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.79 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 7.7 ptm -124.48 168.5 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.909 -1.119 . . . . 0.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.596 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 72.5 t-105 -90.45 145.53 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -151.49 139.67 14.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.403 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.1 m -130.25 98.31 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.9 pp -76.04 123.78 26.34 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.939 -1.1 . . . . 0.0 108.803 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 5' ' ' ARG . 2.4 mp -107.26 166.08 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.461 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 31.5 tt0 -73.69 -9.2 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.28 4.27 15.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.915 . . . . 0.0 109.472 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 149.67 148.61 4.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.5 mp -99.02 127.09 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 110.084 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 7.9 pt-20 -127.87 115.02 17.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.5 p90 -117.54 151.54 36.93 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -132.77 -153.32 0.54 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.141 -0.975 . . . . 0.0 108.38 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 40.8 mttt -124.62 -173.27 2.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 5.9 tppt? -45.5 -25.65 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.976 -1.077 . . . . 0.0 109.255 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -148.53 -50.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.54 10.86 3.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' ASP . 1.4 m-20 42.61 23.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -169.84 108.19 0.46 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.051 -1.031 . . . . 0.0 109.706 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.1 Cg_endo -71.49 136.57 28.82 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.8 1.666 . . . . 0.0 110.549 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.79 -17.95 27.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.02 140.36 4.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.1 mtm -133.16 124.8 28.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.29 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 73' ' ' THR . 6.5 mt -89.73 134.84 31.43 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 48' ' ' ILE . 56.7 Cg_endo -72.13 137.76 29.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.689 1.592 . . . . 0.0 110.078 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.675 HD23 ' CG1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.82 38.7 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.542 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -91.53 -70.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.99 72.95 0.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.712 ' H ' HG21 ' A' ' 100' ' ' ILE . 1.5 p -80.12 -170.1 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.363 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.33 111.53 6.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.516 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.756 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.4 tm? -88.59 116.42 26.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.017 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 58' ' ' PRO . 86.8 m -102.09 130.56 48.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.421 -0.799 . . . . 0.0 109.578 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 t -150.05 120.05 3.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.713 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.41 -163.02 2.66 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.595 -1.835 . . . . 0.0 110.396 0.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.15 -158.84 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -71.33 -149.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -84.07 14.31 4.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.418 -0.801 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -10.1 49.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.884 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -124.75 -103.65 1.49 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 42.67 59.44 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.281 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 6.2 ttt-85 179.73 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.8 mtp -141.03 -155.95 0.63 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.471 -0.768 . . . . 0.0 109.766 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -92.99 65.37 4.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.91 . . . . 0.0 109.221 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG11 ' HA2' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -116.25 128.16 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.622 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 7.7 p90 -120.36 173.66 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 109.61 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.627 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 ttpt -129.99 108.34 10.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 0.0 109.396 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.582 HG13 ' CE1' ' A' ' 69' ' ' PHE . 1.3 mt -89.2 165.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 109.377 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.8 m -144.93 91.08 2.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.714 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.7 162.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.364 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -61.09 -13.26 15.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.678 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.99 15.84 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.83 32.28 4.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.55 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -89.95 -175.9 4.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.235 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 77' ' ' GLN . 2.6 m-20 -141.8 146.6 36.1 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.414 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.493 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 80.6 m-70 -145.79 92.63 2.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' CD ' ' A' ' 70' ' ' LYS . 36.1 m-85 -90.48 110.29 21.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.306 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.92 146.11 31.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.698 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -113.06 139.54 48.6 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.471 -0.768 . . . . 0.0 108.948 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.93 -155.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.499 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.73 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 175.62 5.44 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 25.4 tp -56.41 -22.93 34.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 109.109 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -66.07 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.57 -16.88 58.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -0.871 . . . . 0.0 109.153 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.719 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -71.26 -64.04 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.561 ' HA ' HG22 ' A' ' 93' ' ' VAL . 10.4 t0 -62.01 -12.81 20.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.115 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.74 -30.93 28.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 108.666 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.66 ' CH2' HG22 ' A' ' 26' ' ' VAL . 5.8 m95 -84.02 -28.72 27.47 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.1 m -75.28 -36.76 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.543 -0.723 . . . . 0.0 109.535 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 8.5 ptp180 -83.83 -24.72 30.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.5 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' HD11 ' A' ' 28' ' ' LEU . 12.6 t0 -77.14 -45.7 25.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.019 ' O ' HD12 ' A' ' 100' ' ' ILE . 32.1 mt -76.51 -42.32 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 28.1 t-20 -69.44 -31.46 69.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.5 tmtp? -75.37 -50.75 14.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.31 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -54.43 -42.23 70.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.37 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.019 HD12 ' O ' ' A' ' 96' ' ' ILE . 5.2 mt -70.23 -39.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.239 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -71.21 -11.64 61.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.322 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -95.25 -33.91 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 109.244 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.675 ' CG1' HD23 ' A' ' 50' ' ' LEU . 8.5 mm -67.82 -16.9 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 39.3 mt-10 -73.57 -2.99 25.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.517 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.97 17.51 0.93 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 102' ' ' CYS . 2.0 mm? -110.5 60.69 0.61 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -1.012 . . . . 0.0 109.462 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.86 129.61 41.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.345 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -123.85 70.66 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.612 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.37 35.76 1.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.6 115.07 26.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 0.3 OUTLIER 179.17 -154.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.501 ' O ' ' CB ' ' A' ' 113' ' ' HIS . 0.7 OUTLIER 67.42 -86.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 112' ' ' HIS . 20.2 t-80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.492 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.1 mt-10 60.33 162.04 0.1 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 56.0 Cg_endo -75.48 148.92 34.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.009 1.806 . . . . 0.0 110.357 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 9.1 mttm -113.48 96.95 6.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 69.38 136.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.251 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 28.2 mm -73.01 -59.79 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.928 . . . . 0.0 109.739 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 1.024 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.72 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.63 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.979 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -145.33 129.32 17.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.46 -146.95 4.76 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.728 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.9 p90 -135.89 99.84 4.27 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -115.11 153.79 30.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 22' ' ' LYS . 5.7 p -94.1 140.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.894 -1.129 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.74 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 11.3 mttp -123.07 169.7 10.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.92 113.58 21.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.37 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 153.99 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.14 -46.49 70.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' PHE . 2.2 p -50.46 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 12.7 m-85 61.11 159.62 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -76.71 86.04 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.6 p -128.77 171.53 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.521 ' CH2' ' CB ' ' A' ' 80' ' ' PHE . 23.6 m95 -133.01 101.62 5.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.984 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.5 mttm -107.54 134.19 20.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.35 147.77 44.93 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.644 1.563 . . . . 0.0 109.775 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.74 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 23.1 ptm -154.11 162.44 41.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.991 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.683 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.9 t-105 -94.79 147.91 22.84 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -151.52 138.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.491 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.979 HG12 ' HB3' ' A' ' 8' ' ' GLU . 9.7 m -129.46 94.55 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.027 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -68.41 120.15 14.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.808 -1.182 . . . . 0.0 108.882 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.0 mp -102.62 164.83 11.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.56 -0.713 . . . . 0.0 109.372 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -71.63 -14.72 62.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -0.827 . . . . 0.0 109.818 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -109.3 4.62 22.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.657 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 149.62 150.32 5.22 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -92.5 121.11 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 109.938 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.557 ' O ' HG22 ' A' ' 27' ' ' VAL . 10.3 mt-10 -116.75 107.94 15.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.625 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 12.9 p90 -117.68 145.64 44.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.953 -1.092 . . . . 0.0 110.686 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.646 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.44 -154.72 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 2.8 mtmt -91.95 -43.94 9.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 108.46 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -102.09 -170.9 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 108.743 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 mtpt -64.24 -10.04 21.06 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -150.99 -52.13 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 4.2 t70 59.95 11.37 2.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER 41.89 22.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -176.76 99.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.789 -1.194 . . . . 0.0 110.747 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.1 Cg_exo -52.79 135.1 56.52 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.989 1.793 . . . . 0.0 110.525 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.55 -18.74 26.04 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.65 126.16 1.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 51.7 mtm -122.05 123.47 41.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.594 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.918 HG23 HG22 ' A' ' 73' ' ' THR . 26.0 mt -89.82 132.81 35.43 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.005 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 73' ' ' THR . 54.5 Cg_endo -72.11 129.7 15.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.681 1.587 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.735 HD23 ' CG1' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -84.67 43.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.723 ' HB2' HG21 ' A' ' 74' ' ' THR . 8.5 mmtm -95.73 -71.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.52 61.74 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 100' ' ' ILE . 2.4 m -85.43 171.39 11.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -1.171 . . . . 0.0 109.325 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.71 172.06 8.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -0.81 . . . . 0.0 109.455 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 56' ' ' THR . 3.2 tm? -133.96 136.41 44.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 108.74 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.792 ' N ' HD13 ' A' ' 55' ' ' LEU . 32.9 m -126.29 131.5 51.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.076 -1.015 . . . . 0.0 110.118 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.402 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 24.5 p -150.37 119.89 3.72 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.449 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 56' ' ' THR . 52.9 Cg_endo -71.95 -161.49 2.08 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.56 -1.85 . . . . 0.0 110.179 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -146.68 130.12 16.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 57.04 163.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -103.49 -12.03 17.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.915 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -89.14 4.55 48.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.796 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -120.71 -19.48 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -49.65 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -144.1 -77.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.545 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -99.9 -39.86 7.96 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.5 0.667 . . . . 0.0 109.563 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' A' ' 89' ' ' ARG . 0.4 OUTLIER 158.57 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -119.59 128.0 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.7 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 2.3 p90 -109.02 164.54 12.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.051 -1.031 . . . . 0.0 109.673 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -127.0 108.41 10.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mt -89.33 160.29 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 99.8 m -131.59 85.43 2.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 48' ' ' ILE . 6.9 p -44.13 158.14 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -58.71 -15.34 11.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.357 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -90.43 21.8 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 61.01 35.79 18.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.467 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.1 109.18 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.9 m-20 -76.08 146.64 39.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 39.4 m-70 -140.46 116.57 10.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.66 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CB ' ' CH2' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -98.54 128.49 44.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.7 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.94 160.35 40.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 108.783 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -142.14 132.55 25.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -92.75 -84.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' SD ' ' A' ' 66' ' ' MET . . . 179.16 -67.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -114.26 169.72 8.82 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.635 -0.665 . . . . 0.0 109.807 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -62.3 -19.74 63.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.591 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.985 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -71.28 -66.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.129 -0.982 . . . . 0.0 109.415 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -16.54 64.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 1.052 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.02 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.618 ' HA ' HG22 ' A' ' 93' ' ' VAL . 20.2 t70 -67.96 -14.72 63.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.03 -33.73 29.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.027 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 7.8 m95 -82.55 -25.87 32.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.052 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -79.96 -39.3 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.0 ptm180 -77.79 -23.93 49.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.5 t70 -81.61 -49.33 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.06 . . . . 0.0 109.506 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.781 HG13 HD22 ' A' ' 28' ' ' LEU . 32.5 mt -72.92 -31.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 52.7 t30 -81.17 -36.02 30.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 3.2 ttpt -71.6 -37.81 70.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.639 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -68.22 -43.38 78.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.92 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 53' ' ' SER . 60.0 mt -68.37 -30.47 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.163 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 5.4 mmtt -85.03 -10.9 56.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.11 -21.44 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.045 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.735 ' CG1' HD23 ' A' ' 50' ' ' LEU . 2.0 mm -75.51 -28.31 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.009 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.27 -5.54 33.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.17 11.69 5.85 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 106' ' ' LEU . 1.7 mt -101.22 57.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.486 -1.008 . . . . 0.0 109.25 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -120.72 19.51 11.83 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.704 -0.623 . . . . 0.0 109.595 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 5.6 t-80 -170.79 87.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 0.1 OUTLIER 171.07 122.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 84.95 7.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.432 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 58.96 -170.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -58.53 2.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.403 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.475 ' OXT' ' ND1' ' A' ' 113' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.068 -0.967 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 3' ' ' PRO . 15.8 pt-20 -144.8 159.44 50.48 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 2' ' ' GLU . 53.1 Cg_exo -55.22 -143.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.213 1.942 . . . . 0.0 110.474 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 64.07 96.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.75 150.72 40.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.237 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 30' ' ' GLU . 23.0 mm -56.19 -53.65 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.747 ' HB3' HD11 ' A' ' 28' ' ' LEU . 1.7 tpm_? -141.88 108.68 5.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.207 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.983 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.99 131.23 55.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.987 -1.071 . . . . 0.0 109.189 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.4 -149.4 5.61 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.737 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.3 p90 -138.12 95.72 3.07 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.069 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -114.36 169.77 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -96.4 159.81 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.834 -1.166 . . . . 0.0 109.6 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -148.75 130.17 14.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -50.73 150.9 2.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.414 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.06 -139.48 8.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.64 47.84 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -1.11 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 17' ' ' VAL . 10.9 p -155.1 109.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' ASN . 25.1 m-85 58.52 22.0 9.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' PHE . 4.0 m-20 46.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.2 p -125.4 -179.29 4.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.595 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.683 ' CH2' HG21 ' A' ' 68' ' ' VAL . 39.0 m95 -144.97 88.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.204 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.3 mttm -107.8 139.71 20.88 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.746 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.09 167.81 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.959 1.773 . . . . 0.0 110.598 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 25.6 ptm -174.8 158.43 2.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.89 . . . . 0.0 109.479 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.0 t-105 -89.79 147.17 23.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.413 -0.805 . . . . 0.0 109.03 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.61 133.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.666 -178.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.983 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.2 m -125.59 103.26 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.05 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.4 OUTLIER -86.89 108.97 19.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.75 164.26 14.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -73.64 -17.65 61.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.591 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.67 9.4 43.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 50' ' ' LEU . . . 152.23 -176.59 30.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' HA ' ' A' ' 28' ' ' LEU . 2.8 mp -138.16 125.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.256 . . . . 0.0 109.528 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.3 pt-20 -132.23 116.77 17.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 108.929 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.635 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.1 p90 -119.49 147.54 44.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.13 -0.981 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.77 -157.2 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -88.39 -55.66 3.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.48 -178.82 5.02 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -49.28 -21.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.898 -1.126 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -146.63 -47.36 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.679 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 43' ' ' SER . 5.2 t0 62.29 9.9 3.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.8 t30 45.84 21.04 0.08 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.942 -1.099 . . . . 0.0 109.606 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.8 t -173.29 115.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.497 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.3 Cg_endo -72.35 132.27 19.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.922 1.748 . . . . 0.0 110.593 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -89.62 -19.65 24.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . -167.58 120.66 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.0 mtm -119.28 125.58 49.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.118 -1.225 . . . . 0.0 109.84 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.548 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 mt -90.78 121.53 68.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.995 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.76 140.14 38.29 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.719 1.613 . . . . 0.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -84.9 37.82 0.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.864 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -70.09 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.132 -0.98 . . . . 0.0 109.375 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' THR . . . -136.33 24.71 3.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -40.09 141.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.441 -1.035 . . . . 0.0 110.383 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.47 167.26 10.6 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.763 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.2 tm? -137.66 117.38 13.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.985 -1.072 . . . . 0.0 109.449 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 58' ' ' PRO . 23.2 m -107.96 135.54 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -150.35 120.94 3.86 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.878 . . . . 0.0 109.239 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.854 ' O ' HG22 ' A' ' 56' ' ' THR . 55.5 Cg_endo -72.91 -161.14 2.11 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.651 -1.812 . . . . 0.0 110.346 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 9.2 p -102.93 -148.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.899 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.61 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 11.2 tt0 -71.6 -142.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -68.07 -2.23 7.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 68' ' ' VAL . 24.9 m-85 -88.99 -24.71 22.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 108.948 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -74.39 -49.14 12.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -19.83 6.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -1.063 . . . . 0.0 109.189 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -75.48 0.34 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -155.62 0.58 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 109.553 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 25.0 m-85 -97.52 86.66 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.683 HG21 ' CH2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -126.64 136.3 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.539 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.69 175.62 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 13.9 ttpt -142.67 100.74 3.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.898 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 54' ' ' THR . 12.6 mt -90.12 160.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 108.995 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 53.2 m -140.71 105.36 4.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.349 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.612 HG23 ' H ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -48.67 107.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.298 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER 39.55 28.94 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' THR . 5.5 tttt 82.73 46.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.979 -1.076 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -133.44 -86.71 0.43 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.079 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.612 ' H ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -90.9 136.84 32.81 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.645 -0.659 . . . . 0.0 109.669 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -89.29 168.26 12.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -148.04 98.41 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -96.04 119.6 34.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -137.01 167.99 20.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.05 -1.031 . . . . 0.0 109.061 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.607 ' HB3' HG13 ' A' ' 12' ' ' VAL . 34.7 tt0 -135.12 138.03 43.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.704 -1.248 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.14 -89.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.25 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.601 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.07 171.31 14.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD1' ' NH2' ' A' ' 89' ' ' ARG . 24.1 tp -53.65 -42.81 68.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.199 -0.938 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.07 -59.27 4.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.23 -15.12 62.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.277 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 1.021 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -71.99 -65.22 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.546 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -69.56 -11.19 60.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.311 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.52 -41.06 24.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.239 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.069 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.3 m95 -79.19 -28.56 42.64 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.335 -0.853 . . . . 0.0 109.165 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.021 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -71.24 -39.05 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 109.095 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -77.43 -23.03 50.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -76.74 -52.05 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.691 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.051 ' O ' HD12 ' A' ' 100' ' ' ILE . 47.8 mt -73.03 -31.92 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 18.7 t-20 -78.1 -28.65 48.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.331 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.9 -42.29 49.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.11 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.2 -36.35 83.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.871 . . . . 0.0 108.822 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.051 HD12 ' O ' ' A' ' 96' ' ' ILE . 4.9 mt -76.04 -31.47 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.127 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -83.08 -12.35 57.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.1 m -93.49 -28.39 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 108.931 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 30' ' ' GLU . 2.6 tp -64.97 -33.18 61.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.418 -0.801 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -12.55 61.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.25 6.62 25.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.82 54.34 2.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.435 -1.038 . . . . 0.0 109.117 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.56 120.77 43.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -142.96 39.36 1.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.434 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -64.76 -160.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 51.9 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 109' ' ' HIS . 2.7 m-70 -69.64 103.3 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -92.18 114.12 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.3 mm-40 173.65 -61.94 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.696 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 53.7 Cg_endo -71.57 134.97 25.3 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.712 1.608 . . . . 0.0 110.243 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' O ' ' OE2' ' A' ' 8' ' ' GLU . 12.5 mmtt -101.22 73.58 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.299 -0.876 . . . . 0.0 109.275 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER 64.15 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 30' ' ' GLU . 34.3 mt -56.22 -67.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 1.017 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -116.89 148.86 40.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.028 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -157.6 134.33 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.592 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.67 -149.0 5.45 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.028 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -138.48 91.38 2.54 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.379 -1.071 . . . . 0.0 110.099 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 165.3 14.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.745 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.677 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -85.58 131.47 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.198 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HE2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -131.14 152.11 50.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -70.4 125.94 28.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.265 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 178.82 120.46 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 163.74 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.377 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 18' ' ' PHE . 1.5 p -140.37 -47.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.548 ' O ' HG23 ' A' ' 20' ' ' THR . 4.0 p90 -140.01 -172.97 3.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.418 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 18.3 p-10 -47.49 92.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' PHE . 59.2 p -130.07 155.57 45.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.896 ' CH2' HG21 ' A' ' 68' ' ' VAL . 2.0 m0 -126.67 119.75 27.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.452 -0.78 . . . . 0.0 109.389 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.677 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.06 131.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.815 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.6 Cg_exo -53.36 150.75 25.25 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.751 1.634 . . . . 0.0 109.751 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 11.6 ptm -168.98 165.83 11.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.066 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.8 t-105 -89.94 145.89 24.79 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -151.04 136.07 10.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.118 -178.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.028 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.0 m -125.72 103.63 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.017 HD21 ' CB ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -77.59 112.25 14.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' H ' ' A' ' 29' ' ' LEU . 1.8 mp -89.54 159.75 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.447 -0.783 . . . . 0.0 109.496 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HB3' HD11 ' A' ' 6' ' ' ILE . 7.7 pt-20 -70.75 -15.35 62.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' HD11 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -112.56 6.8 18.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 109.687 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.955 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 167.45 -165.81 38.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HD12 ' A' ' 48' ' ' ILE . 1.9 mp -144.85 121.99 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -1.097 . . . . 0.0 109.186 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 8.9 mt-10 -127.56 115.02 18.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.344 -0.848 . . . . 0.0 108.92 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HB3' HG23 ' A' ' 26' ' ' VAL . 8.3 p90 -121.45 145.77 47.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 109.982 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -130.62 -167.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.119 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -80.22 -40.87 26.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -113.06 -176.14 2.83 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.76 -24.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.84 -1.162 . . . . 0.0 109.184 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.6 -49.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 43' ' ' SER . 4.8 t70 61.38 10.97 3.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.373 -0.829 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 27.1 m120 43.96 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.971 -1.08 . . . . 0.0 109.546 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.2 t -170.89 103.13 0.41 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 109.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.505 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 55.6 Cg_endo -72.25 145.14 43.03 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.709 1.606 . . . . 0.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.96 -26.15 20.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.81 147.52 11.35 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.9 mtt -134.1 125.73 28.59 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.492 -1.005 . . . . 0.0 109.159 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.984 HD12 HG21 ' A' ' 33' ' ' ILE . 3.0 mt -89.74 137.06 28.71 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.209 -0.932 . . . . 0.0 109.007 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 51.7 Cg_endo -70.81 147.61 56.5 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.707 1.605 . . . . 0.0 110.284 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -88.21 24.24 1.92 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' ILE . 8.5 tttm -157.02 114.17 3.09 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.106 -0.996 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 96.58 32.84 6.41 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.476 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.451 ' OG ' HG12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -109.48 172.12 7.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.268 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.92 110.98 6.29 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.056 -1.027 . . . . 0.0 109.95 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.4 tm? -89.02 130.66 35.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.155 -0.965 . . . . 0.0 109.015 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.748 ' N ' HD13 ' A' ' 55' ' ' LEU . 7.6 m -113.43 100.54 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 55' ' ' LEU . 79.1 p -133.51 129.19 20.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.08 -1.012 . . . . 0.0 109.747 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.9 Cg_endo -78.95 179.71 29.61 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.696 -1.793 . . . . 0.0 110.128 -0.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 41.6 t -105.42 170.84 7.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.566 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 4.6 mm100 -147.76 143.8 27.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.896 -1.127 . . . . 0.0 110.282 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 6.5 t70 84.17 -54.02 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.15 0.5 . . . . 0.0 109.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -94.64 -55.25 3.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 108.437 179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' HG11 ' A' ' 68' ' ' VAL . . . -91.81 34.76 4.23 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -65.99 -9.31 29.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.611 -0.934 . . . . 0.0 109.542 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' MET . 5.8 mtm180 -76.98 -3.09 37.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.509 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 76.96 171.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.842 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 54.05 20.59 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.786 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.896 HG21 ' CH2' ' A' ' 21' ' ' TRP . 3.3 p -140.41 134.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.89 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CD2' HG12 ' A' ' 93' ' ' VAL . 8.2 p90 -117.22 -179.77 3.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 2.8 ttpt -133.71 111.29 10.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.9 mt -89.29 165.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.066 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.9 m -144.93 90.14 2.03 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.894 HG22 HG23 ' A' ' 48' ' ' ILE . 4.3 p -50.8 161.16 0.38 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -54.63 -17.19 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.815 . . . . 0.0 109.819 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -88.43 24.1 2.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.13 30.51 16.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.423 ' HB3' ' NE2' ' A' ' 79' ' ' HIS . 2.1 tm0? -95.96 100.74 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 56.3 m-20 -69.91 152.78 44.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 97.7 m-70 -150.1 101.39 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.135 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.619 ' CE2' ' CD ' ' A' ' 70' ' ' LYS . 8.4 m-85 -90.98 124.95 35.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.647 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.92 140.59 38.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.128 -0.983 . . . . 0.0 109.404 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.7 tt0 -113.15 136.82 52.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . . . -88.88 -92.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.425 -0.797 . . . . 0.0 109.436 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -145.18 -39.89 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 109.94 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -159.32 175.81 12.92 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.51 -0.743 . . . . 0.0 109.734 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.006 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -51.6 -50.09 60.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.57 -0.706 . . . . 0.0 109.56 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.006 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -49.64 -67.5 0.26 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 110.1 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.76 -13.82 17.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 1.033 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.76 -62.25 1.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.694 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 93' ' ' VAL . 6.8 t70 -64.33 -14.86 58.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.208 -0.932 . . . . 0.0 109.574 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -79.54 -46.83 16.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.4 m95 -71.31 -27.92 63.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.436 -0.79 . . . . 0.0 109.223 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.033 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.7 m -78.64 -38.43 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.378 -0.826 . . . . 0.0 109.827 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -74.42 -19.37 60.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.179 -0.951 . . . . 0.0 109.996 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -86.33 -54.26 4.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.053 -1.029 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.787 HG13 HD22 ' A' ' 28' ' ' LEU . 11.6 mt -66.98 -33.36 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 0.0 108.393 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 25.6 t-20 -76.17 -44.62 37.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -63.76 -27.98 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -51.46 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.181 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.804 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -57.44 -51.52 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.01 -17.35 62.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 109.345 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 44.7 t -81.85 -30.23 32.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.055 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -65.43 -38.31 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -12.43 59.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.264 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.68 7.89 12.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 mt -101.88 57.85 0.83 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 108.953 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -95.73 27.26 3.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.647 -0.658 . . . . 0.0 109.643 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.13 85.33 6.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -145.59 36.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -93.13 104.94 17.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -153.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -175.14 94.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.828 . . . . 0.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.389 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' SD ' ' OE1' ' A' ' 2' ' ' GLU . 8.4 tmm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.318 0.58 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' OE1' ' SD ' ' A' ' 1' ' ' MET . 6.6 pt-20 -141.02 156.21 68.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 2' ' ' GLU . 52.5 Cg_exo -50.59 -176.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.01 1.806 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 78.8 mttt -93.18 74.82 4.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.525 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 64.66 143.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 28' ' ' LEU . 46.1 mm -51.48 -74.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.358 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.925 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.85 142.45 46.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.201 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.991 ' CB ' HG12 ' A' ' 27' ' ' VAL . 3.6 pm0 -149.74 132.14 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.024 -1.048 . . . . 0.0 110.162 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.69 -144.03 3.83 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.847 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.7 p90 -144.67 104.56 4.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.977 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.033 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.05 179.07 4.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 108.753 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.825 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -114.04 125.42 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.765 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -107.46 142.97 36.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 110.014 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -87.15 112.36 21.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.406 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.62 39.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.451 ' OG ' ' HD2' ' A' ' 22' ' ' LYS . 8.5 t -79.54 -50.97 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 0.0 109.392 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 18' ' ' PHE . 4.2 m -148.2 -46.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -136.23 -78.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 8.1 m-20 -137.89 70.39 1.39 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.878 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 5.3 p -127.2 155.95 42.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.632 ' HH2' HG23 ' A' ' 68' ' ' VAL . 47.3 m95 -117.94 98.2 6.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.204 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.825 ' C ' HG23 ' A' ' 12' ' ' VAL . 17.3 mttm -110.87 133.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 0.0 109.711 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.5 Cg_exo -53.35 172.76 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.942 1.761 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.765 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 9.2 ptm 176.03 162.45 0.34 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.601 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 66.6 t-105 -89.3 151.11 22.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.894 HG11 HD22 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -150.85 146.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.147 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.991 HG12 ' CB ' ' A' ' 8' ' ' GLU . 11.1 m -145.29 106.61 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.556 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -78.82 116.39 19.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.465 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.2 mp -104.33 167.27 9.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.675 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.702 ' O ' HD13 ' A' ' 103' ' ' ILE . 5.7 pt-20 -73.67 -17.78 61.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.889 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.1 p30 -101.35 8.73 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 1.106 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 140.22 148.31 5.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.3 mp -94.73 109.01 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -1.166 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 29' ' ' LEU . 7.1 pt-20 -111.12 123.76 50.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 108.856 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.4 p90 -121.26 142.8 49.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -119.5 -151.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.43 -0.794 . . . . 0.0 109.031 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 -39.22 9.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -119.87 -176.04 3.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -43.12 -25.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.024 -1.048 . . . . 0.0 109.567 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -146.57 -53.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' SER . 1.2 t70 62.98 7.67 2.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.453 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' ASP . 5.1 m120 40.6 23.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -164.72 101.49 0.83 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.791 -1.193 . . . . 0.0 110.377 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.5 Cg_exo -51.78 164.07 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.055 1.837 . . . . 0.0 110.702 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 3.1 tppt? -134.52 3.45 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 156.18 134.57 1.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.3 mtt -135.15 138.16 43.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.648 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.5 mt -104.73 125.82 32.9 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HG2' ' OG1' ' A' ' 73' ' ' THR . 53.2 Cg_endo -71.39 130.56 17.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.665 1.577 . . . . 0.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.106 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -74.88 -0.34 18.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.168 -0.957 . . . . 0.0 109.609 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HB2' HG21 ' A' ' 74' ' ' THR . 1.1 mmtp -44.0 -62.28 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.53 57.94 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.7 m -81.21 170.21 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 109.169 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.89 160.52 25.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 55' ' ' LEU . 3.0 tm? -134.72 96.14 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.081 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.634 HG22 ' SG ' ' A' ' 59' ' ' CYS . 85.7 m -90.19 109.36 20.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 55' ' ' LEU . 11.1 p -146.41 142.28 17.29 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.15 -176.11 17.55 Favored 'Cis proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.336 -1.943 . . . . 0.0 110.54 -0.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 56' ' ' THR . 4.8 m -150.28 60.27 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.285 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.532 ' CG ' ' HA ' ' A' ' 64' ' ' LYS . 5.5 tt0 -71.12 124.26 24.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.822 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 1.6 m-20 166.49 -43.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -88.97 -68.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 64' ' ' LYS . . . -81.42 -26.94 49.96 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CG ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 34.41 39.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.452 0.644 . . . . 0.0 110.015 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 ttt-85 -117.99 -137.49 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt -42.51 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.01 . . . . 0.0 109.662 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.61 ' CD1' ' CD ' ' A' ' 89' ' ' ARG . 2.1 m-85 -142.21 111.18 6.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.406 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.632 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -120.66 119.95 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.833 . . . . 0.0 109.653 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.5 p90 -118.14 168.33 10.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.9 pttt -127.91 121.42 29.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 55' ' ' LEU . 9.0 mt -96.1 161.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 108.98 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.555 ' N ' HG22 ' A' ' 54' ' ' THR . 50.4 m -140.27 99.58 3.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.242 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -52.89 155.63 2.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.361 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -41.2 -27.56 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.729 -0.607 . . . . 0.0 109.819 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 73' ' ' THR . 2.0 mmmm -77.63 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.62 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 177.6 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -103.17 72.0 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.076 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 5.7 p-10 -43.51 141.72 1.34 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 109.752 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -127.17 137.73 53.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.09 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 14' ' ' LYS . 40.8 m-85 -93.46 128.95 39.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 1.033 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.8 t80 -129.86 139.44 51.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.558 -0.714 . . . . 0.0 109.366 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.57 ' CB ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.27 119.86 13.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.05 -150.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.819 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -120.27 -26.01 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.054 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -156.18 175.55 13.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 0.0 109.871 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.3 -60.48 3.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.747 . . . . 0.0 110.249 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.072 ' N ' HD13 ' A' ' 86' ' ' LEU . 3.6 tm-20 -46.33 -56.65 5.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.219 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 33.2 tt0 -58.4 -30.52 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.673 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.787 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.926 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.558 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -54.7 -23.26 16.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.06 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.06 -35.75 59.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 109.583 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CE2' HD21 ' A' ' 11' ' ' LEU . 13.0 m95 -76.36 -41.23 48.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.323 -0.861 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -75.37 -28.1 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.797 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.539 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.1 ptm180 -76.83 -30.02 56.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.996 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -90.43 -30.65 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 110.039 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -72.48 -31.22 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.06 . . . . 0.0 108.518 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -85.42 -36.5 20.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -66.82 -47.16 72.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.0 109.096 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.84 -37.16 83.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.876 HG12 HD23 ' A' ' 50' ' ' LEU . 46.6 mt -71.94 -23.9 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.96 -15.04 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 t -95.42 -26.4 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.773 . . . . 0.0 109.337 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.2 tp -76.58 -21.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 51' ' ' LYS . 1.8 mm-40 -67.03 -11.48 57.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.81 5.22 12.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -105.35 58.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.416 -1.049 . . . . 0.0 109.16 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.99 163.14 12.72 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.655 -0.653 . . . . 0.0 109.548 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 94.12 2.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.433 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -46.22 131.88 10.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.492 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' HIS . 6.3 t-160 -128.06 50.83 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 110' ' ' HIS . 37.0 m80 44.2 43.01 5.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -86.73 51.0 2.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 10.3 m80 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.5 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.3 mm-40 -64.33 162.85 29.55 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 53.5 Cg_exo -50.93 163.98 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.973 1.782 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -146.52 73.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.586 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -96.28 146.01 25.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.324 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.26 -46.4 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.62 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.746 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -128.36 138.43 52.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.66 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.004 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -156.06 133.89 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.253 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.02 -146.13 4.63 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' C ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -131.83 97.03 4.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -1.015 . . . . 0.0 110.053 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.045 HD23 ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -108.65 172.69 6.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 108.57 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.945 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.4 p -117.77 125.3 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.879 -1.138 . . . . 0.0 109.402 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 7.6 mmtp -95.53 159.9 14.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.695 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 15.1 ttpp -85.95 94.45 9.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.67 141.29 3.72 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 17' ' ' VAL . 22.8 t -102.21 108.08 19.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.139 . . . . 0.0 109.534 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 16' ' ' SER . 2.6 p 172.19 -30.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.376 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.72 36.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.323 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.84 68.22 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.371 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.6 p -117.95 169.72 9.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 109.701 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.62 ' HH2' HG23 ' A' ' 68' ' ' VAL . 10.7 m95 -148.09 100.37 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.945 ' C ' HG23 ' A' ' 12' ' ' VAL . 19.1 mttt -118.93 136.35 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.839 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.9 Cg_exo -53.99 176.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.833 1.689 . . . . 0.0 109.975 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 19.5 ptm 176.74 159.96 0.36 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.7 t-105 -89.54 146.69 24.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.32 134.28 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.097 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.4 m -128.72 98.66 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.59 -0.693 . . . . 0.0 109.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.05 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 4.0 pp -77.55 123.62 26.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.09 -1.006 . . . . 0.0 109.081 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 32' ' ' GLY . 2.0 mp -109.35 165.16 11.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.82 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.567 ' O ' HD22 ' A' ' 50' ' ' LEU . 1.9 tm-20 -74.87 -9.28 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 2.5 p30 -112.32 7.92 19.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.925 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.782 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 145.06 147.08 4.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.0 mp -103.15 120.59 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -1.162 . . . . 0.0 109.861 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 2.6 pt-20 -120.07 121.94 39.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.675 ' HB3' HG23 ' A' ' 26' ' ' VAL . 10.6 p90 -125.55 141.24 52.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.096 -1.003 . . . . 0.0 110.405 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.86 -145.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 24' ' ' MET . 2.6 mmtm -99.16 -39.18 8.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.076 -1.015 . . . . 0.0 109.349 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -119.42 -178.27 3.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.269 -0.895 . . . . 0.0 109.09 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 tppt? -43.21 -30.8 0.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 108.708 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.448 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -165.29 72.48 0.18 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.515 -0.741 . . . . 0.0 109.49 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 1.6 t0 -51.39 -18.85 1.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 8.6 t-20 91.48 -18.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -127.69 106.3 20.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 42.6 Cg_endo -68.79 134.39 29.97 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.726 1.618 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -25.74 20.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' C ' ' CZ ' ' A' ' 35' ' ' PHE . . . -165.51 145.01 9.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -128.65 -168.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -1.073 . . . . 0.0 109.407 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.63 HG23 HG22 ' A' ' 73' ' ' THR . 3.5 mt -150.31 111.16 3.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.31 131.29 23.04 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.58 1.52 . . . . 0.0 110.355 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.782 HD13 ' HA2' ' A' ' 32' ' ' GLY . 5.4 mp -84.46 41.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -99.15 -40.07 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.641 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.15 76.22 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.526 ' HB2' HD13 ' A' ' 100' ' ' ILE . 6.2 m -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.276 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -115.02 171.76 7.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.647 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.4 tm? -143.51 119.61 10.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.819 . . . . 0.0 108.895 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 1.043 HG22 ' O ' ' A' ' 58' ' ' PRO . 20.7 m -114.42 139.1 49.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.101 -0.999 . . . . 0.0 110.345 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -150.51 118.06 3.49 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.086 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.043 ' O ' HG22 ' A' ' 56' ' ' THR . 46.2 Cg_endo -70.21 -160.05 1.41 Allowed 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.562 -1.849 . . . . 0.0 110.399 0.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -117.14 -78.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.239 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.806 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -134.12 -159.94 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.033 . . . . 0.0 110.25 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.54 14.24 3.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 21' ' ' TRP . 16.6 m-85 -88.5 86.86 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 88.35 41.92 6.01 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 4.5 pttt -37.72 111.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.85 -0.794 . . . . 0.0 110.042 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER 178.26 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.771 ' SD ' ' HB2' ' A' ' 86' ' ' LEU . 22.4 ptp 171.93 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.678 0.751 . . . . 0.0 109.363 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HA ' ' CB ' ' A' ' 89' ' ' ARG . 2.2 m-85 -60.09 -21.79 61.94 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.94 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.62 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.1 p -94.65 105.85 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -99.93 170.78 8.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.682 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -140.24 103.28 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.682 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 72' ' ' THR . 14.3 mt -90.54 165.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.629 ' CB ' HG22 ' A' ' 54' ' ' THR . 59.1 m -141.52 87.78 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.63 HG22 HG23 ' A' ' 48' ' ' ILE . 1.8 p -47.35 160.2 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 0.0 108.841 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.43 -13.67 14.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.706 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.25 20.45 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.94 29.22 16.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -92.45 98.49 11.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.234 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 5.6 p30 -68.5 135.4 51.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.791 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -140.07 95.69 2.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.398 -0.814 . . . . 0.0 108.837 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -109.72 135.59 50.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 0.0 110.144 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 1.045 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -149.99 159.23 44.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.778 . . . . 0.0 109.361 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -114.04 138.08 50.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -139.49 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.269 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -118.48 -7.82 10.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.897 -1.127 . . . . 0.0 110.056 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -168.11 175.64 6.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -0.963 . . . . 0.0 109.751 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.74 -37.17 67.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 109.236 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.968 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -60.21 -49.18 78.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.043 -1.036 . . . . 0.0 109.712 -179.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -72.96 -33.53 65.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.099 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 1.047 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.43 -39.1 92.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.992 . . . . 0.0 109.411 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.705 ' HA ' HG22 ' A' ' 93' ' ' VAL . 13.5 t0 -78.88 -20.03 50.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -0.994 . . . . 0.0 108.614 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -76.94 -26.87 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.05 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 26.8 m95 -85.52 -37.85 19.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.9 m -71.32 -37.74 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 110.113 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 7.1 ptt180 -80.89 -30.93 35.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.226 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 5.4 t0 -75.06 -41.43 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.914 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.2 mt -75.08 -32.96 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 109.334 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 58.8 t-20 -75.25 -32.05 60.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.5 -45.13 40.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.103 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -58.11 -43.05 86.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.842 . . . . 0.0 109.141 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 96' ' ' ILE . 17.0 mt -70.09 -37.76 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.183 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -72.31 -10.57 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.457 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -38.99 12.03 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 50' ' ' LEU . 4.0 mm -65.32 -40.32 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 51' ' ' LYS . 2.4 mt-10 -68.96 -7.6 36.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.09 11.37 5.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 2.3 mt -97.4 56.76 1.36 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.401 -1.058 . . . . 0.0 109.114 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.51 100.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.736 -0.603 . . . . 0.0 109.484 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -113.03 -179.11 3.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -77.59 92.27 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -51.09 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.614 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -92.84 7.42 43.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -68.63 139.29 55.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.408 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 3' ' ' PRO . 28.9 mm-40 -100.62 161.2 24.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' GLU . 51.1 Cg_exo -51.65 -167.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.165 1.91 . . . . 0.0 110.508 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -111.57 92.66 4.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.41 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.679 ' HG3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -43.7 157.21 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' A' ' 30' ' ' GLU . 85.9 mt -76.32 -58.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.646 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.739 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.9 tpm_? -133.34 111.89 11.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.941 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.035 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -118.31 132.5 56.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.054 -1.029 . . . . 0.0 109.417 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.42 -147.69 4.97 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.952 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.3 p90 -141.38 96.62 3.02 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.322 -1.105 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.971 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -121.51 176.42 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.907 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -103.06 147.5 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 26.8 mmtt -118.64 179.82 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 3.6 tttt -133.41 64.1 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.616 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -157.39 131.63 2.96 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 12.6 t 169.54 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.134 . . . . 0.0 109.437 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 4.2 p -100.79 -30.75 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 4.8 m-85 -174.73 176.78 2.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 25.0 p-10 -45.61 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 36.9 p -142.95 -176.83 5.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.727 ' CH2' HG23 ' A' ' 68' ' ' VAL . 56.5 m95 -156.13 105.55 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.143 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.907 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -137.6 135.16 18.84 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.495 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.5 Cg_exo -51.65 166.87 0.48 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.954 1.769 . . . . 0.0 110.461 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 13.1 ptm 178.04 165.36 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -0.907 . . . . 0.0 109.729 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.3 t-105 -90.15 145.16 25.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -150.97 135.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.702 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.035 HG12 ' HB3' ' A' ' 8' ' ' GLU . 8.8 m -125.5 103.2 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -82.44 117.11 22.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.947 -1.095 . . . . 0.0 109.972 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 5' ' ' ARG . 2.0 mp -105.35 166.33 10.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.662 ' CG ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -74.45 -17.61 60.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 0.0 109.435 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -97.39 8.47 44.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.727 ' HA2' HD12 ' A' ' 50' ' ' LEU . . . 139.43 152.13 5.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.8 mp -101.27 118.55 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.196 -1.179 . . . . 0.0 109.655 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 17.8 pt-20 -117.97 116.15 26.34 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 26' ' ' VAL . 1.8 p90 -116.12 150.62 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.054 -1.029 . . . . 0.0 110.594 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -128.6 -153.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -41.38 9.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.0 mttt -115.7 -172.26 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 6.1 tppt? -44.85 -25.36 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 109.288 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -154.83 -47.07 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.594 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.8 t70 61.65 11.21 3.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.35 22.52 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.776 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -163.36 111.37 1.0 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.994 -1.066 . . . . 0.0 109.743 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.2 Cg_endo -71.92 133.25 21.32 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.888 1.725 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 2.2 tttt -89.5 -23.24 22.11 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 178.47 151.79 9.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 mtm -137.65 135.57 36.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -1.154 . . . . 0.0 109.743 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.92 137.68 19.58 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 48.4 Cg_endo -71.0 99.16 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.447 1.431 . . . . 0.0 109.832 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -66.74 -4.51 9.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.945 . . . . 0.0 110.528 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 50' ' ' LEU . 3.4 ptmm? -85.45 48.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.544 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . 151.38 -22.35 0.95 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.891 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.586 ' O ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -42.48 146.75 0.31 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.096 -1.238 . . . . 0.0 109.828 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.2 162.75 13.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 56' ' ' THR . 3.0 tm? -117.51 147.19 42.99 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.063 -1.023 . . . . 0.0 108.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 1.07 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 m -149.31 129.45 13.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.924 -1.11 . . . . 0.0 110.086 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.71 126.81 5.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 109.138 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 57' ' ' SER . 25.0 Cg_exo -67.0 -150.46 0.33 Allowed 'Cis proline' 0 C--N 1.309 -1.52 0 C-N-CA 123.148 -1.605 . . . . 0.0 110.903 -1.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' CA ' ' HD3' ' A' ' 70' ' ' LYS . 30.1 p -131.81 -148.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.407 -0.808 . . . . 0.0 109.974 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 173.98 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -91.62 5.03 51.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.437 -0.789 . . . . 0.0 109.601 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -88.74 45.26 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.219 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 160.22 38.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 85.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.381 -1.07 . . . . 0.0 109.518 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -147.96 23.35 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.561 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 12.8 mtt 62.7 159.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.466 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 2.6 m-85 82.43 -28.85 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.561 -0.712 . . . . 0.0 110.47 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.727 HG23 ' CH2' ' A' ' 21' ' ' TRP . 15.0 p -93.11 135.11 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.195 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.808 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -133.4 -176.47 4.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -150.11 118.93 6.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.07 . . . . 0.0 110.292 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 54' ' ' THR . 3.7 mt -96.67 162.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 54' ' ' THR . 90.4 m -127.39 91.43 3.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 108.842 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.877 HG22 HG22 ' A' ' 48' ' ' ILE . 1.4 p -43.21 144.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.474 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.496 ' HB ' ' HA3' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -41.07 -34.7 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.804 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -66.36 -74.9 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.227 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 166.11 35.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.588 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.469 ' O ' HG23 ' A' ' 73' ' ' THR . 1.4 mm-40 -105.78 118.95 37.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 3.2 m-20 -83.31 103.3 12.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.747 ' CE1' HG23 ' A' ' 48' ' ' ILE . 68.1 m80 -89.78 105.31 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.165 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 5.6 m-85 -94.63 117.99 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.705 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -136.86 138.74 41.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 108.623 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.572 ' CG ' ' CG1' ' A' ' 12' ' ' VAL . 8.3 pt20 -118.01 146.27 44.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 -153.05 0.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 109.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -108.31 -2.21 19.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -169.09 169.94 9.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 0.0 109.187 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.601 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 27.6 tp -69.81 -30.81 68.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -56.89 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 108.868 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -69.17 -15.33 63.38 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.178 -0.951 . . . . 0.0 108.74 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 1.046 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.1 ttt180 -68.94 -63.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.818 . . . . 0.0 109.354 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.92 -13.26 62.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.9 25.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.047 -1.033 . . . . 0.0 108.861 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.971 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 1.9 m95 -81.97 -27.91 32.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -75.33 -33.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.164 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 2.5 mmm180 -79.74 -29.95 40.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.61 ' OD1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -74.74 -49.38 21.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.523 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.006 ' O ' HD12 ' A' ' 100' ' ' ILE . 9.8 mt -72.58 -36.6 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.025 -1.047 . . . . 0.0 108.866 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 58.2 t30 -73.28 -26.39 61.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -76.68 -45.22 30.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.867 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.91 -34.02 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.332 -0.855 . . . . 0.0 108.969 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.006 HD12 ' O ' ' A' ' 96' ' ' ILE . 1.3 mt -74.9 -40.84 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 108.826 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 13.9 tptm -73.2 -7.87 53.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.073 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -40.72 9.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.814 ' CG1' HD21 ' A' ' 50' ' ' LEU . 1.2 mm -60.64 -44.01 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 108.805 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 3.1 mt-10 -46.49 -26.23 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.37 -103.29 2.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER 46.92 66.34 1.02 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.375 -1.073 . . . . 0.0 109.218 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -112.23 38.78 2.61 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.184 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.13 -13.69 32.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.9 m170 58.52 78.12 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.18 73.74 1.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.91 -25.06 11.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.441 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -167.19 137.66 3.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.484 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.441 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.338 0.589 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 6.0 tt0 -179.79 -63.3 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.249 -0.907 . . . . 0.0 109.278 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 50.1 Cg_endo -69.67 173.0 11.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.791 1.661 . . . . 0.0 110.037 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HB3' ' HD2' ' A' ' 5' ' ' ARG . 8.4 mmtt -141.09 106.54 5.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 64.3 120.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.394 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.581 HG21 ' OD1' ' A' ' 95' ' ' ASP . 77.2 mt -47.13 -70.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.702 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -101.58 169.12 9.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.786 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.837 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 173.65 132.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.575 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -173.12 -143.68 4.32 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -124.03 106.97 10.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.933 . . . . 0.0 109.427 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -120.53 178.47 4.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.818 . . . . 0.0 108.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -123.41 122.68 65.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 108.596 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.794 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -104.02 126.62 51.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 109.466 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HG3' ' CD1' ' A' ' 21' ' ' TRP . 19.1 tttt -73.17 99.76 2.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 178.36 48.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 t -98.07 114.5 26.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -1.164 . . . . 0.0 109.56 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 18' ' ' PHE . 5.1 p -167.33 -45.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.53 ' N ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -174.93 48.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.406 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 20.5 m-20 49.56 63.53 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 1.1 p -129.41 161.59 30.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.735 ' CH2' HG21 ' A' ' 68' ' ' VAL . 34.0 m95 -125.64 118.98 26.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.851 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.2 mttt -121.88 130.04 24.91 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.684 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 49.1 Cg_exo -55.04 -179.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.8 1.667 . . . . 0.0 110.119 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.794 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 6.5 ptm 169.29 169.63 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.584 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.7 t-105 -92.46 152.25 19.79 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.741 HG11 ' HB2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -149.66 149.96 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.581 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.837 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.8 m -144.52 112.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.007 HD13 HG13 ' A' ' 96' ' ' ILE . 5.1 mt -78.94 121.66 25.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.449 -0.782 . . . . 0.0 109.095 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.58 HD21 ' CG ' ' A' ' 5' ' ' ARG . 1.1 mp -110.79 156.28 21.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.295 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.539 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.3 tt0 -72.46 -21.97 61.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.872 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' HD11 ' A' ' 103' ' ' ILE . 2.8 m-20 -98.64 10.93 39.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 109.369 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.736 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 146.77 -175.66 26.06 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.512 HD13 ' HB ' ' A' ' 48' ' ' ILE . 1.9 mp -132.47 137.9 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.051 -1.264 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 3.5 pt-20 -144.55 123.44 12.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.299 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CZ ' ' HD3' ' A' ' 13' ' ' LYS . 5.0 p90 -121.65 140.18 52.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -121.69 -148.37 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 109.027 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -60.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.1 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -96.65 -177.14 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 108.727 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.68 -28.39 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 108.612 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -163.01 69.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.452 -0.78 . . . . 0.0 109.387 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 60.6 t0 -48.26 -21.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.7 t-20 91.8 -21.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -118.89 107.03 42.78 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 44.1 Cg_endo -68.86 146.97 67.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.778 1.652 . . . . 0.0 110.826 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 -31.58 9.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.397 -0.814 . . . . 0.0 109.076 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -154.3 143.24 9.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.517 ' C ' HD13 ' A' ' 48' ' ' ILE . 5.8 mtt -133.26 135.74 45.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.644 ' N ' HD13 ' A' ' 48' ' ' ILE . 2.2 mm -95.16 107.94 35.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 109.265 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' A' ' 53' ' ' SER . 46.3 Cg_endo -70.04 118.91 5.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.707 1.605 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.736 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.8 mp -63.29 -9.57 12.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.898 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -71.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 109.84 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' O ' ' CA ' ' A' ' 74' ' ' THR . . . -152.46 71.79 0.28 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -100.53 166.0 11.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.161 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.89 157.32 36.25 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.3 tm? -127.48 102.06 6.71 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 58' ' ' PRO . 19.5 m -89.6 133.45 34.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 0.0 110.009 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -146.6 122.94 5.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.403 -0.811 . . . . 0.0 109.385 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 56' ' ' THR . 49.7 Cg_endo -72.23 -161.88 2.26 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.558 -1.851 . . . . 0.0 110.416 -0.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.769 ' SG ' HG13 ' A' ' 68' ' ' VAL . 21.8 p -103.95 -147.16 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -71.68 -141.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 109.922 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -3.03 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.505 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 68' ' ' VAL . 19.9 m-85 -88.82 -21.13 23.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.509 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.749 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -76.61 -22.81 71.65 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -2.83 31.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.541 -0.976 . . . . 0.0 109.156 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -104.59 -95.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.555 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.489 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 9.4 mtt -94.34 -147.26 0.26 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.645 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 44.2 m-85 -101.79 92.69 4.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 81' ' ' PHE . 3.8 p -135.71 132.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.493 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.731 ' CE1' HD12 ' A' ' 71' ' ' ILE . 3.2 p90 -110.29 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.955 -1.091 . . . . 0.0 109.718 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -124.94 106.12 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.731 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.8 mt -88.48 160.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 74.8 m -133.53 90.69 2.75 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 79' ' ' HIS . 3.3 p -45.3 158.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.062 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -59.89 -14.07 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -86.89 16.81 4.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.58 43.37 4.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' THR . 13.6 tt0 -118.48 118.24 31.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.3 m-20 -70.61 163.3 27.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 73' ' ' THR . 12.3 m-70 -143.98 128.64 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.035 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 14.5 m-85 -91.59 113.42 25.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.858 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 1.7 t80 -128.16 128.19 44.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 110.689 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.576 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -126.91 136.05 51.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -0.827 . . . . 0.0 109.735 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -107.48 -150.84 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 0.0 109.798 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.29 -88.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -106.94 -179.27 3.89 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.59 -0.694 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.029 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -56.08 -58.18 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.69 . . . . 0.0 109.75 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.029 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.1 tp10 -43.46 -70.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.972 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 1.2 tt0 -48.94 -33.71 11.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 93' ' ' VAL . 13.1 ttp180 -56.36 -65.01 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.86 -22.18 9.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.958 . . . . 0.0 109.263 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -70.9 -40.94 71.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.861 ' CE2' HD21 ' A' ' 11' ' ' LEU . 77.8 m95 -73.03 -52.73 13.27 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.507 -0.746 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -65.56 -24.84 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.518 -0.739 . . . . 0.0 110.794 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.552 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.6 ptt85 -85.24 -23.58 28.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.903 -1.123 . . . . 0.0 110.074 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' OD1' HG21 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -85.61 -38.66 18.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.075 -1.016 . . . . 0.0 109.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.007 HG13 HD13 ' A' ' 28' ' ' LEU . 21.1 mt -76.73 -35.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.102 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.46 -31.76 58.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -72.2 -55.92 6.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 108.983 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.0 67.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 59.2 mt -63.67 -45.27 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.035 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -67.88 -8.87 40.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.7 t -95.1 -35.38 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.68 HD12 HD22 ' A' ' 50' ' ' LEU . 2.2 mt -79.82 -26.68 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.032 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -73.14 -7.65 52.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.22 12.51 5.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 107' ' ' GLU . 2.5 mt -99.25 56.74 1.03 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -1.037 . . . . 0.0 109.306 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 106' ' ' LEU . 31.3 mt-10 56.66 160.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.7 -0.625 . . . . 0.0 109.521 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -120.7 48.62 1.58 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.565 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -100.26 68.23 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' HIS . 0.3 OUTLIER 47.64 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.402 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' A' ' 112' ' ' HIS . 72.1 m-70 -115.18 29.21 8.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 9.8 t-160 64.11 113.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.274 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.422 ' OXT' ' O ' ' A' ' 112' ' ' HIS . 7.9 t60 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.393 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.585 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -56.72 -61.83 6.14 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 49.8 Cg_endo -70.85 -173.04 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.849 1.699 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 40.2 64.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.719 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 2.0 mpt_? 57.71 154.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.6 mm -64.36 -56.8 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.217 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.556 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -132.85 90.61 2.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.981 -1.074 . . . . 0.0 110.414 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.011 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -103.33 128.91 50.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.867 -1.146 . . . . 0.0 109.185 178.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.597 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.43 -149.94 5.68 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.929 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.0 p90 -141.26 97.15 3.11 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -114.19 171.65 7.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.929 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.9 p -102.34 129.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.776 -1.202 . . . . 0.0 109.872 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.574 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -119.75 166.04 13.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.311 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 10.8 ttpt -68.21 121.65 16.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.32 -161.69 2.8 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' VAL . 23.3 t -119.16 -16.61 9.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -1.161 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -46.68 -93.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' H ' HG23 ' A' ' 17' ' ' VAL . 36.6 m-85 -126.67 52.0 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.511 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.0 OUTLIER 59.01 78.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 40.0 p -124.74 -165.79 1.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.779 ' HH2' HG23 ' A' ' 68' ' ' VAL . 2.1 m95 -144.78 104.83 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.929 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.9 mttp -132.65 144.0 51.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -52.21 166.39 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.77 1.647 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.632 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 23.1 ptm -176.51 159.53 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -0.954 . . . . 0.0 109.648 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.6 t-105 -89.81 143.64 26.63 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.654 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.27 150.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.672 -179.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.011 HG12 ' CB ' ' A' ' 8' ' ' GLU . 7.6 m -137.52 119.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.873 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.865 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -85.05 105.61 15.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.452 -0.78 . . . . 0.0 108.914 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -96.85 157.92 15.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.0 109.681 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -72.89 -17.5 61.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 109.788 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -101.9 5.86 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 153.29 -171.6 32.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.4 mm -133.05 122.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.383 -1.069 . . . . 0.0 109.283 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 27' ' ' VAL . 6.0 pt-20 -129.12 127.27 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 6.7 p90 -131.09 146.4 52.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.46 -150.31 0.44 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 -32.43 11.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 108.877 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 2.8 tttp -121.05 -179.58 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -45.56 -27.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -166.96 73.36 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.0 109.702 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 24.8 t70 -50.98 -19.04 0.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.996 -1.065 . . . . 0.0 108.172 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 6.3 t-20 90.92 -17.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -132.34 94.55 22.84 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 36' ' ' TYR . 50.7 Cg_exo -49.41 139.0 29.95 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.968 1.779 . . . . 0.0 110.878 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 9.7 mmtt -90.07 -23.02 21.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -164.9 143.8 8.81 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 mtm -134.97 123.87 24.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -1.19 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.77 129.76 41.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.318 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 55.7 Cg_endo -72.51 137.45 27.89 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.687 1.592 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -88.11 23.06 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.612 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 49' ' ' PRO . 12.9 ptpt -91.77 -18.78 23.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.185 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -157.76 -91.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER 56.99 132.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.545 -0.973 . . . . 0.0 110.674 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.567 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.51 167.71 9.85 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -133.73 142.48 47.97 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.027 -1.045 . . . . 0.0 109.025 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.984 ' N ' HD13 ' A' ' 55' ' ' LEU . 52.6 m -130.22 119.88 23.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.891 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.7 t -143.61 120.27 6.6 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.07 -160.92 1.92 Allowed 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.573 -1.844 . . . . 0.0 110.143 -0.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 17.9 p -89.67 -149.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.435 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 18.4 tt0 -110.17 -139.86 0.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.536 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.25 26.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.877 -1.139 . . . . 0.0 109.367 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 1.3 t80 -88.86 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -101.56 -42.3 2.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 7.2 tttt 55.45 19.4 3.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -1.007 . . . . 0.0 109.488 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 9.7 mmm180 -87.09 -144.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mtt -126.62 -4.05 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.11 -0.994 . . . . 0.0 109.85 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' MET . 0.5 OUTLIER -130.08 32.62 4.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.013 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.7 p -128.56 123.49 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.002 -1.062 . . . . 0.0 109.637 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 11.0 p90 -118.79 174.31 6.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -135.06 127.07 29.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.553 HG13 ' CD2' ' A' ' 55' ' ' LEU . 6.6 mt -105.99 163.39 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.567 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 98.0 m -145.13 99.91 3.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.25 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.368 -0.832 . . . . 0.0 109.994 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER 43.46 37.74 1.54 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.935 . . . . 0.0 110.864 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 80.24 45.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 0.0 109.57 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.97 -82.87 0.32 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.028 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.7 OUTLIER -90.17 131.25 36.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.499 -0.75 . . . . 0.0 110.118 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.543 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 9.5 t0 -97.56 145.16 26.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 13' ' ' LYS . 81.3 m-70 -137.72 109.23 6.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -101.39 115.04 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.382 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -143.84 145.98 32.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 109.617 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.503 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 pt20 -116.78 147.01 42.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.51 -0.744 . . . . 0.0 109.052 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -143.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.45 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.91 -60.83 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 110.12 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.28 175.1 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.668 -0.645 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.041 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -45.7 -50.14 13.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.041 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.7 tm-20 -51.63 -57.93 7.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.045 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 92' ' ' TRP . 11.8 tt0 -63.19 -18.04 63.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.977 ' O ' HG13 ' A' ' 93' ' ' VAL . 15.8 ttp180 -72.96 -65.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HA ' HG22 ' A' ' 93' ' ' VAL . 59.3 t0 -65.75 -11.57 46.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.277 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.35 -41.19 22.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.003 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 12.4 m95 -76.68 -31.1 57.05 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.454 -0.779 . . . . 0.0 108.99 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.977 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -70.6 -38.65 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.567 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -78.91 -20.08 50.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.708 ' HB3' HD12 ' A' ' 28' ' ' LEU . 9.5 t70 -77.73 -58.0 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.834 HG13 HD13 ' A' ' 28' ' ' LEU . 1.1 mt -63.6 -35.09 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 108.707 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 35.0 t30 -73.77 -32.54 63.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.91 -57.13 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -51.66 -42.42 62.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.238 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.483 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 45.0 mt -59.68 -50.62 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.314 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -10.89 35.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -93.12 -28.84 16.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.285 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.618 ' CG1' HD23 ' A' ' 50' ' ' LEU . 4.9 mm -78.0 -34.06 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.57 -4.85 33.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.4 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.72 13.02 4.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 106' ' ' LEU . 2.6 mt -97.57 56.7 1.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.448 -1.031 . . . . 0.0 109.218 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -51.9 -84.58 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.665 -0.647 . . . . 0.0 109.533 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -47.57 133.59 13.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.543 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.52 -44.78 1.52 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.468 ' O ' ' CB ' ' A' ' 111' ' ' HIS . 21.1 t-80 -135.98 24.84 3.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER 74.01 31.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.387 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 24.6 t-80 179.45 -71.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 55.0 p-80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 9.7 mt-10 -48.76 -61.75 2.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.6 Cg_endo -72.2 -175.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.762 1.642 . . . . 0.0 110.159 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' PRO . 25.9 mttt 45.72 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.681 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 mpt_? 68.02 169.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.665 HD11 ' CB ' ' A' ' 30' ' ' GLU . 46.7 mt -92.81 -77.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.97 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -107.5 104.83 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 110.099 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.022 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.2 pm0 -115.65 135.51 53.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.3 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.589 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.73 -146.8 4.65 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.764 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.6 p90 -138.57 97.4 3.34 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.411 -1.052 . . . . 0.0 109.78 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -119.36 146.8 45.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.4 p -76.34 137.68 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.026 -1.047 . . . . 0.0 109.298 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -117.18 165.19 13.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.42 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 2.1 tmtt? -116.31 125.11 51.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.348 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' VAL . . . 164.86 -120.11 0.92 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 51.21 -91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -1.146 . . . . 0.0 109.383 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 18' ' ' PHE . 14.8 m -117.51 -147.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.524 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -42.71 165.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.478 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' PHE . 3.1 m120 -43.53 105.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.376 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -132.29 174.42 10.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.764 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CD1' ' O ' ' A' ' 20' ' ' THR . 3.4 m95 -152.33 106.94 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.619 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.6 mmtt -138.18 138.8 23.8 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.33 151.58 17.4 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.849 1.7 . . . . 0.0 109.922 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.774 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.15 171.07 20.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 110.341 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.774 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.9 t-105 -96.94 145.8 25.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -150.19 139.24 15.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.05 -178.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -129.09 106.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.821 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.022 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.5 pp -86.45 111.91 21.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.992 . . . . 0.0 109.193 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.9 mp -93.29 164.58 13.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.789 . . . . 0.0 109.564 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.665 ' CB ' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -74.99 -15.8 60.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.6 p30 -101.87 10.11 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.339 -0.85 . . . . 0.0 109.169 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.932 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 148.49 -165.15 29.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.682 HG21 HD12 ' A' ' 48' ' ' ILE . 2.9 mt -141.07 141.51 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -1.198 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.691 ' HG2' HD11 ' A' ' 29' ' ' LEU . 12.1 pt-20 -148.12 115.03 6.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.747 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.5 p90 -112.81 148.72 34.24 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 110.792 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -124.62 -156.76 0.74 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -46.42 6.56 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -111.37 -169.22 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -46.5 -24.79 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.793 -1.192 . . . . 0.0 109.024 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -153.52 -50.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.199 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.67 10.08 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.418 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' ASP . 38.8 m-20 41.9 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -156.79 96.17 2.18 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 110.037 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.9 Cg_exo -51.82 171.7 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.054 1.836 . . . . 0.0 110.58 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.49 4.98 2.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.455 -0.778 . . . . 0.0 109.287 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.53 141.68 3.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.52 ' HG2' ' CB ' ' A' ' 34' ' ' GLU . 26.4 mtm -124.41 139.69 53.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 0.0 109.634 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 HG22 ' A' ' 73' ' ' THR . 2.3 mt -101.31 125.85 36.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.075 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.71 131.91 19.34 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.547 1.498 . . . . 0.0 110.08 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.048 HD21 ' HB1' ' A' ' 99' ' ' ALA . 1.5 mp -73.74 -0.03 14.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.1 OUTLIER -42.14 -88.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.78 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.51 54.99 0.56 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.397 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -66.95 156.25 36.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.246 . . . . 0.0 108.941 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -103.73 171.07 7.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 108.855 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.2 tm? -143.33 114.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.205 -0.934 . . . . 0.0 109.114 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 58' ' ' PRO . 12.4 m -112.89 128.23 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.19 122.18 4.12 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.473 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 56' ' ' THR . 54.7 Cg_endo -72.31 -177.87 19.21 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.603 -1.832 . . . . 0.0 110.199 -0.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.82 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -96.04 -85.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.82 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -152.95 -165.58 2.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -87.28 21.39 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 14' ' ' LYS . 1.6 t80 -89.26 85.7 6.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 88.94 26.89 25.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER -43.81 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.253 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -141.3 132.63 26.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.1 mtp 44.27 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 6.0 m-85 -145.86 108.25 4.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -113.32 138.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.278 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.84 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 33.9 ttpt -141.67 98.8 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 96' ' ' ILE . 7.5 mt -89.38 163.76 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.642 ' CB ' HG22 ' A' ' 54' ' ' THR . 45.6 m -139.35 87.38 2.19 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.63 155.34 0.16 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.238 -0.914 . . . . 0.0 108.905 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.699 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -55.44 -17.51 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.761 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.15 23.74 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 109.85 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 35.27 18.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.887 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.89 94.09 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.8 m-20 -66.32 153.12 43.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -148.68 114.84 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 109.261 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -108.27 124.15 49.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.502 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.49 -176.29 4.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.544 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 4.8 tt0 -150.38 138.1 19.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.842 -1.162 . . . . 0.0 110.025 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.82 -145.8 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -115.52 -11.45 11.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 109.64 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.599 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -170.61 171.3 6.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -55.79 -48.78 74.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 109.474 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -48.62 -60.45 2.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 0.0 109.769 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -61.49 -22.45 65.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.884 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.995 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.68 -63.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.782 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.583 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -66.08 -12.83 58.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.15 -39.06 26.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.112 -0.992 . . . . 0.0 108.868 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.022 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 9.6 m95 -78.1 -29.76 49.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.805 . . . . 0.0 109.028 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.8 m -74.09 -31.27 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.591 -0.693 . . . . 0.0 109.699 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.7 ptp180 -83.5 -23.16 32.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.901 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.608 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -83.31 -54.54 4.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.07 -1.019 . . . . 0.0 109.713 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.606 ' O ' HD13 ' A' ' 100' ' ' ILE . 2.6 mt -65.14 -39.75 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 108.575 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 20.5 t-20 -70.09 -56.59 6.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.89 . . . . 0.0 109.155 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 22.3 tttm -44.17 -49.69 8.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 1.048 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -57.31 -43.92 83.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.643 HD12 ' HG ' ' A' ' 50' ' ' LEU . 1.2 mp -57.63 -58.79 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.7 -10.78 21.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 109.904 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -92.7 -22.78 19.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.313 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.785 HG12 HD23 ' A' ' 50' ' ' LEU . 3.1 mm -84.7 -22.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.987 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 41.0 mt-10 -68.3 -7.8 34.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.85 9.44 5.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 106' ' ' LEU . 5.8 mt -105.73 59.41 0.66 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.288 -1.125 . . . . 0.0 109.16 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -44.55 162.95 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.61 -0.681 . . . . 0.0 109.709 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 109' ' ' HIS . 74.7 m-70 -105.2 -148.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.498 ' CB ' ' O ' ' A' ' 108' ' ' HIS . 7.6 m80 74.75 79.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 37.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.89 106.92 5.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 171.56 165.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.3 m170 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.454 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 3' ' ' PRO . 1.9 mm-40 -93.64 159.35 35.02 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 2' ' ' GLU . 52.9 Cg_exo -51.09 -170.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.077 1.851 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.7 pttt -116.2 77.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.408 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.511 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -44.69 130.89 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.559 ' HB ' HD11 ' A' ' 28' ' ' LEU . 8.3 mm -46.33 -46.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.591 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -137.88 152.48 49.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 109.491 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.018 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -161.6 124.05 3.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.584 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -157.92 -145.7 4.3 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.024 ' C ' HD13 ' A' ' 11' ' ' LEU . 9.7 p90 -143.26 93.45 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.339 -1.094 . . . . 0.0 109.971 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.117 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -115.37 166.53 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.6 p -90.83 135.61 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.797 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.4 OUTLIER -126.98 131.08 51.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.464 -0.773 . . . . 0.0 109.597 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 35.0 tttm -95.47 138.62 32.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 109.423 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.1 -2.49 4.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 3.7 p -76.72 -93.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.552 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.0 p -97.43 109.54 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.344 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-30 59.23 -180.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 28.8 p-10 -82.73 88.79 6.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 21.6 p -132.24 -167.27 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.755 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.637 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.4 m95 -146.4 116.83 7.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 0.0 109.59 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 12' ' ' VAL . 33.4 mttt -148.17 137.38 12.02 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 110.048 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 46.6 Cg_exo -56.3 161.13 9.66 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.937 1.758 . . . . 0.0 109.787 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.797 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 21.6 ptm -171.1 167.36 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 109.798 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.594 ' CD2' ' HA ' ' A' ' 39' ' ' LYS . 54.5 t-105 -88.77 142.61 27.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.773 ' CG1' HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -150.41 132.39 5.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.446 -178.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' A' ' 8' ' ' GLU . 11.4 m -125.15 105.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.592 -0.693 . . . . 0.0 109.285 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 7' ' ' ARG . 1.7 pp -79.6 124.14 28.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.036 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.7 mp -112.15 166.42 11.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.505 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.773 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -72.02 -12.97 61.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.906 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.607 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.1 m-20 -106.07 -2.67 22.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.63 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.9 151.69 5.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.641 ' N ' HD12 ' A' ' 33' ' ' ILE . 4.7 mp -98.36 108.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' OE2' ' CD1' ' A' ' 29' ' ' LEU . 4.8 pt-20 -107.22 119.96 40.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.666 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.0 p90 -121.3 144.64 48.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 110.431 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.632 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -121.25 -148.93 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -51.97 3.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 109.174 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -105.13 -177.26 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 108.855 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.11 -40.45 10.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.058 -1.026 . . . . 0.0 108.512 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.466 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -153.43 72.04 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 109.765 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 23.6 t70 -50.15 -20.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 3.7 t30 90.86 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 101.6 51.66 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 53.4 Cg_exo -49.69 142.68 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.888 1.725 . . . . 0.0 111.246 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -98.18 -25.63 14.83 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.39 146.77 5.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.435 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 9.5 mtm -127.31 -174.92 3.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -1.166 . . . . 0.0 109.628 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' THR . 39.3 mt -140.59 127.83 12.22 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.46 84.79 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.494 1.462 . . . . 0.0 110.073 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.991 ' HG ' HG21 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -60.95 -14.2 21.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.412 -0.805 . . . . 0.0 109.201 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.672 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -58.36 -15.41 10.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.9 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -165.68 27.91 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.132 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.423 ' OG ' HG23 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -77.54 168.73 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 0.0 109.348 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -126.67 160.25 31.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.403 -0.81 . . . . 0.0 109.167 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 56' ' ' THR . 2.8 tm? -121.28 149.47 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.042 -1.037 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 1.022 ' N ' HD13 ' A' ' 55' ' ' LEU . 98.9 m -136.42 134.79 38.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 110.052 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 5.4 t -150.38 118.87 3.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.327 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 56' ' ' THR . 53.6 Cg_endo -72.49 -161.86 2.29 Favored 'Cis proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.642 -1.816 . . . . 0.0 110.369 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 18.2 p -96.34 -161.25 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.694 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -67.84 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.867 . . . . 0.0 109.756 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -84.89 15.37 4.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.2 t80 -89.16 -27.13 20.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.918 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.613 ' HA3' HG11 ' A' ' 68' ' ' VAL . . . -103.97 -91.69 2.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 tttt 43.66 27.26 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -1.093 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' GLY . 12.7 mtp180 -124.67 -90.14 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.437 -0.789 . . . . 0.0 109.424 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.7 mmm -81.92 -114.36 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.321 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 84.1 m-85 -130.96 89.99 2.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.824 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HA3' ' A' ' 63' ' ' GLY . 1.6 p -129.62 119.71 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.829 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.707 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.8 p90 -97.8 168.77 10.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.091 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 6.0 ttpt -127.17 117.39 22.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.633 HD11 HG21 ' A' ' 96' ' ' ILE . 2.4 mt -95.5 167.84 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.828 . . . . 0.0 108.872 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.2 m -141.05 92.23 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -42.76 152.09 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 1.2 t -52.15 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.522 -0.736 . . . . 0.0 109.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 158.52 -71.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 164.55 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.93 79.08 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.092 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 1.7 p30 -56.07 144.01 30.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.701 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 42.0 m-70 -137.49 145.26 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.8 m-85 -100.88 137.61 39.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 1.117 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.1 t80 -143.97 123.3 13.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 1.2 tt0 -129.36 120.13 25.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.04 . . . . 0.0 109.879 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -89.98 -146.51 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 -90.05 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -96.22 167.88 10.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.86 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -52.45 -20.33 2.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.819 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.86 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -72.35 -46.7 54.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.731 -179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -73.97 -48.61 29.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.88 -30.5 71.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.004 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 51.2 t0 -75.09 -42.36 56.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.989 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -73.91 -19.69 60.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.698 ' CH2' HG22 ' A' ' 26' ' ' VAL . 3.4 m95 -83.6 -37.15 23.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.393 -0.817 . . . . 0.0 109.048 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.89 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 p -76.84 -31.59 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.789 . . . . 0.0 109.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 13.2 mmm180 -83.83 -24.34 30.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.605 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 33.5 t0 -83.71 -39.7 19.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.975 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.3 mt -71.81 -32.79 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 0.0 108.696 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -84.31 -30.7 25.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.222 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -67.16 -50.97 59.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.949 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -67.25 -32.72 73.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.951 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ILE . 20.6 mt -61.91 -41.26 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.423 -0.798 . . . . 0.0 109.095 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -83.58 -13.46 54.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.62 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.67 -12.24 25.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 109.58 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.991 HG21 ' HG ' ' A' ' 50' ' ' LEU . 5.6 tp -93.43 -14.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 4.0 mt-10 -80.15 -6.63 58.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.511 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.97 8.63 7.17 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -100.71 57.23 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.27 -88.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.721 -0.612 . . . . 0.0 109.551 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 171.42 -38.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -119.64 113.61 20.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.409 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -72.24 -154.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -111.83 165.46 12.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.395 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.1 t60 50.7 80.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.446 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 13.5 mm-40 -93.39 164.41 21.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.363 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 54.4 Cg_exo -49.63 -179.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.015 1.81 . . . . 0.0 110.316 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -80.33 80.73 6.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.48 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.713 ' HG2' HD21 ' A' ' 29' ' ' LEU . 4.1 mtt180 58.26 165.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 30' ' ' GLU . 18.9 mt -90.17 -70.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.597 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.719 ' HB3' HD11 ' A' ' 28' ' ' LEU . 3.3 tpm_? -114.45 121.86 44.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.009 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.4 pm0 -130.21 135.42 48.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.122 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.05 -145.68 4.44 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.999 ' O ' HD13 ' A' ' 11' ' ' LEU . 8.2 p90 -142.26 102.41 4.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -1.06 . . . . 0.0 110.485 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.999 HD13 ' O ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -129.54 150.89 50.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG23 ' N ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -81.17 135.82 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.091 -1.006 . . . . 0.0 108.759 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HG3' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -127.82 84.79 2.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.087 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 34.41 -149.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.259 0.552 . . . . 0.0 110.207 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 20' ' ' THR . . . -145.92 163.35 28.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.6 m -89.22 23.24 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG22 ' CD2' ' A' ' 18' ' ' PHE . 2.7 p -167.86 118.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.455 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 17' ' ' VAL . 44.9 m-85 60.24 153.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -59.45 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -119.39 152.48 36.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.517 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.626 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -133.6 121.51 22.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.1 -179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.643 ' N ' HG23 ' A' ' 12' ' ' VAL . 11.6 mttm -147.01 142.87 17.49 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.571 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.583 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 41.1 Cg_endo -73.08 130.79 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.094 1.863 . . . . 0.0 110.224 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.787 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -138.53 175.02 9.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.709 ' O ' ' SD ' ' A' ' 24' ' ' MET . 66.1 t-105 -92.27 145.39 24.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -148.87 144.3 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.101 -178.364 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.009 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -137.1 99.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.369 -0.832 . . . . 0.0 109.566 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.878 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -76.22 120.17 21.13 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.237 -0.914 . . . . 0.0 109.231 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.713 HD21 ' HG2' ' A' ' 5' ' ' ARG . 3.8 mp -106.03 167.27 9.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 109.507 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 6' ' ' ILE . 4.8 pt-20 -71.99 -10.85 60.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.75 -2.23 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.618 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.944 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 154.89 147.7 4.77 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -95.93 108.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.585 ' HG2' HD11 ' A' ' 29' ' ' LEU . 23.8 pt-20 -107.82 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.665 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.787 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 1.4 p90 -117.09 150.49 38.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.094 -1.004 . . . . 0.0 109.993 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -127.5 -172.56 2.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.308 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -77.58 -50.04 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.58 -174.28 2.5 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.7 -23.65 0.44 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.932 -1.105 . . . . 0.0 109.415 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.87 -49.59 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.045 . . . . 0.0 109.642 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 2.8 t70 62.26 9.79 3.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 41.46 23.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 110.066 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -165.14 102.22 0.79 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.169 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.6 Cg_exo -52.79 133.23 49.96 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.978 1.785 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.98 -21.96 22.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 175.09 149.0 7.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.793 ' SD ' ' N ' ' A' ' 47' ' ' MET . 0.5 OUTLIER -125.62 169.02 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 73' ' ' THR . 57.1 mt -132.35 134.69 25.24 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.51 121.26 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.38 1.387 . . . . 0.0 110.472 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 ' CA ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -58.51 -39.02 78.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.429 -0.794 . . . . 0.0 109.707 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -101.11 108.27 19.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 125.24 -1.32 8.27 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.499 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 7.6 t -89.89 170.32 10.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.869 -1.371 . . . . 0.0 109.864 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.511 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.16 122.22 13.74 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.303 -0.873 . . . . 0.0 109.438 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.84 HD21 ' CD2' ' A' ' 69' ' ' PHE . 3.2 tm? -88.91 127.19 35.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.457 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 55' ' ' LEU . 3.4 m -117.46 102.24 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.172 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 3.3 m -140.51 135.84 16.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 57' ' ' SER . 58.4 Cg_endo -77.3 176.32 44.25 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.35 -1.938 . . . . 0.0 110.345 -0.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 70' ' ' LYS . 5.0 m -148.59 82.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -98.69 112.93 24.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -177.74 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 109.562 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.0 t80 -89.14 -39.68 13.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 108.329 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -117.14 -39.32 0.81 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER 39.36 72.44 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.859 . . . . 0.0 109.317 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.57 -95.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.738 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.6 mmm -77.1 -122.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 38.6 m-85 -112.71 92.57 4.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.774 -1.204 . . . . 0.0 109.677 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -118.85 126.77 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.34 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.84 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -112.62 176.19 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 3.0 tmmm? -135.78 114.63 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.783 . . . . 0.0 110.238 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -97.78 171.08 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.8 m -145.89 94.16 2.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.163 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.65 HG22 HG23 ' A' ' 48' ' ' ILE . 2.2 p -59.86 153.53 20.68 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.0 109.094 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -44.46 -23.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.223 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER -86.86 31.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 0.0 109.771 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.85 28.43 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.416 ' OE1' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -89.88 92.29 8.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.287 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.572 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 8.3 t70 -58.92 152.76 18.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -142.55 103.04 4.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.572 ' CZ ' ' OD1' ' A' ' 78' ' ' ASP . 10.8 m-85 -95.1 117.69 30.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -131.58 171.26 13.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.104 -0.998 . . . . 0.0 109.263 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 1.3 tt0 -139.22 130.13 26.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.035 -1.041 . . . . 0.0 109.188 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.75 164.66 14.58 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.471 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -97.43 53.37 1.15 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER 166.08 162.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.915 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -88.33 -51.09 5.93 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.925 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -65.19 -29.22 70.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -79.87 -43.28 22.57 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.481 -0.762 . . . . 0.0 109.426 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.679 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -54.49 -55.7 26.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 m-20 -65.83 -25.81 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 108.866 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.19 -24.66 64.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.99 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 11.7 m95 -83.27 -31.71 26.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.5 m -79.44 -23.34 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.395 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.3 mmp_? -86.4 -34.15 20.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 0.0 109.546 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.77 ' HB3' HD11 ' A' ' 28' ' ' LEU . 2.7 t0 -82.98 -41.55 18.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.149 -0.969 . . . . 0.0 109.681 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.878 ' CG1' HD22 ' A' ' 28' ' ' LEU . 4.4 mt -72.88 -35.17 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.293 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 40.6 t30 -81.59 -32.74 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -68.52 -40.31 80.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 109.18 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -70.94 -40.37 72.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.295 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 96' ' ' ILE . 10.9 mt -67.48 -28.95 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.102 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -89.11 -8.75 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -30.8 13.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.656 HG22 ' HG3' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -70.11 -30.03 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 108.791 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.75 -5.98 34.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.06 10.89 5.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 106' ' ' LEU . 1.4 mt -99.04 57.13 1.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.422 -1.046 . . . . 0.0 109.144 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 108' ' ' HIS . 2.1 mp0 -92.42 68.18 4.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.677 -0.64 . . . . 0.0 109.37 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 107' ' ' GLU . 17.9 p80 -46.49 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.463 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.68 146.43 16.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.516 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -99.57 38.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -120.85 40.19 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 111' ' ' HIS . 1.5 m-70 79.8 -73.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.646 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 66.7 t60 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.446 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -162.23 160.34 21.15 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 2' ' ' GLU . 53.2 Cg_exo -50.25 129.63 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ARG . 26.7 mttt -92.1 75.87 5.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.477 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.5 OUTLIER 61.1 139.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.3 mt -73.17 -28.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.806 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HB3' ' HG ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -145.28 166.53 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.075 -1.015 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.969 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 178.83 127.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.481 -0.762 . . . . 0.0 109.567 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.593 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.87 -145.6 4.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.981 ' C ' HD13 ' A' ' 11' ' ' LEU . 4.2 p90 -140.43 91.96 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 110.219 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.981 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.9 161.88 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.933 . . . . 0.0 108.677 178.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -85.4 141.74 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.672 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HE2' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -123.21 142.72 50.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.203 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HD2' ' CD1' ' A' ' 80' ' ' PHE . 5.2 tttt -88.17 115.62 25.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.4 93.91 0.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -85.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -1.156 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.67 -19.08 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.96 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB3' ' CE ' ' A' ' 14' ' ' LYS . 50.5 m-80 63.95 100.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 17.4 p -149.18 -170.65 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.162 -0.961 . . . . 0.0 109.697 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.585 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.5 m95 -141.6 105.92 4.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.735 ' C ' HG23 ' A' ' 12' ' ' VAL . 35.5 mttt -146.75 136.62 11.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.47 157.55 6.87 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.915 1.744 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.789 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -168.18 165.92 13.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 110.111 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.748 ' O ' ' SD ' ' A' ' 24' ' ' MET . 62.6 t-105 -90.23 143.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.6 138.57 14.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.935 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.969 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.5 m -126.09 120.23 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.802 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 mt -78.95 120.52 23.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.446 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -115.18 158.55 22.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 6.5 pt-20 -73.02 -9.65 58.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.9 p30 -107.89 -3.4 18.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.126 -0.984 . . . . 0.0 109.482 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.653 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.78 155.54 7.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.072 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.53 107.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.349 -1.089 . . . . 0.0 109.252 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 27' ' ' VAL . 2.7 tp10 -104.7 117.84 35.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.2 p90 -125.59 147.71 49.2 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -123.67 -157.69 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -93.77 -43.6 8.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.163 -0.961 . . . . 0.0 108.471 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -111.88 -176.39 2.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -44.95 -25.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.933 -1.105 . . . . 0.0 109.248 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -149.91 -50.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.551 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.9 t0 61.15 10.82 3.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.868 . . . . 0.0 109.352 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.5 m-80 41.6 23.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.745 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -163.93 115.05 0.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.849 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.6 Cg_endo -71.4 134.7 25.12 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.888 1.726 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -89.75 -20.21 23.84 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 168.48 157.73 11.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' OE1' ' A' ' 34' ' ' GLU . 6.7 mtt -133.11 169.82 16.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -1.06 . . . . 0.0 109.18 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 73' ' ' THR . 56.9 mt -136.78 127.35 16.25 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 39.0 Cg_endo -67.78 124.65 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.252 1.301 . . . . 0.0 109.713 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.902 HD11 ' CG1' ' A' ' 103' ' ' ILE . 1.8 pt? -89.19 23.6 2.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.128 -0.983 . . . . 0.0 109.856 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -66.45 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -101.26 -2.19 54.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -39.56 148.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -1.052 . . . . 0.0 110.512 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -119.03 155.94 30.55 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.005 HD11 ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -124.74 130.54 52.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.931 -1.106 . . . . 0.0 109.301 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 55' ' ' LEU . 90.2 m -121.8 123.38 41.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.709 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -150.49 119.56 3.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 56' ' ' THR . 56.9 Cg_endo -74.04 -175.12 14.62 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.7 -1.791 . . . . 0.0 110.299 -0.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.762 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -102.95 170.11 8.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 109.574 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.762 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 mt-30 -107.66 133.19 52.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 3.7 t0 83.84 -49.42 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 5.7 m-85 -100.38 -32.25 10.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 108.727 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA3' ' H ' ' A' ' 59' ' ' CYS . . . -83.83 0.82 89.38 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -89.51 23.23 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -1.176 . . . . 0.0 109.272 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -143.8 -96.96 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.636 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -158.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 109.763 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 81.6 m-85 -97.53 87.97 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 81' ' ' PHE . 2.1 p -135.18 130.71 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 81' ' ' PHE . 3.7 p90 -100.03 167.5 10.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.304 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -125.63 116.91 22.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.77 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 69' ' ' PHE . 3.4 mt -99.51 165.85 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.635 ' N ' HG22 ' A' ' 54' ' ' THR . 16.7 m -142.16 103.85 4.36 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -53.38 108.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.869 0.843 . . . . 0.0 109.689 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.12 27.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 179.406 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 74' ' ' THR . 1.7 ttpp 80.71 42.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.016 . . . . 0.0 109.412 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -132.01 -78.88 0.51 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.551 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -89.96 133.97 34.49 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.533 -0.729 . . . . 0.0 110.254 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 3.5 p30 -95.2 152.18 18.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.356 -0.84 . . . . 0.0 108.752 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -141.99 104.72 4.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 110.214 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.8 m-85 -93.51 109.0 20.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 108.794 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.938 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -118.43 144.91 45.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.416 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 4.4 tm0? -118.93 133.97 55.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.165 . . . . 0.0 109.827 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.47 -145.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 85' ' ' PHE . . . -103.02 -10.1 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 171.19 174.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.829 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.915 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -47.38 -50.08 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.148 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.915 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.9 tt0 -45.07 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 110.21 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -60.51 -14.48 19.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -71.62 -38.82 70.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HA ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -85.09 -27.93 25.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.58 -29.37 56.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CZ3' HD21 ' A' ' 28' ' ' LEU . 10.4 m95 -84.31 -42.72 15.51 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.005 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.8 p -72.12 -29.27 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 14.4 ptm180 -79.01 -34.9 43.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.818 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 13.4 t70 -75.62 -54.43 7.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.0 109.458 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG1' HD13 ' A' ' 28' ' ' LEU . 7.2 mt -55.34 -35.89 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.028 -1.045 . . . . 0.0 108.738 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 101' ' ' LYS . 15.9 t30 -79.72 -24.69 41.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 108.907 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -63.09 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 108.901 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -56.45 -35.4 67.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 34.4 mt -62.35 -35.86 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 108.796 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 97' ' ' ASN . 1.9 mtmp? -83.97 -8.38 59.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.9 t -93.57 -28.0 16.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.902 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -78.55 -79.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.799 ' N ' HG22 ' A' ' 103' ' ' ILE . 68.6 mt-10 37.38 52.5 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.771 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' O ' HD22 ' A' ' 106' ' ' LEU . . . 74.78 93.0 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -154.13 64.82 0.7 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.59 -0.947 . . . . 0.0 109.405 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.8 62.14 0.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.438 -0.788 . . . . 0.0 109.531 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.42 171.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.68 74.85 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 110' ' ' HIS . 28.3 p80 -48.99 120.58 4.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.551 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 112' ' ' HIS . 21.5 m80 52.45 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 111' ' ' HIS . 55.8 m-70 44.82 81.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.478 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.542 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 5.5 mp0 -134.79 164.49 43.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 52.4 Cg_exo -50.87 138.17 42.52 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.025 1.817 . . . . 0.0 110.166 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 97.76 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -58.42 165.07 2.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.447 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.714 ' HB ' HD12 ' A' ' 28' ' ' LEU . 12.1 mt -67.81 -49.04 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.598 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.991 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -144.4 111.04 5.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 109.67 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.023 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -119.65 132.7 55.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.11 -146.21 4.59 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.857 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.0 p90 -142.68 102.73 4.1 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.523 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -121.03 160.47 23.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.213 -0.929 . . . . 0.0 108.555 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.3 p -86.03 151.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.074 -1.016 . . . . 0.0 109.52 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -140.49 147.72 40.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -0.829 . . . . 0.0 109.853 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HD2' ' NE1' ' A' ' 21' ' ' TRP . 24.4 tttm -117.5 133.67 55.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . 168.41 174.3 37.04 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 58.15 -174.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -1.074 . . . . 0.0 109.204 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 18' ' ' PHE . 6.2 p -42.96 -42.63 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' N ' HG13 ' A' ' 17' ' ' VAL . 12.2 m-85 -39.69 -68.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.919 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 22.03 3.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -108.27 -171.52 1.88 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.663 ' HH2' HG23 ' A' ' 68' ' ' VAL . 14.4 m95 -132.03 82.19 2.01 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 108.675 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' N ' HG23 ' A' ' 12' ' ' VAL . 2.1 mttm -115.6 136.95 22.89 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.036 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.74 156.83 6.15 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.055 1.837 . . . . 0.0 110.16 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.762 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -162.31 170.1 19.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -0.952 . . . . 0.0 109.877 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.762 ' O ' ' SD ' ' A' ' 24' ' ' MET . 73.5 t-105 -97.7 142.61 29.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.652 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.17 135.4 10.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.977 -178.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.023 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -125.93 100.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.409 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -76.89 116.37 17.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.883 . . . . 0.0 109.502 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.7 mp -101.08 161.75 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.59 -13.83 62.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 -1.31 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 0.0 109.854 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 1.001 ' HA2' HD23 ' A' ' 50' ' ' LEU . . . 158.5 140.42 2.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 50' ' ' LEU . 3.6 mp -95.57 121.11 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -1.203 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 29' ' ' LEU . 4.1 pt-20 -120.82 120.74 36.45 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.652 ' HB3' HG23 ' A' ' 26' ' ' VAL . 5.6 p90 -121.95 147.44 46.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.981 -1.074 . . . . 0.0 110.893 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.94 -150.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.091 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.19 -43.46 6.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -108.8 -175.96 2.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.103 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -47.87 -22.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.878 -1.139 . . . . 0.0 109.337 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -148.46 -51.54 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.7 t70 61.81 10.34 3.41 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 42.2 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.112 -0.992 . . . . 0.0 109.954 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.1 t -167.54 109.45 0.61 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.938 -1.101 . . . . 0.0 109.891 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 54.1 Cg_endo -71.61 134.26 23.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.849 1.7 . . . . 0.0 110.557 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.75 -19.4 24.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.22 142.5 5.8 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.422 ' HG3' ' C ' ' A' ' 46' ' ' GLY . 16.7 mtm -136.27 126.96 27.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.155 -1.203 . . . . 0.0 109.533 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.581 HG23 HG22 ' A' ' 73' ' ' THR . 4.7 mt -88.94 136.8 30.2 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 108.8 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 48' ' ' ILE . 55.8 Cg_endo -72.31 140.74 34.23 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.721 1.614 . . . . 0.0 110.504 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.001 HD23 ' HA2' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -74.89 0.13 16.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.438 -0.789 . . . . 0.0 109.493 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -92.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.04 68.81 0.24 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.524 ' HA ' ' N ' ' A' ' 74' ' ' THR . 14.4 m -60.27 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 109.6 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.34 122.32 15.61 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 -179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.784 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -89.07 122.1 32.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.175 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 55' ' ' LEU . 59.7 m -115.26 114.43 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.105 -0.997 . . . . 0.0 109.62 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 66.0 p -145.5 121.36 5.84 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 56' ' ' THR . 55.0 Cg_endo -71.92 175.3 43.23 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.559 -1.851 . . . . 0.0 110.342 -0.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.795 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 9.5 t -90.69 -94.75 0.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.6 mt-30 -141.75 -149.76 0.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.371 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -15.12 8.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.901 . . . . 0.0 108.818 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 -28.98 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -85.36 -14.38 68.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 65' ' ' ARG . 5.4 tttm -84.46 70.5 10.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -1.192 . . . . 0.0 109.579 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 165.17 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.586 ' SD ' ' NE2' ' A' ' 82' ' ' GLN . 2.7 mtt 67.2 -172.82 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 1.3 m-85 -88.15 83.37 6.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.2 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.5 p -127.08 136.27 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.841 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -124.3 178.71 5.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.795 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 3.2 tttp -143.35 107.25 4.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 109.808 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -90.45 170.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 108.987 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.561 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.4 m -145.86 90.87 2.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.581 HG22 HG23 ' A' ' 48' ' ' ILE . 2.4 p -40.44 142.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 109.837 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.55 -29.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 0.0 109.963 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -73.02 -70.77 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.319 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.9 pt20 164.15 38.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.0 99.83 9.37 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 p30 -63.35 152.96 36.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -144.57 96.41 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.727 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -91.15 117.65 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.059 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -135.82 162.53 32.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.956 -1.09 . . . . 0.0 109.587 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 36.5 tt0 -127.77 131.11 49.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.994 -1.066 . . . . 0.0 109.272 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.5 -168.37 2.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.439 -0.788 . . . . 0.0 109.732 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.8 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.13 -179.98 4.1 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 109.473 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.044 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -55.62 -59.45 4.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.609 -0.682 . . . . 0.0 109.602 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.044 ' N ' HD23 ' A' ' 86' ' ' LEU . 12.5 tm-20 -47.31 -67.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.048 . . . . 0.0 110.358 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 54.7 tt0 -52.42 -26.44 12.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -68.47 -63.6 1.03 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.036 . . . . 0.0 109.707 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 3.9 p30 -55.78 -27.84 53.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.27 -35.83 68.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 108.956 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.982 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.25 -41.53 73.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.613 -0.679 . . . . 0.0 110.358 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.784 ' CG2' HD11 ' A' ' 55' ' ' LEU . 5.3 p -76.89 -34.68 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 111.052 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -71.56 -23.55 61.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.768 -1.207 . . . . 0.0 109.323 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.41 -39.36 22.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.472 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.624 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.3 mt -69.82 -37.59 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.4 -26.96 38.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.113 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 3.5 tptp -65.13 -44.95 87.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.935 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -71.62 -35.7 70.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.133 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.904 ' HA ' HD13 ' A' ' 50' ' ' LEU . 46.7 mt -72.72 -19.45 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.258 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.36 -16.24 26.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.53 -29.39 14.39 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.824 ' CG1' HD12 ' A' ' 50' ' ' LEU . 7.9 mm -71.52 -26.24 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 67.9 mt-10 -51.92 -22.53 3.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.59 -104.97 1.7 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.42 66.07 1.11 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.412 -1.051 . . . . 0.0 109.576 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.33 135.17 52.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.451 -0.781 . . . . 0.0 109.409 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -120.77 -29.77 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 109.683 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 176.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -85.55 64.07 8.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.461 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -143.75 88.08 1.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -127.29 -37.43 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' C ' ' CG ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.0 mt-10 68.11 161.92 0.14 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 57.9 Cg_endo -75.17 -95.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.28 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.67 90.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' HB2' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -111.46 126.11 54.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.261 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 30' ' ' GLU . 7.5 mt -52.42 -45.98 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.828 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -140.43 145.19 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.857 -179.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.039 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -155.04 132.46 11.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.081 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.46 -147.57 4.88 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.82 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.4 p90 -140.49 93.89 2.67 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.545 -0.973 . . . . 0.0 110.232 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.82 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -118.27 157.08 27.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 108.807 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.672 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -81.49 151.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -132.13 139.87 48.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 14.1 ttpp -84.14 113.92 21.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.375 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.11 167.7 42.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -91.43 -24.84 19.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 3.3 p -46.23 -32.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -177.03 -171.39 0.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.414 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -82.72 85.01 7.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.1 p -127.16 166.0 18.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 20' ' ' THR . 18.1 m95 -150.69 106.82 3.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.672 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -131.73 133.14 23.84 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.23 149.95 20.93 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 109.922 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -159.38 168.3 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.699 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.0 t-105 -92.57 144.22 25.55 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.94 134.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.024 -178.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.5 m -124.07 105.66 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.761 . . . . 0.0 109.396 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.986 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.8 pp -80.74 111.87 17.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.137 -0.977 . . . . 0.0 109.581 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.3 mp -96.98 161.07 14.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.42 -11.23 60.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 4.5 p30 -108.86 2.79 21.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.871 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 150.86 144.57 3.95 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.986 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.6 mm -92.86 130.49 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 110.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 5.5 pt-20 -132.86 113.71 13.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.3 p90 -119.43 147.0 44.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.09 -1.006 . . . . 0.0 110.735 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.572 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -127.92 -150.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.46 -53.54 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.53 -172.62 2.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.6 OUTLIER -54.1 -18.69 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.916 -1.115 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.92 -53.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.1 t0 61.35 9.42 2.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m120 40.5 24.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.221 -0.924 . . . . 0.0 110.071 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.6 t -167.45 122.46 0.84 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.982 -1.074 . . . . 0.0 109.499 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 59.2 Cg_endo -75.56 156.83 40.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.803 1.669 . . . . 0.0 111.276 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 2.8 tptt -119.13 -16.88 9.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -178.68 136.68 2.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.0 mtm -131.41 119.33 21.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -1.137 . . . . 0.0 109.697 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mt -89.77 139.47 27.77 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 38.6 Cg_endo -68.05 148.12 74.95 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.528 1.485 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.943 HD13 ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -85.04 36.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.812 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -167.42 136.6 2.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.995 -1.066 . . . . 0.0 109.927 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 91.07 -36.18 3.69 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 100' ' ' ILE . 2.7 m -42.11 156.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.396 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -123.31 169.89 10.86 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -131.47 124.24 29.75 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.06 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.774 ' N ' HD23 ' A' ' 55' ' ' LEU . 20.4 m -115.97 125.81 53.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -150.2 127.91 5.69 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.588 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' SER . 56.3 Cg_endo -73.96 -178.28 22.12 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.471 -1.887 . . . . 0.0 110.277 -0.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.938 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -150.06 175.1 12.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.662 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.617 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 16.0 tt0 66.84 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -0.795 . . . . 0.0 110.172 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.84 18.61 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.617 ' CE2' ' HG3' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -89.26 -64.25 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -90.84 -21.85 35.15 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 8.0 pttt 40.33 32.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.724 -0.868 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.05 20.71 10.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.583 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 9.8 mtp 58.89 179.32 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' A' ' 66' ' ' MET . 1.8 m-85 81.22 -13.66 0.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.497 -0.752 . . . . 0.0 109.911 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.938 HG22 ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -109.84 135.18 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.979 -1.075 . . . . 0.0 109.423 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.735 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 4.0 p90 -121.36 167.18 13.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 80' ' ' PHE . 19.5 ttpt -129.11 98.03 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.925 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 54' ' ' THR . 20.0 mt -90.9 155.41 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.538 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.569 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 39.9 m -134.61 112.31 10.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.049 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 76' ' ' GLN . 2.7 t -55.83 113.82 1.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 39.29 26.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 111.333 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tptm 80.86 47.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.904 -1.122 . . . . 0.0 109.16 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.593 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -127.77 -83.64 0.6 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.206 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' H ' ' CG2' ' A' ' 73' ' ' THR . 11.0 tt0 -101.21 129.81 47.2 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.662 -0.649 . . . . 0.0 109.441 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.96 171.1 15.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 69.6 m-70 -146.15 96.01 2.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.559 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 22.6 m-85 -93.16 100.22 12.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -0.796 . . . . 0.0 108.887 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.695 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.68 157.62 23.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.394 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 2.4 tt0 -121.19 128.85 52.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.065 -1.022 . . . . 0.0 108.999 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -88.52 -7.66 56.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 83' ' ' ALA . . . 63.05 12.27 5.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.443 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.08 163.37 39.47 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.807 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.034 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -93.35 -48.03 6.61 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.034 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -69.48 -44.32 71.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.52 -0.738 . . . . 0.0 109.281 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.62 -34.65 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.684 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -62.07 -61.63 2.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -37.73 64.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -71.86 -26.79 62.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.084 -1.01 . . . . 0.0 109.773 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.974 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 1.1 m95 -79.84 -31.44 40.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.075 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' LEU . 1.3 p -83.43 -31.55 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.6 ptm180 -77.94 -25.16 48.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.308 -0.87 . . . . 0.0 109.187 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -82.0 -42.5 19.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 100' ' ' ILE . 29.5 mt -72.13 -37.46 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.177 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 62.2 t30 -79.6 -33.81 41.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -67.37 -39.44 85.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.14 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -68.81 -47.45 66.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.32 -0.863 . . . . 0.0 109.091 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.943 ' HA ' HD13 ' A' ' 50' ' ' LEU . 6.9 mt -67.89 -20.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 3.0 mmtp -90.11 -11.29 41.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.351 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.5 m -93.81 -38.16 11.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 108.856 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG1' HD12 ' A' ' 50' ' ' LEU . 2.8 mm -67.91 -29.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.49 -15.9 63.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.13 3.29 26.93 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 106' ' ' LEU . 5.0 mt -106.09 58.94 0.65 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.392 -1.064 . . . . 0.0 109.097 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -64.5 -51.73 61.49 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.624 -0.672 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 0.1 OUTLIER -154.29 177.16 11.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.624 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 41.2 m-70 61.65 152.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.91 -26.86 8.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 66.87 155.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.35 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -46.73 4.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.494 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.7 175.96 0.98 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.553 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 52.9 Cg_exo -51.7 147.94 22.91 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.062 1.841 . . . . 0.0 110.327 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -131.17 95.91 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.535 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -80.95 145.25 31.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.859 HG22 ' OD2' ' A' ' 95' ' ' ASP . 33.3 mt -74.43 -49.01 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.99 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -136.79 142.14 42.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.054 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -148.45 137.05 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.398 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.585 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.42 -149.5 5.69 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 1.023 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.1 p90 -140.42 98.25 3.39 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -1.026 . . . . 0.0 110.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.023 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.09 171.91 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 108.621 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.957 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.2 p -102.97 131.54 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.69 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 18.4 ttmt -132.33 168.09 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -63.83 103.97 0.63 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -67.33 -74.01 0.6 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.491 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.3 OUTLIER 175.84 -159.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -1.155 . . . . 0.0 109.316 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 16' ' ' SER . 2.5 p 39.93 94.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.558 -0.714 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.3 m-85 63.0 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.54 HD21 ' HE2' ' A' ' 62' ' ' PHE . 2.2 m120 -47.75 97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -120.38 -177.19 3.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.757 ' CH2' HG23 ' A' ' 68' ' ' VAL . 2.0 m95 -142.9 106.63 4.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.957 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.8 mmtp -130.33 140.84 39.88 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.85 163.85 1.82 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.876 1.717 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.69 ' SD ' ' HB3' ' A' ' 13' ' ' LYS . 17.7 ptm -176.91 159.67 1.75 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.778 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.9 t-105 -90.24 145.28 25.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.49 136.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.297 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.054 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.1 m -127.38 101.68 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.511 -0.743 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.02 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -74.01 119.68 18.56 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -109.11 165.44 11.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.499 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HG3' HD11 ' A' ' 6' ' ' ILE . 2.1 tt0 -73.44 -14.5 61.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.906 ' C ' HD11 ' A' ' 50' ' ' LEU . 5.2 p-10 -105.6 5.88 31.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.379 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 1.045 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 143.58 144.07 4.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.813 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -90.94 107.79 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.285 -1.126 . . . . 0.0 109.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' HD11 ' A' ' 29' ' ' LEU . 11.3 pt-20 -105.22 116.68 32.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 108.769 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.6 p90 -120.21 147.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.82 -152.06 0.5 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.02 -40.75 9.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.9 OUTLIER -112.83 -178.24 3.34 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -43.0 -25.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.069 -1.019 . . . . 0.0 109.54 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.18 -50.63 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.3 t0 62.99 8.42 3.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m120 41.16 23.58 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.8 t -166.51 96.69 0.72 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.1 Cg_exo -53.26 132.35 47.74 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.056 1.837 . . . . 0.0 110.739 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.525 ' HE3' ' CE ' ' A' ' 24' ' ' MET . 3.0 ttpt -89.77 -22.04 22.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.72 145.82 7.88 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 30.4 mtm -124.22 165.82 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 73' ' ' THR . 2.4 mt -132.93 117.7 15.06 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 54.8 Cg_endo -71.07 125.29 11.32 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.682 1.588 . . . . 0.0 109.916 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.045 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -90.2 39.59 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.319 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -89.77 -43.01 10.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.109 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -159.41 42.8 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.495 ' HB2' HD13 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -68.98 179.04 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -1.153 . . . . 0.0 109.562 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.497 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -144.23 108.75 4.86 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.283 -0.886 . . . . 0.0 109.593 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.832 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.1 tm? -89.79 115.65 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.2 m -110.4 119.86 40.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.175 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -144.2 123.88 7.35 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 0.0 109.654 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.487 ' O ' HG22 ' A' ' 56' ' ' THR . 57.5 Cg_endo -74.5 -170.21 7.88 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.648 -1.813 . . . . 0.0 110.171 -0.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 10.3 t -102.64 -105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.279 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.638 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 pt20 162.97 119.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.944 -1.098 . . . . 0.0 109.789 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER 81.27 -40.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.722 . . . . 0.0 110.651 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' HE2' HD21 ' A' ' 19' ' ' ASN . 0.1 OUTLIER -90.59 85.8 6.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.934 -1.104 . . . . 0.0 110.001 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.601 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 78.08 20.33 73.09 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 51.1 tptt -53.2 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.242 . . . . 0.0 109.175 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' GLY . 3.4 mtt-85 174.6 -86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.551 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mtp -60.38 -148.91 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.581 -0.699 . . . . 0.0 109.473 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 86' ' ' LEU . 98.4 m-85 -99.9 76.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.757 HG23 ' CH2' ' A' ' 21' ' ' TRP . 1.1 p -122.53 128.23 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.31 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 10.4 p90 -122.95 173.4 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -132.97 122.01 23.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.9 mt -93.62 167.94 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.057 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -146.49 85.86 1.66 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 HG23 ' A' ' 48' ' ' ILE . 5.2 p -44.39 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.569 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.09 63.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.246 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 5.9 mttp -89.76 12.06 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.451 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 72.44 26.28 2.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.4 OUTLIER -89.84 119.55 30.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.13 -0.981 . . . . 0.0 108.998 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 4.4 t0 -89.36 135.92 33.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 89.1 m-70 -130.01 97.12 4.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.405 -0.809 . . . . 0.0 108.97 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 78' ' ' ASP . 1.9 m-85 -90.19 120.49 31.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.28 146.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.217 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.55 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 6.5 pt20 -116.52 145.71 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 108.777 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -92.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.72 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.74 174.94 6.36 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.652 -0.655 . . . . 0.0 109.615 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.958 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -65.16 -41.31 94.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.53 -0.731 . . . . 0.0 109.184 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.958 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -57.48 -67.0 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.701 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.5 -31.73 56.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.716 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.82 -65.13 0.71 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 109.967 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.611 ' HA ' HG23 ' A' ' 93' ' ' VAL . 47.6 m-20 -58.84 -23.76 61.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.902 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.91 -31.96 64.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.015 -1.053 . . . . 0.0 109.507 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.02 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 4.2 m95 -82.57 -39.05 22.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.4 -21.92 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.246 -0.909 . . . . 0.0 109.341 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 10.0 ptp180 -85.3 -29.44 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -84.35 -39.32 19.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.589 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HD22 ' A' ' 28' ' ' LEU . 5.6 mt -72.85 -34.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 108.801 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -80.7 -28.93 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -53.33 17.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.01 -40.67 85.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 108.928 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 44.9 mt -65.06 -33.76 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 108.943 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 8.8 ttpt -78.03 -9.42 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.489 ' SG ' ' HG ' ' A' ' 106' ' ' LEU . 8.8 t -95.13 -32.31 13.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.809 . . . . 0.0 109.141 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 50' ' ' LEU . 3.2 mm -67.74 -33.74 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 15.2 mt-10 -75.01 -2.1 25.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.289 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.74 20.7 2.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -87.7 54.34 3.09 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.635 -0.921 . . . . 0.0 109.235 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.04 -170.48 3.15 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -123.44 -37.09 2.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.5 m80 64.55 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -96.8 -64.06 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.4 58.33 1.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -112.1 -58.4 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 109.42 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 21.5 mt-10 -101.16 163.3 18.21 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 51.3 Cg_exo -52.2 -165.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.088 1.859 . . . . 0.0 110.381 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -121.06 100.46 7.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.406 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.573 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 71.99 126.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 30' ' ' GLU . 2.2 mp -67.87 -39.77 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.554 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -131.73 169.55 16.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 109.866 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.916 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 175.09 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 109.676 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.62 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.86 -147.14 5.02 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.962 ' C ' HD13 ' A' ' 11' ' ' LEU . 8.0 p90 -138.96 103.83 4.9 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.975 -1.309 . . . . 0.0 110.902 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.969 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -120.63 158.17 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 0.0 108.546 178.264 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.884 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -86.53 129.78 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.968 -1.083 . . . . 0.0 109.295 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HD2' ' CB ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.97 170.15 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.467 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -116.18 134.83 54.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.82 0.21 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -125.31 -34.02 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -132.31 -84.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 17' ' ' VAL . 4.6 m-85 -133.06 71.8 1.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.61 60.76 3.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 48.7 p -115.83 -165.07 1.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.738 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.3 m95 -149.42 109.01 4.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 0.0 109.668 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.884 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.1 mttm -140.38 143.21 32.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -51.26 156.42 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.987 1.791 . . . . 0.0 110.188 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -160.88 176.65 11.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.759 ' O ' ' SD ' ' A' ' 24' ' ' MET . 68.1 t-105 -109.69 146.16 35.32 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -150.41 147.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.948 -178.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.3 m -130.96 119.32 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -0.969 . . . . 0.0 110.187 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.922 HD21 ' HZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -81.15 124.35 29.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.767 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 mp -119.95 159.94 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.97 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HB3' HD11 ' A' ' 6' ' ' ILE . 8.9 pt-20 -72.88 -22.18 60.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 109.698 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.928 ' C ' HD11 ' A' ' 50' ' ' LEU . 3.2 p30 -96.17 13.07 28.59 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.118 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 1.092 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 137.17 169.77 11.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' MET . 3.6 mp -111.86 112.57 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.126 -1.22 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.767 ' HG2' HD11 ' A' ' 29' ' ' LEU . 16.8 pt-20 -107.83 117.39 34.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 108.637 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.644 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -115.67 148.88 39.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.44 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -130.89 -158.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.11 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 -34.3 14.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.405 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -123.78 -169.05 1.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 6.9 tppt? -46.4 -25.38 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.909 -1.119 . . . . 0.0 109.011 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -155.25 -48.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.4 t70 60.96 11.14 3.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 48.2 t30 43.62 23.07 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.01 -1.056 . . . . 0.0 109.353 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.7 t -164.4 99.99 0.88 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 51.4 Cg_endo -71.43 144.36 45.25 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.919 1.746 . . . . 0.0 110.704 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -89.65 -22.68 22.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.049 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.621 ' N ' ' CE1' ' A' ' 35' ' ' PHE . . . 172.89 158.49 17.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 3.8 mtt -123.3 -178.71 4.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -1.176 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 73' ' ' THR . 5.8 mt -135.98 116.26 11.38 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 109.279 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.58 122.1 8.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.623 1.549 . . . . 0.0 110.099 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.092 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -73.01 -0.61 14.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.167 -0.958 . . . . 0.0 109.744 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.842 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.2 OUTLIER -43.04 -60.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 70.02 0.18 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.129 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.2 m -82.72 177.32 8.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -1.197 . . . . 0.0 109.146 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -134.19 165.47 25.01 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.746 HD11 ' HB ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.08 124.32 42.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.162 -0.961 . . . . 0.0 108.84 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.681 ' N ' HD23 ' A' ' 55' ' ' LEU . 30.5 m -111.77 119.87 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.738 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 52.4 p -150.5 115.89 3.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 56' ' ' THR . 52.6 Cg_endo -71.6 -172.1 8.4 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.596 -1.835 . . . . 0.0 110.263 -0.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -94.69 -91.75 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.733 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 5.8 pt20 -145.36 -155.68 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.818 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 21.1 2.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.57 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 7.8 t80 -89.84 -57.22 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -112.55 16.31 24.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 20.2 tttm -48.55 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -1.167 . . . . 0.0 109.358 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 177.55 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.0 mtm -64.74 -148.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 77.9 m-85 -100.66 79.92 2.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.967 . . . . 0.0 109.464 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -117.45 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.326 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 93' ' ' VAL . 9.2 p90 -126.63 172.09 10.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.663 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -133.43 116.1 15.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 109.786 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.584 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.0 mt -95.4 162.01 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 64.8 m -131.19 92.68 3.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.591 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -57.54 150.3 19.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 108.839 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.842 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -43.2 -26.04 0.15 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.508 -0.745 . . . . 0.0 109.846 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -88.28 35.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.554 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 43.87 31.02 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.743 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -89.64 87.46 7.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 7.7 m-20 -58.17 143.92 42.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.829 . . . . 0.0 110.148 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.62 106.11 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -101.68 111.3 23.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.65 147.71 36.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 0.0 109.181 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -114.12 141.53 47.36 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.162 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.71 -147.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.78 -75.13 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -114.43 179.31 3.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.401 0.619 . . . . 0.0 109.482 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.55 -57.17 13.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.586 -0.696 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.862 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -50.77 -51.02 54.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.589 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 60.8 tt0 -65.37 -24.85 67.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.029 . . . . 0.0 109.662 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.23 -66.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.805 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.576 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 14.5 m-20 -59.29 -32.21 69.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.51 84.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.969 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.1 m95 -71.79 -56.77 5.16 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -0.937 . . . . 0.0 108.586 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.35 -13.65 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.542 -0.724 . . . . 0.0 109.152 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -80.48 -36.01 33.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 0.0 109.558 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.78 -27.19 25.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.06 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.891 ' CG1' HD13 ' A' ' 28' ' ' LEU . 4.8 mt -77.91 -36.9 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.929 -1.107 . . . . 0.0 108.957 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -84.94 -37.24 20.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.172 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.31 -49.74 52.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 0.0 108.971 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.47 95.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.107 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.653 ' CG1' HD23 ' A' ' 50' ' ' LEU . 22.5 mt -62.04 -39.13 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 108.752 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -79.32 -9.86 59.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.52 -20.08 19.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.409 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 50' ' ' LEU . 3.2 tp -88.5 -16.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.18 -12.95 61.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.62 4.86 19.24 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 0.3 OUTLIER -106.28 59.24 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.075 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 31.9 mt-10 61.01 -171.61 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -159.75 -49.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.18 -39.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 140.52 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.77 -75.07 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -161.77 150.88 15.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.2 m80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.49 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -53.34 -61.69 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.835 . . . . 0.0 109.808 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.2 Cg_endo -71.78 158.93 52.04 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.751 1.634 . . . . 0.0 110.68 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 5' ' ' ARG . 3.7 mttt 55.06 101.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER 64.72 150.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.53 -61.52 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.972 . . . . 0.0 109.779 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.981 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -166.48 130.43 2.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.063 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.61 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.31 -148.97 5.33 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.939 ' C ' HD13 ' A' ' 11' ' ' LEU . 13.4 p90 -135.99 89.99 2.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.126 -1.22 . . . . 0.0 110.635 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.939 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -111.46 158.99 18.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 108.758 178.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -83.58 132.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 2.0 tttt -119.1 157.29 28.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -100.34 98.57 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.532 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 80.22 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.96 -42.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -1.117 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 17' ' ' VAL . 10.8 p -179.35 106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 17' ' ' VAL . 5.3 m-85 56.82 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' PHE . 4.4 m120 -43.06 106.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.105 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 1.2 p -148.91 146.79 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.811 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.3 m0 -126.94 113.78 16.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.661 ' C ' HG23 ' A' ' 12' ' ' VAL . 1.5 mmtp -138.61 135.93 18.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.027 -1.046 . . . . 0.0 110.035 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.4 Cg_exo -53.99 152.76 22.68 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.914 1.743 . . . . 0.0 109.882 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.766 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -163.39 168.03 20.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.976 -1.078 . . . . 0.0 109.89 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.766 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.2 t-105 -96.06 143.79 26.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.694 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.61 139.82 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.236 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . 5.7 m -125.94 113.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.045 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -85.82 102.89 14.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 108.964 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 5' ' ' ARG . 1.8 mp -89.51 155.78 19.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.192 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.2 tt0 -70.27 -19.3 63.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.324 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.26 4.91 31.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.989 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 164.21 -179.96 38.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm -137.0 119.42 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -1.153 . . . . 0.0 109.422 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.2 pt-20 -127.51 117.24 21.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 108.87 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.694 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.2 p90 -120.96 147.1 45.93 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.903 -1.123 . . . . 0.0 110.347 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.644 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.96 172.75 12.91 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -61.14 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.033 . . . . 0.0 109.288 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.3 mmtt -78.87 -168.76 1.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.985 . . . . 0.0 108.757 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 7.6 mtpt -77.61 5.69 8.68 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.89 -43.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 109.125 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 43' ' ' SER . 13.2 t0 48.61 18.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.304 -0.872 . . . . 0.0 109.541 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' SER . 59.9 t30 40.65 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.9 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t 178.05 112.83 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.626 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.7 Cg_endo -71.55 142.53 40.54 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.83 1.686 . . . . 0.0 110.638 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.3 -5.45 57.54 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -179.33 129.2 1.33 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.4 mtm -126.69 127.45 45.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -1.207 . . . . 0.0 109.978 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.693 HG23 HG22 ' A' ' 73' ' ' THR . 2.7 mt -94.59 131.81 30.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 151.63 55.86 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.784 1.656 . . . . 0.0 110.626 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.033 HD12 HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -90.95 5.26 49.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -0.865 . . . . 0.0 109.202 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.627 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.43 -72.15 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.125 -0.985 . . . . 0.0 109.689 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.29 74.83 0.17 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB3' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -78.79 -179.7 6.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -1.191 . . . . 0.0 109.382 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.493 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -133.55 107.77 8.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.326 -0.859 . . . . 0.0 109.673 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -89.65 117.71 28.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.324 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.909 ' N ' HD22 ' A' ' 55' ' ' LEU . 8.6 m -106.52 131.95 53.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -142.95 125.22 8.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.286 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.727 ' O ' HG22 ' A' ' 56' ' ' THR . 55.7 Cg_endo -73.25 -161.78 2.38 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.479 -1.884 . . . . 0.0 110.337 -0.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.4 p -104.43 -148.02 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.568 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.525 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.1 pt20 -89.78 -149.84 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.68 19.75 2.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.188 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.03 84.41 6.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.169 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 107.97 -55.91 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 63' ' ' GLY . 3.8 tttt 42.37 26.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.423 -1.045 . . . . 0.0 109.788 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 67' ' ' PHE . 19.4 mtp180 -88.01 16.56 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.295 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.514 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 19.3 mtm 65.8 8.74 5.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 65' ' ' ARG . 1.5 m-85 -135.45 28.29 3.36 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 62' ' ' PHE . 2.5 p -127.18 127.13 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -0.999 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.733 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.51 166.44 10.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 109.884 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 15.8 ttpt -134.88 105.45 6.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.883 . . . . 0.0 109.134 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 96' ' ' ILE . 2.7 mt -89.63 165.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.5 m -144.58 93.27 2.4 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 48' ' ' ILE . 1.6 p -47.88 153.44 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 109.408 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.627 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.7 87.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.655 . . . . 0.0 109.655 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER 158.59 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.9 pt20 178.59 31.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.625 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 10.0 mt-30 -97.12 105.67 17.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 108.758 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.584 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 11.9 p30 -82.85 144.1 30.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.012 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 94.5 m-70 -139.76 91.78 2.5 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -93.54 128.35 39.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.044 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.733 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -145.52 141.91 28.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 3.0 tt0 -110.08 143.82 39.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.14 -146.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.754 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -102.38 -18.65 15.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.627 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -166.9 172.13 10.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.561 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 tp -56.28 -39.94 73.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 109.831 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.16 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 21.5 tt0 -63.68 -16.19 60.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.437 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 1.05 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -72.03 -64.12 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.612 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -66.13 -15.63 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.603 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.39 -40.67 29.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 109.012 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.0 m95 -77.97 -26.91 48.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.05 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.0 m -77.43 -32.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 7.3 ptp180 -80.44 -23.85 39.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.544 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.774 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.1 t70 -85.01 -46.87 10.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.016 -1.052 . . . . 0.0 109.706 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.651 HG21 HD11 ' A' ' 71' ' ' ILE . 5.8 mt -70.05 -30.56 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.072 -1.018 . . . . 0.0 109.141 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 55' ' ' LEU . 7.8 t30 -84.65 -37.62 20.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.255 -0.903 . . . . 0.0 109.707 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 2.6 tppt? -69.92 -29.49 66.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.13 -28.71 32.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 53' ' ' SER . 31.1 mt -77.9 -30.05 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -16.69 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -95.77 -26.57 15.62 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.572 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 1.033 HG21 HD12 ' A' ' 50' ' ' LEU . 8.4 tp -73.33 -25.48 21.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -0.93 . . . . 0.0 109.62 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -50.96 -22.64 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 108.965 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -120.59 -104.5 1.98 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER 43.71 70.89 0.27 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.408 -1.054 . . . . 0.0 109.594 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -110.31 -84.88 0.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -167.86 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.408 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 1.6 t60 -118.66 -164.73 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 109' ' ' HIS . 35.4 t-80 69.86 125.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -98.24 112.28 24.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.536 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -112.71 -50.68 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.424 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.595 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -69.18 -61.95 3.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.595 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.5 Cg_endo -71.73 -32.3 11.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.854 1.703 . . . . 0.0 110.051 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' PRO . 4.0 mttm 59.91 113.91 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -91.09 139.06 31.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.425 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 6' ' ' ILE . 1.5 mp -64.6 -49.04 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.609 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -119.17 147.17 44.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.987 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.007 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 -163.57 122.24 1.98 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.267 -0.895 . . . . 0.0 109.217 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.598 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.19 -145.71 4.42 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.0 p90 -135.48 93.33 2.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.018 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -105.19 161.29 14.39 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -92.65 146.87 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.866 -1.146 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -134.74 150.18 50.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.757 . . . . 0.0 109.224 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 4.1 ttpp -62.11 140.33 58.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.0 158.02 20.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 55.63 2.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.59 -90.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.497 ' H ' HG23 ' A' ' 17' ' ' VAL . 80.3 m-85 -131.91 55.54 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 39.9 t-20 60.31 85.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 38.0 p -138.01 174.01 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.935 . . . . 0.0 109.718 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 80' ' ' PHE . 15.6 m95 -150.2 100.66 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 108.941 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.9 mttm -123.21 145.02 45.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.146 -0.971 . . . . 0.0 110.093 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -53.05 166.01 1.1 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.129 1.886 . . . . 0.0 110.507 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.757 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -173.32 169.33 4.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.276 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.757 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.8 t-105 -89.81 141.39 28.67 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.113 -0.992 . . . . 0.0 108.651 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.2 p -151.53 129.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.964 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.007 HG12 ' CB ' ' A' ' 8' ' ' GLU . 6.2 m -125.37 111.98 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.786 . . . . 0.0 109.568 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.725 HD11 ' OD1' ' A' ' 95' ' ' ASP . 2.6 pp -86.6 113.71 22.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.038 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.596 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -92.93 157.75 16.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.61 -21.42 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.685 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -104.59 13.31 31.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.813 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 157.49 -169.12 34.37 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 3.7 mp -149.63 131.64 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -1.182 . . . . 0.0 109.59 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' HD11 ' A' ' 29' ' ' LEU . 2.8 pt-20 -142.0 122.68 14.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.672 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.8 p90 -120.87 144.4 48.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.19 -155.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -92.28 -50.38 5.69 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.48 -174.26 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.41 -26.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.025 -1.047 . . . . 0.0 109.507 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 1.4 m -150.69 -48.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.348 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 3.4 t0 67.48 -6.58 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.725 -0.609 . . . . 0.0 110.589 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m-20 79.25 -40.57 0.24 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.292 -0.88 . . . . 0.0 110.122 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.1 119.12 35.3 Favored Pre-proline 0 C--N 1.31 -1.129 0 O-C-N 120.918 -1.114 . . . . 0.0 109.987 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 58.7 Cg_endo -74.96 145.26 31.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.799 1.666 . . . . 0.0 110.436 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.18 -32.32 16.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 108.991 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -155.49 138.2 5.95 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.5 mtp -130.59 118.53 21.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -1.121 . . . . 0.0 109.709 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.732 HG23 HG22 ' A' ' 73' ' ' THR . 2.6 mp -89.88 128.99 47.99 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.34 146.65 51.16 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.816 1.677 . . . . 0.0 110.508 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 ' CG1' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -86.98 34.91 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.52 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 74' ' ' THR . 36.3 mtmt -84.91 -82.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -150.01 62.89 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -66.61 -176.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -1.187 . . . . 0.0 109.458 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -136.94 113.36 10.03 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.4 tm? -88.61 118.63 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.412 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 58' ' ' PRO . 7.8 m -109.96 129.56 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.67 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 3.5 m -150.36 121.5 3.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.812 . . . . 0.0 109.251 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 56' ' ' THR . 51.8 Cg_endo -71.8 -170.86 7.31 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.619 -1.826 . . . . 0.0 110.277 -0.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 1.7 t -100.3 -99.56 0.24 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.722 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -143.34 -147.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.997 -1.064 . . . . 0.0 109.756 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 24.5 m-20 -45.36 -22.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -0.996 . . . . 0.0 109.312 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 4.7 m-85 -89.86 -46.17 8.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.021 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.763 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -75.34 1.34 57.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 10.2 pttm -71.95 -9.23 58.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -1.199 . . . . 0.0 109.57 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 mtt180 -147.6 173.76 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ARG . 42.9 mtm 48.97 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.645 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 16.3 m-85 -98.15 65.09 1.7 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG13 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -108.14 124.11 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.682 -0.637 . . . . 0.0 109.338 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.76 177.03 5.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.784 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 5.0 ttpp -141.7 103.8 4.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.65 ' CD1' HG21 ' A' ' 96' ' ' ILE . 6.4 mt -89.41 168.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.089 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.2 m -143.73 88.75 2.01 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -45.01 150.25 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.49 87.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.659 -0.65 . . . . 0.0 109.623 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 159.43 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 5.5 pt20 170.59 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.379 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -100.83 84.84 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.146 -0.971 . . . . 0.0 109.066 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.546 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 7.1 p30 -65.91 138.01 57.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.397 -0.814 . . . . 0.0 109.93 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 54.7 m-70 -132.23 99.61 4.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 108.933 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -94.56 124.31 38.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 109.944 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.816 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.21 142.88 24.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.965 . . . . 0.0 109.179 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 2.5 tt0 -108.15 136.42 47.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -91.7 -148.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.5 -90.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.242 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.91 177.65 4.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.071 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 24.7 tp -59.07 -25.42 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.114 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -63.81 1.0 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.331 -0.855 . . . . 0.0 109.2 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.91 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -64.58 -67.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 109.398 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 93' ' ' VAL . 16.9 t0 -60.71 -14.61 22.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.074 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.74 43.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CE2' HD21 ' A' ' 11' ' ' LEU . 6.2 m95 -78.95 -33.17 45.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.8 m -72.19 -33.89 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.729 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -82.68 -22.76 34.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.725 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -80.01 -49.98 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.053 ' O ' HD12 ' A' ' 100' ' ' ILE . 25.1 mt -68.85 -41.56 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.349 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -72.38 -29.72 64.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 12.1 tttm -70.67 -44.41 67.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -63.97 -44.14 93.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.053 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.2 mt -64.98 -36.12 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.301 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -12.65 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.294 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.37 -25.98 16.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.855 ' CG1' HD12 ' A' ' 50' ' ' LEU . 8.1 mm -81.69 -25.21 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.3 mt-10 -69.06 -6.99 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.29 9.08 7.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -109.33 60.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -1.086 . . . . 0.0 109.302 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 108' ' ' HIS . 51.8 mt-10 -152.7 25.99 0.57 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 107' ' ' GLU . 21.9 t-80 76.17 42.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.88 86.12 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.354 -0.841 . . . . 0.0 109.433 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.18 133.58 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.34 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.3 -174.21 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.45 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -139.81 70.44 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 mtm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.5 mt-10 -143.39 162.37 42.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 57.0 Cg_endo -74.82 149.74 38.03 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.01 1.807 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' O ' ' OE2' ' A' ' 8' ' ' GLU . 3.5 mttt -129.56 78.71 1.87 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.566 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.3 OUTLIER 56.09 169.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.203 -0.936 . . . . 0.0 109.144 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HB ' HD12 ' A' ' 28' ' ' LEU . 19.8 mm -84.88 -42.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.949 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.973 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -150.57 104.29 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.045 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.4 pm0 -113.98 136.77 52.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 109.763 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.581 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.31 -146.69 4.8 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.789 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.8 p90 -141.8 95.81 2.87 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.317 -1.108 . . . . 0.0 109.961 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.803 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -115.77 156.3 26.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 108.748 179.172 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -84.04 130.51 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.479 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 28.6 ttmt -131.29 164.53 25.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.302 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -113.48 138.01 50.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.004 . . . . 0.0 109.735 -179.77 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 161.61 117.08 0.42 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 164.53 -94.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -1.113 . . . . 0.0 109.442 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.822 HG23 ' CD2' ' A' ' 18' ' ' PHE . 13.8 m -98.94 -21.9 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.822 ' CD2' HG23 ' A' ' 17' ' ' VAL . 37.6 p90 -179.92 179.97 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.801 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -53.33 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.854 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.793 HG22 ' CZ ' ' A' ' 18' ' ' PHE . 65.8 p -113.92 151.87 31.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 108.649 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.0 m95 -128.56 113.52 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.762 -1.211 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.824 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -150.43 138.05 11.94 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.67 147.52 23.84 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.716 1.61 . . . . 0.0 109.812 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.726 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.74 167.65 28.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.01 . . . . 0.0 110.012 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.726 ' O ' ' SD ' ' A' ' 24' ' ' MET . 64.6 t-105 -89.79 143.35 26.87 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.86 127.29 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.177 -178.814 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -117.53 101.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.195 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.976 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 pp -81.78 109.81 16.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.1 mp -94.84 161.78 14.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.391 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.692 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 4.2 pt-20 -72.29 -16.77 61.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.973 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.68 7.12 34.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.015 . . . . 0.0 109.441 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 151.6 154.5 6.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 50' ' ' LEU . 2.6 mp -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -1.195 . . . . 0.0 109.877 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 12.3 pt-20 -127.3 113.79 16.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.5 p90 -117.81 147.97 42.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -131.3 -158.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -43.95 9.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 108.534 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.8 mmtt -107.31 -171.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -52.92 -19.61 2.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.195 . . . . 0.0 109.358 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -150.68 -49.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.955 . . . . 0.0 109.489 179.552 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.8 t0 62.0 10.55 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.445 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 33.9 t30 41.69 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.944 . . . . 0.0 109.906 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -168.57 110.13 0.53 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.811 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.4 Cg_endo -71.74 135.4 25.82 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.879 1.719 . . . . 0.0 110.545 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.1 ttpt -89.42 -23.66 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -170.86 148.08 11.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.443 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 5.0 mtm -137.21 128.98 28.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 71' ' ' ILE . 2.8 mt -91.08 109.66 36.85 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' O ' ' OG ' ' A' ' 53' ' ' SER . 50.6 Cg_endo -70.21 125.19 11.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.81 1.673 . . . . 0.0 110.348 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 103' ' ' ILE . 3.1 mp -74.71 -2.79 27.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -44.98 -58.36 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 109.306 179.801 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -162.84 72.45 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -96.73 -175.47 3.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -1.131 . . . . 0.0 109.74 -179.88 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.72 108.06 5.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.377 -0.827 . . . . 0.0 109.551 -179.235 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.7 tm? -89.47 113.24 24.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 109.715 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.562 ' N ' HD22 ' A' ' 55' ' ' LEU . 31.1 m -104.52 113.05 26.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.925 ' HB2' HG21 ' A' ' 93' ' ' VAL . 1.6 t -143.44 139.38 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.422 -0.799 . . . . 0.0 109.532 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 60.0 Cg_endo -78.11 -179.58 27.56 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.277 -1.968 . . . . 0.0 110.503 -0.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.71 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -127.9 137.76 52.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 108.93 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -141.71 90.33 2.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 0.0 109.718 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 2.3 p-10 179.53 -32.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 109.161 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -88.57 -45.38 9.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -113.41 -24.63 4.66 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 178.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 10.9 ttmt 38.49 43.05 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.79 0.805 . . . . 0.0 109.499 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' MET . 6.4 mtt85 -136.24 18.5 3.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 108.892 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.546 ' C ' ' CG ' ' A' ' 67' ' ' PHE . 53.0 mtt 64.37 159.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.506 -0.746 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER 71.81 15.57 5.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.71 HG22 ' SG ' ' A' ' 59' ' ' CYS . 1.9 p -121.26 124.09 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.0 167.05 10.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.392 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 3.0 ptmt -142.86 109.58 5.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.175 -0.953 . . . . 0.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 48' ' ' ILE . 36.2 mt -91.15 166.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.1 m -143.78 86.5 1.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 48' ' ' ILE . 3.0 p -49.54 163.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -20.15 21.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -89.07 26.11 1.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.17 30.01 13.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.9 OUTLIER -89.64 102.23 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.637 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.0 m-20 -77.22 145.97 37.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -143.14 109.96 5.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 1.5 m-85 -107.37 120.79 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -137.54 139.01 40.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 178.722 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 83' ' ' ALA . 1.5 tt0 -105.7 145.4 31.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 0.0 109.32 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.5 -166.93 1.72 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.146 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -86.48 -18.85 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.617 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -160.83 169.83 21.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.632 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.043 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.4 -54.77 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.043 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -43.21 -53.53 5.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.1 tt0 -65.5 -32.16 73.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.958 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -67.26 -26.13 66.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.97 . . . . 0.0 109.767 -179.696 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 3.4 t0 -83.32 -42.2 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . . . -70.01 -22.45 63.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.976 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.2 m95 -83.86 -39.09 20.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 57' ' ' SER . 2.5 p -76.39 -26.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.765 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -82.87 -31.12 28.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -75.45 -53.34 8.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.876 HG13 HD22 ' A' ' 28' ' ' LEU . 22.9 mt -62.69 -32.51 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.222 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 13.1 t30 -79.89 -26.62 40.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.317 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -69.68 -53.57 17.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -62.02 -37.98 86.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.252 -0.905 . . . . 0.0 109.185 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ILE . 26.5 mt -62.64 -38.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.019 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -80.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.581 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 13.5 t -95.32 -18.6 20.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.395 -0.815 . . . . 0.0 109.152 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 50' ' ' LEU . 7.6 mm -90.59 -27.62 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.127 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.2 mt-10 -75.66 -3.41 34.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.36 12.91 5.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -105.72 58.89 0.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -1.025 . . . . 0.0 109.378 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.98 -57.81 1.31 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.558 -0.714 . . . . 0.0 109.433 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -179.71 86.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.365 -179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 109' ' ' HIS . 1.5 m170 61.42 152.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 110' ' ' HIS . 16.0 p80 -68.49 98.43 0.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -138.15 78.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 179.48 87.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.454 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 4' ' ' LYS . 10.5 mt-10 -106.51 162.62 19.12 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 50.2 Cg_exo -52.45 147.65 28.88 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.074 1.849 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HB3' ' NH1' ' A' ' 5' ' ' ARG . 21.0 mttm -152.4 99.32 2.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.287 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.715 ' HD3' HG11 ' A' ' 27' ' ' VAL . 3.5 mtt85 61.2 136.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 30' ' ' GLU . 43.4 mt -63.76 -56.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 109.431 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.905 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.32 148.22 46.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.993 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -161.61 135.84 6.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.384 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.594 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.45 -147.44 4.97 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.967 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.0 p90 -139.18 98.17 3.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.464 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.967 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -118.94 159.07 24.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 108.863 179.56 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.795 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.7 p -86.77 125.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.119 -0.988 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 4.6 tppp? -113.49 145.95 40.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 109.208 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.54 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 9.2 tttt -64.36 150.16 46.82 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.311 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 101.51 -135.8 12.39 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 5.2 t 74.85 0.1 3.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.568 HG13 ' H ' ' A' ' 18' ' ' PHE . 2.6 p 175.48 -52.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.568 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -168.2 73.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.143 -0.973 . . . . 0.0 109.751 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m120 48.23 44.95 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.5 ' OG1' ' CG1' ' A' ' 17' ' ' VAL . 1.5 p -101.86 -166.16 1.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.622 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.4 m95 -141.32 109.34 5.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.007 -1.058 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.795 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -148.93 145.96 20.68 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 0.0 109.563 179.904 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.98 160.06 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.019 1.813 . . . . 0.0 109.923 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.745 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -169.38 166.43 10.4 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.802 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.745 ' O ' ' SD ' ' A' ' 24' ' ' MET . 63.3 t-105 -91.32 142.11 28.06 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.97 130.57 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.119 -178.952 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.993 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.8 m -121.13 113.16 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.489 -0.757 . . . . 0.0 109.556 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.924 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.8 pp -86.32 117.9 25.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.955 . . . . 0.0 109.081 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.5 mp -104.95 162.32 13.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.51 -0.744 . . . . 0.0 109.861 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.3 pt-20 -73.66 -7.43 51.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.431 -0.793 . . . . 0.0 110.366 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -115.1 0.87 13.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.093 -1.004 . . . . 0.0 109.419 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.84 165.83 14.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.858 HG23 ' HA ' ' A' ' 28' ' ' LEU . 6.9 mm -112.92 126.46 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.359 -1.083 . . . . 0.0 110.468 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' HG23 ' A' ' 27' ' ' VAL . 6.4 pt-20 -125.71 112.2 15.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.662 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 4.1 p90 -118.2 143.65 46.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.004 -1.06 . . . . 0.0 110.655 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.623 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -125.22 -150.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.98 -49.46 5.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.74 -175.83 2.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 108.833 179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 1.0 OUTLIER -49.51 -21.84 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.407 -179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -148.08 -51.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.4 t70 59.13 10.97 1.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.933 . . . . 0.0 109.333 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.7 m-80 39.63 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.375 -0.828 . . . . 0.0 110.174 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.0 t -166.04 118.91 0.85 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.764 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 57.7 Cg_endo -74.7 147.89 36.0 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.626 1.55 . . . . 0.0 111.096 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -101.64 -30.21 11.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.72 152.76 12.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 mtt -135.17 138.65 43.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 109.559 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.652 HG22 ' HB2' ' A' ' 53' ' ' SER . 8.6 mt -104.57 134.18 19.8 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 108.732 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' CD ' ' OG1' ' A' ' 73' ' ' THR . 36.4 Cg_endo -66.12 137.53 48.5 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.492 1.462 . . . . 0.0 110.474 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.747 ' HB3' HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.15 -6.32 59.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.276 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 48.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.022 -1.049 . . . . 0.0 109.895 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 175.22 -40.2 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.034 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB2' HG22 ' A' ' 48' ' ' ILE . 3.4 t -42.28 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 110.174 -179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.91 170.15 11.38 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.064 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -130.97 148.5 52.74 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.97 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 1.064 ' N ' HD13 ' A' ' 55' ' ' LEU . 21.3 m -145.17 137.28 25.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 108.941 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' PRO . 32.7 t -138.89 122.75 11.18 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 57' ' ' SER . 59.5 Cg_endo -75.62 -94.89 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.709 -1.788 . . . . 0.0 110.095 -0.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.8 p -143.69 -147.12 0.2 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.397 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.526 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -93.99 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.789 -179.76 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.99 18.67 2.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.217 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.4 t80 -89.11 -26.4 21.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.195 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.623 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -143.84 12.33 2.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 28.6 tttt -49.06 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 169.53 -91.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.462 -0.774 . . . . 0.0 109.191 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.9 mmm -61.5 -141.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 9.7 m-85 -107.42 76.11 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.461 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 63' ' ' GLY . 1.3 p -113.75 122.84 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -105.83 168.94 8.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.902 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 7.8 ttpt -128.53 134.92 48.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.077 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 69' ' ' PHE . 1.8 mt -124.97 169.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 54' ' ' THR . 74.1 m -147.81 110.99 4.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -0.975 . . . . 0.0 110.12 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 73' ' ' THR . 5.8 t -58.08 113.37 1.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.017 . . . . 0.0 110.235 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 40.74 24.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.772 . . . . 0.0 111.042 179.266 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 81.77 45.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.102 . . . . 0.0 109.19 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -126.5 -85.31 0.61 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 -179.785 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.644 ' H ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER -94.16 146.22 24.14 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.641 -0.662 . . . . 0.0 109.649 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 68.3 m-20 -99.72 116.59 32.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -102.1 103.98 14.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -101.28 129.26 47.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 109.402 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -142.18 146.46 35.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.334 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 67' ' ' PHE . 6.0 tt0 -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -91.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.628 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 67' ' ' PHE . . . -160.16 -83.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -101.59 171.92 7.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.705 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -55.04 -58.38 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.772 -179.67 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.046 ' N ' HD23 ' A' ' 86' ' ' LEU . 2.0 tt0 -46.14 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -178.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.561 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 41.9 tt0 -40.87 -38.72 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 110.471 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -58.92 -61.34 2.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.997 . . . . 0.0 110.141 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 71.8 m-20 -57.26 -31.32 65.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.452 -179.312 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.68 68.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.934 -1.103 . . . . 0.0 109.851 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.924 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.2 m95 -76.36 -45.49 31.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.096 -1.002 . . . . 0.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.928 HG23 HD21 ' A' ' 55' ' ' LEU . 13.7 p -69.5 -23.12 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.0 mmt180 -81.4 -36.98 28.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.974 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -77.1 -39.53 49.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.092 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' ILE . 6.0 mt -70.64 -46.31 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.774 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 17.3 t-20 -73.97 -30.55 62.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 0.0 109.712 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 7.8 ttpt -72.1 -34.92 69.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.232 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -77.48 -23.0 50.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 50' ' ' LEU . 5.5 mt -81.76 -36.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.119 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -14.77 48.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 2.4 t -95.77 -33.31 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.437 -0.79 . . . . 0.0 109.56 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 30' ' ' GLU . 5.8 tp -73.06 -15.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 1.2 mm-40 -73.04 -7.66 52.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.93 9.81 7.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -110.92 61.03 0.61 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -1.069 . . . . 0.0 109.236 -179.828 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -61.62 -63.62 1.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.535 -0.728 . . . . 0.0 109.676 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.34 27.25 15.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 48.12 -154.73 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.53 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.458 ' O ' ' CB ' ' A' ' 111' ' ' HIS . 2.9 p-80 -141.77 32.33 1.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 110' ' ' HIS . 6.1 t60 72.73 -172.74 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -56.87 -27.14 60.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -94.01 177.19 2.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.447 -179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' HD2' ' CG ' ' A' ' 2' ' ' GLU . 55.2 Cg_endo -79.05 147.54 21.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.833 1.689 . . . . 0.0 110.264 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -135.86 90.49 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -101.88 161.78 13.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.567 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.74 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.0 mt -90.52 -32.3 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HG2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -139.94 157.56 45.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 179.829 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.031 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.0 pm0 -171.02 126.21 0.68 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.7 -147.33 4.99 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.909 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -136.57 91.98 2.71 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.398 -1.06 . . . . 0.0 110.225 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.909 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.24 168.49 9.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.937 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -100.23 124.46 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 110.071 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 mtpm? -104.68 163.67 12.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.6 -0.687 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -68.2 107.53 2.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 109.259 179.695 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' LYS . . . -41.17 139.99 1.42 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 p -85.69 64.51 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -142.13 -87.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.514 ' H ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-85 -131.27 67.45 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.3 m120 54.55 77.42 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.192 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.1 p -129.08 172.53 11.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.593 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 14' ' ' LYS . 3.1 m95 -141.08 121.86 14.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.361 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.937 ' C ' HG23 ' A' ' 12' ' ' VAL . 8.0 mttt -149.18 136.08 10.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.78 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.2 Cg_exo -53.12 163.35 2.27 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.854 1.703 . . . . 0.0 109.986 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 22.3 ptm -177.34 164.14 2.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.044 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.604 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.9 t-105 -91.06 143.68 26.44 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -150.76 132.69 5.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.153 -179.052 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.031 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.7 m -121.64 100.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 95' ' ' ASP . 2.3 pp -74.64 132.33 41.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.849 -1.157 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 29' ' ' LEU . 2.2 mp -117.95 168.56 10.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.554 -0.716 . . . . 0.0 109.597 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.983 ' O ' HD13 ' A' ' 103' ' ' ILE . 15.1 pt-20 -74.42 -0.17 16.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.032 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD22 ' A' ' 50' ' ' LEU . 2.1 m-20 -121.46 -3.62 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.142 -0.974 . . . . 0.0 109.235 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.691 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.41 158.47 8.69 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 28' ' ' LEU . 2.3 mm -95.26 112.5 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 110.009 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 27' ' ' VAL . 15.2 mt-10 -107.74 103.6 12.92 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.2 p90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.783 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -130.26 -153.96 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.328 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.98 -43.38 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 11.6 mttt -110.65 -176.55 3.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -43.34 -26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 109.531 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -149.61 -46.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.031 . . . . 0.0 109.854 179.863 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.0 t70 62.16 10.11 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.63 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.13 22.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.03 . . . . 0.0 109.823 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.4 t -168.7 98.33 0.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.925 -1.11 . . . . 0.0 110.287 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.6 Cg_exo -51.75 130.09 32.6 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.96 1.774 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 3.1 tttt -89.66 -19.57 24.71 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -176.06 132.62 2.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.1 mtm -121.65 121.17 36.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.211 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 ' HD2' ' A' ' 49' ' ' PRO . 24.6 mt -89.45 139.39 28.25 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 108.777 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.626 ' HD2' HG23 ' A' ' 48' ' ' ILE . 49.8 Cg_endo -70.63 131.85 20.8 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.587 1.524 . . . . 0.0 109.963 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.691 HD13 ' CA ' ' A' ' 32' ' ' GLY . 2.4 tp -76.4 -0.75 23.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -136.11 129.11 31.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -0.994 . . . . 0.0 109.545 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 100.39 -5.51 57.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -97.64 172.97 7.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -1.152 . . . . 0.0 109.658 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -132.25 158.31 42.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.527 -0.733 . . . . 0.0 109.267 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.4 tm? -123.88 110.74 15.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.538 ' N ' HD22 ' A' ' 55' ' ' LEU . 87.0 m -102.83 110.38 22.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.0 p -148.64 131.3 7.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.701 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.77 150.78 93.34 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.462 -1.891 . . . . 0.0 110.391 -0.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 68' ' ' VAL . 1.2 p -90.03 167.53 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 27.2 tt0 -167.31 108.11 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.96 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 9.7 t0 165.63 -43.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 6.6 t80 -89.77 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -94.21 -21.78 26.6 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 31.61 44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.437 0.637 . . . . 0.0 110.206 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' HG12 ' A' ' 68' ' ' VAL . 5.2 ttp180 179.53 -170.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 65' ' ' ARG . 3.1 mtt 42.4 -153.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -110.17 69.29 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.488 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.774 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -107.63 130.25 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.354 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -109.08 169.37 8.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.218 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 56' ' ' THR . 15.3 ttpt -136.63 109.39 7.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.336 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 72' ' ' THR . 7.1 mt -95.41 165.46 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.344 -0.847 . . . . 0.0 108.996 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 89.0 m -138.98 89.79 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 3.1 p -54.63 155.69 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.103 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -51.65 -19.18 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.397 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.47 26.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.99 -1.068 . . . . 0.0 109.6 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.95 30.41 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.16 105.79 17.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.222 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 80' ' ' PHE . 3.4 m-20 -75.21 133.42 41.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -124.97 100.51 6.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -98.57 128.38 44.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.596 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -148.27 144.17 27.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 179.142 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 1.2 tt0 -103.99 136.39 43.73 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.36 -149.59 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.798 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 -86.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.869 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -124.2 173.69 8.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.748 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -42.55 -45.81 4.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.826 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.953 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.6 tt0 -52.61 -66.51 0.37 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.064 -1.023 . . . . 0.0 110.145 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -7.69 21.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.855 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.813 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -76.18 -54.74 6.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.647 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -77.75 -12.61 59.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.7 -33.33 35.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.568 ' CE2' ' HG2' ' A' ' 7' ' ' ARG . 3.7 m95 -78.01 -32.9 51.37 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.3 m -76.98 -29.7 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.667 -0.645 . . . . 0.0 109.771 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 17.0 mmt85 -79.62 -27.19 41.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.834 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.7 OUTLIER -87.02 -44.27 11.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.025 . . . . 0.0 110.041 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.702 ' O ' HD12 ' A' ' 100' ' ' ILE . 4.2 mt -69.23 -31.94 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.044 . . . . 0.0 109.128 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 18.1 t30 -85.09 -36.11 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 27.2 tttt -66.27 -34.39 77.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.229 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -80.78 -30.17 36.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.341 -0.849 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 96' ' ' ILE . 22.9 mt -72.94 -29.55 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 101' ' ' LYS . 7.4 mmpt? -93.43 -17.74 23.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 9.7 m -95.88 -16.58 21.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.481 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.983 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.5 tp -87.27 -15.85 9.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.8 -11.91 61.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.425 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.99 12.34 9.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -103.09 58.4 0.76 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -1.011 . . . . 0.0 109.096 -179.921 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -109.19 -166.77 1.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.9 m170 55.48 27.74 10.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.481 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.95 70.0 1.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -102.21 -16.71 16.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.96 95.26 2.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' HIS . 5.0 t60 -113.96 51.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' HIS . 8.8 t60 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 1.5 mt-10 -147.0 173.86 3.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.566 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 52.0 Cg_exo -55.23 -149.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.296 1.997 . . . . 0.0 110.418 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 3' ' ' PRO . 77.9 mttt 42.51 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.858 ' HE ' HG21 ' A' ' 27' ' ' VAL . 0.6 OUTLIER 69.16 86.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.38 -44.37 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.997 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.4 tpm_? -125.4 150.38 47.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -0.997 . . . . 0.0 110.237 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.768 ' CB ' HG12 ' A' ' 27' ' ' VAL . 2.1 pm0 -160.49 121.26 2.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.144 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.599 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.5 -145.28 4.19 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.785 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.2 p90 -142.1 102.6 4.15 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.286 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.785 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -117.16 169.08 9.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.947 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -101.34 133.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 0.0 109.891 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -128.31 131.89 48.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.635 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -96.3 151.28 19.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 108.795 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.514 ' N ' ' HG3' ' A' ' 14' ' ' LYS . . . 178.45 151.7 9.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 30.9 t 61.06 -88.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.242 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 18' ' ' PHE . 7.2 p -44.44 166.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.609 ' N ' HG22 ' A' ' 17' ' ' VAL . 27.3 p90 -73.78 -176.08 2.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.703 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' ' CD1' ' A' ' 18' ' ' PHE . 5.7 t30 -43.66 109.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 179.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' TRP . 18.6 p -146.38 -58.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -0.9 . . . . 0.0 109.902 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.643 ' NE1' ' CZ ' ' A' ' 62' ' ' PHE . 32.9 m95 63.51 106.1 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.488 0.661 . . . . 0.0 110.207 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . 45.0 mttm -125.54 134.86 26.22 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.65 159.71 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.906 1.737 . . . . 0.0 110.611 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.604 ' HE2' ' CD1' ' A' ' 35' ' ' PHE . 13.5 ptm -173.23 171.05 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.243 -0.91 . . . . 0.0 109.273 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.608 ' CE2' ' HA ' ' A' ' 39' ' ' LYS . 52.4 t-105 -89.56 140.83 29.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.911 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -151.54 127.63 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.171 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.858 HG21 ' HE ' ' A' ' 5' ' ' ARG . 17.2 m -126.42 119.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 109.46 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.939 ' HA ' HG23 ' A' ' 33' ' ' ILE . 2.8 pp -87.99 106.02 17.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -90.34 162.53 15.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.898 . . . . 0.0 109.473 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -72.61 -12.39 61.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.68 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HA ' HD11 ' A' ' 103' ' ' ILE . 1.6 m-20 -107.27 -0.81 22.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 157.93 144.68 4.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.939 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm -96.41 109.07 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -1.105 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 9.2 pt-20 -119.79 131.94 55.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 108.869 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.649 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.8 p90 -127.63 142.36 51.37 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 110.073 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -123.42 -149.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.628 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -63.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 109.179 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.0 -178.66 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 108.939 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.79 -42.75 17.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -144.14 69.54 1.28 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.507 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 18.4 t70 -47.41 -21.33 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 2.9 t-20 91.78 -18.49 0.14 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -134.25 119.63 14.5 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 45.1 Cg_endo -69.43 132.93 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.685 1.59 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.69 -21.56 22.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -160.01 117.98 0.8 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 167.8 9.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -1.156 . . . . 0.0 109.662 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.86 HG23 HG22 ' A' ' 73' ' ' THR . 5.5 mt -140.8 109.72 6.59 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.25 118.23 5.55 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.597 1.531 . . . . 0.0 110.35 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.79 HD11 HD11 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.93 -7.06 25.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.545 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -42.88 -68.13 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.725 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -150.14 71.46 0.3 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.009 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -177.65 5.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.196 . . . . 0.0 109.256 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.17 113.09 8.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.251 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' N ' ' A' ' 56' ' ' THR . 3.4 tm? -88.67 131.37 35.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.281 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 58' ' ' PRO . 31.6 m -115.99 137.63 51.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 17.9 p -150.13 118.03 3.6 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.994 ' O ' HG22 ' A' ' 56' ' ' THR . 48.2 Cg_endo -70.78 -160.87 1.7 Allowed 'Cis proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.493 -1.878 . . . . 0.0 110.424 0.211 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 22.7 p -91.07 -149.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -163.43 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.85 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 21.11 2.34 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.643 ' CZ ' ' NE1' ' A' ' 21' ' ' TRP . 8.3 t80 -88.64 -56.44 3.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 108.738 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -75.27 -50.14 8.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 15.7 pttm 40.53 28.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.98 . . . . 0.0 109.59 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.9 ttt180 -137.75 15.5 2.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.9 mtt 64.6 -162.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 49.31 23.11 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' PHE . 10.7 p -161.28 126.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.715 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.4 p90 -116.23 167.38 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.7 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -124.7 108.61 12.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 96' ' ' ILE . 4.4 mt -90.1 166.71 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.635 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -148.95 89.47 1.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.86 HG22 HG23 ' A' ' 48' ' ' ILE . 3.2 p -47.22 173.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.054 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -22.06 64.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.443 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -74.14 -5.92 44.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.184 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 2.7 mt-30 79.13 36.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.8 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 1.9 pt20 -109.11 90.66 3.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 m-20 -53.76 159.53 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.394 -0.816 . . . . 0.0 110.342 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 77' ' ' GLN . 82.7 m-70 -150.56 124.48 9.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -100.4 114.85 28.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.082 -1.012 . . . . 0.0 109.892 -179.461 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.11 148.8 42.65 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 12' ' ' VAL . 2.7 tt0 -138.14 133.87 33.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.063 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.63 -160.8 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.399 -0.813 . . . . 0.0 109.194 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -106.48 -2.03 22.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.514 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -173.02 167.1 5.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.0 179.973 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.463 ' CD1' ' HD2' ' A' ' 89' ' ' ARG . 33.2 tp -66.36 -14.16 61.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.558 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -67.21 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.189 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.68 -14.68 61.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.274 179.715 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -76.05 -51.55 12.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -68.34 -19.95 64.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 109.478 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -87.47 -31.34 20.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.911 ' CH2' HG22 ' A' ' 26' ' ' VAL . 1.6 m95 -79.95 -32.28 39.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.79 ' CG2' HD11 ' A' ' 55' ' ' LEU . 1.7 p -82.55 -34.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.17 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 7.9 ptm180 -73.58 -25.97 60.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 108.998 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 19.4 t0 -85.4 -49.05 8.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 71' ' ' ILE . 23.9 mt -61.62 -38.42 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.048 -1.032 . . . . 0.0 108.831 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 11.3 t-20 -75.92 -66.02 0.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 8.4 tttp -43.08 -32.75 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.401 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -69.47 -47.09 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.537 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.13 -55.54 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.766 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.482 ' N ' HG22 ' A' ' 100' ' ' ILE . 12.2 mttt -63.69 -12.64 36.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -85.82 -32.39 21.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.8 . . . . 0.0 109.184 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.622 HD12 ' CB ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -78.26 -30.46 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -0.868 . . . . 0.0 108.937 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.0 mm-40 -72.97 -5.35 38.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.356 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.75 13.99 5.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 106' ' ' LEU . 1.7 mt -101.46 57.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.465 -1.02 . . . . 0.0 109.284 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 106' ' ' LEU . 3.9 mt-10 -42.42 139.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.698 -0.626 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -67.22 -169.76 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.27 46.99 25.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.01 61.43 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 64.41 -179.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 42.3 t-80 -125.93 3.32 7.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.435 ' N ' ' ND1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.504 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.575 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 167.33 -61.34 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.689 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.1 Cg_endo -72.06 -160.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.833 1.689 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 5' ' ' ARG . 2.2 mtpt -93.57 92.13 7.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.251 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.797 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 83.75 126.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.312 0.577 . . . . 0.0 109.445 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 6' ' ' ILE . 31.3 mt -63.83 -53.95 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -113.7 147.22 38.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 109.858 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 1.004 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.1 pm0 -163.93 126.05 2.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.794 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.587 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.08 -145.08 4.16 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 1.9 p90 -134.89 92.32 2.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.954 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.098 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.96 162.78 13.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.149 -0.969 . . . . 0.0 109.419 179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 82' ' ' GLN . 2.3 p -98.92 130.38 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HE2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.47 135.11 53.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.322 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 tttt -64.46 96.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LYS . . . -43.61 166.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 t -84.52 -4.45 58.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.541 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 18' ' ' PHE . 2.3 p -93.37 114.55 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' VAL . 21.9 m-85 52.34 174.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 19' ' ' ASN . 1.1 p-10 -87.21 86.39 7.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.252 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 61.3 p -120.58 -177.14 3.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.954 . . . . 0.0 109.757 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.642 ' CZ3' ' CG ' ' A' ' 82' ' ' GLN . 44.0 m95 -154.52 106.2 2.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.035 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.934 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -125.3 133.25 24.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 109.989 -179.55 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.2 Cg_exo -53.55 166.14 1.38 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.972 1.781 . . . . 0.0 110.323 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.77 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -174.92 169.68 3.39 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.77 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.1 t-105 -91.37 145.31 24.74 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -150.34 132.43 5.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.329 -178.324 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -127.79 102.95 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.901 ' HB2' HD12 ' A' ' 33' ' ' ILE . 2.5 pp -79.4 125.8 30.0 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.269 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 5' ' ' ARG . 2.2 mp -112.74 163.66 14.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.428 -0.795 . . . . 0.0 109.114 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 7.6 pt-20 -73.84 -6.27 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.28 -0.1 13.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.296 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 29' ' ' LEU . . . 156.14 148.04 4.93 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.901 HD12 ' HB2' ' A' ' 28' ' ' LEU . 4.0 mm -98.93 108.16 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -1.139 . . . . 0.0 109.313 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 29' ' ' LEU . 10.7 pt-20 -111.1 112.54 24.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.018 -1.051 . . . . 0.0 109.185 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.688 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.9 p90 -115.13 142.6 46.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.192 -0.943 . . . . 0.0 110.053 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.67 -149.38 0.41 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 108.613 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -99.91 -54.64 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 108.586 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -93.15 -171.28 2.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.661 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 8.1 mtpt -63.85 -9.89 17.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.657 -1.277 . . . . 0.0 109.704 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -152.65 -51.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.359 178.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.6 t0 57.46 11.0 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 38.67 24.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.814 . . . . 0.0 110.557 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.7 t -176.68 95.57 0.24 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.831 -1.168 . . . . 0.0 110.029 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 52.8 Cg_exo -53.9 153.77 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.169 1.913 . . . . 0.0 111.524 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.4 tttt -101.55 -21.7 14.67 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.42 141.07 5.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 5.5 mtm -139.83 132.11 28.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.261 . . . . 0.0 109.841 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.761 HG23 HG22 ' A' ' 73' ' ' THR . 19.7 mt -89.07 129.15 49.15 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.8 . . . . 0.0 108.905 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.84 131.75 23.28 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.774 1.649 . . . . 0.0 110.447 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.881 HD23 HG13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -89.22 30.66 0.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.403 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -36.15 15.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.415 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 74' ' ' THR . . . -177.51 84.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.12 -177.68 3.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -1.158 . . . . 0.0 109.675 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -135.43 114.51 12.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.405 -0.809 . . . . 0.0 109.696 -179.193 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 56' ' ' THR . 3.3 tm? -88.58 131.88 34.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.216 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.848 ' N ' HD13 ' A' ' 55' ' ' LEU . 23.9 m -124.06 121.37 35.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 35.6 m -148.46 137.06 11.67 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 109.745 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 57' ' ' SER . 60.7 Cg_endo -78.05 177.89 37.05 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.391 -1.92 . . . . 0.0 110.438 -0.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.779 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 1.9 t -150.14 -149.53 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.907 ' HB2' HG21 ' A' ' 68' ' ' VAL . 2.3 tt0 63.17 115.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.413 -0.804 . . . . 0.0 109.859 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.38 7.14 28.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.015 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -89.49 -42.7 11.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.66 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -118.16 -17.92 5.2 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 36.66 31.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.839 -0.801 . . . . 0.0 109.582 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 22.54 5.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.525 -0.735 . . . . 0.0 109.639 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.563 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER 55.81 -179.43 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 108.956 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 1.1 m-30 83.26 -20.18 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.732 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -102.22 135.45 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.388 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.771 ' CE1' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -110.91 152.32 26.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.958 . . . . 0.0 109.985 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.779 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 1.7 tttp -124.41 103.89 8.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.525 -0.734 . . . . 0.0 109.314 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 69' ' ' PHE . 12.7 mt -90.87 167.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 72' ' ' THR . 3.9 m -145.64 84.11 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 48' ' ' ILE . 4.5 p -42.96 165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 109.594 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -62.68 -16.8 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.472 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.42 19.71 5.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.26 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.17 34.66 16.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.765 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -97.82 94.52 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.727 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 66.2 m-20 -62.8 155.73 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 30.3 m80 -139.38 124.07 18.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.613 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 71.1 m-85 -93.01 124.36 36.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.436 -0.79 . . . . 0.0 109.866 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 1.098 ' CE2' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -122.8 141.78 51.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.337 -0.852 . . . . 0.0 110.017 -179.53 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.959 ' HB2' HG13 ' A' ' 12' ' ' VAL . 1.4 mm100 -135.51 108.74 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.322 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.37 -145.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.505 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -132.75 1.53 3.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.849 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -172.28 154.15 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.061 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.14 -22.18 66.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 -179.821 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 1.061 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -66.16 -68.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 0.0 109.091 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 3.0 tt0 -60.28 -21.95 62.55 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 108.792 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.0 -65.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 179.592 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -57.06 -34.25 68.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.807 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.43 75.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.116 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.976 ' NE1' HD21 ' A' ' 11' ' ' LEU . 13.2 m95 -74.83 -56.29 4.92 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.341 -0.849 . . . . 0.0 108.795 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.791 HG12 HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -64.48 -11.07 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.607 -0.683 . . . . 0.0 109.252 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 19.4 mmt180 -84.42 -39.74 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.694 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -87.28 -21.33 25.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.939 -179.745 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.684 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.2 mt -87.42 -38.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 109.095 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 27.3 t30 -80.17 -33.34 38.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 108.874 179.392 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -72.5 -45.06 61.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.078 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.95 -41.69 95.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.206 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 96' ' ' ILE . 33.6 mt -66.64 -32.79 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.111 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -81.92 -11.83 58.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.16 -24.34 16.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 108.954 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.881 HG13 HD23 ' A' ' 50' ' ' LEU . 9.1 mm -69.05 -23.75 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.457 -0.777 . . . . 0.0 109.213 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.7 -1.78 32.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.407 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.54 19.55 1.02 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 53.77 2.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.554 -0.968 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.01 128.81 36.35 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.704 -0.623 . . . . 0.0 109.437 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 34.9 t60 -75.57 135.37 40.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 108' ' ' HIS . 0.5 OUTLIER 176.12 128.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.958 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -110.98 158.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.63 10.19 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -41.07 56.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.504 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 28' ' ' LEU . 50.6 mt -73.59 -58.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.995 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.35 107.46 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.042 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.8 pt-20 -111.97 143.92 42.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.632 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.19 -151.06 6.26 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.987 ' C ' HD13 ' A' ' 11' ' ' LEU . 6.3 p90 -145.26 96.27 2.81 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.385 -1.068 . . . . 0.0 110.086 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.987 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -119.17 163.5 16.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.722 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -86.17 130.69 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 81' ' ' PHE . 1.1 tttt -122.43 135.0 54.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.388 -0.82 . . . . 0.0 109.717 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -101.13 99.57 10.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 108.864 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 166.69 90.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 2.5 p 161.85 -41.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.35 -1.088 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.63 HG21 ' OG1' ' A' ' 20' ' ' THR . 13.2 m -100.92 -144.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' N ' HG23 ' A' ' 17' ' ' VAL . 19.4 m-85 -94.27 72.95 3.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.772 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 2.8 m-20 44.16 88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.007 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.63 ' OG1' HG21 ' A' ' 17' ' ' VAL . 76.1 p -146.88 -162.52 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.657 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.2 m95 -151.4 102.82 2.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.383 -0.823 . . . . 0.0 109.354 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.722 ' N ' HG23 ' A' ' 12' ' ' VAL . 24.1 mmtt -137.85 142.02 34.8 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.7 Cg_exo -52.63 160.23 4.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.92 1.746 . . . . 0.0 109.759 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -167.43 166.65 14.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.951 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.728 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.1 t-105 -92.78 141.07 28.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.3 p -149.9 133.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.764 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.042 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.0 m -124.98 111.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.06 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.041 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -82.4 119.86 24.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -0.976 . . . . 0.0 108.761 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -106.04 166.75 10.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.811 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.688 ' C ' HD22 ' A' ' 50' ' ' LEU . 3.9 pt-20 -71.93 -6.63 43.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.865 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.91 -1.73 11.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.574 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 155.35 146.64 4.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -97.12 105.15 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -1.087 . . . . 0.0 109.956 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 27' ' ' VAL . 5.4 pt-20 -102.38 128.2 49.06 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.0 p90 -124.7 147.29 48.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 110.903 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.13 -145.41 0.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.7 -42.47 5.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.947 -1.096 . . . . 0.0 108.986 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -115.63 -177.79 3.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 108.821 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 4.2 tppt? -46.68 -34.69 5.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -157.12 73.47 0.75 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.515 -0.741 . . . . 0.0 109.469 178.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 31.5 t70 -52.61 -17.36 1.24 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 5.8 m120 91.16 -18.32 0.15 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -135.45 116.44 11.93 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 47.1 Cg_endo -69.2 144.18 56.12 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.735 1.623 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 8.1 mmtt -90.07 -25.6 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 108.926 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.54 150.5 10.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.4 mtt -118.23 166.97 11.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 39.9 mt -128.99 131.24 23.6 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.77 135.46 30.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.353 1.369 . . . . 0.0 109.797 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -85.49 37.98 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 109.924 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -172.71 99.36 0.14 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.032 -1.042 . . . . 0.0 109.425 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 123.87 11.28 4.94 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.311 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 1.2 t -97.15 156.87 16.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.934 -1.333 . . . . 0.0 109.777 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -116.9 173.13 6.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 93' ' ' VAL . 1.7 tt -134.64 135.64 42.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.021 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.852 ' N ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -121.32 108.23 13.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 13.4 p -142.22 116.14 6.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 57' ' ' SER . 33.7 Cg_exo -62.15 -172.85 2.32 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.936 -1.693 . . . . 0.0 110.682 -1.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.7 p -98.14 -146.78 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.33 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.542 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -102.72 -149.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.3 17.81 3.52 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.337 -0.852 . . . . 0.0 108.887 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -89.33 77.67 7.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.308 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 102.27 -73.42 0.32 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 42.79 29.86 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -1.093 . . . . 0.0 109.477 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -93.78 -99.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 45.3 m-85 -129.55 87.2 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 0.0 109.531 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.3 p -120.15 117.32 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.618 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 4.4 p90 -106.97 165.12 11.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.331 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 1.9 ttpp -123.44 120.02 31.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.813 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.5 mt -106.8 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 54' ' ' THR . 87.1 m -134.17 94.48 3.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.09 150.29 25.45 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 108.976 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -45.94 -21.96 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.242 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -86.62 29.22 0.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 109.801 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.81 31.56 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.99 . . . . 0.0 109.67 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.491 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -97.49 97.45 9.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.42 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 77.4 m-20 -61.55 152.69 29.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.491 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 32.7 m-70 -142.32 88.92 2.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.872 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -91.13 101.63 14.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 108.95 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.42 146.83 51.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.528 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -116.39 143.71 45.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.331 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.64 -146.69 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.666 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -107.48 -15.87 14.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 1.7 p90 -170.59 172.44 5.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.965 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.84 -50.25 66.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 109.969 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.965 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.2 tm-20 -53.28 -39.23 63.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.271 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 20.8 tt0 -83.86 -16.13 45.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.071 -1.018 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 1.6 ttt180 -76.99 -46.51 23.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.992 . . . . 0.0 109.638 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 8.4 t0 -79.97 -27.2 39.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 109.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.509 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -73.81 -34.78 64.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.725 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.041 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -80.22 -48.44 13.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.825 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.984 HG22 HD11 ' A' ' 55' ' ' LEU . 3.6 p -68.71 -27.12 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 33.5 ptt85 -79.76 -30.72 40.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.052 . . . . 0.0 109.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -75.21 -39.39 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.368 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.693 ' O ' HD12 ' A' ' 100' ' ' ILE . 28.2 mt -72.5 -42.4 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.57 -27.09 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 109.252 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 5.3 tppt? -72.27 -46.13 57.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -64.13 -37.15 86.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.875 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 96' ' ' ILE . 7.6 mt -69.58 -34.15 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.403 -0.811 . . . . 0.0 108.928 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -85.26 -8.28 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.399 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.543 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -94.61 -30.97 14.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.507 HG12 HD23 ' A' ' 50' ' ' LEU . 1.1 mm -69.44 -28.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.2 mt-10 -64.86 -10.51 29.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.583 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' HD22 ' A' ' 106' ' ' LEU . . . -131.21 10.93 5.59 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 102' ' ' CYS . 3.2 mm? . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.066 . . . . 0.0 109.385 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.629 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 30' ' ' GLU . 2.5 mp -66.81 -71.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.1 tpm_? -107.35 125.96 51.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 110.094 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.001 ' HB3' HG12 ' A' ' 27' ' ' VAL . 6.7 pm0 -145.88 122.91 11.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 0.0 109.178 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.596 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.62 -147.57 4.94 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.791 ' C ' HD13 ' A' ' 11' ' ' LEU . 16.7 p90 -139.63 99.88 3.82 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.356 -1.085 . . . . 0.0 109.873 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -105.86 -143.03 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.036 HG23 ' C ' ' A' ' 22' ' ' LYS . 9.9 p -149.71 129.12 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.013 . . . . 0.0 109.65 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.79 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.3 tttt -116.38 169.16 9.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -125.71 148.13 49.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 14' ' ' LYS . . . 115.58 107.72 2.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p 177.03 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 18' ' ' PHE . 17.9 m -143.06 -39.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 4.7 m-85 -168.29 61.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 48.69 43.55 20.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.548 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 12.7 p -89.99 172.35 8.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 14' ' ' LYS . 5.1 m95 -126.21 120.08 29.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.036 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.2 mmtp -138.88 129.64 15.01 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.668 ' N ' HG23 ' A' ' 12' ' ' VAL . 32.5 Cg_exo -59.14 119.06 6.08 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.916 1.744 . . . . 0.0 110.177 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.79 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 7.7 ptm -124.48 168.5 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.909 -1.119 . . . . 0.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.596 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 72.5 t-105 -90.45 145.53 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -151.49 139.67 14.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.403 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.1 m -130.25 98.31 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.9 pp -76.04 123.78 26.34 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.939 -1.1 . . . . 0.0 108.803 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 5' ' ' ARG . 2.4 mp -107.26 166.08 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.461 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 31.5 tt0 -73.69 -9.2 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.28 4.27 15.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.915 . . . . 0.0 109.472 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 149.67 148.61 4.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.5 mp -99.02 127.09 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 110.084 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 7.9 pt-20 -127.87 115.02 17.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.5 p90 -117.54 151.54 36.93 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -132.77 -153.32 0.54 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.141 -0.975 . . . . 0.0 108.38 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 40.8 mttt -124.62 -173.27 2.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 5.9 tppt? -45.5 -25.65 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.976 -1.077 . . . . 0.0 109.255 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -148.53 -50.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.54 10.86 3.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' ASP . 1.4 m-20 42.61 23.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -169.84 108.19 0.46 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.051 -1.031 . . . . 0.0 109.706 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.1 Cg_endo -71.49 136.57 28.82 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.8 1.666 . . . . 0.0 110.549 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.79 -17.95 27.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.02 140.36 4.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.1 mtm -133.16 124.8 28.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.29 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 73' ' ' THR . 6.5 mt -89.73 134.84 31.43 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 48' ' ' ILE . 56.7 Cg_endo -72.13 137.76 29.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.689 1.592 . . . . 0.0 110.078 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.675 HD23 ' CG1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.82 38.7 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.542 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -91.53 -70.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.99 72.95 0.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.712 ' H ' HG21 ' A' ' 100' ' ' ILE . 1.5 p -80.12 -170.1 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.363 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.33 111.53 6.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.516 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.756 ' C ' HD13 ' A' ' 55' ' ' LEU . 3.4 tm? -88.59 116.42 26.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.017 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 58' ' ' PRO . 86.8 m -102.09 130.56 48.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.421 -0.799 . . . . 0.0 109.578 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 t -150.05 120.05 3.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.713 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.41 -163.02 2.66 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.595 -1.835 . . . . 0.0 110.396 0.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.15 -158.84 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -71.33 -149.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -84.07 14.31 4.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.418 -0.801 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -10.1 49.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.884 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -124.75 -103.65 1.49 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 42.67 59.44 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.281 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 6.2 ttt-85 179.73 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.8 mtp -141.03 -155.95 0.63 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.471 -0.768 . . . . 0.0 109.766 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -92.99 65.37 4.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.91 . . . . 0.0 109.221 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.554 HG11 ' HA2' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -116.25 128.16 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.622 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 7.7 p90 -120.36 173.66 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 109.61 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.627 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 ttpt -129.99 108.34 10.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 0.0 109.396 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.582 HG13 ' CE1' ' A' ' 69' ' ' PHE . 1.3 mt -89.2 165.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 109.377 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.8 m -144.93 91.08 2.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.714 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.7 162.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.364 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -61.09 -13.26 15.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.678 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.99 15.84 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.83 32.28 4.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.55 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -89.95 -175.9 4.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.235 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 77' ' ' GLN . 2.6 m-20 -141.8 146.6 36.1 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.414 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.493 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 80.6 m-70 -145.79 92.63 2.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' CD ' ' A' ' 70' ' ' LYS . 36.1 m-85 -90.48 110.29 21.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.306 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.92 146.11 31.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.698 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 2.4 tt0 -113.06 139.54 48.6 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.471 -0.768 . . . . 0.0 108.948 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.93 -155.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.499 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.73 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 175.62 5.44 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 25.4 tp -56.41 -22.93 34.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 109.109 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -66.07 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.57 -16.88 58.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -0.871 . . . . 0.0 109.153 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.719 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -71.26 -64.04 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.561 ' HA ' HG22 ' A' ' 93' ' ' VAL . 10.4 t0 -62.01 -12.81 20.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.115 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.74 -30.93 28.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 108.666 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.66 ' CH2' HG22 ' A' ' 26' ' ' VAL . 5.8 m95 -84.02 -28.72 27.47 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.1 m -75.28 -36.76 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.543 -0.723 . . . . 0.0 109.535 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 8.5 ptp180 -83.83 -24.72 30.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.5 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' HD11 ' A' ' 28' ' ' LEU . 12.6 t0 -77.14 -45.7 25.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.019 ' O ' HD12 ' A' ' 100' ' ' ILE . 32.1 mt -76.51 -42.32 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 28.1 t-20 -69.44 -31.46 69.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.5 tmtp? -75.37 -50.75 14.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.31 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -54.43 -42.23 70.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.37 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.019 HD12 ' O ' ' A' ' 96' ' ' ILE . 5.2 mt -70.23 -39.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.239 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -71.21 -11.64 61.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.322 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -95.25 -33.91 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 109.244 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.675 ' CG1' HD23 ' A' ' 50' ' ' LEU . 8.5 mm -67.82 -16.9 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 39.3 mt-10 -73.57 -2.99 25.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.517 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.97 17.51 0.93 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 102' ' ' CYS . 2.0 mm? . . . . . 0 C--N 1.301 -1.526 0 O-C-N 121.48 -1.012 . . . . 0.0 109.462 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 28.2 mm -73.01 -59.79 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.928 . . . . 0.0 109.739 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 1.024 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.72 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.63 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.979 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -145.33 129.32 17.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.46 -146.95 4.76 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.728 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.9 p90 -135.89 99.84 4.27 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -115.11 153.79 30.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 22' ' ' LYS . 5.7 p -94.1 140.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.894 -1.129 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.74 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 11.3 mttp -123.07 169.7 10.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.92 113.58 21.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.37 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 153.99 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.14 -46.49 70.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' PHE . 2.2 p -50.46 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 12.7 m-85 61.11 159.62 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -76.71 86.04 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.6 p -128.77 171.53 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.521 ' CH2' ' CB ' ' A' ' 80' ' ' PHE . 23.6 m95 -133.01 101.62 5.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.984 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.5 mttm -107.54 134.19 20.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.35 147.77 44.93 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.644 1.563 . . . . 0.0 109.775 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.74 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 23.1 ptm -154.11 162.44 41.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.991 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.683 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.9 t-105 -94.79 147.91 22.84 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -151.52 138.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.491 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.979 HG12 ' HB3' ' A' ' 8' ' ' GLU . 9.7 m -129.46 94.55 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.027 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -68.41 120.15 14.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.808 -1.182 . . . . 0.0 108.882 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.0 mp -102.62 164.83 11.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.56 -0.713 . . . . 0.0 109.372 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -71.63 -14.72 62.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -0.827 . . . . 0.0 109.818 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -109.3 4.62 22.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.657 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 149.62 150.32 5.22 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -92.5 121.11 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 109.938 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.557 ' O ' HG22 ' A' ' 27' ' ' VAL . 10.3 mt-10 -116.75 107.94 15.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.625 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 12.9 p90 -117.68 145.64 44.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.953 -1.092 . . . . 0.0 110.686 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.646 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.44 -154.72 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 2.8 mtmt -91.95 -43.94 9.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 108.46 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -102.09 -170.9 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 108.743 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 mtpt -64.24 -10.04 21.06 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -150.99 -52.13 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 4.2 t70 59.95 11.37 2.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER 41.89 22.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -176.76 99.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.789 -1.194 . . . . 0.0 110.747 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.1 Cg_exo -52.79 135.1 56.52 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.989 1.793 . . . . 0.0 110.525 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.55 -18.74 26.04 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.65 126.16 1.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 51.7 mtm -122.05 123.47 41.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.594 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.918 HG23 HG22 ' A' ' 73' ' ' THR . 26.0 mt -89.82 132.81 35.43 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.005 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 73' ' ' THR . 54.5 Cg_endo -72.11 129.7 15.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.681 1.587 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.735 HD23 ' CG1' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -84.67 43.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.723 ' HB2' HG21 ' A' ' 74' ' ' THR . 8.5 mmtm -95.73 -71.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.52 61.74 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 100' ' ' ILE . 2.4 m -85.43 171.39 11.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -1.171 . . . . 0.0 109.325 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.71 172.06 8.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -0.81 . . . . 0.0 109.455 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 56' ' ' THR . 3.2 tm? -133.96 136.41 44.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 108.74 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.792 ' N ' HD13 ' A' ' 55' ' ' LEU . 32.9 m -126.29 131.5 51.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.076 -1.015 . . . . 0.0 110.118 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.402 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 24.5 p -150.37 119.89 3.72 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.449 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 56' ' ' THR . 52.9 Cg_endo -71.95 -161.49 2.08 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.56 -1.85 . . . . 0.0 110.179 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -146.68 130.12 16.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 57.04 163.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -103.49 -12.03 17.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.915 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -89.14 4.55 48.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.796 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -120.71 -19.48 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -49.65 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -144.1 -77.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.545 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -99.9 -39.86 7.96 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.5 0.667 . . . . 0.0 109.563 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' A' ' 89' ' ' ARG . 0.4 OUTLIER 158.57 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -119.59 128.0 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.7 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 2.3 p90 -109.02 164.54 12.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.051 -1.031 . . . . 0.0 109.673 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -127.0 108.41 10.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mt -89.33 160.29 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 99.8 m -131.59 85.43 2.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 48' ' ' ILE . 6.9 p -44.13 158.14 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -58.71 -15.34 11.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.357 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -90.43 21.8 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 61.01 35.79 18.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.467 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.1 109.18 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.9 m-20 -76.08 146.64 39.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 39.4 m-70 -140.46 116.57 10.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.66 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CB ' ' CH2' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -98.54 128.49 44.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.7 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.94 160.35 40.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 108.783 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -142.14 132.55 25.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -92.75 -84.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' SD ' ' A' ' 66' ' ' MET . . . 179.16 -67.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -114.26 169.72 8.82 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.635 -0.665 . . . . 0.0 109.807 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -62.3 -19.74 63.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.591 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.985 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -71.28 -66.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.129 -0.982 . . . . 0.0 109.415 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -16.54 64.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 1.052 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.02 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.618 ' HA ' HG22 ' A' ' 93' ' ' VAL . 20.2 t70 -67.96 -14.72 63.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.03 -33.73 29.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.027 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 7.8 m95 -82.55 -25.87 32.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.052 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -79.96 -39.3 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.0 ptm180 -77.79 -23.93 49.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.689 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.5 t70 -81.61 -49.33 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.06 . . . . 0.0 109.506 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.781 HG13 HD22 ' A' ' 28' ' ' LEU . 32.5 mt -72.92 -31.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 6.1 t-20 -81.17 -36.02 30.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 3.2 ttpt -71.6 -37.81 70.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.639 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -68.22 -43.38 78.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.92 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 53' ' ' SER . 60.0 mt -68.37 -30.47 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.163 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 5.4 mmtt -85.03 -10.9 56.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.11 -21.44 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.045 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.735 ' CG1' HD23 ' A' ' 50' ' ' LEU . 2.0 mm -75.51 -28.31 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.009 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.27 -5.54 33.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.17 11.69 5.85 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 106' ' ' LEU . 1.7 mt . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.486 -1.008 . . . . 0.0 109.25 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 30' ' ' GLU . 23.0 mm -56.19 -53.65 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.747 ' HB3' HD11 ' A' ' 28' ' ' LEU . 1.7 tpm_? -141.88 108.68 5.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.207 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.983 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.99 131.23 55.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.987 -1.071 . . . . 0.0 109.189 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.4 -149.4 5.61 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.737 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.3 p90 -138.12 95.72 3.07 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.069 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -114.36 169.77 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -96.4 159.81 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.834 -1.166 . . . . 0.0 109.6 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -148.75 130.17 14.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -50.73 150.9 2.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.414 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.06 -139.48 8.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.64 47.84 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -1.11 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 17' ' ' VAL . 10.9 p -155.1 109.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' ASN . 25.1 m-85 58.52 22.0 9.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' PHE . 4.0 m-20 46.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.2 p -125.4 -179.29 4.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.595 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.683 ' CH2' HG21 ' A' ' 68' ' ' VAL . 39.0 m95 -144.97 88.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.204 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.3 mttm -107.8 139.71 20.88 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.746 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.09 167.81 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.959 1.773 . . . . 0.0 110.598 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 25.6 ptm -174.8 158.43 2.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.89 . . . . 0.0 109.479 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.0 t-105 -89.79 147.17 23.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.413 -0.805 . . . . 0.0 109.03 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.61 133.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.666 -178.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.983 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.2 m -125.59 103.26 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.05 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.4 OUTLIER -86.89 108.97 19.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.75 164.26 14.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -73.64 -17.65 61.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.591 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.67 9.4 43.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 50' ' ' LEU . . . 152.23 -176.59 30.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' HA ' ' A' ' 28' ' ' LEU . 2.8 mp -138.16 125.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.256 . . . . 0.0 109.528 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.3 pt-20 -132.23 116.77 17.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 108.929 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.635 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.1 p90 -119.49 147.54 44.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.13 -0.981 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.77 -157.2 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -88.39 -55.66 3.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.48 -178.82 5.02 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -49.28 -21.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.898 -1.126 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -146.63 -47.36 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.679 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 43' ' ' SER . 5.2 t0 62.29 9.9 3.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.8 t30 45.84 21.04 0.08 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.942 -1.099 . . . . 0.0 109.606 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.8 t -173.29 115.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.497 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.3 Cg_endo -72.35 132.27 19.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.922 1.748 . . . . 0.0 110.593 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -89.62 -19.65 24.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . -167.58 120.66 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.0 mtm -119.28 125.58 49.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.118 -1.225 . . . . 0.0 109.84 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.548 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 mt -90.78 121.53 68.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.995 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.76 140.14 38.29 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.719 1.613 . . . . 0.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -84.9 37.82 0.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.864 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -70.09 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.132 -0.98 . . . . 0.0 109.375 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' THR . . . -136.33 24.71 3.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -40.09 141.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.441 -1.035 . . . . 0.0 110.383 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.47 167.26 10.6 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.763 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.2 tm? -137.66 117.38 13.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.985 -1.072 . . . . 0.0 109.449 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 58' ' ' PRO . 23.2 m -107.96 135.54 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -150.35 120.94 3.86 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.878 . . . . 0.0 109.239 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.854 ' O ' HG22 ' A' ' 56' ' ' THR . 55.5 Cg_endo -72.91 -161.14 2.11 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.651 -1.812 . . . . 0.0 110.346 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 9.2 p -102.93 -148.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.899 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.61 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 11.2 tt0 -71.6 -142.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -68.07 -2.23 7.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 68' ' ' VAL . 24.9 m-85 -88.99 -24.71 22.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 108.948 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -74.39 -49.14 12.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -19.83 6.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -1.063 . . . . 0.0 109.189 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -75.48 0.34 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -155.62 0.58 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 109.553 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 25.0 m-85 -97.52 86.66 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.683 HG21 ' CH2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -126.64 136.3 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.539 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.69 175.62 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 13.9 ttpt -142.67 100.74 3.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.898 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 54' ' ' THR . 12.6 mt -90.12 160.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 108.995 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 53.2 m -140.71 105.36 4.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.349 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.612 HG23 ' H ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -48.67 107.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.298 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER 39.55 28.94 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' THR . 5.5 tttt 82.73 46.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.979 -1.076 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -133.44 -86.71 0.43 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.079 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.612 ' H ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -90.9 136.84 32.81 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.645 -0.659 . . . . 0.0 109.669 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -89.29 168.26 12.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -148.04 98.41 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -96.04 119.6 34.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -137.01 167.99 20.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.05 -1.031 . . . . 0.0 109.061 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.607 ' HB3' HG13 ' A' ' 12' ' ' VAL . 34.7 tt0 -135.12 138.03 43.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.704 -1.248 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.14 -89.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.25 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.601 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.07 171.31 14.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD1' ' NH2' ' A' ' 89' ' ' ARG . 24.1 tp -53.65 -42.81 68.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.199 -0.938 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.07 -59.27 4.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.23 -15.12 62.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.277 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 1.021 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -71.99 -65.22 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.546 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -69.56 -11.19 60.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.311 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.52 -41.06 24.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.239 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.069 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.3 m95 -79.19 -28.56 42.64 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.335 -0.853 . . . . 0.0 109.165 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.021 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -71.24 -39.05 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 109.095 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -77.43 -23.03 50.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -76.74 -52.05 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.691 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.051 ' O ' HD12 ' A' ' 100' ' ' ILE . 47.8 mt -73.03 -31.92 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 18.7 t-20 -78.1 -28.65 48.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.331 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.9 -42.29 49.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.11 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.2 -36.35 83.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.871 . . . . 0.0 108.822 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.051 HD12 ' O ' ' A' ' 96' ' ' ILE . 4.9 mt -76.04 -31.47 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.127 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -83.08 -12.35 57.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.1 m -93.49 -28.39 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 108.931 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 30' ' ' GLU . 2.6 tp -64.97 -33.18 61.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.418 -0.801 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -12.55 61.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.25 6.62 25.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.435 -1.038 . . . . 0.0 109.117 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.43 ' CG ' ' HB ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.338 0.589 . . . . 0.0 109.482 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 30' ' ' GLU . 34.3 mt -56.22 -67.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 1.017 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -116.89 148.86 40.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.028 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -157.6 134.33 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.592 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.67 -149.0 5.45 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.028 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -138.48 91.38 2.54 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.379 -1.071 . . . . 0.0 110.099 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 165.3 14.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.745 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.677 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -85.58 131.47 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.198 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HE2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -131.14 152.11 50.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -70.4 125.94 28.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.265 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 178.82 120.46 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 163.74 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.377 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 18' ' ' PHE . 1.5 p -140.37 -47.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.548 ' O ' HG23 ' A' ' 20' ' ' THR . 4.0 p90 -140.01 -172.97 3.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.418 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 18.3 p-10 -47.49 92.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' PHE . 59.2 p -130.07 155.57 45.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.896 ' CH2' HG21 ' A' ' 68' ' ' VAL . 2.0 m0 -126.67 119.75 27.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.452 -0.78 . . . . 0.0 109.389 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.677 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.06 131.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.815 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.6 Cg_exo -53.36 150.75 25.25 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.751 1.634 . . . . 0.0 109.751 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 11.6 ptm -168.98 165.83 11.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.066 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.8 t-105 -89.94 145.89 24.79 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -151.04 136.07 10.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.118 -178.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.028 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.0 m -125.72 103.63 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.017 HD21 ' CB ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -77.59 112.25 14.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' H ' ' A' ' 29' ' ' LEU . 1.8 mp -89.54 159.75 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.447 -0.783 . . . . 0.0 109.496 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HB3' HD11 ' A' ' 6' ' ' ILE . 7.7 pt-20 -70.75 -15.35 62.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' HD11 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -112.56 6.8 18.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 109.687 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.955 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 167.45 -165.81 38.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HD12 ' A' ' 48' ' ' ILE . 1.9 mp -144.85 121.99 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -1.097 . . . . 0.0 109.186 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 8.9 mt-10 -127.56 115.02 18.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.344 -0.848 . . . . 0.0 108.92 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HB3' HG23 ' A' ' 26' ' ' VAL . 8.3 p90 -121.45 145.77 47.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 109.982 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -130.62 -167.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.119 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -80.22 -40.87 26.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -113.06 -176.14 2.83 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.76 -24.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.84 -1.162 . . . . 0.0 109.184 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.6 -49.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 43' ' ' SER . 4.8 t70 61.38 10.97 3.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.373 -0.829 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 27.1 m120 43.96 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.971 -1.08 . . . . 0.0 109.546 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.2 t -170.89 103.13 0.41 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 109.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.505 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 55.6 Cg_endo -72.25 145.14 43.03 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.709 1.606 . . . . 0.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.96 -26.15 20.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.81 147.52 11.35 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.9 mtt -134.1 125.73 28.59 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.492 -1.005 . . . . 0.0 109.159 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.984 HD12 HG21 ' A' ' 33' ' ' ILE . 3.0 mt -89.74 137.06 28.71 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.209 -0.932 . . . . 0.0 109.007 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 51.7 Cg_endo -70.81 147.61 56.5 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.707 1.605 . . . . 0.0 110.284 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -88.21 24.24 1.92 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' ILE . 8.5 tttm -157.02 114.17 3.09 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.106 -0.996 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 96.58 32.84 6.41 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.476 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.451 ' OG ' HG12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -109.48 172.12 7.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.268 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.92 110.98 6.29 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.056 -1.027 . . . . 0.0 109.95 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.76 ' C ' HD13 ' A' ' 55' ' ' LEU . 3.4 tm? -89.02 130.66 35.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.155 -0.965 . . . . 0.0 109.015 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.748 ' N ' HD13 ' A' ' 55' ' ' LEU . 7.6 m -113.43 100.54 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 55' ' ' LEU . 79.1 p -133.51 129.19 20.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.08 -1.012 . . . . 0.0 109.747 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.9 Cg_endo -78.95 179.71 29.61 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.696 -1.793 . . . . 0.0 110.128 -0.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 41.6 t -105.42 170.84 7.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.566 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 4.6 mm100 -147.76 143.8 27.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.896 -1.127 . . . . 0.0 110.282 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 6.5 t70 84.17 -54.02 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.15 0.5 . . . . 0.0 109.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -94.64 -55.25 3.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 108.437 179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' HG11 ' A' ' 68' ' ' VAL . . . -91.81 34.76 4.23 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -65.99 -9.31 29.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.611 -0.934 . . . . 0.0 109.542 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' MET . 5.8 mtm180 -76.98 -3.09 37.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.509 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 76.96 171.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.842 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 54.05 20.59 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.786 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.896 HG21 ' CH2' ' A' ' 21' ' ' TRP . 3.3 p -140.41 134.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.89 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CD2' HG12 ' A' ' 93' ' ' VAL . 8.2 p90 -117.22 -179.77 3.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 2.8 ttpt -133.71 111.29 10.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.9 mt -89.29 165.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.066 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.9 m -144.93 90.14 2.03 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.894 HG22 HG23 ' A' ' 48' ' ' ILE . 4.3 p -50.8 161.16 0.38 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -54.63 -17.19 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.815 . . . . 0.0 109.819 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -88.43 24.1 2.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.13 30.51 16.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.423 ' HB3' ' NE2' ' A' ' 79' ' ' HIS . 2.1 tm0? -95.96 100.74 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 56.3 m-20 -69.91 152.78 44.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 97.7 m-70 -150.1 101.39 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.135 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.619 ' CE2' ' CD ' ' A' ' 70' ' ' LYS . 8.4 m-85 -90.98 124.95 35.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.647 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.92 140.59 38.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.128 -0.983 . . . . 0.0 109.404 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.7 tt0 -113.15 136.82 52.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . . . -88.88 -92.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.425 -0.797 . . . . 0.0 109.436 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -145.18 -39.89 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 109.94 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -159.32 175.81 12.92 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.51 -0.743 . . . . 0.0 109.734 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.006 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -51.6 -50.09 60.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.57 -0.706 . . . . 0.0 109.56 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.006 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -49.64 -67.5 0.26 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 110.1 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.76 -13.82 17.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 1.033 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.76 -62.25 1.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.694 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 93' ' ' VAL . 6.8 t70 -64.33 -14.86 58.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.208 -0.932 . . . . 0.0 109.574 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -79.54 -46.83 16.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.4 m95 -71.31 -27.92 63.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.436 -0.79 . . . . 0.0 109.223 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.033 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.7 m -78.64 -38.43 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.378 -0.826 . . . . 0.0 109.827 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -74.42 -19.37 60.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.179 -0.951 . . . . 0.0 109.996 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -86.33 -54.26 4.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.053 -1.029 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.787 HG13 HD22 ' A' ' 28' ' ' LEU . 11.6 mt -66.98 -33.36 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 0.0 108.393 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 25.6 t-20 -76.17 -44.62 37.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -63.76 -27.98 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -51.46 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.181 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.804 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -57.44 -51.52 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.01 -17.35 62.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 109.345 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 44.7 t -81.85 -30.23 32.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.055 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -65.43 -38.31 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -12.43 59.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.264 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.68 7.89 12.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 mt . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 108.953 179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.525 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 28' ' ' LEU . 46.1 mm -51.48 -74.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.358 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.925 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.85 142.45 46.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.201 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.991 ' CB ' HG12 ' A' ' 27' ' ' VAL . 3.6 pm0 -149.74 132.14 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.024 -1.048 . . . . 0.0 110.162 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.69 -144.03 3.83 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.847 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.7 p90 -144.67 104.56 4.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.977 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.033 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.05 179.07 4.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 108.753 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.825 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -114.04 125.42 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.765 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -107.46 142.97 36.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 110.014 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -87.15 112.36 21.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.406 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.62 39.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.451 ' OG ' ' HD2' ' A' ' 22' ' ' LYS . 8.5 t -79.54 -50.97 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 0.0 109.392 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 18' ' ' PHE . 4.2 m -148.2 -46.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -136.23 -78.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 8.1 m-20 -137.89 70.39 1.39 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.878 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 5.3 p -127.2 155.95 42.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.632 ' HH2' HG23 ' A' ' 68' ' ' VAL . 47.3 m95 -117.94 98.2 6.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.204 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.825 ' C ' HG23 ' A' ' 12' ' ' VAL . 17.3 mttm -110.87 133.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 0.0 109.711 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.5 Cg_exo -53.35 172.76 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.942 1.761 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.765 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 9.2 ptm 176.03 162.45 0.34 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.601 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 66.6 t-105 -89.3 151.11 22.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.894 HG11 HD22 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -150.85 146.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.147 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.991 HG12 ' CB ' ' A' ' 8' ' ' GLU . 11.1 m -145.29 106.61 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.556 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -78.82 116.39 19.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.465 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.2 mp -104.33 167.27 9.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.675 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.702 ' O ' HD13 ' A' ' 103' ' ' ILE . 5.7 pt-20 -73.67 -17.78 61.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.889 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.1 p30 -101.35 8.73 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 1.106 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 140.22 148.31 5.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.3 mp -94.73 109.01 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -1.166 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 29' ' ' LEU . 7.1 pt-20 -111.12 123.76 50.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 108.856 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.4 p90 -121.26 142.8 49.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -119.5 -151.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.43 -0.794 . . . . 0.0 109.031 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 -39.22 9.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -119.87 -176.04 3.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -43.12 -25.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.024 -1.048 . . . . 0.0 109.567 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -146.57 -53.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' SER . 1.2 t70 62.98 7.67 2.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.453 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.5 m-80 40.6 23.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -164.72 101.49 0.83 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.791 -1.193 . . . . 0.0 110.377 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.5 Cg_exo -51.78 164.07 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.055 1.837 . . . . 0.0 110.702 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 3.1 tppt? -134.52 3.45 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 156.18 134.57 1.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.3 mtt -135.15 138.16 43.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.648 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.5 mt -104.73 125.82 32.9 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HG2' ' OG1' ' A' ' 73' ' ' THR . 53.2 Cg_endo -71.39 130.56 17.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.665 1.577 . . . . 0.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.106 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -74.88 -0.34 18.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.168 -0.957 . . . . 0.0 109.609 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HB2' HG21 ' A' ' 74' ' ' THR . 1.1 mmtp -44.0 -62.28 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.53 57.94 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.7 m -81.21 170.21 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 109.169 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.89 160.52 25.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 55' ' ' LEU . 3.0 tm? -134.72 96.14 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.081 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.634 HG22 ' SG ' ' A' ' 59' ' ' CYS . 85.7 m -90.19 109.36 20.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 55' ' ' LEU . 11.1 p -146.41 142.28 17.29 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.15 -176.11 17.55 Favored 'Cis proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.336 -1.943 . . . . 0.0 110.54 -0.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 56' ' ' THR . 4.8 m -150.28 60.27 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.285 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.532 ' CG ' ' HA ' ' A' ' 64' ' ' LYS . 5.5 tt0 -71.12 124.26 24.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.822 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 1.6 m-20 166.49 -43.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -88.97 -68.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 64' ' ' LYS . . . -81.42 -26.94 49.96 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CG ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 34.41 39.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.452 0.644 . . . . 0.0 110.015 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 ttt-85 -117.99 -137.49 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt -42.51 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.01 . . . . 0.0 109.662 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.61 ' CD1' ' CD ' ' A' ' 89' ' ' ARG . 2.1 m-85 -142.21 111.18 6.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.406 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.632 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -120.66 119.95 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.833 . . . . 0.0 109.653 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.5 p90 -118.14 168.33 10.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.9 pttt -127.91 121.42 29.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 55' ' ' LEU . 9.0 mt -96.1 161.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 108.98 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.555 ' N ' HG22 ' A' ' 54' ' ' THR . 50.4 m -140.27 99.58 3.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.242 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -52.89 155.63 2.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.361 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -41.2 -27.56 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.729 -0.607 . . . . 0.0 109.819 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 73' ' ' THR . 2.0 mmmm -77.63 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.62 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 177.6 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -103.17 72.0 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.076 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 5.7 p-10 -43.51 141.72 1.34 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 109.752 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -127.17 137.73 53.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.09 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 14' ' ' LYS . 40.8 m-85 -93.46 128.95 39.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 1.033 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.8 t80 -129.86 139.44 51.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.558 -0.714 . . . . 0.0 109.366 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.57 ' CB ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.27 119.86 13.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.05 -150.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.819 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -120.27 -26.01 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.054 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -156.18 175.55 13.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 0.0 109.871 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.3 -60.48 3.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.747 . . . . 0.0 110.249 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.072 ' N ' HD13 ' A' ' 86' ' ' LEU . 3.6 tm-20 -46.33 -56.65 5.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.219 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 33.2 tt0 -58.4 -30.52 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.673 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.787 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.926 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.558 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -54.7 -23.26 16.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.06 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.06 -35.75 59.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 109.583 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CE2' HD21 ' A' ' 11' ' ' LEU . 13.0 m95 -76.36 -41.23 48.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.323 -0.861 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -75.37 -28.1 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.797 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.539 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.1 ptm180 -76.83 -30.02 56.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.996 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -90.43 -30.65 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 110.039 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -72.48 -31.22 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.06 . . . . 0.0 108.518 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -85.42 -36.5 20.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -66.82 -47.16 72.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.0 109.096 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.84 -37.16 83.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.876 HG12 HD23 ' A' ' 50' ' ' LEU . 46.6 mt -71.94 -23.9 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.96 -15.04 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 t -95.42 -26.4 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.773 . . . . 0.0 109.337 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.2 tp -76.58 -21.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 51' ' ' LYS . 1.8 mm-40 -67.03 -11.48 57.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.81 5.22 12.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.416 -1.049 . . . . 0.0 109.16 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.26 -46.4 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.62 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.746 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -128.36 138.43 52.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.66 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.004 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -156.06 133.89 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.253 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.02 -146.13 4.63 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' C ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -131.83 97.03 4.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -1.015 . . . . 0.0 110.053 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.045 HD23 ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -108.65 172.69 6.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 108.57 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.945 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.4 p -117.77 125.3 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.879 -1.138 . . . . 0.0 109.402 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 7.6 mmtp -95.53 159.9 14.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.695 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 15.1 ttpp -85.95 94.45 9.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.67 141.29 3.72 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 17' ' ' VAL . 22.8 t -102.21 108.08 19.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.139 . . . . 0.0 109.534 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 16' ' ' SER . 2.6 p 172.19 -30.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.376 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.72 36.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.323 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.84 68.22 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.371 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.6 p -117.95 169.72 9.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 109.701 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.62 ' HH2' HG23 ' A' ' 68' ' ' VAL . 10.7 m95 -148.09 100.37 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.945 ' C ' HG23 ' A' ' 12' ' ' VAL . 19.1 mttt -118.93 136.35 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.839 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.9 Cg_exo -53.99 176.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.833 1.689 . . . . 0.0 109.975 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 19.5 ptm 176.74 159.96 0.36 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.7 t-105 -89.54 146.69 24.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.32 134.28 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.097 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.4 m -128.72 98.66 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.59 -0.693 . . . . 0.0 109.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.05 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 4.0 pp -77.55 123.62 26.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.09 -1.006 . . . . 0.0 109.081 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 32' ' ' GLY . 2.0 mp -109.35 165.16 11.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.82 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.567 ' O ' HD22 ' A' ' 50' ' ' LEU . 1.9 tm-20 -74.87 -9.28 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.5 p30 -112.32 7.92 19.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.925 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.782 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 145.06 147.08 4.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.0 mp -103.15 120.59 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -1.162 . . . . 0.0 109.861 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 2.6 pt-20 -120.07 121.94 39.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.675 ' HB3' HG23 ' A' ' 26' ' ' VAL . 10.6 p90 -125.55 141.24 52.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.096 -1.003 . . . . 0.0 110.405 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.86 -145.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 24' ' ' MET . 2.6 mmtm -99.16 -39.18 8.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.076 -1.015 . . . . 0.0 109.349 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -119.42 -178.27 3.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.269 -0.895 . . . . 0.0 109.09 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 tppt? -43.21 -30.8 0.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 108.708 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.448 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -165.29 72.48 0.18 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.515 -0.741 . . . . 0.0 109.49 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 1.6 t0 -51.39 -18.85 1.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.6 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 8.6 t-20 91.48 -18.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -127.69 106.3 20.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 42.6 Cg_endo -68.79 134.39 29.97 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.726 1.618 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -25.74 20.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' C ' ' CZ ' ' A' ' 35' ' ' PHE . . . -165.51 145.01 9.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -128.65 -168.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -1.073 . . . . 0.0 109.407 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.63 HG23 HG22 ' A' ' 73' ' ' THR . 3.5 mt -150.31 111.16 3.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.31 131.29 23.04 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.58 1.52 . . . . 0.0 110.355 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.782 HD13 ' HA2' ' A' ' 32' ' ' GLY . 5.4 mp -84.46 41.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -99.15 -40.07 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.641 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.15 76.22 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.526 ' HB2' HD13 ' A' ' 100' ' ' ILE . 6.2 m -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.276 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -115.02 171.76 7.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.647 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.4 tm? -143.51 119.61 10.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.819 . . . . 0.0 108.895 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 1.043 HG22 ' O ' ' A' ' 58' ' ' PRO . 20.7 m -114.42 139.1 49.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.101 -0.999 . . . . 0.0 110.345 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -150.51 118.06 3.49 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.086 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.043 ' O ' HG22 ' A' ' 56' ' ' THR . 46.2 Cg_endo -70.21 -160.05 1.41 Allowed 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.562 -1.849 . . . . 0.0 110.399 0.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -117.14 -78.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.239 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.806 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -134.12 -159.94 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.033 . . . . 0.0 110.25 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.54 14.24 3.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 21' ' ' TRP . 16.6 m-85 -88.5 86.86 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 88.35 41.92 6.01 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 4.5 pttt -37.72 111.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.85 -0.794 . . . . 0.0 110.042 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER 178.26 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.771 ' SD ' ' HB2' ' A' ' 86' ' ' LEU . 22.4 ptp 171.93 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.678 0.751 . . . . 0.0 109.363 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HA ' ' CB ' ' A' ' 89' ' ' ARG . 2.2 m-85 -60.09 -21.79 61.94 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.94 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.62 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.1 p -94.65 105.85 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -99.93 170.78 8.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.682 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -140.24 103.28 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.682 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 72' ' ' THR . 14.3 mt -90.54 165.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.629 ' CB ' HG22 ' A' ' 54' ' ' THR . 59.1 m -141.52 87.78 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.63 HG22 HG23 ' A' ' 48' ' ' ILE . 1.8 p -47.35 160.2 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 0.0 108.841 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.43 -13.67 14.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.706 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.25 20.45 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.94 29.22 16.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -92.45 98.49 11.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.234 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 5.6 p30 -68.5 135.4 51.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.791 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -140.07 95.69 2.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.398 -0.814 . . . . 0.0 108.837 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -109.72 135.59 50.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 0.0 110.144 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 1.045 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -149.99 159.23 44.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.778 . . . . 0.0 109.361 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 67' ' ' PHE . 6.8 tt0 -114.04 138.08 50.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -139.49 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.269 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -118.48 -7.82 10.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.897 -1.127 . . . . 0.0 110.056 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -168.11 175.64 6.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -0.963 . . . . 0.0 109.751 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.74 -37.17 67.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 109.236 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.968 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -60.21 -49.18 78.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.043 -1.036 . . . . 0.0 109.712 -179.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -72.96 -33.53 65.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.099 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 1.047 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.43 -39.1 92.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.992 . . . . 0.0 109.411 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.705 ' HA ' HG22 ' A' ' 93' ' ' VAL . 13.5 t0 -78.88 -20.03 50.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -0.994 . . . . 0.0 108.614 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -76.94 -26.87 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.05 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 26.8 m95 -85.52 -37.85 19.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.9 m -71.32 -37.74 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 110.113 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 7.1 ptt180 -80.89 -30.93 35.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.226 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 5.4 t0 -75.06 -41.43 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.914 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.2 mt -75.08 -32.96 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 109.334 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 58.8 t-20 -75.25 -32.05 60.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.5 -45.13 40.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.103 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -58.11 -43.05 86.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.842 . . . . 0.0 109.141 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 96' ' ' ILE . 17.0 mt -70.09 -37.76 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.183 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -72.31 -10.57 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.457 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -38.99 12.03 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 50' ' ' LEU . 4.0 mm -65.32 -40.32 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 51' ' ' LYS . 2.4 mt-10 -68.96 -7.6 36.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.09 11.37 5.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 2.3 mt . . . . . 0 C--N 1.302 -1.46 0 O-C-N 121.401 -1.058 . . . . 0.0 109.114 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.679 ' HG3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.267 0.556 . . . . 0.0 109.782 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' A' ' 30' ' ' GLU . 85.9 mt -76.32 -58.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.646 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.739 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.9 tpm_? -133.34 111.89 11.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.941 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.035 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -118.31 132.5 56.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.054 -1.029 . . . . 0.0 109.417 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.42 -147.69 4.97 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.952 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.3 p90 -141.38 96.62 3.02 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.322 -1.105 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.971 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -121.51 176.42 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.907 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -103.06 147.5 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 26.8 mmtt -118.64 179.82 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 3.6 tttt -133.41 64.1 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.616 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -157.39 131.63 2.96 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 12.6 t 169.54 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.134 . . . . 0.0 109.437 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 4.2 p -100.79 -30.75 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 4.8 m-85 -174.73 176.78 2.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 25.0 p-10 -45.61 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 36.9 p -142.95 -176.83 5.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.727 ' CH2' HG23 ' A' ' 68' ' ' VAL . 56.5 m95 -156.13 105.55 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.143 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.907 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -137.6 135.16 18.84 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.495 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.5 Cg_exo -51.65 166.87 0.48 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.954 1.769 . . . . 0.0 110.461 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 13.1 ptm 178.04 165.36 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -0.907 . . . . 0.0 109.729 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.3 t-105 -90.15 145.16 25.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -150.97 135.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.702 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.035 HG12 ' HB3' ' A' ' 8' ' ' GLU . 8.8 m -125.5 103.2 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -82.44 117.11 22.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.947 -1.095 . . . . 0.0 109.972 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 5' ' ' ARG . 2.0 mp -105.35 166.33 10.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.662 ' CG ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -74.45 -17.61 60.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 0.0 109.435 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -97.39 8.47 44.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.727 ' HA2' HD12 ' A' ' 50' ' ' LEU . . . 139.43 152.13 5.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.8 mp -101.27 118.55 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.196 -1.179 . . . . 0.0 109.655 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 17.8 pt-20 -117.97 116.15 26.34 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 26' ' ' VAL . 1.8 p90 -116.12 150.62 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.054 -1.029 . . . . 0.0 110.594 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -128.6 -153.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -41.38 9.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.0 mttt -115.7 -172.26 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 6.1 tppt? -44.85 -25.36 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 109.288 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -154.83 -47.07 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.594 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.8 t70 61.65 11.21 3.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.35 22.52 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.776 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -163.36 111.37 1.0 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.994 -1.066 . . . . 0.0 109.743 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.2 Cg_endo -71.92 133.25 21.32 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.888 1.725 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 2.2 tttt -89.5 -23.24 22.11 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 178.47 151.79 9.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 mtm -137.65 135.57 36.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -1.154 . . . . 0.0 109.743 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.92 137.68 19.58 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 48.4 Cg_endo -71.0 99.16 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.447 1.431 . . . . 0.0 109.832 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -66.74 -4.51 9.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.945 . . . . 0.0 110.528 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 50' ' ' LEU . 3.4 ptmm? -85.45 48.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.544 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . 151.38 -22.35 0.95 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.891 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.586 ' O ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -42.48 146.75 0.31 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.096 -1.238 . . . . 0.0 109.828 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.2 162.75 13.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 56' ' ' THR . 3.0 tm? -117.51 147.19 42.99 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.063 -1.023 . . . . 0.0 108.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 1.07 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 m -149.31 129.45 13.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.924 -1.11 . . . . 0.0 110.086 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.71 126.81 5.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 109.138 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 57' ' ' SER . 25.0 Cg_exo -67.0 -150.46 0.33 Allowed 'Cis proline' 0 C--N 1.309 -1.52 0 C-N-CA 123.148 -1.605 . . . . 0.0 110.903 -1.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 30.1 p -131.81 -148.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.407 -0.808 . . . . 0.0 109.974 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 173.98 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -91.62 5.03 51.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.437 -0.789 . . . . 0.0 109.601 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -88.74 45.26 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.219 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 160.22 38.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 85.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.381 -1.07 . . . . 0.0 109.518 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -147.96 23.35 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.561 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 12.8 mtt 62.7 159.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.466 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 2.6 m-85 82.43 -28.85 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.561 -0.712 . . . . 0.0 110.47 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.727 HG23 ' CH2' ' A' ' 21' ' ' TRP . 15.0 p -93.11 135.11 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.195 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.808 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -133.4 -176.47 4.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -150.11 118.93 6.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.07 . . . . 0.0 110.292 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 54' ' ' THR . 3.7 mt -96.67 162.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 54' ' ' THR . 90.4 m -127.39 91.43 3.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 108.842 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.877 HG22 HG22 ' A' ' 48' ' ' ILE . 1.4 p -43.21 144.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.474 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.496 ' HB ' ' HA3' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -41.07 -34.7 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.804 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -66.36 -74.9 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.227 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 166.11 35.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.588 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.469 ' O ' HG23 ' A' ' 73' ' ' THR . 1.4 mm-40 -105.78 118.95 37.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 3.2 m-20 -83.31 103.3 12.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 48' ' ' ILE . 53.3 m-70 -89.78 105.31 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.165 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 5.6 m-85 -94.63 117.99 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.705 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -136.86 138.74 41.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 108.623 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.572 ' CG ' ' CG1' ' A' ' 12' ' ' VAL . 8.3 pt20 -118.01 146.27 44.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 -153.05 0.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 109.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -108.31 -2.21 19.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -169.09 169.94 9.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 0.0 109.187 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.601 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 27.6 tp -69.81 -30.81 68.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -56.89 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 108.868 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -69.17 -15.33 63.38 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.178 -0.951 . . . . 0.0 108.74 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 1.046 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.1 ttt180 -68.94 -63.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.818 . . . . 0.0 109.354 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.92 -13.26 62.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.9 25.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.047 -1.033 . . . . 0.0 108.861 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.971 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 1.9 m95 -81.97 -27.91 32.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -75.33 -33.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.164 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 2.5 mmm180 -79.74 -29.95 40.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.61 ' OD1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -74.74 -49.38 21.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.523 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.006 ' O ' HD12 ' A' ' 100' ' ' ILE . 9.8 mt -72.58 -36.6 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.025 -1.047 . . . . 0.0 108.866 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 11.1 t-20 -73.28 -26.39 61.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -76.68 -45.22 30.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.867 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.91 -34.02 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.332 -0.855 . . . . 0.0 108.969 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.006 HD12 ' O ' ' A' ' 96' ' ' ILE . 1.3 mt -74.9 -40.84 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 108.826 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 101' ' ' LYS . 13.9 tptm -73.2 -7.87 53.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.073 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -40.72 9.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.814 ' CG1' HD21 ' A' ' 50' ' ' LEU . 1.2 mm -60.64 -44.01 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 108.805 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 3.1 mt-10 -46.49 -26.23 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.37 -103.29 2.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.537 ' C ' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.543 0 O-C-N 121.375 -1.073 . . . . 0.0 109.218 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.581 HG21 ' OD1' ' A' ' 95' ' ' ASP . 77.2 mt -47.13 -70.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.702 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -101.58 169.12 9.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.786 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.837 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 173.65 132.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.575 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -173.12 -143.68 4.32 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.566 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -124.03 106.97 10.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.933 . . . . 0.0 109.427 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -120.53 178.47 4.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.818 . . . . 0.0 108.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -123.41 122.68 65.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 108.596 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.794 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -104.02 126.62 51.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 109.466 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HG3' ' CD1' ' A' ' 21' ' ' TRP . 19.1 tttt -73.17 99.76 2.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 178.36 48.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 t -98.07 114.5 26.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -1.164 . . . . 0.0 109.56 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 18' ' ' PHE . 5.1 p -167.33 -45.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.53 ' N ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -174.93 48.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.406 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 20.5 m-20 49.56 63.53 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 1.1 p -129.41 161.59 30.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.735 ' CH2' HG21 ' A' ' 68' ' ' VAL . 34.0 m95 -125.64 118.98 26.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.851 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.2 mttt -121.88 130.04 24.91 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.684 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 49.1 Cg_exo -55.04 -179.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.8 1.667 . . . . 0.0 110.119 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.794 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 6.5 ptm 169.29 169.63 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.584 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.7 t-105 -92.46 152.25 19.79 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.741 HG11 ' HB2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -149.66 149.96 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.581 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.837 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.8 m -144.52 112.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.007 HD13 HG13 ' A' ' 96' ' ' ILE . 5.1 mt -78.94 121.66 25.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.449 -0.782 . . . . 0.0 109.095 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.58 HD21 ' CG ' ' A' ' 5' ' ' ARG . 1.1 mp -110.79 156.28 21.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.295 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.539 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.3 tt0 -72.46 -21.97 61.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.872 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' HD11 ' A' ' 103' ' ' ILE . 2.8 m-20 -98.64 10.93 39.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 109.369 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.736 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 146.77 -175.66 26.06 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.512 HD13 ' HB ' ' A' ' 48' ' ' ILE . 1.9 mp -132.47 137.9 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.051 -1.264 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 3.5 pt-20 -144.55 123.44 12.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.299 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CZ ' ' HD3' ' A' ' 13' ' ' LYS . 5.0 p90 -121.65 140.18 52.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -121.69 -148.37 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 109.027 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -60.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.1 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -96.65 -177.14 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 108.727 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.68 -28.39 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 108.612 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.447 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -163.01 69.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.452 -0.78 . . . . 0.0 109.387 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 60.6 t0 -48.26 -21.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.7 t-20 91.8 -21.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -118.89 107.03 42.78 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 44.1 Cg_endo -68.86 146.97 67.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.778 1.652 . . . . 0.0 110.826 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 -31.58 9.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.397 -0.814 . . . . 0.0 109.076 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -154.3 143.24 9.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.517 ' C ' HD13 ' A' ' 48' ' ' ILE . 5.8 mtt -133.26 135.74 45.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 48' ' ' ILE . 2.2 mm -95.16 107.94 35.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 109.265 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' A' ' 53' ' ' SER . 46.3 Cg_endo -70.04 118.91 5.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.707 1.605 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.736 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.8 mp -63.29 -9.57 12.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.898 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -71.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 109.84 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' O ' ' CA ' ' A' ' 74' ' ' THR . . . -152.46 71.79 0.28 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -100.53 166.0 11.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.161 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.89 157.32 36.25 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.3 tm? -127.48 102.06 6.71 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 58' ' ' PRO . 19.5 m -89.6 133.45 34.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 0.0 110.009 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -146.6 122.94 5.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.403 -0.811 . . . . 0.0 109.385 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 56' ' ' THR . 49.7 Cg_endo -72.23 -161.88 2.26 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.558 -1.851 . . . . 0.0 110.416 -0.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.769 ' SG ' HG13 ' A' ' 68' ' ' VAL . 21.8 p -103.95 -147.16 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -71.68 -141.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 109.922 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -3.03 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.505 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 68' ' ' VAL . 19.9 m-85 -88.82 -21.13 23.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.509 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.749 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -76.61 -22.81 71.65 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -2.83 31.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.541 -0.976 . . . . 0.0 109.156 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -104.59 -95.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.555 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.489 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 9.4 mtt -94.34 -147.26 0.26 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.645 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 44.2 m-85 -101.79 92.69 4.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 81' ' ' PHE . 3.8 p -135.71 132.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.493 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.731 ' CE1' HD12 ' A' ' 71' ' ' ILE . 3.2 p90 -110.29 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.955 -1.091 . . . . 0.0 109.718 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -124.94 106.12 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.731 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.8 mt -88.48 160.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 74.8 m -133.53 90.69 2.75 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 79' ' ' HIS . 3.3 p -45.3 158.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.062 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -59.89 -14.07 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -86.89 16.81 4.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.58 43.37 4.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' THR . 13.6 tt0 -118.48 118.24 31.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.3 m-20 -70.61 163.3 27.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 73' ' ' THR . 12.3 m-70 -143.98 128.64 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.035 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 14.5 m-85 -91.59 113.42 25.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.858 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 1.7 t80 -128.16 128.19 44.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 110.689 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.576 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -126.91 136.05 51.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -0.827 . . . . 0.0 109.735 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -107.48 -150.84 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 0.0 109.798 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.29 -88.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -106.94 -179.27 3.89 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.59 -0.694 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.029 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -56.08 -58.18 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.69 . . . . 0.0 109.75 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.029 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.1 tp10 -43.46 -70.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.972 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 1.2 tt0 -48.94 -33.71 11.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 93' ' ' VAL . 13.1 ttp180 -56.36 -65.01 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.86 -22.18 9.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.958 . . . . 0.0 109.263 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -70.9 -40.94 71.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.861 ' CE2' HD21 ' A' ' 11' ' ' LEU . 77.8 m95 -73.03 -52.73 13.27 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.507 -0.746 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -65.56 -24.84 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.518 -0.739 . . . . 0.0 110.794 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.552 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.6 ptt85 -85.24 -23.58 28.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.903 -1.123 . . . . 0.0 110.074 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.581 ' OD1' HG21 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -85.61 -38.66 18.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.075 -1.016 . . . . 0.0 109.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.007 HG13 HD13 ' A' ' 28' ' ' LEU . 21.1 mt -76.73 -35.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.102 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.46 -31.76 58.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -72.2 -55.92 6.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 108.983 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.0 67.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 59.2 mt -63.67 -45.27 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.035 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -67.88 -8.87 40.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.7 t -95.1 -35.38 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.68 HD12 HD22 ' A' ' 50' ' ' LEU . 2.2 mt -79.82 -26.68 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.032 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -73.14 -7.65 52.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.22 12.51 5.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 2.5 mt . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.438 -1.037 . . . . 0.0 109.306 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 2.0 mpt_? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.361 0.6 . . . . 0.0 109.73 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.6 mm -64.36 -56.8 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.217 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.556 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -132.85 90.61 2.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.981 -1.074 . . . . 0.0 110.414 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.011 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -103.33 128.91 50.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.867 -1.146 . . . . 0.0 109.185 178.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.597 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.43 -149.94 5.68 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.929 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.0 p90 -141.26 97.15 3.11 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -114.19 171.65 7.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.929 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.9 p -102.34 129.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.776 -1.202 . . . . 0.0 109.872 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.574 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -119.75 166.04 13.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.311 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 10.8 ttpt -68.21 121.65 16.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.32 -161.69 2.8 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' VAL . 23.3 t -119.16 -16.61 9.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -1.161 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -46.68 -93.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.473 ' H ' HG23 ' A' ' 17' ' ' VAL . 36.6 m-85 -126.67 52.0 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.511 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.0 OUTLIER 59.01 78.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 40.0 p -124.74 -165.79 1.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.779 ' HH2' HG23 ' A' ' 68' ' ' VAL . 2.1 m95 -144.78 104.83 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.929 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.9 mttp -132.65 144.0 51.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -52.21 166.39 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.77 1.647 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.632 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 23.1 ptm -176.51 159.53 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -0.954 . . . . 0.0 109.648 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.6 t-105 -89.81 143.64 26.63 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.654 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.27 150.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.672 -179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.011 HG12 ' CB ' ' A' ' 8' ' ' GLU . 7.6 m -137.52 119.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.873 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.865 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -85.05 105.61 15.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.452 -0.78 . . . . 0.0 108.914 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -96.85 157.92 15.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.0 109.681 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -72.89 -17.5 61.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 109.788 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -101.9 5.86 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 153.29 -171.6 32.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.4 mm -133.05 122.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.383 -1.069 . . . . 0.0 109.283 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 27' ' ' VAL . 6.0 pt-20 -129.12 127.27 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 6.7 p90 -131.09 146.4 52.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.46 -150.31 0.44 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 -32.43 11.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 108.877 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 2.8 tttp -121.05 -179.58 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -45.56 -27.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -166.96 73.36 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.0 109.702 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 24.8 t70 -50.98 -19.04 0.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.996 -1.065 . . . . 0.0 108.172 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 6.3 t-20 90.92 -17.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -132.34 94.55 22.84 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 36' ' ' TYR . 50.7 Cg_exo -49.41 139.0 29.95 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.968 1.779 . . . . 0.0 110.878 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 9.7 mmtt -90.07 -23.02 21.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -164.9 143.8 8.81 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 mtm -134.97 123.87 24.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -1.19 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.77 129.76 41.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.318 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 55.7 Cg_endo -72.51 137.45 27.89 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.687 1.592 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -88.11 23.06 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.612 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 49' ' ' PRO . 12.9 ptpt -91.77 -18.78 23.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.185 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -157.76 -91.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER 56.99 132.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.545 -0.973 . . . . 0.0 110.674 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.567 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.51 167.71 9.85 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -133.73 142.48 47.97 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.027 -1.045 . . . . 0.0 109.025 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.984 ' N ' HD13 ' A' ' 55' ' ' LEU . 52.6 m -130.22 119.88 23.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.891 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.7 t -143.61 120.27 6.6 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.07 -160.92 1.92 Allowed 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.573 -1.844 . . . . 0.0 110.143 -0.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 17.9 p -89.67 -149.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.435 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 18.4 tt0 -110.17 -139.86 0.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.536 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.25 26.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.877 -1.139 . . . . 0.0 109.367 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 1.3 t80 -88.86 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -101.56 -42.3 2.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 7.2 tttt 55.45 19.4 3.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -1.007 . . . . 0.0 109.488 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 9.7 mmm180 -87.09 -144.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mtt -126.62 -4.05 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.11 -0.994 . . . . 0.0 109.85 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' MET . 0.5 OUTLIER -130.08 32.62 4.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.013 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.7 p -128.56 123.49 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.002 -1.062 . . . . 0.0 109.637 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 11.0 p90 -118.79 174.31 6.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -135.06 127.07 29.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.553 HG13 ' CD2' ' A' ' 55' ' ' LEU . 6.6 mt -105.99 163.39 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.567 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 98.0 m -145.13 99.91 3.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.25 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.368 -0.832 . . . . 0.0 109.994 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER 43.46 37.74 1.54 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.935 . . . . 0.0 110.864 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 80.24 45.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 0.0 109.57 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.97 -82.87 0.32 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.028 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.7 OUTLIER -90.17 131.25 36.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.499 -0.75 . . . . 0.0 110.118 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.543 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 9.5 t0 -97.56 145.16 26.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 13' ' ' LYS . 81.3 m-70 -137.72 109.23 6.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -101.39 115.04 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.382 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -143.84 145.98 32.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 109.617 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.503 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 pt20 -116.78 147.01 42.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.51 -0.744 . . . . 0.0 109.052 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -143.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.45 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.91 -60.83 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 110.12 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.28 175.1 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.668 -0.645 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.041 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -45.7 -50.14 13.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.041 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.7 tm-20 -51.63 -57.93 7.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.045 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 92' ' ' TRP . 11.8 tt0 -63.19 -18.04 63.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.977 ' O ' HG13 ' A' ' 93' ' ' VAL . 15.8 ttp180 -72.96 -65.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HA ' HG22 ' A' ' 93' ' ' VAL . 59.3 t0 -65.75 -11.57 46.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.277 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.35 -41.19 22.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.003 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 12.4 m95 -76.68 -31.1 57.05 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.454 -0.779 . . . . 0.0 108.99 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.977 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -70.6 -38.65 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.567 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -78.91 -20.08 50.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.708 ' HB3' HD12 ' A' ' 28' ' ' LEU . 9.5 t70 -77.73 -58.0 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.834 HG13 HD13 ' A' ' 28' ' ' LEU . 1.1 mt -63.6 -35.09 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 108.707 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 35.0 t30 -73.77 -32.54 63.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.91 -57.13 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -51.66 -42.42 62.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.238 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.483 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 45.0 mt -59.68 -50.62 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.314 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -10.89 35.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -93.12 -28.84 16.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.285 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.618 ' CG1' HD23 ' A' ' 50' ' ' LEU . 4.9 mm -78.0 -34.06 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.57 -4.85 33.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.4 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.72 13.02 4.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 106' ' ' LEU . 2.6 mt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.448 -1.031 . . . . 0.0 109.218 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.665 HD11 ' CB ' ' A' ' 30' ' ' GLU . 46.7 mt -92.81 -77.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.97 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -107.5 104.83 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 110.099 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.022 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.2 pm0 -115.65 135.51 53.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.3 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.589 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.73 -146.8 4.65 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.764 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.6 p90 -138.57 97.4 3.34 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.411 -1.052 . . . . 0.0 109.78 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -119.36 146.8 45.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.4 p -76.34 137.68 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.026 -1.047 . . . . 0.0 109.298 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -117.18 165.19 13.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.42 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 2.1 tmtt? -116.31 125.11 51.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.348 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' VAL . . . 164.86 -120.11 0.92 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 51.21 -91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -1.146 . . . . 0.0 109.383 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 18' ' ' PHE . 14.8 m -117.51 -147.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.524 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -42.71 165.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.478 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' PHE . 3.1 m120 -43.53 105.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.376 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -132.29 174.42 10.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.764 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CD1' ' O ' ' A' ' 20' ' ' THR . 3.4 m95 -152.33 106.94 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.619 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.6 mmtt -138.18 138.8 23.8 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.33 151.58 17.4 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.849 1.7 . . . . 0.0 109.922 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.774 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.15 171.07 20.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 110.341 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.774 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.9 t-105 -96.94 145.8 25.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -150.19 139.24 15.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.05 -178.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -129.09 106.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.821 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.022 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.5 pp -86.45 111.91 21.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.992 . . . . 0.0 109.193 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.9 mp -93.29 164.58 13.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.789 . . . . 0.0 109.564 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.665 ' CB ' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -74.99 -15.8 60.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.6 p30 -101.87 10.11 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.339 -0.85 . . . . 0.0 109.169 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.932 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 148.49 -165.15 29.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.682 HG21 HD12 ' A' ' 48' ' ' ILE . 2.9 mt -141.07 141.51 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -1.198 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.691 ' HG2' HD11 ' A' ' 29' ' ' LEU . 12.1 pt-20 -148.12 115.03 6.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.747 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.5 p90 -112.81 148.72 34.24 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 110.792 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -124.62 -156.76 0.74 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -46.42 6.56 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -111.37 -169.22 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -46.5 -24.79 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.793 -1.192 . . . . 0.0 109.024 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -153.52 -50.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.199 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.67 10.08 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.418 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' ASP . 38.8 m-20 41.9 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -156.79 96.17 2.18 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 110.037 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.9 Cg_exo -51.82 171.7 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.054 1.836 . . . . 0.0 110.58 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.49 4.98 2.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.455 -0.778 . . . . 0.0 109.287 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.53 141.68 3.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.52 ' HG2' ' CB ' ' A' ' 34' ' ' GLU . 26.4 mtm -124.41 139.69 53.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 0.0 109.634 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 HG22 ' A' ' 73' ' ' THR . 2.3 mt -101.31 125.85 36.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.075 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.71 131.91 19.34 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.547 1.498 . . . . 0.0 110.08 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.048 HD21 ' HB1' ' A' ' 99' ' ' ALA . 1.5 mp -73.74 -0.03 14.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.699 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.1 OUTLIER -42.14 -88.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.78 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.51 54.99 0.56 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.397 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -66.95 156.25 36.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.246 . . . . 0.0 108.941 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -103.73 171.07 7.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 108.855 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.606 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.2 tm? -143.33 114.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.205 -0.934 . . . . 0.0 109.114 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 58' ' ' PRO . 12.4 m -112.89 128.23 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.19 122.18 4.12 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.473 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 56' ' ' THR . 54.7 Cg_endo -72.31 -177.87 19.21 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.603 -1.832 . . . . 0.0 110.199 -0.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.82 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -96.04 -85.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.82 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -152.95 -165.58 2.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -87.28 21.39 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 14' ' ' LYS . 1.6 t80 -89.26 85.7 6.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 88.94 26.89 25.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER -43.81 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.253 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -141.3 132.63 26.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.1 mtp 44.27 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 6.0 m-85 -145.86 108.25 4.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -113.32 138.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.278 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.84 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 33.9 ttpt -141.67 98.8 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 96' ' ' ILE . 7.5 mt -89.38 163.76 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.642 ' CB ' HG22 ' A' ' 54' ' ' THR . 45.6 m -139.35 87.38 2.19 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.63 155.34 0.16 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.238 -0.914 . . . . 0.0 108.905 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.699 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -55.44 -17.51 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.761 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.15 23.74 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 109.85 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 35.27 18.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.887 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.89 94.09 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.8 m-20 -66.32 153.12 43.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -148.68 114.84 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 109.261 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -108.27 124.15 49.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.502 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.49 -176.29 4.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.544 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 1.8 tt0 -150.38 138.1 19.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.842 -1.162 . . . . 0.0 110.025 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.82 -145.8 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -115.52 -11.45 11.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 109.64 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.599 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -170.61 171.3 6.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -55.79 -48.78 74.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 109.474 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -48.62 -60.45 2.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 0.0 109.769 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -61.49 -22.45 65.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.884 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.995 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.68 -63.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.782 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.583 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -66.08 -12.83 58.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.15 -39.06 26.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.112 -0.992 . . . . 0.0 108.868 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.022 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 9.6 m95 -78.1 -29.76 49.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.805 . . . . 0.0 109.028 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.8 m -74.09 -31.27 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.591 -0.693 . . . . 0.0 109.699 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.7 ptp180 -83.5 -23.16 32.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.901 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.608 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -83.31 -54.54 4.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.07 -1.019 . . . . 0.0 109.713 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.606 ' O ' HD13 ' A' ' 100' ' ' ILE . 2.6 mt -65.14 -39.75 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 108.575 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 20.5 t-20 -70.09 -56.59 6.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.89 . . . . 0.0 109.155 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 22.3 tttm -44.17 -49.69 8.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 1.048 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -57.31 -43.92 83.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.643 HD12 ' HG ' ' A' ' 50' ' ' LEU . 1.2 mp -57.63 -58.79 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.494 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.7 -10.78 21.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 109.904 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -92.7 -22.78 19.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.313 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.785 HG12 HD23 ' A' ' 50' ' ' LEU . 3.1 mm -84.7 -22.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.987 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 41.0 mt-10 -68.3 -7.8 34.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.85 9.44 5.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 106' ' ' LEU . 5.8 mt . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.288 -1.125 . . . . 0.0 109.16 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.511 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.254 0.549 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.559 ' HB ' HD11 ' A' ' 28' ' ' LEU . 8.3 mm -46.33 -46.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.591 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -137.88 152.48 49.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 109.491 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.018 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -161.6 124.05 3.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.584 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -157.92 -145.7 4.3 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.024 ' C ' HD13 ' A' ' 11' ' ' LEU . 9.7 p90 -143.26 93.45 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.339 -1.094 . . . . 0.0 109.971 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.117 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -115.37 166.53 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.6 p -90.83 135.61 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.797 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.4 OUTLIER -126.98 131.08 51.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.464 -0.773 . . . . 0.0 109.597 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 35.0 tttm -95.47 138.62 32.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 109.423 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.1 -2.49 4.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 3.7 p -76.72 -93.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.552 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 17' ' ' VAL . 12.0 p -97.43 109.54 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.344 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-30 59.23 -180.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 28.8 p-10 -82.73 88.79 6.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 21.6 p -132.24 -167.27 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.755 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.637 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.4 m95 -146.4 116.83 7.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 0.0 109.59 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 12' ' ' VAL . 33.4 mttt -148.17 137.38 12.02 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 110.048 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 46.6 Cg_exo -56.3 161.13 9.66 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.937 1.758 . . . . 0.0 109.787 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.797 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 21.6 ptm -171.1 167.36 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 109.798 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.594 ' CD2' ' HA ' ' A' ' 39' ' ' LYS . 54.5 t-105 -88.77 142.61 27.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.773 ' CG1' HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -150.41 132.39 5.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.446 -178.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' A' ' 8' ' ' GLU . 11.4 m -125.15 105.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.592 -0.693 . . . . 0.0 109.285 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 7' ' ' ARG . 1.7 pp -79.6 124.14 28.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.036 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.7 mp -112.15 166.42 11.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.505 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.773 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -72.02 -12.97 61.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.906 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.607 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.1 m-20 -106.07 -2.67 22.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.63 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.9 151.69 5.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 33' ' ' ILE . 4.7 mp -98.36 108.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' OE2' ' CD1' ' A' ' 29' ' ' LEU . 4.8 pt-20 -107.22 119.96 40.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.666 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.0 p90 -121.3 144.64 48.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 110.431 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.632 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -121.25 -148.93 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -51.97 3.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 109.174 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -105.13 -177.26 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 108.855 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.11 -40.45 10.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.058 -1.026 . . . . 0.0 108.512 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.466 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -153.43 72.04 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 109.765 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 23.6 t70 -50.15 -20.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 3.7 t30 90.86 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 101.6 51.66 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 53.4 Cg_exo -49.69 142.68 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.888 1.725 . . . . 0.0 111.246 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -98.18 -25.63 14.83 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.39 146.77 5.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.435 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 9.5 mtm -127.31 -174.92 3.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -1.166 . . . . 0.0 109.628 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' THR . 39.3 mt -140.59 127.83 12.22 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.46 84.79 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.494 1.462 . . . . 0.0 110.073 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.991 ' HG ' HG21 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -60.95 -14.2 21.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.412 -0.805 . . . . 0.0 109.201 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.672 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -58.36 -15.41 10.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.9 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -165.68 27.91 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.132 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.423 ' OG ' HG23 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -77.54 168.73 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 0.0 109.348 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -126.67 160.25 31.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.403 -0.81 . . . . 0.0 109.167 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 56' ' ' THR . 2.8 tm? -121.28 149.47 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.042 -1.037 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 1.022 ' N ' HD13 ' A' ' 55' ' ' LEU . 98.9 m -136.42 134.79 38.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 110.052 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 5.4 t -150.38 118.87 3.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.327 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 56' ' ' THR . 53.6 Cg_endo -72.49 -161.86 2.29 Favored 'Cis proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.642 -1.816 . . . . 0.0 110.369 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 18.2 p -96.34 -161.25 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.694 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -67.84 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.867 . . . . 0.0 109.756 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -84.89 15.37 4.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.2 t80 -89.16 -27.13 20.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.918 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.613 ' HA3' HG11 ' A' ' 68' ' ' VAL . . . -103.97 -91.69 2.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 tttt 43.66 27.26 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -1.093 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' GLY . 12.7 mtp180 -124.67 -90.14 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.437 -0.789 . . . . 0.0 109.424 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.7 mmm -81.92 -114.36 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.321 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 84.1 m-85 -130.96 89.99 2.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.824 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HA3' ' A' ' 63' ' ' GLY . 1.6 p -129.62 119.71 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.829 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.707 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.8 p90 -97.8 168.77 10.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.091 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 6.0 ttpt -127.17 117.39 22.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.633 HD11 HG21 ' A' ' 96' ' ' ILE . 2.4 mt -95.5 167.84 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.828 . . . . 0.0 108.872 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.2 m -141.05 92.23 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -42.76 152.09 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 1.2 t -52.15 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.522 -0.736 . . . . 0.0 109.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 158.52 -71.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 164.55 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.93 79.08 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.092 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 1.7 p30 -56.07 144.01 30.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.701 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 42.0 m-70 -137.49 145.26 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.8 m-85 -100.88 137.61 39.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 1.117 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.1 t80 -143.97 123.3 13.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -129.36 120.13 25.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.04 . . . . 0.0 109.879 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -89.98 -146.51 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 -90.05 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -96.22 167.88 10.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.86 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -52.45 -20.33 2.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.819 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.86 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -72.35 -46.7 54.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.731 -179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -73.97 -48.61 29.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.88 -30.5 71.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.004 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 51.2 t0 -75.09 -42.36 56.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.989 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -73.91 -19.69 60.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.698 ' CH2' HG22 ' A' ' 26' ' ' VAL . 3.4 m95 -83.6 -37.15 23.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.393 -0.817 . . . . 0.0 109.048 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.89 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 p -76.84 -31.59 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.789 . . . . 0.0 109.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 13.2 mmm180 -83.83 -24.34 30.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.605 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 33.5 t0 -83.71 -39.7 19.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.975 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.3 mt -71.81 -32.79 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 0.0 108.696 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -84.31 -30.7 25.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.222 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -67.16 -50.97 59.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.949 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -67.25 -32.72 73.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.951 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ILE . 20.6 mt -61.91 -41.26 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.423 -0.798 . . . . 0.0 109.095 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -83.58 -13.46 54.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.62 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.67 -12.24 25.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 109.58 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.991 HG21 ' HG ' ' A' ' 50' ' ' LEU . 5.6 tp -93.43 -14.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 4.0 mt-10 -80.15 -6.63 58.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.511 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.97 8.63 7.17 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.713 ' HG2' HD21 ' A' ' 29' ' ' LEU . 4.1 mtt180 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.233 0.54 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 30' ' ' GLU . 18.9 mt -90.17 -70.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.597 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.719 ' HB3' HD11 ' A' ' 28' ' ' LEU . 3.3 tpm_? -114.45 121.86 44.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.009 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.4 pm0 -130.21 135.42 48.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.122 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.05 -145.68 4.44 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.999 ' O ' HD13 ' A' ' 11' ' ' LEU . 8.2 p90 -142.26 102.41 4.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -1.06 . . . . 0.0 110.485 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.999 HD13 ' O ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -129.54 150.89 50.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG23 ' N ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -81.17 135.82 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.091 -1.006 . . . . 0.0 108.759 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HG3' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -127.82 84.79 2.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.087 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 34.41 -149.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.259 0.552 . . . . 0.0 110.207 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 20' ' ' THR . . . -145.92 163.35 28.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.6 m -89.22 23.24 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.564 HG22 ' CD2' ' A' ' 18' ' ' PHE . 2.7 p -167.86 118.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.455 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 17' ' ' VAL . 44.9 m-85 60.24 153.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -59.45 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -119.39 152.48 36.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.517 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.626 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -133.6 121.51 22.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.1 -179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.643 ' N ' HG23 ' A' ' 12' ' ' VAL . 11.6 mttm -147.01 142.87 17.49 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.571 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.583 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 41.1 Cg_endo -73.08 130.79 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.094 1.863 . . . . 0.0 110.224 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.787 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -138.53 175.02 9.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.709 ' O ' ' SD ' ' A' ' 24' ' ' MET . 66.1 t-105 -92.27 145.39 24.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -148.87 144.3 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.101 -178.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.009 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -137.1 99.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.369 -0.832 . . . . 0.0 109.566 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.878 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -76.22 120.17 21.13 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.237 -0.914 . . . . 0.0 109.231 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.713 HD21 ' HG2' ' A' ' 5' ' ' ARG . 3.8 mp -106.03 167.27 9.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 109.507 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 6' ' ' ILE . 4.8 pt-20 -71.99 -10.85 60.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.75 -2.23 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.618 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.944 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 154.89 147.7 4.77 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -95.93 108.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.585 ' HG2' HD11 ' A' ' 29' ' ' LEU . 23.8 pt-20 -107.82 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.665 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.787 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 1.4 p90 -117.09 150.49 38.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.094 -1.004 . . . . 0.0 109.993 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -127.5 -172.56 2.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.308 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -77.58 -50.04 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.58 -174.28 2.5 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.7 -23.65 0.44 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.932 -1.105 . . . . 0.0 109.415 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.87 -49.59 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.045 . . . . 0.0 109.642 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 2.8 t70 62.26 9.79 3.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 41.46 23.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 110.066 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -165.14 102.22 0.79 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.169 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.6 Cg_exo -52.79 133.23 49.96 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.978 1.785 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.98 -21.96 22.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 175.09 149.0 7.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.793 ' N ' ' SD ' ' A' ' 47' ' ' MET . 0.5 OUTLIER -125.62 169.02 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 73' ' ' THR . 57.1 mt -132.35 134.69 25.24 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.51 121.26 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.38 1.387 . . . . 0.0 110.472 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 ' CA ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -58.51 -39.02 78.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.429 -0.794 . . . . 0.0 109.707 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -101.11 108.27 19.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 125.24 -1.32 8.27 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.499 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 7.6 t -89.89 170.32 10.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.869 -1.371 . . . . 0.0 109.864 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.511 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.16 122.22 13.74 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.303 -0.873 . . . . 0.0 109.438 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.84 HD21 ' CD2' ' A' ' 69' ' ' PHE . 3.2 tm? -88.91 127.19 35.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.457 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 55' ' ' LEU . 3.4 m -117.46 102.24 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.172 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 3.3 m -140.51 135.84 16.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 57' ' ' SER . 58.4 Cg_endo -77.3 176.32 44.25 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.35 -1.938 . . . . 0.0 110.345 -0.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 70' ' ' LYS . 5.0 m -148.59 82.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -98.69 112.93 24.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -177.74 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 109.562 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.0 t80 -89.14 -39.68 13.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 108.329 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -117.14 -39.32 0.81 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER 39.36 72.44 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.859 . . . . 0.0 109.317 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.57 -95.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.738 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.6 mmm -77.1 -122.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 38.6 m-85 -112.71 92.57 4.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.774 -1.204 . . . . 0.0 109.677 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -118.85 126.77 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.34 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.84 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -112.62 176.19 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 3.0 tmmm? -135.78 114.63 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.783 . . . . 0.0 110.238 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -97.78 171.08 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.8 m -145.89 94.16 2.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.163 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.65 HG22 HG23 ' A' ' 48' ' ' ILE . 2.2 p -59.86 153.53 20.68 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.0 109.094 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -44.46 -23.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.223 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER -86.86 31.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 0.0 109.771 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.85 28.43 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.416 ' OE1' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -89.88 92.29 8.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.287 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.572 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 8.3 t70 -58.92 152.76 18.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -142.55 103.04 4.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.572 ' CZ ' ' OD1' ' A' ' 78' ' ' ASP . 10.8 m-85 -95.1 117.69 30.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -131.58 171.26 13.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.104 -0.998 . . . . 0.0 109.263 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.22 130.13 26.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.035 -1.041 . . . . 0.0 109.188 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.75 164.66 14.58 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.471 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -97.43 53.37 1.15 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER 166.08 162.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.915 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -88.33 -51.09 5.93 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.925 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -65.19 -29.22 70.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -79.87 -43.28 22.57 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.481 -0.762 . . . . 0.0 109.426 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.679 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -54.49 -55.7 26.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 m-20 -65.83 -25.81 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 108.866 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.19 -24.66 64.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.99 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 11.7 m95 -83.27 -31.71 26.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.5 m -79.44 -23.34 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.395 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.3 mmp_? -86.4 -34.15 20.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 0.0 109.546 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.77 ' HB3' HD11 ' A' ' 28' ' ' LEU . 2.7 t0 -82.98 -41.55 18.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.149 -0.969 . . . . 0.0 109.681 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.878 ' CG1' HD22 ' A' ' 28' ' ' LEU . 4.4 mt -72.88 -35.17 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.293 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 1.5 t-20 -81.59 -32.74 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -68.52 -40.31 80.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 109.18 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -70.94 -40.37 72.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.295 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 96' ' ' ILE . 10.9 mt -67.48 -28.95 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.102 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -89.11 -8.75 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -30.8 13.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.656 HG22 ' HG3' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -70.11 -30.03 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 108.791 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.75 -5.98 34.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.06 10.89 5.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 106' ' ' LEU . 1.4 mt . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.422 -1.046 . . . . 0.0 109.144 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.477 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.314 0.578 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.3 mt -73.17 -28.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.806 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HB3' ' HG ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -145.28 166.53 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.075 -1.015 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.969 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 178.83 127.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.481 -0.762 . . . . 0.0 109.567 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.593 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.87 -145.6 4.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.981 ' C ' HD13 ' A' ' 11' ' ' LEU . 4.2 p90 -140.43 91.96 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 110.219 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.981 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.9 161.88 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.933 . . . . 0.0 108.677 178.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.735 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -85.4 141.74 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.672 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HE2' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -123.21 142.72 50.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.203 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HD2' ' CD1' ' A' ' 80' ' ' PHE . 5.2 tttt -88.17 115.62 25.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.4 93.91 0.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -85.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -1.156 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.67 -19.08 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.96 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB3' ' CE ' ' A' ' 14' ' ' LYS . 50.5 m-80 63.95 100.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 17.4 p -149.18 -170.65 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.162 -0.961 . . . . 0.0 109.697 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.585 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.5 m95 -141.6 105.92 4.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.735 ' C ' HG23 ' A' ' 12' ' ' VAL . 35.5 mttt -146.75 136.62 11.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.47 157.55 6.87 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.915 1.744 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.789 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -168.18 165.92 13.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 110.111 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.748 ' O ' ' SD ' ' A' ' 24' ' ' MET . 62.6 t-105 -90.23 143.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.6 138.57 14.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.935 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.969 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.5 m -126.09 120.23 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.802 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 mt -78.95 120.52 23.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.446 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -115.18 158.55 22.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 6.5 pt-20 -73.02 -9.65 58.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.9 p30 -107.89 -3.4 18.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.126 -0.984 . . . . 0.0 109.482 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.653 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.78 155.54 7.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.072 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.53 107.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.349 -1.089 . . . . 0.0 109.252 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 27' ' ' VAL . 2.7 tp10 -104.7 117.84 35.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.2 p90 -125.59 147.71 49.2 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -123.67 -157.69 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -93.77 -43.6 8.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.163 -0.961 . . . . 0.0 108.471 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -111.88 -176.39 2.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -44.95 -25.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.933 -1.105 . . . . 0.0 109.248 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -149.91 -50.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.551 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.9 t0 61.15 10.82 3.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.868 . . . . 0.0 109.352 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.5 m-80 41.6 23.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.745 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -163.93 115.05 0.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.849 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.6 Cg_endo -71.4 134.7 25.12 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.888 1.726 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -89.75 -20.21 23.84 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 168.48 157.73 11.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' OE1' ' A' ' 34' ' ' GLU . 6.7 mtt -133.11 169.82 16.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -1.06 . . . . 0.0 109.18 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 73' ' ' THR . 56.9 mt -136.78 127.35 16.25 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 39.0 Cg_endo -67.78 124.65 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.252 1.301 . . . . 0.0 109.713 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.902 HD11 ' CG1' ' A' ' 103' ' ' ILE . 1.8 pt? -89.19 23.6 2.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.128 -0.983 . . . . 0.0 109.856 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -66.45 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -101.26 -2.19 54.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -39.56 148.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -1.052 . . . . 0.0 110.512 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -119.03 155.94 30.55 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.005 HD11 ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -124.74 130.54 52.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.931 -1.106 . . . . 0.0 109.301 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 55' ' ' LEU . 90.2 m -121.8 123.38 41.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.709 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -150.49 119.56 3.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 56' ' ' THR . 56.9 Cg_endo -74.04 -175.12 14.62 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.7 -1.791 . . . . 0.0 110.299 -0.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.762 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -102.95 170.11 8.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 109.574 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.762 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 mt-30 -107.66 133.19 52.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 3.7 t0 83.84 -49.42 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 5.7 m-85 -100.38 -32.25 10.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 108.727 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA3' ' H ' ' A' ' 59' ' ' CYS . . . -83.83 0.82 89.38 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -89.51 23.23 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -1.176 . . . . 0.0 109.272 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -143.8 -96.96 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.636 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -158.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 109.763 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 81.6 m-85 -97.53 87.97 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 81' ' ' PHE . 2.1 p -135.18 130.71 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 81' ' ' PHE . 3.7 p90 -100.03 167.5 10.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.304 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -125.63 116.91 22.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.77 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 69' ' ' PHE . 3.4 mt -99.51 165.85 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.635 ' N ' HG22 ' A' ' 54' ' ' THR . 16.7 m -142.16 103.85 4.36 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -53.38 108.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.869 0.843 . . . . 0.0 109.689 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.12 27.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 179.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 74' ' ' THR . 1.7 ttpp 80.71 42.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.016 . . . . 0.0 109.412 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -132.01 -78.88 0.51 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.551 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -89.96 133.97 34.49 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.533 -0.729 . . . . 0.0 110.254 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 3.5 p30 -95.2 152.18 18.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.356 -0.84 . . . . 0.0 108.752 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -141.99 104.72 4.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 110.214 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.8 m-85 -93.51 109.0 20.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 108.794 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.938 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -118.43 144.91 45.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.416 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 4.4 tm0? -118.93 133.97 55.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.165 . . . . 0.0 109.827 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.47 -145.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 85' ' ' PHE . . . -103.02 -10.1 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 171.19 174.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.829 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.915 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -47.38 -50.08 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.148 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.915 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.9 tt0 -45.07 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 110.21 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -60.51 -14.48 19.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -71.62 -38.82 70.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HA ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -85.09 -27.93 25.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.58 -29.37 56.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CZ3' HD21 ' A' ' 28' ' ' LEU . 10.4 m95 -84.31 -42.72 15.51 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.005 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.8 p -72.12 -29.27 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.533 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 14.4 ptm180 -79.01 -34.9 43.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.818 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 13.4 t70 -75.62 -54.43 7.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.0 109.458 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG1' HD13 ' A' ' 28' ' ' LEU . 7.2 mt -55.34 -35.89 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.028 -1.045 . . . . 0.0 108.738 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 101' ' ' LYS . 15.9 t30 -79.72 -24.69 41.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 108.907 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -63.09 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 108.901 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -56.45 -35.4 67.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 34.4 mt -62.35 -35.86 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 108.796 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 97' ' ' ASN . 1.9 mtmp? -83.97 -8.38 59.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.9 t -93.57 -28.0 16.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.902 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -78.55 -79.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.799 ' N ' HG22 ' A' ' 103' ' ' ILE . 68.6 mt-10 37.38 52.5 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.771 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' O ' HD22 ' A' ' 106' ' ' LEU . . . 74.78 93.0 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.743 0 O-C-N 121.59 -0.947 . . . . 0.0 109.405 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.714 ' HB ' HD12 ' A' ' 28' ' ' LEU . 12.1 mt -67.81 -49.04 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.598 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.991 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -144.4 111.04 5.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 109.67 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.023 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -119.65 132.7 55.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.11 -146.21 4.59 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.857 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.0 p90 -142.68 102.73 4.1 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.523 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -121.03 160.47 23.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.213 -0.929 . . . . 0.0 108.555 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.3 p -86.03 151.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.074 -1.016 . . . . 0.0 109.52 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -140.49 147.72 40.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -0.829 . . . . 0.0 109.853 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HD2' ' NE1' ' A' ' 21' ' ' TRP . 24.4 tttm -117.5 133.67 55.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . 168.41 174.3 37.04 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 58.15 -174.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -1.074 . . . . 0.0 109.204 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 18' ' ' PHE . 6.2 p -42.96 -42.63 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.658 ' N ' HG13 ' A' ' 17' ' ' VAL . 12.2 m-85 -39.69 -68.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.919 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 22.03 3.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -108.27 -171.52 1.88 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.663 ' HH2' HG23 ' A' ' 68' ' ' VAL . 14.4 m95 -132.03 82.19 2.01 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 108.675 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' N ' HG23 ' A' ' 12' ' ' VAL . 2.1 mttm -115.6 136.95 22.89 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.036 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.74 156.83 6.15 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.055 1.837 . . . . 0.0 110.16 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.762 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -162.31 170.1 19.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -0.952 . . . . 0.0 109.877 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.762 ' O ' ' SD ' ' A' ' 24' ' ' MET . 73.5 t-105 -97.7 142.61 29.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.652 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.17 135.4 10.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.977 -178.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.023 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -125.93 100.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.409 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -76.89 116.37 17.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.883 . . . . 0.0 109.502 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.7 mp -101.08 161.75 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.59 -13.83 62.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 -1.31 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 0.0 109.854 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 1.001 ' HA2' HD23 ' A' ' 50' ' ' LEU . . . 158.5 140.42 2.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 50' ' ' LEU . 3.6 mp -95.57 121.11 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -1.203 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 29' ' ' LEU . 4.1 pt-20 -120.82 120.74 36.45 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.652 ' HB3' HG23 ' A' ' 26' ' ' VAL . 5.6 p90 -121.95 147.44 46.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.981 -1.074 . . . . 0.0 110.893 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.94 -150.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.19 -43.46 6.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -108.8 -175.96 2.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -47.87 -22.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.878 -1.139 . . . . 0.0 109.337 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -148.46 -51.54 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.7 t70 61.81 10.34 3.41 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 42.2 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.112 -0.992 . . . . 0.0 109.954 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.1 t -167.54 109.45 0.61 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.938 -1.101 . . . . 0.0 109.891 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 54.1 Cg_endo -71.61 134.26 23.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.849 1.7 . . . . 0.0 110.557 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.75 -19.4 24.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.22 142.5 5.8 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.422 ' HG3' ' C ' ' A' ' 46' ' ' GLY . 16.7 mtm -136.27 126.96 27.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.155 -1.203 . . . . 0.0 109.533 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.581 HG23 HG22 ' A' ' 73' ' ' THR . 4.7 mt -88.94 136.8 30.2 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 108.8 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 48' ' ' ILE . 55.8 Cg_endo -72.31 140.74 34.23 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.721 1.614 . . . . 0.0 110.504 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.001 HD23 ' HA2' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -74.89 0.13 16.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.438 -0.789 . . . . 0.0 109.493 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -92.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.04 68.81 0.24 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.524 ' HA ' ' N ' ' A' ' 74' ' ' THR . 14.4 m -60.27 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 109.6 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.34 122.32 15.61 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 -179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.784 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -89.07 122.1 32.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.175 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 55' ' ' LEU . 59.7 m -115.26 114.43 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.105 -0.997 . . . . 0.0 109.62 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 66.0 p -145.5 121.36 5.84 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 56' ' ' THR . 55.0 Cg_endo -71.92 175.3 43.23 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.559 -1.851 . . . . 0.0 110.342 -0.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.795 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 9.5 t -90.69 -94.75 0.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.6 mt-30 -141.75 -149.76 0.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.371 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -15.12 8.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.901 . . . . 0.0 108.818 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 -28.98 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -85.36 -14.38 68.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 65' ' ' ARG . 5.4 tttm -84.46 70.5 10.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -1.192 . . . . 0.0 109.579 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 165.17 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.586 ' SD ' ' NE2' ' A' ' 82' ' ' GLN . 2.7 mtt 67.2 -172.82 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 1.3 m-85 -88.15 83.37 6.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.2 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.5 p -127.08 136.27 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.841 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.598 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -124.3 178.71 5.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.795 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 3.2 tttp -143.35 107.25 4.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 109.808 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -90.45 170.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 108.987 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.561 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.4 m -145.86 90.87 2.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.581 HG22 HG23 ' A' ' 48' ' ' ILE . 2.4 p -40.44 142.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 109.837 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.55 -29.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 0.0 109.963 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -73.02 -70.77 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.319 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.9 pt20 164.15 38.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.0 99.83 9.37 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 p30 -63.35 152.96 36.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -144.57 96.41 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.727 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -91.15 117.65 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.059 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -135.82 162.53 32.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.956 -1.09 . . . . 0.0 109.587 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 36.5 tt0 -127.77 131.11 49.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.994 -1.066 . . . . 0.0 109.272 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.5 -168.37 2.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.439 -0.788 . . . . 0.0 109.732 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.8 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.13 -179.98 4.1 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 109.473 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.044 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -55.62 -59.45 4.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.609 -0.682 . . . . 0.0 109.602 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.044 ' N ' HD23 ' A' ' 86' ' ' LEU . 12.5 tm-20 -47.31 -67.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.048 . . . . 0.0 110.358 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 54.7 tt0 -52.42 -26.44 12.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -68.47 -63.6 1.03 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.036 . . . . 0.0 109.707 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 3.9 p30 -55.78 -27.84 53.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.27 -35.83 68.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 108.956 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.982 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.25 -41.53 73.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.613 -0.679 . . . . 0.0 110.358 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.784 ' CG2' HD11 ' A' ' 55' ' ' LEU . 5.3 p -76.89 -34.68 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 111.052 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -71.56 -23.55 61.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.768 -1.207 . . . . 0.0 109.323 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.41 -39.36 22.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.472 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.624 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.3 mt -69.82 -37.59 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.4 -26.96 38.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.113 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 3.5 tptp -65.13 -44.95 87.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.935 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -71.62 -35.7 70.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.133 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.904 ' HA ' HD13 ' A' ' 50' ' ' LEU . 46.7 mt -72.72 -19.45 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.258 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.36 -16.24 26.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.53 -29.39 14.39 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.824 ' CG1' HD12 ' A' ' 50' ' ' LEU . 7.9 mm -71.52 -26.24 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 67.9 mt-10 -51.92 -22.53 3.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.59 -104.97 1.7 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.624 0 O-C-N 121.412 -1.051 . . . . 0.0 109.576 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' HB2' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 30' ' ' GLU . 7.5 mt -52.42 -45.98 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.828 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -140.43 145.19 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.857 -179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.039 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -155.04 132.46 11.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.081 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.46 -147.57 4.88 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.82 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.4 p90 -140.49 93.89 2.67 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.545 -0.973 . . . . 0.0 110.232 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.82 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -118.27 157.08 27.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 108.807 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.672 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -81.49 151.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -132.13 139.87 48.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 14.1 ttpp -84.14 113.92 21.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.375 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.11 167.7 42.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -91.43 -24.84 19.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 3.3 p -46.23 -32.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -177.03 -171.39 0.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.414 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -82.72 85.01 7.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.1 p -127.16 166.0 18.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 20' ' ' THR . 18.1 m95 -150.69 106.82 3.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.672 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -131.73 133.14 23.84 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.23 149.95 20.93 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 109.922 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -159.38 168.3 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.699 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.0 t-105 -92.57 144.22 25.55 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.94 134.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.024 -178.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.5 m -124.07 105.66 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.761 . . . . 0.0 109.396 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.986 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.8 pp -80.74 111.87 17.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.137 -0.977 . . . . 0.0 109.581 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.3 mp -96.98 161.07 14.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.42 -11.23 60.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 4.5 p30 -108.86 2.79 21.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.871 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 150.86 144.57 3.95 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.986 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.6 mm -92.86 130.49 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 110.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 5.5 pt-20 -132.86 113.71 13.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.3 p90 -119.43 147.0 44.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.09 -1.006 . . . . 0.0 110.735 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.572 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -127.92 -150.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.46 -53.54 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.53 -172.62 2.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.6 OUTLIER -54.1 -18.69 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.916 -1.115 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.92 -53.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.1 t0 61.35 9.42 2.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m120 40.5 24.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.221 -0.924 . . . . 0.0 110.071 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.6 t -167.45 122.46 0.84 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.982 -1.074 . . . . 0.0 109.499 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 59.2 Cg_endo -75.56 156.83 40.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.803 1.669 . . . . 0.0 111.276 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 2.8 tptt -119.13 -16.88 9.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -178.68 136.68 2.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.0 mtm -131.41 119.33 21.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -1.137 . . . . 0.0 109.697 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mt -89.77 139.47 27.77 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 38.6 Cg_endo -68.05 148.12 74.95 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.528 1.485 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.943 HD13 ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -85.04 36.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.812 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -167.42 136.6 2.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.995 -1.066 . . . . 0.0 109.927 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 91.07 -36.18 3.69 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 100' ' ' ILE . 2.7 m -42.11 156.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.396 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -123.31 169.89 10.86 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -131.47 124.24 29.75 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.06 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.774 ' N ' HD23 ' A' ' 55' ' ' LEU . 20.4 m -115.97 125.81 53.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -150.2 127.91 5.69 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.588 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' SER . 56.3 Cg_endo -73.96 -178.28 22.12 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.471 -1.887 . . . . 0.0 110.277 -0.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.938 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -150.06 175.1 12.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.662 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.617 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 2.3 tt0 66.84 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -0.795 . . . . 0.0 110.172 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.84 18.61 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.617 ' CE2' ' HG3' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -89.26 -64.25 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -90.84 -21.85 35.15 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 8.0 pttt 40.33 32.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.724 -0.868 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.05 20.71 10.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.583 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 9.8 mtp 58.89 179.32 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' A' ' 66' ' ' MET . 1.8 m-85 81.22 -13.66 0.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.497 -0.752 . . . . 0.0 109.911 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.938 HG22 ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -109.84 135.18 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.979 -1.075 . . . . 0.0 109.423 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.735 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 4.0 p90 -121.36 167.18 13.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 80' ' ' PHE . 19.5 ttpt -129.11 98.03 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.925 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 54' ' ' THR . 20.0 mt -90.9 155.41 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.538 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.569 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 39.9 m -134.61 112.31 10.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.049 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 76' ' ' GLN . 2.7 t -55.83 113.82 1.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 39.29 26.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 111.333 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tptm 80.86 47.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.904 -1.122 . . . . 0.0 109.16 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.593 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -127.77 -83.64 0.6 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.206 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' H ' ' CG2' ' A' ' 73' ' ' THR . 11.0 tt0 -101.21 129.81 47.2 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.662 -0.649 . . . . 0.0 109.441 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.96 171.1 15.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 69.6 m-70 -146.15 96.01 2.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.559 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 22.6 m-85 -93.16 100.22 12.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -0.796 . . . . 0.0 108.887 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.695 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.68 157.62 23.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.394 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 2.4 tt0 -121.19 128.85 52.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.065 -1.022 . . . . 0.0 108.999 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -88.52 -7.66 56.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 83' ' ' ALA . . . 63.05 12.27 5.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.443 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.08 163.37 39.47 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.807 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.034 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -93.35 -48.03 6.61 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.034 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -69.48 -44.32 71.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.52 -0.738 . . . . 0.0 109.281 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.62 -34.65 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.684 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -62.07 -61.63 2.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -37.73 64.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -71.86 -26.79 62.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.084 -1.01 . . . . 0.0 109.773 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.974 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 1.1 m95 -79.84 -31.44 40.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.075 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' LEU . 1.3 p -83.43 -31.55 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.6 ptm180 -77.94 -25.16 48.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.308 -0.87 . . . . 0.0 109.187 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -82.0 -42.5 19.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 100' ' ' ILE . 29.5 mt -72.13 -37.46 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.177 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 7.7 t-20 -79.6 -33.81 41.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -67.37 -39.44 85.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.14 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -68.81 -47.45 66.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.32 -0.863 . . . . 0.0 109.091 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.943 ' HA ' HD13 ' A' ' 50' ' ' LEU . 6.9 mt -67.89 -20.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 3.0 mmtp -90.11 -11.29 41.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.351 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.5 m -93.81 -38.16 11.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 108.856 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG1' HD12 ' A' ' 50' ' ' LEU . 2.8 mm -67.91 -29.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.49 -15.9 63.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.13 3.29 26.93 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 106' ' ' LEU . 5.0 mt . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.392 -1.064 . . . . 0.0 109.097 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.859 HG22 ' OD2' ' A' ' 95' ' ' ASP . 33.3 mt -74.43 -49.01 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.99 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -136.79 142.14 42.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.054 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -148.45 137.05 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.398 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.585 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.42 -149.5 5.69 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 1.023 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.1 p90 -140.42 98.25 3.39 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -1.026 . . . . 0.0 110.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.023 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.09 171.91 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 108.621 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.957 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.2 p -102.97 131.54 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.69 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 18.4 ttmt -132.33 168.09 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -63.83 103.97 0.63 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -67.33 -74.01 0.6 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.491 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.3 OUTLIER 175.84 -159.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -1.155 . . . . 0.0 109.316 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 16' ' ' SER . 2.5 p 39.93 94.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.558 -0.714 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.3 m-85 63.0 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.465 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -47.75 97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -120.38 -177.19 3.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.757 ' CH2' HG23 ' A' ' 68' ' ' VAL . 2.0 m95 -142.9 106.63 4.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.957 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.8 mmtp -130.33 140.84 39.88 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.85 163.85 1.82 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.876 1.717 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.69 ' SD ' ' HB3' ' A' ' 13' ' ' LYS . 17.7 ptm -176.91 159.67 1.75 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.778 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.9 t-105 -90.24 145.28 25.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.49 136.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.297 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.054 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.1 m -127.38 101.68 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.511 -0.743 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.02 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -74.01 119.68 18.56 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -109.11 165.44 11.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.499 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HG3' HD11 ' A' ' 6' ' ' ILE . 2.1 tt0 -73.44 -14.5 61.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.906 ' C ' HD11 ' A' ' 50' ' ' LEU . 5.2 p-10 -105.6 5.88 31.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.379 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 1.045 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 143.58 144.07 4.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.813 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -90.94 107.79 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.285 -1.126 . . . . 0.0 109.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' HD11 ' A' ' 29' ' ' LEU . 11.3 pt-20 -105.22 116.68 32.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 108.769 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.6 p90 -120.21 147.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.82 -152.06 0.5 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.02 -40.75 9.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.9 OUTLIER -112.83 -178.24 3.34 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -43.0 -25.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.069 -1.019 . . . . 0.0 109.54 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.18 -50.63 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.3 t0 62.99 8.42 3.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m120 41.16 23.58 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.8 t -166.51 96.69 0.72 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.1 Cg_exo -53.26 132.35 47.74 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.056 1.837 . . . . 0.0 110.739 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.525 ' HE3' ' CE ' ' A' ' 24' ' ' MET . 3.0 ttpt -89.77 -22.04 22.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.72 145.82 7.88 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 30.4 mtm -124.22 165.82 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 73' ' ' THR . 2.4 mt -132.93 117.7 15.06 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 54.8 Cg_endo -71.07 125.29 11.32 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.682 1.588 . . . . 0.0 109.916 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.045 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -90.2 39.59 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.319 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -89.77 -43.01 10.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.109 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -159.41 42.8 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.495 ' HB2' HD13 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -68.98 179.04 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -1.153 . . . . 0.0 109.562 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.497 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -144.23 108.75 4.86 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.283 -0.886 . . . . 0.0 109.593 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.832 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.1 tm? -89.79 115.65 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.2 m -110.4 119.86 40.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.175 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -144.2 123.88 7.35 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 0.0 109.654 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.487 ' O ' HG22 ' A' ' 56' ' ' THR . 57.5 Cg_endo -74.5 -170.21 7.88 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.648 -1.813 . . . . 0.0 110.171 -0.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 10.3 t -102.64 -105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.279 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.638 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 pt20 162.97 119.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.944 -1.098 . . . . 0.0 109.789 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER 81.27 -40.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.722 . . . . 0.0 110.651 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -90.59 85.8 6.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.934 -1.104 . . . . 0.0 110.001 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.601 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 78.08 20.33 73.09 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 51.1 tptt -53.2 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.242 . . . . 0.0 109.175 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' GLY . 3.4 mtt-85 174.6 -86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.551 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mtp -60.38 -148.91 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.581 -0.699 . . . . 0.0 109.473 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 86' ' ' LEU . 98.4 m-85 -99.9 76.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.757 HG23 ' CH2' ' A' ' 21' ' ' TRP . 1.1 p -122.53 128.23 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.31 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 10.4 p90 -122.95 173.4 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -132.97 122.01 23.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.9 mt -93.62 167.94 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.057 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -146.49 85.86 1.66 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 HG23 ' A' ' 48' ' ' ILE . 5.2 p -44.39 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.569 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.09 63.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.246 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 5.9 mttp -89.76 12.06 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.451 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 72.44 26.28 2.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.4 OUTLIER -89.84 119.55 30.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.13 -0.981 . . . . 0.0 108.998 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 4.4 t0 -89.36 135.92 33.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 89.1 m-70 -130.01 97.12 4.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.405 -0.809 . . . . 0.0 108.97 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 78' ' ' ASP . 1.9 m-85 -90.19 120.49 31.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.28 146.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.217 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.55 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 6.5 pt20 -116.52 145.71 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 108.777 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -92.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.72 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.74 174.94 6.36 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.652 -0.655 . . . . 0.0 109.615 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.958 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -65.16 -41.31 94.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.53 -0.731 . . . . 0.0 109.184 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.958 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -57.48 -67.0 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.701 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.5 -31.73 56.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.716 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.82 -65.13 0.71 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 109.967 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.611 ' HA ' HG23 ' A' ' 93' ' ' VAL . 47.6 m-20 -58.84 -23.76 61.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.902 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.91 -31.96 64.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.015 -1.053 . . . . 0.0 109.507 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.02 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 4.2 m95 -82.57 -39.05 22.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.4 -21.92 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.246 -0.909 . . . . 0.0 109.341 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 90' ' ' ASP . 10.0 ptp180 -85.3 -29.44 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.859 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -84.35 -39.32 19.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.589 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HD22 ' A' ' 28' ' ' LEU . 5.6 mt -72.85 -34.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 108.801 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -80.7 -28.93 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -53.33 17.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.01 -40.67 85.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 108.928 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 44.9 mt -65.06 -33.76 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 108.943 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 8.8 ttpt -78.03 -9.42 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.489 ' SG ' ' HG ' ' A' ' 106' ' ' LEU . 8.8 t -95.13 -32.31 13.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.809 . . . . 0.0 109.141 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 50' ' ' LEU . 3.2 mm -67.74 -33.74 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 15.2 mt-10 -75.01 -2.1 25.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.289 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.74 20.7 2.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.635 -0.921 . . . . 0.0 109.235 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.573 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 30' ' ' GLU . 2.2 mp -67.87 -39.77 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.554 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -131.73 169.55 16.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 109.866 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.916 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 175.09 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 109.676 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.62 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.86 -147.14 5.02 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.962 ' C ' HD13 ' A' ' 11' ' ' LEU . 8.0 p90 -138.96 103.83 4.9 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.975 -1.309 . . . . 0.0 110.902 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.969 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -120.63 158.17 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 0.0 108.546 178.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.884 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -86.53 129.78 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.968 -1.083 . . . . 0.0 109.295 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HD2' ' CB ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.97 170.15 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.467 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -116.18 134.83 54.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.82 0.21 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -125.31 -34.02 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -132.31 -84.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 17' ' ' VAL . 4.6 m-85 -133.06 71.8 1.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.61 60.76 3.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 48.7 p -115.83 -165.07 1.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.738 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.3 m95 -149.42 109.01 4.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 0.0 109.668 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.884 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.1 mttm -140.38 143.21 32.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -51.26 156.42 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.987 1.791 . . . . 0.0 110.188 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -160.88 176.65 11.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.759 ' O ' ' SD ' ' A' ' 24' ' ' MET . 68.1 t-105 -109.69 146.16 35.32 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -150.41 147.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.948 -178.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.3 m -130.96 119.32 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -0.969 . . . . 0.0 110.187 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.922 HD21 ' HZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -81.15 124.35 29.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.767 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 mp -119.95 159.94 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.97 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HB3' HD11 ' A' ' 6' ' ' ILE . 8.9 pt-20 -72.88 -22.18 60.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 109.698 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.928 ' C ' HD11 ' A' ' 50' ' ' LEU . 3.2 p30 -96.17 13.07 28.59 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.118 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 1.092 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 137.17 169.77 11.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' MET . 3.6 mp -111.86 112.57 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.126 -1.22 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.767 ' HG2' HD11 ' A' ' 29' ' ' LEU . 16.8 pt-20 -107.83 117.39 34.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 108.637 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.644 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -115.67 148.88 39.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.44 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -130.89 -158.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 -34.3 14.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.405 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.503 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -123.78 -169.05 1.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 6.9 tppt? -46.4 -25.38 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.909 -1.119 . . . . 0.0 109.011 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -155.25 -48.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.4 t70 60.96 11.14 3.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 48.2 t30 43.62 23.07 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.01 -1.056 . . . . 0.0 109.353 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.7 t -164.4 99.99 0.88 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 51.4 Cg_endo -71.43 144.36 45.25 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.919 1.746 . . . . 0.0 110.704 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -89.65 -22.68 22.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.049 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.621 ' N ' ' CE1' ' A' ' 35' ' ' PHE . . . 172.89 158.49 17.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 3.8 mtt -123.3 -178.71 4.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -1.176 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 73' ' ' THR . 5.8 mt -135.98 116.26 11.38 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 109.279 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.58 122.1 8.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.623 1.549 . . . . 0.0 110.099 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.092 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -73.01 -0.61 14.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.167 -0.958 . . . . 0.0 109.744 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.842 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.2 OUTLIER -43.04 -60.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 70.02 0.18 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.129 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.2 m -82.72 177.32 8.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -1.197 . . . . 0.0 109.146 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -134.19 165.47 25.01 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.746 HD11 ' HB ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.08 124.32 42.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.162 -0.961 . . . . 0.0 108.84 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.681 ' N ' HD23 ' A' ' 55' ' ' LEU . 30.5 m -111.77 119.87 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.738 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 52.4 p -150.5 115.89 3.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 56' ' ' THR . 52.6 Cg_endo -71.6 -172.1 8.4 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.596 -1.835 . . . . 0.0 110.263 -0.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -94.69 -91.75 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.733 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 10.5 pt20 -145.36 -155.68 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.818 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 21.1 2.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.57 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 7.8 t80 -89.84 -57.22 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -112.55 16.31 24.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 20.2 tttm -48.55 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -1.167 . . . . 0.0 109.358 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 177.55 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.0 mtm -64.74 -148.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 77.9 m-85 -100.66 79.92 2.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.967 . . . . 0.0 109.464 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -117.45 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.326 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 93' ' ' VAL . 9.2 p90 -126.63 172.09 10.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.663 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -133.43 116.1 15.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 109.786 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.584 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.0 mt -95.4 162.01 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 64.8 m -131.19 92.68 3.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.591 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -57.54 150.3 19.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 108.839 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.842 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -43.2 -26.04 0.15 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.508 -0.745 . . . . 0.0 109.846 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -88.28 35.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.554 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 43.87 31.02 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.743 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -89.64 87.46 7.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 7.7 m-20 -58.17 143.92 42.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.829 . . . . 0.0 110.148 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.62 106.11 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -101.68 111.3 23.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.65 147.71 36.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 0.0 109.181 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -114.12 141.53 47.36 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.162 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.71 -147.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.78 -75.13 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -114.43 179.31 3.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.401 0.619 . . . . 0.0 109.482 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.55 -57.17 13.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.586 -0.696 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.862 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -50.77 -51.02 54.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.589 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 60.8 tt0 -65.37 -24.85 67.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.029 . . . . 0.0 109.662 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.23 -66.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.805 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.576 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 14.5 m-20 -59.29 -32.21 69.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.51 84.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.969 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.1 m95 -71.79 -56.77 5.16 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -0.937 . . . . 0.0 108.586 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.35 -13.65 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.542 -0.724 . . . . 0.0 109.152 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -80.48 -36.01 33.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 0.0 109.558 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.78 -27.19 25.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.06 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.891 ' CG1' HD13 ' A' ' 28' ' ' LEU . 4.8 mt -77.91 -36.9 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.929 -1.107 . . . . 0.0 108.957 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -84.94 -37.24 20.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.172 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.31 -49.74 52.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 0.0 108.971 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.47 95.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.107 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.653 ' CG1' HD23 ' A' ' 50' ' ' LEU . 22.5 mt -62.04 -39.13 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 108.752 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -79.32 -9.86 59.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.52 -20.08 19.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.409 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 50' ' ' LEU . 3.2 tp -88.5 -16.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.18 -12.95 61.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.62 4.86 19.24 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.075 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.53 -61.52 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.972 . . . . 0.0 109.779 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.981 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -166.48 130.43 2.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.063 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.61 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.31 -148.97 5.33 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.939 ' C ' HD13 ' A' ' 11' ' ' LEU . 13.4 p90 -135.99 89.99 2.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.126 -1.22 . . . . 0.0 110.635 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.939 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -111.46 158.99 18.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 108.758 178.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -83.58 132.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 2.0 tttt -119.1 157.29 28.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -100.34 98.57 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.532 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 80.22 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.96 -42.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -1.117 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 17' ' ' VAL . 10.8 p -179.35 106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 17' ' ' VAL . 5.3 m-85 56.82 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' PHE . 4.4 m120 -43.06 106.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.105 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 1.2 p -148.91 146.79 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.811 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.3 m0 -126.94 113.78 16.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.661 ' C ' HG23 ' A' ' 12' ' ' VAL . 1.5 mmtp -138.61 135.93 18.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.027 -1.046 . . . . 0.0 110.035 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.4 Cg_exo -53.99 152.76 22.68 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.914 1.743 . . . . 0.0 109.882 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.766 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -163.39 168.03 20.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.976 -1.078 . . . . 0.0 109.89 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.766 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.2 t-105 -96.06 143.79 26.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.694 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.61 139.82 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.236 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . 5.7 m -125.94 113.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.045 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -85.82 102.89 14.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 108.964 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 5' ' ' ARG . 1.8 mp -89.51 155.78 19.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.192 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.2 tt0 -70.27 -19.3 63.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.324 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.26 4.91 31.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.989 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 164.21 -179.96 38.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm -137.0 119.42 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -1.153 . . . . 0.0 109.422 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.2 pt-20 -127.51 117.24 21.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 108.87 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.694 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.2 p90 -120.96 147.1 45.93 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.903 -1.123 . . . . 0.0 110.347 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.644 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.96 172.75 12.91 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -61.14 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.033 . . . . 0.0 109.288 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.3 mmtt -78.87 -168.76 1.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.985 . . . . 0.0 108.757 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 7.6 mtpt -77.61 5.69 8.68 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.89 -43.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 109.125 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 43' ' ' SER . 13.2 t0 48.61 18.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.304 -0.872 . . . . 0.0 109.541 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' SER . 59.9 t30 40.65 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.9 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t 178.05 112.83 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.626 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.7 Cg_endo -71.55 142.53 40.54 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.83 1.686 . . . . 0.0 110.638 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.3 -5.45 57.54 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -179.33 129.2 1.33 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.4 mtm -126.69 127.45 45.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -1.207 . . . . 0.0 109.978 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.693 HG23 HG22 ' A' ' 73' ' ' THR . 2.7 mt -94.59 131.81 30.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 151.63 55.86 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.784 1.656 . . . . 0.0 110.626 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.033 HD12 HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -90.95 5.26 49.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -0.865 . . . . 0.0 109.202 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.627 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.43 -72.15 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.125 -0.985 . . . . 0.0 109.689 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.29 74.83 0.17 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB3' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -78.79 -179.7 6.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -1.191 . . . . 0.0 109.382 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.493 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -133.55 107.77 8.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.326 -0.859 . . . . 0.0 109.673 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -89.65 117.71 28.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.324 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.909 ' N ' HD22 ' A' ' 55' ' ' LEU . 8.6 m -106.52 131.95 53.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -142.95 125.22 8.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.286 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.727 ' O ' HG22 ' A' ' 56' ' ' THR . 55.7 Cg_endo -73.25 -161.78 2.38 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.479 -1.884 . . . . 0.0 110.337 -0.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.4 p -104.43 -148.02 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.568 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.525 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.6 OUTLIER -89.78 -149.84 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.68 19.75 2.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.188 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.03 84.41 6.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.169 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 107.97 -55.91 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 63' ' ' GLY . 3.8 tttt 42.37 26.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.423 -1.045 . . . . 0.0 109.788 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 67' ' ' PHE . 19.4 mtp180 -88.01 16.56 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.295 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.514 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 19.3 mtm 65.8 8.74 5.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 65' ' ' ARG . 1.5 m-85 -135.45 28.29 3.36 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 62' ' ' PHE . 2.5 p -127.18 127.13 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -0.999 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.733 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.51 166.44 10.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 109.884 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 15.8 ttpt -134.88 105.45 6.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.883 . . . . 0.0 109.134 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 96' ' ' ILE . 2.7 mt -89.63 165.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.5 m -144.58 93.27 2.4 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 48' ' ' ILE . 1.6 p -47.88 153.44 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 109.408 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.627 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.7 87.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.655 . . . . 0.0 109.655 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER 158.59 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.9 pt20 178.59 31.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.625 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 10.0 mt-30 -97.12 105.67 17.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 108.758 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.584 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 11.9 p30 -82.85 144.1 30.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.012 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 94.5 m-70 -139.76 91.78 2.5 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -93.54 128.35 39.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.044 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.733 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -145.52 141.91 28.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -110.08 143.82 39.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.14 -146.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.754 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -102.38 -18.65 15.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.627 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -166.9 172.13 10.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.561 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 tp -56.28 -39.94 73.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 109.831 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.16 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 21.5 tt0 -63.68 -16.19 60.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.437 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 1.05 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -72.03 -64.12 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.612 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -66.13 -15.63 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.603 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.39 -40.67 29.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 109.012 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.0 m95 -77.97 -26.91 48.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.05 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.0 m -77.43 -32.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 7.3 ptp180 -80.44 -23.85 39.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.544 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.774 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.1 t70 -85.01 -46.87 10.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.016 -1.052 . . . . 0.0 109.706 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.651 HG21 HD11 ' A' ' 71' ' ' ILE . 5.8 mt -70.05 -30.56 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.072 -1.018 . . . . 0.0 109.141 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 55' ' ' LEU . 7.8 t30 -84.65 -37.62 20.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.255 -0.903 . . . . 0.0 109.707 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 2.6 tppt? -69.92 -29.49 66.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.13 -28.71 32.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 53' ' ' SER . 31.1 mt -77.9 -30.05 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -16.69 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -95.77 -26.57 15.62 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.572 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 1.033 HG21 HD12 ' A' ' 50' ' ' LEU . 8.4 tp -73.33 -25.48 21.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -0.93 . . . . 0.0 109.62 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -50.96 -22.64 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 108.965 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -120.59 -104.5 1.98 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.557 0 O-C-N 121.408 -1.054 . . . . 0.0 109.594 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 6' ' ' ILE . 1.5 mp -64.6 -49.04 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.609 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -119.17 147.17 44.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.987 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.007 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 -163.57 122.24 1.98 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.267 -0.895 . . . . 0.0 109.217 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.598 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.19 -145.71 4.42 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.0 p90 -135.48 93.33 2.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.018 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -105.19 161.29 14.39 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -92.65 146.87 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.866 -1.146 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -134.74 150.18 50.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.757 . . . . 0.0 109.224 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 4.1 ttpp -62.11 140.33 58.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.0 158.02 20.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 55.63 2.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.59 -90.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.497 ' H ' HG23 ' A' ' 17' ' ' VAL . 80.3 m-85 -131.91 55.54 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 39.9 t-20 60.31 85.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 38.0 p -138.01 174.01 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.935 . . . . 0.0 109.718 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 80' ' ' PHE . 15.6 m95 -150.2 100.66 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 108.941 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.9 mttm -123.21 145.02 45.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.146 -0.971 . . . . 0.0 110.093 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -53.05 166.01 1.1 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.129 1.886 . . . . 0.0 110.507 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.757 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -173.32 169.33 4.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.276 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.757 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.8 t-105 -89.81 141.39 28.67 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.113 -0.992 . . . . 0.0 108.651 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.2 p -151.53 129.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.964 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.007 HG12 ' CB ' ' A' ' 8' ' ' GLU . 6.2 m -125.37 111.98 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.786 . . . . 0.0 109.568 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.725 HD11 ' OD1' ' A' ' 95' ' ' ASP . 2.6 pp -86.6 113.71 22.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.038 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.596 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -92.93 157.75 16.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.61 -21.42 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.685 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -104.59 13.31 31.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.813 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 157.49 -169.12 34.37 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 3.7 mp -149.63 131.64 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -1.182 . . . . 0.0 109.59 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' HD11 ' A' ' 29' ' ' LEU . 2.8 pt-20 -142.0 122.68 14.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.672 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.8 p90 -120.87 144.4 48.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.19 -155.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -92.28 -50.38 5.69 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.48 -174.26 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.41 -26.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.025 -1.047 . . . . 0.0 109.507 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 1.4 m -150.69 -48.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.348 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 3.4 t0 67.48 -6.58 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.725 -0.609 . . . . 0.0 110.589 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m-20 79.25 -40.57 0.24 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.292 -0.88 . . . . 0.0 110.122 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.1 119.12 35.3 Favored Pre-proline 0 C--N 1.31 -1.129 0 O-C-N 120.918 -1.114 . . . . 0.0 109.987 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 58.7 Cg_endo -74.96 145.26 31.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.799 1.666 . . . . 0.0 110.436 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.18 -32.32 16.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 108.991 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -155.49 138.2 5.95 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.5 mtp -130.59 118.53 21.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -1.121 . . . . 0.0 109.709 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.732 HG23 HG22 ' A' ' 73' ' ' THR . 2.6 mp -89.88 128.99 47.99 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.34 146.65 51.16 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.816 1.677 . . . . 0.0 110.508 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 ' CG1' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -86.98 34.91 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.52 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 74' ' ' THR . 36.3 mtmt -84.91 -82.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -150.01 62.89 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -66.61 -176.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -1.187 . . . . 0.0 109.458 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -136.94 113.36 10.03 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.76 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.4 tm? -88.61 118.63 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.412 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 58' ' ' PRO . 7.8 m -109.96 129.56 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.67 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 3.5 m -150.36 121.5 3.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.812 . . . . 0.0 109.251 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 56' ' ' THR . 51.8 Cg_endo -71.8 -170.86 7.31 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.619 -1.826 . . . . 0.0 110.277 -0.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 1.7 t -100.3 -99.56 0.24 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.722 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -143.34 -147.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.997 -1.064 . . . . 0.0 109.756 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 24.5 m-20 -45.36 -22.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -0.996 . . . . 0.0 109.312 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 4.7 m-85 -89.86 -46.17 8.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.021 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.763 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -75.34 1.34 57.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 10.2 pttm -71.95 -9.23 58.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -1.199 . . . . 0.0 109.57 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 mtt180 -147.6 173.76 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ARG . 42.9 mtm 48.97 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.645 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 16.3 m-85 -98.15 65.09 1.7 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG13 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -108.14 124.11 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.682 -0.637 . . . . 0.0 109.338 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.76 177.03 5.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.784 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 5.0 ttpp -141.7 103.8 4.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.65 ' CD1' HG21 ' A' ' 96' ' ' ILE . 6.4 mt -89.41 168.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.089 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.2 m -143.73 88.75 2.01 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -45.01 150.25 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.49 87.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.659 -0.65 . . . . 0.0 109.623 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 159.43 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 5.5 pt20 170.59 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.379 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -100.83 84.84 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.146 -0.971 . . . . 0.0 109.066 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.546 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 7.1 p30 -65.91 138.01 57.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.397 -0.814 . . . . 0.0 109.93 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 54.7 m-70 -132.23 99.61 4.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 108.933 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -94.56 124.31 38.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 109.944 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.816 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.21 142.88 24.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.965 . . . . 0.0 109.179 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 2.5 tt0 -108.15 136.42 47.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -91.7 -148.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.5 -90.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.242 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.91 177.65 4.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.071 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 24.7 tp -59.07 -25.42 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.114 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -63.81 1.0 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.331 -0.855 . . . . 0.0 109.2 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.91 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -64.58 -67.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 109.398 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 93' ' ' VAL . 16.9 t0 -60.71 -14.61 22.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.074 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.74 43.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CE2' HD21 ' A' ' 11' ' ' LEU . 6.2 m95 -78.95 -33.17 45.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.8 m -72.19 -33.89 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.729 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -82.68 -22.76 34.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.725 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -80.01 -49.98 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.053 ' O ' HD12 ' A' ' 100' ' ' ILE . 25.1 mt -68.85 -41.56 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.349 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -72.38 -29.72 64.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 12.1 tttm -70.67 -44.41 67.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.645 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -63.97 -44.14 93.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.053 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.2 mt -64.98 -36.12 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.301 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -12.65 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.294 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.37 -25.98 16.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.855 ' CG1' HD12 ' A' ' 50' ' ' LEU . 8.1 mm -81.69 -25.21 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.3 mt-10 -69.06 -6.99 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.29 9.08 7.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.354 -1.086 . . . . 0.0 109.302 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.566 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HB ' HD12 ' A' ' 28' ' ' LEU . 19.8 mm -84.88 -42.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.949 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.973 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -150.57 104.29 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.045 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.4 pm0 -113.98 136.77 52.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 109.763 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.581 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.31 -146.69 4.8 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.789 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.8 p90 -141.8 95.81 2.87 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.317 -1.108 . . . . 0.0 109.961 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.803 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -115.77 156.3 26.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 108.748 179.172 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -84.04 130.51 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.479 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 28.6 ttmt -131.29 164.53 25.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.302 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -113.48 138.01 50.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.004 . . . . 0.0 109.735 -179.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 161.61 117.08 0.42 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 164.53 -94.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -1.113 . . . . 0.0 109.442 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.822 HG23 ' CD2' ' A' ' 18' ' ' PHE . 13.8 m -98.94 -21.9 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.822 ' CD2' HG23 ' A' ' 17' ' ' VAL . 37.6 p90 -179.92 179.97 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.801 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.9 p30 -53.33 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.854 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.793 HG22 ' CZ ' ' A' ' 18' ' ' PHE . 65.8 p -113.92 151.87 31.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 108.649 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.0 m95 -128.56 113.52 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.762 -1.211 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.824 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -150.43 138.05 11.94 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.67 147.52 23.84 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.716 1.61 . . . . 0.0 109.812 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.726 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.74 167.65 28.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.01 . . . . 0.0 110.012 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.726 ' O ' ' SD ' ' A' ' 24' ' ' MET . 64.6 t-105 -89.79 143.35 26.87 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.86 127.29 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.177 -178.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -117.53 101.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.195 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.976 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 pp -81.78 109.81 16.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.1 mp -94.84 161.78 14.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.391 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.692 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 4.2 pt-20 -72.29 -16.77 61.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.973 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.68 7.12 34.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.015 . . . . 0.0 109.441 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 151.6 154.5 6.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 50' ' ' LEU . 2.6 mp -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -1.195 . . . . 0.0 109.877 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 12.3 pt-20 -127.3 113.79 16.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.5 p90 -117.81 147.97 42.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -131.3 -158.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -43.95 9.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 108.534 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.8 mmtt -107.31 -171.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -52.92 -19.61 2.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.195 . . . . 0.0 109.358 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -150.68 -49.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.955 . . . . 0.0 109.489 179.552 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.8 t0 62.0 10.55 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.445 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 33.9 t30 41.69 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.944 . . . . 0.0 109.906 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -168.57 110.13 0.53 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.811 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.4 Cg_endo -71.74 135.4 25.82 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.879 1.719 . . . . 0.0 110.545 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.1 ttpt -89.42 -23.66 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -170.86 148.08 11.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.443 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 5.0 mtm -137.21 128.98 28.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 71' ' ' ILE . 2.8 mt -91.08 109.66 36.85 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.457 ' O ' ' OG ' ' A' ' 53' ' ' SER . 50.6 Cg_endo -70.21 125.19 11.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.81 1.673 . . . . 0.0 110.348 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 103' ' ' ILE . 3.1 mp -74.71 -2.79 27.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -44.98 -58.36 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 109.306 179.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -162.84 72.45 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -96.73 -175.47 3.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -1.131 . . . . 0.0 109.74 -179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.72 108.06 5.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.377 -0.827 . . . . 0.0 109.551 -179.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.7 tm? -89.47 113.24 24.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 109.715 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.562 ' N ' HD22 ' A' ' 55' ' ' LEU . 31.1 m -104.52 113.05 26.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.925 ' HB2' HG21 ' A' ' 93' ' ' VAL . 1.6 t -143.44 139.38 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.422 -0.799 . . . . 0.0 109.532 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 60.0 Cg_endo -78.11 -179.58 27.56 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.277 -1.968 . . . . 0.0 110.503 -0.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.71 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -127.9 137.76 52.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 108.93 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.41 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -141.71 90.33 2.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 0.0 109.718 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 2.3 p-10 179.53 -32.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 109.161 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -88.57 -45.38 9.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -113.41 -24.63 4.66 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 178.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 10.9 ttmt 38.49 43.05 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.79 0.805 . . . . 0.0 109.499 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' MET . 6.4 mtt85 -136.24 18.5 3.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 108.892 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.546 ' C ' ' CG ' ' A' ' 67' ' ' PHE . 53.0 mtt 64.37 159.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.506 -0.746 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER 71.81 15.57 5.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.71 HG22 ' SG ' ' A' ' 59' ' ' CYS . 1.9 p -121.26 124.09 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.0 167.05 10.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.392 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 3.0 ptmt -142.86 109.58 5.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.175 -0.953 . . . . 0.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 48' ' ' ILE . 36.2 mt -91.15 166.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.1 m -143.78 86.5 1.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 48' ' ' ILE . 3.0 p -49.54 163.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -20.15 21.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -89.07 26.11 1.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.17 30.01 13.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 1.4 mt-30 -89.64 102.23 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.0 m-20 -77.22 145.97 37.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -143.14 109.96 5.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 1.5 m-85 -107.37 120.79 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -137.54 139.01 40.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 178.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 83' ' ' ALA . 1.5 tt0 -105.7 145.4 31.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 0.0 109.32 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.5 -166.93 1.72 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.146 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -86.48 -18.85 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.617 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -160.83 169.83 21.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.632 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.043 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.4 -54.77 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.043 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -43.21 -53.53 5.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.1 tt0 -65.5 -32.16 73.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.958 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -67.26 -26.13 66.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.97 . . . . 0.0 109.767 -179.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 3.4 t0 -83.32 -42.2 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . . . -70.01 -22.45 63.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.976 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.2 m95 -83.86 -39.09 20.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 57' ' ' SER . 2.5 p -76.39 -26.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.765 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -82.87 -31.12 28.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -75.45 -53.34 8.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.876 HG13 HD22 ' A' ' 28' ' ' LEU . 22.9 mt -62.69 -32.51 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.222 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 4.4 t-20 -79.89 -26.62 40.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.317 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -69.68 -53.57 17.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -62.02 -37.98 86.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.252 -0.905 . . . . 0.0 109.185 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ILE . 26.5 mt -62.64 -38.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.019 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -80.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.581 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 13.5 t -95.32 -18.6 20.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.395 -0.815 . . . . 0.0 109.152 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 50' ' ' LEU . 7.6 mm -90.59 -27.62 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.127 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.2 mt-10 -75.66 -3.41 34.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.36 12.91 5.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.457 -1.025 . . . . 0.0 109.378 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.715 ' HD3' HG11 ' A' ' 27' ' ' VAL . 3.5 mtt85 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 30' ' ' GLU . 43.4 mt -63.76 -56.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 109.431 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.905 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.32 148.22 46.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.993 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -161.61 135.84 6.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.384 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.594 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.45 -147.44 4.97 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.967 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.0 p90 -139.18 98.17 3.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.464 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.967 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -118.94 159.07 24.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 108.863 179.56 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.795 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.7 p -86.77 125.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.119 -0.988 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 4.6 tppp? -113.49 145.95 40.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 109.208 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.54 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 9.2 tttt -64.36 150.16 46.82 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.311 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 101.51 -135.8 12.39 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 5.2 t 74.85 0.1 3.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.568 HG13 ' H ' ' A' ' 18' ' ' PHE . 2.6 p 175.48 -52.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.568 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -168.2 73.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.143 -0.973 . . . . 0.0 109.751 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m120 48.23 44.95 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.5 ' OG1' ' CG1' ' A' ' 17' ' ' VAL . 1.5 p -101.86 -166.16 1.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.622 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.4 m95 -141.32 109.34 5.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.007 -1.058 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.795 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -148.93 145.96 20.68 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 0.0 109.563 179.904 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.98 160.06 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.019 1.813 . . . . 0.0 109.923 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.745 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -169.38 166.43 10.4 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.802 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.745 ' O ' ' SD ' ' A' ' 24' ' ' MET . 63.3 t-105 -91.32 142.11 28.06 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.97 130.57 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.119 -178.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.993 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.8 m -121.13 113.16 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.489 -0.757 . . . . 0.0 109.556 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.924 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.8 pp -86.32 117.9 25.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.955 . . . . 0.0 109.081 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.5 mp -104.95 162.32 13.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.51 -0.744 . . . . 0.0 109.861 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.3 pt-20 -73.66 -7.43 51.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.431 -0.793 . . . . 0.0 110.366 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -115.1 0.87 13.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.093 -1.004 . . . . 0.0 109.419 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.84 165.83 14.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.858 HG23 ' HA ' ' A' ' 28' ' ' LEU . 6.9 mm -112.92 126.46 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.359 -1.083 . . . . 0.0 110.468 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' HG23 ' A' ' 27' ' ' VAL . 6.4 pt-20 -125.71 112.2 15.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.662 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 4.1 p90 -118.2 143.65 46.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.004 -1.06 . . . . 0.0 110.655 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.623 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -125.22 -150.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.98 -49.46 5.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.74 -175.83 2.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 108.833 179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 1.0 OUTLIER -49.51 -21.84 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.407 -179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -148.08 -51.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.4 t70 59.13 10.97 1.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.933 . . . . 0.0 109.333 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.7 m-80 39.63 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.375 -0.828 . . . . 0.0 110.174 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.0 t -166.04 118.91 0.85 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.764 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 57.7 Cg_endo -74.7 147.89 36.0 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.626 1.55 . . . . 0.0 111.096 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -101.64 -30.21 11.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.72 152.76 12.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 mtt -135.17 138.65 43.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 109.559 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.652 HG22 ' HB2' ' A' ' 53' ' ' SER . 8.6 mt -104.57 134.18 19.8 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 108.732 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' CD ' ' OG1' ' A' ' 73' ' ' THR . 36.4 Cg_endo -66.12 137.53 48.5 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.492 1.462 . . . . 0.0 110.474 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.747 ' HB3' HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.15 -6.32 59.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.276 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 48.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.022 -1.049 . . . . 0.0 109.895 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 175.22 -40.2 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.034 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB2' HG22 ' A' ' 48' ' ' ILE . 3.4 t -42.28 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 110.174 -179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.91 170.15 11.38 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.064 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -130.97 148.5 52.74 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.97 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 1.064 ' N ' HD13 ' A' ' 55' ' ' LEU . 21.3 m -145.17 137.28 25.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 108.941 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' PRO . 32.7 t -138.89 122.75 11.18 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 57' ' ' SER . 59.5 Cg_endo -75.62 -94.89 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.709 -1.788 . . . . 0.0 110.095 -0.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.8 p -143.69 -147.12 0.2 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.397 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.526 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -93.99 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.789 -179.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.99 18.67 2.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.217 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.4 t80 -89.11 -26.4 21.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.195 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.623 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -143.84 12.33 2.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 28.6 tttt -49.06 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 169.53 -91.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.462 -0.774 . . . . 0.0 109.191 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.9 mmm -61.5 -141.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 9.7 m-85 -107.42 76.11 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.461 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 63' ' ' GLY . 1.3 p -113.75 122.84 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -105.83 168.94 8.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.902 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 7.8 ttpt -128.53 134.92 48.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.077 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 69' ' ' PHE . 1.8 mt -124.97 169.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 54' ' ' THR . 74.1 m -147.81 110.99 4.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -0.975 . . . . 0.0 110.12 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 73' ' ' THR . 5.8 t -58.08 113.37 1.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.017 . . . . 0.0 110.235 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 40.74 24.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.772 . . . . 0.0 111.042 179.266 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 81.77 45.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.102 . . . . 0.0 109.19 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -126.5 -85.31 0.61 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 -179.785 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.644 ' H ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER -94.16 146.22 24.14 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.641 -0.662 . . . . 0.0 109.649 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 68.3 m-20 -99.72 116.59 32.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -102.1 103.98 14.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -101.28 129.26 47.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 109.402 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -142.18 146.46 35.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.334 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 67' ' ' PHE . 6.0 tt0 -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -91.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.628 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 67' ' ' PHE . . . -160.16 -83.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -101.59 171.92 7.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.705 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -55.04 -58.38 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.772 -179.67 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.046 ' N ' HD23 ' A' ' 86' ' ' LEU . 2.0 tt0 -46.14 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.561 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 41.9 tt0 -40.87 -38.72 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 110.471 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -58.92 -61.34 2.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.997 . . . . 0.0 110.141 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 71.8 m-20 -57.26 -31.32 65.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.452 -179.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.68 68.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.934 -1.103 . . . . 0.0 109.851 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.924 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.2 m95 -76.36 -45.49 31.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.096 -1.002 . . . . 0.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.928 HG23 HD21 ' A' ' 55' ' ' LEU . 13.7 p -69.5 -23.12 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.0 mmt180 -81.4 -36.98 28.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.974 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -77.1 -39.53 49.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.092 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' ILE . 6.0 mt -70.64 -46.31 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.774 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 17.3 t-20 -73.97 -30.55 62.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 0.0 109.712 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 7.8 ttpt -72.1 -34.92 69.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.232 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -77.48 -23.0 50.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 50' ' ' LEU . 5.5 mt -81.76 -36.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.119 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -14.77 48.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 2.4 t -95.77 -33.31 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.437 -0.79 . . . . 0.0 109.56 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 30' ' ' GLU . 5.8 tp -73.06 -15.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 1.2 mm-40 -73.04 -7.66 52.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.93 9.81 7.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.382 -1.069 . . . . 0.0 109.236 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.74 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.0 mt -90.52 -32.3 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HG2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -139.94 157.56 45.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 179.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.031 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.0 pm0 -171.02 126.21 0.68 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.7 -147.33 4.99 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.909 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -136.57 91.98 2.71 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.398 -1.06 . . . . 0.0 110.225 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.909 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.24 168.49 9.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.937 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -100.23 124.46 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 110.071 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 mtpm? -104.68 163.67 12.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.6 -0.687 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -68.2 107.53 2.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 109.259 179.695 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' LYS . . . -41.17 139.99 1.42 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 p -85.69 64.51 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -142.13 -87.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' H ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-85 -131.27 67.45 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.3 m120 54.55 77.42 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.192 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.1 p -129.08 172.53 11.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.593 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 14' ' ' LYS . 3.1 m95 -141.08 121.86 14.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.361 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.937 ' C ' HG23 ' A' ' 12' ' ' VAL . 8.0 mttt -149.18 136.08 10.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.78 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.2 Cg_exo -53.12 163.35 2.27 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.854 1.703 . . . . 0.0 109.986 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 22.3 ptm -177.34 164.14 2.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.044 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.604 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.9 t-105 -91.06 143.68 26.44 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -150.76 132.69 5.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.153 -179.052 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.031 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.7 m -121.64 100.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 95' ' ' ASP . 2.3 pp -74.64 132.33 41.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.849 -1.157 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 29' ' ' LEU . 2.2 mp -117.95 168.56 10.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.554 -0.716 . . . . 0.0 109.597 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.983 ' O ' HD13 ' A' ' 103' ' ' ILE . 15.1 pt-20 -74.42 -0.17 16.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.032 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD22 ' A' ' 50' ' ' LEU . 2.1 m-20 -121.46 -3.62 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.142 -0.974 . . . . 0.0 109.235 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.691 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.41 158.47 8.69 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 28' ' ' LEU . 2.3 mm -95.26 112.5 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 110.009 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 27' ' ' VAL . 15.2 mt-10 -107.74 103.6 12.92 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.2 p90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.783 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -130.26 -153.96 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.328 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.98 -43.38 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 11.6 mttt -110.65 -176.55 3.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -43.34 -26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 109.531 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -149.61 -46.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.031 . . . . 0.0 109.854 179.863 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.0 t70 62.16 10.11 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.63 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.13 22.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.03 . . . . 0.0 109.823 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.4 t -168.7 98.33 0.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.925 -1.11 . . . . 0.0 110.287 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.6 Cg_exo -51.75 130.09 32.6 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.96 1.774 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 3.1 tttt -89.66 -19.57 24.71 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -176.06 132.62 2.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.1 mtm -121.65 121.17 36.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.211 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 ' HD2' ' A' ' 49' ' ' PRO . 24.6 mt -89.45 139.39 28.25 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 108.777 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.626 ' HD2' HG23 ' A' ' 48' ' ' ILE . 49.8 Cg_endo -70.63 131.85 20.8 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.587 1.524 . . . . 0.0 109.963 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.691 HD13 ' CA ' ' A' ' 32' ' ' GLY . 2.4 tp -76.4 -0.75 23.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -136.11 129.11 31.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -0.994 . . . . 0.0 109.545 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 100.39 -5.51 57.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -97.64 172.97 7.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -1.152 . . . . 0.0 109.658 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -132.25 158.31 42.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.527 -0.733 . . . . 0.0 109.267 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.4 tm? -123.88 110.74 15.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.538 ' N ' HD22 ' A' ' 55' ' ' LEU . 87.0 m -102.83 110.38 22.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.0 p -148.64 131.3 7.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.701 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.77 150.78 93.34 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.462 -1.891 . . . . 0.0 110.391 -0.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 68' ' ' VAL . 1.2 p -90.03 167.53 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 27.2 tt0 -167.31 108.11 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.96 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 9.7 t0 165.63 -43.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 6.6 t80 -89.77 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -94.21 -21.78 26.6 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 31.61 44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.437 0.637 . . . . 0.0 110.206 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' HG12 ' A' ' 68' ' ' VAL . 5.2 ttp180 179.53 -170.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 65' ' ' ARG . 3.1 mtt 42.4 -153.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -110.17 69.29 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.488 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.774 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -107.63 130.25 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.354 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -109.08 169.37 8.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.218 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 56' ' ' THR . 15.3 ttpt -136.63 109.39 7.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.336 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 72' ' ' THR . 7.1 mt -95.41 165.46 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.344 -0.847 . . . . 0.0 108.996 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 89.0 m -138.98 89.79 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 3.1 p -54.63 155.69 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.103 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -51.65 -19.18 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.397 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.47 26.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.99 -1.068 . . . . 0.0 109.6 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.95 30.41 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.16 105.79 17.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.222 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 80' ' ' PHE . 3.4 m-20 -75.21 133.42 41.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -124.97 100.51 6.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -98.57 128.38 44.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.596 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -148.27 144.17 27.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 179.142 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 1.2 tt0 -103.99 136.39 43.73 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.36 -149.59 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.798 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 -86.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.869 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -124.2 173.69 8.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.748 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -42.55 -45.81 4.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.826 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.953 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.6 tt0 -52.61 -66.51 0.37 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.064 -1.023 . . . . 0.0 110.145 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -7.69 21.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.855 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.813 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -76.18 -54.74 6.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.647 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -77.75 -12.61 59.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.7 -33.33 35.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.568 ' CE2' ' HG2' ' A' ' 7' ' ' ARG . 3.7 m95 -78.01 -32.9 51.37 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.3 m -76.98 -29.7 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.667 -0.645 . . . . 0.0 109.771 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 17.0 mmt85 -79.62 -27.19 41.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.834 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.7 OUTLIER -87.02 -44.27 11.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.025 . . . . 0.0 110.041 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.702 ' O ' HD12 ' A' ' 100' ' ' ILE . 4.2 mt -69.23 -31.94 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.044 . . . . 0.0 109.128 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 3.7 t-20 -85.09 -36.11 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 27.2 tttt -66.27 -34.39 77.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.229 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -80.78 -30.17 36.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.341 -0.849 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 96' ' ' ILE . 22.9 mt -72.94 -29.55 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 7.4 mmpt? -93.43 -17.74 23.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 9.7 m -95.88 -16.58 21.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.481 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.983 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.5 tp -87.27 -15.85 9.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.8 -11.91 61.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.425 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.99 12.34 9.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.482 -1.011 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.858 ' HE ' HG21 ' A' ' 27' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.38 -44.37 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.997 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.4 tpm_? -125.4 150.38 47.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -0.997 . . . . 0.0 110.237 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.768 ' CB ' HG12 ' A' ' 27' ' ' VAL . 2.1 pm0 -160.49 121.26 2.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.144 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.599 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.5 -145.28 4.19 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.785 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.2 p90 -142.1 102.6 4.15 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.286 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.785 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -117.16 169.08 9.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -101.34 133.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 0.0 109.891 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -128.31 131.89 48.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.635 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -96.3 151.28 19.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 108.795 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.514 ' N ' ' HG3' ' A' ' 14' ' ' LYS . . . 178.45 151.7 9.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 30.9 t 61.06 -88.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.242 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 18' ' ' PHE . 7.2 p -44.44 166.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.609 ' N ' HG22 ' A' ' 17' ' ' VAL . 27.3 p90 -73.78 -176.08 2.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.703 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' ' CD1' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -43.66 109.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' TRP . 18.6 p -146.38 -58.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -0.9 . . . . 0.0 109.902 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.643 ' NE1' ' CZ ' ' A' ' 62' ' ' PHE . 32.9 m95 63.51 106.1 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.488 0.661 . . . . 0.0 110.207 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . 45.0 mttm -125.54 134.86 26.22 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.65 159.71 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.906 1.737 . . . . 0.0 110.611 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.604 ' HE2' ' CD1' ' A' ' 35' ' ' PHE . 13.5 ptm -173.23 171.05 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.243 -0.91 . . . . 0.0 109.273 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.608 ' CE2' ' HA ' ' A' ' 39' ' ' LYS . 52.4 t-105 -89.56 140.83 29.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.911 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -151.54 127.63 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.171 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.858 HG21 ' HE ' ' A' ' 5' ' ' ARG . 17.2 m -126.42 119.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 109.46 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.939 ' HA ' HG23 ' A' ' 33' ' ' ILE . 2.8 pp -87.99 106.02 17.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -90.34 162.53 15.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.898 . . . . 0.0 109.473 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -72.61 -12.39 61.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.68 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HA ' HD11 ' A' ' 103' ' ' ILE . 1.6 m-20 -107.27 -0.81 22.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 157.93 144.68 4.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.939 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm -96.41 109.07 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -1.105 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 9.2 pt-20 -119.79 131.94 55.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 108.869 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.649 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.8 p90 -127.63 142.36 51.37 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 110.073 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -123.42 -149.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.628 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -63.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 109.179 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.0 -178.66 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 108.939 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.79 -42.75 17.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -144.14 69.54 1.28 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.507 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 18.4 t70 -47.41 -21.33 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 2.9 t-20 91.78 -18.49 0.14 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -134.25 119.63 14.5 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 45.1 Cg_endo -69.43 132.93 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.685 1.59 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.69 -21.56 22.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -160.01 117.98 0.8 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 167.8 9.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -1.156 . . . . 0.0 109.662 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.86 HG23 HG22 ' A' ' 73' ' ' THR . 5.5 mt -140.8 109.72 6.59 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.25 118.23 5.55 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.597 1.531 . . . . 0.0 110.35 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.79 HD11 HD11 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.93 -7.06 25.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.545 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -42.88 -68.13 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.725 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -150.14 71.46 0.3 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.009 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -177.65 5.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.196 . . . . 0.0 109.256 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.17 113.09 8.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.251 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' N ' ' A' ' 56' ' ' THR . 3.4 tm? -88.67 131.37 35.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.281 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 58' ' ' PRO . 31.6 m -115.99 137.63 51.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 17.9 p -150.13 118.03 3.6 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.994 ' O ' HG22 ' A' ' 56' ' ' THR . 48.2 Cg_endo -70.78 -160.87 1.7 Allowed 'Cis proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.493 -1.878 . . . . 0.0 110.424 0.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 22.7 p -91.07 -149.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -163.43 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.85 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 21.11 2.34 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.643 ' CZ ' ' NE1' ' A' ' 21' ' ' TRP . 8.3 t80 -88.64 -56.44 3.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 108.738 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -75.27 -50.14 8.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 15.7 pttm 40.53 28.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.98 . . . . 0.0 109.59 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.9 ttt180 -137.75 15.5 2.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.9 mtt 64.6 -162.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 49.31 23.11 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' PHE . 10.7 p -161.28 126.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.715 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.4 p90 -116.23 167.38 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.7 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -124.7 108.61 12.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 96' ' ' ILE . 4.4 mt -90.1 166.71 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.635 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -148.95 89.47 1.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.86 HG22 HG23 ' A' ' 48' ' ' ILE . 3.2 p -47.22 173.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -22.06 64.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.443 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -74.14 -5.92 44.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.184 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 2.7 mt-30 79.13 36.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.8 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 1.9 pt20 -109.11 90.66 3.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 m-20 -53.76 159.53 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.394 -0.816 . . . . 0.0 110.342 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 77' ' ' GLN . 82.7 m-70 -150.56 124.48 9.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -100.4 114.85 28.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.082 -1.012 . . . . 0.0 109.892 -179.461 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.11 148.8 42.65 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 12' ' ' VAL . 2.7 tt0 -138.14 133.87 33.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.063 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.63 -160.8 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.399 -0.813 . . . . 0.0 109.194 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -106.48 -2.03 22.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.514 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -173.02 167.1 5.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.0 179.973 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.463 ' CD1' ' HD2' ' A' ' 89' ' ' ARG . 33.2 tp -66.36 -14.16 61.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.558 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -67.21 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.189 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.68 -14.68 61.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.274 179.715 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -76.05 -51.55 12.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -68.34 -19.95 64.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 109.478 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -87.47 -31.34 20.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.911 ' CH2' HG22 ' A' ' 26' ' ' VAL . 1.6 m95 -79.95 -32.28 39.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.79 ' CG2' HD11 ' A' ' 55' ' ' LEU . 1.7 p -82.55 -34.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.17 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 7.9 ptm180 -73.58 -25.97 60.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 108.998 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 19.4 t0 -85.4 -49.05 8.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 71' ' ' ILE . 23.9 mt -61.62 -38.42 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.048 -1.032 . . . . 0.0 108.831 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 11.3 t-20 -75.92 -66.02 0.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 8.4 tttp -43.08 -32.75 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.401 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -69.47 -47.09 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.537 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.13 -55.54 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.766 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.482 ' N ' HG22 ' A' ' 100' ' ' ILE . 12.2 mttt -63.69 -12.64 36.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -85.82 -32.39 21.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.8 . . . . 0.0 109.184 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.622 HD12 ' CB ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -78.26 -30.46 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -0.868 . . . . 0.0 108.937 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.454 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.0 mm-40 -72.97 -5.35 38.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.356 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.75 13.99 5.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 106' ' ' LEU . 1.7 mt . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.465 -1.02 . . . . 0.0 109.284 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.797 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.312 0.577 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 6' ' ' ILE . 31.3 mt -63.83 -53.95 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.559 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -113.7 147.22 38.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 109.858 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 1.004 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.1 pm0 -163.93 126.05 2.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.794 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.587 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.08 -145.08 4.16 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.9 p90 -134.89 92.32 2.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.954 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.098 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.96 162.78 13.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.149 -0.969 . . . . 0.0 109.419 179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 82' ' ' GLN . 2.3 p -98.92 130.38 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HE2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.47 135.11 53.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.322 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 tttt -64.46 96.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LYS . . . -43.61 166.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 t -84.52 -4.45 58.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.541 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 18' ' ' PHE . 2.3 p -93.37 114.55 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' VAL . 21.9 m-85 52.34 174.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -87.21 86.39 7.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.252 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 61.3 p -120.58 -177.14 3.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.954 . . . . 0.0 109.757 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.642 ' CZ3' ' CG ' ' A' ' 82' ' ' GLN . 44.0 m95 -154.52 106.2 2.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.035 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.934 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -125.3 133.25 24.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 109.989 -179.55 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.2 Cg_exo -53.55 166.14 1.38 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.972 1.781 . . . . 0.0 110.323 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.77 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -174.92 169.68 3.39 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.77 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.1 t-105 -91.37 145.31 24.74 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -150.34 132.43 5.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.329 -178.324 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -127.79 102.95 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.901 ' HB2' HD12 ' A' ' 33' ' ' ILE . 2.5 pp -79.4 125.8 30.0 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.269 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 5' ' ' ARG . 2.2 mp -112.74 163.66 14.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.428 -0.795 . . . . 0.0 109.114 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 7.6 pt-20 -73.84 -6.27 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.28 -0.1 13.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.296 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 29' ' ' LEU . . . 156.14 148.04 4.93 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.901 HD12 ' HB2' ' A' ' 28' ' ' LEU . 4.0 mm -98.93 108.16 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -1.139 . . . . 0.0 109.313 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 29' ' ' LEU . 10.7 pt-20 -111.1 112.54 24.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.018 -1.051 . . . . 0.0 109.185 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.688 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.9 p90 -115.13 142.6 46.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.192 -0.943 . . . . 0.0 110.053 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.67 -149.38 0.41 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 108.613 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -99.91 -54.64 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 108.586 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -93.15 -171.28 2.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.661 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 8.1 mtpt -63.85 -9.89 17.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.657 -1.277 . . . . 0.0 109.704 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -152.65 -51.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.359 178.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.6 t0 57.46 11.0 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 38.67 24.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.814 . . . . 0.0 110.557 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.7 t -176.68 95.57 0.24 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.831 -1.168 . . . . 0.0 110.029 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 52.8 Cg_exo -53.9 153.77 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.169 1.913 . . . . 0.0 111.524 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 1.4 tttt -101.55 -21.7 14.67 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.42 141.07 5.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 5.5 mtm -139.83 132.11 28.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.261 . . . . 0.0 109.841 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.761 HG23 HG22 ' A' ' 73' ' ' THR . 19.7 mt -89.07 129.15 49.15 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.8 . . . . 0.0 108.905 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.84 131.75 23.28 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.774 1.649 . . . . 0.0 110.447 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.881 HD23 HG13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -89.22 30.66 0.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.403 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -36.15 15.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.415 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 74' ' ' THR . . . -177.51 84.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.12 -177.68 3.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -1.158 . . . . 0.0 109.675 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -135.43 114.51 12.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.405 -0.809 . . . . 0.0 109.696 -179.193 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 56' ' ' THR . 3.3 tm? -88.58 131.88 34.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.216 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.848 ' N ' HD13 ' A' ' 55' ' ' LEU . 23.9 m -124.06 121.37 35.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 35.6 m -148.46 137.06 11.67 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 109.745 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 57' ' ' SER . 60.7 Cg_endo -78.05 177.89 37.05 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.391 -1.92 . . . . 0.0 110.438 -0.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.779 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 1.9 t -150.14 -149.53 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.907 ' HB2' HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 63.17 115.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.413 -0.804 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.38 7.14 28.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.015 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -89.49 -42.7 11.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.66 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -118.16 -17.92 5.2 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 36.66 31.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.839 -0.801 . . . . 0.0 109.582 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 22.54 5.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.525 -0.735 . . . . 0.0 109.639 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.563 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER 55.81 -179.43 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 108.956 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 1.1 m-30 83.26 -20.18 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.732 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -102.22 135.45 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.388 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.771 ' CE1' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -110.91 152.32 26.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.958 . . . . 0.0 109.985 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.779 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 1.7 tttp -124.41 103.89 8.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.525 -0.734 . . . . 0.0 109.314 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 69' ' ' PHE . 12.7 mt -90.87 167.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 72' ' ' THR . 3.9 m -145.64 84.11 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 48' ' ' ILE . 4.5 p -42.96 165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 109.594 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -62.68 -16.8 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.472 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.42 19.71 5.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.26 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.17 34.66 16.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.765 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -97.82 94.52 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 66.2 m-20 -62.8 155.73 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 51.3 m-70 -139.38 124.07 18.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.613 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 71.1 m-85 -93.01 124.36 36.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.436 -0.79 . . . . 0.0 109.866 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 1.098 ' CE2' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -122.8 141.78 51.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.337 -0.852 . . . . 0.0 110.017 -179.53 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.959 ' HB2' HG13 ' A' ' 12' ' ' VAL . 1.4 mm100 -135.51 108.74 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.322 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.37 -145.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.505 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -132.75 1.53 3.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.849 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -172.28 154.15 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.061 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.14 -22.18 66.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 -179.821 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 1.061 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -66.16 -68.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 0.0 109.091 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 3.0 tt0 -60.28 -21.95 62.55 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 108.792 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.0 -65.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 179.592 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -57.06 -34.25 68.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.807 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.43 75.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.116 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.976 ' NE1' HD21 ' A' ' 11' ' ' LEU . 13.2 m95 -74.83 -56.29 4.92 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.341 -0.849 . . . . 0.0 108.795 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.791 HG12 HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -64.48 -11.07 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.607 -0.683 . . . . 0.0 109.252 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 19.4 mmt180 -84.42 -39.74 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.694 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -87.28 -21.33 25.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.939 -179.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.684 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.2 mt -87.42 -38.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 109.095 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 2.0 t-20 -80.17 -33.34 38.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 108.874 179.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -72.5 -45.06 61.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.078 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.95 -41.69 95.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.206 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 96' ' ' ILE . 33.6 mt -66.64 -32.79 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.111 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -81.92 -11.83 58.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.16 -24.34 16.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 108.954 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.881 HG13 HD23 ' A' ' 50' ' ' LEU . 9.1 mm -69.05 -23.75 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.457 -0.777 . . . . 0.0 109.213 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.7 -1.78 32.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.407 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.54 19.55 1.02 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.299 -1.595 0 O-C-N 121.554 -0.968 . . . . 0.0 109.113 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 1.1 mt-10 -72.51 -51.51 7.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.654 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 53.6 Cg_exo -49.31 124.95 12.67 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.774 1.649 . . . . 0.0 110.219 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 71.05 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.728 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -118.69 167.86 11.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.283 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' A' ' 28' ' ' LEU . 50.6 mt -73.59 -58.17 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 109.614 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.995 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -138.35 107.46 6.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 109.809 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.042 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.8 pt-20 -111.97 143.92 42.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.916 . . . . 0.0 109.632 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.19 -151.06 6.26 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.987 ' C ' HD13 ' A' ' 11' ' ' LEU . 6.3 p90 -145.26 96.27 2.81 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.385 -1.068 . . . . 0.0 110.086 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.987 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -119.17 163.5 16.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.148 -0.97 . . . . 0.0 109.095 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.722 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -86.17 130.69 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.076 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 81' ' ' PHE . 1.1 tttt -122.43 135.0 54.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.388 -0.82 . . . . 0.0 109.717 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -101.13 99.57 10.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.401 -0.812 . . . . 0.0 108.864 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 166.69 90.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 2.5 p 161.85 -41.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.35 -1.088 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG21 ' OG1' ' A' ' 20' ' ' THR . 13.2 m -100.92 -144.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.492 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' N ' HG23 ' A' ' 17' ' ' VAL . 19.4 m-85 -94.27 72.95 3.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.772 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 2.8 m-20 44.16 88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.871 . . . . 0.0 110.007 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.63 ' OG1' HG21 ' A' ' 17' ' ' VAL . 76.1 p -146.88 -162.52 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.657 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.2 m95 -151.4 102.82 2.94 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.383 -0.823 . . . . 0.0 109.354 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.722 ' N ' HG23 ' A' ' 12' ' ' VAL . 24.1 mmtt -137.85 142.02 34.8 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.224 -0.923 . . . . 0.0 109.779 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.7 Cg_exo -52.63 160.23 4.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.92 1.746 . . . . 0.0 109.759 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -167.43 166.65 14.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 109.951 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.728 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.1 t-105 -92.78 141.07 28.86 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.3 p -149.9 133.12 7.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.764 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.042 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.0 m -124.98 111.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 110.06 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.041 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -82.4 119.86 24.71 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.139 -0.976 . . . . 0.0 108.761 179.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 32' ' ' GLY . 3.5 mp -106.04 166.75 10.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.811 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.688 ' C ' HD22 ' A' ' 50' ' ' LEU . 3.9 pt-20 -71.93 -6.63 43.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.865 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.91 -1.73 11.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.108 -0.995 . . . . 0.0 109.511 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.574 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 155.35 146.64 4.49 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -97.12 105.15 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.352 -1.087 . . . . 0.0 109.956 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 27' ' ' VAL . 5.4 pt-20 -102.38 128.2 49.06 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.0 p90 -124.7 147.29 48.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 110.903 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.627 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.13 -145.41 0.34 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.7 -42.47 5.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.947 -1.096 . . . . 0.0 108.986 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -115.63 -177.79 3.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 108.821 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 4.2 tppt? -46.68 -34.69 5.3 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -157.12 73.47 0.75 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.515 -0.741 . . . . 0.0 109.469 178.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 31.5 t70 -52.61 -17.36 1.24 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 5.8 m120 91.16 -18.32 0.15 Allowed 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.5 t -135.45 116.44 11.93 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 47.1 Cg_endo -69.2 144.18 56.12 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.735 1.623 . . . . 0.0 110.721 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 8.1 mmtt -90.07 -25.6 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.441 -0.787 . . . . 0.0 108.926 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.54 150.5 10.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 42.4 mtt -118.23 166.97 11.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.291 -1.123 . . . . 0.0 109.493 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 39.9 mt -128.99 131.24 23.6 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.77 135.46 30.49 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.353 1.369 . . . . 0.0 109.797 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.011 HD21 ' HB1' ' A' ' 99' ' ' ALA . 0.5 OUTLIER -85.49 37.98 0.71 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 0.0 109.924 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -172.71 99.36 0.14 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.032 -1.042 . . . . 0.0 109.425 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 123.87 11.28 4.94 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.311 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 1.2 t -97.15 156.87 16.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.934 -1.333 . . . . 0.0 109.777 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -116.9 173.13 6.81 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 93' ' ' VAL . 1.7 tt -134.64 135.64 42.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.021 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.852 ' N ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -121.32 108.23 13.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.138 -0.976 . . . . 0.0 109.375 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.541 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 13.4 p -142.22 116.14 6.56 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 57' ' ' SER . 33.7 Cg_exo -62.15 -172.85 2.32 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.936 -1.693 . . . . 0.0 110.682 -1.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.7 p -98.14 -146.78 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.33 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.542 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -102.72 -149.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -86.3 17.81 3.52 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.337 -0.852 . . . . 0.0 108.887 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -89.33 77.67 7.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 109.308 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 102.27 -73.42 0.32 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 42.79 29.86 0.2 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -1.093 . . . . 0.0 109.477 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -93.78 -99.97 0.14 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 109.671 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 45.3 m-85 -129.55 87.2 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 0.0 109.531 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.3 p -120.15 117.32 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.403 -0.811 . . . . 0.0 109.618 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 4.4 p90 -106.97 165.12 11.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.146 -0.971 . . . . 0.0 109.331 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 56' ' ' THR . 1.9 ttpp -123.44 120.02 31.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.813 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.572 HG13 ' CE1' ' A' ' 69' ' ' PHE . 4.5 mt -106.8 160.77 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 54' ' ' THR . 87.1 m -134.17 94.48 3.24 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.122 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 2.6 p -59.09 150.29 25.45 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.325 -0.859 . . . . 0.0 108.976 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -45.94 -21.96 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.444 -0.785 . . . . 0.0 110.242 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -86.62 29.22 0.8 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.894 -1.129 . . . . 0.0 109.801 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.81 31.56 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.99 . . . . 0.0 109.67 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.491 ' OE1' ' NE2' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -97.49 97.45 9.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.42 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 77.4 m-20 -61.55 152.69 29.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.491 ' NE2' ' OE1' ' A' ' 77' ' ' GLN . 32.7 m-70 -142.32 88.92 2.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -0.872 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -91.13 101.63 14.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 108.95 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -129.42 146.83 51.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.028 . . . . 0.0 109.528 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -116.39 143.71 45.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.442 -0.786 . . . . 0.0 109.331 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.64 -146.69 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.394 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.666 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -107.48 -15.87 14.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.703 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 1.7 p90 -170.59 172.44 5.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.377 -0.827 . . . . 0.0 109.533 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.965 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.84 -50.25 66.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 109.969 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.965 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.2 tm-20 -53.28 -39.23 63.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 110.271 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 20.8 tt0 -83.86 -16.13 45.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.071 -1.018 . . . . 0.0 110.036 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.544 ' CG ' ' HB3' ' A' ' 67' ' ' PHE . 1.6 ttt180 -76.99 -46.51 23.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.992 . . . . 0.0 109.638 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 94' ' ' ARG . 8.4 t0 -79.97 -27.2 39.72 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 109.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.509 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -73.81 -34.78 64.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.725 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.041 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -80.22 -48.44 13.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.825 -179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.984 HG22 HD11 ' A' ' 55' ' ' LEU . 3.6 p -68.71 -27.12 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 33.5 ptt85 -79.76 -30.72 40.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.052 . . . . 0.0 109.234 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -75.21 -39.39 60.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.368 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.693 ' O ' HD12 ' A' ' 100' ' ' ILE . 28.2 mt -72.5 -42.4 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -0.899 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -72.57 -27.09 61.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.905 . . . . 0.0 109.252 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 5.3 tppt? -72.27 -46.13 57.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.075 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.011 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -64.13 -37.15 86.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.299 -0.875 . . . . 0.0 109.035 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.693 HD12 ' O ' ' A' ' 96' ' ' ILE . 7.6 mt -69.58 -34.15 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.403 -0.811 . . . . 0.0 108.928 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -85.26 -8.28 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.399 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.543 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -94.61 -30.97 14.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.288 -0.883 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.507 HG12 HD23 ' A' ' 50' ' ' LEU . 1.1 mm -69.44 -28.47 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.2 mt-10 -64.86 -10.51 29.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -0.875 . . . . 0.0 109.583 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.54 ' O ' HD22 ' A' ' 106' ' ' LEU . . . -131.21 10.93 5.59 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 102' ' ' CYS . 3.2 mm? -116.65 62.67 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.066 . . . . 0.0 109.385 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -102.36 171.79 7.26 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.489 -0.757 . . . . 0.0 109.316 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -117.43 -157.54 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 55.72 87.34 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -91.28 141.64 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -121.18 52.65 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -69.14 -34.21 74.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.44 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' CB ' ' HG3' ' A' ' 4' ' ' LYS . 1.5 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.367 0.603 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.576 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.8 mt-10 -60.85 -61.63 7.6 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.173 -0.954 . . . . 0.0 109.744 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 56.0 Cg_endo -71.54 -95.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.91 1.74 . . . . 0.0 110.431 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 1' ' ' MET . 0.7 OUTLIER 56.16 93.12 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.505 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.629 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -79.06 148.19 32.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.513 HD11 ' HB2' ' A' ' 30' ' ' GLU . 2.5 mp -66.81 -71.1 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.1 tpm_? -107.35 125.96 51.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.14 -0.975 . . . . 0.0 110.094 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.001 ' HB3' HG12 ' A' ' 27' ' ' VAL . 6.7 pm0 -145.88 122.91 11.4 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.249 -0.907 . . . . 0.0 109.178 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.596 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.62 -147.57 4.94 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.791 ' C ' HD13 ' A' ' 11' ' ' LEU . 16.7 p90 -139.63 99.88 3.82 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.356 -1.085 . . . . 0.0 109.873 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -105.86 -143.03 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.036 HG23 ' C ' ' A' ' 22' ' ' LYS . 9.9 p -149.71 129.12 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.013 . . . . 0.0 109.65 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.79 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.3 tttt -116.38 169.16 9.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -125.71 148.13 49.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 109.513 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' HD2' ' A' ' 14' ' ' LYS . . . 115.58 107.72 2.62 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 p 177.03 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -1.104 . . . . 0.0 109.265 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 18' ' ' PHE . 17.9 m -143.06 -39.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 4.7 m-85 -168.29 61.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.614 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.9 OUTLIER 48.69 43.55 20.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.183 -0.948 . . . . 0.0 109.548 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 12.7 p -89.99 172.35 8.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.332 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 14' ' ' LYS . 5.1 m95 -126.21 120.08 29.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.036 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.2 mmtp -138.88 129.64 15.01 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.666 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.668 ' N ' HG23 ' A' ' 12' ' ' VAL . 32.5 Cg_exo -59.14 119.06 6.08 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.916 1.744 . . . . 0.0 110.177 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.79 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 7.7 ptm -124.48 168.5 12.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.909 -1.119 . . . . 0.0 110.168 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.596 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 72.5 t-105 -90.45 145.53 24.85 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.66 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -151.49 139.67 14.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.403 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.001 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.1 m -130.25 98.31 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.87 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.755 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.9 pp -76.04 123.78 26.34 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.939 -1.1 . . . . 0.0 108.803 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 5' ' ' ARG . 2.4 mp -107.26 166.08 10.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.461 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 31.5 tt0 -73.69 -9.2 58.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 109.662 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.28 4.27 15.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.237 -0.915 . . . . 0.0 109.472 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 149.67 148.61 4.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.755 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.5 mp -99.02 127.09 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -1.168 . . . . 0.0 110.084 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 7.9 pt-20 -127.87 115.02 17.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.5 p90 -117.54 151.54 36.93 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 110.47 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -132.77 -153.32 0.54 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -33.75 13.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.141 -0.975 . . . . 0.0 108.38 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 40.8 mttt -124.62 -173.27 2.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 5.9 tppt? -45.5 -25.65 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.976 -1.077 . . . . 0.0 109.255 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -148.53 -50.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.54 10.86 3.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.839 . . . . 0.0 109.478 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 41' ' ' ASP . 1.4 m-20 42.61 23.12 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.14 -0.975 . . . . 0.0 109.754 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -169.84 108.19 0.46 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.051 -1.031 . . . . 0.0 109.706 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 56.1 Cg_endo -71.49 136.57 28.82 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.8 1.666 . . . . 0.0 110.549 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.79 -17.95 27.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.02 140.36 4.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.1 mtm -133.16 124.8 28.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.316 -1.108 . . . . 0.0 109.29 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.714 HG23 HG22 ' A' ' 73' ' ' THR . 6.5 mt -89.73 134.84 31.43 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.104 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 48' ' ' ILE . 56.7 Cg_endo -72.13 137.76 29.46 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.689 1.592 . . . . 0.0 110.078 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.675 HD23 ' CG1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.82 38.7 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 109.542 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -91.53 -70.75 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.619 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.99 72.95 0.24 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.712 ' H ' HG21 ' A' ' 100' ' ' ILE . 1.5 p -80.12 -170.1 2.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.363 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.33 111.53 6.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.311 -0.868 . . . . 0.0 109.516 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.756 ' C ' HD13 ' A' ' 55' ' ' LEU . 3.4 tm? -88.59 116.42 26.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.017 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 58' ' ' PRO . 86.8 m -102.09 130.56 48.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.421 -0.799 . . . . 0.0 109.578 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 t -150.05 120.05 3.84 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.713 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.41 -163.02 2.66 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.595 -1.835 . . . . 0.0 110.396 0.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.9 p -106.15 -158.84 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -71.33 -149.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.599 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -84.07 14.31 4.3 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.418 -0.801 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.84 -10.1 49.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.884 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HG11 ' A' ' 68' ' ' VAL . . . -124.75 -103.65 1.49 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 64' ' ' LYS . 0.4 OUTLIER 42.67 59.44 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -1.131 . . . . 0.0 109.281 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 6.2 ttt-85 179.73 -31.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.903 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.8 mtp -141.03 -155.95 0.63 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.471 -0.768 . . . . 0.0 109.766 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -92.99 65.37 4.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.91 . . . . 0.0 109.221 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.554 HG11 ' HA2' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -116.25 128.16 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.397 -0.814 . . . . 0.0 109.622 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 7.7 p90 -120.36 173.66 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.0 109.61 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.627 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 ttpt -129.99 108.34 10.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.457 -0.777 . . . . 0.0 109.396 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.582 HG13 ' CE1' ' A' ' 69' ' ' PHE . 1.3 mt -89.2 165.18 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -0.991 . . . . 0.0 109.377 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.8 m -144.93 91.08 2.11 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.714 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.7 162.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.364 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.454 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -61.09 -13.26 15.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.678 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.99 15.84 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.83 32.28 4.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.55 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -89.95 -175.9 4.74 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.235 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 77' ' ' GLN . 2.6 m-20 -141.8 146.6 36.1 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.414 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.493 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 80.6 m-70 -145.79 92.63 2.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.917 . . . . 0.0 109.871 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CZ ' ' CD ' ' A' ' 70' ' ' LYS . 36.1 m-85 -90.48 110.29 21.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 109.306 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.92 146.11 31.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.052 . . . . 0.0 109.698 179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 2.4 tt0 -113.06 139.54 48.6 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.471 -0.768 . . . . 0.0 108.948 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.93 -155.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.499 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.73 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.663 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.77 175.62 5.44 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 25.4 tp -56.41 -22.93 34.91 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.103 -0.998 . . . . 0.0 109.109 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -66.07 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.233 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -62.57 -16.88 58.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -0.871 . . . . 0.0 109.153 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.719 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -71.26 -64.04 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.254 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.561 ' HA ' HG22 ' A' ' 93' ' ' VAL . 10.4 t0 -62.01 -12.81 20.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.115 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.74 -30.93 28.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -0.987 . . . . 0.0 108.666 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.66 ' CH2' HG22 ' A' ' 26' ' ' VAL . 5.8 m95 -84.02 -28.72 27.47 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.1 m -75.28 -36.76 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.543 -0.723 . . . . 0.0 109.535 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 8.5 ptp180 -83.83 -24.72 30.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.5 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' HD11 ' A' ' 28' ' ' LEU . 12.6 t0 -77.14 -45.7 25.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.45 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.019 ' O ' HD12 ' A' ' 100' ' ' ILE . 32.1 mt -76.51 -42.32 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 0.0 109.48 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 28.1 t-20 -69.44 -31.46 69.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.5 tmtp? -75.37 -50.75 14.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.31 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -54.43 -42.23 70.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.37 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.019 HD12 ' O ' ' A' ' 96' ' ' ILE . 5.2 mt -70.23 -39.43 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.239 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -71.21 -11.64 61.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 109.322 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -95.25 -33.91 12.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 109.244 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.675 ' CG1' HD23 ' A' ' 50' ' ' LEU . 8.5 mm -67.82 -16.9 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 39.3 mt-10 -73.57 -2.99 25.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.293 -0.88 . . . . 0.0 109.517 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.97 17.51 0.93 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 102' ' ' CYS . 2.0 mm? -110.5 60.69 0.61 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.48 -1.012 . . . . 0.0 109.462 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -62.86 129.61 41.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 0.0 109.345 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -123.85 70.66 1.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 109.612 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.37 35.76 1.73 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.6 115.07 26.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 112' ' ' HIS . 0.3 OUTLIER 179.17 -154.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.501 ' O ' ' CB ' ' A' ' 113' ' ' HIS . 0.7 OUTLIER 67.42 -86.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 112' ' ' HIS . 20.2 t-80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.492 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.1 mt-10 60.33 162.04 0.1 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 0.0 109.445 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 56.0 Cg_endo -75.48 148.92 34.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.009 1.806 . . . . 0.0 110.357 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 9.1 mttm -113.48 96.95 6.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.844 . . . . 0.0 109.174 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER 69.38 136.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 109.251 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' OD1' ' A' ' 95' ' ' ASP . 28.2 mm -73.01 -59.79 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.928 . . . . 0.0 109.739 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 1.024 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.72 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.63 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.979 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -145.33 129.32 17.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.495 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.46 -146.95 4.76 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.728 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.9 p90 -135.89 99.84 4.27 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.744 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -115.11 153.79 30.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.984 HG23 ' C ' ' A' ' 22' ' ' LYS . 5.7 p -94.1 140.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.894 -1.129 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.74 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 11.3 mttp -123.07 169.7 10.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -84.92 113.58 21.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.37 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.29 153.99 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.14 -46.49 70.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -1.112 . . . . 0.0 109.507 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' PHE . 2.2 p -50.46 98.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 12.7 m-85 61.11 159.62 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 0.0 109.496 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -76.71 86.04 3.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.36 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.441 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 4.6 p -128.77 171.53 12.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.521 ' CH2' ' CB ' ' A' ' 80' ' ' PHE . 23.6 m95 -133.01 101.62 5.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.984 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.5 mttm -107.54 134.19 20.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.277 -0.89 . . . . 0.0 109.401 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.9 Cg_exo -54.35 147.77 44.93 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.644 1.563 . . . . 0.0 109.775 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.74 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 23.1 ptm -154.11 162.44 41.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.991 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.683 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.9 t-105 -94.79 147.91 22.84 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.6 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -151.52 138.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.491 -178.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.979 HG12 ' HB3' ' A' ' 8' ' ' GLU . 9.7 m -129.46 94.55 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.504 -0.748 . . . . 0.0 109.41 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.027 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -68.41 120.15 14.04 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.808 -1.182 . . . . 0.0 108.882 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 3.0 mp -102.62 164.83 11.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.56 -0.713 . . . . 0.0 109.372 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -71.63 -14.72 62.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.377 -0.827 . . . . 0.0 109.818 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -109.3 4.62 22.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.657 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' CD1' ' A' ' 29' ' ' LEU . . . 149.62 150.32 5.22 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.4 mp -92.5 121.11 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -1.173 . . . . 0.0 109.938 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.557 ' O ' HG22 ' A' ' 27' ' ' VAL . 10.3 mt-10 -116.75 107.94 15.27 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.625 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 12.9 p90 -117.68 145.64 44.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.953 -1.092 . . . . 0.0 110.686 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.646 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.44 -154.72 0.62 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' HB3' ' HD2' ' A' ' 38' ' ' LYS . 2.8 mtmt -91.95 -43.94 9.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 108.46 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -102.09 -170.9 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.355 -0.84 . . . . 0.0 108.743 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.683 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 mtpt -64.24 -10.04 21.06 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.787 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -150.99 -52.13 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 36' ' ' TYR . 4.2 t70 59.95 11.37 2.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.295 -0.878 . . . . 0.0 109.396 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.3 OUTLIER 41.89 22.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -176.76 99.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.789 -1.194 . . . . 0.0 110.747 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.57 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.1 Cg_exo -52.79 135.1 56.52 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.989 1.793 . . . . 0.0 110.525 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.55 -18.74 26.04 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -167.65 126.16 1.39 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 51.7 mtm -122.05 123.47 41.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -1.127 . . . . 0.0 109.594 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.918 HG23 HG22 ' A' ' 73' ' ' THR . 26.0 mt -89.82 132.81 35.43 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 109.005 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' CG ' ' HB ' ' A' ' 73' ' ' THR . 54.5 Cg_endo -72.11 129.7 15.51 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.681 1.587 . . . . 0.0 110.176 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.735 HD23 ' CG1' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -84.67 43.03 0.95 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 109.566 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.723 ' HB2' HG21 ' A' ' 74' ' ' THR . 8.5 mmtm -95.73 -71.43 0.67 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.922 . . . . 0.0 109.692 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -145.52 61.74 0.48 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.678 ' HB2' HD13 ' A' ' 100' ' ' ILE . 2.4 m -85.43 171.39 11.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -1.171 . . . . 0.0 109.325 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.71 172.06 8.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.404 -0.81 . . . . 0.0 109.455 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 56' ' ' THR . 3.2 tm? -133.96 136.41 44.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.27 -0.894 . . . . 0.0 108.74 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.792 ' N ' HD13 ' A' ' 55' ' ' LEU . 32.9 m -126.29 131.5 51.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.076 -1.015 . . . . 0.0 110.118 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.402 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 24.5 p -150.37 119.89 3.72 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.449 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.638 ' O ' HG22 ' A' ' 56' ' ' THR . 52.9 Cg_endo -71.95 -161.49 2.08 Favored 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.56 -1.85 . . . . 0.0 110.179 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -146.68 130.12 16.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 57.04 163.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -103.49 -12.03 17.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.915 . . . . 0.0 109.43 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -89.14 4.55 48.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 109.796 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -120.71 -19.48 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -49.65 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -144.1 -77.09 0.23 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.545 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -99.9 -39.86 7.96 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.5 0.667 . . . . 0.0 109.563 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CD1' ' HG3' ' A' ' 89' ' ' ARG . 0.4 OUTLIER 158.57 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -119.59 128.0 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 -179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.7 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 2.3 p90 -109.02 164.54 12.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.051 -1.031 . . . . 0.0 109.673 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.74 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -127.0 108.41 10.91 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.694 HD12 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mt -89.33 160.29 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.454 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 99.8 m -131.59 85.43 2.25 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 48' ' ' ILE . 6.9 p -44.13 158.14 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.015 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.723 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -58.71 -15.34 11.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 109.357 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -90.43 21.8 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.681 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 61.01 35.79 18.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.467 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -103.1 109.18 20.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.9 m-20 -76.08 146.64 39.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 39.4 m-70 -140.46 116.57 10.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.92 . . . . 0.0 109.66 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CB ' ' CH2' ' A' ' 21' ' ' TRP . 1.0 OUTLIER -98.54 128.49 44.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.7 ' CD1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.94 160.35 40.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.326 -0.859 . . . . 0.0 108.783 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -142.14 132.55 25.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.841 -1.162 . . . . 0.0 110.057 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -92.75 -84.47 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.582 -0.699 . . . . 0.0 109.625 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.503 ' O ' ' SD ' ' A' ' 66' ' ' MET . . . 179.16 -67.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 110.174 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -114.26 169.72 8.82 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.635 -0.665 . . . . 0.0 109.807 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -62.3 -19.74 63.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.42 -0.8 . . . . 0.0 109.591 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.985 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -71.28 -66.15 0.66 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.129 -0.982 . . . . 0.0 109.415 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.57 -16.54 64.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.264 -0.898 . . . . 0.0 109.28 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 1.052 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -74.02 -59.63 2.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.618 ' HA ' HG22 ' A' ' 93' ' ' VAL . 20.2 t70 -67.96 -14.72 63.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -82.03 -33.73 29.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.027 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 7.8 m95 -82.55 -25.87 32.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.052 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -79.96 -39.3 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.449 -0.782 . . . . 0.0 109.323 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.0 ptm180 -77.79 -23.93 49.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.689 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.5 t70 -81.61 -49.33 10.64 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.06 . . . . 0.0 109.506 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.781 HG13 HD22 ' A' ' 28' ' ' LEU . 32.5 mt -72.92 -31.25 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.332 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 6.1 t-20 -81.17 -36.02 30.69 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.393 -0.817 . . . . 0.0 109.775 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 3.2 ttpt -71.6 -37.81 70.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.639 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -68.22 -43.38 78.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.92 . . . . 0.0 109.149 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 53' ' ' SER . 60.0 mt -68.37 -30.47 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.163 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 5.4 mmtt -85.03 -10.9 56.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.376 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 42.0 t -94.11 -21.44 19.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.329 -0.857 . . . . 0.0 109.045 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.735 ' CG1' HD23 ' A' ' 50' ' ' LEU . 2.0 mm -75.51 -28.31 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.009 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -71.27 -5.54 33.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.17 11.69 5.85 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 106' ' ' LEU . 1.7 mt -101.22 57.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.486 -1.008 . . . . 0.0 109.25 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -120.72 19.51 11.83 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.704 -0.623 . . . . 0.0 109.595 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 5.6 t-80 -170.79 87.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 0.1 OUTLIER 171.07 122.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.19 84.95 7.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.946 . . . . 0.0 109.432 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 58.96 -170.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -58.53 2.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.403 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.475 ' OXT' ' ND1' ' A' ' 113' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.068 -0.967 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 3' ' ' PRO . 15.8 pt-20 -144.8 159.44 50.48 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.488 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 2' ' ' GLU . 53.1 Cg_exo -55.22 -143.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.213 1.942 . . . . 0.0 110.474 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 64.07 96.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.75 150.72 40.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.237 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.722 HD11 ' HG3' ' A' ' 30' ' ' GLU . 23.0 mm -56.19 -53.65 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.518 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.747 ' HB3' HD11 ' A' ' 28' ' ' LEU . 1.7 tpm_? -141.88 108.68 5.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.012 . . . . 0.0 110.207 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.983 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -119.99 131.23 55.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.987 -1.071 . . . . 0.0 109.189 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.4 -149.4 5.61 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.737 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.3 p90 -138.12 95.72 3.07 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.394 -1.062 . . . . 0.0 110.163 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.069 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -114.36 169.77 8.79 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -96.4 159.81 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.834 -1.166 . . . . 0.0 109.6 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.728 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.7 OUTLIER -148.75 130.17 14.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.88 . . . . 0.0 109.597 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' THR . 0.7 OUTLIER -50.73 150.9 2.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.414 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.06 -139.48 8.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.64 47.84 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -1.11 . . . . 0.0 109.511 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 17' ' ' VAL . 10.9 p -155.1 109.03 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' ASN . 25.1 m-85 58.52 22.0 9.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' PHE . 4.0 m-20 46.39 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.2 p -125.4 -179.29 4.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.595 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.683 ' CH2' HG21 ' A' ' 68' ' ' VAL . 39.0 m95 -144.97 88.44 1.89 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.204 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.475 ' O ' HG23 ' A' ' 12' ' ' VAL . 12.3 mttm -107.8 139.71 20.88 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 0.0 109.746 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.09 167.81 0.45 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.959 1.773 . . . . 0.0 110.598 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 25.6 ptm -174.8 158.43 2.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.89 . . . . 0.0 109.479 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.0 t-105 -89.79 147.17 23.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.413 -0.805 . . . . 0.0 109.03 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -151.61 133.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.666 -178.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.983 HG12 ' CB ' ' A' ' 8' ' ' GLU . 8.2 m -125.59 103.26 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.05 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.4 OUTLIER -86.89 108.97 19.01 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.129 -0.982 . . . . 0.0 109.631 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mp -90.75 164.26 14.17 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.848 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -73.64 -17.65 61.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.591 -179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.67 9.4 43.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.285 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 50' ' ' LEU . . . 152.23 -176.59 30.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG23 ' HA ' ' A' ' 28' ' ' LEU . 2.8 mp -138.16 125.81 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.064 -1.256 . . . . 0.0 109.528 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 4.3 pt-20 -132.23 116.77 17.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 108.929 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.635 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.1 p90 -119.49 147.54 44.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.13 -0.981 . . . . 0.0 110.083 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.631 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -133.77 -157.2 0.79 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -88.39 -55.66 3.64 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.48 -178.82 5.02 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -49.28 -21.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.898 -1.126 . . . . 0.0 109.562 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -146.63 -47.36 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.679 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' O ' ' A' ' 43' ' ' SER . 5.2 t0 62.29 9.9 3.53 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.555 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.8 t30 45.84 21.04 0.08 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.942 -1.099 . . . . 0.0 109.606 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.469 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.8 t -173.29 115.74 0.36 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.999 -1.063 . . . . 0.0 109.943 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.497 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.3 Cg_endo -72.35 132.27 19.0 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.922 1.748 . . . . 0.0 110.593 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -89.62 -19.65 24.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . -167.58 120.66 0.92 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.0 mtm -119.28 125.58 49.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.118 -1.225 . . . . 0.0 109.84 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.548 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 mt -90.78 121.53 68.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.278 -0.889 . . . . 0.0 108.995 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.76 140.14 38.29 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.719 1.613 . . . . 0.0 110.307 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -84.9 37.82 0.68 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.864 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 -70.09 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.132 -0.98 . . . . 0.0 109.375 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' THR . . . -136.33 24.71 3.21 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -40.09 141.39 0.47 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.441 -1.035 . . . . 0.0 110.383 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -112.47 167.26 10.6 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.763 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.2 tm? -137.66 117.38 13.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.985 -1.072 . . . . 0.0 109.449 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.854 HG22 ' O ' ' A' ' 58' ' ' PRO . 23.2 m -107.96 135.54 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.909 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -150.35 120.94 3.86 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.878 . . . . 0.0 109.239 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.854 ' O ' HG22 ' A' ' 56' ' ' THR . 55.5 Cg_endo -72.91 -161.14 2.11 Favored 'Cis proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.651 -1.812 . . . . 0.0 110.346 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.708 ' SG ' ' N ' ' A' ' 63' ' ' GLY . 9.2 p -102.93 -148.44 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.899 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.61 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 11.2 tt0 -71.6 -142.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.297 -0.877 . . . . 0.0 109.92 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -68.07 -2.23 7.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.902 . . . . 0.0 109.677 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.57 ' HB3' HG11 ' A' ' 68' ' ' VAL . 24.9 m-85 -88.99 -24.71 22.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 108.948 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.708 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -74.39 -49.14 12.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -19.83 6.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.392 -1.063 . . . . 0.0 109.189 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -75.48 0.34 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.56 -155.62 0.58 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.594 -0.691 . . . . 0.0 109.553 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.445 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 25.0 m-85 -97.52 86.66 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.683 HG21 ' CH2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -126.64 136.3 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.339 -0.851 . . . . 0.0 109.539 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.621 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.69 175.62 5.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.694 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 13.9 ttpt -142.67 100.74 3.73 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.898 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 54' ' ' THR . 12.6 mt -90.12 160.41 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 108.995 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 53.2 m -140.71 105.36 4.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.91 . . . . 0.0 109.349 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.612 HG23 ' H ' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -48.67 107.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.308 -0.87 . . . . 0.0 110.298 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER 39.55 28.94 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 178.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' THR . 5.5 tttt 82.73 46.0 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.979 -1.076 . . . . 0.0 109.2 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -133.44 -86.71 0.43 Allowed 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.079 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.612 ' H ' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -90.9 136.84 32.81 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.645 -0.659 . . . . 0.0 109.669 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -89.29 168.26 12.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -148.04 98.41 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.156 -0.965 . . . . 0.0 109.385 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 0.5 OUTLIER -96.04 119.6 34.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.357 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -137.01 167.99 20.45 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.05 -1.031 . . . . 0.0 109.061 179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.607 ' HB3' HG13 ' A' ' 12' ' ' VAL . 34.7 tt0 -135.12 138.03 43.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.704 -1.248 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.14 -89.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.426 -0.796 . . . . 0.0 109.44 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.25 -49.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.601 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.07 171.31 14.6 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' CD1' ' NH2' ' A' ' 89' ' ' ARG . 24.1 tp -53.65 -42.81 68.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.199 -0.938 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -53.07 -59.27 4.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 109.542 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.23 -15.12 62.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.277 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 1.021 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -71.99 -65.22 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.546 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -69.56 -11.19 60.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.311 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.52 -41.06 24.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.239 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.069 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.3 m95 -79.19 -28.56 42.64 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.335 -0.853 . . . . 0.0 109.165 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.021 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -71.24 -39.05 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.347 -0.846 . . . . 0.0 109.095 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -77.43 -23.03 50.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -76.74 -52.05 10.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.691 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.051 ' O ' HD12 ' A' ' 100' ' ' ILE . 47.8 mt -73.03 -31.92 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 18.7 t-20 -78.1 -28.65 48.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.169 -0.957 . . . . 0.0 109.331 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.9 -42.29 49.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.11 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.598 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.2 -36.35 83.78 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.307 -0.871 . . . . 0.0 108.822 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.051 HD12 ' O ' ' A' ' 96' ' ' ILE . 4.9 mt -76.04 -31.47 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.127 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.1 OUTLIER -83.08 -12.35 57.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.197 -0.939 . . . . 0.0 109.52 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 11.1 m -93.49 -28.39 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 0.0 108.931 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 30' ' ' GLU . 2.6 tp -64.97 -33.18 61.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.418 -0.801 . . . . 0.0 109.326 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.92 -12.55 61.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.25 6.62 25.04 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.82 54.34 2.64 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.435 -1.038 . . . . 0.0 109.117 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -107.56 120.77 43.12 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -142.96 39.36 1.47 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.434 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 111' ' ' HIS . 0.2 OUTLIER -64.76 -160.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 51.9 -90.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 109' ' ' HIS . 2.7 m-70 -69.64 103.3 2.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.299 -0.876 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -92.18 114.12 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.538 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.593 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 2.3 mm-40 173.65 -61.94 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.196 -0.94 . . . . 0.0 109.696 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 53.7 Cg_endo -71.57 134.97 25.3 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.712 1.608 . . . . 0.0 110.243 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' O ' ' OE2' ' A' ' 8' ' ' GLU . 12.5 mmtt -101.22 73.58 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.299 -0.876 . . . . 0.0 109.275 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER 64.15 136.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.562 HD11 ' HB3' ' A' ' 30' ' ' GLU . 34.3 mt -56.22 -67.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 1.017 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -116.89 148.86 40.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.687 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.028 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -157.6 134.33 9.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.592 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.67 -149.0 5.45 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.028 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -138.48 91.38 2.54 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.379 -1.071 . . . . 0.0 110.099 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.028 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.11 165.3 14.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.745 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.677 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.4 p -85.58 131.47 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 109.198 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.623 ' HE2' HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -131.14 152.11 50.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -70.4 125.94 28.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 109.265 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 178.82 120.46 0.66 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 163.74 -84.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.26 -1.141 . . . . 0.0 109.377 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 18' ' ' PHE . 1.5 p -140.37 -47.07 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.24 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.548 ' O ' HG23 ' A' ' 20' ' ' THR . 4.0 p90 -140.01 -172.97 3.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.418 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 18.3 p-10 -47.49 92.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 18' ' ' PHE . 59.2 p -130.07 155.57 45.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.261 -0.9 . . . . 0.0 109.786 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.896 ' CH2' HG21 ' A' ' 68' ' ' VAL . 2.0 m0 -126.67 119.75 27.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.452 -0.78 . . . . 0.0 109.389 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.677 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -149.06 131.86 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.0 109.815 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.6 Cg_exo -53.36 150.75 25.25 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.751 1.634 . . . . 0.0 109.751 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.629 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 11.6 ptm -168.98 165.83 11.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.066 . . . . 0.0 110.202 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.8 t-105 -89.94 145.89 24.79 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -151.04 136.07 10.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.118 -178.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.028 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.0 m -125.72 103.63 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.441 -0.787 . . . . 0.0 109.329 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.017 HD21 ' CB ' ' A' ' 7' ' ' ARG . 0.8 OUTLIER -77.59 112.25 14.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.19 -0.944 . . . . 0.0 109.118 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.744 HD12 ' H ' ' A' ' 29' ' ' LEU . 1.8 mp -89.54 159.75 17.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.447 -0.783 . . . . 0.0 109.496 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.562 ' HB3' HD11 ' A' ' 6' ' ' ILE . 7.7 pt-20 -70.75 -15.35 62.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.171 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HA ' HD11 ' A' ' 103' ' ' ILE . 0.7 OUTLIER -112.56 6.8 18.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.075 -1.016 . . . . 0.0 109.687 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.955 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 167.45 -165.81 38.88 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.984 HG21 HD12 ' A' ' 48' ' ' ILE . 1.9 mp -144.85 121.99 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -1.097 . . . . 0.0 109.186 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 8.9 mt-10 -127.56 115.02 18.17 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.344 -0.848 . . . . 0.0 108.92 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.668 ' HB3' HG23 ' A' ' 26' ' ' VAL . 8.3 p90 -121.45 145.77 47.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 109.982 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -130.62 -167.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 109.119 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -80.22 -40.87 26.23 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -113.06 -176.14 2.83 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.76 -24.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.84 -1.162 . . . . 0.0 109.184 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.6 -49.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' ' O ' ' A' ' 43' ' ' SER . 4.8 t70 61.38 10.97 3.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.373 -0.829 . . . . 0.0 109.383 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 27.1 m120 43.96 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.971 -1.08 . . . . 0.0 109.546 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.476 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 2.2 t -170.89 103.13 0.41 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 109.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.505 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 55.6 Cg_endo -72.25 145.14 43.03 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.709 1.606 . . . . 0.0 110.516 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -89.96 -26.15 20.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 108.938 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.81 147.52 11.35 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.9 mtt -134.1 125.73 28.59 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.492 -1.005 . . . . 0.0 109.159 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.984 HD12 HG21 ' A' ' 33' ' ' ILE . 3.0 mt -89.74 137.06 28.71 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.209 -0.932 . . . . 0.0 109.007 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 51.7 Cg_endo -70.81 147.61 56.5 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.707 1.605 . . . . 0.0 110.284 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.028 HD12 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -88.21 24.24 1.92 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.872 . . . . 0.0 109.493 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' ILE . 8.5 tttm -157.02 114.17 3.09 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.106 -0.996 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 96.58 32.84 6.41 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.476 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.451 ' OG ' HG12 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -109.48 172.12 7.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.045 -1.268 . . . . 0.0 109.284 179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.92 110.98 6.29 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.056 -1.027 . . . . 0.0 109.95 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.76 ' C ' HD13 ' A' ' 55' ' ' LEU . 3.4 tm? -89.02 130.66 35.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.155 -0.965 . . . . 0.0 109.015 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.748 ' N ' HD13 ' A' ' 55' ' ' LEU . 7.6 m -113.43 100.54 8.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.27 -0.894 . . . . 0.0 109.363 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 55' ' ' LEU . 79.1 p -133.51 129.19 20.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.08 -1.012 . . . . 0.0 109.747 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 60.9 Cg_endo -78.95 179.71 29.61 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.696 -1.793 . . . . 0.0 110.128 -0.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 41.6 t -105.42 170.84 7.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 108.687 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.566 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 4.6 mm100 -147.76 143.8 27.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.896 -1.127 . . . . 0.0 110.282 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 6.5 t70 84.17 -54.02 0.13 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.15 0.5 . . . . 0.0 109.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -94.64 -55.25 3.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.142 -0.974 . . . . 0.0 108.437 179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' HG11 ' A' ' 68' ' ' VAL . . . -91.81 34.76 4.23 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HE2' ' HG2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -65.99 -9.31 29.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.611 -0.934 . . . . 0.0 109.542 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 66' ' ' MET . 5.8 mtm180 -76.98 -3.09 37.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.938 . . . . 0.0 109.509 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.527 ' CB ' ' O ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER 76.96 171.65 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.842 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER 54.05 20.59 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.437 -0.789 . . . . 0.0 109.786 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.896 HG21 ' CH2' ' A' ' 21' ' ' TRP . 3.3 p -140.41 134.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 0.0 109.89 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.754 ' CD2' HG12 ' A' ' 93' ' ' VAL . 8.2 p90 -117.22 -179.77 3.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' CD ' ' CE2' ' A' ' 80' ' ' PHE . 2.8 ttpt -133.71 111.29 10.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.551 HG13 ' CE1' ' A' ' 69' ' ' PHE . 9.9 mt -89.29 165.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 109.066 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.9 m -144.93 90.14 2.03 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.894 HG22 HG23 ' A' ' 48' ' ' ILE . 4.3 p -50.8 161.16 0.38 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.415 -0.803 . . . . 0.0 109.191 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -54.63 -17.19 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.815 . . . . 0.0 109.819 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -88.43 24.1 2.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 56.13 30.51 16.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.423 ' HB3' ' NE2' ' A' ' 79' ' ' HIS . 2.1 tm0? -95.96 100.74 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 56.3 m-20 -69.91 152.78 44.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.871 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 97.7 m-70 -150.1 101.39 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.135 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.619 ' CE2' ' CD ' ' A' ' 70' ' ' LYS . 8.4 m-85 -90.98 124.95 35.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.647 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.71 ' CE2' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.92 140.59 38.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.128 -0.983 . . . . 0.0 109.404 179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 3.7 tt0 -113.15 136.82 52.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.511 -0.743 . . . . 0.0 109.128 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' LEU . . . -88.88 -92.54 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.425 -0.797 . . . . 0.0 109.436 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.667 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -145.18 -39.89 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 0.0 109.94 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.667 ' CE1' ' HB1' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -159.32 175.81 12.92 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.51 -0.743 . . . . 0.0 109.734 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.006 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -51.6 -50.09 60.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.57 -0.706 . . . . 0.0 109.56 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.006 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -49.64 -67.5 0.26 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.107 -0.995 . . . . 0.0 110.1 -178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.76 -13.82 17.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 1.033 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.76 -62.25 1.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 0.0 109.694 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.608 ' HA ' HG22 ' A' ' 93' ' ' VAL . 6.8 t70 -64.33 -14.86 58.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.208 -0.932 . . . . 0.0 109.574 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -79.54 -46.83 16.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 108.959 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.725 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.4 m95 -71.31 -27.92 63.74 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.436 -0.79 . . . . 0.0 109.223 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.033 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.7 m -78.64 -38.43 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.378 -0.826 . . . . 0.0 109.827 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -74.42 -19.37 60.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.179 -0.951 . . . . 0.0 109.996 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -86.33 -54.26 4.54 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.053 -1.029 . . . . 0.0 109.594 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.787 HG13 HD22 ' A' ' 28' ' ' LEU . 11.6 mt -66.98 -33.36 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 0.0 108.393 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.503 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 25.6 t-20 -76.17 -44.62 37.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.391 -0.818 . . . . 0.0 109.45 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -63.76 -27.98 69.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 108.98 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.66 -51.46 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.181 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.804 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -57.44 -51.52 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.01 -17.35 62.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 109.345 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 44.7 t -81.85 -30.23 32.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.055 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.028 HD13 HD12 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -65.43 -38.31 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 108.867 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -12.43 59.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.264 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.68 7.89 12.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 mt -101.88 57.85 0.83 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.364 -1.08 . . . . 0.0 108.953 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -95.73 27.26 3.57 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.647 -0.658 . . . . 0.0 109.643 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -82.13 85.33 6.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.365 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -145.59 36.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.245 -0.909 . . . . 0.0 109.569 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -93.13 104.94 17.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -153.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.55 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -175.14 94.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.828 . . . . 0.0 109.415 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.389 -179.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' SD ' ' OE1' ' A' ' 2' ' ' GLU . 8.4 tmm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.318 0.58 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' OE1' ' SD ' ' A' ' 1' ' ' MET . 6.6 pt-20 -141.02 156.21 68.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 2' ' ' GLU . 52.5 Cg_exo -50.59 -176.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.01 1.806 . . . . 0.0 110.205 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 78.8 mttt -93.18 74.82 4.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.525 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 64.66 143.07 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' HD12 ' A' ' 28' ' ' LEU . 46.1 mm -51.48 -74.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.358 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.925 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.85 142.45 46.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 109.201 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.991 ' CB ' HG12 ' A' ' 27' ' ' VAL . 3.6 pm0 -149.74 132.14 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.024 -1.048 . . . . 0.0 110.162 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.69 -144.03 3.83 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.847 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.7 p90 -144.67 104.56 4.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.977 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.033 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.05 179.07 4.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.216 -0.927 . . . . 0.0 108.753 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.825 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -114.04 125.42 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.765 ' HG3' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -107.46 142.97 36.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.201 -0.937 . . . . 0.0 110.014 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -87.15 112.36 21.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.407 -0.808 . . . . 0.0 109.406 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.62 39.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.451 ' OG ' ' HD2' ' A' ' 22' ' ' LYS . 8.5 t -79.54 -50.97 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.279 -1.13 . . . . 0.0 109.392 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 18' ' ' PHE . 4.2 m -148.2 -46.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.456 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -136.23 -78.13 0.42 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.211 -0.931 . . . . 0.0 109.425 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 14' ' ' LYS . 8.1 m-20 -137.89 70.39 1.39 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.294 -0.878 . . . . 0.0 109.074 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 5.3 p -127.2 155.95 42.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.285 -0.884 . . . . 0.0 110.047 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.632 ' HH2' HG23 ' A' ' 68' ' ' VAL . 47.3 m95 -117.94 98.2 6.21 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.204 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.825 ' C ' HG23 ' A' ' 12' ' ' VAL . 17.3 mttm -110.87 133.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.907 . . . . 0.0 109.711 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.5 Cg_exo -53.35 172.76 0.2 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.942 1.761 . . . . 0.0 110.541 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.765 ' SD ' ' HG3' ' A' ' 13' ' ' LYS . 9.2 ptm 176.03 162.45 0.34 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.566 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.601 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 66.6 t-105 -89.3 151.11 22.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.894 HG11 HD22 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -150.85 146.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.147 -178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.991 HG12 ' CB ' ' A' ' 8' ' ' GLU . 11.1 m -145.29 106.61 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.556 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.925 HD21 ' CB ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -78.82 116.39 19.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.465 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.2 mp -104.33 167.27 9.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.675 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.702 ' O ' HD13 ' A' ' 103' ' ' ILE . 5.7 pt-20 -73.67 -17.78 61.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.889 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.1 p30 -101.35 8.73 42.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 1.106 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 140.22 148.31 5.14 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.667 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.3 mp -94.73 109.01 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -1.166 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 29' ' ' LEU . 7.1 pt-20 -111.12 123.76 50.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 108.856 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 3.4 p90 -121.26 142.8 49.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -0.982 . . . . 0.0 110.29 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.593 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -119.5 -151.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.43 -0.794 . . . . 0.0 109.031 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 -39.22 9.05 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -119.87 -176.04 3.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.4 OUTLIER -43.12 -25.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.024 -1.048 . . . . 0.0 109.567 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -146.57 -53.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 43' ' ' SER . 1.2 t70 62.98 7.67 2.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.453 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.5 m-80 40.6 23.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -164.72 101.49 0.83 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.791 -1.193 . . . . 0.0 110.377 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.5 Cg_exo -51.78 164.07 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.055 1.837 . . . . 0.0 110.702 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 3.1 tppt? -134.52 3.45 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' O ' ' CZ ' ' A' ' 35' ' ' PHE . . . 156.18 134.57 1.83 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 1.3 mtt -135.15 138.16 43.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -1.171 . . . . 0.0 109.648 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.5 mt -104.73 125.82 32.9 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.188 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' HG2' ' OG1' ' A' ' 73' ' ' THR . 53.2 Cg_endo -71.39 130.56 17.54 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 121.665 1.577 . . . . 0.0 110.114 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.106 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -74.88 -0.34 18.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.168 -0.957 . . . . 0.0 109.609 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HB2' HG21 ' A' ' 74' ' ' THR . 1.1 mmtp -44.0 -62.28 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.594 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.53 57.94 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.7 m -81.21 170.21 16.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 109.169 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -122.89 160.52 25.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 55' ' ' LEU . 3.0 tm? -134.72 96.14 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.081 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.634 HG22 ' SG ' ' A' ' 59' ' ' CYS . 85.7 m -90.19 109.36 20.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.542 ' OG ' HD11 ' A' ' 55' ' ' LEU . 11.1 p -146.41 142.28 17.29 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.385 -0.822 . . . . 0.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.15 -176.11 17.55 Favored 'Cis proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.336 -1.943 . . . . 0.0 110.54 -0.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 56' ' ' THR . 4.8 m -150.28 60.27 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.285 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.532 ' CG ' ' HA ' ' A' ' 64' ' ' LYS . 5.5 tt0 -71.12 124.26 24.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.822 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 1.6 m-20 166.49 -43.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -88.97 -68.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 64' ' ' LYS . . . -81.42 -26.94 49.96 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HA ' ' CG ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER 34.41 39.21 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.452 0.644 . . . . 0.0 110.015 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 ttt-85 -117.99 -137.49 0.35 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.458 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.9 mtt -42.51 -92.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.01 . . . . 0.0 109.662 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.61 ' CD1' ' CD ' ' A' ' 89' ' ' ARG . 2.1 m-85 -142.21 111.18 6.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 109.406 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.632 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -120.66 119.95 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.833 . . . . 0.0 109.653 -179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.5 p90 -118.14 168.33 10.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HE2' HG21 ' A' ' 56' ' ' THR . 5.9 pttt -127.91 121.42 29.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 55' ' ' LEU . 9.0 mt -96.1 161.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 108.98 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.555 ' N ' HG22 ' A' ' 54' ' ' THR . 50.4 m -140.27 99.58 3.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.242 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.457 ' OG1' ' HG2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -52.89 155.63 2.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.935 . . . . 0.0 109.361 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.626 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -41.2 -27.56 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.729 -0.607 . . . . 0.0 109.819 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 73' ' ' THR . 2.0 mmmm -77.63 -93.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 109.62 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 177.6 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.158 -0.964 . . . . 0.0 109.516 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -103.17 72.0 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.076 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 5.7 p-10 -43.51 141.72 1.34 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 109.752 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -127.17 137.73 53.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.09 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 14' ' ' LYS . 40.8 m-85 -93.46 128.95 39.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 1.033 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.8 t80 -129.86 139.44 51.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.558 -0.714 . . . . 0.0 109.366 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.57 ' CB ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.27 119.86 13.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.05 -150.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.959 . . . . 0.0 109.457 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.819 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -120.27 -26.01 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.002 . . . . 0.0 110.054 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -156.18 175.55 13.84 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.346 -0.846 . . . . 0.0 109.871 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.3 -60.48 3.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.504 -0.747 . . . . 0.0 110.249 -179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.072 ' N ' HD13 ' A' ' 86' ' ' LEU . 3.6 tm-20 -46.33 -56.65 5.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.219 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 33.2 tt0 -58.4 -30.52 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.673 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.787 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.926 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.558 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -54.7 -23.26 16.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.939 . . . . 0.0 110.06 -179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.06 -35.75 59.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.093 -1.004 . . . . 0.0 109.583 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CE2' HD21 ' A' ' 11' ' ' LEU . 13.0 m95 -76.36 -41.23 48.83 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.323 -0.861 . . . . 0.0 109.497 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -75.37 -28.1 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.797 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.539 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.1 ptm180 -76.83 -30.02 56.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 109.996 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' CB ' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -90.43 -30.65 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 110.039 -179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 HG13 ' CB ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -72.48 -31.22 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.005 -1.06 . . . . 0.0 108.518 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.3 OUTLIER -85.42 -36.5 20.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.808 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -66.82 -47.16 72.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.0 109.096 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.84 -37.16 83.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.348 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.876 HG12 HD23 ' A' ' 50' ' ' LEU . 46.6 mt -71.94 -23.9 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.348 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -89.96 -15.04 32.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.502 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 t -95.42 -26.4 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.464 -0.773 . . . . 0.0 109.337 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.702 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.2 tp -76.58 -21.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' OE1' ' O ' ' A' ' 51' ' ' LYS . 1.8 mm-40 -67.03 -11.48 57.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.286 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.81 5.22 12.75 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -105.35 58.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.416 -1.049 . . . . 0.0 109.16 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.99 163.14 12.72 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.655 -0.653 . . . . 0.0 109.548 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 94.12 2.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.222 -0.924 . . . . 0.0 109.433 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -46.22 131.88 10.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.492 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' HIS . 6.3 t-160 -128.06 50.83 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.197 -0.939 . . . . 0.0 109.449 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.421 ' C ' ' O ' ' A' ' 110' ' ' HIS . 37.0 m80 44.2 43.01 5.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.933 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -86.73 51.0 2.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.5 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.3 mm-40 -64.33 162.85 29.55 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.411 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 53.5 Cg_exo -50.93 163.98 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.973 1.782 . . . . 0.0 110.111 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -146.52 73.44 1.32 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.586 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.516 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -96.28 146.01 25.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.324 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 mt -78.26 -46.4 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.62 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.746 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -128.36 138.43 52.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.905 . . . . 0.0 109.66 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.004 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -156.06 133.89 11.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.253 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.583 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.02 -146.13 4.63 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' C ' HD13 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -131.83 97.03 4.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -1.015 . . . . 0.0 110.053 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.045 HD23 ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -108.65 172.69 6.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 108.57 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.945 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.4 p -117.77 125.3 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.879 -1.138 . . . . 0.0 109.402 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.752 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 7.6 mmtp -95.53 159.9 14.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 109.695 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 15.1 ttpp -85.95 94.45 9.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.485 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -44.67 141.29 3.72 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 17' ' ' VAL . 22.8 t -102.21 108.08 19.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -1.139 . . . . 0.0 109.534 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 16' ' ' SER . 2.6 p 172.19 -30.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.376 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -166.72 36.93 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.323 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.84 68.22 0.89 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.371 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.573 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.6 p -117.95 169.72 9.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 109.701 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.62 ' HH2' HG23 ' A' ' 68' ' ' VAL . 10.7 m95 -148.09 100.37 3.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.945 ' C ' HG23 ' A' ' 12' ' ' VAL . 19.1 mttt -118.93 136.35 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.839 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.9 Cg_exo -53.99 176.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 121.833 1.689 . . . . 0.0 109.975 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 19.5 ptm 176.74 159.96 0.36 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.301 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.7 t-105 -89.54 146.69 24.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.32 134.28 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.097 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.4 m -128.72 98.66 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.59 -0.693 . . . . 0.0 109.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.05 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 4.0 pp -77.55 123.62 26.84 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.09 -1.006 . . . . 0.0 109.081 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 32' ' ' GLY . 2.0 mp -109.35 165.16 11.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.82 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.567 ' O ' HD22 ' A' ' 50' ' ' LEU . 1.9 tm-20 -74.87 -9.28 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.5 p30 -112.32 7.92 19.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.225 -0.922 . . . . 0.0 108.925 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.782 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 145.06 147.08 4.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.0 mp -103.15 120.59 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.225 -1.162 . . . . 0.0 109.861 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' HG3' ' OH ' ' A' ' 36' ' ' TYR . 2.6 pt-20 -120.07 121.94 39.98 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.675 ' HB3' HG23 ' A' ' 26' ' ' VAL . 10.6 p90 -125.55 141.24 52.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.096 -1.003 . . . . 0.0 110.405 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.629 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.86 -145.62 0.34 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 24' ' ' MET . 2.6 mmtm -99.16 -39.18 8.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.076 -1.015 . . . . 0.0 109.349 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -119.42 -178.27 3.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.269 -0.895 . . . . 0.0 109.09 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 6.8 tppt? -43.21 -30.8 0.52 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 108.708 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.448 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -165.29 72.48 0.18 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.515 -0.741 . . . . 0.0 109.49 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.6 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 1.6 t0 -51.39 -18.85 1.13 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.6 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 8.6 t-20 91.48 -18.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -127.69 106.3 20.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 42.6 Cg_endo -68.79 134.39 29.97 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 121.726 1.618 . . . . 0.0 110.652 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -25.74 20.7 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' C ' ' CZ ' ' A' ' 35' ' ' PHE . . . -165.51 145.01 9.72 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -128.65 -168.52 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -1.073 . . . . 0.0 109.407 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.63 HG23 HG22 ' A' ' 73' ' ' THR . 3.5 mt -150.31 111.16 3.24 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 109.238 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.31 131.29 23.04 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.58 1.52 . . . . 0.0 110.355 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.782 HD13 ' HA2' ' A' ' 32' ' ' GLY . 5.4 mp -84.46 41.2 0.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.361 -0.837 . . . . 0.0 109.713 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -99.15 -40.07 8.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.641 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.15 76.22 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.526 ' HB2' HD13 ' A' ' 100' ' ' ILE . 6.2 m -105.41 165.86 10.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.276 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.629 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -115.02 171.76 7.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.334 -0.854 . . . . 0.0 109.647 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.4 tm? -143.51 119.61 10.74 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.389 -0.819 . . . . 0.0 108.895 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 1.043 HG22 ' O ' ' A' ' 58' ' ' PRO . 20.7 m -114.42 139.1 49.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.101 -0.999 . . . . 0.0 110.345 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER -150.51 118.06 3.49 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.386 -0.821 . . . . 0.0 109.086 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.043 ' O ' HG22 ' A' ' 56' ' ' THR . 46.2 Cg_endo -70.21 -160.05 1.41 Allowed 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.562 -1.849 . . . . 0.0 110.399 0.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -117.14 -78.54 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.239 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.806 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -134.12 -159.94 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.048 -1.033 . . . . 0.0 110.25 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -83.54 14.24 3.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.294 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' HB3' ' CZ2' ' A' ' 21' ' ' TRP . 16.6 m-85 -88.5 86.86 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . 88.35 41.92 6.01 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 4.5 pttt -37.72 111.44 0.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.85 -0.794 . . . . 0.0 110.042 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER 178.26 -78.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.46 -0.775 . . . . 0.0 109.12 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.771 ' SD ' ' HB2' ' A' ' 86' ' ' LEU . 22.4 ptp 171.93 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.678 0.751 . . . . 0.0 109.363 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HA ' ' CB ' ' A' ' 89' ' ' ARG . 2.2 m-85 -60.09 -21.79 61.94 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.55 -0.719 . . . . 0.0 109.94 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.62 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.1 p -94.65 105.85 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -99.93 170.78 8.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.682 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -140.24 103.28 4.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.682 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 72' ' ' THR . 14.3 mt -90.54 165.48 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.629 ' CB ' HG22 ' A' ' 54' ' ' THR . 59.1 m -141.52 87.78 2.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.63 HG22 HG23 ' A' ' 48' ' ' ILE . 1.8 p -47.35 160.2 0.11 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.134 -0.979 . . . . 0.0 108.841 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.43 -13.67 14.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.706 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' OE1' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.25 20.45 6.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.94 29.22 16.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.3 OUTLIER -92.45 98.49 11.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.234 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 78' ' ' ASP . 5.6 p30 -68.5 135.4 51.54 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 0.0 109.791 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.0 m-70 -140.07 95.69 2.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.398 -0.814 . . . . 0.0 108.837 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -109.72 135.59 50.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 0.0 110.144 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 1.045 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -149.99 159.23 44.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.778 . . . . 0.0 109.361 179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.546 ' CG ' ' HB2' ' A' ' 67' ' ' PHE . 6.8 tt0 -114.04 138.08 50.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.402 -0.811 . . . . 0.0 109.46 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -139.49 0.13 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.944 . . . . 0.0 109.269 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -118.48 -7.82 10.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.897 -1.127 . . . . 0.0 110.056 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -168.11 175.64 6.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.16 -0.963 . . . . 0.0 109.751 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.968 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -72.74 -37.17 67.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 109.236 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.968 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -60.21 -49.18 78.64 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.043 -1.036 . . . . 0.0 109.712 -179.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -72.96 -33.53 65.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 110.099 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 1.047 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.43 -39.1 92.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.112 -0.992 . . . . 0.0 109.411 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.705 ' HA ' HG22 ' A' ' 93' ' ' VAL . 13.5 t0 -78.88 -20.03 50.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -0.994 . . . . 0.0 108.614 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -76.94 -26.87 54.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.05 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 26.8 m95 -85.52 -37.85 19.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.047 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.9 m -71.32 -37.74 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.615 -0.678 . . . . 0.0 110.113 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 7.1 ptt180 -80.89 -30.93 35.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 110.226 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 5.4 t0 -75.06 -41.43 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.019 -1.051 . . . . 0.0 109.914 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.637 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.2 mt -75.08 -32.96 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 109.334 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 58.8 t-20 -75.25 -32.05 60.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.277 -0.889 . . . . 0.0 109.601 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -75.5 -45.13 40.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -0.959 . . . . 0.0 109.103 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -58.11 -43.05 86.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.842 . . . . 0.0 109.141 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 96' ' ' ILE . 17.0 mt -70.09 -37.76 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.183 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 0.0 OUTLIER -72.31 -10.57 59.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.457 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.79 -38.99 12.03 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 50' ' ' LEU . 4.0 mm -65.32 -40.32 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' CD ' ' O ' ' A' ' 51' ' ' LYS . 2.4 mt-10 -68.96 -7.6 36.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -130.09 11.37 5.89 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 2.3 mt -97.4 56.76 1.36 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.401 -1.058 . . . . 0.0 109.114 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.51 100.23 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.736 -0.603 . . . . 0.0 109.484 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -113.03 -179.11 3.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.339 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -77.59 92.27 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.154 -0.966 . . . . 0.0 109.456 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -51.09 100.47 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.614 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -92.84 7.42 43.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -68.63 139.29 55.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.408 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 3' ' ' PRO . 28.9 mm-40 -100.62 161.2 24.68 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.196 -0.94 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' GLU . 51.1 Cg_exo -51.65 -167.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.165 1.91 . . . . 0.0 110.508 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -111.57 92.66 4.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.41 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.679 ' HG3' HD21 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -43.7 157.21 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 109.782 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' A' ' 30' ' ' GLU . 85.9 mt -76.32 -58.5 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 0.0 109.646 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.739 ' HB3' HD11 ' A' ' 28' ' ' LEU . 4.9 tpm_? -133.34 111.89 11.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.941 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.035 ' HB3' HG12 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -118.31 132.5 56.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.054 -1.029 . . . . 0.0 109.417 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.42 -147.69 4.97 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.952 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.3 p90 -141.38 96.62 3.02 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.322 -1.105 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.971 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -121.51 176.42 5.69 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.907 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -103.06 147.5 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.036 -1.04 . . . . 0.0 109.569 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.695 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 26.8 mmtt -118.64 179.82 4.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 3.6 tttt -133.41 64.1 1.62 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.616 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -157.39 131.63 2.96 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 12.6 t 169.54 -90.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -1.134 . . . . 0.0 109.437 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 4.2 p -100.79 -30.75 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.555 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 4.8 m-85 -174.73 176.78 2.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' HA ' ' CE ' ' A' ' 14' ' ' LYS . 25.0 p-10 -45.61 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 36.9 p -142.95 -176.83 5.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.652 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.727 ' CH2' HG23 ' A' ' 68' ' ' VAL . 56.5 m95 -156.13 105.55 2.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.426 -0.796 . . . . 0.0 109.143 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.907 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -137.6 135.16 18.84 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.495 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.5 Cg_exo -51.65 166.87 0.48 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.954 1.769 . . . . 0.0 110.461 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 13.1 ptm 178.04 165.36 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.248 -0.907 . . . . 0.0 109.729 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.3 t-105 -90.15 145.16 25.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -150.97 135.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.702 -178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.035 HG12 ' HB3' ' A' ' 8' ' ' GLU . 8.8 m -125.5 103.2 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -82.44 117.11 22.23 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.947 -1.095 . . . . 0.0 109.972 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.679 HD21 ' HG3' ' A' ' 5' ' ' ARG . 2.0 mp -105.35 166.33 10.49 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.662 ' CG ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -74.45 -17.61 60.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 0.0 109.435 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -97.39 8.47 44.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.727 ' HA2' HD12 ' A' ' 50' ' ' LEU . . . 139.43 152.13 5.82 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 50' ' ' LEU . 2.8 mp -101.27 118.55 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.196 -1.179 . . . . 0.0 109.655 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 17.8 pt-20 -117.97 116.15 26.34 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 26' ' ' VAL . 1.8 p90 -116.12 150.62 37.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.054 -1.029 . . . . 0.0 110.594 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -128.6 -153.66 0.58 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -41.38 9.06 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.0 mttt -115.7 -172.26 2.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 6.1 tppt? -44.85 -25.36 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.983 -1.073 . . . . 0.0 109.288 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -154.83 -47.07 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.989 . . . . 0.0 109.594 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.8 t70 61.65 11.21 3.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.578 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.35 22.52 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.093 -1.005 . . . . 0.0 109.776 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.6 t -163.36 111.37 1.0 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.994 -1.066 . . . . 0.0 109.743 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.2 Cg_endo -71.92 133.25 21.32 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.888 1.725 . . . . 0.0 110.6 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 2.2 tttt -89.5 -23.24 22.11 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.575 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 178.47 151.79 9.78 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 mtm -137.65 135.57 36.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -1.154 . . . . 0.0 109.743 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.92 137.68 19.58 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 48.4 Cg_endo -71.0 99.16 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.447 1.431 . . . . 0.0 109.832 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -66.74 -4.51 9.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.945 . . . . 0.0 110.528 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.96 ' N ' HD13 ' A' ' 50' ' ' LEU . 3.4 ptmm? -85.45 48.25 1.55 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.094 -1.004 . . . . 0.0 110.544 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . 151.38 -22.35 0.95 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.16 -1.495 . . . . 0.0 110.891 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.586 ' O ' HG21 ' A' ' 100' ' ' ILE . 0.0 OUTLIER -42.48 146.75 0.31 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.096 -1.238 . . . . 0.0 109.828 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -105.2 162.75 13.13 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.07 HD13 ' N ' ' A' ' 56' ' ' THR . 3.0 tm? -117.51 147.19 42.99 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.063 -1.023 . . . . 0.0 108.906 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 1.07 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 m -149.31 129.45 13.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.924 -1.11 . . . . 0.0 110.086 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.71 126.81 5.07 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.463 -0.773 . . . . 0.0 109.138 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 57' ' ' SER . 25.0 Cg_exo -67.0 -150.46 0.33 Allowed 'Cis proline' 0 C--N 1.309 -1.52 0 C-N-CA 123.148 -1.605 . . . . 0.0 110.903 -1.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 70' ' ' LYS . 30.1 p -131.81 -148.08 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.407 -0.808 . . . . 0.0 109.974 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.0 173.98 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.285 -0.884 . . . . 0.0 110.114 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -91.62 5.03 51.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.437 -0.789 . . . . 0.0 109.601 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -88.74 45.26 1.27 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 109.219 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 160.22 38.55 0.02 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 85.33 0.45 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.381 -1.07 . . . . 0.0 109.518 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER -147.96 23.35 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.561 ' O ' ' CD2' ' A' ' 67' ' ' PHE . 12.8 mtt 62.7 159.87 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.458 -0.776 . . . . 0.0 109.466 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.601 ' CE1' ' N ' ' A' ' 86' ' ' LEU . 2.6 m-85 82.43 -28.85 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.561 -0.712 . . . . 0.0 110.47 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.727 HG23 ' CH2' ' A' ' 21' ' ' TRP . 15.0 p -93.11 135.11 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.768 -1.208 . . . . 0.0 110.195 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.808 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -133.4 -176.47 4.15 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.411 -0.806 . . . . 0.0 109.662 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 0.4 OUTLIER -150.11 118.93 6.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.989 -1.07 . . . . 0.0 110.292 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 54' ' ' THR . 3.7 mt -96.67 162.72 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 54' ' ' THR . 90.4 m -127.39 91.43 3.31 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 108.842 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.877 HG22 HG22 ' A' ' 48' ' ' ILE . 1.4 p -43.21 144.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.474 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.496 ' HB ' ' HA3' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -41.07 -34.7 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.804 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -66.36 -74.9 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.227 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 166.11 35.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.588 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.469 ' O ' HG23 ' A' ' 73' ' ' THR . 1.4 mm-40 -105.78 118.95 37.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 80' ' ' PHE . 3.2 m-20 -83.31 103.3 12.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.302 -0.874 . . . . 0.0 109.633 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 48' ' ' ILE . 53.3 m-70 -89.78 105.31 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.165 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 5.6 m-85 -94.63 117.99 31.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 109.926 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.705 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -136.86 138.74 41.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 108.623 178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.572 ' CG ' ' CG1' ' A' ' 12' ' ' VAL . 8.3 pt20 -118.01 146.27 44.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.48 -153.05 0.26 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.432 -0.792 . . . . 0.0 109.418 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -108.31 -2.21 19.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.163 -0.961 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -169.09 169.94 9.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.213 -0.929 . . . . 0.0 109.187 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.601 ' N ' ' CE1' ' A' ' 67' ' ' PHE . 27.6 tp -69.81 -30.81 68.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -56.89 15.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.156 -0.965 . . . . 0.0 108.868 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -69.17 -15.33 63.38 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.178 -0.951 . . . . 0.0 108.74 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 1.046 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.1 ttt180 -68.94 -63.9 0.97 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.818 . . . . 0.0 109.354 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.92 -13.26 62.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.42 -33.9 25.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.047 -1.033 . . . . 0.0 108.861 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.971 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 1.9 m95 -81.97 -27.91 32.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.1 m -75.33 -33.61 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.164 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.513 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 2.5 mmm180 -79.74 -29.95 40.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 109.406 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.61 ' OD1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -74.74 -49.38 21.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.523 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.006 ' O ' HD12 ' A' ' 100' ' ' ILE . 9.8 mt -72.58 -36.6 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.025 -1.047 . . . . 0.0 108.866 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 11.1 t-20 -73.28 -26.39 61.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.51 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -76.68 -45.22 30.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.867 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.91 -34.02 72.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.332 -0.855 . . . . 0.0 108.969 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.006 HD12 ' O ' ' A' ' 96' ' ' ILE . 1.3 mt -74.9 -40.84 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 108.826 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 101' ' ' LYS . 13.9 tptm -73.2 -7.87 53.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.898 . . . . 0.0 109.073 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.3 -40.72 9.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.814 ' CG1' HD21 ' A' ' 50' ' ' LEU . 1.2 mm -60.64 -44.01 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.875 . . . . 0.0 108.805 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 3.1 mt-10 -46.49 -26.23 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -114.37 -103.29 2.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.537 ' C ' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER 46.92 66.34 1.02 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.375 -1.073 . . . . 0.0 109.218 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -112.23 38.78 2.61 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.586 -0.696 . . . . 0.0 109.184 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.13 -13.69 32.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.9 m170 58.52 78.12 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.18 73.74 1.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -106.91 -25.06 11.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.159 -0.963 . . . . 0.0 109.441 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -167.19 137.66 3.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 109.484 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.441 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.338 0.589 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 6.0 tt0 -179.79 -63.3 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.249 -0.907 . . . . 0.0 109.278 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 50.1 Cg_endo -69.67 173.0 11.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.791 1.661 . . . . 0.0 110.037 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HB3' ' HD2' ' A' ' 5' ' ' ARG . 8.4 mmtt -141.09 106.54 5.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' CG ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 64.3 120.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.394 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.581 HG21 ' OD1' ' A' ' 95' ' ' ASP . 77.2 mt -47.13 -70.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.336 -0.853 . . . . 0.0 109.563 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.702 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -101.58 169.12 9.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 0.0 109.786 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.837 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 173.65 132.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.382 -0.824 . . . . 0.0 109.692 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.575 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -173.12 -143.68 4.32 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -124.03 106.97 10.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.933 . . . . 0.0 109.427 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.8 OUTLIER -120.53 178.47 4.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.39 -0.818 . . . . 0.0 108.921 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.851 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -123.41 122.68 65.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 108.596 178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.794 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -104.02 126.62 51.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -0.841 . . . . 0.0 109.466 -179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.589 ' HG3' ' CD1' ' A' ' 21' ' ' TRP . 19.1 tttt -73.17 99.76 2.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 178.36 48.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 t -98.07 114.5 26.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -1.164 . . . . 0.0 109.56 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 18' ' ' PHE . 5.1 p -167.33 -45.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.53 ' N ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -174.93 48.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.319 -0.863 . . . . 0.0 109.406 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 20.5 m-20 49.56 63.53 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 1.1 p -129.41 161.59 30.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.735 ' CH2' HG21 ' A' ' 68' ' ' VAL . 34.0 m95 -125.64 118.98 26.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.851 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.2 mttt -121.88 130.04 24.91 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.684 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 49.1 Cg_exo -55.04 -179.57 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.8 1.667 . . . . 0.0 110.119 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.794 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 6.5 ptm 169.29 169.63 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.584 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 71.7 t-105 -92.46 152.25 19.79 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.741 HG11 ' HB2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -149.66 149.96 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.581 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.837 HG12 ' CB ' ' A' ' 8' ' ' GLU . 4.8 m -144.52 112.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.223 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.007 HD13 HG13 ' A' ' 96' ' ' ILE . 5.1 mt -78.94 121.66 25.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.449 -0.782 . . . . 0.0 109.095 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.58 HD21 ' CG ' ' A' ' 5' ' ' ARG . 1.1 mp -110.79 156.28 21.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.979 . . . . 0.0 109.295 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.539 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.3 tt0 -72.46 -21.97 61.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.872 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HA ' HD11 ' A' ' 103' ' ' ILE . 2.8 m-20 -98.64 10.93 39.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 109.369 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.736 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 146.77 -175.66 26.06 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.512 HD13 ' HB ' ' A' ' 48' ' ' ILE . 1.9 mp -132.47 137.9 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.051 -1.264 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 3.5 pt-20 -144.55 123.44 12.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.299 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CZ ' ' HD3' ' A' ' 13' ' ' LYS . 5.0 p90 -121.65 140.18 52.61 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.226 -0.921 . . . . 0.0 109.815 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -121.69 -148.37 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 109.027 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -60.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.1 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -96.65 -177.14 3.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -0.916 . . . . 0.0 108.727 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.68 -28.39 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 108.612 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.447 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -163.01 69.04 0.22 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.452 -0.78 . . . . 0.0 109.387 178.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 60.6 t0 -48.26 -21.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.7 t-20 91.8 -21.2 0.1 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -118.89 107.03 42.78 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 44.1 Cg_endo -68.86 146.97 67.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.778 1.652 . . . . 0.0 110.826 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 -31.58 9.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.397 -0.814 . . . . 0.0 109.076 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.506 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -154.3 143.24 9.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.517 ' C ' HD13 ' A' ' 48' ' ' ILE . 5.8 mtt -133.26 135.74 45.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.644 HD13 ' N ' ' A' ' 48' ' ' ILE . 2.2 mm -95.16 107.94 35.41 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.853 . . . . 0.0 109.265 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' O ' ' OG ' ' A' ' 53' ' ' SER . 46.3 Cg_endo -70.04 118.91 5.96 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.707 1.605 . . . . 0.0 110.191 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.736 HD13 ' HA2' ' A' ' 32' ' ' GLY . 2.8 mp -63.29 -9.57 12.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 109.898 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.657 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -71.22 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.101 -0.999 . . . . 0.0 109.84 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' O ' ' CA ' ' A' ' 74' ' ' THR . . . -152.46 71.79 0.28 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.226 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -100.53 166.0 11.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.19 -1.182 . . . . 0.0 109.161 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.89 157.32 36.25 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.3 tm? -127.48 102.06 6.71 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.812 HG22 ' O ' ' A' ' 58' ' ' PRO . 19.5 m -89.6 133.45 34.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.323 -0.861 . . . . 0.0 110.009 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.405 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.0 OUTLIER -146.6 122.94 5.67 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.403 -0.811 . . . . 0.0 109.385 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 56' ' ' THR . 49.7 Cg_endo -72.23 -161.88 2.26 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.558 -1.851 . . . . 0.0 110.416 -0.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.769 ' SG ' HG13 ' A' ' 68' ' ' VAL . 21.8 p -103.95 -147.16 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 109.694 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -71.68 -141.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 109.922 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -3.03 9.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 109.505 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HB3' HG11 ' A' ' 68' ' ' VAL . 19.9 m-85 -88.82 -21.13 23.89 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.509 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.749 ' N ' ' SG ' ' A' ' 59' ' ' CYS . . . -76.61 -22.81 71.65 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -2.83 31.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.541 -0.976 . . . . 0.0 109.156 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -104.59 -95.67 0.33 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.555 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.489 ' HB2' ' NE2' ' A' ' 82' ' ' GLN . 9.4 mtt -94.34 -147.26 0.26 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.645 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 44.2 m-85 -101.79 92.69 4.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 81' ' ' PHE . 3.8 p -135.71 132.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.493 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.731 ' CE1' HD12 ' A' ' 71' ' ' ILE . 3.2 p90 -110.29 170.46 8.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.955 -1.091 . . . . 0.0 109.718 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -124.94 106.12 9.73 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.731 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.8 mt -88.48 160.74 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 74.8 m -133.53 90.69 2.75 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 79' ' ' HIS . 3.3 p -45.3 158.81 0.06 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.062 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.657 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -59.89 -14.07 13.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.645 -179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -86.89 16.81 4.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.207 -0.933 . . . . 0.0 109.603 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.58 43.37 4.41 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 72' ' ' THR . 13.6 tt0 -118.48 118.24 31.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 109.238 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.3 m-20 -70.61 163.3 27.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.485 ' CD2' HG23 ' A' ' 73' ' ' THR . 12.3 m-70 -143.98 128.64 18.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.035 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 14.5 m-85 -91.59 113.42 25.68 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.858 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 1.7 t80 -128.16 128.19 44.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 110.689 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.576 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -126.91 136.05 51.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.376 -0.827 . . . . 0.0 109.735 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -107.48 -150.84 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.399 -0.813 . . . . 0.0 109.798 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.29 -88.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -106.94 -179.27 3.89 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.59 -0.694 . . . . 0.0 109.569 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.029 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -56.08 -58.18 9.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.69 . . . . 0.0 109.75 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.029 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.1 tp10 -43.46 -70.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.972 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 1.2 tt0 -48.94 -33.71 11.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 109.805 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HG22 ' A' ' 93' ' ' VAL . 13.1 ttp180 -56.36 -65.01 0.68 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.399 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' HA ' HG23 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -53.86 -22.18 9.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.168 -0.958 . . . . 0.0 109.263 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.552 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -70.9 -40.94 71.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.148 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.861 ' CE2' HD21 ' A' ' 11' ' ' LEU . 77.8 m95 -73.03 -52.73 13.27 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.507 -0.746 . . . . 0.0 109.608 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -65.56 -24.84 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.518 -0.739 . . . . 0.0 110.794 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.552 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 3.6 ptt85 -85.24 -23.58 28.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.903 -1.123 . . . . 0.0 110.074 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' OD1' HG21 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -85.61 -38.66 18.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.075 -1.016 . . . . 0.0 109.695 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.007 HG13 HD13 ' A' ' 28' ' ' LEU . 21.1 mt -76.73 -35.69 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.118 -0.989 . . . . 0.0 109.102 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -76.46 -31.76 58.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -72.2 -55.92 6.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 108.983 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.75 -39.0 67.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.23 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 59.2 mt -63.67 -45.27 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -0.852 . . . . 0.0 109.035 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -67.88 -8.87 40.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.455 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.7 t -95.1 -35.38 11.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.68 HD12 HD22 ' A' ' 50' ' ' LEU . 2.2 mt -79.82 -26.68 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.032 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -73.14 -7.65 52.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -132.22 12.51 5.25 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 107' ' ' GLU . 2.5 mt -99.25 56.74 1.03 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -1.037 . . . . 0.0 109.306 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 106' ' ' LEU . 31.3 mt-10 56.66 160.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.7 -0.625 . . . . 0.0 109.521 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -120.7 48.62 1.58 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.565 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 110' ' ' HIS . 0.9 OUTLIER -100.26 68.23 1.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' A' ' 109' ' ' HIS . 0.3 OUTLIER 47.64 -174.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.915 . . . . 0.0 109.402 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.429 ' O ' ' HB3' ' A' ' 112' ' ' HIS . 72.1 m-70 -115.18 29.21 8.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 111' ' ' HIS . 9.8 t-160 64.11 113.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.274 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.422 ' OXT' ' O ' ' A' ' 112' ' ' HIS . 7.9 t60 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.393 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.585 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -56.72 -61.83 6.14 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.628 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.585 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 49.8 Cg_endo -70.85 -173.04 0.77 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.849 1.699 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 40.2 64.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 0.0 109.719 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.0 mpt_? 57.71 154.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.76 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 28' ' ' LEU . 23.6 mm -64.36 -56.8 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.293 -0.879 . . . . 0.0 110.217 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.556 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -132.85 90.61 2.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.981 -1.074 . . . . 0.0 110.414 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.011 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -103.33 128.91 50.27 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.867 -1.146 . . . . 0.0 109.185 178.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.597 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -159.43 -149.94 5.68 Favored Glycine 0 N--CA 1.481 1.646 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.929 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.0 p90 -141.26 97.15 3.11 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -114.19 171.65 7.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.929 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.9 p -102.34 129.4 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.776 -1.202 . . . . 0.0 109.872 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.574 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -119.75 166.04 13.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.311 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 10.8 ttpt -68.21 121.65 16.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.536 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.32 -161.69 2.8 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' VAL . 23.3 t -119.16 -16.61 9.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -1.161 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -46.68 -93.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.489 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' H ' HG23 ' A' ' 17' ' ' VAL . 36.6 m-85 -126.67 52.0 1.79 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.173 -0.954 . . . . 0.0 109.511 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.0 OUTLIER 59.01 78.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.421 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 40.0 p -124.74 -165.79 1.43 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.596 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.779 ' HH2' HG23 ' A' ' 68' ' ' VAL . 2.1 m95 -144.78 104.83 4.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.228 -0.92 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.929 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.9 mttp -132.65 144.0 51.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -52.21 166.39 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.77 1.647 . . . . 0.0 109.887 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.632 ' CE ' ' CD1' ' A' ' 35' ' ' PHE . 23.1 ptm -176.51 159.53 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.174 -0.954 . . . . 0.0 109.648 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 9' ' ' GLY . 73.6 t-105 -89.81 143.64 26.63 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.654 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -150.27 150.07 13.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.672 -179.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.011 HG12 ' CB ' ' A' ' 8' ' ' GLU . 7.6 m -137.52 119.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.873 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.865 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.0 OUTLIER -85.05 105.61 15.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.452 -0.78 . . . . 0.0 108.914 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -96.85 157.92 15.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.872 . . . . 0.0 109.681 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -72.89 -17.5 61.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 109.788 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -101.9 5.86 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.912 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 153.29 -171.6 32.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.668 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.4 mm -133.05 122.87 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.383 -1.069 . . . . 0.0 109.283 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 27' ' ' VAL . 6.0 pt-20 -129.12 127.27 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 108.977 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.632 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 6.7 p90 -131.09 146.4 52.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.266 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -127.46 -150.31 0.44 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.3 -32.43 11.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 0.0 108.877 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 2.8 tttp -121.05 -179.58 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.3 OUTLIER -45.56 -27.33 0.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.026 -1.046 . . . . 0.0 108.414 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.443 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -166.96 73.36 0.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.0 109.702 178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 24.8 t70 -50.98 -19.04 0.9 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.996 -1.065 . . . . 0.0 108.172 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 6.3 t-20 90.92 -17.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 t -132.34 94.55 22.84 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 36' ' ' TYR . 50.7 Cg_exo -49.41 139.0 29.95 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.968 1.779 . . . . 0.0 110.878 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG2' ' HA ' ' A' ' 36' ' ' TYR . 9.7 mmtt -90.07 -23.02 21.53 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.55 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -164.9 143.8 8.81 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 mtm -134.97 123.87 24.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -1.19 . . . . 0.0 109.565 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.77 129.76 41.16 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.318 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 51' ' ' LYS . 55.7 Cg_endo -72.51 137.45 27.89 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.687 1.592 . . . . 0.0 110.265 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD21 ' C ' ' A' ' 99' ' ' ALA . 0.2 OUTLIER -88.11 23.06 2.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.612 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HG2' ' HB2' ' A' ' 49' ' ' PRO . 12.9 ptpt -91.77 -18.78 23.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.185 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -157.76 -91.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER 56.99 132.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.545 -0.973 . . . . 0.0 110.674 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.567 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.51 167.71 9.85 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.984 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -133.73 142.48 47.97 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.027 -1.045 . . . . 0.0 109.025 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.984 ' N ' HD13 ' A' ' 55' ' ' LEU . 52.6 m -130.22 119.88 23.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.998 -1.064 . . . . 0.0 109.891 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 1.7 t -143.61 120.27 6.6 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.791 ' O ' HG22 ' A' ' 56' ' ' THR . 55.3 Cg_endo -72.07 -160.92 1.92 Allowed 'Cis proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.573 -1.844 . . . . 0.0 110.143 -0.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 17.9 p -89.67 -149.4 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.435 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 18.4 tt0 -110.17 -139.86 0.38 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.536 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -84.25 26.49 0.76 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.877 -1.139 . . . . 0.0 109.367 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 1.3 t80 -88.86 -65.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 65' ' ' ARG . . . -101.56 -42.3 2.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 7.2 tttt 55.45 19.4 3.11 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -1.007 . . . . 0.0 109.488 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 9.7 mmm180 -87.09 -144.33 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.536 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 10.1 mtt -126.62 -4.05 6.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.11 -0.994 . . . . 0.0 109.85 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 66' ' ' MET . 0.5 OUTLIER -130.08 32.62 4.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 110.013 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.779 HG23 ' HH2' ' A' ' 21' ' ' TRP . 2.7 p -128.56 123.49 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.002 -1.062 . . . . 0.0 109.637 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.645 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 11.0 p90 -118.79 174.31 6.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.603 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.602 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -135.06 127.07 29.67 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.409 -0.807 . . . . 0.0 109.435 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.553 HG13 ' CD2' ' A' ' 55' ' ' LEU . 6.6 mt -105.99 163.39 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 108.868 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.567 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 98.0 m -145.13 99.91 3.39 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.25 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.368 -0.832 . . . . 0.0 109.994 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER 43.46 37.74 1.54 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.205 -0.935 . . . . 0.0 110.864 179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 80.24 45.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 0.0 109.57 178.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.97 -82.87 0.32 Allowed 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.028 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.549 ' HB2' ' CG2' ' A' ' 73' ' ' THR . 0.7 OUTLIER -90.17 131.25 36.11 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.499 -0.75 . . . . 0.0 110.118 -178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.543 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 9.5 t0 -97.56 145.16 26.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.409 ' HB3' ' HD3' ' A' ' 13' ' ' LYS . 81.3 m-70 -137.72 109.23 6.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 109.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.0 OUTLIER -101.39 115.04 29.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.382 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -143.84 145.98 32.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 109.617 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.503 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 1.1 pt20 -116.78 147.01 42.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.51 -0.744 . . . . 0.0 109.052 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -143.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -0.821 . . . . 0.0 109.45 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -91.91 -60.83 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.121 -0.987 . . . . 0.0 110.12 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.28 175.1 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.668 -0.645 . . . . 0.0 109.693 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.041 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -45.7 -50.14 13.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.543 -0.723 . . . . 0.0 109.929 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.041 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.7 tm-20 -51.63 -57.93 7.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 110.045 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 92' ' ' TRP . 11.8 tt0 -63.19 -18.04 63.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 109.703 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.977 ' O ' HG13 ' A' ' 93' ' ' VAL . 15.8 ttp180 -72.96 -65.69 0.77 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.27 -0.894 . . . . 0.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HA ' HG22 ' A' ' 93' ' ' VAL . 59.3 t0 -65.75 -11.57 46.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.277 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.35 -41.19 22.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.003 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 12.4 m95 -76.68 -31.1 57.05 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.454 -0.779 . . . . 0.0 108.99 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.977 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.9 m -70.6 -38.65 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.567 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -78.91 -20.08 50.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.77 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.708 ' HB3' HD12 ' A' ' 28' ' ' LEU . 9.5 t70 -77.73 -58.0 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.873 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.834 HG13 HD13 ' A' ' 28' ' ' LEU . 1.1 mt -63.6 -35.09 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.908 -1.12 . . . . 0.0 108.707 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 35.0 t30 -73.77 -32.54 63.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.019 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.91 -57.13 5.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -51.66 -42.42 62.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.238 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.483 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 45.0 mt -59.68 -50.62 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.871 . . . . 0.0 109.314 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.22 -10.89 35.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -93.12 -28.84 16.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 109.285 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.618 ' CG1' HD23 ' A' ' 50' ' ' LEU . 4.9 mm -78.0 -34.06 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -72.57 -4.85 33.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.4 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.72 13.02 4.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 106' ' ' LEU . 2.6 mt -97.57 56.7 1.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.448 -1.031 . . . . 0.0 109.218 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -51.9 -84.58 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.665 -0.647 . . . . 0.0 109.533 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.475 ' CD2' ' N ' ' A' ' 108' ' ' HIS . 0.1 OUTLIER -47.57 133.59 13.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.543 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.52 -44.78 1.52 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.534 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.468 ' O ' ' CB ' ' A' ' 111' ' ' HIS . 21.1 t-80 -135.98 24.84 3.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.52 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 110' ' ' HIS . 0.1 OUTLIER 74.01 31.75 1.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.387 179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 111' ' ' HIS . 5.6 t60 179.45 -71.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' O ' ' CG ' ' A' ' 113' ' ' HIS . 55.0 p-80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.407 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.589 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 9.7 mt-10 -48.76 -61.75 2.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.6 Cg_endo -72.2 -175.1 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.762 1.642 . . . . 0.0 110.159 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 3' ' ' PRO . 25.9 mttt 45.72 95.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.681 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' LYS . 1.2 mpt_? 68.02 169.77 0.27 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.861 . . . . 0.0 109.373 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.665 HD11 ' CB ' ' A' ' 30' ' ' GLU . 46.7 mt -92.81 -77.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.732 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.97 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -107.5 104.83 14.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 110.099 -179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.022 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.2 pm0 -115.65 135.51 53.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.3 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.589 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.73 -146.8 4.65 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.764 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.6 p90 -138.57 97.4 3.34 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.411 -1.052 . . . . 0.0 109.78 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -119.36 146.8 45.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.4 p -76.34 137.68 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.026 -1.047 . . . . 0.0 109.298 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -117.18 165.19 13.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.868 . . . . 0.0 109.42 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 62' ' ' PHE . 2.1 tmtt? -116.31 125.11 51.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.348 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 17' ' ' VAL . . . 164.86 -120.11 0.92 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 51.21 -91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -1.146 . . . . 0.0 109.383 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 18' ' ' PHE . 14.8 m -117.51 -147.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.524 ' N ' HG23 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -42.71 165.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.334 -0.854 . . . . 0.0 109.478 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 18' ' ' PHE . 3.1 m120 -43.53 105.93 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 0.0 109.376 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -132.29 174.42 10.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -0.899 . . . . 0.0 109.764 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.571 ' CD1' ' O ' ' A' ' 20' ' ' THR . 3.4 m95 -152.33 106.94 3.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.619 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.6 mmtt -138.18 138.8 23.8 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.33 151.58 17.4 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.849 1.7 . . . . 0.0 109.922 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.774 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.15 171.07 20.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.994 -1.066 . . . . 0.0 110.341 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.774 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.9 t-105 -96.94 145.8 25.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -150.19 139.24 15.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.05 -178.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.022 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -129.09 106.98 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.821 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.022 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.5 pp -86.45 111.91 21.0 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.114 -0.992 . . . . 0.0 109.193 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.9 mp -93.29 164.58 13.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.438 -0.789 . . . . 0.0 109.564 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.665 ' CB ' HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -74.99 -15.8 60.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.355 -0.84 . . . . 0.0 109.487 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 2.6 p30 -101.87 10.11 40.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.339 -0.85 . . . . 0.0 109.169 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.932 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 148.49 -165.15 29.09 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.682 HG21 HD12 ' A' ' 48' ' ' ILE . 2.9 mt -141.07 141.51 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.163 -1.198 . . . . 0.0 109.957 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.691 ' HG2' HD11 ' A' ' 29' ' ' LEU . 12.1 pt-20 -148.12 115.03 6.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.747 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.5 p90 -112.81 148.72 34.24 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 110.792 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -124.62 -156.76 0.74 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.86 -46.42 6.56 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -111.37 -169.22 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -46.5 -24.79 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.793 -1.192 . . . . 0.0 109.024 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -153.52 -50.09 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.199 179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.2 t70 61.67 10.08 3.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.418 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 41' ' ' ASP . 38.8 m-20 41.9 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -156.79 96.17 2.18 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.925 -1.11 . . . . 0.0 110.037 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.9 Cg_exo -51.82 171.7 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.054 1.836 . . . . 0.0 110.58 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.49 4.98 2.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.455 -0.778 . . . . 0.0 109.287 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.53 141.68 3.84 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.52 ' HG2' ' CB ' ' A' ' 34' ' ' GLU . 26.4 mtm -124.41 139.69 53.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 0.0 109.634 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.683 HG23 HG22 ' A' ' 73' ' ' THR . 2.3 mt -101.31 125.85 36.5 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.075 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.71 131.91 19.34 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.547 1.498 . . . . 0.0 110.08 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.048 HD21 ' HB1' ' A' ' 99' ' ' ALA . 1.5 mp -73.74 -0.03 14.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.21 -0.931 . . . . 0.0 109.777 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.1 OUTLIER -42.14 -88.23 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.78 -179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -144.51 54.99 0.56 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.397 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -66.95 156.25 36.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.246 . . . . 0.0 108.941 179.245 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.642 HG22 ' CB ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -103.73 171.07 7.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 108.855 179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.606 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.2 tm? -143.33 114.32 7.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.205 -0.934 . . . . 0.0 109.114 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 58' ' ' PRO . 12.4 m -112.89 128.23 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER -150.19 122.18 4.12 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.328 -0.857 . . . . 0.0 109.473 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 56' ' ' THR . 54.7 Cg_endo -72.31 -177.87 19.21 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.603 -1.832 . . . . 0.0 110.199 -0.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.82 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -96.04 -85.0 0.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.698 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.82 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -152.95 -165.58 2.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.735 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -87.28 21.39 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 14' ' ' LYS . 1.6 t80 -89.26 85.7 6.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 88.94 26.89 25.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER -43.81 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -1.155 . . . . 0.0 109.253 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -141.3 132.63 26.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.412 ' C ' ' O ' ' A' ' 65' ' ' ARG . 8.1 mtp 44.27 -100.38 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.217 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 6.0 m-85 -145.86 108.25 4.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.615 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -113.32 138.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.863 . . . . 0.0 109.278 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.84 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 33.9 ttpt -141.67 98.8 3.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.546 ' CD1' HG21 ' A' ' 96' ' ' ILE . 7.5 mt -89.38 163.76 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.642 ' CB ' HG22 ' A' ' 54' ' ' THR . 45.6 m -139.35 87.38 2.19 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.683 HG22 HG23 ' A' ' 48' ' ' ILE . 2.7 p -45.63 155.34 0.16 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.238 -0.914 . . . . 0.0 108.905 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.699 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -55.44 -17.51 5.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.761 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.15 23.74 2.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.0 109.85 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.32 35.27 18.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.166 -0.959 . . . . 0.0 109.887 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.487 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -101.89 94.09 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.358 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 10.8 m-20 -66.32 153.12 43.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -148.68 114.84 5.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.375 -0.828 . . . . 0.0 109.261 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 0.6 OUTLIER -108.27 124.15 49.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.153 -0.967 . . . . 0.0 109.502 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD1' ' CD1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -138.49 -176.29 4.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.153 -0.967 . . . . 0.0 109.096 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.544 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 1.8 tt0 -150.38 138.1 19.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.842 -1.162 . . . . 0.0 110.025 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.968 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.82 -145.8 0.17 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.599 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -115.52 -11.45 11.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.068 -1.02 . . . . 0.0 109.64 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.599 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -170.61 171.3 6.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.367 -0.833 . . . . 0.0 109.55 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.039 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -55.79 -48.78 74.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.326 -0.859 . . . . 0.0 109.474 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.039 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -48.62 -60.45 2.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.19 -0.944 . . . . 0.0 109.769 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -61.49 -22.45 65.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.884 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.995 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.68 -63.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.135 -0.978 . . . . 0.0 109.782 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.583 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -66.08 -12.83 58.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.15 -39.06 26.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.112 -0.992 . . . . 0.0 108.868 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.022 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 9.6 m95 -78.1 -29.76 49.14 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.411 -0.805 . . . . 0.0 109.028 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.995 HG13 ' O ' ' A' ' 89' ' ' ARG . 2.8 m -74.09 -31.27 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.591 -0.693 . . . . 0.0 109.699 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.7 ptp180 -83.5 -23.16 32.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.901 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.608 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -83.31 -54.54 4.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.07 -1.019 . . . . 0.0 109.713 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.606 ' O ' HD13 ' A' ' 100' ' ' ILE . 2.6 mt -65.14 -39.75 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 108.575 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 20.5 t-20 -70.09 -56.59 6.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.89 . . . . 0.0 109.155 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 22.3 tttm -44.17 -49.69 8.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 1.048 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -57.31 -43.92 83.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 109.574 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.643 HD12 ' HG ' ' A' ' 50' ' ' LEU . 1.2 mp -57.63 -58.79 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.325 -0.86 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' N ' HG22 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -63.7 -10.78 21.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 0.0 109.904 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -92.7 -22.78 19.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 0.0 109.313 179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.785 HG12 HD23 ' A' ' 50' ' ' LEU . 3.1 mm -84.7 -22.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 108.987 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 41.0 mt-10 -68.3 -7.8 34.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.85 9.44 5.47 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 106' ' ' LEU . 5.8 mt -105.73 59.41 0.66 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.288 -1.125 . . . . 0.0 109.16 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -44.55 162.95 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.61 -0.681 . . . . 0.0 109.709 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.501 ' C ' ' CD2' ' A' ' 109' ' ' HIS . 74.7 m-70 -105.2 -148.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.37 -0.831 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.501 ' CD2' ' C ' ' A' ' 108' ' ' HIS . 16.6 m-70 74.75 79.58 0.11 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.455 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -170.81 37.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.451 ' CD2' ' N ' ' A' ' 111' ' ' HIS . 20.0 m170 -72.89 106.92 5.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 171.56 165.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.355 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 36.3 m170 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.454 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpp? . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 3' ' ' PRO . 1.9 mm-40 -93.64 159.35 35.02 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 2' ' ' GLU . 52.9 Cg_exo -51.09 -170.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.077 1.851 . . . . 0.0 110.351 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 4' ' ' LYS . 5.7 pttt -116.2 77.19 1.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.408 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.511 ' HD3' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -44.69 130.89 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.522 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.559 ' HB ' HD11 ' A' ' 28' ' ' LEU . 8.3 mm -46.33 -46.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.591 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -137.88 152.48 49.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 109.491 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.018 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -161.6 124.05 3.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.284 -0.885 . . . . 0.0 109.455 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.584 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -157.92 -145.7 4.3 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.024 ' C ' HD13 ' A' ' 11' ' ' LEU . 9.7 p90 -143.26 93.45 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.339 -1.094 . . . . 0.0 109.971 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.117 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -115.37 166.53 11.76 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.6 p -90.83 135.61 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.797 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 0.4 OUTLIER -126.98 131.08 51.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.464 -0.773 . . . . 0.0 109.597 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 35.0 tttm -95.47 138.62 32.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.356 -0.84 . . . . 0.0 109.423 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.1 -2.49 4.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 3.7 p -76.72 -93.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -1.171 . . . . 0.0 109.552 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 17' ' ' VAL . 12.0 p -97.43 109.54 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.344 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.7 m-30 59.23 -180.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.31 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . 28.8 p-10 -82.73 88.79 6.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.389 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.454 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 21.6 p -132.24 -167.27 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.755 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.637 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 2.4 m95 -146.4 116.83 7.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 0.0 109.59 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.587 ' N ' HG23 ' A' ' 12' ' ' VAL . 33.4 mttt -148.17 137.38 12.02 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 110.048 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 46.6 Cg_exo -56.3 161.13 9.66 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 121.937 1.758 . . . . 0.0 109.787 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.797 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 21.6 ptm -171.1 167.36 7.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 109.798 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.594 ' CD2' ' HA ' ' A' ' 39' ' ' LYS . 54.5 t-105 -88.77 142.61 27.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.773 ' CG1' HD22 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -150.41 132.39 5.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.446 -178.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.018 HG12 ' HB3' ' A' ' 8' ' ' GLU . 11.4 m -125.15 105.77 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.592 -0.693 . . . . 0.0 109.285 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 7' ' ' ARG . 1.7 pp -79.6 124.14 28.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.053 -1.029 . . . . 0.0 109.036 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' O ' HD13 ' A' ' 50' ' ' LEU . 2.7 mp -112.15 166.42 11.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.358 -0.839 . . . . 0.0 109.505 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.773 ' O ' HD13 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -72.02 -12.97 61.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 109.906 -179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.607 ' C ' HD22 ' A' ' 50' ' ' LEU . 1.1 m-20 -106.07 -2.67 22.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.63 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.9 151.69 5.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.641 HD12 ' N ' ' A' ' 33' ' ' ILE . 4.7 mp -98.36 108.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.739 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' OE2' ' CD1' ' A' ' 29' ' ' LEU . 4.8 pt-20 -107.22 119.96 40.81 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.666 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.0 p90 -121.3 144.64 48.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.14 -0.975 . . . . 0.0 110.431 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.632 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -121.25 -148.93 0.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -51.97 3.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -0.879 . . . . 0.0 109.174 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -105.13 -177.26 3.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.885 . . . . 0.0 108.855 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.11 -40.45 10.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.058 -1.026 . . . . 0.0 108.512 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.466 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 0.4 OUTLIER -153.43 72.04 0.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 109.765 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 23.6 t70 -50.15 -20.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 3.7 t30 90.86 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.76 101.6 51.66 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 53.4 Cg_exo -49.69 142.68 24.25 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.888 1.725 . . . . 0.0 111.246 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 16' ' ' SER . 0.0 OUTLIER -98.18 -25.63 14.83 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.39 146.77 5.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.435 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 9.5 mtm -127.31 -174.92 3.29 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.218 -1.166 . . . . 0.0 109.628 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.425 HG23 HG22 ' A' ' 73' ' ' THR . 39.3 mt -140.59 127.83 12.22 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.46 84.79 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.494 1.462 . . . . 0.0 110.073 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.991 ' HG ' HG21 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -60.95 -14.2 21.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.412 -0.805 . . . . 0.0 109.201 -179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.672 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -58.36 -15.41 10.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.9 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -165.68 27.91 0.19 Allowed Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.132 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.423 ' OG ' HG23 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -77.54 168.73 19.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -1.234 . . . . 0.0 109.348 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -126.67 160.25 31.31 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.403 -0.81 . . . . 0.0 109.167 -179.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.022 HD13 ' N ' ' A' ' 56' ' ' THR . 2.8 tm? -121.28 149.47 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.042 -1.037 . . . . 0.0 109.248 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 1.022 ' N ' HD13 ' A' ' 55' ' ' LEU . 98.9 m -136.42 134.79 38.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 110.052 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 5.4 t -150.38 118.87 3.6 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.327 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 56' ' ' THR . 53.6 Cg_endo -72.49 -161.86 2.29 Favored 'Cis proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.642 -1.816 . . . . 0.0 110.369 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 18.2 p -96.34 -161.25 0.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.694 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -67.84 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.867 . . . . 0.0 109.756 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -84.89 15.37 4.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.2 t80 -89.16 -27.13 20.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 108.918 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.613 ' HA3' HG11 ' A' ' 68' ' ' VAL . . . -103.97 -91.69 2.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 tttt 43.66 27.26 0.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.343 -1.093 . . . . 0.0 109.261 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' GLY . 12.7 mtp180 -124.67 -90.14 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.437 -0.789 . . . . 0.0 109.424 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.7 mmm -81.92 -114.36 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.321 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 86' ' ' LEU . 84.1 m-85 -130.96 89.99 2.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.824 -1.172 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HA3' ' A' ' 63' ' ' GLY . 1.6 p -129.62 119.71 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.829 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.707 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.8 p90 -97.8 168.77 10.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.155 -0.966 . . . . 0.0 109.091 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 6.0 ttpt -127.17 117.39 22.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.854 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.633 HD11 HG21 ' A' ' 96' ' ' ILE . 2.4 mt -95.5 167.84 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.828 . . . . 0.0 108.872 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.2 m -141.05 92.23 2.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 75' ' ' LYS . 1.6 p -42.76 152.09 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 1.2 t -52.15 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.522 -0.736 . . . . 0.0 109.725 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 158.52 -71.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 164.55 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.93 79.08 2.0 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.215 -0.928 . . . . 0.0 109.092 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 1.7 p30 -56.07 144.01 30.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.701 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 42.0 m-70 -137.49 145.26 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.8 m-85 -100.88 137.61 39.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 1.117 ' CE2' HD23 ' A' ' 11' ' ' LEU . 1.1 t80 -143.97 123.3 13.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -129.36 120.13 25.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.037 -1.04 . . . . 0.0 109.879 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -89.98 -146.51 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.549 -0.719 . . . . 0.0 109.602 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 -90.05 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.234 -0.916 . . . . 0.0 109.875 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -96.22 167.88 10.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.484 -0.76 . . . . 0.0 109.449 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.86 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -52.45 -20.33 2.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.819 -179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.86 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -72.35 -46.7 54.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 109.731 -179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -73.97 -48.61 29.18 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.55 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -64.88 -30.5 71.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.004 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 51.2 t0 -75.09 -42.36 56.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.117 -0.989 . . . . 0.0 109.396 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -73.91 -19.69 60.62 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 109.117 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.698 ' CH2' HG22 ' A' ' 26' ' ' VAL . 3.4 m95 -83.6 -37.15 23.29 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.393 -0.817 . . . . 0.0 109.048 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.89 ' CG2' HD11 ' A' ' 55' ' ' LEU . 3.9 p -76.84 -31.59 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.789 . . . . 0.0 109.155 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' ASP . 13.2 mmm180 -83.83 -24.34 30.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.388 -0.82 . . . . 0.0 109.605 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 33.5 t0 -83.71 -39.7 19.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.975 . . . . 0.0 109.303 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 100' ' ' ILE . 5.3 mt -71.81 -32.79 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 0.0 108.696 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -84.31 -30.7 25.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 109.222 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -67.16 -50.97 59.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.258 -0.901 . . . . 0.0 108.949 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -67.25 -32.72 73.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.315 -0.866 . . . . 0.0 108.951 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.644 HD12 ' O ' ' A' ' 96' ' ' ILE . 20.6 mt -61.91 -41.26 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.423 -0.798 . . . . 0.0 109.095 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -83.58 -13.46 54.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.233 -0.917 . . . . 0.0 109.62 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.67 -12.24 25.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 109.58 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.991 HG21 ' HG ' ' A' ' 50' ' ' LEU . 5.6 tp -93.43 -14.98 8.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.229 -0.919 . . . . 0.0 109.451 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 4.0 mt-10 -80.15 -6.63 58.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.511 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.97 8.63 7.17 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.2 OUTLIER -100.71 57.23 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -100.27 -88.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.721 -0.612 . . . . 0.0 109.551 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 171.42 -38.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -119.64 113.61 20.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.409 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -72.24 -154.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.524 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -111.83 165.46 12.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.395 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.1 t60 50.7 80.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.446 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 13.5 mm-40 -93.39 164.41 21.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.363 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 54.4 Cg_exo -49.63 -179.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.015 1.81 . . . . 0.0 110.316 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -80.33 80.73 6.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.0 109.48 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.713 ' HG2' HD21 ' A' ' 29' ' ' LEU . 4.1 mtt180 58.26 165.64 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 109.606 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 30' ' ' GLU . 18.9 mt -90.17 -70.55 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.597 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.719 ' HB3' HD11 ' A' ' 28' ' ' LEU . 3.3 tpm_? -114.45 121.86 44.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.937 . . . . 0.0 109.873 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.009 ' HB3' HG12 ' A' ' 27' ' ' VAL . 3.4 pm0 -130.21 135.42 48.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.122 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.6 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.05 -145.68 4.44 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.999 ' O ' HD13 ' A' ' 11' ' ' LEU . 8.2 p90 -142.26 102.41 4.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -1.06 . . . . 0.0 110.485 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.999 HD13 ' O ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -129.54 150.89 50.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG23 ' N ' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -81.17 135.82 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.091 -1.006 . . . . 0.0 108.759 179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HG3' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -127.82 84.79 2.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.18 -0.95 . . . . 0.0 110.087 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER 34.41 -149.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.259 0.552 . . . . 0.0 110.207 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' OG1' ' A' ' 20' ' ' THR . . . -145.92 163.35 28.32 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.6 m -89.22 23.24 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -1.179 . . . . 0.0 109.57 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG22 ' CD2' ' A' ' 18' ' ' PHE . 2.7 p -167.86 118.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.235 -0.916 . . . . 0.0 109.455 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 17' ' ' VAL . 44.9 m-85 60.24 153.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.118 -0.989 . . . . 0.0 109.433 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' ND2' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -59.45 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.484 ' OG1' ' HA3' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -119.39 152.48 36.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.517 -179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.626 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -133.6 121.51 22.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 110.1 -179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.643 ' N ' HG23 ' A' ' 12' ' ' VAL . 11.6 mttm -147.01 142.87 17.49 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.571 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.583 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 41.1 Cg_endo -73.08 130.79 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.094 1.863 . . . . 0.0 110.224 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.787 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -138.53 175.02 9.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 110.033 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.709 ' O ' ' SD ' ' A' ' 24' ' ' MET . 66.1 t-105 -92.27 145.39 24.52 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.2 OUTLIER -148.87 144.3 18.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.101 -178.364 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.009 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -137.1 99.61 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.369 -0.832 . . . . 0.0 109.566 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.878 HD22 ' CG1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -76.22 120.17 21.13 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.237 -0.914 . . . . 0.0 109.231 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.713 HD21 ' HG2' ' A' ' 5' ' ' ARG . 3.8 mp -106.03 167.27 9.91 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.433 -0.792 . . . . 0.0 109.507 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HB3' HD11 ' A' ' 6' ' ' ILE . 4.8 pt-20 -71.99 -10.85 60.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.99 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -110.75 -2.23 16.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.618 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.944 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 154.89 147.7 4.77 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.664 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -95.93 108.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -1.15 . . . . 0.0 110.13 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.585 ' HG2' HD11 ' A' ' 29' ' ' LEU . 23.8 pt-20 -107.82 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.665 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.787 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 1.4 p90 -117.09 150.49 38.57 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.094 -1.004 . . . . 0.0 109.993 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.642 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -127.5 -172.56 2.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.271 -0.893 . . . . 0.0 109.308 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -77.58 -50.04 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.58 -174.28 2.5 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -46.7 -23.65 0.44 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.932 -1.105 . . . . 0.0 109.415 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -149.87 -49.59 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.029 -1.045 . . . . 0.0 109.642 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 2.8 t70 62.26 9.79 3.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 41.46 23.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.174 -0.954 . . . . 0.0 110.066 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -165.14 102.22 0.79 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.998 -1.064 . . . . 0.0 110.169 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.6 Cg_exo -52.79 133.23 49.96 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 121.978 1.785 . . . . 0.0 110.523 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.98 -21.96 22.15 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 175.09 149.0 7.0 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.793 ' N ' ' SD ' ' A' ' 47' ' ' MET . 0.5 OUTLIER -125.62 169.02 12.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -1.163 . . . . 0.0 109.681 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.65 HG23 HG22 ' A' ' 73' ' ' THR . 57.1 mt -132.35 134.69 25.24 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.51 121.26 8.01 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.38 1.387 . . . . 0.0 110.472 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.944 HD23 ' CA ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -58.51 -39.02 78.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.429 -0.794 . . . . 0.0 109.707 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.656 ' HG3' HG22 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -101.11 108.27 19.91 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 125.24 -1.32 8.27 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.653 -1.26 . . . . 0.0 110.499 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 7.6 t -89.89 170.32 10.49 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.869 -1.371 . . . . 0.0 109.864 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.511 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -142.16 122.22 13.74 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.303 -0.873 . . . . 0.0 109.438 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.84 HD21 ' CD2' ' A' ' 69' ' ' PHE . 3.2 tm? -88.91 127.19 35.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.03 -1.044 . . . . 0.0 109.457 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.766 ' N ' HD13 ' A' ' 55' ' ' LEU . 3.4 m -117.46 102.24 9.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.172 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.432 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 3.3 m -140.51 135.84 16.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 57' ' ' SER . 58.4 Cg_endo -77.3 176.32 44.25 Favored 'Cis proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.35 -1.938 . . . . 0.0 110.345 -0.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 70' ' ' LYS . 5.0 m -148.59 82.45 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.375 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -98.69 112.93 24.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 109.44 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -177.74 -36.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 109.562 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.0 t80 -89.14 -39.68 13.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 0.0 108.329 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -117.14 -39.32 0.81 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER 39.36 72.44 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.74 -0.859 . . . . 0.0 109.317 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.57 -95.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.738 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.6 mmm -77.1 -122.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' CG ' ' A' ' 89' ' ' ARG . 38.6 m-85 -112.71 92.57 4.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.774 -1.204 . . . . 0.0 109.677 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -118.85 126.77 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.357 -0.839 . . . . 0.0 109.34 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.84 ' CD2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -112.62 176.19 5.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HB3' ' SG ' ' A' ' 59' ' ' CYS . 3.0 tmmm? -135.78 114.63 12.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.448 -0.783 . . . . 0.0 110.238 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -97.78 171.08 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.567 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 2.8 m -145.89 94.16 2.44 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.163 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.65 HG22 HG23 ' A' ' 48' ' ' ILE . 2.2 p -59.86 153.53 20.68 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.309 -0.869 . . . . 0.0 109.094 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -44.46 -23.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.498 -0.751 . . . . 0.0 110.223 -179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER -86.86 31.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 0.0 109.771 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.85 28.43 1.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.513 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.416 ' OE1' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -89.88 92.29 8.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.287 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.572 ' OD1' ' CZ ' ' A' ' 80' ' ' PHE . 8.3 t70 -58.92 152.76 18.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.907 . . . . 0.0 109.45 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -142.55 103.04 4.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.572 ' CZ ' ' OD1' ' A' ' 78' ' ' ASP . 10.8 m-85 -95.1 117.69 30.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.675 ' CD1' ' CE1' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -131.58 171.26 13.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.104 -0.998 . . . . 0.0 109.263 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.22 130.13 26.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.035 -1.041 . . . . 0.0 109.188 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.75 164.66 14.58 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.403 -0.811 . . . . 0.0 109.471 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.6 ' O ' ' CD1' ' A' ' 85' ' ' PHE . . . -97.43 53.37 1.15 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 0.1 OUTLIER 166.08 162.93 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.915 -179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.925 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -88.33 -51.09 5.93 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.925 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -65.19 -29.22 70.03 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -79.87 -43.28 22.57 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.481 -0.762 . . . . 0.0 109.426 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.679 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -54.49 -55.7 26.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.347 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.634 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.5 m-20 -65.83 -25.81 67.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 108.866 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.19 -24.66 64.07 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.99 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 11.7 m95 -83.27 -31.71 26.8 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.5 m -79.44 -23.34 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.508 -0.745 . . . . 0.0 109.395 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.3 mmp_? -86.4 -34.15 20.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.391 -0.818 . . . . 0.0 109.546 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.77 ' HB3' HD11 ' A' ' 28' ' ' LEU . 2.7 t0 -82.98 -41.55 18.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.149 -0.969 . . . . 0.0 109.681 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.878 ' CG1' HD22 ' A' ' 28' ' ' LEU . 4.4 mt -72.88 -35.17 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 109.293 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 1.5 t-20 -81.59 -32.74 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.118 -0.989 . . . . 0.0 109.187 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 1.1 tptt -68.52 -40.31 80.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 109.18 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -70.94 -40.37 72.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.357 -0.84 . . . . 0.0 109.295 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 96' ' ' ILE . 10.9 mt -67.48 -28.95 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.102 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -89.11 -8.75 53.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -30.8 13.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.656 HG22 ' HG3' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -70.11 -30.03 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.33 -0.856 . . . . 0.0 108.791 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.75 -5.98 34.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.06 10.89 5.1 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 106' ' ' LEU . 1.4 mt -99.04 57.13 1.07 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.422 -1.046 . . . . 0.0 109.144 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 108' ' ' HIS . 2.1 mp0 -92.42 68.18 4.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.677 -0.64 . . . . 0.0 109.37 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 107' ' ' GLU . 17.9 p80 -46.49 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 109.463 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.68 146.43 16.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.516 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -99.57 38.02 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 112' ' ' HIS . 0.2 OUTLIER -120.85 40.19 3.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.558 ' CD2' ' N ' ' A' ' 112' ' ' HIS . 2.7 m170 79.8 -73.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.566 -0.709 . . . . 0.0 109.646 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 66.7 t60 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.446 -179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -162.23 160.34 21.15 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.34 -0.85 . . . . 0.0 109.355 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 2' ' ' GLU . 53.2 Cg_exo -50.25 129.63 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 121.935 1.757 . . . . 0.0 110.054 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ARG . 26.7 mttt -92.1 75.87 5.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.666 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.477 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.5 OUTLIER 61.1 139.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.532 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 79.3 mt -73.17 -28.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -0.863 . . . . 0.0 109.806 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HB3' ' HG ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -145.28 166.53 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.075 -1.015 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.969 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 178.83 127.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.481 -0.762 . . . . 0.0 109.567 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.593 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.87 -145.6 4.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.981 ' C ' HD13 ' A' ' 11' ' ' LEU . 4.2 p90 -140.43 91.96 2.48 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 110.219 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.981 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -118.9 161.88 19.43 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.208 -0.933 . . . . 0.0 108.677 178.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.735 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -85.4 141.74 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.672 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HE2' ' CB ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -123.21 142.72 50.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.203 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HD2' ' CD1' ' A' ' 80' ' ' PHE . 5.2 tttt -88.17 115.62 25.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.128 -0.983 . . . . 0.0 109.512 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.4 93.91 0.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.96 -85.49 0.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -1.156 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.67 -19.08 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.573 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.96 63.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' HB3' ' CE ' ' A' ' 14' ' ' LYS . 50.5 m-80 63.95 100.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 109.377 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 17.4 p -149.18 -170.65 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.162 -0.961 . . . . 0.0 109.697 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.585 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.5 m95 -141.6 105.92 4.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.735 ' C ' HG23 ' A' ' 12' ' ' VAL . 35.5 mttt -146.75 136.62 11.92 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.118 -0.989 . . . . 0.0 109.849 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.551 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 50.0 Cg_exo -52.47 157.55 6.87 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.915 1.744 . . . . 0.0 110.119 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.789 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -168.18 165.92 13.0 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.025 -1.047 . . . . 0.0 110.111 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.748 ' O ' ' SD ' ' A' ' 24' ' ' MET . 62.6 t-105 -90.23 143.87 26.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.596 ' CB ' ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.6 138.57 14.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.935 -178.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.969 HG12 ' HB3' ' A' ' 8' ' ' GLU . 6.5 m -126.09 120.23 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.416 -0.802 . . . . 0.0 109.602 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD21 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 mt -78.95 120.52 23.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.41 -0.806 . . . . 0.0 109.446 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -115.18 158.55 22.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.182 -0.949 . . . . 0.0 108.981 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' CG1' ' A' ' 103' ' ' ILE . 6.5 pt-20 -73.02 -9.65 58.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' C ' HD22 ' A' ' 50' ' ' LEU . 2.9 p30 -107.89 -3.4 18.96 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.126 -0.984 . . . . 0.0 109.482 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.653 ' N ' HD22 ' A' ' 50' ' ' LEU . . . 152.78 155.54 7.15 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.676 -1.249 . . . . 0.0 110.072 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.53 107.16 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.349 -1.089 . . . . 0.0 109.252 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 27' ' ' VAL . 2.7 tp10 -104.7 117.84 35.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.2 p90 -125.59 147.71 49.2 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.666 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -123.67 -157.69 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.43 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -93.77 -43.6 8.54 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.163 -0.961 . . . . 0.0 108.471 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -111.88 -176.39 2.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -44.95 -25.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.933 -1.105 . . . . 0.0 109.248 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -149.91 -50.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.551 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.9 t0 61.15 10.82 3.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.868 . . . . 0.0 109.352 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.5 m-80 41.6 23.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.745 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -163.93 115.05 0.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.849 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.6 Cg_endo -71.4 134.7 25.12 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.888 1.726 . . . . 0.0 110.456 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -89.75 -20.21 23.84 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . 168.48 157.73 11.67 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' OE1' ' A' ' 34' ' ' GLU . 6.7 mtt -133.11 169.82 16.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.398 -1.06 . . . . 0.0 109.18 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.468 HG23 HG22 ' A' ' 73' ' ' THR . 56.9 mt -136.78 127.35 16.25 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 39.0 Cg_endo -67.78 124.65 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.252 1.301 . . . . 0.0 109.713 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.902 HD11 ' CG1' ' A' ' 103' ' ' ILE . 1.8 pt? -89.19 23.6 2.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.128 -0.983 . . . . 0.0 109.856 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -66.45 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.277 -0.889 . . . . 0.0 109.864 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA3' ' HB ' ' A' ' 74' ' ' THR . . . -101.26 -2.19 54.15 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -39.56 148.39 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.412 -1.052 . . . . 0.0 110.512 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -119.03 155.94 30.55 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.005 HD11 ' CG2' ' A' ' 93' ' ' VAL . 3.1 tm? -124.74 130.54 52.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.931 -1.106 . . . . 0.0 109.301 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 55' ' ' LEU . 90.2 m -121.8 123.38 41.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.709 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -150.49 119.56 3.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.582 ' O ' HG22 ' A' ' 56' ' ' THR . 56.9 Cg_endo -74.04 -175.12 14.62 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.7 -1.791 . . . . 0.0 110.299 -0.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.762 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER -102.95 170.11 8.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.389 -0.819 . . . . 0.0 109.574 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.762 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 mt-30 -107.66 133.19 52.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.923 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 3.7 t0 83.84 -49.42 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 5.7 m-85 -100.38 -32.25 10.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 108.727 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' HA3' ' H ' ' A' ' 59' ' ' CYS . . . -83.83 0.82 89.38 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -89.51 23.23 2.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -1.176 . . . . 0.0 109.272 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -143.8 -96.96 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.636 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -158.22 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 109.763 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 81.6 m-85 -97.53 87.97 4.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.872 . . . . 0.0 109.486 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 81' ' ' PHE . 2.1 p -135.18 130.71 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.847 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.688 ' CE2' ' CE1' ' A' ' 81' ' ' PHE . 3.7 p90 -100.03 167.5 10.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.205 -0.934 . . . . 0.0 109.304 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -125.63 116.91 22.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.77 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.613 HD12 ' CE1' ' A' ' 69' ' ' PHE . 3.4 mt -99.51 165.85 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 108.926 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.635 ' N ' HG22 ' A' ' 54' ' ' THR . 16.7 m -142.16 103.85 4.36 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -53.38 108.25 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.869 0.843 . . . . 0.0 109.689 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.564 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER 43.12 27.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.684 -0.635 . . . . 0.0 110.591 179.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' CB ' ' O ' ' A' ' 74' ' ' THR . 1.7 ttpp 80.71 42.43 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.075 -1.016 . . . . 0.0 109.412 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' N ' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -132.01 -78.88 0.51 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.551 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -89.96 133.97 34.49 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.533 -0.729 . . . . 0.0 110.254 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 3.5 p30 -95.2 152.18 18.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.356 -0.84 . . . . 0.0 108.752 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -141.99 104.72 4.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.995 -1.066 . . . . 0.0 110.214 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.575 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 1.8 m-85 -93.51 109.0 20.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 108.794 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.938 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -118.43 144.91 45.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.116 -0.99 . . . . 0.0 109.416 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.554 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 4.4 tm0? -118.93 133.97 55.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.837 -1.165 . . . . 0.0 109.827 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.47 -145.68 0.16 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' CD2' ' A' ' 85' ' ' PHE . . . -103.02 -10.1 19.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.052 -1.03 . . . . 0.0 109.796 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 171.19 174.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.829 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.915 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -47.38 -50.08 23.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.784 . . . . 0.0 110.148 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.915 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.9 tt0 -45.07 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.969 . . . . 0.0 110.21 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.514 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -60.51 -14.48 19.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -71.62 -38.82 70.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HA ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -85.09 -27.93 25.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . . . -76.58 -29.37 56.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.937 ' CZ3' HD21 ' A' ' 28' ' ' LEU . 10.4 m95 -84.31 -42.72 15.51 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.213 -0.929 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.005 ' CG2' HD11 ' A' ' 55' ' ' LEU . 4.8 p -72.12 -29.27 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.533 ' CD ' ' HA ' ' A' ' 91' ' ' ALA . 14.4 ptm180 -79.01 -34.9 43.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.818 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 13.4 t70 -75.62 -54.43 7.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.0 109.458 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG1' HD13 ' A' ' 28' ' ' LEU . 7.2 mt -55.34 -35.89 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.028 -1.045 . . . . 0.0 108.738 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.43 ' OD1' ' HG3' ' A' ' 101' ' ' LYS . 15.9 t30 -79.72 -24.69 41.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 108.907 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -63.09 1.13 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.343 -0.848 . . . . 0.0 108.901 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.68 ' O ' HD12 ' A' ' 50' ' ' LEU . . . -56.45 -35.4 67.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.539 ' CG1' ' HB2' ' A' ' 50' ' ' LEU . 34.4 mt -62.35 -35.86 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 108.796 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 97' ' ' ASN . 1.9 mtmp? -83.97 -8.38 59.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.552 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 8.9 t -93.57 -28.0 16.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.244 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.902 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -78.55 -79.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.799 ' N ' HG22 ' A' ' 103' ' ' ILE . 68.6 mt-10 37.38 52.5 1.25 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.771 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' O ' HD22 ' A' ' 106' ' ' LEU . . . 74.78 93.0 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -154.13 64.82 0.7 Allowed 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.59 -0.947 . . . . 0.0 109.405 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.8 62.14 0.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.438 -0.788 . . . . 0.0 109.531 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.42 171.94 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.213 -0.929 . . . . 0.0 109.415 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.68 74.85 0.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 28.3 p80 -48.99 120.58 4.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.551 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 112' ' ' HIS . 21.5 m80 52.45 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 111' ' ' HIS . 55.8 m-70 44.82 81.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.0 109.478 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.542 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 5.5 mp0 -134.79 164.49 43.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.466 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 52.4 Cg_exo -50.87 138.17 42.52 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.025 1.817 . . . . 0.0 110.166 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.04 97.76 5.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.281 -0.887 . . . . 0.0 109.507 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -58.42 165.07 2.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.447 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.714 ' HB ' HD12 ' A' ' 28' ' ' LEU . 12.1 mt -67.81 -49.04 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.598 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.991 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -144.4 111.04 5.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 109.67 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.023 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -119.65 132.7 55.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.54 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.59 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.11 -146.21 4.59 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.857 ' C ' HD13 ' A' ' 11' ' ' LEU . 20.0 p90 -142.68 102.73 4.1 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.251 -1.146 . . . . 0.0 110.523 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.861 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -121.03 160.47 23.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.213 -0.929 . . . . 0.0 108.555 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.3 p -86.03 151.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.074 -1.016 . . . . 0.0 109.52 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -140.49 147.72 40.02 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -0.829 . . . . 0.0 109.853 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HD2' ' NE1' ' A' ' 21' ' ' TRP . 24.4 tttm -117.5 133.67 55.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . 168.41 174.3 37.04 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.557 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.6 OUTLIER 58.15 -174.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -1.074 . . . . 0.0 109.204 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 18' ' ' PHE . 6.2 p -42.96 -42.63 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.258 -0.901 . . . . 0.0 108.626 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.658 ' N ' HG13 ' A' ' 17' ' ' VAL . 12.2 m-85 -39.69 -68.17 0.19 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.919 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.23 22.03 3.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.587 HG23 ' C ' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -108.27 -171.52 1.88 Allowed 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.663 ' HH2' HG23 ' A' ' 68' ' ' VAL . 14.4 m95 -132.03 82.19 2.01 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.127 -0.983 . . . . 0.0 108.675 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' N ' HG23 ' A' ' 12' ' ' VAL . 2.1 mttm -115.6 136.95 22.89 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.036 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.74 156.83 6.15 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.055 1.837 . . . . 0.0 110.16 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.762 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.1 OUTLIER -162.31 170.1 19.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.176 -0.952 . . . . 0.0 109.877 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.762 ' O ' ' SD ' ' A' ' 24' ' ' MET . 73.5 t-105 -97.7 142.61 29.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.652 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.17 135.4 10.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.166 -1.014 . . . . 0.0 109.977 -178.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.023 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.3 m -125.93 100.31 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.409 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -76.89 116.37 17.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.286 -0.883 . . . . 0.0 109.502 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' A' ' 32' ' ' GLY . 2.7 mp -101.08 161.75 13.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.463 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.566 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -70.59 -13.83 62.25 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.19 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.17 -1.31 17.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.009 -1.057 . . . . 0.0 109.854 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 1.001 ' HA2' HD23 ' A' ' 50' ' ' LEU . . . 158.5 140.42 2.91 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 50' ' ' LEU . 3.6 mp -95.57 121.11 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -1.203 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 29' ' ' LEU . 4.1 pt-20 -120.82 120.74 36.45 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.652 ' HB3' HG23 ' A' ' 26' ' ' VAL . 5.6 p90 -121.95 147.44 46.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.981 -1.074 . . . . 0.0 110.893 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.94 -150.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.19 -43.46 6.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -108.8 -175.96 2.91 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -47.87 -22.85 0.62 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.878 -1.139 . . . . 0.0 109.337 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -148.46 -51.54 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.7 t70 61.81 10.34 3.41 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.353 -0.842 . . . . 0.0 109.575 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 42.2 22.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.112 -0.992 . . . . 0.0 109.954 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.1 t -167.54 109.45 0.61 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 120.938 -1.101 . . . . 0.0 109.891 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 54.1 Cg_endo -71.61 134.26 23.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.849 1.7 . . . . 0.0 110.557 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.75 -19.4 24.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -177.22 142.5 5.8 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.422 ' HG3' ' C ' ' A' ' 46' ' ' GLY . 16.7 mtm -136.27 126.96 27.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.155 -1.203 . . . . 0.0 109.533 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.581 HG23 HG22 ' A' ' 73' ' ' THR . 4.7 mt -88.94 136.8 30.2 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.372 -0.83 . . . . 0.0 108.8 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' HG23 ' A' ' 48' ' ' ILE . 55.8 Cg_endo -72.31 140.74 34.23 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.721 1.614 . . . . 0.0 110.504 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.001 HD23 ' HA2' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -74.89 0.13 16.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.438 -0.789 . . . . 0.0 109.493 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.579 ' CB ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -44.8 -92.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.04 68.81 0.24 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.524 ' HA ' ' N ' ' A' ' 74' ' ' THR . 14.4 m -60.27 -161.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 109.6 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.34 122.32 15.61 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.332 -0.855 . . . . 0.0 109.661 -179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.784 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -89.07 122.1 32.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.175 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.575 ' N ' HD23 ' A' ' 55' ' ' LEU . 59.7 m -115.26 114.43 25.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.105 -0.997 . . . . 0.0 109.62 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 66.0 p -145.5 121.36 5.84 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' O ' HG22 ' A' ' 56' ' ' THR . 55.0 Cg_endo -71.92 175.3 43.23 Favored 'Cis proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.559 -1.851 . . . . 0.0 110.342 -0.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.795 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 9.5 t -90.69 -94.75 0.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.246 -0.909 . . . . 0.0 109.5 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.504 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.6 mt-30 -141.75 -149.76 0.29 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.371 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -15.12 8.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.259 -0.901 . . . . 0.0 108.818 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.28 -28.98 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.441 -0.787 . . . . 0.0 109.078 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.626 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -85.36 -14.38 68.74 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 65' ' ' ARG . 5.4 tttm -84.46 70.5 10.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -1.192 . . . . 0.0 109.579 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 165.17 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.423 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.586 ' SD ' ' NE2' ' A' ' 82' ' ' GLN . 2.7 mtt 67.2 -172.82 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 85' ' ' PHE . 1.3 m-85 -88.15 83.37 6.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.2 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 ' HH2' ' A' ' 21' ' ' TRP . 1.5 p -127.08 136.27 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.841 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.598 ' C ' ' CD1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -124.3 178.71 5.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.369 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.795 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 3.2 tttp -143.35 107.25 4.67 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.166 -0.959 . . . . 0.0 109.808 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -90.45 170.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 108.987 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.561 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.4 m -145.86 90.87 2.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.581 HG22 HG23 ' A' ' 48' ' ' ILE . 2.4 p -40.44 142.98 0.35 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.47 -0.769 . . . . 0.0 109.837 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.55 -29.27 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 0.0 109.963 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -73.02 -70.77 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.114 -0.991 . . . . 0.0 109.319 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.506 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.9 pt20 164.15 38.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -0.87 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.0 99.83 9.37 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 p30 -63.35 152.96 36.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -144.57 96.41 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.172 -0.955 . . . . 0.0 109.727 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -91.15 117.65 29.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.214 -0.929 . . . . 0.0 109.059 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.607 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -135.82 162.53 32.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.956 -1.09 . . . . 0.0 109.587 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.586 ' NE2' ' SD ' ' A' ' 66' ' ' MET . 36.5 tt0 -127.77 131.11 49.67 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.994 -1.066 . . . . 0.0 109.272 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HA ' HD12 ' A' ' 11' ' ' LEU . . . -89.5 -168.37 2.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.439 -0.788 . . . . 0.0 109.732 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -70.8 -89.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.011 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.13 -179.98 4.1 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 109.473 -179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.044 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -55.62 -59.45 4.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.609 -0.682 . . . . 0.0 109.602 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.044 ' N ' HD23 ' A' ' 86' ' ' LEU . 12.5 tm-20 -47.31 -67.06 0.31 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.048 . . . . 0.0 110.358 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 54.7 tt0 -52.42 -26.44 12.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.347 -179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -68.47 -63.6 1.03 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.043 -1.036 . . . . 0.0 109.707 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' N ' ' HD3' ' A' ' 89' ' ' ARG . 3.9 p30 -55.78 -27.84 53.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.27 -35.83 68.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 108.956 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.982 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.25 -41.53 73.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.613 -0.679 . . . . 0.0 110.358 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.784 ' CG2' HD11 ' A' ' 55' ' ' LEU . 5.3 p -76.89 -34.68 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 111.052 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 0.1 OUTLIER -71.56 -23.55 61.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.768 -1.207 . . . . 0.0 109.323 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -82.41 -39.36 22.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.154 -0.966 . . . . 0.0 109.472 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.624 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.3 mt -69.82 -37.59 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.082 -1.011 . . . . 0.0 109.187 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.4 -26.96 38.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.113 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 3.5 tptp -65.13 -44.95 87.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 108.935 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 6' ' ' ILE . . . -71.62 -35.7 70.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.133 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.904 ' HA ' HD13 ' A' ' 50' ' ' LEU . 46.7 mt -72.72 -19.45 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.416 -0.803 . . . . 0.0 109.258 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.36 -16.24 26.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.53 -29.39 14.39 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.428 -0.795 . . . . 0.0 109.483 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.824 ' CG1' HD12 ' A' ' 50' ' ' LEU . 7.9 mm -71.52 -26.24 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.235 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 67.9 mt-10 -51.92 -22.53 3.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 108.962 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -123.59 -104.97 1.7 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.42 66.07 1.11 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.412 -1.051 . . . . 0.0 109.576 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.33 135.17 52.26 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.451 -0.781 . . . . 0.0 109.409 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -120.77 -29.77 4.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 109.683 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -62.45 176.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -85.55 64.07 8.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.461 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -143.75 88.08 1.96 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -127.29 -37.43 2.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' C ' ' CG ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.51 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.0 mt-10 68.11 161.92 0.14 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 57.9 Cg_endo -75.17 -95.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.088 1.859 . . . . 0.0 110.28 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.67 90.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.569 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' HB2' ' OE2' ' A' ' 8' ' ' GLU . 0.4 OUTLIER -111.46 126.11 54.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.261 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 30' ' ' GLU . 7.5 mt -52.42 -45.98 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.828 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -140.43 145.19 36.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.857 -179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.039 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.6 pm0 -155.04 132.46 11.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.081 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.586 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.46 -147.57 4.88 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.82 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.4 p90 -140.49 93.89 2.67 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.545 -0.973 . . . . 0.0 110.232 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.82 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -118.27 157.08 27.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 108.807 179.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.672 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.6 p -81.49 151.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -132.13 139.87 48.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB2' ' CE2' ' A' ' 21' ' ' TRP . 14.1 ttpp -84.14 113.92 21.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.375 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.11 167.7 42.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -91.43 -24.84 19.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -1.128 . . . . 0.0 109.378 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 3.3 p -46.23 -32.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 109.447 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -177.03 -171.39 0.35 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.911 . . . . 0.0 109.414 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -82.72 85.01 7.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.579 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 27.1 p -127.16 166.0 18.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 20' ' ' THR . 18.1 m95 -150.69 106.82 3.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.672 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -131.73 133.14 23.84 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.4 Cg_exo -52.23 149.95 20.93 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 109.922 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.749 ' SD ' ' HB2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -159.38 168.3 26.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.02 -1.05 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.699 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.0 t-105 -92.57 144.22 25.55 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -150.94 134.1 7.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.024 -178.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.039 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.5 m -124.07 105.66 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.483 -0.761 . . . . 0.0 109.396 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.986 ' HA ' HG23 ' A' ' 33' ' ' ILE . 1.8 pp -80.74 111.87 17.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.137 -0.977 . . . . 0.0 109.581 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.3 mp -96.98 161.07 14.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -73.42 -11.23 60.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.625 -179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 4.5 p30 -108.86 2.79 21.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.871 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 150.86 144.57 3.95 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.986 HG23 ' HA ' ' A' ' 28' ' ' LEU . 4.6 mm -92.86 130.49 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 110.003 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 5.5 pt-20 -132.86 113.71 13.21 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.3 p90 -119.43 147.0 44.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.09 -1.006 . . . . 0.0 110.735 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.572 ' O ' ' SD ' ' A' ' 24' ' ' MET . 0.1 OUTLIER -127.92 -150.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.46 -53.54 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.53 -172.62 2.19 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.6 OUTLIER -54.1 -18.69 3.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.916 -1.115 . . . . 0.0 109.351 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.92 -53.91 0.2 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.1 t0 61.35 9.42 2.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 109.255 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.4 m120 40.5 24.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.221 -0.924 . . . . 0.0 110.071 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.6 t -167.45 122.46 0.84 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.982 -1.074 . . . . 0.0 109.499 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.568 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 59.2 Cg_endo -75.56 156.83 40.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.803 1.669 . . . . 0.0 111.276 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 2.8 tptt -119.13 -16.88 9.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -178.68 136.68 2.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.0 mtm -131.41 119.33 21.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -1.137 . . . . 0.0 109.697 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.539 ' CG2' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mt -89.77 139.47 27.77 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' CG2' ' A' ' 48' ' ' ILE . 38.6 Cg_endo -68.05 148.12 74.95 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.528 1.485 . . . . 0.0 110.56 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.943 HD13 ' HA ' ' A' ' 100' ' ' ILE . 0.2 OUTLIER -85.04 36.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.451 -0.781 . . . . 0.0 109.812 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -167.42 136.6 2.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.995 -1.066 . . . . 0.0 109.927 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 91.07 -36.18 3.69 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 100' ' ' ILE . 2.7 m -42.11 156.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.191 -1.182 . . . . 0.0 110.396 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -123.31 169.89 10.86 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -131.47 124.24 29.75 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.071 -1.018 . . . . 0.0 109.06 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.774 ' N ' HD23 ' A' ' 55' ' ' LEU . 20.4 m -115.97 125.81 53.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -150.2 127.91 5.69 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.588 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' SER . 56.3 Cg_endo -73.96 -178.28 22.12 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.471 -1.887 . . . . 0.0 110.277 -0.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.938 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.5 OUTLIER -150.06 175.1 12.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 109.662 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.617 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 2.3 tt0 66.84 138.22 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.427 -0.795 . . . . 0.0 110.172 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -129.84 18.61 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.617 ' CE2' ' HG3' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -89.26 -64.25 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -90.84 -21.85 35.15 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 8.0 pttt 40.33 32.88 0.15 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.724 -0.868 . . . . 0.0 109.39 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.05 20.71 10.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.583 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 9.8 mtp 58.89 179.32 0.07 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' A' ' 66' ' ' MET . 1.8 m-85 81.22 -13.66 0.89 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.497 -0.752 . . . . 0.0 109.911 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.938 HG22 ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER -109.84 135.18 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.979 -1.075 . . . . 0.0 109.423 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.735 ' C ' ' SG ' ' A' ' 59' ' ' CYS . 4.0 p90 -121.36 167.18 13.06 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 80' ' ' PHE . 19.5 ttpt -129.11 98.03 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 109.925 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 54' ' ' THR . 20.0 mt -90.9 155.41 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 108.538 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.569 ' CG2' ' HA ' ' A' ' 75' ' ' LYS . 39.9 m -134.61 112.31 10.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.049 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 76' ' ' GLN . 2.7 t -55.83 113.82 1.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 39.29 26.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.687 -0.633 . . . . 0.0 111.333 178.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 72' ' ' THR . 4.0 tptm 80.86 47.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.904 -1.122 . . . . 0.0 109.16 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.593 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -127.77 -83.64 0.6 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.206 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' H ' ' CG2' ' A' ' 73' ' ' THR . 11.0 tt0 -101.21 129.81 47.2 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.662 -0.649 . . . . 0.0 109.441 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.96 171.1 15.68 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.273 -0.892 . . . . 0.0 109.282 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 69.6 m-70 -146.15 96.01 2.71 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.559 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' O ' ' CH2' ' A' ' 21' ' ' TRP . 22.6 m-85 -93.16 100.22 12.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -0.796 . . . . 0.0 108.887 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.695 ' CE1' ' CE2' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -115.68 157.62 23.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.394 -179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.549 ' HB3' ' CG1' ' A' ' 12' ' ' VAL . 2.4 tt0 -121.19 128.85 52.87 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.065 -1.022 . . . . 0.0 108.999 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.54 ' O ' ' HB3' ' A' ' 84' ' ' ALA . . . -88.52 -7.66 56.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 83' ' ' ALA . . . 63.05 12.27 5.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.443 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.08 163.37 39.47 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.807 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.034 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -93.35 -48.03 6.61 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.034 ' N ' HD23 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -69.48 -44.32 71.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.52 -0.738 . . . . 0.0 109.281 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.62 -34.65 76.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.684 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -62.07 -61.63 2.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.882 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.16 -37.73 64.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -178.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 95' ' ' ASP . . . -71.86 -26.79 62.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.084 -1.01 . . . . 0.0 109.773 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.974 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 1.1 m95 -79.84 -31.44 40.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 110.075 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.74 HG22 HD11 ' A' ' 55' ' ' LEU . 1.3 p -83.43 -31.55 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -0.961 . . . . 0.0 109.566 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 6.6 ptm180 -77.94 -25.16 48.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.308 -0.87 . . . . 0.0 109.187 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ALA . 0.3 OUTLIER -82.0 -42.5 19.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 109.258 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 100' ' ' ILE . 29.5 mt -72.13 -37.46 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.177 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 7.7 t-20 -79.6 -33.81 41.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.502 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -67.37 -39.44 85.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.14 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -68.81 -47.45 66.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.32 -0.863 . . . . 0.0 109.091 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.943 ' HA ' HD13 ' A' ' 50' ' ' LEU . 6.9 mt -67.89 -20.83 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 97' ' ' ASN . 3.0 mmtp -90.11 -11.29 41.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.351 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 33.5 m -93.81 -38.16 11.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 0.0 108.856 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG1' HD12 ' A' ' 50' ' ' LEU . 2.8 mm -67.91 -29.72 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.49 -15.9 63.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -112.13 3.29 26.93 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.486 ' HA ' HD23 ' A' ' 106' ' ' LEU . 5.0 mt -106.09 58.94 0.65 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.392 -1.064 . . . . 0.0 109.097 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -64.5 -51.73 61.49 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.624 -0.672 . . . . 0.0 109.582 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 108' ' ' HIS . 0.1 OUTLIER -154.29 177.16 11.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.624 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 41.2 m-70 61.65 152.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.322 -0.861 . . . . 0.0 109.46 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -111.91 -26.86 8.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 66.87 155.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.35 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.61 -46.73 4.09 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.494 179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -172.7 175.96 0.98 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -0.883 . . . . 0.0 109.553 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 52.9 Cg_exo -51.7 147.94 22.91 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.062 1.841 . . . . 0.0 110.327 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -131.17 95.91 3.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.535 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -80.95 145.25 31.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.433 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.859 HG22 ' OD2' ' A' ' 95' ' ' ASP . 33.3 mt -74.43 -49.01 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.404 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.99 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -136.79 142.14 42.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.631 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.054 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -148.45 137.05 21.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.398 179.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.585 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.42 -149.5 5.69 Favored Glycine 0 N--CA 1.483 1.785 0 N-CA-C 109.091 -1.603 . . . . 0.0 109.091 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 1.023 ' C ' HD13 ' A' ' 11' ' ' LEU . 5.1 p90 -140.42 98.25 3.39 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.456 -1.026 . . . . 0.0 110.037 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.023 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -120.09 171.91 8.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 108.621 178.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.957 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.2 p -102.97 131.54 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 109.665 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.69 ' HB3' ' SD ' ' A' ' 24' ' ' MET . 18.4 ttmt -132.33 168.09 18.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.472 -0.768 . . . . 0.0 109.367 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' CD ' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -63.83 103.97 0.63 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.464 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 16' ' ' SER . . . -67.33 -74.01 0.6 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.491 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.3 OUTLIER 175.84 -159.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -1.155 . . . . 0.0 109.316 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.491 ' CG1' ' O ' ' A' ' 16' ' ' SER . 2.5 p 39.93 94.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.558 -0.714 . . . . 0.0 110.01 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.48 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 3.3 m-85 63.0 127.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.465 ' HA ' ' CD ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -47.75 97.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.487 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -120.38 -177.19 3.39 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 0.0 109.584 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.757 ' CH2' HG23 ' A' ' 68' ' ' VAL . 2.0 m95 -142.9 106.63 4.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.271 -0.893 . . . . 0.0 109.472 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.957 ' C ' HG23 ' A' ' 12' ' ' VAL . 2.8 mmtp -130.33 140.84 39.88 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.85 163.85 1.82 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.876 1.717 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.69 ' SD ' ' HB3' ' A' ' 13' ' ' LYS . 17.7 ptm -176.91 159.67 1.75 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.278 -0.889 . . . . 0.0 109.778 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 73.9 t-105 -90.24 145.28 25.12 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.49 136.44 11.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 118.939 -1.105 . . . . 0.0 110.297 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.054 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.1 m -127.38 101.68 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.511 -0.743 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.02 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -74.01 119.68 18.56 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.296 -0.877 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.543 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.8 mp -109.11 165.44 11.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.878 . . . . 0.0 109.499 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HG3' HD11 ' A' ' 6' ' ' ILE . 2.1 tt0 -73.44 -14.5 61.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.906 ' C ' HD11 ' A' ' 50' ' ' LEU . 5.2 p-10 -105.6 5.88 31.64 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.379 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 1.045 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 143.58 144.07 4.19 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.813 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.6 mp -90.94 107.79 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.285 -1.126 . . . . 0.0 109.445 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' HD11 ' A' ' 29' ' ' LEU . 11.3 pt-20 -105.22 116.68 32.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 108.769 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.656 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.6 p90 -120.21 147.72 44.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -128.82 -152.06 0.5 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.02 -40.75 9.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 0.9 OUTLIER -112.83 -178.24 3.34 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.5 OUTLIER -43.0 -25.99 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.069 -1.019 . . . . 0.0 109.54 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -147.18 -50.63 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 0.0 109.613 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.3 t0 62.99 8.42 3.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.514 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m120 41.16 23.58 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.8 t -166.51 96.69 0.72 Allowed Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.924 -1.11 . . . . 0.0 110.271 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 52.1 Cg_exo -53.26 132.35 47.74 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.056 1.837 . . . . 0.0 110.739 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.525 ' HE3' ' CE ' ' A' ' 24' ' ' MET . 3.0 ttpt -89.77 -22.04 22.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.72 145.82 7.88 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 30.4 mtm -124.22 165.82 16.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -1.174 . . . . 0.0 109.496 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.663 HG23 HG22 ' A' ' 73' ' ' THR . 2.4 mt -132.93 117.7 15.06 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.923 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HG2' ' HB ' ' A' ' 73' ' ' THR . 54.8 Cg_endo -71.07 125.29 11.32 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.682 1.588 . . . . 0.0 109.916 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.045 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -90.2 39.59 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.319 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -89.77 -43.01 10.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.109 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -159.41 42.8 0.46 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.495 ' HB2' HD13 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -68.98 179.04 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -1.153 . . . . 0.0 109.562 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.497 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -144.23 108.75 4.86 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.283 -0.886 . . . . 0.0 109.593 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.832 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.1 tm? -89.79 115.65 27.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.713 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.2 m -110.4 119.86 40.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.894 . . . . 0.0 109.175 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.6 p -144.2 123.88 7.35 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 0.0 109.654 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.487 ' O ' HG22 ' A' ' 56' ' ' THR . 57.5 Cg_endo -74.5 -170.21 7.88 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.648 -1.813 . . . . 0.0 110.171 -0.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.638 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 10.3 t -102.64 -105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 109.279 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.638 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 2.9 pt20 162.97 119.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.944 -1.098 . . . . 0.0 109.789 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 60' ' ' GLN . 0.8 OUTLIER 81.27 -40.35 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.722 . . . . 0.0 110.651 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 0.1 OUTLIER -90.59 85.8 6.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.934 -1.104 . . . . 0.0 110.001 -179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.601 ' O ' HG11 ' A' ' 68' ' ' VAL . . . 78.08 20.33 73.09 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 51.1 tptt -53.2 89.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.242 . . . . 0.0 109.175 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' GLY . 3.4 mtt-85 174.6 -86.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 0.0 109.551 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 65' ' ' ARG . 1.1 mtp -60.38 -148.91 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.581 -0.699 . . . . 0.0 109.473 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 86' ' ' LEU . 98.4 m-85 -99.9 76.12 1.93 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.402 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.757 HG23 ' CH2' ' A' ' 21' ' ' TRP . 1.1 p -122.53 128.23 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.445 -0.785 . . . . 0.0 109.31 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.614 ' CE2' ' CE2' ' A' ' 81' ' ' PHE . 10.4 p90 -122.95 173.4 7.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HG2' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -132.97 122.01 23.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.569 ' CG2' ' N ' ' A' ' 72' ' ' THR . 2.9 mt -93.62 167.94 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.875 . . . . 0.0 109.057 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -146.49 85.86 1.66 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.663 HG22 HG23 ' A' ' 48' ' ' ILE . 5.2 p -44.39 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.569 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.09 63.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.946 . . . . 0.0 109.246 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 5.9 mttp -89.76 12.06 18.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.404 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.451 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 72.44 26.28 2.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.4 OUTLIER -89.84 119.55 30.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.13 -0.981 . . . . 0.0 108.998 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 4.4 t0 -89.36 135.92 33.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.957 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 89.1 m-70 -130.01 97.12 4.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.405 -0.809 . . . . 0.0 108.97 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.446 ' CZ ' ' CG ' ' A' ' 78' ' ' ASP . 1.9 m-85 -90.19 120.49 31.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.665 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.28 146.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.217 179.381 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.55 ' HG2' ' CG1' ' A' ' 12' ' ' VAL . 6.5 pt20 -116.52 145.71 43.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.379 -0.826 . . . . 0.0 108.777 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -92.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.397 -0.814 . . . . 0.0 109.597 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -163.72 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.74 174.94 6.36 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.652 -0.655 . . . . 0.0 109.615 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.958 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -65.16 -41.31 94.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.53 -0.731 . . . . 0.0 109.184 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.958 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -57.48 -67.0 0.37 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.701 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -54.5 -31.73 56.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.937 . . . . 0.0 109.765 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.716 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.82 -65.13 0.71 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.939 . . . . 0.0 109.967 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.611 ' HA ' HG23 ' A' ' 93' ' ' VAL . 47.6 m-20 -58.84 -23.76 61.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.902 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -72.91 -31.96 64.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.015 -1.053 . . . . 0.0 109.507 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.02 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 4.2 m95 -82.57 -39.05 22.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.228 -0.92 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.4 -21.92 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.246 -0.909 . . . . 0.0 109.341 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 90' ' ' ASP . 10.0 ptp180 -85.3 -29.44 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -0.947 . . . . 0.0 109.482 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.859 ' OD2' HG22 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -84.35 -39.32 19.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.589 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HD22 ' A' ' 28' ' ' LEU . 5.6 mt -72.85 -34.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -0.934 . . . . 0.0 108.801 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -80.7 -28.93 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -53.33 17.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 108.972 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' HB2' HD13 ' A' ' 6' ' ' ILE . . . -59.01 -40.67 85.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 108.928 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.505 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 44.9 mt -65.06 -33.76 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.386 -0.821 . . . . 0.0 108.943 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 8.8 ttpt -78.03 -9.42 59.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.489 ' SG ' ' HG ' ' A' ' 106' ' ' LEU . 8.8 t -95.13 -32.31 13.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.406 -0.809 . . . . 0.0 109.141 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 50' ' ' LEU . 3.2 mm -67.74 -33.74 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 15.2 mt-10 -75.01 -2.1 25.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.289 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.74 20.7 2.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HG ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -87.7 54.34 3.09 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.635 -0.921 . . . . 0.0 109.235 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.04 -170.48 3.15 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.8 -0.563 . . . . 0.0 109.545 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -123.44 -37.09 2.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 64.55 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 0.0 109.542 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -96.8 -64.06 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.4 58.33 1.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -112.1 -58.4 2.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.265 -0.897 . . . . 0.0 109.42 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 21.5 mt-10 -101.16 163.3 18.21 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.954 . . . . 0.0 109.53 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 51.3 Cg_exo -52.2 -165.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.088 1.859 . . . . 0.0 110.381 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -121.06 100.46 7.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.406 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.573 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.0 OUTLIER 71.99 126.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.324 -0.86 . . . . 0.0 109.434 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' HB3' ' A' ' 30' ' ' GLU . 2.2 mp -67.87 -39.77 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.807 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.554 ' HG3' ' CB ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -131.73 169.55 16.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.031 -1.043 . . . . 0.0 109.866 -179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.916 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.1 OUTLIER 175.09 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.381 -0.824 . . . . 0.0 109.676 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.62 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -164.86 -147.14 5.02 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.962 ' C ' HD13 ' A' ' 11' ' ' LEU . 8.0 p90 -138.96 103.83 4.9 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.975 -1.309 . . . . 0.0 110.902 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.969 HD21 ' CZ2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -120.63 158.17 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.935 . . . . 0.0 108.546 178.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.884 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -86.53 129.78 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.968 -1.083 . . . . 0.0 109.295 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HD2' ' CB ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -116.97 170.15 8.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.467 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -116.18 134.83 54.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.82 0.21 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 t -125.31 -34.02 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -1.157 . . . . 0.0 109.609 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -132.31 -84.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.529 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 17' ' ' VAL . 4.6 m-85 -133.06 71.8 1.48 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.393 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 54.61 60.76 3.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.208 -0.933 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.518 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 48.7 p -115.83 -165.07 1.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.606 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.738 ' HH2' HG23 ' A' ' 68' ' ' VAL . 3.3 m95 -149.42 109.01 4.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.88 . . . . 0.0 109.668 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.884 ' C ' HG23 ' A' ' 12' ' ' VAL . 6.1 mttm -140.38 143.21 32.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 109.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' CA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -51.26 156.42 5.53 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.987 1.791 . . . . 0.0 110.188 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.759 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -160.88 176.65 11.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.211 -0.93 . . . . 0.0 109.545 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.759 ' O ' ' SD ' ' A' ' 24' ' ' MET . 68.1 t-105 -109.69 146.16 35.32 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 92' ' ' TRP . 0.5 OUTLIER -150.41 147.25 16.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 118.966 -1.094 . . . . 0.0 109.948 -178.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 8' ' ' GLU . 5.3 m -130.96 119.32 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -0.969 . . . . 0.0 110.187 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.922 HD21 ' HZ3' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -81.15 124.35 29.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.767 HD11 ' HG2' ' A' ' 34' ' ' GLU . 2.4 mp -119.95 159.94 23.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 108.97 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HB3' HD11 ' A' ' 6' ' ' ILE . 8.9 pt-20 -72.88 -22.18 60.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 109.698 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.928 ' C ' HD11 ' A' ' 50' ' ' LEU . 3.2 p30 -96.17 13.07 28.59 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 109.118 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 1.092 ' N ' HD11 ' A' ' 50' ' ' LEU . . . 137.17 169.77 11.73 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' MET . 3.6 mp -111.86 112.57 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.126 -1.22 . . . . 0.0 109.363 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.767 ' HG2' HD11 ' A' ' 29' ' ' LEU . 16.8 pt-20 -107.83 117.39 34.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 108.637 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.644 ' CD1' ' CE ' ' A' ' 24' ' ' MET . 7.1 p90 -115.67 148.88 39.21 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.44 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -130.89 -158.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 -34.3 14.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.405 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -123.78 -169.05 1.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.147 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' HA ' ' NE1' ' A' ' 25' ' ' TRP . 6.9 tppt? -46.4 -25.38 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.909 -1.119 . . . . 0.0 109.011 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -155.25 -48.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 43' ' ' SER . 5.4 t70 60.96 11.14 3.15 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 41' ' ' ASP . 48.2 t30 43.62 23.07 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.01 -1.056 . . . . 0.0 109.353 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.7 t -164.4 99.99 0.88 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.558 ' HB3' ' CE2' ' A' ' 36' ' ' TYR . 51.4 Cg_endo -71.43 144.36 45.25 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.919 1.746 . . . . 0.0 110.704 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -89.65 -22.68 22.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.049 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.621 ' N ' ' CE1' ' A' ' 35' ' ' PHE . . . 172.89 158.49 17.35 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 3.8 mtt -123.3 -178.71 4.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -1.176 . . . . 0.0 109.444 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 73' ' ' THR . 5.8 mt -135.98 116.26 11.38 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.198 -0.939 . . . . 0.0 109.279 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.58 122.1 8.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.623 1.549 . . . . 0.0 110.099 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.092 HD11 ' N ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -73.01 -0.61 14.3 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.167 -0.958 . . . . 0.0 109.744 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.842 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.2 OUTLIER -43.04 -60.44 1.64 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 70.02 0.18 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.129 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.2 m -82.72 177.32 8.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -1.197 . . . . 0.0 109.146 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -134.19 165.47 25.01 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.557 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.746 HD11 ' HB ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.08 124.32 42.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.162 -0.961 . . . . 0.0 108.84 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.681 ' N ' HD23 ' A' ' 55' ' ' LEU . 30.5 m -111.77 119.87 40.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 109.738 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 52.4 p -150.5 115.89 3.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 56' ' ' THR . 52.6 Cg_endo -71.6 -172.1 8.4 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.596 -1.835 . . . . 0.0 110.263 -0.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 0.6 OUTLIER -94.69 -91.75 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.733 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 10.5 pt20 -145.36 -155.68 0.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.969 . . . . 0.0 109.818 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 21.1 2.06 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.57 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 7.8 t80 -89.84 -57.22 2.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -112.55 16.31 24.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 20.2 tttm -48.55 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.216 -1.167 . . . . 0.0 109.358 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.7 OUTLIER 177.55 -94.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.596 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 18.0 mtm -64.74 -148.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.462 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 77.9 m-85 -100.66 79.92 2.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.967 . . . . 0.0 109.464 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG23 ' HH2' ' A' ' 21' ' ' TRP . 0.9 OUTLIER -117.45 132.59 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.455 -0.778 . . . . 0.0 109.326 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.659 ' CE2' HG13 ' A' ' 93' ' ' VAL . 9.2 p90 -126.63 172.09 10.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.663 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -133.43 116.1 15.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 109.786 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.584 HD12 ' CE1' ' A' ' 69' ' ' PHE . 5.0 mt -95.4 162.01 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 64.8 m -131.19 92.68 3.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.315 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.591 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -57.54 150.3 19.3 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.239 -0.913 . . . . 0.0 108.839 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.842 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -43.2 -26.04 0.15 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.508 -0.745 . . . . 0.0 109.846 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -88.28 35.43 0.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.13 -0.981 . . . . 0.0 109.554 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 43.87 31.02 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.338 -0.851 . . . . 0.0 109.743 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -89.64 87.46 7.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.007 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 7.7 m-20 -58.17 143.92 42.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.374 -0.829 . . . . 0.0 110.148 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -135.62 106.11 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -101.68 111.3 23.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -142.65 147.71 36.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 0.0 109.181 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -114.12 141.53 47.36 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.483 -0.761 . . . . 0.0 109.162 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.498 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.71 -147.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.78 -75.13 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.192 -0.942 . . . . 0.0 109.694 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -114.43 179.31 3.99 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.401 0.619 . . . . 0.0 109.482 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.862 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -56.55 -57.17 13.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.586 -0.696 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.862 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -50.77 -51.02 54.45 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.303 -0.873 . . . . 0.0 110.423 -178.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.589 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 60.8 tt0 -65.37 -24.85 67.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.029 . . . . 0.0 109.662 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -67.23 -66.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -0.894 . . . . 0.0 109.805 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.576 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 14.5 m-20 -59.29 -32.21 69.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.51 84.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.156 -0.965 . . . . 0.0 109.349 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.969 ' CZ2' HD21 ' A' ' 11' ' ' LEU . 3.1 m95 -71.79 -56.77 5.16 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.201 -0.937 . . . . 0.0 108.586 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.35 -13.65 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.542 -0.724 . . . . 0.0 109.152 179.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 0.1 OUTLIER -80.48 -36.01 33.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.332 -0.855 . . . . 0.0 109.558 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.789 ' HB3' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -85.78 -27.19 25.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 0.0 110.06 -179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.891 ' CG1' HD13 ' A' ' 28' ' ' LEU . 4.8 mt -77.91 -36.9 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.929 -1.107 . . . . 0.0 108.957 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -84.94 -37.24 20.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.172 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -69.31 -49.74 52.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 0.0 108.971 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.47 95.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.48 -0.762 . . . . 0.0 109.107 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.653 ' CG1' HD23 ' A' ' 50' ' ' LEU . 22.5 mt -62.04 -39.13 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.897 . . . . 0.0 108.752 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -79.32 -9.86 59.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.52 -20.08 19.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.409 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 50' ' ' LEU . 3.2 tp -88.5 -16.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.356 -0.84 . . . . 0.0 109.325 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.18 -12.95 61.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -116.62 4.86 19.24 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 0.3 OUTLIER -106.28 59.24 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -1.104 . . . . 0.0 109.075 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LEU . 31.9 mt-10 61.01 -171.61 0.14 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.548 -0.72 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -159.75 -49.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -0.904 . . . . 0.0 109.411 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.18 -39.51 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.322 -0.861 . . . . 0.0 109.357 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 140.52 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.77 -75.07 0.55 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.431 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -161.77 150.88 15.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 15.2 m80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.49 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -53.34 -61.69 4.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.835 . . . . 0.0 109.808 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.2 Cg_endo -71.78 158.93 52.04 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.751 1.634 . . . . 0.0 110.68 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 5' ' ' ARG . 3.7 mttt 55.06 101.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.683 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CD ' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER 64.72 150.88 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -112.53 -61.52 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.972 . . . . 0.0 109.779 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.927 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.127 -0.983 . . . . 0.0 109.981 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.656 ' CB ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -166.48 130.43 2.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.423 -0.798 . . . . 0.0 109.063 179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.61 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.31 -148.97 5.33 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.939 ' C ' HD13 ' A' ' 11' ' ' LEU . 13.4 p90 -135.99 89.99 2.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.126 -1.22 . . . . 0.0 110.635 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.939 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -111.46 158.99 18.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 108.758 178.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.661 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -83.58 132.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.107 -0.995 . . . . 0.0 109.675 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 2.0 tttt -119.1 157.29 28.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -100.34 98.57 9.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.532 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.83 80.22 0.05 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.96 -42.09 0.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -1.117 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 17' ' ' VAL . 10.8 p -179.35 106.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 17' ' ' VAL . 5.3 m-85 56.82 164.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.426 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' PHE . 4.4 m120 -43.06 106.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.365 -0.835 . . . . 0.0 109.105 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 1.2 p -148.91 146.79 28.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -0.927 . . . . 0.0 109.811 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.573 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.3 m0 -126.94 113.78 16.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.661 ' C ' HG23 ' A' ' 12' ' ' VAL . 1.5 mmtp -138.61 135.93 18.41 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.027 -1.046 . . . . 0.0 110.035 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.4 Cg_exo -53.99 152.76 22.68 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.914 1.743 . . . . 0.0 109.882 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.766 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -163.39 168.03 20.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.976 -1.078 . . . . 0.0 109.89 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.766 ' O ' ' SD ' ' A' ' 24' ' ' MET . 70.2 t-105 -96.06 143.79 26.9 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.694 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.61 139.82 14.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.236 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . 5.7 m -125.94 113.01 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.003 . . . . 0.0 109.59 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.045 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.1 pp -85.82 102.89 14.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 108.964 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' A' ' 5' ' ' ARG . 1.8 mp -89.51 155.78 19.06 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.454 -0.779 . . . . 0.0 109.192 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.2 tt0 -70.27 -19.3 63.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.324 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.26 4.91 31.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.704 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.989 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 164.21 -179.96 38.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm -137.0 119.42 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.239 -1.153 . . . . 0.0 109.422 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.659 ' O ' HG22 ' A' ' 27' ' ' VAL . 4.2 pt-20 -127.51 117.24 21.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 108.87 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.694 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.2 p90 -120.96 147.1 45.93 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.903 -1.123 . . . . 0.0 110.347 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.644 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -145.96 172.75 12.91 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -61.14 2.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.033 . . . . 0.0 109.288 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 13.3 mmtt -78.87 -168.76 1.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.985 . . . . 0.0 108.757 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 7.6 mtpt -77.61 5.69 8.68 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.788 -1.195 . . . . 0.0 110.006 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.89 -43.51 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.343 -0.848 . . . . 0.0 109.125 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 43' ' ' SER . 13.2 t0 48.61 18.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.304 -0.872 . . . . 0.0 109.541 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 43' ' ' SER . 59.9 t30 40.65 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.9 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t 178.05 112.83 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.108 -0.995 . . . . 0.0 109.626 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 53.7 Cg_endo -71.55 142.53 40.54 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.83 1.686 . . . . 0.0 110.638 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -89.3 -5.45 57.54 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -179.33 129.2 1.33 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 6.4 mtm -126.69 127.45 45.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -1.207 . . . . 0.0 109.978 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.693 HG23 HG22 ' A' ' 73' ' ' THR . 2.7 mt -94.59 131.81 30.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.08 151.63 55.86 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.784 1.656 . . . . 0.0 110.626 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.033 HD12 HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -90.95 5.26 49.41 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.316 -0.865 . . . . 0.0 109.202 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.627 ' HB3' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -51.43 -72.15 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.125 -0.985 . . . . 0.0 109.689 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.29 74.83 0.17 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.544 ' HB3' HD13 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -78.79 -179.7 6.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -1.191 . . . . 0.0 109.382 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.493 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -133.55 107.77 8.2 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.326 -0.859 . . . . 0.0 109.673 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.975 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -89.65 117.71 28.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.419 -0.801 . . . . 0.0 109.324 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.909 ' N ' HD22 ' A' ' 55' ' ' LEU . 8.6 m -106.52 131.95 53.1 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.369 -0.832 . . . . 0.0 109.365 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -142.95 125.22 8.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.434 -0.791 . . . . 0.0 109.286 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.727 ' O ' HG22 ' A' ' 56' ' ' THR . 55.7 Cg_endo -73.25 -161.78 2.38 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.479 -1.884 . . . . 0.0 110.337 -0.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.4 p -104.43 -148.02 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.568 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.525 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.6 OUTLIER -89.78 -149.84 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.742 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.68 19.75 2.36 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.329 -0.857 . . . . 0.0 109.188 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -89.03 84.41 6.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.169 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . 107.97 -55.91 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 63' ' ' GLY . 3.8 tttt 42.37 26.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.423 -1.045 . . . . 0.0 109.788 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 67' ' ' PHE . 19.4 mtp180 -88.01 16.56 5.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.295 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.514 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 19.3 mtm 65.8 8.74 5.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.342 -0.849 . . . . 0.0 109.956 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' CE2' ' O ' ' A' ' 65' ' ' ARG . 1.5 m-85 -135.45 28.29 3.36 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.566 -0.709 . . . . 0.0 109.512 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 62' ' ' PHE . 2.5 p -127.18 127.13 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.101 -0.999 . . . . 0.0 109.817 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.733 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.51 166.44 10.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.237 -0.915 . . . . 0.0 109.884 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 15.8 ttpt -134.88 105.45 6.41 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -0.883 . . . . 0.0 109.134 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.651 HD11 HG21 ' A' ' 96' ' ' ILE . 2.7 mt -89.63 165.17 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 109.653 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.54 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.5 m -144.58 93.27 2.4 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.693 HG22 HG23 ' A' ' 48' ' ' ILE . 1.6 p -47.88 153.44 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 109.408 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.627 HG21 ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.7 87.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.651 -0.655 . . . . 0.0 109.655 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.5 OUTLIER 158.59 -80.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.447 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 2.9 pt20 178.59 31.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.386 -0.821 . . . . 0.0 109.625 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 10.0 mt-30 -97.12 105.67 17.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 108.758 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.584 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 11.9 p30 -82.85 144.1 30.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.012 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 94.5 m-70 -139.76 91.78 2.5 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -93.54 128.35 39.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.044 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.733 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -145.52 141.91 28.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -110.08 143.82 39.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.469 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.14 -146.46 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.754 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -102.38 -18.65 15.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.627 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.2 OUTLIER -166.9 172.13 10.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.481 -0.762 . . . . 0.0 109.561 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.1 tp -56.28 -39.94 73.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 109.831 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -53.16 -61.22 2.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.08 -1.013 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HB3' ' HB1' ' A' ' 83' ' ' ALA . 21.5 tt0 -63.68 -16.19 60.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.437 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 1.05 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -72.03 -64.12 1.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.725 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.612 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -66.13 -15.63 63.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.603 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.39 -40.67 29.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 109.012 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 1.045 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.0 m95 -77.97 -26.91 48.98 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.05 HG13 ' O ' ' A' ' 89' ' ' ARG . 3.0 m -77.43 -32.2 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 7.3 ptp180 -80.44 -23.85 39.98 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.394 -0.816 . . . . 0.0 109.544 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.774 ' OD1' HD11 ' A' ' 28' ' ' LEU . 1.1 t70 -85.01 -46.87 10.79 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.016 -1.052 . . . . 0.0 109.706 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.651 HG21 HD11 ' A' ' 71' ' ' ILE . 5.8 mt -70.05 -30.56 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.072 -1.018 . . . . 0.0 109.141 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 55' ' ' LEU . 7.8 t30 -84.65 -37.62 20.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.255 -0.903 . . . . 0.0 109.707 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 2.6 tppt? -69.92 -29.49 66.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.074 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.13 -28.71 32.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.544 HD13 ' HB3' ' A' ' 53' ' ' SER . 31.1 mt -77.9 -30.05 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -16.69 27.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 109.54 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -95.77 -26.57 15.62 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.572 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 1.033 HG21 HD12 ' A' ' 50' ' ' LEU . 8.4 tp -73.33 -25.48 21.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -0.93 . . . . 0.0 109.62 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -50.96 -22.64 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 108.965 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . . . -120.59 -104.5 1.98 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER 43.71 70.89 0.27 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.408 -1.054 . . . . 0.0 109.594 179.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -110.31 -84.88 0.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -167.86 -61.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.409 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.408 ' O ' ' CB ' ' A' ' 110' ' ' HIS . 1.6 t60 -118.66 -164.73 1.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 109' ' ' HIS . 35.4 t-80 69.86 125.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -98.24 112.28 24.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.536 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 113' ' ' HIS . 10.9 t-160 -112.71 -50.68 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.394 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.403 ' CD2' ' O ' ' A' ' 112' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.424 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.595 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -69.18 -61.95 3.02 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.682 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.595 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.5 Cg_endo -71.73 -32.3 11.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 121.854 1.703 . . . . 0.0 110.051 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' PRO . 4.0 mttm 59.91 113.91 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -91.09 139.06 31.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.425 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 6' ' ' ILE . 1.5 mp -64.6 -49.04 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.609 ' HB2' HD21 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -119.17 147.17 44.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.12 -0.987 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.007 ' CB ' HG12 ' A' ' 27' ' ' VAL . 1.3 pm0 -163.57 122.24 1.98 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.267 -0.895 . . . . 0.0 109.217 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.598 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.19 -145.71 4.42 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.606 ' C ' HD13 ' A' ' 11' ' ' LEU . 2.0 p90 -135.48 93.33 2.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.277 -1.131 . . . . 0.0 110.018 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.966 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -105.19 161.29 14.39 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.044 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.5 p -92.65 146.87 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.866 -1.146 . . . . 0.0 109.76 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -134.74 150.18 50.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.488 -0.757 . . . . 0.0 109.224 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' A' ' 62' ' ' PHE . 4.1 ttpp -62.11 140.33 58.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -99.0 158.02 20.12 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 55.63 2.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -1.165 . . . . 0.0 109.525 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.59 -90.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.497 ' H ' HG23 ' A' ' 17' ' ' VAL . 80.3 m-85 -131.91 55.54 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 14' ' ' LYS . 39.9 t-20 60.31 85.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.551 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 38.0 p -138.01 174.01 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -0.935 . . . . 0.0 109.718 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.553 ' CZ2' ' HB2' ' A' ' 80' ' ' PHE . 15.6 m95 -150.2 100.66 2.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.367 -0.833 . . . . 0.0 108.941 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 12' ' ' VAL . 4.9 mttm -123.21 145.02 45.08 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.146 -0.971 . . . . 0.0 110.093 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.3 Cg_exo -53.05 166.01 1.1 Allowed 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.129 1.886 . . . . 0.0 110.507 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.757 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -173.32 169.33 4.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.276 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.757 ' O ' ' SD ' ' A' ' 24' ' ' MET . 60.8 t-105 -89.81 141.39 28.67 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.113 -0.992 . . . . 0.0 108.651 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 92' ' ' TRP . 1.2 p -151.53 129.59 2.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.964 -179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.007 HG12 ' CB ' ' A' ' 8' ' ' GLU . 6.2 m -125.37 111.98 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.442 -0.786 . . . . 0.0 109.568 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.725 HD11 ' OD1' ' A' ' 95' ' ' ASP . 2.6 pp -86.6 113.71 22.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.124 -0.985 . . . . 0.0 109.038 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.596 HD11 ' HG2' ' A' ' 34' ' ' GLU . 1.5 mp -92.93 157.75 16.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.61 -21.42 61.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.353 -0.842 . . . . 0.0 109.685 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -104.59 13.31 31.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.432 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.813 ' CA ' HD23 ' A' ' 50' ' ' LEU . . . 157.49 -169.12 34.37 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 3.7 mp -149.63 131.64 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.191 -1.182 . . . . 0.0 109.59 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' HD11 ' A' ' 29' ' ' LEU . 2.8 pt-20 -142.0 122.68 14.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.166 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.672 ' HB3' HG23 ' A' ' 26' ' ' VAL . 3.8 p90 -120.87 144.4 48.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.067 -1.021 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -129.19 -155.21 0.68 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -92.28 -50.38 5.69 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -101.48 -174.26 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.8 OUTLIER -43.41 -26.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.025 -1.047 . . . . 0.0 109.507 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' TYR . 1.4 m -150.69 -48.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -0.956 . . . . 0.0 109.348 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 3.4 t0 67.48 -6.58 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.725 -0.609 . . . . 0.0 110.589 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 4.2 m-20 79.25 -40.57 0.24 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.292 -0.88 . . . . 0.0 110.122 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.1 119.12 35.3 Favored Pre-proline 0 C--N 1.31 -1.129 0 O-C-N 120.918 -1.114 . . . . 0.0 109.987 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 58.7 Cg_endo -74.96 145.26 31.38 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.799 1.666 . . . . 0.0 110.436 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.18 -32.32 16.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 108.991 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' CZ ' ' A' ' 35' ' ' PHE . . . -155.49 138.2 5.95 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.5 mtp -130.59 118.53 21.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -1.121 . . . . 0.0 109.709 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.732 HG23 HG22 ' A' ' 73' ' ' THR . 2.6 mp -89.88 128.99 47.99 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 108.893 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.34 146.65 51.16 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.816 1.677 . . . . 0.0 110.508 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.855 HD12 ' CG1' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -86.98 34.91 0.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.52 179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB2' HG21 ' A' ' 74' ' ' THR . 36.3 mtmt -84.91 -82.34 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -150.01 62.89 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -66.61 -176.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -1.187 . . . . 0.0 109.458 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -136.94 113.36 10.03 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.216 -0.927 . . . . 0.0 109.476 -179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.76 ' C ' HD13 ' A' ' 55' ' ' LEU . 2.4 tm? -88.61 118.63 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.412 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 58' ' ' PRO . 7.8 m -109.96 129.56 55.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.67 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 3.5 m -150.36 121.5 3.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.812 . . . . 0.0 109.251 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 56' ' ' THR . 51.8 Cg_endo -71.8 -170.86 7.31 Favored 'Cis proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.619 -1.826 . . . . 0.0 110.277 -0.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 70' ' ' LYS . 1.7 t -100.3 -99.56 0.24 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.722 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -143.34 -147.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.997 -1.064 . . . . 0.0 109.756 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 24.5 m-20 -45.36 -22.44 0.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.107 -0.996 . . . . 0.0 109.312 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 4.7 m-85 -89.86 -46.17 8.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.021 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.763 ' HA2' HG13 ' A' ' 68' ' ' VAL . . . -75.34 1.34 57.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 61' ' ' ASP . 10.2 pttm -71.95 -9.23 58.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -1.199 . . . . 0.0 109.57 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' MET . 2.7 mtt180 -147.6 173.76 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ARG . 42.9 mtm 48.97 -179.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.645 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 86' ' ' LEU . 16.3 m-85 -98.15 65.09 1.7 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.269 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG13 ' HA2' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -108.14 124.11 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.682 -0.637 . . . . 0.0 109.338 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.706 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.76 177.03 5.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.861 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.784 ' HB2' ' SG ' ' A' ' 59' ' ' CYS . 5.0 ttpp -141.7 103.8 4.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.65 ' CD1' HG21 ' A' ' 96' ' ' ILE . 6.4 mt -89.41 168.12 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.089 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.571 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 5.2 m -143.73 88.75 2.01 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.732 HG22 HG23 ' A' ' 48' ' ' ILE . 2.8 p -45.01 150.25 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.406 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.49 87.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.659 -0.65 . . . . 0.0 109.623 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER 159.43 -76.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 75' ' ' LYS . 5.5 pt20 170.59 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.379 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -100.83 84.84 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.146 -0.971 . . . . 0.0 109.066 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.546 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 7.1 p30 -65.91 138.01 57.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.397 -0.814 . . . . 0.0 109.93 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 13' ' ' LYS . 54.7 m-70 -132.23 99.61 4.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 108.933 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . 0.3 OUTLIER -94.56 124.31 38.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 109.944 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.816 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.21 142.88 24.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.965 . . . . 0.0 109.179 179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 2.5 tt0 -108.15 136.42 47.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.544 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' A' ' 11' ' ' LEU . . . -91.7 -148.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.5 -90.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.329 -0.857 . . . . 0.0 110.242 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -105.91 177.65 4.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.45 -0.781 . . . . 0.0 109.071 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . 24.7 tp -59.07 -25.42 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.114 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -63.81 1.0 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.331 -0.855 . . . . 0.0 109.2 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.91 . . . . 0.0 108.922 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.755 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -64.58 -67.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.414 -0.804 . . . . 0.0 109.398 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 93' ' ' VAL . 16.9 t0 -60.71 -14.61 22.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 109.074 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.19 -33.74 43.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.966 ' CE2' HD21 ' A' ' 11' ' ' LEU . 6.2 m95 -78.95 -33.17 45.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 89' ' ' ARG . 1.8 m -72.19 -33.89 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.729 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -82.68 -22.76 34.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.725 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -80.01 -49.98 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.053 ' O ' HD12 ' A' ' 100' ' ' ILE . 25.1 mt -68.85 -41.56 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 109.349 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -72.38 -29.72 64.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -0.903 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 12.1 tttm -70.67 -44.41 67.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 109.542 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.645 ' C ' HD11 ' A' ' 50' ' ' LEU . . . -63.97 -44.14 93.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.053 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.2 mt -64.98 -36.12 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.301 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.18 -12.65 60.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.934 . . . . 0.0 109.294 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.37 -25.98 16.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.855 ' CG1' HD12 ' A' ' 50' ' ' LEU . 8.1 mm -81.69 -25.21 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 11.3 mt-10 -69.06 -6.99 31.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.29 9.08 7.86 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -109.33 60.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.354 -1.086 . . . . 0.0 109.302 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 108' ' ' HIS . 51.8 mt-10 -152.7 25.99 0.57 Allowed 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 107' ' ' GLU . 21.9 t-80 76.17 42.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.88 86.12 2.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.354 -0.841 . . . . 0.0 109.433 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.18 133.58 55.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 0.0 109.34 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -142.3 -174.21 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -139.81 70.44 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 mtm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.5 mt-10 -143.39 162.37 42.69 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 57.0 Cg_endo -74.82 149.74 38.03 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.01 1.807 . . . . 0.0 110.441 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' O ' ' OE2' ' A' ' 8' ' ' GLU . 3.5 mttt -129.56 78.71 1.87 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.566 ' HE ' HG11 ' A' ' 27' ' ' VAL . 0.3 OUTLIER 56.09 169.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.203 -0.936 . . . . 0.0 109.144 -179.655 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' HB ' HD12 ' A' ' 28' ' ' LEU . 19.8 mm -84.88 -42.32 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.949 -179.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.973 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -150.57 104.29 3.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.045 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.4 pm0 -113.98 136.77 52.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.115 -0.991 . . . . 0.0 109.763 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.581 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -163.31 -146.69 4.8 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.789 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.8 p90 -141.8 95.81 2.87 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.317 -1.108 . . . . 0.0 109.961 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.803 HD21 ' CE2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -115.77 156.3 26.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 108.748 179.172 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.824 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -84.04 130.51 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.975 . . . . 0.0 109.479 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' CE ' ' HB3' ' A' ' 81' ' ' PHE . 28.6 ttmt -131.29 164.53 25.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.302 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 20' ' ' THR . 0.1 OUTLIER -113.48 138.01 50.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.094 -1.004 . . . . 0.0 109.735 -179.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 161.61 117.08 0.42 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 164.53 -94.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -1.113 . . . . 0.0 109.442 179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.822 HG23 ' CD2' ' A' ' 18' ' ' PHE . 13.8 m -98.94 -21.9 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.974 . . . . 0.0 109.123 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.822 ' CD2' HG23 ' A' ' 17' ' ' VAL . 37.6 p90 -179.92 179.97 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.418 -0.801 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 1.9 p30 -53.33 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 109.854 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.793 HG22 ' CZ ' ' A' ' 18' ' ' PHE . 65.8 p -113.92 151.87 31.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.888 . . . . 0.0 108.649 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 14' ' ' LYS . 2.0 m95 -128.56 113.52 15.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.762 -1.211 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.824 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -150.43 138.05 11.94 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 109.218 179.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.67 147.52 23.84 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.716 1.61 . . . . 0.0 109.812 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.726 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -158.74 167.65 28.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.083 -1.01 . . . . 0.0 110.012 -179.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.726 ' O ' ' SD ' ' A' ' 24' ' ' MET . 64.6 t-105 -89.79 143.35 26.87 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -150.86 127.29 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.177 -178.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.045 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -117.53 101.28 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.195 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.976 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.6 pp -81.78 109.81 16.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 -179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' CD1' ' HG2' ' A' ' 34' ' ' GLU . 2.1 mp -94.84 161.78 14.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.27 -0.894 . . . . 0.0 109.391 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.692 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 4.2 pt-20 -72.29 -16.77 61.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.343 -0.848 . . . . 0.0 109.973 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.68 7.12 34.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.015 . . . . 0.0 109.441 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA2' HD13 ' A' ' 50' ' ' LEU . . . 151.6 154.5 6.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.546 HD12 ' CD1' ' A' ' 50' ' ' LEU . 2.6 mp -109.92 126.03 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.169 -1.195 . . . . 0.0 109.877 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 12.3 pt-20 -127.3 113.79 16.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.68 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 3.5 p90 -117.81 147.97 42.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -178.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.65 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -131.3 -158.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.86 -43.95 9.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 108.534 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.8 mmtt -107.31 -171.84 1.96 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -52.92 -19.61 2.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.787 -1.195 . . . . 0.0 109.358 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -150.68 -49.82 0.13 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.955 . . . . 0.0 109.489 179.552 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.8 t0 62.0 10.55 3.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.445 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 33.9 t30 41.69 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.944 . . . . 0.0 109.906 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.1 t -168.57 110.13 0.53 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.934 -1.104 . . . . 0.0 109.811 -179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 55.4 Cg_endo -71.74 135.4 25.82 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.879 1.719 . . . . 0.0 110.545 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 1.1 ttpt -89.42 -23.66 22.09 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.598 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -170.86 148.08 11.02 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.443 ' O ' ' HD3' ' A' ' 49' ' ' PRO . 5.0 mtm -137.21 128.98 28.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.259 -1.142 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 71' ' ' ILE . 2.8 mt -91.08 109.66 36.85 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.396 -0.815 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.457 ' O ' ' OG ' ' A' ' 53' ' ' SER . 50.6 Cg_endo -70.21 125.19 11.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.81 1.673 . . . . 0.0 110.348 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 103' ' ' ILE . 3.1 mp -74.71 -2.79 27.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.616 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -44.98 -58.36 3.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.0 109.306 179.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -162.84 72.45 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -96.73 -175.47 3.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -1.131 . . . . 0.0 109.74 -179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.48 ' OG1' ' HB ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -141.72 108.06 5.27 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.377 -0.827 . . . . 0.0 109.551 -179.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.793 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.7 tm? -89.47 113.24 24.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 109.715 -179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.562 ' N ' HD22 ' A' ' 55' ' ' LEU . 31.1 m -104.52 113.05 26.36 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.346 -0.846 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.925 ' HB2' HG21 ' A' ' 93' ' ' VAL . 1.6 t -143.44 139.38 16.4 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.422 -0.799 . . . . 0.0 109.532 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HB3' ' NH2' ' A' ' 89' ' ' ARG . 60.0 Cg_endo -78.11 -179.58 27.56 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.277 -1.968 . . . . 0.0 110.503 -0.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.71 ' SG ' HG22 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -127.9 137.76 52.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 108.93 179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.41 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -141.71 90.33 2.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 0.0 109.718 -179.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 2.3 p-10 179.53 -32.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 109.161 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.625 ' CD2' ' CD1' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -88.57 -45.38 9.94 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -113.41 -24.63 4.66 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 178.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.557 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 10.9 ttmt 38.49 43.05 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.79 0.805 . . . . 0.0 109.499 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 66' ' ' MET . 6.4 mtt85 -136.24 18.5 3.18 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.279 -0.888 . . . . 0.0 108.892 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.546 ' C ' ' CG ' ' A' ' 67' ' ' PHE . 53.0 mtt 64.37 159.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.506 -0.746 . . . . 0.0 109.522 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER 71.81 15.57 5.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.399 -0.813 . . . . 0.0 109.602 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.71 HG22 ' SG ' ' A' ' 59' ' ' CYS . 1.9 p -121.26 124.09 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 109.41 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.723 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -110.0 167.05 10.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.128 -0.982 . . . . 0.0 109.392 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' CG ' ' HB ' ' A' ' 56' ' ' THR . 3.0 ptmt -142.86 109.58 5.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.175 -0.953 . . . . 0.0 109.916 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 48' ' ' ILE . 36.2 mt -91.15 166.51 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.377 -0.827 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.569 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 4.1 m -143.78 86.5 1.87 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 48' ' ' ILE . 3.0 p -49.54 163.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.401 -0.812 . . . . 0.0 109.484 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -20.15 21.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -89.07 26.11 1.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.973 . . . . 0.0 109.418 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.17 30.01 13.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.519 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 1.4 mt-30 -89.64 102.23 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 80' ' ' PHE . 4.0 m-20 -77.22 145.97 37.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.044 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -143.14 109.96 5.54 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' ' CD2' ' A' ' 62' ' ' PHE . 1.5 m-85 -107.37 120.79 43.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 110.186 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.723 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -137.54 139.01 40.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.213 -0.929 . . . . 0.0 108.844 178.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 83' ' ' ALA . 1.5 tt0 -105.7 145.4 31.13 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 0.0 109.32 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 82' ' ' GLN . . . -89.5 -166.93 1.72 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.146 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -86.48 -18.85 30.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.12 -0.987 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.617 ' CE1' ' HB3' ' A' ' 84' ' ' ALA . 0.1 OUTLIER -160.83 169.83 21.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.511 -0.743 . . . . 0.0 109.274 179.632 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.043 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -60.4 -54.77 41.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.043 ' N ' HD23 ' A' ' 86' ' ' LEU . 3.6 tt0 -43.21 -53.53 5.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 110.062 -179.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.1 tt0 -65.5 -32.16 73.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.143 -0.973 . . . . 0.0 109.958 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' A' ' 58' ' ' PRO . 0.2 OUTLIER -67.26 -26.13 66.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.97 . . . . 0.0 109.767 -179.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 3.4 t0 -83.32 -42.2 17.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.536 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . . . -70.01 -22.45 63.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -0.904 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.976 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 3.2 m95 -83.86 -39.09 20.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.925 HG21 ' HB2' ' A' ' 57' ' ' SER . 2.5 p -76.39 -26.9 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.765 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.536 ' CG ' ' HA ' ' A' ' 91' ' ' ALA . 0.0 OUTLIER -82.87 -31.12 28.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.481 ' OD2' ' HG3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -75.45 -53.34 8.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.264 -0.897 . . . . 0.0 109.179 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.876 HG13 HD22 ' A' ' 28' ' ' LEU . 22.9 mt -62.69 -32.51 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.222 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 4.4 t-20 -79.89 -26.62 40.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.317 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 0.2 OUTLIER -69.68 -53.57 17.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.156 179.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.692 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -62.02 -37.98 86.94 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.252 -0.905 . . . . 0.0 109.185 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 96' ' ' ILE . 26.5 mt -62.64 -38.36 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.306 -0.871 . . . . 0.0 109.019 179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -80.12 -12.33 59.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.581 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 13.5 t -95.32 -18.6 20.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.395 -0.815 . . . . 0.0 109.152 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG13 HD22 ' A' ' 50' ' ' LEU . 7.6 mm -90.59 -27.62 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.355 -0.841 . . . . 0.0 109.127 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.2 mt-10 -75.66 -3.41 34.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.36 12.91 5.45 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 106' ' ' LEU . 0.2 OUTLIER -105.72 58.89 0.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.457 -1.025 . . . . 0.0 109.378 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.98 -57.81 1.31 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.558 -0.714 . . . . 0.0 109.433 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.402 ' O ' ' O ' ' A' ' 109' ' ' HIS . 0.0 OUTLIER -179.71 86.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 0.0 109.365 -179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 109' ' ' HIS . 1.5 m170 61.42 152.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.473 ' ND1' ' O ' ' A' ' 110' ' ' HIS . 16.0 p80 -68.49 98.43 0.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.255 -0.903 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -138.15 78.69 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 179.48 87.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.454 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 4' ' ' LYS . 10.5 mt-10 -106.51 162.62 19.12 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 50.2 Cg_exo -52.45 147.65 28.88 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.074 1.849 . . . . 0.0 110.484 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HB3' ' NH1' ' A' ' 5' ' ' ARG . 21.0 mttm -152.4 99.32 2.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 109.287 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.715 ' HD3' HG11 ' A' ' 27' ' ' VAL . 3.5 mtt85 61.2 136.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 -179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 30' ' ' GLU . 43.4 mt -63.76 -56.22 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 109.431 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.905 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.32 148.22 46.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 0.0 109.805 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.993 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.7 pm0 -161.61 135.84 6.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.384 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.594 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -161.45 -147.44 4.97 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.967 ' C ' HD13 ' A' ' 11' ' ' LEU . 11.0 p90 -139.18 98.17 3.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.311 -1.111 . . . . 0.0 109.464 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.967 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -118.94 159.07 24.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 108.863 179.56 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.795 HG23 ' C ' ' A' ' 22' ' ' LYS . 1.7 p -86.77 125.1 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.119 -0.988 . . . . 0.0 109.386 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 14' ' ' LYS . 4.6 tppp? -113.49 145.95 40.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -0.828 . . . . 0.0 109.208 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.54 ' HD2' ' CZ ' ' A' ' 62' ' ' PHE . 9.2 tttt -64.36 150.16 46.82 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.311 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 16' ' ' SER . . . 101.51 -135.8 12.39 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 5.2 t 74.85 0.1 3.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -1.138 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.568 HG13 ' H ' ' A' ' 18' ' ' PHE . 2.6 p 175.48 -52.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.561 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.568 ' H ' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -168.2 73.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.143 -0.973 . . . . 0.0 109.751 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 m120 48.23 44.95 19.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.816 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.5 ' OG1' ' CG1' ' A' ' 17' ' ' VAL . 1.5 p -101.86 -166.16 1.26 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.622 ' NE1' ' CE1' ' A' ' 62' ' ' PHE . 1.4 m95 -141.32 109.34 5.77 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.007 -1.058 . . . . 0.0 109.735 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.795 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -148.93 145.96 20.68 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.409 -0.807 . . . . 0.0 109.563 179.904 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.4 Cg_exo -51.98 160.06 3.36 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.019 1.813 . . . . 0.0 109.923 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.745 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -169.38 166.43 10.4 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.136 -0.977 . . . . 0.0 109.802 179.984 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.745 ' O ' ' SD ' ' A' ' 24' ' ' MET . 63.3 t-105 -91.32 142.11 28.06 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -150.97 130.57 3.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.119 -178.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.993 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.8 m -121.13 113.16 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.489 -0.757 . . . . 0.0 109.556 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.924 HD23 ' CZ3' ' A' ' 92' ' ' TRP . 1.8 pp -86.32 117.9 25.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.955 . . . . 0.0 109.081 179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 34' ' ' GLU . 3.5 mp -104.95 162.32 13.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.51 -0.744 . . . . 0.0 109.861 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.957 ' O ' HD13 ' A' ' 103' ' ' ILE . 7.3 pt-20 -73.66 -7.43 51.96 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.431 -0.793 . . . . 0.0 110.366 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -115.1 0.87 13.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.093 -1.004 . . . . 0.0 109.419 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.84 165.83 14.51 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.858 HG23 ' HA ' ' A' ' 28' ' ' LEU . 6.9 mm -112.92 126.46 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.359 -1.083 . . . . 0.0 110.468 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.569 ' HG2' HG23 ' A' ' 27' ' ' VAL . 6.4 pt-20 -125.71 112.2 15.82 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 178.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.662 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 4.1 p90 -118.2 143.65 46.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.004 -1.06 . . . . 0.0 110.655 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.623 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -125.22 -150.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -96.98 -49.46 5.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -106.74 -175.83 2.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 108.833 179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 1.0 OUTLIER -49.51 -21.84 1.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.99 -1.069 . . . . 0.0 109.407 -179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.551 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -148.08 -51.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 43' ' ' SER . 10.4 t70 59.13 10.97 1.84 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.206 -0.933 . . . . 0.0 109.333 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 41' ' ' ASP . 2.7 m-80 39.63 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.375 -0.828 . . . . 0.0 110.174 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 41' ' ' ASP . 3.0 t -166.04 118.91 0.85 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.955 -1.091 . . . . 0.0 109.764 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 57.7 Cg_endo -74.7 147.89 36.0 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.626 1.55 . . . . 0.0 111.096 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' CE ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -101.64 -30.21 11.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.505 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.72 152.76 12.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 12.4 mtt -135.17 138.65 43.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 109.559 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.652 HG22 ' HB2' ' A' ' 53' ' ' SER . 8.6 mt -104.57 134.18 19.8 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.34 -0.85 . . . . 0.0 108.732 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' CD ' ' OG1' ' A' ' 73' ' ' THR . 36.4 Cg_endo -66.12 137.53 48.5 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.492 1.462 . . . . 0.0 110.474 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.747 ' HB3' HG21 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -85.15 -6.32 59.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.53 -0.731 . . . . 0.0 110.276 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.85 48.2 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.022 -1.049 . . . . 0.0 109.895 -179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' SER . . . 175.22 -40.2 0.11 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.034 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB2' HG22 ' A' ' 48' ' ' ILE . 3.4 t -42.28 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -1.118 . . . . 0.0 110.174 -179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -124.91 170.15 11.38 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.064 HD13 ' N ' ' A' ' 56' ' ' THR . 3.1 tm? -130.97 148.5 52.74 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 0.0 108.97 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 1.064 ' N ' HD13 ' A' ' 55' ' ' LEU . 21.3 m -145.17 137.28 25.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.209 -0.932 . . . . 0.0 108.941 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 58' ' ' PRO . 32.7 t -138.89 122.75 11.18 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' O ' ' HA ' ' A' ' 57' ' ' SER . 59.5 Cg_endo -75.62 -94.89 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.709 -1.788 . . . . 0.0 110.095 -0.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 60' ' ' GLN . 14.8 p -143.69 -147.12 0.2 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.397 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.526 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -93.99 -159.95 0.73 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 109.789 -179.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.99 18.67 2.39 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 109.217 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 7.4 t80 -89.11 -26.4 21.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.195 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.623 ' O ' HG11 ' A' ' 68' ' ' VAL . . . -143.84 12.33 2.16 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 28.6 tttt -49.06 99.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 169.53 -91.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.462 -0.774 . . . . 0.0 109.191 -179.823 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' ARG . 33.9 mmm -61.5 -141.29 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 9.7 m-85 -107.42 76.11 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.963 -1.086 . . . . 0.0 109.461 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG11 ' O ' ' A' ' 63' ' ' GLY . 1.3 p -113.75 122.84 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.402 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.713 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -105.83 168.94 8.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.902 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.565 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 7.8 ttpt -128.53 134.92 48.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 110.077 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.587 HG13 ' CE2' ' A' ' 69' ' ' PHE . 1.8 mt -124.97 169.16 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 54' ' ' THR . 74.1 m -147.81 110.99 4.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.14 -0.975 . . . . 0.0 110.12 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 73' ' ' THR . 5.8 t -58.08 113.37 1.88 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.017 . . . . 0.0 110.235 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER 40.74 24.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.464 -0.772 . . . . 0.0 111.042 179.266 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' THR . 0.1 OUTLIER 81.77 45.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.102 . . . . 0.0 109.19 179.181 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.584 ' HB2' HG23 ' A' ' 73' ' ' THR . 0.1 OUTLIER -126.5 -85.31 0.61 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 -179.785 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.644 ' H ' HG22 ' A' ' 73' ' ' THR . 0.3 OUTLIER -94.16 146.22 24.14 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.641 -0.662 . . . . 0.0 109.649 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 68.3 m-20 -99.72 116.59 32.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.29 -0.881 . . . . 0.0 109.653 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -102.1 103.98 14.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -101.28 129.26 47.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.188 -0.945 . . . . 0.0 109.402 179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -142.18 146.46 35.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.334 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 67' ' ' PHE . 6.0 tt0 -104.32 140.33 38.04 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.51 -91.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.947 . . . . 0.0 109.628 -179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' O ' ' CD1' ' A' ' 67' ' ' PHE . . . -160.16 -83.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.512 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -101.59 171.92 7.27 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.705 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.046 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -55.04 -58.38 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.772 -179.67 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.046 ' N ' HD23 ' A' ' 86' ' ' LEU . 2.0 tt0 -46.14 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -178.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.561 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 41.9 tt0 -40.87 -38.72 0.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.439 -0.788 . . . . 0.0 110.471 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -58.92 -61.34 2.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.104 -0.997 . . . . 0.0 110.141 -179.29 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.485 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 71.8 m-20 -57.26 -31.32 65.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.452 -179.312 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.68 68.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.934 -1.103 . . . . 0.0 109.851 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.924 ' CZ3' HD23 ' A' ' 28' ' ' LEU . 2.2 m95 -76.36 -45.49 31.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.096 -1.002 . . . . 0.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.928 HG23 HD21 ' A' ' 55' ' ' LEU . 13.7 p -69.5 -23.12 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 109.538 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 2.0 mmt180 -81.4 -36.98 28.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.974 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' OD1' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -77.1 -39.53 49.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 0.0 110.092 -179.3 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 100' ' ' ILE . 6.0 mt -70.64 -46.31 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.774 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 17.3 t-20 -73.97 -30.55 62.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 0.0 109.712 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 7.8 ttpt -72.1 -34.92 69.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.232 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.678 ' O ' HG22 ' A' ' 103' ' ' ILE . . . -77.48 -23.0 50.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.247 -0.908 . . . . 0.0 109.365 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG12 ' HA ' ' A' ' 50' ' ' LEU . 5.5 mt -81.76 -36.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.119 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -14.77 48.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.384 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 2.4 t -95.77 -33.31 12.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.437 -0.79 . . . . 0.0 109.56 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 30' ' ' GLU . 5.8 tp -73.06 -15.19 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 100' ' ' ILE . 1.2 mm-40 -73.04 -7.66 52.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -125.93 9.81 7.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -110.92 61.03 0.61 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.382 -1.069 . . . . 0.0 109.236 -179.828 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -61.62 -63.62 1.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.535 -0.728 . . . . 0.0 109.676 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 63.34 27.25 15.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 38.7 m-70 48.12 -154.73 0.08 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.53 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.458 ' O ' ' CB ' ' A' ' 111' ' ' HIS . 2.9 p-80 -141.77 32.33 1.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 110' ' ' HIS . 6.1 t60 72.73 -172.74 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -0.839 . . . . 0.0 109.43 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -56.87 -27.14 60.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.486 179.995 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -94.01 177.19 2.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.293 -0.879 . . . . 0.0 109.447 -179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.578 ' HD2' ' CG ' ' A' ' 2' ' ' GLU . 55.2 Cg_endo -79.05 147.54 21.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.833 1.689 . . . . 0.0 110.264 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -135.86 90.49 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.582 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' HB2' ' OE1' ' A' ' 8' ' ' GLU . 0.2 OUTLIER -101.88 161.78 13.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.567 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.74 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.0 mt -90.52 -32.3 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.568 ' HG2' ' CE2' ' A' ' 92' ' ' TRP . 0.0 OUTLIER -139.94 157.56 45.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.729 179.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.031 ' HB3' HG12 ' A' ' 27' ' ' VAL . 2.0 pm0 -171.02 126.21 0.68 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.591 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -162.7 -147.33 4.99 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.909 ' C ' HD13 ' A' ' 11' ' ' LEU . 3.9 p90 -136.57 91.98 2.71 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.398 -1.06 . . . . 0.0 110.225 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.909 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -110.24 168.49 9.4 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.68 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.937 HG23 ' C ' ' A' ' 22' ' ' LYS . 2.1 p -100.23 124.46 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 110.071 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 5.6 mtpm? -104.68 163.67 12.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.6 -0.687 . . . . 0.0 109.484 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.598 ' HG2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -68.2 107.53 2.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 109.259 179.695 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' LYS . . . -41.17 139.99 1.42 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.3 p -85.69 64.51 8.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -1.162 . . . . 0.0 109.432 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG23 ' H ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -142.13 -87.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.514 ' H ' HG23 ' A' ' 17' ' ' VAL . 10.1 m-85 -131.27 67.45 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.3 m120 54.55 77.42 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.192 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 2.1 p -129.08 172.53 11.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.593 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.598 ' CD1' ' HG2' ' A' ' 14' ' ' LYS . 3.1 m95 -141.08 121.86 14.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 109.361 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.937 ' C ' HG23 ' A' ' 12' ' ' VAL . 8.0 mttt -149.18 136.08 10.7 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 109.78 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 51.2 Cg_exo -53.12 163.35 2.27 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.854 1.703 . . . . 0.0 109.986 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 13' ' ' LYS . 22.3 ptm -177.34 164.14 2.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.044 . . . . 0.0 109.873 179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.604 ' CD1' ' HA ' ' A' ' 39' ' ' LYS . 74.9 t-105 -91.06 143.68 26.44 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.693 HG23 ' HB3' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -150.76 132.69 5.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.153 -179.052 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.031 HG12 ' HB3' ' A' ' 8' ' ' GLU . 5.7 m -121.64 100.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 95' ' ' ASP . 2.3 pp -74.64 132.33 41.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.849 -1.157 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 29' ' ' LEU . 2.2 mp -117.95 168.56 10.4 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.554 -0.716 . . . . 0.0 109.597 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.983 ' O ' HD13 ' A' ' 103' ' ' ILE . 15.1 pt-20 -74.42 -0.17 16.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 110.032 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' N ' HD22 ' A' ' 50' ' ' LEU . 2.1 m-20 -121.46 -3.62 9.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.142 -0.974 . . . . 0.0 109.235 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.691 ' CA ' HD13 ' A' ' 50' ' ' LEU . . . 154.41 158.47 8.69 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.802 HD12 ' HB2' ' A' ' 28' ' ' LEU . 2.3 mm -95.26 112.5 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.289 -1.124 . . . . 0.0 110.009 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' O ' HG22 ' A' ' 27' ' ' VAL . 15.2 mt-10 -107.74 103.6 12.92 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.693 ' HB3' HG23 ' A' ' 26' ' ' VAL . 13.2 p90 -115.61 148.66 39.37 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.783 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -130.26 -153.96 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.328 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.98 -43.38 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 11.6 mttt -110.65 -176.55 3.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -43.34 -26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 109.531 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.57 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -149.61 -46.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.051 -1.031 . . . . 0.0 109.854 179.863 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' N ' ' A' ' 43' ' ' SER . 4.0 t70 62.16 10.11 3.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.63 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER 43.13 22.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.051 -1.03 . . . . 0.0 109.823 -179.87 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' ASP . 1.4 t -168.7 98.33 0.53 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.925 -1.11 . . . . 0.0 110.287 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 50.6 Cg_exo -51.75 130.09 32.6 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.96 1.774 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 3.1 tttt -89.66 -19.57 24.71 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' CA ' ' CE1' ' A' ' 35' ' ' PHE . . . -176.06 132.62 2.15 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 7.1 mtm -121.65 121.17 36.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.211 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.626 HG23 ' HD2' ' A' ' 49' ' ' PRO . 24.6 mt -89.45 139.39 28.25 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 108.777 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.626 ' HD2' HG23 ' A' ' 48' ' ' ILE . 49.8 Cg_endo -70.63 131.85 20.8 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.587 1.524 . . . . 0.0 109.963 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.691 HD13 ' CA ' ' A' ' 32' ' ' GLY . 2.4 tp -76.4 -0.75 23.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 110.033 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.5 pttm -136.11 129.11 31.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -0.994 . . . . 0.0 109.545 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 74' ' ' THR . . . 100.39 -5.51 57.31 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -97.64 172.97 7.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -1.152 . . . . 0.0 109.658 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 72' ' ' THR . 0.5 OUTLIER -132.25 158.31 42.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.527 -0.733 . . . . 0.0 109.267 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 55' ' ' LEU . 1.4 tm? -123.88 110.74 15.23 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.047 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.538 ' N ' HD22 ' A' ' 55' ' ' LEU . 87.0 m -102.83 110.38 22.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.38 -0.825 . . . . 0.0 109.361 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.0 p -148.64 131.3 7.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.701 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.77 150.78 93.34 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.462 -1.891 . . . . 0.0 110.391 -0.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 68' ' ' VAL . 1.2 p -90.03 167.53 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 27.2 tt0 -167.31 108.11 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.982 . . . . 0.0 109.96 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 60' ' ' GLN . 9.7 t0 165.63 -43.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.53 ' CE1' ' NE1' ' A' ' 21' ' ' TRP . 6.6 t80 -89.77 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 64' ' ' LYS . . . -94.21 -21.78 26.6 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 31.61 44.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.437 0.637 . . . . 0.0 110.206 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' O ' HG12 ' A' ' 68' ' ' VAL . 5.2 ttp180 179.53 -170.69 0.14 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.44 ' C ' ' O ' ' A' ' 65' ' ' ARG . 3.1 mtt 42.4 -153.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.602 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . 0.8 OUTLIER -110.17 69.29 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.488 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.774 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -107.63 130.25 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 0.0 109.354 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.697 ' CE1' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -109.08 169.37 8.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.218 179.709 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' O ' ' HB ' ' A' ' 56' ' ' THR . 15.3 ttpt -136.63 109.39 7.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.156 -0.965 . . . . 0.0 110.336 -179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 72' ' ' THR . 7.1 mt -95.41 165.46 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.344 -0.847 . . . . 0.0 108.996 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 89.0 m -138.98 89.79 2.39 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.241 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' SER . 3.1 p -54.63 155.69 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.103 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -51.65 -19.18 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.2 -179.397 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.47 26.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.99 -1.068 . . . . 0.0 109.6 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.95 30.41 11.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.16 105.79 17.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 109.222 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.524 ' CB ' ' CZ ' ' A' ' 80' ' ' PHE . 3.4 m-20 -75.21 133.42 41.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.677 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -124.97 100.51 6.62 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' ' CB ' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -98.57 128.38 44.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.799 -179.596 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.697 ' CD2' ' CE1' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -148.27 144.17 27.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 179.142 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 67' ' ' PHE . 1.2 tt0 -103.99 136.39 43.73 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.36 -149.59 0.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.798 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.77 -86.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.869 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -124.2 173.69 8.16 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.748 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -42.55 -45.81 4.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.826 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.953 ' N ' HD23 ' A' ' 86' ' ' LEU . 7.6 tt0 -52.61 -66.51 0.37 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.064 -1.023 . . . . 0.0 110.145 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.46 -7.69 21.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.984 . . . . 0.0 109.855 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.813 ' O ' HG13 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -76.18 -54.74 6.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 109.53 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.647 ' HA ' HG22 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -77.75 -12.61 59.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.315 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.7 -33.33 35.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.568 ' CE2' ' HG2' ' A' ' 7' ' ' ARG . 3.7 m95 -78.01 -32.9 51.37 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 89' ' ' ARG . 4.3 m -76.98 -29.7 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.667 -0.645 . . . . 0.0 109.771 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 98' ' ' LYS . 17.0 mmt85 -79.62 -27.19 41.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.834 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.7 OUTLIER -87.02 -44.27 11.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.06 -1.025 . . . . 0.0 110.041 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.702 ' O ' HD12 ' A' ' 100' ' ' ILE . 4.2 mt -69.23 -31.94 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.029 -1.044 . . . . 0.0 109.128 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 3.7 t-20 -85.09 -36.11 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.429 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 94' ' ' ARG . 27.2 tttt -66.27 -34.39 77.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.229 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HB1' HD21 ' A' ' 50' ' ' LEU . . . -80.78 -30.17 36.03 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.341 -0.849 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 96' ' ' ILE . 22.9 mt -72.94 -29.55 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.125 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 7.4 mmpt? -93.43 -17.74 23.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 109.531 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 9.7 m -95.88 -16.58 21.71 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.409 -0.807 . . . . 0.0 109.481 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.983 HD13 ' O ' ' A' ' 30' ' ' GLU . 6.5 tp -87.27 -15.85 9.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.3 -0.875 . . . . 0.0 109.64 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.8 -11.91 61.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.425 179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.99 12.34 9.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 103' ' ' ILE . 0.9 OUTLIER -103.09 58.4 0.76 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -1.011 . . . . 0.0 109.096 -179.921 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -109.19 -166.77 1.14 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.663 -0.648 . . . . 0.0 109.491 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.9 m170 55.48 27.74 10.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.481 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.95 70.0 1.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -102.21 -16.71 16.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.96 95.26 2.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.531 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.495 ' O ' ' CB ' ' A' ' 113' ' ' HIS . 5.0 t60 -113.96 51.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 112' ' ' HIS . 8.8 t60 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 1.5 mt-10 -147.0 173.86 3.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 0.0 109.566 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 52.0 Cg_exo -55.23 -149.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.296 1.997 . . . . 0.0 110.418 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 3' ' ' PRO . 77.9 mttt 42.51 82.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.858 ' HE ' HG21 ' A' ' 27' ' ' VAL . 0.6 OUTLIER 69.16 86.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.0 109.134 -179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.38 -44.37 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.997 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.574 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.4 tpm_? -125.4 150.38 47.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.104 -0.997 . . . . 0.0 110.237 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.768 ' CB ' HG12 ' A' ' 27' ' ' VAL . 2.1 pm0 -160.49 121.26 2.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.463 -0.773 . . . . 0.0 109.144 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.599 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -158.5 -145.28 4.19 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.785 ' C ' HD13 ' A' ' 11' ' ' LEU . 7.2 p90 -142.1 102.6 4.15 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.286 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.785 HD13 ' C ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -117.16 169.08 9.72 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.947 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.766 HG23 ' N ' ' A' ' 22' ' ' LYS . 1.5 p -101.34 133.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.988 -1.07 . . . . 0.0 109.891 -179.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -128.31 131.89 48.65 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.8 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.635 ' HB2' ' CD1' ' A' ' 21' ' ' TRP . 0.0 OUTLIER -96.3 151.28 19.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 108.795 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.514 ' N ' ' HG3' ' A' ' 14' ' ' LYS . . . 178.45 151.7 9.71 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 30.9 t 61.06 -88.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.242 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 18' ' ' PHE . 7.2 p -44.44 166.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.609 ' N ' HG22 ' A' ' 17' ' ' VAL . 27.3 p90 -73.78 -176.08 2.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.703 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' O ' ' CD1' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -43.66 109.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 108.822 179.573 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 21' ' ' TRP . 18.6 p -146.38 -58.71 0.3 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -0.9 . . . . 0.0 109.902 -179.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.643 ' NE1' ' CZ ' ' A' ' 62' ' ' PHE . 32.9 m95 63.51 106.1 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.488 0.661 . . . . 0.0 110.207 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.766 ' N ' HG23 ' A' ' 12' ' ' VAL . 45.0 mttm -125.54 134.86 26.22 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 50.8 Cg_exo -52.65 159.71 4.54 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.906 1.737 . . . . 0.0 110.611 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.604 ' HE2' ' CD1' ' A' ' 35' ' ' PHE . 13.5 ptm -173.23 171.05 4.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.243 -0.91 . . . . 0.0 109.273 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.608 ' CE2' ' HA ' ' A' ' 39' ' ' LYS . 52.4 t-105 -89.56 140.83 29.16 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.256 -0.902 . . . . 0.0 108.848 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.911 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.9 OUTLIER -151.54 127.63 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.171 -178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.858 HG21 ' HE ' ' A' ' 5' ' ' ARG . 17.2 m -126.42 119.62 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.408 -0.807 . . . . 0.0 109.46 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.939 ' HA ' HG23 ' A' ' 33' ' ' ILE . 2.8 pp -87.99 106.02 17.85 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 HG23 ' A' ' 27' ' ' VAL . 3.6 mp -90.34 162.53 15.11 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.262 -0.898 . . . . 0.0 109.473 -179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.552 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -72.61 -12.39 61.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.68 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.575 ' HA ' HD11 ' A' ' 103' ' ' ILE . 1.6 m-20 -107.27 -0.81 22.31 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 109.699 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 50' ' ' LEU . . . 157.93 144.68 4.01 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.939 HG23 ' HA ' ' A' ' 28' ' ' LEU . 3.1 mm -96.41 109.07 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -1.105 . . . . 0.0 109.451 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' HG2' ' CD1' ' A' ' 29' ' ' LEU . 9.2 pt-20 -119.79 131.94 55.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 108.869 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.649 ' HB3' HG23 ' A' ' 26' ' ' VAL . 7.8 p90 -127.63 142.36 51.37 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 110.073 -179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -123.42 -149.65 0.43 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.628 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.14 -63.51 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.935 . . . . 0.0 109.179 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -92.0 -178.66 5.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 108.939 179.701 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 0.7 OUTLIER -46.79 -42.75 17.55 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.681 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.475 ' C ' ' N ' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -144.14 69.54 1.28 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 109.507 178.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 18.4 t70 -47.41 -21.33 0.3 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 41' ' ' ASP . 2.9 t-20 91.78 -18.49 0.14 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.8 t -134.25 119.63 14.5 Favored Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HA ' ' CD2' ' A' ' 36' ' ' TYR . 45.1 Cg_endo -69.43 132.93 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.685 1.59 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -89.69 -21.56 22.67 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 35' ' ' PHE . . . -160.01 117.98 0.8 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 167.8 9.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -1.156 . . . . 0.0 109.662 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.86 HG23 HG22 ' A' ' 73' ' ' THR . 5.5 mt -140.8 109.72 6.59 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.25 118.23 5.55 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.597 1.531 . . . . 0.0 110.35 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.79 HD11 HD11 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.93 -7.06 25.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.267 -0.895 . . . . 0.0 109.545 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -42.88 -68.13 0.22 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.725 -179.774 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA2' ' OE2' ' A' ' 104' ' ' GLU . . . -150.14 71.46 0.3 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.009 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -177.65 5.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -1.196 . . . . 0.0 109.256 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -140.17 113.09 8.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.236 -0.915 . . . . 0.0 109.554 -179.251 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.801 HD13 ' N ' ' A' ' 56' ' ' THR . 3.4 tm? -88.67 131.37 35.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.281 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.994 HG22 ' O ' ' A' ' 58' ' ' PRO . 31.6 m -115.99 137.63 51.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 17.9 p -150.13 118.03 3.6 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.425 -0.797 . . . . 0.0 109.105 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.994 ' O ' HG22 ' A' ' 56' ' ' THR . 48.2 Cg_endo -70.78 -160.87 1.7 Allowed 'Cis proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.493 -1.878 . . . . 0.0 110.424 0.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 22.7 p -91.07 -149.48 0.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.881 -179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 -163.43 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.85 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.83 21.11 2.34 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.643 ' CZ ' ' NE1' ' A' ' 21' ' ' TRP . 8.3 t80 -88.64 -56.44 3.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 108.738 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' LYS . . . -75.27 -50.14 8.69 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 63' ' ' GLY . 15.7 pttm 40.53 28.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.535 -0.98 . . . . 0.0 109.59 179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.9 ttt180 -137.75 15.5 2.9 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.372 -0.83 . . . . 0.0 109.429 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.9 mtt 64.6 -162.25 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER 49.31 23.11 0.77 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 -179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 81' ' ' PHE . 10.7 p -161.28 126.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.715 ' CE2' ' CD1' ' A' ' 81' ' ' PHE . 4.4 p90 -116.23 167.38 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.7 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.696 ' HE3' HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -124.7 108.61 12.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.468 -0.77 . . . . 0.0 109.094 179.657 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 96' ' ' ILE . 4.4 mt -90.1 166.71 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.635 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.574 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 3.7 m -148.95 89.47 1.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.86 HG22 HG23 ' A' ' 48' ' ' ILE . 3.2 p -47.22 173.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.197 -0.939 . . . . 0.0 109.468 -179.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -22.06 64.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.312 -0.868 . . . . 0.0 109.443 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -74.14 -5.92 44.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.184 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 2.7 mt-30 79.13 36.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.425 -0.797 . . . . 0.0 109.8 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' O ' ' CD2' ' A' ' 79' ' ' HIS . 1.9 pt20 -109.11 90.66 3.36 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 108.628 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 2.8 m-20 -53.76 159.53 1.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.394 -0.816 . . . . 0.0 110.342 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 77' ' ' GLN . 82.7 m-70 -150.56 124.48 9.26 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.635 ' CB ' ' CZ2' ' A' ' 21' ' ' TRP . 0.7 OUTLIER -100.4 114.85 28.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.082 -1.012 . . . . 0.0 109.892 -179.461 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.843 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -119.11 148.8 42.65 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.569 ' HB3' HG13 ' A' ' 12' ' ' VAL . 2.7 tt0 -138.14 133.87 33.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.084 -1.01 . . . . 0.0 110.063 -179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.63 -160.8 0.71 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.399 -0.813 . . . . 0.0 109.194 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 85' ' ' PHE . . . -106.48 -2.03 22.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 0.0 109.514 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.615 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -173.02 167.1 5.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.234 -0.916 . . . . 0.0 109.0 179.973 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.463 ' CD1' ' HD2' ' A' ' 89' ' ' ARG . 33.2 tp -66.36 -14.16 61.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.558 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -67.21 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.189 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -65.68 -14.68 61.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.274 179.715 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -76.05 -51.55 12.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -68.34 -19.95 64.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.12 -0.987 . . . . 0.0 109.478 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . . . -87.47 -31.34 20.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.643 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.911 ' CH2' HG22 ' A' ' 26' ' ' VAL . 1.6 m95 -79.95 -32.28 39.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.79 ' CG2' HD11 ' A' ' 55' ' ' LEU . 1.7 p -82.55 -34.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 0.0 109.17 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 91' ' ' ALA . 7.9 ptm180 -73.58 -25.97 60.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.799 . . . . 0.0 108.998 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 19.4 t0 -85.4 -49.05 8.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.373 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 71' ' ' ILE . 23.9 mt -61.62 -38.42 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.048 -1.032 . . . . 0.0 108.831 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 11.3 t-20 -75.92 -66.02 0.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 102' ' ' CYS . 8.4 tttp -43.08 -32.75 0.74 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.447 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.401 ' C ' HD21 ' A' ' 50' ' ' LEU . . . -69.47 -47.09 65.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.296 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.537 ' CD1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.13 -55.54 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 108.766 179.693 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.482 ' N ' HG22 ' A' ' 100' ' ' ILE . 12.2 mttt -63.69 -12.64 36.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.541 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' LYS . 0.5 OUTLIER -85.82 -32.39 21.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.419 -0.8 . . . . 0.0 109.184 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.622 HD12 ' CB ' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -78.26 -30.46 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -0.868 . . . . 0.0 108.937 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.454 ' OE2' ' HA2' ' A' ' 52' ' ' GLY . 3.0 mm-40 -72.97 -5.35 38.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.356 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -131.75 13.99 5.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 106' ' ' LEU . 1.7 mt -101.46 57.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.465 -1.02 . . . . 0.0 109.284 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 106' ' ' LEU . 3.9 mt-10 -42.42 139.53 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.698 -0.626 . . . . 0.0 109.627 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -67.22 -169.76 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.27 46.99 25.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 109.437 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.01 61.43 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 64.41 -179.41 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.588 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.512 ' O ' ' CG ' ' A' ' 112' ' ' HIS . 42.3 t-80 -125.93 3.32 7.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.289 -0.882 . . . . 0.0 109.607 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.435 ' N ' ' ND1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.504 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' O ' ' CG ' ' A' ' 2' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.575 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 167.33 -61.34 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.689 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 55.1 Cg_endo -72.06 -160.04 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.833 1.689 . . . . 0.0 110.537 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 5' ' ' ARG . 2.2 mtpt -93.57 92.13 7.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.316 -0.865 . . . . 0.0 109.251 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.797 ' HG2' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER 83.75 126.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.312 0.577 . . . . 0.0 109.445 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 6' ' ' ILE . 31.3 mt -63.83 -53.95 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 -179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.559 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -113.7 147.22 38.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 109.858 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 1.004 ' HB3' HG12 ' A' ' 27' ' ' VAL . 1.1 pm0 -163.93 126.05 2.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.794 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.587 ' O ' ' CE3' ' A' ' 25' ' ' TRP . . . -160.08 -145.08 4.16 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 1.9 p90 -134.89 92.32 2.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 109.954 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.098 HD23 ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -106.96 162.78 13.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.149 -0.969 . . . . 0.0 109.419 179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 82' ' ' GLN . 2.3 p -98.92 130.38 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HE2' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -112.47 135.11 53.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.322 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.561 ' HE3' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 tttt -64.46 96.49 0.17 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 0.0 109.262 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LYS . . . -43.61 166.47 0.02 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 t -84.52 -4.45 58.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.541 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 18' ' ' PHE . 2.3 p -93.37 114.55 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' VAL . 21.9 m-85 52.34 174.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.486 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -87.21 86.39 7.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.252 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 21' ' ' TRP . 61.3 p -120.58 -177.14 3.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.954 . . . . 0.0 109.757 -179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.642 ' CZ3' ' CG ' ' A' ' 82' ' ' GLN . 44.0 m95 -154.52 106.2 2.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.035 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.934 ' C ' HG23 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -125.3 133.25 24.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.133 -0.979 . . . . 0.0 109.989 -179.55 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 52.2 Cg_exo -53.55 166.14 1.38 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 C-N-CA 121.972 1.781 . . . . 0.0 110.323 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.77 ' SD ' ' O ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -174.92 169.68 3.39 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.77 ' O ' ' SD ' ' A' ' 24' ' ' MET . 67.1 t-105 -91.37 145.31 24.74 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG22 ' CH2' ' A' ' 92' ' ' TRP . 0.4 OUTLIER -150.34 132.43 5.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.329 -178.324 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.004 HG12 ' HB3' ' A' ' 8' ' ' GLU . 7.5 m -127.79 102.95 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.457 -0.777 . . . . 0.0 109.513 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.901 ' HB2' HD12 ' A' ' 33' ' ' ILE . 2.5 pp -79.4 125.8 30.0 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.269 179.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.797 HD21 ' HG2' ' A' ' 5' ' ' ARG . 2.2 mp -112.74 163.66 14.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.428 -0.795 . . . . 0.0 109.114 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.726 ' HA ' ' HB1' ' A' ' 99' ' ' ALA . 7.6 pt-20 -73.84 -6.27 46.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.806 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.28 -0.1 13.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 109.296 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 29' ' ' LEU . . . 156.14 148.04 4.93 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.901 HD12 ' HB2' ' A' ' 28' ' ' LEU . 4.0 mm -98.93 108.16 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -1.139 . . . . 0.0 109.313 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.572 ' HG2' HD11 ' A' ' 29' ' ' LEU . 10.7 pt-20 -111.1 112.54 24.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.018 -1.051 . . . . 0.0 109.185 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.688 ' HB2' ' SD ' ' A' ' 24' ' ' MET . 2.9 p90 -115.13 142.6 46.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.192 -0.943 . . . . 0.0 110.053 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.611 ' CD1' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -126.67 -149.38 0.41 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 108.613 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -99.91 -54.64 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 108.586 179.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 25' ' ' TRP . 0.2 OUTLIER -93.15 -171.28 2.63 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.661 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 8.1 mtpt -63.85 -9.89 17.45 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.657 -1.277 . . . . 0.0 109.704 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.558 ' O ' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -152.65 -51.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.272 -0.893 . . . . 0.0 109.359 178.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.55 ' O ' ' N ' ' A' ' 43' ' ' SER . 6.6 t0 57.46 11.0 1.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.481 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 38.67 24.09 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.398 -0.814 . . . . 0.0 110.557 -179.913 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 41' ' ' ASP . 2.7 t -176.68 95.57 0.24 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.831 -1.168 . . . . 0.0 110.029 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.611 ' HA ' ' CD1' ' A' ' 36' ' ' TYR . 52.8 Cg_exo -53.9 153.77 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.169 1.913 . . . . 0.0 111.524 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 1.4 tttt -101.55 -21.7 14.67 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 35' ' ' PHE . . . -175.42 141.07 5.53 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 5.5 mtm -139.83 132.11 28.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.056 -1.261 . . . . 0.0 109.841 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.761 HG23 HG22 ' A' ' 73' ' ' THR . 19.7 mt -89.07 129.15 49.15 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.8 . . . . 0.0 108.905 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.84 131.75 23.28 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.774 1.649 . . . . 0.0 110.447 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.881 HD23 HG13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -89.22 30.66 0.95 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.403 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.34 -36.15 15.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.415 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 74' ' ' THR . . . -177.51 84.59 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.12 -177.68 3.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -1.158 . . . . 0.0 109.675 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -135.43 114.51 12.22 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.405 -0.809 . . . . 0.0 109.696 -179.193 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.848 HD13 ' N ' ' A' ' 56' ' ' THR . 3.3 tm? -88.58 131.88 34.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.216 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.848 ' N ' HD13 ' A' ' 55' ' ' LEU . 23.9 m -124.06 121.37 35.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.94 . . . . 0.0 109.512 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.404 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 35.6 m -148.46 137.06 11.67 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.071 -1.018 . . . . 0.0 109.745 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 57' ' ' SER . 60.7 Cg_endo -78.05 177.89 37.05 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.391 -1.92 . . . . 0.0 110.438 -0.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.779 ' SG ' ' HD3' ' A' ' 70' ' ' LYS . 1.9 t -150.14 -149.53 0.31 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.907 ' HB2' HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER 63.17 115.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.413 -0.804 . . . . 0.0 109.859 179.651 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.38 7.14 28.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.015 179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CZ ' ' HE3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -89.49 -42.7 11.32 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.66 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 65' ' ' ARG . . . -118.16 -17.92 5.2 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 36.66 31.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.839 -0.801 . . . . 0.0 109.582 -179.802 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 22.54 5.77 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.525 -0.735 . . . . 0.0 109.639 -179.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.563 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 0.6 OUTLIER 55.81 -179.43 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.162 -0.961 . . . . 0.0 108.956 -179.545 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 67' ' ' PHE . 1.1 m-30 83.26 -20.18 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.55 -0.719 . . . . 0.0 109.732 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 60' ' ' GLN . 0.1 OUTLIER -102.22 135.45 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.388 179.385 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.771 ' CE1' HD12 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -110.91 152.32 26.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.958 . . . . 0.0 109.985 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.779 ' HD3' ' SG ' ' A' ' 59' ' ' CYS . 1.7 tttp -124.41 103.89 8.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.525 -0.734 . . . . 0.0 109.314 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.771 HD12 ' CE1' ' A' ' 69' ' ' PHE . 12.7 mt -90.87 167.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.198 -0.939 . . . . 0.0 109.256 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 72' ' ' THR . 3.9 m -145.64 84.11 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 48' ' ' ILE . 4.5 p -42.96 165.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.443 -0.786 . . . . 0.0 109.594 -179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -62.68 -16.8 58.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.472 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.42 19.71 5.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.26 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.17 34.66 16.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.765 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 73' ' ' THR . 0.0 OUTLIER -97.82 94.52 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 0.0 109.13 179.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 66.2 m-20 -62.8 155.73 25.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.161 -0.962 . . . . 0.0 109.748 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 51.3 m-70 -139.38 124.07 18.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.385 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.613 ' HB3' ' CH2' ' A' ' 21' ' ' TRP . 71.1 m-85 -93.01 124.36 36.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.436 -0.79 . . . . 0.0 109.866 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 1.098 ' CE2' HD23 ' A' ' 11' ' ' LEU . 0.5 OUTLIER -122.8 141.78 51.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.337 -0.852 . . . . 0.0 110.017 -179.53 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.959 ' HB2' HG13 ' A' ' 12' ' ' VAL . 1.4 mm100 -135.51 108.74 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 109.322 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.37 -145.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.505 ' C ' ' CG ' ' A' ' 85' ' ' PHE . . . -132.75 1.53 3.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.074 -1.016 . . . . 0.0 109.849 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -172.28 154.15 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.129 -0.982 . . . . 0.0 109.375 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.061 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -65.14 -22.18 66.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.426 -179.821 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 1.061 ' N ' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -66.16 -68.35 0.38 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.256 -0.902 . . . . 0.0 109.091 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 3.0 tt0 -60.28 -21.95 62.55 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.332 -0.855 . . . . 0.0 108.792 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.0 -65.2 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.325 -0.859 . . . . 0.0 109.263 179.592 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.569 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -57.06 -34.25 68.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.807 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.78 -33.43 75.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.144 -0.972 . . . . 0.0 109.116 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.976 ' NE1' HD21 ' A' ' 11' ' ' LEU . 13.2 m95 -74.83 -56.29 4.92 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.341 -0.849 . . . . 0.0 108.795 179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.791 HG12 HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -64.48 -11.07 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.607 -0.683 . . . . 0.0 109.252 179.555 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 90' ' ' ASP . 19.4 mmt180 -84.42 -39.74 18.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.694 ' HB3' HD21 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -87.28 -21.33 25.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.939 -179.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.684 ' CG1' HD22 ' A' ' 28' ' ' LEU . 6.2 mt -87.42 -38.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 109.095 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 2.0 t-20 -80.17 -33.34 38.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 108.874 179.392 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -72.5 -45.06 61.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.331 -0.856 . . . . 0.0 109.078 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 30' ' ' GLU . . . -64.95 -41.69 95.26 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.206 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.678 HD12 ' O ' ' A' ' 96' ' ' ILE . 33.6 mt -66.64 -32.79 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.111 179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -81.92 -11.83 58.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.431 179.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.16 -24.34 16.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -0.816 . . . . 0.0 108.954 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.881 HG13 HD23 ' A' ' 50' ' ' LEU . 9.1 mm -69.05 -23.75 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.457 -0.777 . . . . 0.0 109.213 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -77.7 -1.78 32.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.407 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.54 19.55 1.02 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.78 53.77 2.89 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.554 -0.968 . . . . 0.0 109.113 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.01 128.81 36.35 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.704 -0.623 . . . . 0.0 109.437 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 34.9 t60 -75.57 135.37 40.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 109.486 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 108' ' ' HIS . 0.5 OUTLIER 176.12 128.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 109.454 -179.958 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -110.98 158.39 18.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.63 10.19 2.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.474 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -41.07 56.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.504 -179.958 . . . . . . . . 1 1 . 1 stop_ save_